0000950123-12-001407.txt : 20120126 0000950123-12-001407.hdr.sgml : 20120126 20120126165058 ACCESSION NUMBER: 0000950123-12-001407 CONFORMED SUBMISSION TYPE: N-Q PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20111130 FILED AS OF DATE: 20120126 DATE AS OF CHANGE: 20120126 EFFECTIVENESS DATE: 20120126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GMO TRUST CENTRAL INDEX KEY: 0000772129 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: N-Q SEC ACT: 1940 Act SEC FILE NUMBER: 811-04347 FILM NUMBER: 12548260 BUSINESS ADDRESS: STREET 1: 40 ROWES WHARF CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 6173467646 MAIL ADDRESS: STREET 1: 40 ROWES WHARF CITY: BOSTON STATE: MA ZIP: 02110 FORMER COMPANY: FORMER CONFORMED NAME: GMO CORE TRUST DATE OF NAME CHANGE: 19900927 0000772129 S000004081 GMO U.S. Core Equity Fund C000011423 Class III GMUEX C000011424 Class IV GMRTX C000011426 Class VI GMCQX C000011427 Class M GMTMX 0000772129 S000004083 GMO Tobacco-Free Core Fund C000011431 Class III GMTCX 0000772129 S000004084 GMO Quality Fund C000011437 Class III GQETX C000011438 Class IV GQEFX C000011439 Class V GQLFX C000011440 Class VI GQLOX 0000772129 S000004135 GMO U.S. Intrinsic Value Fund C000011589 Class III GMVUX 0000772129 S000004138 GMO U.S. Growth Fund C000011603 Class III GMGWX C000011607 Class M GMWMX 0000772129 S000004141 GMO U.S. Small/Mid Cap Value Fund C000011619 Class III GMSUX 0000772129 S000004144 GMO U.S. Small/Mid Cap Growth Fund C000011635 Class III GMSPX 0000772129 S000004146 GMO Real Estate Fund C000011645 Class III GMORX 0000772129 S000004157 GMO International Core Equity Fund C000011701 Class III GMIEX C000011702 Class IV GMIRX C000011704 Class VI GCEFX 0000772129 S000004218 GMO International Growth Equity Fund C000011867 Class III GMIGX C000011868 Class IV GMGFX 0000772129 S000004224 GMO International Intrinsic Value Fund C000011880 Class II GMICX C000011881 Class III GMOIX C000011882 Class IV GMCFX C000011885 Class M GMVMX 0000772129 S000004227 GMO Developed World Stock Fund C000011892 Class III GDWTX C000011893 Class IV GDWFX 0000772129 S000004228 GMO Currency Hedged International Equity Fund C000011898 Class III GMOCX 0000772129 S000004229 GMO Foreign Fund C000011904 Class II GMFRX C000011905 Class III GMOFX C000011906 Class IV GMFFX C000011909 Class M GMFMX 0000772129 S000004230 GMO Foreign Small Companies Fund C000011910 Class III GMFSX C000011911 Class IV GFSFX 0000772129 S000004231 GMO International Small Companies Fund C000011914 Class III GMISX 0000772129 S000004911 GMO Emerging Markets Fund C000013268 Class II GMEMX C000013269 Class III GMOEX C000013270 Class IV GMEFX C000013271 Class V GEMVX C000013272 Class VI GEMMX 0000772129 S000004912 GMO Emerging Countries Fund C000013275 Class III GMCEX C000013279 Class M GECMX 0000772129 S000004913 GMO Tax-Managed International Equities Fund C000013282 Class III GTMIX 0000772129 S000004914 GMO Domestic Bond Fund C000013286 Class III GMDBX C000013289 Class VI GDBSX 0000772129 S000004917 GMO Core Plus Bond Fund C000013294 Class III GUGAX C000013295 Class IV GPBFX 0000772129 S000004918 GMO International Bond Fund C000013302 Class III GMIBX 0000772129 S000004919 GMO Currency Hedged International Bond Fund C000013310 Class III GMHBX 0000772129 S000004920 GMO Global Bond Fund C000013318 Class III GMGBX 0000772129 S000004922 GMO Emerging Country Debt Fund C000013327 Class III GMCDX C000013328 Class IV GMDFX 0000772129 S000004924 GMO Short-Duration Investment Fund C000013332 Class III GMSIX 0000772129 S000004926 GMO Alpha Only Fund C000013338 Class III GGHEX C000013339 Class IV GAPOX 0000772129 S000005485 GMO Benchmark-Free Allocation Fund C000014927 Class III GBMFX 0000772129 S000005486 GMO International Equity Allocation Fund C000014930 Class III GIEAX 0000772129 S000005487 GMO Global Balanced Asset Allocation Fund C000014933 Class III GMWAX 0000772129 S000005488 GMO Global Equity Allocation Fund C000014936 Class III GMGEX 0000772129 S000005489 GMO Strategic Opportunities Allocation Fund C000014937 Class III GBATX 0000772129 S000005490 GMO World Opportunities Equity Allocation Fund C000014938 Class III GWOAX 0000772129 S000005491 GMO U.S. Equity Allocation Fund C000014941 Class III GUSAX 0000772129 S000005494 GMO Alternative Asset Opportunity Fund C000014953 Class III 0000772129 S000005495 GMO Taiwan Fund C000014957 Class III GMOTX 0000772129 S000007515 GMO World Opportunity Overlay Fund C000020547 GMO World Opportunity Overlay Fund 0000772129 S000007516 GMO Short-Duration Collateral Fund C000020548 GMO Short-Duration Collateral Fund GMOSX 0000772129 S000007517 GMO Special Purpose Holding Fund C000020549 GMO Special Purpose Holding Fund 0000772129 S000007518 GMO Short-Duration Collateral Share Fund C000020550 Class III GMDCX 0000772129 S000011778 GMO Inflation Indexed Plus Bond Fund C000032211 Class III GMITX C000032214 Class VI GMIPX 0000772129 S000012210 GMO Strategic Fixed Income Fund C000033338 III GFITX C000033341 VI GMFIX 0000772129 S000012211 GMO International Opportunities Equity Allocation Fund C000033342 III GIOTX 0000772129 S000019254 GMO Special Situations Fund C000053096 Class III C000053097 Class VI 0000772129 S000023608 GMO Flexible Equities Fund C000069468 Class III GFEFX C000069469 Class VI GFFEX 0000772129 S000025186 GMO U.S. Treasury Fund C000075084 GMO U.S. Treasury Fund GUSTX 0000772129 S000025199 GMO Asset Allocation Bond Fund C000075099 Class III GMOBX C000075103 Class VI GABFX 0000772129 S000027944 GMO Debt Opportunities Fund C000084919 Class VI 0000772129 S000029579 GMO Emerging Domestic Opportunities Fund C000090805 Class II GEDTX C000090808 Class V GEDOX 0000772129 S000033464 GMO Benchmark-Free Fund C000102896 Class III N-Q 1 b89666a1nvq.htm GMO TRUST nvq
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-Q
QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED
MANAGEMENT INVESTMENT COMPANY
Investment Company Act file number    811-04347
GMO Trust
 
(Exact name of registrant as specified in charter)
     
40 Rowes Wharf, Boston, MA   02110
     
(Address of principal executive offices)   (Zip code)
J.B. Kittredge, Chief Executive Officer, 40 Rowes Wharf, Boston, MA 02110
 
(Name and address of agent for service)
Registrant’s telephone number, including area code:    617-346-7646
Date of fiscal year end:   02/29/12
Date of reporting period:   11/30/11
 
 

 


 

Item 1. Schedule of Investments.
    The Schedules of Investments for each series of the registrant for the periods ended November 30, 2011 are filed herewith.

 


 

GMO Alpha Only Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares     Description   Value ($)  
 
       
MUTUAL FUNDS — 88.8%
       
       
 
       
       
United States — 88.8%
       
       
Affiliated Issuers
       
  17,261,193    
GMO International Growth Equity Fund, Class IV
    369,389,527  
  28,378,805    
GMO International Intrinsic Value Fund, Class IV
    553,386,700  
  27,582,893    
GMO Quality Fund, Class VI
    602,410,392  
  25,722,604    
GMO U.S. Core Equity Fund, Class VI
    312,272,417  
  1,199,545    
GMO U.S. Treasury Fund
    30,000,626  
       
 
     
       
TOTAL UNITED STATES
    1,867,459,662  
       
 
     
       
TOTAL MUTUAL FUNDS (COST $1,855,551,315)
    1,867,459,662  
       
 
     
       
 
       
       
INVESTMENT FUNDS — 2.2%
       
       
 
       
       
United States — 2.2%
       
  1,107,841    
Vanguard Emerging Markets ETF (a)
    45,199,913  
       
 
     
       
TOTAL INVESTMENT FUNDS (COST $48,528,455)
    45,199,913  
       
 
     
                 
Par Value     Description   Value ($)  
 
       
SHORT-TERM INVESTMENTS — 2.2%
       
       
 
       
       
Time Deposits — 2.2%
       
USD 15,000,000    
Bank of Tokyo-Mitsubishi (Tokyo) Time Deposit, 0.03%, due 12/01/11
    15,000,000  
USD   1,968,707    
Lloyds Bank (London) Time Deposit, 0.03%, due 12/01/11
    1,968,707  
USD 15,000,000    
Royal Bank of Scotland (London) Time Deposit, 0.03%, due 12/01/11
    15,000,000  
USD 15,000,000    
Skandinaviska Enskilda Banken, AB (Stockholm) Time Deposit, 0.03%, due 12/01/11
    15,000,000  
       
 
     
       
Total Time Deposits
    46,968,707  
       
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $46,968,707)
    46,968,707  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 93.2%
(Cost $1,951,048,477)
    1,959,628,282  
       
Other Assets and Liabilities (net) — 6.8%
    143,336,288  
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 2,102,964,570  
       
 
     

 


 

A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
                                         
                                    Net Unrealized  
Settlement                                 Appreciation  
Date     Counterparty   Deliver/Receive     Units of Currency     Value     (Depreciation)  
Sales #  
 
                               
  12/16/11    
Bank of America, N.A.
  AUD     4,912,247     $ 5,043,023     $ (59,067 )
  12/16/11    
Deutsche Bank AG
  AUD     5,488,718       5,634,841       (87,366 )
  12/16/11    
Morgan Stanley Capital Services Inc.
  AUD     4,586,569       4,708,674       (207,645 )
  12/16/11    
Royal Bank of Scotland PLC
  AUD     3,303,403       3,391,347       (67,097 )
  12/16/11    
State Street Bank and Trust Company
  AUD     5,209,374       5,348,060       (77,997 )
  12/16/11    
Bank of America, N.A.
  CHF     5,980,971       6,548,841       91,149  
  12/16/11    
Bank of New York Mellon
  CHF     6,597,275       7,223,660       84,963  
  12/16/11    
Barclays Bank PLC
  CHF     4,507,208       4,935,150       59,263  
  12/16/11    
Deutsche Bank AG
  CHF     3,128,070       3,425,068       (4,113 )
  12/16/11    
Bank of America N.A.
  DKK     6,607,373       1,194,146       13,076  
  12/16/11    
Barclays Bank PLC
  DKK     4,173,855       754,338       11,915  
  12/16/11    
Morgan Stanley Capital Services Inc.
  DKK     4,521,490       817,166       14,000  
  12/16/11    
Bank of New York Mellon
  EUR     6,305,930       8,474,152       135,032  
  12/16/11    
Brown Brothers Harriman & Co.
  EUR     11,709,295       15,735,402       274,483  
  12/16/11    
Deutsche Bank AG
  EUR     7,605,198       10,220,158       53,270  
  12/16/11    
Morgan Stanley Capital Services Inc.
  EUR     9,855,026       13,243,564       234,436  
  12/16/11    
Royal Bank of Scotland PLC
  EUR     9,367,977       12,589,049       208,432  
  12/16/11    
State Street Bank and Trust Company
  EUR     8,425,608       11,322,657       208,462  
  12/16/11    
Bank of America, N.A.
  GBP     3,968,901       6,225,942       (13,901 )
  12/16/11    
Bank of New York Mellon
  GBP     5,360,946       8,409,617       (17,485 )
  12/16/11    
Brown Brothers Harriman & Co.
  GBP     5,595,736       8,777,928       (12,319 )
  12/16/11    
Deutsche Bank AG
  GBP     3,591,294       5,633,597       9,044  
  12/16/11    
JPMorgan Chase Bank, N.A.
  GBP     4,124,354       6,469,798       7,912  
  12/16/11    
Morgan Stanley Capital Services Inc.
  GBP     6,857,488       10,757,215       (19,130 )
  12/16/11    
State Street Bank and Trust Company
  GBP     8,261,631       12,959,868       (48,285 )
  12/16/11    
Bank of New York Mellon
  HKD     26,486,794       3,409,612       (6,277 )
  12/16/11    
Brown Brothers Harriman & Co.
  HKD     16,069,259       2,068,576       (912 )
  12/16/11    
JPMorgan Chase Bank, N.A.
  HKD     14,772,798       1,901,684       (1,395 )

 


 

                                         
  12/16/11    
Bank of America, N.A.
  JPY     1,149,714,290       14,828,510       129,120  
  12/16/11    
Barclays Bank PLC
  JPY     775,784,777       10,005,731       112,497  
  12/16/11    
JPMorgan Chase Bank, N.A.
  JPY     909,118,951       11,725,417       127,194  
  12/16/11    
Royal Bank of Scotland PLC
  JPY     538,195,012       6,941,403       76,744  
  12/16/11    
State Street Bank and Trust Company
  JPY     1,035,083,157       13,350,048       142,882  
  12/16/11    
Barclays Bank PLC
  NOK     5,296,702       916,417       17,186  
  12/16/11    
Morgan Stanley Capital Services Inc.
  NOK     8,950,217       1,548,535       18,803  
  12/16/11    
Brown Brothers Harriman & Co.
  NZD     378,476       295,239       3,541  
  12/16/11    
Bank of America, N.A.
  SEK     12,430,758       1,835,577       (3,844 )
  12/16/11    
Bank of New York Mellon
  SEK     6,878,269       1,015,674       9,841  
  12/16/11    
JPMorgan Chase Bank, N.A.
  SEK     9,883,287       1,459,407       11,141  
  12/16/11    
Morgan Stanley Capital Services Inc.
  SEK     10,411,349       1,537,383       16,926  
  12/16/11    
State Street Bank and Trust Company
  SEK     11,613,817       1,714,945       20,067  
  12/16/11    
Bank of New York Mellon
  SGD     2,199,618       1,716,266       8,467  
  12/16/11    
Deutsche Bank AG
  SGD     3,659,591       2,855,419       (389 )
       
 
                           
       
 
                  $ 258,969,104     $ 1,472,624  
       
 
                           
 
  Fund buys foreign currency; sells USD.
 
#   Fund sells foreign currency; buys USD.
Futures Contracts
                             
                      Net Unrealized  
Number of         Expiration           Appreciation
Contracts     Type   Date   Value     (Depreciation)  
Sales  
 
                   
  54    
Amesterdam IDX
  December 2011   $ 4,373,724     $ (120,269 )
  386    
CAC 40
  December 2011     16,398,769       (581,983 )
  73    
DAX
  December 2011     14,995,837       (2,121,298 )
  484    
FTSE 100
  December 2011     41,888,502       (2,406,163 )
  41    
FTSE/MIB
  December 2011     4,220,950       (521,542 )
  39    
Hang Seng
  December 2011     4,691,594       (132,598 )
  52    
IBEX 35
  December 2011     5,910,565       (98,485 )
  62    
MSCI Singapore
  December 2011     3,037,050       (88,101 )
  387    
OMXS 30
  December 2011     5,658,010       (176,456 )
  4,280    
Russell 2000 Mini
  December 2011     315,307,600       (22,433,779 )
  394    
S&P 400 E-Mini Index
  December 2011     34,794,140       (1,818,408 )
  10,228    
S&P 500 E-Mini Index
  December 2011     637,204,400       (30,119,961 )
  150    
SPI 200
  December 2011     16,384,340       (628,262 )
  414    
TOPIX
  December 2011     39,768,874       (149,116 )
                         
       
 
      $ 1,144,634,355     $ (61,396,421 )
                         

 


 

Swap Agreements
Total Return Swaps
                                 
                            Net Unrealized  
Notional     Expiration                 Appreciation/  
Amount     Date     Counterparty   Fund Pays   Fund Receives   (Depreciation)  
  48,194,814       1/27/2012     BNP Paribas  
MSCI Daily Total Return EAFE
  12 month USD LIBOR BBA minus 0.54%   $ 6,294,299  
  40,768,636       2/7/2012     Citibank N.A.  
MSCI Daily Total Return EAFE
  12 month USD LIBOR BBA minus 0.50%     5,756,481  
  71,790,697       3/12/2012     JP Morgan Chase Bank, N.A.  
MSCI Daily Total Return EAFE
  12 month USD LIBOR BBA minus 0.59%     10,527,493  
  34,844,229       3/15/2012     Morgan Stanley Capital Services Inc.  
MSCI Daily Total Return EAFE
  12 month USD LIBOR BBA minus 0.55%     3,779,440  
  67,674,918       3/21/2012     BNP Paribas  
MSCI Daily Total Return EAFE
  12 month USD LIBOR BBA minus 0.60%     5,680,516  
  41,682,173       4/3/2012     Deutsche Bank AG  
MSCI Daily Total Return EAFE
  12 month USD LIBOR BBA minus 0.65%     5,569,041  
  199,997,901       5/9/2012     JP Morgan Chase Bank, N.A.  
MSCI Daily Total Return EAFE
  12 month USD LIBOR BBA minus 0.60%     33,007,220  
  124,881,524       5/11/2012     BNP Paribas  
MSCI Daily Total Return EAFE
  12 month USD LIBOR BBA minus 0.61%     20,335,993  
  58,999,209       6/12/2012     Citibank N.A.  
MSCI Daily Total Return EAFE
  12 month USD LIBOR BBA minus 0.56%     7,257,536  
  55,599,968       7/19/2012     Citibank N.A.  
MSCI Daily Total Return EAFE
  12 month USD LIBOR BBA minus 0.52%     6,635,588  
  42,003,150       8/7/2012     CitiBank N.A.  
MSCI Daily Total Return EAFE
  12 month USD LIBOR BBA minus 0.54%     2,498,868  
                   
 
         
                   
 
      $ 107,342,475  
                   
 
  Premiums to (Pay) Receive   $  
                   
 
         
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
Notes to Schedule of Investments:
BBA — British Banks Association
ETF — Exchange-Traded Fund
MSCI — Morgan Stanley Capital International
USD LIBOR — London Interbank Offered Rate denominated in United States Dollars
(a)   Represents an investment to obtain exposure in emerging markets. The Vanguard Emerging Markets ETF is a separate investment portfolio of Vanguard, Inc., a registered investment company. The Vanguard Emerging Markets ETF prospectus states that the fund invests substantially all (normally about 95%) of its assets in the common stocks included in the MSCI Emerging Market Index, while employing a form of sampling to reduce risk.

 


 

Currency Abbreviations:
AUD — Australian Dollar
CHF — Swiss Franc
DKK — Danish Krone
EUR — Euro
GBP — British Pound
HKD — Hong Kong Dollar
JPY — Japanese Yen
NOK — Norwegian Krone
NZD — New Zealand Dollar
SEK — Swedish Krona
SGD — Singapore Dollar
USD — United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
             
    Gross   Gross   Net Unrealized
    Unrealized   Unrealized   Appreciation
Aggregate Cost   Appreciation   (Depreciation)   (Depreciation)
$2,115,549,146   $—   $(155,920,864)   $(155,920,864)
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO International Growth Equity Fund, Class IV
  $ 442,255,674     $ 266,853,504     $ 274,344,115     $ 3,824,404     $     $ 369,389,527  
GMO International Intrinsic Value Fund, Class IV
    442,388,249       388,351,490       182,323,378       10,650,746             553,386,700  
GMO Quality Fund, Class VI
    580,359,319       349,740,323       346,412,842       10,856,623             602,410,392  
GMO U.S. Core Equity Fund, Class VI
    300,019,377       175,514,348       160,978,985       5,280,748             312,272,417  
GMO U.S. Treasury Fund
    95,036,569       1,256,123,669       1,321,213,634       38,052       5,618       30,000,626  
 
                                   
Totals
  $ 1,860,059,188     $ 2,436,583,334     $ 2,285,272,954     $ 30,650,573     $ 5,618     $ 1,867,459,662  
 
                                   

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Shares of the funds in which the Fund invests (“underlying funds”) and other investment funds are generally valued at their net asset value. Investments held by the underlying funds are valued as follows: Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly and indirectly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented less than 0.1% of net assets. The Fund and the underlying funds classify such securities (levels defined below) as Level 3. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivatives contracts based on the creditworthiness of its counterparties. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund, either directly or through investments in the underlying funds, that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below and as described in the disclosures of the underlying funds.
     
Security Type   Percentage of Net Assets of the Fund
Equity Securities
  44.2%
Futures Contracts
  (0.2)%
Swap Agreements
  5.1%
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:

 


 

Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include: fair value adjustments provided by an independent pricing service applied to equity securities (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) due to market events that have occurred since the local market close but prior to the close of the NYSE.
Level 3 — Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Mutual Funds
                               
United States
  $ 1,867,459,662     $     $     $ 1,867,459,662  
 
                       
TOTAL MUTUAL FUNDS
    1,867,459,662                   1,867,459,662  
 
                       
Investment Funds
                               
United States
    45,199,913                   45,199,913  
 
                       
TOTAL INVESTMENT FUNDS
    45,199,913                   45,199,913  
 
                       
Short-Term Investments
    46,968,707                   46,968,707  
 
                       
Total Investments
    1,959,628,282                   1,959,628,282  
 
                       
Derivatives *
                               
Forward Currency Contracts
                               
Foreign Currency risk
          2,099,846             2,099,846  
Swap Agreements
                               
Equity risk
          107,342,475             107,342,475  
 
                       
Total Derivatives
          109,442,321             109,442,321  
 
                       
Total
  $ 1,959,628,282     $ 109,442,321     $     $ 2,069,070,603  
 
                       
LIABILITY VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Liabilities     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Derivatives *
                               
Forward Currency Contracts
                               
Foreign Currency risk
  $     $ (627,222 )   $     $ (627,222 )
Futures Contracts
                               
Equity risk
    (54,372,148 )     (7,024,273 )           (61,396,421 )
 
                       
Total Derivatives
    (54,372,148 )     (7,651,495 )           (62,023,643 )
 
                       
Total
  $ (54,372,148 )   $ (7,651,495 )   $     $ (62,023,643 )
 
                       

 


 

The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
* Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net values of the Fund’s indirect investments in securities using Level 3 inputs were less than 0.1% of total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011 whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. References to investments include those held directly by the Fund and indirectly through the Fund’s investments in the underlying funds. The Fund and some of the underlying funds are non-diversified investment companies under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund or an underlying fund may affect the Fund’s or the underlying fund’s performance more than if the Fund or the underlying fund were diversified. Selected risks of investing in the Fund are summarized below, including those risks to which the Fund is exposed as a result of its investments in the underlying funds. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If the Fund or an underlying fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of the

 


 

value of those investments. The Fund or an underlying fund also may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. In addition, the value of the Fund’s shares will be adversely affected if the equity investments that are the subject of the Fund’s short positions appreciate in value.
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent a Fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in the underlying funds, including the risk that the underlying funds in which it invests will not perform as expected or that the Fund will invest in underlying funds with higher fees or expenses.
Market Risk — Fixed Income Securities — Typically, the market value of fixed income securities will decline during periods of rising interest rates and widening credit spreads.
Market Risk — Asset-Backed Securities — Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
Leveraging Risk — The use of reverse repurchase agreements and other derivatives may cause the Fund’s portfolio to be leveraged. The Fund and some underlying funds are not limited in the extent to which they may use derivatives or in the absolute face value of their derivative positions. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of foreign currency holdings and investments denominated in foreign currencies, or that the U.S. dollar will decline in value relative to the foreign currency being hedged.
Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Real Estate Risk — To the extent an underlying fund concentrates its assets in real estate-related investments, the value of its portfolio is subject to factors affecting the real estate industry and may fluctuate more than the value of a portfolio that consists of securities of companies in a broader range of industries.
Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
Short Sales Risk — The Fund runs the risk that the Fund’s loss on a short sale of securities that the Fund does not own is unlimited.
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies or in industries with high positive correlations to one another creates additional risk.

 


 

Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds, or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. For example, the Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives, to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives. The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For example, if the Fund holds a large proportion of stocks of companies in a particular sector and the Manager believes that stocks of companies in another sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index). In adjusting its investment exposure, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net long exposures in excess of its net assets. The Fund is not limited in the extent to which it uses derivatives or in the absolute face value of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate exposure of its assets, and its net long exposure may exceed 100% of its net assets. The Fund’s foreign currency exposure may differ significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.

 


 

Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk that it will be required to pay the full notional value of the swap contract in the event of a default.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most forward currency contracts are not collateralized. During the period ended November 30, 2011, the Fund used forward currency contracts to hedge some or all of the currency exposure of the underlying Funds and assets in which the Fund invests, adjust against anticipated currency exchange rate changes and adjust exposure to foreign currencies. Forward currency contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded (unless otherwise adjusted due to the time at which foreign markets close). The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until

 


 

the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. Because regular trading on many foreign exchanges closes prior to the close of the NYSE, closing prices for these foreign futures contracts (including foreign index futures) do not reflect the events that occur after that close but before the close of the NYSE. As a result, the Fund and the underlying funds generally value foreign futures contracts using fair value prices, which are based on local closing prices adjusted by a factor, supplied by a third party vendor using that vendor’s proprietary models. During the period ended November 30, 2011, the Fund used futures contracts to hedge some or all of the broad market exposure of the underlying Funds and assets in which the Fund invests. Futures contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on

 


 

notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers (unless otherwise adjusted due to the time at which foreign markets close) and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. During the period ended November 30, 2011, the Fund used swap agreements to hedge some or all of the broad market exposure of the underlying Funds and assets in which the Fund invests. Swap agreements outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.

 


 

The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Assets:
                                               
Unrealized appreciation on forward currency contracts
  $     $ 2,099,846     $     $     $     $ 2,099,846  
Unrealized appreciation on swap agreements
                      107,342,475             107,342,475  
 
                                   
Total
  $     $ 2,099,846     $     $ 107,342,475     $     $ 109,442,321  
 
                                   
 
                                               
Liabilities:
                                               
Unrealized depreciation on forward currency contracts
  $     $ (627,222 )   $     $     $     $ (627,222 )
Unrealized depreciation on futures contracts*
                      (61,396,421 )           (61,396,421 )
 
                                   
Total
  $     $ (627,222 )   $     $ (61,396,421 )   $     $ (62,023,643 )
 
                                   
 
*   The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of futures contracts as reported in the Schedule of Investments.
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts and futures contracts) or notional amounts (swap agreements) outstanding at each month-end, was as follows for the period ended November 30, 2011:
                         
    Forward              
    Currency     Futures     Swap  
    Contracts     Contracts     Agreements  
Average amount outstanding
  $ 366,342,801     $ 1,277,077,198     $ 745,131,487  

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Alternative Asset Opportunity Fund
(A Series of GMO Trust)
Consolidated Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Par Value ($) /            
Shares     Description   Value ($)  
 
       
DEBT OBLIGATIONS — 18.8%
       
       
 
       
       
U.S. Government — 18.8%
       
  8,050,032    
U.S. Treasury Inflation Indexed Note, 2.00%, due 04/15/12(a)(b)(c)
    8,077,072  
       
 
     
       
TOTAL DEBT OBLIGATIONS (COST $8,145,406)
    8,077,072  
       
 
     
       
 
       
       
MUTUAL FUNDS — 45.5%
       
       
 
       
       
Affiliated Issuers — 45.5%
       
  791,020    
GMO Short-Duration Collateral Fund
    5,228,644  
  573,668    
GMO U.S. Treasury Fund
    14,347,435  
       
 
     
       
Total Affiliated Issuers
    19,576,079  
       
 
     
       
TOTAL MUTUAL FUNDS (COST $20,778,576)
    19,576,079  
       
 
     
       
 
       
       
SHORT-TERM INVESTMENTS — 36.0%
       
       
 
       
       
Money Market Funds — 1.2%
       
  331,329    
SSgA USD Liquidity Fund-Class S2 Shares, 0.00%(a)(d)(e)
    331,329  
  185,678    
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00%(e)
    185,678  
       
 
     
       
Total Money Market Funds
    517,007  
       
 
     
       
 
       
       
U.S. Government — 34.8%
       
  1,900,000    
U.S. Treasury Bill, 0.10%, due 10/18/12 (c)(f)
    1,898,301  
  13,100,000    
U.S. Treasury Bill, 0.10%, due 10/18/12 (a)(f)
    13,088,289  
       
 
     
       
Total U.S. Government
    14,986,590  
       
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $15,503,060)
    15,503,597  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 100.3%
(Cost $44,427,042)
    43,156,748  
       
 
       
       
Other Assets and Liabilities (net) — (0.3%)
    (141,386 )
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 43,015,362  
       
 
     

 


 

A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
                                         
                                    Net Unrealized  
Settlement                                 Appreciation  
Date     Counterparty   Deliver/Receive     Units of Currency     Value     (Depreciation)  
Buys †  
 
                               
  12/06/11    
Deutsche Bank AG
  AUD     1,500,000     $ 1,541,882     $ 1,317  
  12/13/11    
Deutsche Bank AG
  CAD     700,000       686,105       (35 )
  1/10/12    
Credit Suisse International
  GBP     1,500,000       2,352,521       (13,799 )
  2/14/12    
Deutsche Bank AG
  JPY     211,600,000       2,732,525       (21,249 )
  1/24/12    
Credit Suisse International
  NZD     200,000       155,589       (1,351 )
  1/24/12    
Deutsche Bank AG
  NZD     1,500,000       1,166,913       (15,667 )
       
 
                           
       
 
                  $ 8,635,535     $ (50,784 )
       
 
                           
       
 
                               
Sales #  
 
                               
  12/06/11    
Deutsche Bank AG
  AUD     1,200,000     $ 1,233,506     $ (32,675 )
  12/13/11    
Deutsche Bank AG
  CAD     6,000,000       5,880,901       (10,830 )
  1/10/12    
Credit Suisse International
  GBP     1,700,000       2,666,190       17,884  
  1/24/12    
Deutsche Bank AG
  NZD     800,000       622,354       (13,314 )
       
 
                           
       
 
                  $ 10,402,951     $ (38,935 )
       
 
                           
 
  Fund buys foreign currency; sells USD.
 
#   Fund sells foreign currency; buys USD.
Futures Contracts
                             
                        Net Unrealized  
Number of       Expiration           Appreciation  
Contracts   Type   Date   Value     (Depreciation)  
Buys  
 
                   
  52    
FTSE 100
  December 2011   $ 4,500,419     $ 75,767  
  133    
FTSE JSE 40
  December 2011     4,859,644       161,081  
  16    
Gasoline RBOB(a)
  December 2011     1,719,245       (53,347 )
  18    
Live Cattle(a)
  February 2012     889,920       (15,914 )
  9    
S&P 500 Index
  December 2011     2,803,500       72,684  
       
 
               
       
 
      $ 14,772,728     $ 240,271  
       
 
               
       
 
                   
Sales  
 
                   
  6    
Hang Seng
  December 2011   $ 721,784     $ (24,548 )
  2    
Light Sweet Crude Oil(a)
  December 2011     200,720       (2,827 )
  7    
MSCI Taiwan
  December 2011     177,597       (6,257 )
  48    
Natural Gas(a)
  December 2011     1,704,000       175,911  
  56    
Nikkei 225
  December 2011     6,239,303       5,020  
  43    
S&P TSE 60 Index
  December 2011     5,855,875       (63,410 )
  5    
Silver(a)
  March 2012     820,100       27,739  
  14    
Soybean(a)
  January 2012     791,875       64,862  
  15    
SPI 200
  December 2011     1,638,435       (12,408 )
  5    
UK Gilt Long Bond
  March 2012     890,351       (1,267 )
       
 
               
       
 
      $ 19,040,040     $ 162,815  
       
 
               
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.

 


 

 
Notes to Consolidated Schedule of Investments:
 
RBOB — Reformulated Blendstock for Oxygenate Blending.
 
(a)   All or a portion of this security is owned by GMO Alternative Asset SPC Ltd., which is a 100% owned subsidiary of GMO Alternative Asset Opportunity Fund.
 
(b)   Indexed security in which price and/or coupon is linked to the prices of a specific instrument or financial statistic.
 
(c)   All or a portion of this security has been pledged to cover margin requirements on futures contracts, collateral on swap contracts, forward currency contracts, and/or written options, if any.
 
(d)   Fund is domiciled in Ireland.
 
(e)   Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.
 
(f)   Rate shown represents yield-to-maturity.
Currency Abbreviations:
AUD — Australian Dollar

CAD — Canadian Dollar

GBP — British Pound

JPY — Japanese Yen

NZD — New Zealand Dollar

USD — United States Dollar

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                             
        Gross     Gross     Net Unrealized  
        Unrealized     Unrealized     Appreciation  
Aggregate Cost     Appreciation     (Depreciation)     (Depreciation)  
$ 52,627,615     $ 95,344   $ (9,566,211 )   $ (9,470,867 )
Investments in Affiliated Issuers
In addition to its consolidated subsidiary, the Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                         
    Value,                             Distributions                
    beginning of             Sales     Dividend     of Realized     Return of     Value, end  
Affiliate   period     Purchases     Proceeds     Income*     Gains*     Capital*     of period  
GMO Short-Duration Collateral Fund
  $ 8,210,791     $     $     $ 62,197     $     $ 2,739,474     $ 5,228,644  
GMO U.S. Treasury Fund
    5,481,937       11,958,378       3,095,000       2,096       280             14,347,435  
 
                                         
Totals
  $ 13,692,728     $ 11,958,378     $ 3,095,000     $ 64,293     $ 280     $ 2,739,474     $ 19,576,079  
 
                                         
 
*   The table above includes estimated sources of all distributions paid by the underlying funds during the period March 1, 2011 through November 30, 2011 for tax purposes. The actual tax characterization of distributions paid by the underlying funds will be determined at the end of the fiscal year ending February 29, 2012.

 


 

Basis of presentation and principles of consolidation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
The accompanying consolidated Schedule of Investments include the accounts of the GMO Alternative Asset Opportunity Fund and its wholly owned investment in GMO Alternative Asset SPC Ltd. The consolidated Schedule of Investments include 100% of the assets and liabilities of GMO Alternative Asset SPC Ltd.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly and indirectly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 0.4% of net assets. The underlying funds classify such securities (levels defined below) as Level 3. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivatives contracts based on the creditworthiness of its counterparties. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below.
     
Security Type   Percentage of Net Assets of the Fund
Futures Contracts
  0.5%
Typically the Fund and the underlying funds value debt instruments based on the most recent quoted price supplied by a single pricing source chosen by the Manager. Although the Manager normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and may change a pricing source at any time. The Manager monitors erratic or unusual movements (including unusual inactivity) in the prices supplied for a security and has discretion to override a price supplied by a source (e.g., by taking a price supplied by another) when it believes that the price supplied is not reliable. Although alternative prices may be available for securities held by the Fund and the underlying funds, those alternative sources are not typically part of the valuation process and do not necessarily provide greater certainty about the prices used by the Fund and the underlying funds. As of November 30, 2011, the total value of securities held directly and indirectly for which no alternative pricing source was available represented 1.3% of the net assets of the Fund.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the

 


 

valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include: most recent quoted prices, interest rates, prepayment speeds, credit risk, yield curves and similar data. They may also include fair value adjustments provided by an independent pricing service applied to equity securities (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) due to market events that have occurred since the local market close but prior to the close of the NYSE.
Level 3 — Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Debt Obligations
  $     $ 8,077,072     $     $ 8,077,072  
Mutual Funds
    19,576,079                   19,576,079  
Short-Term Investments
    15,503,597                   15,503,597  
 
                       
Total Investments
    35,079,676       8,077,072             43,156,748  
 
                       
Derivatives*
                               
Forward Currency Contracts
                               
Foreign currency risk
          19,201             19,201  
Futures Contracts
                               
Physical commodity contract risk
    268,512                   268,512  
Equity risk
    72,684       241,868             314,552  
 
                       
Total
  $ 35,420,872     $ 8,338,141     $     $ 43,759,013  
 
                       
LIABILITY VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Liabilities     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Derivatives*
                               
Forward Currency Contracts
                               
Foreign currency risk
  $     $ (108,920 )   $     $ (108,920 )
Futures Contracts
                               
Physical commodity contract risk
    (72,088 )                 (72,088 )
Equity risk
    (63,410 )     (43,213 )           (106,623 )
Interest rate risk
    (1,267 )                 (1,267 )
 
                       
Total
  $ (136,765 )   $ (152,133 )   $     $ (288,898 )
 
                       

 


 

The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
 
*   Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net values of the Fund’s indirect investments in securities and derivative financial instruments using Level 3 inputs were 8.7% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011 whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Loan agreements
The Fund may invest in loans to corporate, governmental, or other borrowers. The Fund’s investments in loans may be in the form of participations in loans or assignments of all or a portion of loans. A loan is often administered by a bank or other financial institution that acts as agent for all holders. The agent administers the terms of the loan, as specified in the loan agreement. When investing in a loan participation, (i) the Fund has the right to receive payments of principal, interest and any fees to which it is entitled only from the party from whom the Fund has purchased the participation and only upon receipt by that party of payments from the borrower and (ii) the Fund generally has no right to enforce compliance by the borrower with the terms of the loan agreement or to vote on matters arising under the loan agreement. Thus, the Fund may be subject to credit risk both of the party from whom it purchased the loan participation and the borrower and the Fund may have minimal control over the terms of any loan modification. When the Fund purchases assignments of loans, it acquires direct rights against the borrower. The Fund had no loan agreements outstanding at the end of the period.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase the security at an agreed upon price and date. The Fund, through its custodian, takes possession of securities it acquired under the repurchase agreement. The value of the securities acquired is required by contract to be marked to market daily and additional collateral is required to be transferred so that the market value is at least equal to the amount owed to the Fund by the seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings and/or the value of the securities subject to the repurchase agreement is insufficient, the Fund’s recovery of cash from the seller may be delayed and the Fund may incur a loss equal to the difference between the cash it paid and the value of the securities. The Fund had no repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same assets at an agreed upon price and date. The Fund can use the proceeds received from entering into a reverse repurchase agreement to make additional investments, which generally causes the Fund’s portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the securities it sold and as a result would realize a loss equal to the difference between the value of those securities and the payment it received for them. The size of this loss will depend upon the difference between what the buyer paid for the securities the Fund sold to it and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of $100). In the event of a buyer’s bankruptcy or insolvency, the Fund’s use of proceeds from the sale of its securities may be restricted while the other party or its trustee or receiver determines whether to honor the Fund’s right to repurchase the securities. The Fund had no reverse repurchase agreements outstanding at the end of the period.

 


 

Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income securities whose principal value is adjusted periodically according to the rate of inflation. Two structures are common. The U.S. Treasury and some other issuers use a structure that reflects inflation in the principal value of the bond. Most other issuers pay out any inflation related accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real interest rates. Real interest rates, in turn, are tied to the relationship between nominal interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e. nominal interest rate minus inflation) might decline, leading to an increase in value of inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than inflation, real interest rates might rise, leading to a decrease in value of inflation indexed bonds. There can be no assurance, however, that the value of inflation indexed bonds will be directly correlated to changes in nominal interest rates, and short term increases in inflation may lead to a decline in their value. Coupon payments received by the Fund from inflation indexed bonds are included in the Fund’s gross income for the period in which they accrue. In addition, any increase or decrease in the principal amount of an inflation indexed bond will increase or decrease taxable ordinary income to the Fund, even though principal is not paid until maturity. Inflation-indexed bonds outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Because the Fund invests in its wholly-owned subsidiary, other GMO Funds, including GMO Short-Duration Collateral Fund and GMO U.S. Treasury Fund, and unaffiliated money market funds, it is exposed to the risks to which its wholly-owned subsidiary and the other underlying funds in which it invests are exposed, as well as the risk that investments made through its wholly-owned subsidiary will not perform as expected. Therefore, unless otherwise noted herein, the selected risks summarized below include both direct and indirect risks of the Fund, and as indicated above, references in this section to investments made by the Fund include those made both directly by the Fund and indirectly by the Fund through its wholly-owned subsidiary, another GMO Fund or an unaffiliated money market fund.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of foreign currency holdings and investments denominated in foreign currencies.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If the Fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of the value of those investments. The Fund also may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Market Risk — Fixed Income Securities — Typically, the market value of fixed income securities will decline during periods of rising interest rates and widening of credit spreads.
Commodities Risk — Because of the Fund’s exposure to commodity markets, the value of its shares is affected by factors particular to the commodity markets and may fluctuate more than the value of shares of a fund with a broader range of investments.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other

 


 

income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations. The risk of counterparty default is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions.
Short Sales Risk — The Fund runs the risk that the Fund’s loss on a short sale of securities that the Fund does not own is unlimited.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating. Below investment grade securities have speculative characteristics, and changes in economic conditions or other circumstances are more likely to impair the capacity of issuers to make principal and interest payments than is the case with issuers of investment grade securities.
Liquidity Risk — Low trading volume, lack of a market maker, a large size position or legal restrictions may limit or prevent the Fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Leveraging Risk — The Fund’s use of reverse repurchase agreements and other derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Market Risk Asset-Backed Securities — Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in the underlying funds, including the risk that the underlying funds in which it invests will not perform as expected or that the Fund will invest in underlying funds with higher fees or expenses.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds, or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Among other trading agreements, the Fund is party to International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Agreements”) or other similar types of agreements with selected counterparties that generally govern over-the-counter derivative transactions entered into by the Fund. The ISDA Agreements typically include representations and warranties as well as contractual terms related to collateral, events of default, termination events, and other provisions. Termination events may include the

 


 

decline in the net assets of the Fund below a certain level over a specified period of time and entitle a counterparty to elect to terminate early with respect to some or all the transactions under the ISDA Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse effect on the Fund’s operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. In particular, the Fund may use swaps or other derivatives on an index, a single security or a basket of securities to gain investment exposures (e.g., by selling protection under a credit default swap). The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). For example, the Fund may use credit default swaps to take a short position with respect to the likelihood of default by an issuer. The Fund also may use currency derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For instance, the Manager may alter the interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is designed to maintain the Fund’s exposure to the credit of an issuer through the debt instrument but adjust the Fund’s interest rate exposure through the swap. With these swaps, the Fund and its counterparties exchange interest rate exposure, such as fixed versus variable rates and shorter duration versus longer duration exposure. In adjusting its investment exposures, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund is not limited in the extent to which it uses derivatives or in the absolute face value of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate exposure of its assets, and its net long exposure may exceed 100% of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives

 


 

with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk that it will be required to pay the full notional value of the swap contract in the event of a default.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. During the period ended November 30, 2011, the Fund used forward currency contracts to adjust exposure to foreign currencies and otherwise adjust currency exchange rate risk. Forward currency contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded (unless otherwise adjusted due to the time at which foreign markets close). The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. During the period ended November 30, 2011, the Fund used futures contracts to adjust exposure to certain markets and enhance the diversity and liquidity of the portfolio. Futures contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.

 


 

Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.

 


 

For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers (unless otherwise adjusted due to the time at which foreign markets close) and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. During the period ended November 30, 2011, the Fund used swap agreements to adjust exposure to certain markets. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.

 


 

The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Physical commodity        
    contracts     contracts     contracts     contracts     contracts     Total  
Assets:
Unrealized appreciation on forward currency contracts
  $     $ 19,201     $     $     $     $ 19,201  
Unrealized appreciation on futures contracts*
                      314,552       268,512       583,064  
 
                                   
Total
  $     $ 19,201     $     $ 314,552     $ 268,512     $ 602,265  
 
                                   
 
Liabilities:
                                               
Unrealized depreciation on forward currency contracts
  $     $ (108,920 )   $     $     $     $ (108,920 )
Unrealized depreciation on futures contracts*
    (1,267 )                 (106,623 )     (72,088 )     (179,978 )
 
                                   
Total
  $ (1,267 )   $ (108,920 )   $     $ (106,623 )   $ (72,088 )   $ (288,898 )
 
                                   
 
*   The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of futures contracts as reported in the Schedule of Investments.
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts and futures contracts), or notional amounts (swap agreements), outstanding at each month-end, was as follows for the period ended November 30, 2011:
                         
    Forward        
    Currency   Futures   Swap
    Contracts   Contracts   Agreements
Average amount outstanding
  $ 3,451,156   $ 9,428,733   $ 9,648,555
For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Asset Allocation Bond Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Par Value ($)/            
Shares/ Number of Contracts/
Principal Amount
    Description   Value ($)  
 
       
DEBT OBLIGATIONS — 104.0%
       
       
 
       
       
U.S. Government — 104.0%
       
  116,000,000    
U.S. Treasury Note, 1.00%, due 07/15/13
    117,431,904  
  78,000,000    
U.S. Treasury Note, 1.13%, due 06/15/13(a)(b)
    79,066,416  
       
 
     
       
Total U.S. Government
    196,498,320  
       
 
     
       
TOTAL DEBT OBLIGATIONS (COST $195,701,646)
    196,498,320  
       
 
     
       
 
       
       
MUTUAL FUNDS — 1.9%
       
       
 
       
       
Affiliated Issuers — 1.9%
       
  142,787    
GMO U.S. Treasury Fund
    3,571,109  
       
 
     
       
TOTAL MUTUAL FUNDS (COST $3,571,109)
    3,571,109  
       
 
     
       
 
       
       
OPTIONS PURCHASED — 2.0%
       
       
 
       
       
Options on Futures — 0.3%
       
  600    
10 Year U.S. Treasury Note Future Options Call, Expires 12/23/11, Strike 129.50
    553,125  
  600    
10 Year U.S. Treasury Note Future Options Call, Expires 12/23/11, Strike 132.50
    75,000  
       
 
     
       
Total Options on Futures
    628,125  
       
 
     
       
 
       
       
Options on Interest Rate Swaps — 1.7%
       
  300,000,000    
Swaption Call, Expires 12/01/11, Strike 1.00%, Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of 300,000,000 USD in which it will pay 3 month USD LIBOR and will receive 1.00%, maturing on December 5, 2013, (OTC) (CP — Merrill Lynch Capital Services Inc.)
    2,016,300  
  250,000,000    
Swaption Call, Expires 05/21/12, Strike 0.77%, Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of 250,000,000 USD in which it will pay 3 month USD LIBOR and will receive 0.77%, maturing on May 23, 2013, (OTC) (CP — Merrill Lynch Capital Services Inc.)
    586,250  
  250,000,000    
Swaption Call, Expires 05/20/13, Strike 0.77%, Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of 250,000,000 USD in which it will pay a 3 month USD LIBOR and will receive 0.77%, maturing on May 22, 2014, (OTC) (CP — Merrill Lynch Capital Services Inc.)
    643,000  
       
 
     
       
Total Options on Interest Rate Swaps
    3,245,550  
       
 
     
       
TOTAL OPTIONS PURCHASED (COST $2,686,366)
    3,873,675  
       
 
       
       
SHORT-TERM INVESTMENTS — 0.7%
       
       
 
       
       
Money Market Funds — 0.7%
       
  1,347,409    
State Street Institutional U.S. Government Money Market Fund-Institutional Class, 0.00%(c)
    1,347,409  
       
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $1,347,409)
    1,347,409  
       
 
     

 


 

                 
       
TOTAL INVESTMENTS — 108.6%
(Cost $203,306,530)
    205,290,513  
       
Other Assets and Liabilities (net) — (8.6%)
    (16,341,704 )
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 188,948,809  
       
 
     
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Futures Contracts
                                 
                            Net Unrealized  
Number of         Expiration             Appreciation  
Contracts     Type   Date     Value     (Depreciation)  
Buys  
 
                       
  1,275    
Euro Dollar 90 Day
  March 2012   $ 316,837,500     $ 192,763  
       
 
                   
       
 
                       
Sales  
 
                       
  1,275    
Euro Dollar 90 Day
  March 2013   $ 316,582,500     $ (346,848 )
       
 
                   
Reverse Repurchase Agreements
                 
Face Value   Description   Market Value  
USD    12,983,750  
Deutsche Bank AG, 0.15%, dated 11/03/11, to be repurchased on demand at face value plus accrued interest with a stated maturity date of 12/5/11.
  $ (12,985,211 )
USD    4,993,750  
Deutsche Bank AG, 0.16%, dated 11/23/11, to be repurchased on demand at face value plus accrued interest with a stated maturity date of 12/23/11.
    (4,993,928 )
       
 
     
       
 
  $ (17,979,139 )
       
 
     
         
Average balance outstanding
  $ (30,166,766 )
Average interest rate
    0.16 %
Maximum balance outstanding
  $ (51,381,250 )
Average balance outstanding was calculated based on daily face value balances outstanding during the period that the Fund has entered into reverse repurchase agreements.
Written Options
A summary of open written option contracts for the fund at November 30, 2011 is as follows:
Options on Futures
                                                 
        Contract     Expiration                         Market  
        Number     Date             Description   Premiums     Value  
Call     1,200       12/23/2011     USD  
10 Year U.S. Treasury Note Option Call, Strike 131.00
  $ (972,384 )   $ (450,000 )
                               
 
           

 


 

Options on Interest Rate Swaps
                                    Description of underlying swap              
    Notional     Expiration           Receive     Fixed     Variable            
Description   Amount     Date     Counterparty     (Pay) #     Rate     Rate     Premiums     Market Value  
Call- OTC 2 Year Interest Rate Swap
    600,000,000     USD     12/01/11     Merrill Lynch Capital Services Inc.   (Pay)     0.60%     3 Month LIBOR   $ (360,000 )   $ (1,200 )
                                                                         
Call — OTC 2 Year Interest Rate Swap
    250,000,000     USD     05/21/12     Merrill Lynch
Capital Services Inc.
  (Pay)     0.77%   3 Month LIBOR     (193,750 )     (832,250 )
 
                                                                   
 
                                                          $ (553,750 )   $ (833,450 )
 
                                                                   
 
                                                          $ (1,526,134 )   $ (1,283,450 )
 
                                                                   
Swap Agreements
Interest Rate Swaps
                                                         
                                                    Net Unrealized  
Notional     Expiration             Receive                     Appreciation/  
Amount     Date     Counterparty     (Pay)#     Fixed Rate     Variable Rate     (Depreciation)  
190,000,000
  USD     1/15/2014     Barclays Bank PLC   (Pay)     0.92 %   3 Month LIBOR   $ (878,905 )
75,000,000
  USD     1/15/2017     Barclays Bank PLC   Receive     2.19 %   3 Month LIBOR     3,007,749  
 
                                                     
 
                                                  $ 2,128,844  
 
                                                     
 
                                  Premiums to (Pay) Receive     $  
 
                                                     
 
#   Receive — Fund receives fixed rate and pays variable rate.
 
    (Pay) — Fund pays fixed rate and receives variable rate.
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
 
Notes to Schedule of Investments:
CP — Counterparty

LIBOR — London Interbank Offered Rate

OTC — Over-the-Counter
(a)   All or a portion of this security has been pledged to cover margin requirements on futures contracts, collateral on swap contracts, forward currency contracts, and/or written options.
 
(b)   All or a portion of this security has been pledged to cover collateral requirements on reverse repurchase agreements.
 
(c)   Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.
Currency Abbreviations:
USD — United States Dollar

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                         
    Gross     Gross     Net Unrealized  
    Unrealized     Unrealized     Appreciation  
Aggregate cost   Appreciation     (Depreciation)     (Depreciation)  
$           203,273,976
  $ 2,534,778     $ (518,241 )   $ 2,016,537  
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO U.S. Treasury Fund
  $ 9,857,886     $ 209,531,678     $ 215,813,100     $ 6,488     $ 190     $ 3,571,109  
 
                                   

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivative contracts based on the creditworthiness of its counterparties. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Typically the Fund and the underlying funds value debt instruments based on the most recent quoted price supplied by a single pricing source chosen by the Manager. Although the Manager normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and may change a pricing source at any time. The Manager monitors erratic or unusual movements (including unusual inactivity) in the prices supplied for a security and has discretion to override a price supplied by a source (e.g., by taking a price supplied by another) when it believes that the price supplied is not reliable. Although alternative prices may be available for securities held by the Fund and the underlying funds, those alternative sources are not typically part of the valuation process and do not necessarily provide greater certainty about the prices used by the Fund and the underlying funds.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit risk, yield curves and similar data.
Level 3 — Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Debt Obligations
                               
U.S. Government
  $ 196,498,320     $     $     $ 196,498,320  
 
                         
TOTAL DEBT OBLIGATIONS
    196,498,320                   196,498,320  
 
                         
Mutual Funds
    3,571,109                   3,571,109  
Options Purchased
    628,125       3,245,550             3,873,675  
Short-Term Investments
    1,347,409                   1,347,409  
 
                       
Total Investments
    202,044,963       3,245,550             205,290,513  
 
                       
Derivatives*
                               
Futures Contracts
                               
Interest Rate Risk
    192,763                   192,763  
Swap Agreements
                               
Interest Rate Risk
          3,007,749             3,007,749  
 
                       
Total
  $ 202,237,726     $ 6,253,299     $     $ 208,491,025  
 
                       
LIABILITY VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Liabilities     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Derivatives*
                               
Written Options
                               
Interest Rate Risk
  $ (450,000 )   $ (833,450 )         $ (1,283,450 )
Futures Contracts
                               
Interest Rate Risk
    (346,848 )                 (346,848 )
Swap Agreements
                               
Interest Rate Risk
          (878,905 )           (878,905 )
 
                       
Total
  $ (796,848 )   $ (1,712,355 )         $ (2,509,203 )
 
                       

 


 

The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
 
*  Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase the security at an agreed upon price and date. The Fund, through its custodian, takes possession of securities it acquired under the repurchase agreement. The value of the securities acquired is required by contract to be marked to market daily and additional collateral is required to be transferred so that the market value is at least equal to the amount owed to the Fund by the seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings and/or the value of the securities subject to the repurchase agreement is insufficient, the Fund’s recovery of cash from the seller may be delayed and the Fund may incur a loss equal to the difference between the cash it paid and the value of the securities. The Fund had no repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same assets at an agreed upon price and date. The Fund can use the proceeds received from entering into a reverse repurchase agreement to make additional investments, which generally causes the Fund’s portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the securities it sold and as a result would realize a loss equal to the difference between the value of those securities and the payment it received for them. The size of this loss will depend upon the difference between what the buyer paid for the securities the Fund sold to it and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of $100). In the event of a buyer’s bankruptcy or insolvency, the Fund’s use of proceeds from the sale of its securities may be restricted while the other party or its trustee or receiver determines whether to honor the Fund’s right to repurchase the securities. As of November 30, 2011, the Fund had received $17,977,500 from reverse repurchase agreements relating to securities with a market value, plus accrued interest, of $18,339,600. Reverse repurchase agreements outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income securities whose principal value is adjusted periodically according to the rate of inflation. Two structures are common. The U.S. Treasury and some other issuers use a structure that reflects inflation in the principal value of the bond. Most other issuers pay out any inflation related accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real interest rates. Real interest rates, in turn, are tied to the relationship between nominal interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e. nominal interest rate minus inflation) might decline, leading to an increase in value of inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than inflation, real interest rates might rise, leading to a decrease in value of inflation indexed bonds. There can be no assurance, however, that the

 


 

value of inflation indexed bonds will be directly correlated to changes in nominal interest rates, and short term increases in inflation may lead to a decline in their value. Coupon payments received by the Fund from inflation indexed bonds are included in the Fund’s gross income for the period in which they accrue. In addition, any increase or decrease in the principal amount of an inflation indexed bond will increase or decrease taxable ordinary income to the Fund, even though principal is not paid until maturity. The Fund had no inflation-indexed bonds outstanding at the end of the period.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk Fixed Income Securities — Typically, the market value of the Fund’s fixed income securities will decline during periods of rising interest rates and widening of credit spreads.
 
Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating. The Fund’s investments in below investment grade securities have speculative characteristics, and changes in economic conditions or other circumstances are more likely to impair the capacity of issuers to make principal and interest payments than is the case with issuers of investment grade securities.
 
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations. The risk of counterparty default is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions.
 
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
 
Leveraging Risk — The Fund’s use of reverse repurchase agreements and other derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
 
Market Risk Asset-Backed Securities — Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
 
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
 
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse

 


 

changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
 
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies.
 
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
 
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies with high positive correlations to one another creates additional risk.
 
Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in underlying funds, including the risk that the underlying funds in which it invests will not perform as expected.
 
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
 
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Among other trading agreements, the Fund is party to International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Agreements”) or other similar types of agreements with selected counterparties that generally govern over-the-counter derivative transactions entered into by the Fund. The ISDA Agreements typically include representations and warranties as well as contractual terms related to collateral, events of default, termination events, and other provisions. Termination events may include the decline in the net assets of the Fund below a certain level over a specified period of time and entitle a counterparty to elect to terminate early with respect to some or all the transactions under the ISDA Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse effect on the Fund’s operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. In particular, the Fund may use swaps or other derivatives on an index, a single security or a basket of securities to gain investment exposures (e.g., by selling protection under a credit default swap). The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). For example, the Fund may use credit default swaps to take a short position with respect to the likelihood of default by an issuer. The Fund also may use currency derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of the currency

 


 

exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For instance, the Manager may alter the interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is designed to maintain the Fund’s exposure to the credit of an issuer through the debt instrument but adjust the Fund’s interest rate exposure through the swap. With these swaps, the Fund and its counterparties exchange interest rate exposure, such as fixed versus variable rates and shorter duration versus longer duration exposure. In adjusting their investment exposures, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund is not limited in the extent to which it uses derivatives or in the absolute face value of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate exposure of its assets, and its net long exposure may exceed 100% of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk that it will be required to pay the full notional value of the swap contract in the event of a default.

 


 

Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. The Fund had no forward currency contracts outstanding at the end of the period.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded. The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. During the period ended November 30, 2011, the Fund used futures contracts to adjust interest rate exposure and maintain the diversity and liquidity of the portfolio. Futures contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. During the period ended November 30, 2011, the Fund used purchased option contracts to adjust interest rate exposure. Option contracts purchased by the Fund and outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund

 


 

does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. During the period ended November 30, 2011, the Fund used written option contracts to adjust interest rate exposure. Written options outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
For the period ended November 30, 2011, investment activity in options contracts written by the Fund was as follows:
                                                 
    Puts     Calls  
    Principal     Number             Principal            
    Amount of     of             Amount of     Number of        
    Contracts     Contracts     Premiums     Contracts     Contracts     Premiums  
Outstanding, beginning of period
  $           $     $ (600,000,000 )     (500 )   $ (396,500 )
Options written
                      (250,000,000 )     (2,400 )     (1,913,518 )
Options bought back
                            1,700       783,884  
Options expired
                                   
Options sold
                                   
 
                                   
Outstanding, end of period
  $           $     $ (850,000,000 )     (1,200 )   $ (1,526,134 )
 
                                   
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other

 


 

agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. During the period ended November 30, 2011, the Fund used swap agreements to adjust interest rate exposure. Swap agreements outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.

 


 

The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
                                                       
          Interest rate     Foreign currency     Credit     Equity     Other        
Fair Values of Derivative Instruments as of November 30, 2011:           contracts     contracts     contracts     contracts     contracts     Total  
Assets:
                                                       
Investments, at value (purchased options)
          $ 3,873,675     $     $     $     $     $ 3,873,675  
Unrealized appreciation on futures contracts*
            192,763                               192,763  
Unrealized appreciation on swap agreements
            3,007,749                               3,007,749  
 
                                           
 
  Total   $ 7,074,187     $     $     $     $     $ 7,074,187  
 
                                           
 
                                                       
Liabilities:
                                                       
Written options outstanding
          $ (1,283,450 )   $     $     $     $     $ (1,283,450 )
Unrealized depreciation on futures contracts*
            (346,848 )                             (346,848 )
Unrealized depreciation on swap agreements
            (878,905 )                             (878,905 )
 
                                           
 
  Total   $ (2,509,203 )   $     $     $     $     $ (2,509,203 )
 
                                           
 
*   The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of futures contracts as reported in the Schedule of Investments.
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (futures contracts), notional amounts (swap agreements), or principal amounts (options), outstanding at each month-end, was as follows for the period ended November 30, 2011:
                         
    Futures     Swap        
    Contracts     Agreements     Options  
Average amount outstanding
  $ 2,735,211,417     $ 1,322,666,667     $ 1,623,311,111  

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Benchmark-Free Allocation Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares / Par Value ($)     Description   Value ($)  
 
       
MUTUAL FUNDS — 99.9%
       
       
 
       
       
Affiliated Issuers — 99.9%
       
  1,295,649    
GMO Alpha Only Fund, Class IV
    32,248,698  
  70,767    
GMO Alternative Asset Opportunity Fund
    2,098,944  
  1,167,908    
GMO Currency Hedged International Equity Fund, Class III
    24,526,066  
  50,094    
GMO Debt Opportunities Fund, Class VI
    1,246,330  
  349,911    
GMO Emerging Country Debt Fund, Class IV
    3,313,658  
  1,434,027    
GMO Emerging Markets Fund, Class VI
    16,763,776  
  643,686    
GMO Flexible Equities Fund, Class VI
    11,032,771  
  2,039,394    
GMO Quality Fund, Class VI
    44,540,361  
  271,150    
GMO Special Situations Fund, Class VI
    7,169,211  
  1,093,863    
GMO Strategic Fixed Income Fund, Class VI
    18,617,554  
  52,430    
GMO World Opportunity Overlay Fund
    1,237,343  
       
 
     
       
TOTAL MUTUAL FUNDS (COST $173,029,865)
    162,794,712  
       
 
     
       
 
       
       
DEBT OBLIGATIONS — 0.2%
       
       
 
       
       
Asset-Backed Securities — 0.1%
       
       
 
       
       
CMBS Collateralized Debt Obligations — 0.0%
       
  1,599,399    
American Capital Strategies Ltd. Commercial Real Estate CDO Trust, Series 07-1A, Class A, 144A, 3 mo. LIBOR + .80%, 1.30%, due 11/23/52
    15,994  
       
 
     
       
 
       
       
Insured Other — 0.1%
       
  2,500,000    
Toll Road Investment Part II, Series C, 144A, MBIA, Zero Coupon, due 02/15/37
    156,475  
       
 
     
       
Total Asset-Backed Securities
    172,469  
       
 
     
       
 
       
       
U.S. Government Agency — 0.1%
       
  16,900    
Agency for International Development Floater (Support of C.A.B.E.I.), 6 mo. U.S. Treasury Bill + .40%, 0.47%, due 10/01/12(a)
    16,703  
  33,334    
Agency for International Development Floater (Support of Zimbabwe), 3 mo. U.S. Treasury Bill x 115%, 0.04%, due 01/01/12(a)
    33,283  
       
 
     
       
Total U.S. Government Agency
    49,986  
       
 
     
       
TOTAL DEBT OBLIGATIONS (COST $638,559)
    222,455  
       
 
     
       
 
       
       
SHORT-TERM INVESTMENTS — 0.0%
       
       
 
       
       
Money Market Funds — 0.0%
       
  12,686    
State Street Institutional U.S. Government Money Market Fund-Institutional Class, 0.00%(b)
    12,686  
       
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $12,686)
    12,686  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 100.1%
(Cost $173,681,110)
    163,029,853  
       
Other Assets and Liabilities (net) — (0.1%)
    (121,018 )
       
 
     
       
TOTAL NET ASSETS — 100.0%
  $ 162,908,835  
       
 
     

 


 

Notes to Schedule of Investments:
144A — Securities exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional investors.
C.A.B.E.I. — Central American Bank for Economic Integration
CDO — Collateralized Debt Obligation
CMBS — Commercial Mortgage Backed Security
LIBOR — London Interbank Offered Rate
MBIA — Insured as to the payment of principal and interest by MBIA Insurance Corp.
The rates shown on variable rate notes are the current interest rates at November 30, 2011, which are subject to change based on the terms of the security.
(a)   Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust.
 
(b)   Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                         
    Gross   Gross   Net Unrealized
    Unrealized   Unrealized   Appreciation
Aggregate Cost   Appreciation   (Depreciation)   (Depreciation)
$199,875,402
  $ 1,849,627     $ (38,695,176 )   $ (36,845,549 )
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO Alpha Only Fund, Class IV
  $ 599,996,684     $ 197,074,875     $ 792,155,653     $     $     $ 32,248,698  
GMO Alternative Asset Opportunity Fund
    24,921,958       875,402       22,888,196                   2,098,944  
GMO Asset Allocation Bond Fund, Class VI
    244,450,911       70,337,131       309,024,681       1,006,285       11,911,428        
GMO Currency Hedged International Equity Fund, Class III
    363,301,368       54,090,981       372,947,091             1,635,149       24,526,066  
GMO Debt Opportunities Fund, Class VI
          1,250,622       1,790                   1,246,330  
GMO Emerging Country Debt Fund, Class IV
    54,942,811       4,117,286       58,755,133       565,954             3,313,658  
GMO Emerging Markets Fund, Class VI
    340,226,922       57,009,354       355,580,075       6,934       23,871,370       16,763,776  
GMO Flexible Equities Fund, Class VI
    72,002,968       89,749,325       148,362,232                   11,032,771  
GMO Quality Fund, Class VI
    851,695,924       79,507,946       896,986,741       8,441,682             44,540,361  
GMO Special Situations Fund, Class VI
    148,674,177       9,445,979       146,946,136                   7,169,211  
GMO Strategic Fixed Income Fund, Class VI
    417,114,334       30,522,730       450,772,882                   18,617,554  
GMO World Opportunity Overlay Fund
    22,044,262             20,920,476                   1,237,343  
 
                                   
Totals
  $ 3,139,372,319     $ 593,981,631     $ 3,575,341,086     $ 10,020,855     $ 37,417,947     $ 162,794,712  
 
                                   

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Shares of the underlying funds and other investment funds are generally valued at their net asset value. Investments held by the Fund and the underlying funds are valued as follows: Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly and indirectly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 0.8% of net assets. The Fund and the underlying funds classify such securities (levels defined below) as Level 3.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund, either directly or through investments in the underlying funds, that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below and as described in the disclosures of the underlying funds.
         
Security Type   Percentage of Net Assets of the Fund
Equity Securities
    39.5 %
Futures Contracts
    0.1 %
Swap Agreements
    1.0 %
Typically the Fund and the underlying funds value debt instruments based on the most recent quoted price supplied by a single pricing source chosen by the Manager. Although the Manager normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and may change a pricing source at any time. The Manager monitors erratic or unusual movements (including unusual inactivity) in the prices supplied for a security and has discretion to override a price supplied by a source (e.g., by taking a price supplied by another) when it believes that the price supplied is not reliable. Although alternative prices may be available for securities held by the Fund and the underlying funds, those alternative sources are not typically part of the valuation process and do not necessarily provide greater certainty about the prices used by the Fund and the underlying funds. As of November 30, 2011, the total value of securities held directly and indirectly for which no alternative pricing source was available represented 1.2% of the net assets of the Fund.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

 


 

During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit risk, yield curves and similar data.
Level 3 — Valuations based primarily on inputs that are unobservable and significant. The Fund utilized a number of fair value techniques on Level 3 investments, including the following: The Fund valued certain debt securities using quoted prices. The Fund valued certain other debt securities by using a specified spread above the LIBOR rate.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Mutual Funds
  $ 162,794,712     $     $     $ 162,794,712  
Debt Obligations
                               
Asset-Backed Securities
          156,475       15,994       172,469  
U.S. Government Agency
                49,986       49,986  
 
                       
TOTAL DEBT OBLIGATIONS
          156,475       65,980       222,455  
 
                       
Short-Term Investments
    12,686                   12,686  
 
                       
Total Investments
    162,807,398       156,475       65,980       163,029,853  
 
                       
Total
  $ 162,807,398     $ 156,475     $ 65,980     $ 163,029,853  
 
                       

 


 

The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net values of the Fund’s investments (both direct and indirect) in securities and derivative financial instruments using Level 3 inputs were 5.4% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant unobservable inputs (Level 3) were used in determining value:
                                                                                 
                                                                            Net Change in  
                                                                            Unrealized  
                                                                            Appreciation  
                                                                            (Depreciation)  
                                                                            from  
                                            Change in                     Balances     Investments  
    Balances as                     Accrued     Total     Unrealized     Transfers     Transfers     as of     Held as of  
    of February                     Discounts/     Realized     Appreciation     into     out of     November     November  
    28, 2011     Purchases     Sales     Premiums     Gain/(Loss)     (Depreciation)     Level 3*     Level 3*     30, 2011     30,2011  
Debt Obligations
                                                                               
Asset-Backed Securities
  $ 21,992,549     $     $ (21,265,322 )   $ 101,703     $ 1,082,690     $ (1,895,626 )   $     $     $ 15,994     $ (1,077 )
U.S. Government Agency
    167,552             (118,269 )     (133 )     446       390                 $ 49,986       657  
 
                                                           
Total Debt Obligations
    22,160,101             (21,383,591 )     101,570       1,083,136       (1,895,236 )                 65,980       (420 )
 
                                                           
Total
  $ 22,160,101     $     $ (21,383,591 )   $ 101,570     $ 1,083,136     $ (1,895,236 )   $     $     $ 65,980     $ (420 )
 
                                                           
 
*   The fund accounts for investments transferred into Level 3 at the value at the beginning of the period and transfers out of Level 3 at the value at the end of the period.

 


 

Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. References to investments include those held directly by the Fund and indirectly through the Fund’s investments in the underlying funds. Some of the underlying funds are non-diversified investment companies under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by those Funds may affect their performance more than if they were diversified. Selected risks of investing in the Fund are summarized below, including those risks to which the Fund is exposed as a result of its investments in the underlying funds. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If an underlying fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of the value of those investments. An underlying fund also may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Market Risk — Fixed Income Securities — Typically, the market value of fixed income securities will decline during periods of rising interest rates and widening of credit spreads.
Market Risk — Asset-Backed Securities — Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of companies with smaller market capitalizations often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalization.
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund or an underlying fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of foreign currency holdings and investments denominated in foreign currencies.
Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in the underlying funds, including the risk that the underlying funds in which it invests do not perform as expected. Because the Fund bears the fees and expenses of the underlying funds in which it invests, new investments in underlying funds with higher fees or expenses than those of the

 


 

underlying funds in which the Fund is currently invested will increase the Fund’s total expenses. The fees and expenses associated with an investment in the Fund are less predictable and may be higher than fees and expenses associated with an investment in funds that charge a fixed management fee.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating. Below investment grade securities have speculative characteristics, and changes in economic conditions or other circumstances are more likely to impair the capacity of issuers to make principal and interest payments than is the case with issuers of investment grade securities.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Commodities Risk — To the extent an underlying fund has exposure to global commodity markets, the value of its shares is affected by factors particular to the commodity markets and may fluctuate more than the value of shares of a fund with a broader range of investments.
Leveraging Risk — The use of reverse repurchase agreements and other derivatives and securities lending may cause the Fund’s portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Real Estate Risk — To the extent an underlying fund concentrates its assets in real estate-related investments, the value of its portfolio is subject to factors affecting the real estate industry and may fluctuate more than the value of a portfolio that consists of securities of companies in a broader range of industries.
Short Sales Risk — The Fund runs the risk that an underlying fund’s loss on a short sale of securities that the underlying fund does not own is unlimited.
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies or in industries with high positive correlations to one another creates additional risk.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
The Fund invests (including through investment in underlying funds) in asset-backed securities, which may be backed by many types of assets, including pools of residential and commercial mortgages, automobile loans, educational loans, home equity loans, or credit card receivables, which expose the Fund to additional types of market risk. They also may be backed by pools of corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds and loans (commonly referred to as “collateralized debt obligations” or “collateralized loan obligations”) and by the fees earned by service providers. Payment of interest on asset backed securities and repayment of principal largely depend on the cash flows generated by the assets backing the securities. The market risk of a particular asset-backed security depends on many factors, including the deal structure (e.g., determination as to the amount of underlying assets or other support needed to produce the cash flows necessary to service interest and make principal payments), the quality of the underlying assets and, if any, the level of credit support and the credit quality of the credit-support provider. Asset-

 


 

backed securities involve risk of loss of principal if obligors of the underlying obligations default and the value of the defaulted obligations exceeds whatever credit support the securities may have. The obligations of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and other laws affecting the rights and remedies of creditors. Many asset-backed securities in which the Fund has invested are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal and/or interest will be paid because the insurer could default on its obligations. In recent years, a significant number of asset-backed security insurers have defaulted on their obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about the creditworthiness of those securities (and underlying assets) caused credit spreads (the difference between yields on the asset-backed securities and U.S. Government securities) to widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions to make markets in many fixed income securities. These events reduced liquidity and contributed to substantial declines in the value of asset-backed and other fixed income securities. There can be no assurance these conditions will not occur again. Also, government actions and proposals affecting the terms of underlying home and consumer loans, changes in demand for products (e.g., automobiles) financed by those loans, and the inability of borrowers to refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying assets and is, therefore, subject to risks associated with the negligence or defalcation of its servicer. In some circumstances, the mishandling of related documentation also may affect the rights of security holders in and to the underlying assets. The insolvency of entities that generate receivables or that utilize the assets may result in a decline in the value of the underlying assets, as well as costs and delays. The obligations underlying asset-backed securities, in particular securities backed by pools of residential and commercial mortgages, also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as high a yield as is provided by the asset-backed security. The risk of investing in asset-backed securities has increased because performance of the various sectors in which the assets underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime mortgages, and credit card receivables) has become more highly correlated since the deterioration in worldwide economic and liquidity conditions.
Derivative financial instruments
At November 30, 2011, the Fund held no derivative financial instruments directly. For a listing of derivative financial instruments held by the underlying funds, if any, please refer to the underlying funds’ Schedule of Investments.
Subsequent events
On January 1, 2012, the Fund instituted a fee arrangement pursuant to which Class III shares of the Fund pay the Manager a 0.65% management fee and a 0.15% shareholder service fee.
For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Benchmark-Free Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares / Par Value ($)     Description   Value ($)  
  | |
       
MUTUAL FUNDS — 100.0%
       
       
 
       
       
Affiliated Issuers — 100.0%
       
  25,570,956    
GMO Alpha Only Fund, Class IV
    636,461,095  
  1,360,461    
GMO Alternative Asset Opportunity Fund
    40,351,269  
  23,159,675    
GMO Currency Hedged International Equity Fund, Class III
    486,353,174  
  952,678    
GMO Debt Opportunities Fund, Class VI
    23,702,634  
  6,176,520    
GMO Emerging Country Debt Fund, Class IV
    58,491,649  
  28,523,466    
GMO Emerging Markets Fund, Class VI
    333,439,316  
  12,304,236    
GMO Flexible Equities Fund, Class VI
    210,894,599  
  40,521,686    
GMO Quality Fund, Class VI
    884,993,618  
  5,324,963    
GMO Special Situations Fund, Class VI
    140,792,009  
  22,400,886    
GMO Strategic Fixed Income Fund, Class VI
    381,263,081  
  919,464    
GMO World Opportunity Overlay Fund
    21,699,355  
       
 
     
       
TOTAL MUTUAL FUNDS (COST $3,216,263,706)
    3,218,441,799  
       
 
     
       
 
       
       
SHORT-TERM INVESTMENTS — 0.0%
       
       
 
       
       
Time Deposits — 0.0%
       
  56,610    
State Street Eurodollar Time Deposit, 0.01%, due 12/1/11
    56,610  
       
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $56,610)
    56,610  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 100.0%
(Cost $3,216,320,316)
    3,218,498,409  
       
 
       
       
Other Assets and Liabilities (net) — (0.0%)
    (82,423 )
       
 
     
       
TOTAL NET ASSETS — 100.0%
  $ 3,218,415,986  
       
 
     

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                           
      Gross   Gross   Net Unrealized
      Unrealized   Unrealized   Appreciation
Aggregate Cost   Appreciation   (Depreciation)   (Depreciation)
 
$3,216,320,316
  $ 62,921,132     $ (60,743,039 )   $ 2,178,093  
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO Alpha Only Fund, Class IV
  $     $ 875,909,533     $ 256,088,549     $     $     $ 636,461,095  
GMO Alternative Asset Opportunity Fund
          41,667,279                         40,351,269  
GMO Asset Allocation Bond Fund, Class VI
          251,967,993       249,306,832       2,449,871              
GMO Currency Hedged International Equity Fund, Class III
          491,405,563                         486,353,174  
GMO Debt Opportunities Fund, Class VI
          23,750,000                         23,702,634  
GMO Emerging Country Debt Fund, Class IV
          59,154,781             217,065             58,491,649  
GMO Emerging Markets Fund, Class VI
          374,498,695       1,429,284       134,530       65,834       333,439,316  
GMO Flexible Equities Fund, Class VI
          222,074,091                         210,894,599  
GMO Quality Fund, Class VI
          848,133,970       672,591       5,354,206             884,993,618  
GMO Special Situations Fund, Class VI
          143,718,849                         140,792,009  
GMO Strategic Fixed Income Fund, Class VI
          441,971,273       84,511,567                   381,263,081  
GMO World Opportunity Overlay Fund
          20,918,725                         21,699,355  
 
                                   
Totals
  $     $ 3,795,170,752     $ 592,008,823     $ 8,155,672     $ 65,834     $ 3,218,441,799  
 
                                   

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Shares of the underlying funds and other investment funds are generally valued at their net asset value. Investments held by the underlying funds are valued as follows: Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly and indirectly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 0.8% of net assets. The Fund and the underlying funds classify such securities (levels defined below) as Level 3.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund, either directly or through investments in the underlying funds, that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below and as described in the disclosures of the underlying funds.
         
Security Type     Percentage of Net Assets of the Fund
Equity Securities
    39.4 %
Futures Contracts
    0.1 %
Swap Agreements
    1.0 %
Typically the Fund and the underlying funds value debt instruments based on the most recent quoted price supplied by a single pricing source chosen by the Manager. Although the Manager normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and may change a pricing source at any time. The Manager monitors erratic or unusual movements (including unusual inactivity) in the prices supplied for a security and has discretion to override a price supplied by a source (e.g., by taking a price supplied by another) when it believes that the price supplied is not reliable. Although alternative prices may be available for securities held by the Fund and the underlying funds, those alternative sources are not typically part of the valuation process and do not necessarily provide greater certainty about the prices used by the Fund and the underlying funds. As of November 30, 2011, the total value of securities held directly and indirectly for which no alternative pricing source was available represented 1.1% of the net assets of the Fund.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

 


 

During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 – Valuations based on quoted prices for identical securities in active markets.
Level 2 – Valuations determined using other significant direct or indirect observable inputs.
Level 3 – Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Mutual Funds
  $ 3,218,441,799     $     $     $ 3,218,441,799  
Short-Term Investments
    56,610                   56,610  
 
                       
Total Investments
    3,218,498,409                   3,218,498,409  
 
                       
Total
  $ 3,218,498,409     $     $     $ 3,218,498,409  
 
                       

 


 

The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net values of the Fund’s investments (both direct and indirect) in securities and derivative financial instruments using Level 3 inputs were 5.3% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at November 30, 2011, whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. References to investments include those held directly by the Fund and indirectly through the Fund’s investments in the underlying funds. Some of the underlying funds are non-diversified investment companies under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by those Funds may affect their performance more than if they were diversified. Selected risks of investing in the Fund are summarized below, including those risks to which the Fund is exposed as a result of its investments in the underlying funds. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk – Equity Securities – The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If an underlying fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of the value of those investments. An underlying fund also may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Foreign Investment Risk – The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Market Risk Fixed Income Securities – Typically, the market value of fixed income securities will decline during periods of rising interest rates and widening of credit spreads.
Market Risk Asset-Backed Securities – Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
Smaller Company Risk – Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of companies with smaller market capitalizations often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalization.
Liquidity Risk – Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund or an underlying fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.

 


 

Derivatives Risk – The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Currency Risk – Fluctuations in exchange rates can adversely affect the market value of foreign currency holdings and investments denominated in foreign currencies.
Fund of Funds Risk – The Fund is indirectly exposed to all of the risks of an investment in the underlying funds, including the risk that the underlying funds in which it invests do not perform as expected. Because the Fund bears the fees and expenses of the underlying funds in which it invests, new investments in underlying funds with higher fees or expenses than those of the underlying funds in which the Fund is currently invested will increase the Fund’s total expenses. The fees and expenses associated with an investment in the Fund are less predictable and may be higher than fees and expenses associated with an investment in funds that charge a fixed management fee.
Management and Operational Risk – The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Credit Risk – The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating. Below investment grade securities have speculative characteristics, and changes in economic conditions or other circumstances are more likely to impair the capacity of issuers to make principal and interest payments than is the case with issuers of investment grade securities.
Counterparty Risk – The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Commodities Risk – To the extent an underlying fund has exposure to global commodity markets, the value of its shares is affected by factors particular to the commodity markets and may fluctuate more than the value of shares of a fund with a broader range of investments.
Leveraging Risk – The use of reverse repurchase agreements and other derivatives and securities lending may cause the Fund’s portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Real Estate Risk – To the extent an underlying fund concentrates its assets in real estate-related investments, the value of its portfolio is subject to factors affecting the real estate industry and may fluctuate more than the value of a portfolio that consists of securities of companies in a broader range of industries.
Short Sales Risk – The Fund runs the risk that an underlying fund’s loss on a short sale of securities that the underlying fund does not own is unlimited.
Focused Investment Risk – Focusing investments in countries, regions, sectors or companies or in industries with high positive correlations to one another creates additional risk.
Market Disruption and Geopolitical Risk – Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk – To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.

 


 

The Fund invests (including through investment in underlying funds) in asset-backed securities, which may be backed by many types of assets, including pools of residential and commercial mortgages, automobile loans, educational loans, home equity loans, or credit card receivables, which expose the Fund to additional types of market risk. They also may be backed by pools of corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds and loans (commonly referred to as “collateralized debt obligations” or “collateralized loan obligations”) and by the fees earned by service providers. Payment of interest on asset backed securities and repayment of principal largely depend on the cash flows generated by the assets backing the securities. The market risk of a particular asset-backed security depends on many factors, including the deal structure (e.g., determination as to the amount of underlying assets or other support needed to produce the cash flows necessary to service interest and make principal payments), the quality of the underlying assets and, if any, the level of credit support and the credit quality of the credit-support provider. Asset-backed securities involve risk of loss of principal if obligors of the underlying obligations default and the value of the defaulted obligations exceeds whatever credit support the securities may have. The obligations of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and other laws affecting the rights and remedies of creditors. Many asset-backed securities in which the Fund has invested are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal and/or interest will be paid because the insurer could default on its obligations. In recent years, a significant number of asset-backed security insurers have defaulted on their obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about the creditworthiness of those securities (and underlying assets) caused credit spreads (the difference between yields on the asset-backed securities and U.S. Government securities) to widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions to make markets in many fixed income securities. These events reduced liquidity and contributed to substantial declines in the value of asset-backed and other fixed income securities. There can be no assurance these conditions will not occur again. Also, government actions and proposals affecting the terms of underlying home and consumer loans, changes in demand for products (e.g., automobiles) financed by those loans, and the inability of borrowers to refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying assets and is, therefore, subject to risks associated with the negligence or defalcation of its servicer. In some circumstances, the mishandling of related documentation also may affect the rights of security holders in and to the underlying assets. The insolvency of entities that generate receivables or that utilize the assets may result in a decline in the value of the underlying assets, as well as costs and delays. The obligations underlying asset-backed securities, in particular securities backed by pools of residential and commercial mortgages, also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as high a yield as is provided by the asset-backed security. The risk of investing in asset-backed securities has increased because performance of the various sectors in which the assets underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime mortgages, and credit card receivables) has become more highly correlated since the deterioration in worldwide economic and liquidity conditions.
Derivative financial instruments
At November 30, 2011, the Fund held no derivative financial instruments directly. For a listing of derivative financial instruments held by the underlying funds, if any, please refer to the underlying funds’ Schedule of Investments.
For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Core Plus Bond Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Par Value   Description   Value ($)  
 
       
DEBT OBLIGATIONS — 46.3%
       
       
 
       
       
Australia — 0.2%
       
       
 
       
       
Asset-Backed Securities
       
USD   170,411  
Crusade Global Trust, Series 07-1, Class A1, 3 mo. LIBOR + .06%, 0.47%, due 04/19/38
    163,751  
USD   241,147  
Medallion Trust, Series 05-1G, Class A1, 3 mo. LIBOR + .08%, 0.52%, due 05/10/36
    232,509  
       
 
     
       
Total Australia
    396,260  
       
 
     
       
 
       
       
United Kingdom — 0.2%
       
       
 
       
       
Asset-Backed Securities
       
USD   493,644  
Brunel Residential Mortgages, Series 07-1A, Class A4C, 144A, 3 mo. LIBOR + .10%, 0.50%, due 01/13/39
    437,359  
USD   28,821  
Granite Master Issuer Plc, Series 06-2, Class A4, 1 mo. LIBOR + .04%, 0.33%, due 12/20/54
    27,610  
USD   150,000  
Permanent Master Issuer Plc, Series 07-1, Class 4A, 3 mo. LIBOR + .08%, 0.48%, due 10/15/33
    149,235  
       
 
     
       
Total United Kingdom
    614,204  
       
 
     
       
 
       
       
United States — 45.9%
       
       
 
       
       
Asset-Backed Securities — 2.7%
       
USD   293,914  
Alliance Bancorp Trust, Series 07-S1, Class A1, 144A, 1 mo. LIBOR + .20%, 0.46%, due 05/25/37
    14,696  
USD   104,140  
AmeriCredit Automobile Receivables Trust, Series 07-AX, Class A4, XL, 1 mo. LIBOR + .04%, 0.29%, due 10/06/13
    103,880  
USD   1,020,265  
Argent Securities, Inc., Series 06-M1, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 07/25/36
    264,950  
USD   102,563  
Argent Securities, Inc., Series 06-M2, Class A2B, 1 mo. LIBOR + .11%, 0.37%, due 09/25/36
    30,000  
USD   858,523  
Argent Securities, Inc., Series 06-W5, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 06/25/36
    225,899  
USD   132,754  
Bayview Commercial Asset Trust, Series 05-4A, Class A2, 144A, 1 mo. LIBOR + .39%, 0.65%, due 01/25/36
    83,635  
USD   500,000  
Charming Shoppes Master Trust, Series 07-1A, Class A1, 144A, 1 mo. LIBOR + 1.25%, 1.50%, due 09/15/17
    500,825  
USD   300,000  
College Loan Corp. Trust, Series 07-2, Class A1, 3 mo. LIBOR + .25%, 0.67%, due 01/25/24
    292,500  
USD   428,691  
Crest Exeter Street Solar, Series 04-1A, Class A1, 144A, 3 mo. LIBOR + .35%, 0.71%, due 06/28/19
    394,395  
USD   132,689  
Daimler Chrysler Auto Trust, Series 08-B, Class A4B, 1 mo. LIBOR + 1.85%, 2.10%, due 11/10/14
    133,020  
USD   633,335  
First Franklin Mortgage Loan Asset Backed Certificates, Series 06-FF5, Class 2A3, 1 mo. LIBOR + .16%, 0.42%, due 04/25/36
    376,043  
USD   383,994  
Fremont Home Loan Trust, Series 06-A, Class 1A2, 1 mo. LIBOR + .20%, 0.45%, due 05/25/36
    205,737  
USD   95,080  
Fremont Home Loan Trust, Series 06-B, Class 2A3, 1 mo. LIBOR + .16%, 0.42%, due 08/25/36
    26,622  
USD   776,581  
GE Business Loan Trust, Series 05-2A, Class A, 144A, 1 mo. LIBOR + .24%, 0.49%, due 11/15/33
    636,796  
USD   800,000  
GS Mortgage Securities Corp., Series 07-EOP, Class A2, 144A, 1 mo. LIBOR + .57%, 1.32%, due 03/06/20
    792,000  
USD   155,556  
Master Asset-Backed Securities Trust, Series 06-FRE2, Class A4, 1 mo. LIBOR + .15%, 0.41%, due 03/25/36
    54,445  
USD   700,000  
Master Asset-Backed Securities Trust, Series 06-HE2, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 06/25/36
    210,000  
USD   500,000  
Morgan Stanley Capital, Inc., Series 07-HE4, Class A2C, 1 mo. LIBOR + .23%, 0.49%, due 02/25/37
    105,000  
USD   36,862  
National Collegiate Student Loan Trust, Series 06-1, Class A2, 1 mo. LIBOR + .14%, 0.40%, due 08/25/23
    35,756  
USD   14,299  
Residential Asset Securities Corp., Series 07-KS3, Class AI1, 1 mo. LIBOR + .11%, 0.37%, due 04/25/37
    14,196  
USD   55,326  
Residential Funding Mortgage Securities II, Series 03-HS1, Class AII, FGIC, 1 mo. LIBOR + .29%, 0.55%, due 12/25/32
    16,044  
USD   100,421  
SBI Heloc Trust, Series 05-HE1, Class 1A, 144A, FSA, 1 mo. LIBOR + .19%, 0.45%, due 11/25/35
    90,971  
USD   261,468  
Sierra Receivables Funding Co., Series 06-1A, Class A2, 144A, MBIA, 1 mo. LIBOR + .15%, 0.40%, due 05/20/18
    258,774  
USD   136,777  
SLM Student Loan Trust, Series 07-A, Class A1, 3 mo. LIBOR + .03%, 0.38%, due 09/15/22
    136,436  

 


 

                 
USD   39,152  
Structured Asset Securities Corp., Series 05-S6, Class A2, 1 mo. LIBOR + .29%, 0.84%, due 11/25/35
    30,245  
USD   296,211  
Triad Auto Receivables Owner Trust, Series 07-B, Class A4B, FSA, 1 mo. LIBOR + 1.20%, 1.45%, due 07/14/14
    297,653  
USD   517,441  
Wachovia Auto Owner Trust, Series 08-A, Class A4B, 1 mo. LIBOR + 1.15%, 1.40%, due 03/20/14
    519,195  
USD   400,000  
World Financial Network Credit Card Master Trust, Series 06-A, Class A, 144A, 1 mo. LIBOR + .13%, 0.38%, due 02/15/17
    396,876  
       
 
     
       
 
    6,246,589  
       
 
     
       
 
       
       
Corporate Debt — 0.5%
       
USD   210,000  
CIT Group, Inc., 144A, 7.00%, due 05/04/15
    209,475  
USD   350,000  
CIT Group, Inc., 144A, 7.00%, due 05/02/16
    343,700  
USD   490,000  
CIT Group, Inc., 144A, 7.00%, due 05/02/17
    481,425  
       
 
     
       
 
    1,034,600  
       
 
     
       
 
       
       
U.S. Government — 33.7%
       
USD   14,281,227  
Republic of Albania Par Bond, Zero Coupon, due 08/31/25(a)
    6,997,801  
USD   18,895,214  
U.S. Treasury Inflation Indexed Note, 2.00%, due 04/15/12(b)(c)
    18,958,683  
USD   30,000,000  
U.S. Treasury Note, 2.50%, due 03/31/15(b)
    31,989,840  
USD   10,100,000  
U.S. Treasury Receipts, 0.00%, due 02/15/12(d)
    10,078,659  
USD   10,100,000  
U.S. Treasury Receipts, 0.00%, due 08/15/12(d)
    10,020,947  
       
 
     
       
 
    78,045,930  
       
 
     
       
 
       
       
U.S. Government Agency — 9.0%
       
USD   20,000,000  
Federal National Mortage Assoc.,TBA, 4.00%, due 02/01/40
    20,825,000  
       
 
     
       
Total United States
    106,152,119  
       
 
     
       
TOTAL DEBT OBLIGATIONS (COST $104,703,068)
    107,162,583  
       
 
     
                 
Shares     Description   Value ($)  
 
       
MUTUAL FUNDS — 62.0%
       
       
 
       
       
United States — 62.0%
       
       
 
       
       
Affiliated Issuers
       
  854,029    
GMO Emerging Country Debt Fund, Class IV
    8,087,653  
  7,417,054    
GMO Short-Duration Collateral Fund
    49,026,728  
  93,858    
GMO Special Purpose Holding Fund(e)
    36,604  
  1,533,857    
GMO U.S. Treasury Fund
    38,361,760  
  2,030,456    
GMO World Opportunity Overlay Fund
    47,918,767  
       
 
     
       
Total United States
    143,431,512  
       
 
     
       
 
       
       
TOTAL MUTUAL FUNDS (COST $148,632,765)
    143,431,512  
       
 
     
                 
       
SHORT-TERM INVESTMENTS — 0.7%
       
                 
       
Money Market Funds — 0.1%
       
  264,081    
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00%(f)
    264,081  
       
U.S. Government — 0.6%
       
  1,300,000    
U.S. Treasury Bill, 0.10%, due 10/18/12 (b)(g)
    1,298,838  
       
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $1,562,825)
    1,562,919  
       
 
     
       
TOTAL INVESTMENTS — 109.0%
(Cost $254,898,658)
    252,157,014  
       
Other Assets and Liabilities (net) — (9.0%)
    (20,772,312 )
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 231,384,702  
       
 
     

 


 

A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
                                         
                                    Net Unrealized  
Settlement                                 Appreciation  
Date     Counterparty   Deliver/Receive     Units of Currency     Value     (Depreciation)  
Buys  
 
                               
  12/06/11    
Barclays Bank PLC
  AUD     1,700,000     $ 1,747,466     $ (7,040 )
  12/06/11    
Citibank N.A.
  AUD     300,000       308,376       (4,512 )
  12/06/11    
Credit Suisse International
  AUD     1,900,000       1,953,050       91,088  
  12/06/11    
Deutsche Bank AG
  AUD     12,100,000       12,437,847       637,787  
  12/06/11    
Royal Bank of Scotland PLC
  AUD     700,000       719,545       6,528  
  12/13/11    
Barclays Bank PLC
  CAD     900,000       882,135       (22,028 )
  12/13/11    
Citibank N.A.
  CAD     800,000       784,120       (19,957 )
  12/13/11    
Credit Suisse International
  CAD     5,100,000       4,998,766       (23,682 )
  12/13/11    
Deutsche Bank AG
  CAD     5,800,000       5,684,871       36,380  
  12/13/11    
Royal Bank of Scotland PLC
  CAD     3,800,000       3,724,571       (61,193 )
  1/31/12    
Deutsche Bank AG
  CHF     600,000       657,851       2,178  
  2/07/12    
Citibank N.A.
  EUR     300,000       403,371       (2,073 )
  2/07/12    
Credit Suisse International
  EUR     1,700,000       2,285,769       16,915  
  1/10/12    
Citibank N.A.
  GBP     1,200,000       1,882,017       (40,153 )
  1/10/12    
Credit Suisse International
  GBP     3,800,000       5,959,720       (89,982 )
  1/10/12    
Deutsche Bank AG
  GBP     700,000       1,097,843       (24,257 )
  1/10/12    
Royal Bank of Scotland PLC
  GBP     1,200,000       1,882,017       (13,137 )
  2/14/12    
Credit Suisse International
  JPY     210,000,000       2,711,864       2,291  
  2/21/12    
Deutsche Bank AG
  NOK     29,000,000       5,003,329       59,586  
  2/21/12    
Royal Bank of Scotland PLC
  NOK     5,100,000       879,896       13,689  
  1/24/12    
Credit Suisse International
  NZD     1,500,000       1,166,913       (10,137 )
  12/20/11    
Barclays Bank PLC
  SEK     14,700,000       2,170,368       (44,155 )

 


 

                                         
  12/20/11    
Citibank N.A.
  SEK     10,600,000       1,565,027       (9,463 )
  12/20/11    
Credit Suisse International
  SEK     18,400,000       2,716,651       54,014  
  12/20/11    
Deutsche Bank AG
  SEK     12,400,000       1,830,786       (106,909 )
       
 
                           
       
 
                  $ 65,454,169     $ 441,778  
       
 
                           
       
 
                               
Sales #  
 
                               
  12/06/11    
Citibank N.A.
  AUD     1,500,000     $ 1,541,882     $ 10,645  
  12/06/11    
Credit Suisse International
  AUD     3,800,000       3,906,101       (30,735 )
  12/06/11    
Deutsche Bank AG
  AUD     1,600,000       1,644,674       (14,274 )
  12/06/11    
Royal Bank of Scotland PLC
  AUD     1,900,000       1,953,051       (95,550 )
  12/13/11    
Citibank N.A.
  CAD     1,200,000       1,176,180       5,108  
  12/13/11    
Credit Suisse International
  CAD     1,400,000       1,372,210       (52,452 )
  12/13/11    
Deutsche Bank AG
  CAD     16,900,000       16,564,538       (256,915 )
  1/31/12    
Barclays Bank PLC
  CHF     1,100,000       1,206,061       17,916  
  1/31/12    
Credit Suisse International
  CHF     5,300,000       5,811,021       153,080  
  1/31/12    
Royal Bank of Scotland PLC
  CHF     2,200,000       2,412,122       41,182  
  2/07/12    
Citibank N.A.
  EUR     900,000       1,210,113       1,602  
  2/07/12    
Deutsche Bank AG
  EUR     10,800,000       14,521,358       182,842  
  1/10/12    
Citibank N.A.
  GBP     1,500,000       2,352,521       (17,621 )
  1/10/12    
Credit Suisse International
  GBP     3,200,000       5,018,711       (24,037 )
  1/10/12    
Deutsche Bank AG
  GBP     500,000       784,174       6,026  
  1/10/12    
Royal Bank of Scotland PLC
  GBP     700,000       1,097,843       5,031  
  2/14/12    
Barclays Bank PLC
  JPY     70,000,000       903,955       7,884  
  2/14/12    
Citibank N.A.
  JPY     110,000,000       1,420,500       982  
  2/14/12    
Credit Suisse International
  JPY     130,000,000       1,678,773       15,546  
  2/14/12    
Deutsche Bank AG
  JPY     500,000,000       6,456,818       50,210  
  2/14/12    
Royal Bank of Scotland PLC
  JPY     120,000,000       1,549,636       12,335  
  1/24/12    
Citibank N.A.
  NZD     600,000       466,765       (13,705 )
  1/24/12    
Deutsche Bank AG
  NZD     1,000,000       777,942       10,108  
  1/24/12    
Royal Bank of Scotland PLC
  NZD     1,000,000       777,942       (19,732 )
  12/20/11    
Barclays Bank PLC
  SEK     9,000,000       1,328,797       500  
  12/20/11    
Credit Suisse International
  SEK     42,000,000       6,201,050       300,175  
       
 
                           
       
 
                  $ 84,134,738     $ 296,151  
       
 
                           
 
  Fund buys foreign currency; sells USD.
 
#   Fund sells foreign currency; buys USD.

 


 

Futures Contracts
                                 
                            Net Unrealized  
Number of         Expiration             Appreciation  
Contracts     Type   Date     Value     (Depreciation)  
Buys  
 
                       
  95    
Euro Bund
  December 2011   $ 17,082,318     $ (365,359 )
  4    
Japanese Government Bond 10 Yr. (TSE)
  December 2011     7,311,501       (55,355 )
  75    
U.S. Treasury Note 10 Yr. (CBT)
  March 2012     9,700,781       (91,629 )
       
 
                   
       
 
          $ 34,094,600     $ (512,343 )
       
 
                   
       
Sales  
 
                       
  69    
Australian Government Bond 10 Yr.
  December 2011   $ 8,278,555     $ (181,976 )
  40    
Canadian Government Bond 10 Yr.
  March 2012     5,177,509       (27,456 )
  2    
Euro BOBL
  December 2011     329,556       (180 )
  2    
Euro SCHATZ
  December 2011     296,178       (631 )
  12    
U.S. Treasury Bond 30 Yr. (CBT)
  March 2012     1,696,500       15,339  
  83    
U.S. Treasury Note 2 Yr. (CBT)
  March 2012     18,301,500       (5,436 )
  31    
U.S. Treasury Note 5 Yr. (CBT)
  March 2012     3,801,860       4,751  
  65    
UK Gilt Long Bond
  March 2012     11,574,564       129,105  
       
 
                   
       
 
          $ 49,456,222     $ (66,484 )
       
 
                   
Swap Agreements
Credit Default Swaps
                                                 
                                        Maximum Potential      
                        Implied             Amount of Future   Net Unrealized  
Notional   Expiration       Receive   Annual     Credit     Reference     Payments by the Fund   Appreciation/  
Amount   Date   Counterparty   (Pay)^   Premium     Spread (1)     Entity     Under the Contract (2)   (Depreciation)  
2,000,000 USD
  12/20/2013   Barclays Bank PLC   Receive     0.25 %     5.45 %   SLM Corp.   2,000,000 USD   $ (196,502 )
 
                                             
 
                    Premiums to (Pay) Receive   $  
 
                                             
 
^   Receive — Fund receives premium and sells credit protection. If a credit event occurs, as defined under the terms of that particular swap agreement, the Fund will either (i) pay to the buyer of protection an amount equal to the notional amount of the swap and take delivery of the referenced obligation or underlying securities comprising the referenced index or (ii) pay a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation or underlying securities comprising the referenced index.
 
    (Pay) — Fund pays premium and buys credit protection. If a credit event occurs, as defined under the terms of that particular swap agreement, the Fund will either (i) receive from the seller of protection an amount equal to the notional amount of the swap and deliver the referenced obligation or underlying securities comprising the referenced index or (ii) receive a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation or underlying securities comprising the referenced index.
 
(1)   Implied credit spreads, represented in absolute terms, utilized in determining the market value of credit default swap agreements on the reference security, as of November 30, 2011, serve as an indicator of the current status of the payment/performance risk and reflect the likelihood or risk of default for the reference entity. The implied credit spread of a particular referenced entity reflects the cost of buying/selling protection. Wider (i.e. higher) credit spreads represent a deterioration of the referenced entity’s credit soundness and a greater likelihood or risk of default or other credit event occurring as defined under the terms of the agreement.
 
(2)   The maximum potential amount the Fund could be required to pay as a seller of credit protection if a credit event occurs as defined under the terms of that particular swap agreement.

 


 

Interest Rate Swaps
                                 
                            Net Unrealized  
Notional   Expiration       Receive               Appreciation/  
Amount   Date   Counterparty   (Pay)#   Fixed Rate     Variable Rate   (Depreciation)  
3,700,000 CHF
  3/21/2022   Citibank N.A.   Receive     1.80 %   6 Month CHF LIBOR   $ 132,453  
4,600,000 CHF
  3/21/2022   Deutsche Bank AG   Receive     1.80 %   6 Month CHF LIBOR     164,671  
3,900,000 CHF
  3/21/2022   Barclays Bank PLC   Receive     1.80 %   6 Month CHF LIBOR     139,612  
40,400,000 SEK
  3/21/2022   JPMorgan Chase Bank, N.A.   (Pay)     2.90 %   3 Month SEK STIBOR     (271,431 )
57,100,000 SEK
  3/21/2022   Barclays Bank PLC   (Pay)     2.90 %   3 Month SEK STIBOR     (383,631 )
 
                             
 
                          $ (218,326 )
 
                             
 
        Premiums to (Pay) Receive   $ 93,846  
 
                             
 
#   Receive — Fund receives fixed rate and pays variable rate.
 
    (Pay) — Fund pays fixed rate and receives variable rate.
Total Return Swaps
                         
                    Net Unrealized  
Notional   Expiration               Appreciation/  
Amount   Date   Counterparty   Fund Pays   Fund Receives   (Depreciation)  
175,000,000 USD
  2/17/2012   Merrill Lynch Capital Services, Inc.   1 month LIBOR minus 0.15%   Lehman Aggregate Total Return Index   $ (410,153 )
 
                     
 
      Premiums to (Pay) Receive   $  
 
                     
As of November 30, 2011 for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
Notes to Schedule of Investments:
144A — Securities exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional investors.
CHF LIBOR — London Interbank Offered Rate denominated in Swiss Franc.
FGIC — Insured as to the payment of principal and interest by Financial Guaranty Insurance Corporation.
FSA — Insured as to the payment of principal and interest by Financial Security Assurance.
LIBOR — London Interbank Offered Rate
MBIA — Insured as to the payment of principal and interest by MBIA Insurance Corp.
SEK STIBOR — Stockholm Interbank Offered Rate denominated in Swedish Krona.
TBA — To Be Announced — Delayed Delivery Security
XL — Insured as to the payment of principal and interest by XL Capital Assurance.
The rates shown on variable rate notes are the current interest rates at November 30, 2011, which are subject to change based on the terms of the security.
(a)   Security is backed by the U.S. Government.
 
(b)   All or a portion of this security has been pledged to cover margin requirements on futures contracts, collateral on swap contracts, forward currency contracts, and/or written options, if any. (Note 4).
 
(c)   Indexed security in which price and/or coupon is linked to the prices of a specific instrument or financial statistic.

 


 

(d)   Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust.
 
(e)   Underlying investment represents interests in defaulted claims. See “Other matters” for additional information.
 
(f)   Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.
 
(g)   Rate shown represents yield-to-maturity.
Currency Abbreviations:
AUD — Australian Dollar
CAD — Canadian Dollar
CHF — Swiss Franc
EUR — Euro
GBP — British Pound
JPY — Japanese Yen
NOK — Norwegian Krone
NZD — New Zealand Dollar
SEK — Swedish Krona
USD — United States Dollar

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
             
    Gross   Gross   Net Unrealized
    Unrealized   Unrealized   Appreciation
Aggregate Cost   Appreciation   (Depreciation)   (Depreciation)
$280,404,549
  $4,952,485   $(33,200,020)   $(28,247,535)
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                         
    Value,                             Distributions              
    beginning of             Sales     Dividend     of Realized     Returm of     Value, end  
     Affiliate   period     Purchases     Proceeds     Income*     Gains*     Capital*     of period  
GMO Emerging Country Debt Fund, Class IV
  $ 7,081,912     $ 1,124,659     $ 400,000     $ 94,659     $     $     $ 8,087,653  
GMO Short-Duration Collateral Fund
    76,989,022                   583,195             25,686,857       49,026,728  
GMO Special Purpose Holding Fund
    46,929                                     36,604  
GMO U.S. Treasury Fund
    7,570,707       58,587,844       27,800,000       6,608       1,236             38,361,760  
GMO World Opportunity Overlay Fund
    47,034,438       2,150,000       3,175,000                         47,918,767  
 
                                         
Totals
  $ 138,723,008     $ 61,862,503     $ 31,375,000     $ 684,462     $ 1,236     $ 25,686,857     $ 143,431,512  
 
                                         
 
*   The table above includes estimated sources of all distributions paid by the underlying funds during the period March 1, 2011 through November 30, 2011 for tax purposes. The actual tax characterization of distributions paid by the underlying funds will be determined through the fiscal year ending February 29, 2012.

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly and indirectly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 9.8% of net assets. The Fund and the underlying funds classify such securities (levels defined below) as Level 3. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivatives contracts based on the creditworthiness of its counterparties. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Typically the Fund and the underlying funds value debt instruments based on the most recent quoted price supplied by a single pricing source chosen by the Manager. Although the Manager normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and may change a pricing source at any time. The Manager monitors erratic or unusual movements (including unusual inactivity) in the prices supplied for a security and has discretion to override a price supplied by a source (e.g., by taking a price supplied by another) when it believes that the price supplied is not reliable. Although alternative prices may be available for securities held by the Fund and the underlying funds, those alternative sources are not typically part of the valuation process and do not necessarily provide greater certainty about the prices used by the Fund and the underlying funds. As of November 30, 2011, the total value of securities held directly and indirectly for which no alternative pricing source was available represented 7.8% of the net assets of the Fund.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.

 


 

Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit risk, yield curves and similar data. The Fund also used third party valuation services (which use industry models and inputs from pricing vendors) to value credit default swaps.
Level 3 — Valuations based primarily on inputs that are unobservable and significant. The Fund utilized a number of fair value techniques on Level 3 investments, including the following: The Fund valued certain debt securities using quoted prices. The Fund also valued certain other debt securities by using an estimated specified spread above the LIBOR rate or U.S. Treasury yield.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Debt Obligations
                               
Asset-Backed Securities
  $     $ 557,010     $ 6,700,043     $ 7,257,053  
Corporate Debt
          1,034,600             1,034,600  
U.S. Government
    31,989,840       25,956,484       20,099,606       78,045,930  
U.S. Government Agency
          20,825,000             20,825,000  
 
                       
TOTAL DEBT OBLIGATIONS
    31,989,840       48,373,094       26,799,649       107,162,583  
 
                       
Mutual Funds
    143,394,908       36,604             143,431,512  
Short-Term Investments
    1,562,919                   1,562,919  
 
                       
Total Investments
    176,947,667       48,409,698       26,799,649       252,157,014  
 
                       
Derivatives*
                               
Forward Currency Contracts
                               
Foreign Currency risk
          1,741,628             1,741,628  
Futures Contracts
                               
Interest Rate risk
    149,195                   149,195  
Swap Agreements
                               
Interest Rate risk
          436,736             436,736  
 
                       
Total
  $ 177,096,862     $ 50,588,062     $ 26,799,649     $ 254,484,573  
 
                       
LIABILITY VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Liabilities     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Derivatives*
                               
Forward Currency Contracts
                               
Foreign Currency risk
  $     $ (1,003,699 )   $     $ (1,003,699 )
Futures Contracts
                               
Interest Rate risk
    (728,022 )                 (728,022 )
Swap Agreements
                               
Credit risk
          (196,502 )           (196,502 )
Interest Rate risk
          (1,065,215 )           (1,065,215 )
 
                       
Total
  $ (728,022 )   $ (2,265,416 )   $     $ (2,993,438 )
 
                       

 


 

The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
 
*   Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as either Level 1 or Level 2. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net values of the Fund’s investments (both direct and indirect) in securities and derivative financial instruments using Level 3 inputs were 33.5% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant unobservable inputs (Level 3) were used in determining value:

 


 

                                                                                 
                                                                            Net Change in  
                                                                            Unrealized  
                                                                            Appreciation  
                                                                            (Depreciation)  
                                                                            from  
                                            Change in                             Investments Still  
    Balances as of                     Accrued             Unrealized                     Balances as of     Held as of  
    February 28,                     Discounts/     Total Realized     Appreciation     Transfers into     Transfers out of     November 30,     November 30,  
    2011     Purchases     Sales     Premiums     Gain/(Loss)     (Depreciation)     level 3 *     level 3 *     2011     2011  
Debt Obligations
                                                                               
Asset Backed Securities
  $ 9,187,027     $     $ (1,897,778 )   $ 107,138     $ 253,386     $ (949,730 )   $     $     $ 6,700,043     $ (919,037 )
U.S Government
    19,856,848                   961,293             (718,535 )                 20,099,606       (718,535 )
 
                                                           
Total
  $ 29,043,875     $     $ (1,897,778 )   $ 1,068,431     $ 253,386     $ (1,668,265 )   $     $     $ 26,799,649     $ (1,637,572 )
 
                                                           
 
*   The Fund accounts for investments and derivatives transferred into Level 3 at the value at the beginning of the period and transferred out of Level 3 at the value at the end of the period.

 


 

Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase the security at an agreed upon price and date. The Fund, through its custodian, takes possession of securities it acquired under the repurchase agreement. The value of the securities acquired is required by contract to be marked to market daily and additional collateral is required to be transferred so that the market value is at least equal to the amount owed to the Fund by the seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings and/or the value of the securities subject to the repurchase agreement is insufficient, the Fund’s recovery of cash from the seller may be delayed and the Fund may incur a loss equal to the difference between the cash it paid and the value of the securities. The Fund had no repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same assets at an agreed upon price and date. The Fund can use the proceeds received from entering into a reverse repurchase agreement to make additional investments, which generally causes the Fund’s portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the securities it sold and as a result would realize a loss equal to the difference between the value of those securities and the payment it received for them. The size of this loss will depend upon the difference between what the buyer paid for the securities the Fund sold to it and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of $100). In the event of a buyer’s bankruptcy or insolvency, the Fund’s use of proceeds from the sale of its securities may be restricted while the other party or its trustee or receiver determines whether to honor the Fund’s right to repurchase the securities. The Fund had no reverse repurchase agreements outstanding at the end of the period.
Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income securities whose principal value is adjusted periodically according to the rate of inflation. Two structures are common. The U.S. Treasury and some other issuers use a structure that reflects inflation in the principal value of the bond. Most other issuers pay out any inflation related accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real interest rates. Real interest rates, in turn, are tied to the relationship between nominal interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e. nominal interest rate minus inflation) might decline, leading to an increase in value of inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than inflation, real interest rates might rise, leading to a decrease in value of inflation indexed bonds. There can be no assurance, however, that the value of inflation indexed bonds will be directly correlated to changes in nominal interest rates, and short term increases in inflation may lead to a decline in their value. Coupon payments received by the Fund from inflation indexed bonds are included in the Fund’s gross income for the period in which they accrue. In addition, any increase or decrease in the principal amount of an inflation indexed bond will increase or decrease taxable ordinary income to the Fund, even though principal is not paid until maturity. Inflation-indexed bonds outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
The Fund may purchase or sell securities on a when-issued or forward commitment basis. Payment and delivery may take place a month or more after the date of the transaction. The price of the underlying securities and the date when the securities will be delivered and paid for are fixed at the time the transaction is negotiated. Collateral consisting of liquid securities or cash and cash equivalents is maintained with the custodian in an amount at least equal to these commitments. Delayed delivery commitments outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Other matters
GMO Special Purpose Holding Fund (“SPHF”), an investment of the Fund, has litigation pending against various entities related to the 2002 fraud and related default of securities previously held by SPHF. The outcome of the lawsuits against the remaining defendants is not known and any potential recoveries are not reflected in the net asset value of SPHF. For the period ended November 30, 2011, the Fund received no distributions from SPHF in connection with the defaulted securities or the related litigation.

 


 

Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Fixed Income Securities — Typically, the market value of the Fund’s fixed income securities will decline during periods of rising interest rates and widening of credit spreads.
 
Market Risk — Asset-Backed Securities — Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
 
Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating. The Fund’s investments in below investment grade securities have speculative characteristics, and changes in economic conditions or other circumstances are more likely to impair the capacity of issuers to make principal and interest payments than is the case with issuers of investment grade securities.
 
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
 
Derivatives Risk — The use of derivatives involves the risk that their value may or may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
 
Leveraging Risk — The Fund’s use of reverse repurchase agreements and other derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
 
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations. The risk of counterparty default is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions.
 
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies with high positive correlations to one another, such as the Fund’s investments in asset-backed securities secured by different types of consumer debt (e.g., credit-card receivables, automobile loans and home equity loans), creates additional risk.
 
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies.
 
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
 
Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in underlying funds, including the risk that the underlying funds in which it invests will not perform as expected.

 


 

Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
 
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
 
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
The Fund invests (including through investment in underlying funds) in asset-backed securities, which may be backed by many types of assets, including pools of residential and commercial mortgages, automobile loans, educational loans, home equity loans, or credit card receivables, which expose the Fund to additional types of market risk. They also may be backed by pools of corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds and loans (commonly referred to as “collateralized debt obligations” or “collateralized loan obligations”) and by the fees earned by service providers. Payment of interest on asset backed securities and repayment of principal largely depend on the cash flows generated by the assets backing the securities. The market risk of a particular asset-backed security depends on many factors, including the deal structure (e.g., determination as to the amount of underlying assets or other support needed to produce the cash flows necessary to service interest and make principal payments), the quality of the underlying assets and, if any, the level of credit support and the credit quality of the credit-support provider. Asset-backed securities involve risk of loss of principal if obligors of the underlying obligations default and the value of the defaulted obligations exceeds whatever credit support the securities may have. The obligations of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and other laws affecting the rights and remedies of creditors. Many asset-backed securities in which the Fund has invested are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal and/or interest will be paid because the insurer could default on its obligations. In recent years, a significant number of asset-backed security insurers have defaulted on their obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about the creditworthiness of those securities (and underlying assets) caused credit spreads (the difference between yields on the asset-backed securities and U.S. Government securities) to widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions to make markets in many fixed income securities. These events reduced liquidity and contributed to substantial declines in the value of asset-backed and other fixed income securities. There can be no assurance these conditions will not occur again. Also, government actions and proposals affecting the terms of underlying home and consumer loans, changes in demand for products (e.g., automobiles) financed by those loans, and the inability of borrowers to refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying assets and is, therefore, subject to risks associated with the negligence or defalcation of its servicer. In some circumstances, the mishandling of related documentation also may affect the rights of security holders in and to the underlying assets. The insolvency of entities that generate receivables or that utilize the assets may result in a decline in the value of the underlying assets, as well as costs and delays. The obligations underlying asset-backed securities, in particular securities backed by pools of residential and commercial mortgages, also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as high a yield as is provided by the asset-backed security. The risk of investing in asset-backed securities has increased because performance of the various sectors in which the assets underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime mortgages, and credit card receivables) has become more highly correlated since the deterioration in worldwide economic and liquidity conditions.

 


 

Among other trading agreements, the Fund is party to International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Agreements”) or other similar types of agreements with selected counterparties that generally govern over-the-counter derivative transactions entered into by the Fund. The ISDA Agreements typically include representations and warranties as well as contractual terms related to collateral, events of default, termination events, and other provisions. Termination events may include the decline in the net assets of the Fund below a certain level over a specified period of time and entitle a counterparty to elect to terminate early with respect to some or all the transactions under the ISDA Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse effect on the Fund’s operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. In particular, the Fund may use swaps or other derivatives on an index, a single security or a basket of securities to gain investment exposures (e.g., by selling protection under a credit default swap). The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). For example, the Fund may use credit default swaps to take a short position with respect to the likelihood of default by an issuer. The Fund also may use currency derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For instance, the Manager may alter the interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is designed to maintain the Fund’s exposure to the credit of an issuer through the debt instrument but adjust the Fund’s interest rate exposure through the swap. With these swaps, the Fund and its counterparties exchange interest rate exposure, such as fixed versus variable rates and shorter duration versus longer duration exposure. In adjusting its investment exposures, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund is not limited in the extent to which it uses derivatives or in the absolute face value of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate exposure of its assets, and its net long exposure may exceed 100% of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.

 


 

Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk that it will be required to pay the full notional value of the swap contract in the event of a default.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. During the period ended November 30, 2011, the Fund used forward currency contracts to adjust exposure to foreign currencies and otherwise adjust currency exchange rate risk. Forward currency contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded. The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees,

 


 

risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. During the period ended November 30, 2011, the Fund used futures contracts to adjust exposure to certain markets and maintain the diversity and liquidity of the portfolio. Futures contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. During the period ended November 30, 2011, the Fund used purchased option contracts to adjust exposure to foreign currencies and otherwise manage currency exchange rate risk. The Fund had no purchased options contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. During the period ended November 30, 2011, the Fund used written option contracts to adjust exposure to foreign currencies and otherwise manage currency exchange rate risk. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
For the period ended November 30, 2011, investment activity in options contracts written by the Fund was as follows:
                                                 
    Puts     Calls  
    Principal                   Principal              
    Amount of     Number of           Amount of     Number of        
    Contracts     Contracts     Premiums     Contracts     Contracts     Premiums  
Outstanding, beginning of period
    (18,200,000 )         $ (358,868 )               $  
Options written
                                   
Options exercised
    18,200,000             358,868                    
Options expired
                                   
Options sold
                                   
 
                                   
Outstanding, end of period
              $                 $  
 
                                   
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.

 


 

Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. During the period ended November 30, 2011, the Fund used swap agreements to adjust interest rate exposure and adjust exposure to certain markets, achieve exposure to a reference entity’s credit, and/or provide a measure of protection against default loss. Swap agreements outstanding at the end of the period are listed in the Fund’s Schedule of Investments.

 


 

Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.

 


 

The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Assets:
                                               
Unrealized appreciation on forward currency contracts
  $     $ 1,741,628     $     $     $     $ 1,741,628  
Unrealized appreciation on futures contracts*
    149,195                               149,195  
Unrealized appreciation on swap agreements
    436,736                               436,736  
 
                                   
Total
  $ 585,931     $ 1,741,628     $     $     $     $ 2,327,559  
 
                                   
 
                                               
Liabilities:
                                               
Unrealized depreciation on forward currency contracts
  $     $ (1,003,699 )                     $ (1,003,699 )
Unrealized depreciation on futures contracts*
    (728,022 )                             (728,022 )
Unrealized depreciation on swap agreements
    (1,065,215 )           (196,502 )                 (1,261,717 )
 
                                   
Total
  $ (1,793,237 )   $ (1,003,699 )   $ (196,502 )   $     $     $ (2,993,438 )
 
                                   
 
*   The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of futures contracts as reported in the Schedule of Investments.
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts and futures contracts), notional amounts (swap agreements), or principal amounts (options) outstanding at each month-end, was as follows for the period ended November 30, 2011:
                                 
    Forward                    
    Currency     Futures     Swap        
    Contracts     Contracts     Agreements     Options  
Average amount outstanding
  $ 115,604,669     $ 141,462,660     $ 264,476,201     $ 8,616,483  

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Currency Hedged International Bond Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Par Value/Shares     Description   Value ($)  
 
       
DEBT OBLIGATIONS — 35.5%
       
       
 
       
       
Canada — 3.2%
       
       
 
       
       
Foreign Government Obligations — 3.2%
       
CAD  2,000,000    
Government of Canada, 3.50%, due 06/01/20
    2,182,401  
       
 
     
       
 
       
       
France — 6.5%
       
       
 
       
       
Foreign Government Obligations — 6.5%
       
EUR  3,300,000    
Government of France, 4.00%, due 10/25/38
    4,452,699  
       
 
     
       
 
       
       
Germany — 6.3%
       
       
 
       
       
Foreign Government Obligations — 6.3%
       
EUR  2,500,000    
Republic of Deutschland, 4.75%, due 07/04/34(a)
    4,274,980  
       
 
     
       
 
       
       
Italy — 4.6%
       
       
 
       
       
Foreign Government Obligations — 4.6%
       
EUR  3,100,000    
Italy Buoni Poliennali Del Tesoro, 5.00%, due 08/01/34
    3,135,348  
       
 
     
       
 
       
       
Netherlands — 1.1%
       
       
 
       
       
Foreign Government Obligations — 1.1%
       
EUR  500,000    
Netherlands Government Bond, 3.75%, due 01/15/42
    770,236  
       
 
     
       
 
       
       
Spain — 2.9%
       
       
 
       
       
Foreign Government Obligations — 2.9%
       
EUR  1,900,000    
Government of Spain, 4.70%, due 07/30/41
    1,970,836  
       
 
     
       
 
       
       
United Kingdom — 5.2%
       
       
 
       
       
Foreign Government Obligations — 5.2%
       
GBP  2,000,000    
United Kingdom Gilt, 3.75%, due 09/07/19
    3,540,695  
       
 
     
       
 
       
       
United States — 5.7%
       
       
 
       
       
U.S. Government — 5.7%
       
USD  3,913,210    
U.S. Treasury Inflation Indexed Note, 2.00%, due 04/15/12(a)(b)
    3,926,355  
       
 
     
       
TOTAL DEBT OBLIGATIONS (COST $23,156,613)
    24,253,550  
       
 
     
 
 
       
MUTUAL FUNDS — 63.0%
       
       
 
       
       
United States — 63.0%
       
       
 
       
       
Affiliated Issuers — 63.0%
       
  253,387    
GMO Emerging Country Debt Fund, Class IV
    2,399,577  
  2,683,050    
GMO Short-Duration Collateral Fund
    17,734,963  
  5,496    
GMO Special Purpose Holding Fund(c)
    2,143  
  352,464    
GMO U.S. Treasury Fund
    8,815,122  
  599,715    
GMO World Opportunity Overlay Fund
    14,153,284  
       
 
     
       
Total United States
    43,105,089  
       
 
     
       
TOTAL MUTUAL FUNDS (COST $44,317,664)
    43,105,089  
       
 
     

 


 

                 
Shares/Par Value     Description   Value ($)  
 
       
SHORT-TERM INVESTMENTS — 1.4%
       
       
 
       
       
Money Market Funds — 0.5%
       
  356,735    
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00%(d)
    356,735  
       
 
       
       
U.S. Government — 0.9%
       
USD  625,000    
U.S. Treasury Bill, 0.10%, due 10/18/12 (a)(e)
    624,441  
       
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $981,131)
    981,176  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 99.9%
       
       
(Cost $68,455,408)
    68,339,815  
       
 
       
       
Other Assets and Liabilities (net) — 0.1%
    54,159  
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 68,393,974  
       
 
     

 


 

A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
                                 
Settlement                           Net Unrealized
Appreciation
 
Date   Counterparty   Deliver/Receive   Units of Currency     Value     (Depreciation)  
Buys †  
 
                           
12/06/11  
Barclays Bank PLC
  AUD     400,000     $ 411,169     $ (1,472 )
12/06/11  
Citibank N.A.
  AUD     200,000       205,584       (3,008 )
12/06/11  
Credit Suisse International
  AUD     200,000       205,584       9,588  
12/06/11  
Deutsche Bank AG
  AUD     3,900,000       4,008,893       206,202  
12/06/11  
Royal Bank of Scotland PLC
  AUD     200,000       205,584       1,865  
12/13/11  
Barclays Bank PLC
  CAD     200,000       196,030       (4,895 )
12/13/11  
Citibank N.A.
  CAD     300,000       294,045       (7,484 )
12/13/11  
Credit Suisse International
  CAD     1,400,000       1,372,210       (5,597 )
12/13/11  
Deutsche Bank AG
  CAD     1,700,000       1,666,255       11,153  
12/13/11  
Royal Bank of Scotland PLC
  CAD     1,300,000       1,274,195       (17,826 )
1/31/12  
Deutsche Bank AG
  CHF     200,000       219,284       726  
2/07/12  
Citibank N.A.
  EUR     200,000       268,914       (1,382 )
2/07/12  
Credit Suisse International
  EUR     500,000       672,285       4,975  
1/10/12  
Citibank N.A.
  GBP     300,000       470,504       (10,323 )
1/10/12  
Credit Suisse International
  GBP     900,000       1,411,513       (30,599 )
1/10/12  
Deutsche Bank AG
  GBP     200,000       313,669       (6,931 )
1/10/12  
Royal Bank of Scotland PLC
  GBP     300,000       470,504       (6,974 )
2/14/12  
Credit Suisse International
  JPY     60,000,000       774,818       655  
2/21/12  
Deutsche Bank AG
  NOK     8,600,000       1,483,746       17,670  
2/21/12  
Royal Bank of Scotland PLC
  NOK     1,400,000       241,540       3,758  
1/24/12  
Credit Suisse International
  NZD     400,000       311,177       (2,703 )
12/20/11  
Barclays Bank PLC
  SEK     4,300,000       634,869       (12,765 )
12/20/11  
Citibank N.A.
  SEK     3,100,000       457,697       (2,749 )
12/20/11  
Credit Suisse International
  SEK     6,300,000       930,158       18,260  

 


 

                                 
12/20/11  
Deutsche Bank AG
  SEK     3,600,000       531,519       (31,165 )
   
 
                       
   
 
              $ 19,031,746     $ 128,979  
   
 
                       
 
Sales #  
 
                           
12/06/11  
Citibank N.A.
  AUD     400,000     $ 411,168     $ 4,961  
12/06/11  
Credit Suisse International
  AUD     1,200,000       1,233,505       (11,071 )
12/06/11  
Deutsche Bank AG
  AUD     500,000       513,961       (4,461 )
12/06/11  
Royal Bank of Scotland PLC
  AUD     500,000       513,961       (24,041 )
12/13/11  
Citibank N.A.
  CAD     400,000       392,060       1,703  
12/13/11  
Credit Suisse International
  CAD     100,000       98,015       (3,747 )
12/13/11  
Deutsche Bank AG
  CAD     7,600,000       7,449,141       (123,044 )
1/31/12  
Barclays Bank PLC
  CHF     300,000       328,926       4,886  
1/31/12  
Credit Suisse International
  CHF     1,600,000       1,754,271       42,973  
1/31/12  
Royal Bank of Scotland PLC
  CHF     700,000       767,493       13,103  
2/07/12  
Citibank N.A.
  EUR     100,000       134,457       178  
2/07/12  
Deutsche Bank AG
  EUR     14,300,000       19,227,354       242,096  
1/10/12  
Citibank N.A.
  GBP     400,000       627,339       (4,699 )
1/10/12  
Credit Suisse International
  GBP     3,000,000       4,705,042       (56,610 )
1/10/12  
Deutsche Bank AG
  GBP     100,000       156,835       1,205  
1/10/12  
Royal Bank of Scotland PLC
  GBP     200,000       313,669       1,438  
2/14/12  
Barclays Bank PLC
  JPY     20,000,000       258,273       2,253  
2/14/12  
Citibank N.A.
  JPY     30,000,000       387,409       268  
2/14/12  
Credit Suisse International
  JPY     40,000,000       516,545       4,783  
2/14/12  
Deutsche Bank AG
  JPY     150,000,000       1,937,045       15,063  
2/14/12  
Royal Bank of Scotland PLC
  JPY     30,000,000       387,409       3,084  
1/24/12  
Citibank N.A.
  NZD     200,000       155,588       (4,568 )
1/24/12  
Deutsche Bank AG
  NZD     300,000       233,383       3,032  
1/24/12  
Royal Bank of Scotland PLC
  NZD     200,000       155,588       (3,946 )
12/20/11  
Barclays Bank PLC
  SEK     2,600,000       383,875       144  
12/20/11  
Credit Suisse International
  SEK     13,200,000       1,948,902       96,124  
   
 
                       
   
 
              $ 44,991,214     $ 201,107  
   
 
                       
 
  Fund buys foreign currency; sells USD.
 
#   Fund sells foreign currency; buys USD.

 


 

Futures Contracts
                                 
                            Net Unrealized  
Number of       Expiration           Appreciation  
Contracts   Type   Date   Value     (Depreciation)  
Buys  
 
                       
  11    
Australian Government Bond 3 Yr.
  December 2011   $ 1,222,846     $ 12,678  
  82    
Euro BOBL
  December 2011     13,511,786       4,457  
  25    
Euro Bund
  December 2011     4,495,347       (119,052 )
  44    
Euro SCHATZ
  December 2011     6,515,921       19,098  
  1    
Japanese Government Bond 10 Yr. (TSE)
  December 2011     1,827,875       (15,223 )
  2    
U.S. Treasury Note 2 Yr. (CBT)
  March 2012     441,000       25  
  2    
U.S. Treasury Note 10 Yr. (CBT)
  March 2012     258,688       (2,443 )
  47    
UK Gilt Long Bond
  March 2012     8,369,300       (74,575 )
       
 
                   
       
 
          $ 36,642,763     $ (175,035 )
       
 
                   
 
Sales  
 
                       
  15    
Australian Government Bond 10 Yr.
  December 2011   $ 1,799,686     $ (39,626 )
  5    
Canadian Government Bond 10 Yr.
  March 2012     647,189       (3,908 )
  3    
U.S. Treasury Bond 30 Yr. (CBT)
  March 2012     424,125       11,382  
       
 
                   
       
 
          $ 2,871,000     $ (32,152 )
       
 
                   
Swap Agreements
Credit Default Swaps
                                                 
                                        Maximum Potential      
                            Implied         Amount of Future   Net Unrealized  
Notional   Expiration       Receive   Annual     Credit     Reference   Payments by the Fund   Appreciation/  
Amount   Date   Counterparty   (Pay)^   Premium     Spread (1)     Entity   Under the Contract (2)   (Depreciation)  
14,000,000
  USD   3/20/2014   Deutsche Bank AG   (Pay)     1.70 %     5.01 %   Republic of Italy   NA   $ 930,266  
10,000,000
  USD   3/20/2019   Deutsche Bank AG   Receive     1.66 %     4.75 %   Republic of Italy   10,000,000 USD     (1,629,036 )
 
                                             
 
                                          $ (698,770 )
 
                                             
Premiums to (Pay) Receive
  $  
 
                                             
 
^   Receive — Fund receives premium and sells credit protection. If a credit event occurs, as defined under the terms of that particular swap agreement, the Fund will either (i) pay to the buyer of protection an amount equal to the notional amount of the swap and take delivery of the referenced obligation or underlying securities comprising the referenced index or (ii) pay a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation or underlying securities comprising the referenced index.

(Pay) — Fund pays premium and buys credit protection. If a credit event occurs, as defined under the terms of that particular swap agreement, the Fund will either (i) receive from the seller of protection an amount equal to the notional amount of the swap and deliver the referenced obligation or underlying securities comprising the referenced index or (ii) receive a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation or underlying securities comprising the referenced index.
 
(1)   Implied credit spreads, represented in absolute terms, utilized in determining the market value of credit default swap agreements on the reference security, as of November 30, 2011, serve as an indicator of the current status of the payment/performance risk and reflect the likelihood or risk of default for the reference entity. The implied credit spread of a particular referenced entity reflects the cost of buying/selling protection. Wider (i.e.higher) credit spreads represent a deterioration of the referenced entity’s credit soundness and a greater likelihood or risk of default or other credit event occurring as defined under the terms of the agreement.
 
(2)   The maximum potential amount the Fund could be required to pay as a seller of credit protection if a credit event occurs as defined under the terms of that particular swap agreement.

 


 

Interest Rate Swaps
                                      
                            Net Unrealized  
Notional   Expiration       Receive               Appreciation/  
Amount   Date   Counterparty   (Pay)#   Fixed Rate     Variable Rate   (Depreciation)  
   1,300,000  CHF
  3/21/2022   Citibank N.A.   Receive     1.80 %   6 Month CHF LIBOR   $ 46,537  
   1,500,000  CHF
  3/21/2022   Deutsche Bank AG   Receive     1.80 %   6 Month CHF LIBOR     53,697  
   1,200,000  CHF
  3/21/2022   Barclays Bank PLC   Receive     1.80 %   6 Month CHF LIBOR     42,958  
 15,000,000  EUR
  6/29/2013   Merrill Lynch Capital Services   Receive     2.02 %   3 Month EUR LIBOR     185,933  
 13,000,000  SEK
  3/21/2022   JPMorgan Chase Bank, N.A.   (Pay)     2.90 %   3 Month SEK STIBOR     (87,341 )
 12,000,000  SEK
  3/21/2022   Barclays Bank PLC   (Pay)     2.90 %   3 Month SEK STIBOR     (80,623 )
 
                             
 
                          $ 161,161  
 
                             
 
                  Premiums to (Pay) Receive   $ 26,426  
 
                             
 
#   Receive — Fund receives fixed rate and pays variable rate.
 
    (Pay) — Fund pays fixed rate and receives variable rate.
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
 
Notes to Schedule of Investments:
 
CHF LIBOR — London Interbank Offered Rate denominated in Swiss Franc.
 
EUR LIBOR — London Interbank Offered Rate denominated in Euros.
 
SEK STIBOR — Stockholm Interbank Offered Rate denominated in Swedish Krona.
 
(a)   All or a portion of this security has been pledged to cover margin requirements on futures contracts, collateral on swap contracts, forward currency contracts, and/or written options, if any.
 
(b)   Indexed security in which price and/or coupon is linked to the prices of a specific instrument or financial statistic.
 
(c)   Underlying investment represents interests in defaulted claims. See “Other Matters” for additional information.
 
(d)   Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.
 
(e)   Rate shown represents yield-to-maturity.
Currency Abbreviations:
AUD — Australian Dollar

CAD — Canadian Dollar

CHF — Swiss Franc

EUR — Euro

GBP — British Pound

JPY — Japanese Yen

NOK — Norwegian Krone

NZD — New Zealand Dollar

SEK — Swedish Krona

USD — United States Dollar

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                           
      Gross     Gross     Net Unrealized  
      Unrealized     Unrealized     Appreciation  
Aggregate Cost   Appreciation     (Depreciation)     (Depreciation)  
$
75,697,825   $ 2,224,998     $ (9,583,008 )   $ (7,358,010 )
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                           
    Value,                     Distributions            
    beginning of         Sales   Dividend   of Realized   Return of   Value, end
Affiliate   period   Purchases   Proceeds   Income*   Gains*   Capital*   of period
GMO Emerging Country Debt Fund, Class IV
  $ 2,089,035   $ 632,923   $ 390,000   $ 27,923   $   $   $ 2,399,577
GMO Short-Duration Collateral Fund
    27,850,062             210,965         9,291,982     17,734,963
GMO Special Purpose Holding Fund
    2,748                         2,143
GMO U.S. Treasury Fund
    5,008,836     22,153,742     18,350,000     3,293     449         8,815,122
GMO World Opportunity Overlay Fund
    14,255,462     1,600,000     2,300,000                 14,153,284
 
                           
Totals
  $ 49,206,143   $ 24,386,665   $ 21,040,000   $ 242,181   $ 449   $ 9,291,982   $ 43,105,089
 
                           
 
*   The table above includes estimated sources of all distributions paid by the underlying funds during the period March 1, 2011 through November 30, 2011 for tax purposes. The actual tax characterization of distributions paid by the underlying funds will be determined at the end of the fiscal year ending February 29, 2012.

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly and indirectly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 1.3% of net assets. The underlying funds classify such securities (levels defined below) as Level 3. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivatives contracts based on the creditworthiness of its counterparties. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Typically the Fund and the underlying funds value debt instruments based on the most recent quoted price supplied by a single pricing source chosen by the Manager. Although the Manager normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and may change a pricing source at any time. The Manager monitors erratic or unusual movements (including unusual inactivity) in the prices supplied for a security and has discretion to override a price supplied by a source (e.g., by taking a price supplied by another) when it believes that the price supplied is not reliable. Although alternative prices may be available for securities held by the Fund and the underlying funds, those alternative sources are not typically part of the valuation process and do not necessarily provide greater certainty about the prices used by the Fund and the underlying funds. As of November 30, 2011, the total value of securities held directly and indirectly for which no alternative pricing source was available represented 8.9% of the net assets of the Fund.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit risk, yield curves and similar data. The Fund also used third party valuation services (which use industry models and inputs from pricing vendors) to value credit default swaps.
Level 3 — Valuations based primarily on inputs that are unobservable and significant.

 


 

The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Debt Obligations
                               
U.S. Government
  $     $ 3,926,355     $     $ 3,926,355  
Foreign Government Obligations
          20,327,195             20,327,195  
 
                       
TOTAL DEBT OBLIGATIONS
          24,253,550             24,253,550  
 
                       
Mutual Funds
    43,102,946       2,143             43,105,089  
Short-Term Investments
    981,176                   981,176  
 
                       
Total Investments
    44,084,122       24,255,693             68,339,815  
 
                       
Derivatives*
                               
Forward Currency Contracts
                               
Foreign Currency Risk
          712,146             712,146  
Futures Contracts
                               
Interest Rate Risk
    47,640                   47,640  
Swap Agreements
                               
Credit Risk
          930,266             930,266  
Interest Rate Risk
          329,125             329,125  
 
                       
Total
  $ 44,131,762     $ 26,227,230     $     $ 70,358,992  
 
                       
LIABILITY VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Liabilities     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Derivatives*
                               
Forward Currency Contracts
                               
Foreign Currency Risk
  $     $ (382,060 )   $     $ (382,060 )
Futures Contracts
                               
Interest Rate Risk
    (254,827 )                 (254,827 )
Swap Agreements
                               
Credit Risk
          (1,629,036 )           (1,629,036 )
Interest Rate Risk
          (167,964 )           (167,964 )
 
                       
Total
  $ (254,827 )   $ (2,179,060 )   $     $ (2,433,887 )
 
                       

 


 

The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
 
*   Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as either Level 1 or Level 2. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net values of the Fund’s investments (both direct and indirect) in securities and derivative financial instruments using Level 3 inputs were 25.3% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011 whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase the security at an agreed upon price and date. The Fund, through its custodian, takes possession of securities it acquired under the repurchase agreement. The value of the securities acquired is required by contract to be marked to market daily and additional collateral is required to be transferred so that the market value is at least equal to the amount owed to the Fund by the seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings and/or the value of the securities subject to the repurchase agreement is insufficient, the Fund’s recovery of cash from the seller may be delayed and the Fund may incur a loss equal to the difference between the cash it paid and the value of the securities. The Fund had no repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same assets at an agreed upon price and date. The Fund can use the proceeds received from entering into a reverse repurchase agreement to make additional investments, which generally causes the Fund’s portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the securities it sold and as a result would realize a loss equal to the difference between the value of those securities and the payment it received for them. The size of this loss will depend upon the difference between what the buyer paid for the securities the Fund sold to it and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of $100). In the event of a buyer’s bankruptcy or insolvency, the Fund’s use of proceeds from the sale of its securities may be restricted while the other party or its trustee or receiver determines whether to honor the Fund’s right to repurchase the securities. The Fund had no reverse repurchase agreements outstanding at the end of the period.
Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income securities whose principal value is adjusted periodically according to the rate of inflation. Two structures are common. The U.S. Treasury and some other issuers use a structure that reflects inflation in the principal value of the bond. Most other issuers pay out any inflation related accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real interest rates. Real interest rates, in turn, are tied to the relationship between nominal interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e. nominal interest rate minus inflation) might decline, leading to an increase in value of inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than inflation,

 


 

real interest rates might rise, leading to a decrease in value of inflation indexed bonds. There can be no assurance, however, that the value of inflation indexed bonds will be directly correlated to changes in nominal interest rates, and short term increases in inflation may lead to a decline in their value. Coupon payments received by the Fund from inflation indexed bonds are included in the Fund’s gross income for the period in which they accrue. In addition, any increase or decrease in the principal amount of an inflation indexed bond will increase or decrease taxable ordinary income to the Fund, even though principal is not paid until maturity. Inflation-indexed bonds outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Other matters
GMO Special Purpose Holding Fund (“SPHF”), an investment of the Fund, has litigation pending against various entities related to the 2002 fraud and related default of securities previously held by SPHF. The outcome of the lawsuits against the remaining defendants is not known and any potential recoveries are not reflected in the net asset value of SPHF. For the period ended November 30, 2011, the Fund received no distributions from SPHF in connection with the defaulted securities or the related litigation.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Fixed Income Securities — Typically, the market value of fixed income securities will decline during periods of rising interest rates and widening of credit spreads.
Market Risk Asset-Backed Securities — Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating. The Fund’s investments in below investment grade securities have speculative characteristics, and changes in economic conditions or other circumstances are more likely to impair the capacity of issuers to make principal and interest payments than is the case with issuers of investment grade securities.
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Derivatives Risk — The use of derivatives involves the risk that their value may or may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Leveraging Risk — The Fund’s use of reverse repurchase agreements and other derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations. The risk of counterparty default is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions.
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies with high positive correlations to one another, such as the Fund’s investments in asset-backed securities secured by different types of consumer debt (e.g., credit-card receivables, automobile loans and home equity loans), creates additional risk.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies.

 


 

Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in underlying funds, including the risk that the underlying funds in which it invests will not perform as expected.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
The Fund invests (including through investment in underlying funds) in asset-backed securities, which may be backed by many types of assets, including pools of residential and commercial mortgages, automobile loans, educational loans, home equity loans, or credit card receivables, which expose the Fund to additional types of market risk. They also may be backed by pools of corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds and loans (commonly referred to as “collateralized debt obligations” or “collateralized loan obligations”) and by the fees earned by service providers. Payment of interest on asset backed securities and repayment of principal largely depend on the cash flows generated by the assets backing the securities. The market risk of a particular asset-backed security depends on many factors, including the deal structure (e.g., determination as to the amount of underlying assets or other support needed to produce the cash flows necessary to service interest and make principal payments), the quality of the underlying assets and, if any, the level of credit support and the credit quality of the credit-support provider. Asset-backed securities involve risk of loss of principal if obligors of the underlying obligations default and the value of the defaulted obligations exceeds whatever credit support the securities may have. The obligations of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and other laws affecting the rights and remedies of creditors. Many asset-backed securities in which the Fund has invested are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal and/or interest will be paid because the insurer could default on its obligations. In recent years, a significant number of asset-backed security insurers have defaulted on their obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about the creditworthiness of those securities (and underlying assets) caused credit spreads (the difference between yields on the asset-backed securities and U.S. Government securities) to widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions to make markets in many fixed income securities. These events reduced liquidity and contributed to substantial declines in the value of asset-backed and other fixed income securities. There can be no assurance these conditions will not occur again. Also, government actions and proposals affecting the terms of underlying home and consumer loans, changes in demand

 


 

for products (e.g., automobiles) financed by those loans, and the inability of borrowers to refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying assets and is, therefore, subject to risks associated with the negligence or defalcation of its servicer. In some circumstances, the mishandling of related documentation also may affect the rights of security holders in and to the underlying assets. The insolvency of entities that generate receivables or that utilize the assets may result in a decline in the value of the underlying assets, as well as costs and delays. The obligations underlying asset-backed securities, in particular securities backed by pools of residential and commercial mortgages, also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as high a yield as is provided by the asset-backed security. The risk of investing in asset-backed securities has increased because performance of the various sectors in which the assets underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime mortgages, and credit card receivables) has become more highly correlated since the deterioration in worldwide economic and liquidity conditions.
Among other trading agreements, the Fund is party to International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Agreements”) or other similar types of agreements with selected counterparties that generally govern over-the-counter derivative transactions entered into by the Fund. The ISDA Agreements typically include representations and warranties as well as contractual terms related to collateral, events of default, termination events, and other provisions. Termination events may include the decline in the net assets of the Fund below a certain level over a specified period of time and entitle a counterparty to elect to terminate early with respect to some or all the transactions under the ISDA Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse effect on the Fund’s operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. In particular, the Fund may use swaps or other derivatives on an index, a single security or a basket of securities to gain investment exposures (e.g., by selling protection under a credit default swap). The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). For example, the Fund may use credit default swaps to take a short position with respect to the likelihood of default by an issuer. The Fund also may use currency derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For instance, the Manager may alter the interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is designed to maintain the Fund’s exposure to the credit of an issuer through the debt instrument but adjust the Fund’s interest rate exposure through the swap. With these swaps, the Fund and its counterparties exchange interest rate exposure, such as fixed versus variable rates and shorter duration versus longer duration exposure. In adjusting its investment exposures, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund is not limited in the extent to which it uses derivatives or in the absolute face value of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate exposure of its assets, and its net long exposure may exceed 100% of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.

 


 

The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk that it will be required to pay the full notional value of the swap contract in the event of a default.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. During the period ended November 30, 2011, the Fund used forward currency contracts to adjust exposure to foreign

 


 

currencies and otherwise adjust currency exchange rate risk. Forward currency contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded. The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. During the period ended November 30, 2011, the Fund used futures contracts to adjust interest rate exposure and maintain the diversity and liquidity of the portfolio. Futures contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. During the period ended November 30, 2011, the Fund used purchased option contracts to adjust interest rate exposure, to adjust exposure to foreign currencies and otherwise manage currency exchange rate risk. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. During the period ended November 30, 2011, the Fund used written option contracts to adjust exposure to foreign currencies and otherwise manage currency exchange rate risk. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
For the period ended November 30, 2011, investment activity in options contracts written by the Fund was as follows:
                                                 
    Puts     Calls  
    Principal                     Principal              
    Amount of     Number of             Amount of     Number of        
    Contracts     Contracts     Premiums     Contracts     Contracts     Premiums  
Outstanding, beginning of period
    (8,000,000 )         $ (157,744 )               $  
Options written
                                   
Options exercised
                                   
Options expired
    8,000,000             157,744                    
Options bought back
                                   
 
                                   
Outstanding, end of period
              $                 $  
 
                                   

 


 

Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.

 


 

Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. During the period ended November 30, 2011, the Fund used swap agreements to adjust interest rate exposure, achieve exposure to a reference entity’s credit, and/or provide a measure of protection against default loss. Swap agreements outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.

 


 

The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Assets:
                                               
Unrealized appreciation on forward currency contracts
  $     $ 712,146     $     $     $     $ 712,146  
Unrealized appreciation on futures contracts*
    47,640                               47,640  
Unrealized appreciation on swap agreements
    329,125             930,266                   1,259,391  
 
                                   
Total
  $ 376,765     $ 712,146     $ 930,266     $     $     $ 2,019,177  
 
                                   
 
                                               
Liabilities:
                                               
Unrealized depreciation on forward currency contracts
  $     $ (382,060 )   $     $     $     $ (382,060 )
Unrealized depreciation on futures contracts*
    (254,827 )                             (254,827 )
Unrealized depreciation on swap agreements
    (167,964 )           (1,629,036 )                 (1,797,000 )
 
                                   
Total
  $ (422,791 )   $ (382,060 )   $ (1,629,036 )   $     $     $ (2,433,887 )
 
                                   
 
*   The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of futures contracts as reported in the Schedule of Investments.
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts and futures contracts), notional amounts (swap agreements), or principal amounts (options) outstanding at each month-end, was as follows for the period ended November 30, 2011:
                                 
    Forward                    
    Currency     Futures     Swap        
    Contracts     Contracts     Agreements     Options  
Average amount outstanding
  $ 54,522,151     $ 49,600,340     $ 66,652,943     $ 3,787,465  

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Currency Hedged International Equity Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares/Par Value     Description   Value ($)  
 
       
MUTUAL FUNDS — 98.6%
       
       
 
       
       
United States — 98.6%
       
       
 
       
       
Affiliated Issuers
       
  11,292,804    
GMO International Growth Equity Fund, Class IV
    241,666,004  
  18,564,730    
GMO International Intrinsic Value Fund, Class IV
    362,012,225  
       
 
     
       
TOTAL MUTUAL FUNDS (COST $603,538,697)
    603,678,229  
       
 
     
       
 
       
       
SHORT-TERM INVESTMENTS — 1.0%
       
       
 
       
       
Time Deposits — 1.0%
       
 
USD 2,000,000    
Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11
    2,000,000  
EUR 7,033    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.10%, due 12/01/11
    9,430  
USD 2,000,000    
Citibank (New York) Time Deposit, 0.03%, due 12/01/11
    2,000,000  
USD 154,731    
HSBC Bank (New York) Time Deposit, 0.03%, due 12/01/11
    154,731  
USD 2,000,000    
JPMorgan Chase (New York) Time Deposit, 0.03%, due 12/01/11
    2,000,000  
       
 
     
       
Total Time Deposits
    6,164,161  
       
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $6,164,161)
    6,164,161  
       
 
     
       
 
       
        TOTAL INVESTMENTS — 99.6%
(Cost $609,702,858)
    609,842,390  
       
 
       
       
Other Assets and Liabilities (net) — 0.4%
    2,708,508  
       
 
     
 
       
TOTAL NET ASSETS — 100.0%
  $ 612,550,898  
       
 
     

 


 

A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
                                         
                                    Net Unrealized  
Settlement                                 Appreciation  
Date     Counterparty   Deliver/Receive     Units of Currency     Value     (Depreciation)  
Buys  
 
                               
  12/16/11    
JPMorgan Chase Bank, N.A.
  EUR     2,308,000     $ 3,101,579     $ (73,234 )
  12/16/11    
Royal Bank of Scotland PLC
  EUR     12,536,000       16,846,360       (317,156 )
  12/16/11    
Brown Brothers Harriman & Co.
  GBP     2,065,000       3,239,328       (59,580 )
  12/16/11    
State Street Bank and Trust Company
  JPY     214,446,000       2,765,830       (12,814 )
  12/16/11    
Morgan Stanley Capital Services Inc.
  SGD     2,519,429       1,965,801       (15,303 )
       
 
                           
       
 
                  $ 27,918,898     $ (478,087 )
       
 
                           
       
 
                               
Sales #  
 
                               
  12/16/11    
Bank of America, N.A.
  AUD     8,156,794     $ 8,373,947     $ (98,080 )
  12/16/11    
Barclays Bank PLC
  AUD     15,106,904       15,509,086       (277,323 )
  12/16/11    
JPMorgan Chase Bank, N.A.
  AUD     10,646,477       10,929,911       (581,426 )
  12/16/11    
Morgan Stanley Capital Services Inc.
  AUD     4,585,677       4,707,759       (69,805 )
  12/16/11    
Royal Bank of Scotland PLC
  AUD     6,715,716       6,894,504       (136,405 )
  12/16/11    
State Street Bank and Trust Company
  AUD     4,607,576       4,730,241       (68,986 )
  12/16/11    
Bank of America, N.A.
  CAD     1,736,750       1,702,140       3,360  
  12/16/11    
Barclays Bank PLC
  CAD     3,216,000       3,151,912       2,292  
  12/16/11    
Deutsche Bank AG
  CAD     2,161,000       2,117,936       (4,489 )
  12/16/11    
Royal Bank of Scotland PLC
  CAD     1,719,249       1,684,988       (6,885 )
  12/16/11    
State Street Bank and Trust Company
  CAD     3,283,000       3,217,577       (54,597 )
  12/16/11    
Bank of New York Mellon
  CHF     3,799,379       4,160,115       48,930  
  12/16/11    
Barclays Bank PLC
  CHF     5,196,967       5,690,399       68,333  
  12/16/11    
Brown Brothers Harriman & Co.
  CHF     11,722,497       12,835,502       (35,041 )

 


 

                                         
  12/16/11    
Deutsche Bank AG
  CHF     9,754,433       10,680,578       148,897  
  12/16/11    
JPMorgan Chase Bank, N.A.
  CHF     7,313,575       8,007,970       106,819  
  12/16/11    
Morgan Stanley Capital Services Inc.
  CHF     6,690,116       7,325,316       80,916  
  12/16/11    
Royal Bank of Scotland PLC
  CHF     2,619,000       2,867,664       17,438  
  12/16/11    
State Street Bank and Trust Company
  CHF     3,784,000       4,143,276       52,079  
  12/16/11    
Bank of New York Mellon
  DKK     23,630,000       4,270,632       65,929  
  12/16/11    
Brown Brothers Harriman & Co.
  DKK     20,808,155       3,760,642       61,576  
  12/16/11    
JPMorgan Chase Bank, N.A.
  DKK     18,116,000       3,274,091       57,174  
  12/16/11    
Morgan Stanley Capital Services Inc.
  DKK     21,090,000       3,811,580       65,301  
  12/16/11    
Royal Bank of Scotland PLC
  DKK     26,622,000       4,811,374       (16,732 )
  12/16/11    
State Street Bank and Trust Company
  DKK     16,476,000       2,977,695       49,058  
  12/16/11    
Bank of America, N.A.
  EUR     11,812,312       15,873,840       323,296  
  12/16/11    
Bank of New York Mellon
  EUR     7,817,983       10,506,107       194,988  
  12/16/11    
Barclays Bank PLC
  EUR     16,229,535       21,809,875       142,044  
  12/16/11    
Brown Brothers Harriman & Co.
  EUR     8,731,571       11,733,822       204,680  
  12/16/11    
JPMorgan Chase Bank, N.A.
  EUR     15,708,607       21,109,832       399,367  
  12/16/11    
Morgan Stanley Capital Services Inc.
  EUR     12,466,375       16,752,795       296,555  
  12/16/11    
Royal Bank of Scotland PLC
  EUR     26,283,068       35,320,200       527,561  
  12/16/11    
State Street Bank and Trust Company
  EUR     11,679,244       15,695,018       504,440  
  12/16/11    
Bank of America, N.A.
  GBP     8,040,133       12,612,409       (28,161 )
  12/16/11    
Bank of New York Mellon
  GBP     5,052,133       7,925,188       (16,478 )
  12/16/11    
Barclays Bank PLC
  GBP     5,497,670       8,624,094       (17,601 )
  12/16/11    
Brown Brothers Harriman & Co.
  GBP     13,060,000       20,486,981       (279,815 )
  12/16/11    
Deutsche Bank AG
  GBP     9,701,416       15,218,433       (44,175 )
  12/16/11    
JPMorgan Chase Bank, N.A.
  GBP     7,391,732       11,595,274       133,349  
  12/16/11    
Morgan Stanley Capital Services Inc.
  GBP     12,812,586       20,098,868       (35,742 )
  12/16/11    
Royal Bank of Scotland PLC
  GBP     5,640,000       8,847,364       (23,612 )

 


 

                                         
  12/16/11    
State Street Bank and Trust Company
  GBP     9,077,000       14,238,923       (55,112 )
  12/16/11    
JPMorgan Chase Bank, N.A.
  HKD     74,228,380       9,555,327       (8,080 )
  12/16/11    
Morgan Stanley Capital Services Inc.
  HKD     10,690,000       1,376,110       (812 )
  12/16/11    
Bank of America, N.A.
  JPY     1,407,000,929       18,146,880       197,474  
  12/16/11    
Bank of New York Mellon
  JPY     968,666,160       12,493,431       139,162  
  12/16/11    
Brown Brothers Harriman & Co.
  JPY     1,193,276,769       15,390,360       178,786  
  12/16/11    
Deutsche Bank, AG
  JPY     2,045,064,280       26,376,341       286,470  
  12/16/11    
Morgan Stanley Capital Services Inc.
  JPY     954,196,868       12,306,812       137,800  
  12/16/11    
State Street Bank and Trust Company
  JPY     2,370,126,057       30,568,845       327,171  
  12/16/11    
Bank of America, N.A.
  NOK     21,030,774       3,638,671       85,405  
  12/16/11    
Barclays Bank PLC
  NOK     38,428,750       6,648,808       124,687  
  12/16/11    
Morgan Stanley Capital Services Inc.
  NOK     35,940,000       6,218,214       117,376  
  12/16/11    
Royal Bank of Scotland PLC
  NOK     21,671,000       3,749,441       (63,291 )
  12/16/11    
JPMorgan Chase Bank, N.A.
  NZD     3,111,000       2,426,811       (43,500 )
  12/16/11    
Morgan Stanley Capital Services Inc.
  NZD     2,244,000       1,750,487       19,221  
  12/16/11    
State Street Bank and Trust Company
  NZD     2,635,000       2,055,496       23,582  
  12/16/11    
Bank of America, N.A.
  SEK     15,789,000       2,331,469       33,969  
  12/16/11    
Brown Brothers Harriman & Co.
  SEK     12,090,886       1,785,391       19,731  
  12/16/11    
JPMorgan Chase Bank, N.A.
  SEK     24,891,000       3,675,509       28,058  
  12/16/11    
Morgan Stanley Capital Services Inc.
  SEK     17,442,000       2,575,558       42,311  
  12/16/11    
State Street Bank and Trust Company
  SEK     3,724,121       549,919       6,435  
  12/16/11    
Morgan Stanley Capital Services Inc.
  SGD     2,774,000       2,164,431       (2,855 )
       
 
                           
       
 
                  $ 575,870,169     $ 3,353,017  
       
 
                           
 
  Fund buys foreign currency; sells USD.
 
#   Fund sells foreign currency; buys USD.

 


 

Currency Abbreviations:
AUD — Australian Dollar
CAD — Canadian Dollar
CHF — Swiss Franc
DKK — Danish Krone
EUR — Euro
GBP — British Pound
HKD — Hong Kong Dollar
JPY — Japanese Yen
NOK — Norwegian Krone
NZD — New Zealand Dollar
SEK — Swedish Krona
SGD — Singapore Dollar
USD — United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                         
    Gross     Gross     Net Unrealized  
    Unrealized     Unrealized     Appreciation  
Aggregate Cost   Appreciation     (Depreciation)     (Depreciation)  
$615,556,547
  $     $ (5,714,157 )   $ (5,714,157 )
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO International Growth Equity Fund, Class IV
  $ 243,215,675     $ 105,609,127     $ 91,325,791     $ 1,180,645     $     $ 241,666,004  
GMO International Intrinsic Value Fund, Class IV
    243,669,947       226,504,506       84,404,601       3,280,660             362,012,225  
 
                                   
Totals
  $ 486,885,622     $ 332,113,633     $ 175,730,392     $ 4,461,305     $     $ 603,678,229  
 
                                   

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Shares of the underlying funds and other investment funds are generally valued at their net asset value. Investments held by the underlying funds are valued as follows: Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly and indirectly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented less than 0.1% of net assets. The Fund classifies such securities (levels defined below) as Level 3. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivatives contracts based on the creditworthiness of its counterparties. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund, either directly or through investments in the underlying funds, that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below and as described in the disclosures of the underlying funds.
     
Security Type
 
Percentage of Net Assets of the Fund
Equity Securities
  89.4%
Futures Contracts
  0.4%
Swap Agreements
  (0.0)^
 
^   Rounds to 0.0%.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:

 


 

Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs.
Level 3 — Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Mutual Funds
                               
United States
  $ 603,678,229     $     $     $ 603,678,229  
 
                       
TOTAL MUTUAL FUNDS
    603,678,229                   603,678,229  
 
                       
Short-Term Investments
    6,164,161                   6,164,161  
 
                       
Total Investments
    609,842,390                   609,842,390  
 
                       
Derivatives*
                               
Forward Currency Contracts
                               
Foreign currency risk
          5,322,020             5,322,020  
 
                       
Total
  $ 609,842,390     $ 5,322,020     $     $ 615,164,410  
 
                       
LIABILITY VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active                    
    Markets for     Significant Other     Significant        
    Identical     Observable     Unobservable        
    Liabilities     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Derivatives*
                               
Forward Currency Contracts
                               
Foreign currency risk
  $     $ (2,447,090 )   $     $ (2,447,090 )
 
                       
Total
  $     $ (2,447,090 )   $     $ (2,447,090 )
 
                       

 


 

The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
* Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net values of the Fund’s indirect investments in securities using Level 3 inputs were less than 0.1% of total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011 whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. References to investments include those held directly by the Fund and indirectly through the Fund’s investments in the underlying funds. The Fund and some of the underlying funds are non-diversified investment companies under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund or an underlying fund may affect the Fund’s or the underlying fund’s performance more than if the Fund or underlying fund were diversified. Selected risks of investing in the Fund are summarized below, including those risks to which the Fund is exposed as a result of its investments in the underlying funds. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If the Fund or an underlying fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of the value of those investments. The Fund or an underlying fund also may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Because the Fund and the underlying funds normally do not take temporary defensive positions, declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and

 


 

custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in the underlying funds, including the risk that the underlying funds in which it invests will not perform as expected. Because the Fund bears the fees and expenses of the underlying funds in which it invests, new investments in underlying funds with higher fees or expenses than those of the underlying funds in which the Fund is currently invested will increase the Fund’s total expenses. The fees and expenses associated with an investment in the Fund are less predictable and may be higher than fees and expenses associated with an investment in funds that charge a fixed management fee.
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies, or that the U.S. dollar will decline in value relative to the foreign currency being hedged by the Fund or an underlying fund.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Leveraging Risk — The use of derivatives and securities lending may cause the Fund’s portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of investments decline.
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies or in industries with high positive correlations to one another creates additional risk.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Among other trading agreements, the Fund is party to International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Agreements”) or other similar types of agreements with selected counterparties that generally govern over-the-counter derivative transactions entered into by the Fund. The ISDA Agreements typically include representations and warranties as well as contractual terms related to collateral, events of default, termination events, and other provisions. Termination events may include the decline in the net assets of the Fund below a certain level over a specified period of time and entitle a counterparty to elect to terminate early with respect to some or all the transactions under the ISDA Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse effect on the Fund’s operations.

 


 

Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. For example, the Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives, to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives. The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For example, if the Fund holds a large proportion of stocks of companies in a particular sector and the Manager believes that stocks of companies in another sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index). In adjusting its investment exposure, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net long exposures in excess of its net assets. The Fund’s foreign currency exposure may differ significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.

 


 

The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most forward currency contracts are not collateralized. During the period ended November 30, 2011, the Fund used forward currency contracts to hedge foreign currency exposure in the underlying Funds’ investments relative to the U.S. dollar. Forward currency contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded (unless otherwise adjusted due to the time at which foreign markets close). The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.

 


 

The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the

 


 

expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers (unless otherwise adjusted due to the time at which foreign markets close) and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.

 


 

The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Assets:
                                               
Unrealized appreciation on forward currency contracts
  $     $ 5,322,020     $     $     $     $ 5,322,020  
 
                                   
Total
  $     $ 5,322,020     $     $     $     $ 5,322,020  
 
                                   
 
                                               
Liabilities:
                                               
Unrealized depreciation on forward currency contracts
  $     $ (2,447,090 )   $     $     $     $ (2,447,090 )
 
                                   
Total
  $     $ (2,447,090 )   $     $     $     $ (2,447,090 )
 
                                   
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts) outstanding at each month-end, was as follows for the period ended November 30, 2011:
         
    Forward  
    Currency  
    Contracts  
Average amount outstanding
  $ 471,453,787  

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Debt Opportunities Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Par Value ($)     Description   Value ($)  
 
       
DEBT OBLIGATIONS — 98.6%
       
       
 
       
       
Asset-Backed Securities — 94.5%
       
       
 
       
       
Airlines — 0.5%
       
  1,721,076    
Aircraft Finance Trust, Series 99-1A, Class A1, 144A, 1 mo. LIBOR + .48%, 0.73%, due 05/15/24
    826,117  
       
 
     
       
 
       
       
Auto Financing — 10.1%
       
  467,809    
Capital Auto Receivable Asset Trust, Series 08-1, Class A4B, 1 mo. LIBOR + 1.35%, 1.60%, due 07/15/14
    469,273  
  2,910,301    
Carmax Auto Owner Trust, Series 08-2, Class A4B, 1 mo. LIBOR + 1.65%, 1.90%, due 08/15/13
    2,928,025  
  928,820    
Daimler Chrysler Auto Trust, Series 08-B, Class A4B, 1 mo. LIBOR + 1.85%, 2.10%, due 11/10/14
    931,142  
  3,375,000    
Ford Credit Floorplan Master Owner Trust, Series 10-3, Class C, 144A, 4.99%, due 02/15/17
    3,595,050  
  61,199    
Franklin Auto Trust, Series 08-A, Class A4B, 1 mo. LIBOR + 1.95%, 2.20%, due 05/20/16
    61,260  
  244,602    
Merrill Auto Trust Securitization, Series 08-1, Class A4B, 1 mo. LIBOR + 2.20%, 2.45%, due 04/15/15
    245,556  
  77,819    
Merrill Auto Trust Securitization, Series 07-1, Class A4, 1 mo. LIBOR + .06%, 0.31%, due 12/15/13
    77,795  
  3,000,000    
Santander Consumer Acquired Receivables Trust, Series 11-WO, Class C, 144A, 3.19%, due 10/15/15
    2,985,000  
  5,000,000    
Santander Drive Auto Receivables Trust, Series 10-2, Class C, 3.89%, due 07/17/17
    5,075,000  
  840,841    
Wachovia Auto Owner Trust, Series 08-A, Class A4B, 1 mo. LIBOR + 1.15%, 1.40%, due 03/20/14
    843,691  
       
 
     
       
Total Auto Financing
    17,211,792  
       
 
     
       
 
       
       
 
       
       
Business Loans — 9.0%
       
  466,726    
ACAS Business Loan Trust, Series 07-1A, Class A, 144A, 3 mo. LIBOR + .14%, 0.60%, due 08/16/19
    455,058  
  261,610    
Bayview Commercial Asset Trust, Series 04-1, Class A, 144A, 1 mo. LIBOR + .36%, 0.62%, due 04/25/34
    198,824  
  377,489    
Bayview Commercial Asset Trust, Series 04-3, Class A1, 144A, 1 mo. LIBOR + .37%, 0.63%, due 01/25/35
    283,117  
  1,239,041    
Bayview Commercial Asset Trust, Series 05-4A, Class A2, 144A, 1 mo. LIBOR + .39%, 0.65%, due 01/25/36
    780,595  
  848,649    
Bayview Commercial Asset Trust, Series 07-3, Class A1, 144A, 1 mo. LIBOR + .24%, 0.50%, due 07/25/37
    534,649  
  1,000,000    
CNH Wholesale Master Note Trust, Series 2011-1A, Class B, 144A, 1 mo. LIBOR + 1.65%, 1.90%, due 12/15/15
    998,750  
  327,052    
GE Business Loan Trust, Series 04-1, Class A, 144A, 1 mo. LIBOR + .29%, 0.54%, due 05/15/32
    289,441  
  716,844    
GE Business Loan Trust, Series 05-2A, Class A, 144A, 1 mo. LIBOR + .24%, 0.49%, due 11/15/33
    587,812  
  4,500,000    
Great America Leasing Receivables, Series 09-1, Class C, 144A, 6.48%, due 12/15/16
    4,736,250  
  1,604,560    
Lehman Brothers Small Balance Commercial, Series 07-3A, Class 1A2, 144A, 1 mo. LIBOR + .85%, 1.11%, due 10/25/37
    1,283,038  
  884,322    
Lehman Brothers Small Balance Commercial, Series 05-1A, Class A, 144A, 1 mo. LIBOR + .25%, 0.51%, due 02/25/30
    680,539  
  668,975    
Lehman Brothers Small Balance Commercial, Series 05-2A, Class 1A, 144A, 1 mo. LIBOR + .25%, 0.51%, due 09/25/30
    527,755  
  2,000,000    
Navistar Financial Dealer Note Master Trust, Series 09-1, Class B, 144A, 1 mo. LIBOR + 4.25%, 4.51%, due 10/26/15
    2,049,400  
  2,000,000    
Navistar Financial Dealer Note Master Trust, Series 11-1, Class C, 144A, 1 mo. LIBOR + 2.50%, 2.76%, due 10/25/16
    2,000,000  
       
 
     
       
Total Business Loans
    15,405,228  
       
 
     
       
 
       
       
CMBS — 5.6%
       
  1,367,744    
Citigroup/Deutsche Bank Commercial Mortgage, Series 05-CD1, Class A2FL, 1 mo. LIBOR + .12%, 0.37%, due 07/15/44
    1,350,647  
  5,100,000    
Commercial Mortgage Pass-Through Certificates, Series 06-FL12, Class AJ, 144A, 1 mo. LIBOR + .13%, 0.38%, due 12/15/20
    4,615,500  

 


 

                 
  696,036    
GS Mortgage Securities Corp., Series 07-EOP, Class A1, 144A, 1 mo. LIBOR + .39%, 1.14%, due 03/06/20
    689,076  
  800,000    
GS Mortgage Securities Corp., Series 07-EOP, Class A2, 144A, 1 mo. LIBOR + .57%, 1.32%, due 03/06/20
    792,000  
  2,222,875    
Wachovia Bank Commercial Mortgage Trust, Series 06-WL7A, Class A1, 144A, 1 mo. LIBOR + .09%, 0.34%, due 09/15/21
    2,111,732  
       
 
     
       
Total CMBS
    9,558,955  
       
 
     
       
 
       
       
CMBS Collateralized Debt Obligations — 3.7%
       
  1,499,437    
American Capital Strategies Ltd. Commercial Real Estate CDO Trust, Series 07-1A, Class A, 144A, 3 mo. LIBOR + .80%, 1.30%, due 11/23/52
    14,994  
  896,353    
Crest Exeter Street Solar, Series 04-1A, Class A1, 144A, 3 mo. LIBOR + .35%, 0.71%, due 06/28/19
    824,645  
  1,489,226    
G-Force LLC, Series 05-RR2, Class A2, 144A, 5.16%, due 12/25/39
    1,399,872  
  835,999    
Guggenheim Structured Real Estate Funding, Series 05-2A, Class A, 144A, 1 mo. LIBOR + .32%, 0.58%, due 08/26/30
    771,209  
  4,500,988    
Marathon Real Estate CDO, Series 06-1A, Class A1, 144A, 1 mo. LIBOR + .33%, 0.59%, due 05/25/46
    3,285,721  
       
 
     
       
Total CMBS Collateralized Debt Obligations
    6,296,441  
       
 
     
       
 
       
       
Corporate Collateralized Debt Obligations — 2.7%
       
  5,200,000    
Morgan Stanley ACES SPC, Series 06-13A, Class A, 144A, 3 mo. LIBOR + .29%, 0.64%, due 06/20/13
    4,580,680  
       
 
     
       
 
       
       
Credit Cards — 7.8%
       
  4,000,000    
Capital One Multi-Asset Execution Trust, Series 03-C3, Class C3, 1 mo. LIBOR + 2.25%, 2.50%, due 07/15/16
    4,028,800  
  5,400,000    
Charming Shoppes Master Trust, Series 07-1A, Class A1, 144A, 1 mo. LIBOR + 1.25%, 1.50%, due 09/15/17
    5,408,910  
  4,000,000    
World Financial Network Credit Card Master Trust, Series 06-A, Class B, 144A, 1 mo. LIBOR + .35%, 0.60%, due 02/15/17
    3,918,437  
       
 
     
       
Total Credit Cards
    13,356,147  
       
 
     
       
 
       
       
Insured Auto Financing — 7.5%
       
  885,191    
AmeriCredit Automobile Receivables Trust, Series 07-AX, Class A4, XL, 1 mo. LIBOR + .04%, 0.29%, due 10/06/13
    882,978  
  654,310    
AmeriCredit Automobile Receivables Trust, Series 07-BF, Class A4, FSA, 1 mo. LIBOR + .05%, 0.30%, due 12/06/13
    654,297  
  869,064    
AmeriCredit Automobile Receivables Trust, Series 07-DF, Class A4B, FSA, 1 mo. LIBOR + .80%, 1.05%, due 06/06/14
    868,616  
  2,014,016    
AmeriCredit Prime Automobile Receivable Trust, Series 07-2M, Class A4B, MBIA, 1 mo. LIBOR + .50%, 0.75%, due 03/08/16
    2,006,363  
  3,040,000    
Avis Budget Rental Car Funding AESOP LLC Series, 07-02A, Class A, 144A, AMBAC, 1 mo. LIBOR + 14%, 0.39%, due 08/20/13
    3,006,156  
  5,331,795    
Triad Auto Receivables Owner Trust, Series 07-B, Class A4B, FSA, 1 mo. LIBOR + 1.20%, 1.45%, due 07/14/14
    5,357,760  
       
 
     
       
Total Insured Auto Financing
    12,776,170  
       
 
     
       
 
       
       
Insured Business Loans — 0.1%
       
  246,368    
CNL Commercial Mortgage Loan Trust, Series 03-2A, Class A1, 144A, AMBAC, 1 mo. LIBOR + .44%, 0.70%, due 10/25/30
    178,617  
       
 
     
       
 
       
       
Insured High Yield Collateralized Debt Obligations ♣ — 1.0%
       
  1,901,923    
Augusta Funding Ltd., Series 10A, Class F1, 144A, CapMAC, 3mo. LIBOR +.25%, 0.62%, due 06/30/17(a)
    1,671,714  
  34,396    
GSC Partners CDO Fund Ltd., Series 03-4A, Class A3, 144A, AMBAC, 3 mo. LIBOR + .46%, 0.87%, due 12/16/15
    33,880  
       
 
     
       
Total Insured High Yield Collateralized Debt Obligations
    1,705,594  
       
 
     

 


 

                 
       
Insured Other — 5.8%
       
  5,900,000    
Dominos Pizza Master Issuer LLC, Series 07-1, Class A2, 144A, MBIA, 5.26%, due 04/25/37
    5,922,715  
  1,255,927    
Henderson Receivables LLC, Series 06-3A, Class A1, 144A, MBIA, 1 mo. LIBOR + .20%, 0.45%, due 09/15/41
    1,112,820  
  1,778,421    
Henderson Receivables LLC, Series 06-4A, Class A1, 144A, MBIA, 1 mo. LIBOR + .20%, 0.45%, due 12/15/41
    1,582,169  
  1,239,551    
TIB Card Receivables Fund, Series 2005-B,144A, FGIC, 3 mo. LIBOR + .25%, 0.63%, due 01/05/14
    991,641  
  300,000    
Toll Road Investment Part II, Series 1999B, 144A, MBIA, Zero Coupon, due 02/15/30
    40,599  
  4,200,000    
Toll Road Investment Part II, Series C, 144A, MBIA, Zero Coupon, due 02/15/37
    262,878  
       
 
     
       
Total Insured Other
    9,912,822  
       
 
     
       
 
       
       
Insured Residential Asset-Backed Securities (United States) ♦ — 1.0%
       
  782,825    
Ameriquest Mortgage Securities, Inc., Series 04-R6, Class A1, XL, 1 mo. LIBOR + .21%, 0.68%, due 07/25/34
    618,432  
  240,999    
Citigroup Mortgage Loan Trust, Inc., Series 03-HE3, Class A, AMBAC, 1 mo. LIBOR + .38%, 0.64%, due 12/25/33
    194,004  
  70,722    
Quest Trust, Series 04-X1, Class A, 144A, AMBAC, 1 mo. LIBOR + .33%, 0.59%, due 03/25/34
    53,041  
  1,186,080    
Residential Asset Mortgage Products, Inc., Series 05-RS9, Class AI3, FGIC, 1 mo. LIBOR + .22%, 0.48%, due 11/25/35
    830,256  
       
 
     
       
Total Insured Residential Asset-Backed Securities (United States)
    1,695,733  
       
 
     
       
 
       
       
Insured Residential Mortgage-Backed Securities (United States) — 0.9%
       
  47,178    
Chevy Chase Mortgage Funding Corp., Series 03-4A, Class A1, 144A, AMBAC, 1 mo. LIBOR + .34%, 0.60%, due 10/25/34
    30,147  
  125,438    
Chevy Chase Mortgage Funding Corp., Series 04-1A, Class A2, 144A, AMBAC, 1 mo. LIBOR + .33%, 0.59%, due 01/25/35
    78,398  
  1,053,463    
Countrywide Home Equity Loan Trust, Series 07-E, Class A, MBIA, 1 mo. LIBOR + .15%, 0.40%, due 06/15/37
    621,543  
  529,229    
GMAC Mortgage Corp. Loan Trust, Series 04-HE3, Class A3, FSA, 1 mo. LIBOR + .23%, 0.49%, due 10/25/34
    371,307  
  26,500    
GreenPoint Home Equity Loan Trust, Series 04-1, Class A, AMBAC, 1 mo. LIBOR + .23%, 0.72%, due 07/25/29
    17,840  
  34,612    
GreenPoint Home Equity Loan Trust, Series 04-4, Class A, AMBAC, 1 mo. LIBOR + .28%, 0.81%, due 08/15/30
    21,380  
  63,772    
Lehman ABS Corp., Series 04-2, Class A, AMBAC, 1 mo. LIBOR + .22%, 0.70%, due 06/25/34
    42,089  
  15,089    
Residential Funding Mortgage Securities II, Series 03-HS1, Class AII, FGIC, 1 mo. LIBOR + .29%, 0.55%, due 12/25/32
    4,376  
  476,998    
SBI Heloc Trust, Series 05-HE1, Class 1A, 144A, FSA, 1 mo. LIBOR + .19%, 0.45%, due 11/25/35
    432,113  
       
 
     
       
Total Insured Residential Mortgage-Backed Securities (United States)
    1,619,193  
       
 
     
       
 
       
       
Insured Time Share — 1.0%
       
  283,257    
Sierra Receivables Funding Co., Series 06-1A, Class A2, 144A, MBIA, 1 mo. LIBOR + .15%, 0.40%, due 05/20/18
    280,338  
  242,773    
Sierra Receivables Funding Co., Series 07-1A, Class A2, 144A, FGIC, 1 mo. LIBOR + .15%, 0.40%, due 03/20/19
    233,821  
  1,193,971    
Sierra Receivables Funding Co., Series 07-2A, Class A2, 144A, MBIA, 1 mo. LIBOR + 1.00%, 1.25%, due 09/20/19
    1,159,097  
       
 
     
       
Total Insured Time Share
    1,673,256  
       
 
     

 


 

                 
       
Insured Transportation — 0.4%
       
  431,108    
CLI Funding LLC, Series 06-1A, Class A, 144A, AMBAC, 1 mo. LIBOR + .18%, 0.43%, due 08/18/21
    396,620  
  314,167    
GE Seaco Finance SRL, Series 04-1A, Class A, 144A, AMBAC, 1 mo. LIBOR + .30%, 0.55%, due 04/17/19
    305,527  
       
 
     
       
Total Insured Transportation
    702,147  
       
 
     
       
 
       
       
Residential Asset-Backed Securities (United States) ♦ — 21.5%
       
  104,471    
Accredited Mortgage Loan Trust, Series 04-4, Class A1B, 1 mo. LIBOR + .39%, 0.65%, due 01/25/35
    81,879  
  813,469    
ACE Securities Corp., Series 06-CW1, Class A2B, 1 mo. LIBOR + .10%, 0.36%, due 07/25/36
    760,594  
  252,094    
ACE Securities Corp., Series 06-HE3, Class A2B, 1 mo. LIBOR + .09%, 0.35%, due 06/25/36
    229,406  
  263,483    
ACE Securities Corp., Series 06-ASP4, Class A2B, 1 mo. LIBOR + .10%, 0.36%, due 08/25/36
    243,392  
  91,202    
ACE Securities Corp., Series 06-SL4, Class A1, 1 mo. LIBOR + .12%, 0.38%, due 09/25/36
    18,696  
  481,157    
ACE Securities Corp., Series 06-SL1, Class A, 1 mo. LIBOR + .16%, 0.58%, due 09/25/35
    84,203  
  567,865    
ACE Securities Corp., Series 06-ASP2, Class A2C, 1 mo. LIBOR + .18%, 0.44%, due 03/25/36
    469,908  
  1,462,478    
ACE Securities Corp., Series 06-HE2, Class A2C, 1 mo. LIBOR + .16%, 0.42%, due 05/25/36
    716,614  
  2,800,000    
ACE Securities Corp., Series 06-ASP5, Class A2C, 1 mo. LIBOR + .18%, 0.44%, due 10/25/36
    784,000  
  1,061,437    
ACE Securities Corp., Series 06-SL3, Class A1, 1 mo. LIBOR + .10%, 0.36%, due 06/25/36
    172,484  
  1,234,921    
ACE Securities Corp., Series 06-SL3, Class A2, 1 mo. LIBOR + .17%, 0.43%, due 06/25/36
    151,278  
  557,627    
ACE Securities Corp., Series 07-WM1, Class A2A, 1 mo. LIBOR + .07%, 0.33%, due 11/25/36
    186,805  
  273,161    
ACE Securities Corp., Series 06-ASL1, Class A, 1 mo. LIBOR + .14%, 0.40%, due 02/25/36
    56,681  
  1,070,976    
ACE Securities Corp., Series 06-OP1, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 04/25/36
    626,521  
  727,749    
ACE Securities Corp., Series 07-HE1, Class A2A, 1 mo. LIBOR + .09%, 0.35%, due 01/25/37
    214,686  
  436,796    
ACE Securities Corp., Series 07-ASL1, Class A2, 1 mo. LIBOR + .17%, 0.43%, due 12/25/36
    41,496  
  1,322,611    
Alliance Bancorp Trust, Series 07-S1, Class A1, 144A, 1 mo. LIBOR + .20%, 0.46%, due 05/25/37
    66,130  
  391,426    
Argent Securities, Inc., Series 04-W8, Class A5, 1 mo. LIBOR + .52%, 1.30%, due 05/25/34
    338,400  
  1,317,607    
Argent Securities, Inc., Series 06-W2, Class A2B, 1 mo. LIBOR + .19%, 0.45%, due 03/25/36
    382,106  
  8,247,144    
Argent Securities, Inc., Series 06-M1, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 07/25/36
    2,141,680  
  1,373,637    
Argent Securities, Inc., Series 06-W5, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 06/25/36
    361,438  
  1,384,594    
Argent Securities, Inc., Series 06-M2, Class A2B, 1 mo. LIBOR + .11%, 0.37%, due 09/25/36
    404,994  
  1,701,426    
Asset Backed Funding Certificates, Series 06-OPT2, Class A3C, 1 mo. LIBOR + .15%, 0.41%, due 10/25/36
    986,827  
  2,407,936    
Asset Backed Funding Certificates, Series 07-NC1, Class A1, 144A, 1 mo. LIBOR + .22%, 0.48%, due 05/25/37
    1,896,250  
  668,697    
Bayview Financial Acquisition Trust, Series 04-B, Class A1, 144A, 1 mo. LIBOR + .50%, 1.26%, due 05/28/39
    217,327  
  742,997    
Bayview Financial Acquisition Trust, Series 04-B, Class A2, 144A, 1 mo. LIBOR + .65%, 1.56%, due 05/28/39
    209,897  
  1,573,823    
Bayview Financial Acquisition Trust, Series 05-A, Class A1, 144A, 1 mo. LIBOR + .50%, 1.26%, due 02/28/40
    945,867  
  654,442    
Bear Stearns Asset Backed Securities, Inc., Series 07-AQ1, Class A1, 1 mo. LIBOR + .11%, 0.37%, due 11/25/36
    397,181  
  1,500,000    
Bear Stearns Asset Backed Securities, Inc., Series 07-AQ1, Class A2, 1 mo. LIBOR + .20%, 0.46%, due 11/25/36
    200,250  
  337,160    
Bear Stearns Mortgage Funding Trust, Series 07-SL2, Class 1A, 1 mo. LIBOR + .16%, 0.58%, due 02/25/37
    53,305  
  4,700,000    
Carrington Mortgage Loan Trust, Series 07-FRE1, Class A2, 1 mo. LIBOR + .20%, 0.46%, due 02/25/37
    2,896,610  
  1,306,618    
Centex Home Equity, Series 06-A, Class AV3, 1 mo. LIBOR + .16%, 0.42%, due 06/25/36
    993,030  
  20,921    
Chase Funding Mortgage Loan Trust, Series 03-3, Class 2A2, 1 mo. LIBOR + .27%, 0.80%, due 04/25/33
    17,574  
  800,000    
Citigroup Mortgage Loan Trust, Inc., Series 06-WFH4, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 11/25/36
    552,000  
  1,600,000    
Citigroup Mortgage Loan Trust, Inc., Series 06-HE3, Class A2C, 1 mo. LIBOR + .16%, 0.42%, due 12/25/36
    480,000  
  8,530    
Citigroup Mortgage Loan Trust, Inc., Series 04-OPT1, Class A1B, 1 mo. LIBOR + .41%, 0.67%, due 10/25/34
    7,933  
  5,200,000    
Countrywide Asset-Backed Certificates, Series 06-BC3, Class 2A2, 1 mo. LIBOR + .14%, 0.40%, due 02/25/37
    3,783,000  
  57,388    
Equity One ABS, Inc., Series 04-1, Class AV2, 1 mo. LIBOR + .30%, 0.56%, due 04/25/34
    41,229  

 


 

                 
  1,187,503    
First Franklin Mortgage Loan Asset Backed Certificates, Series 06-FF5, Class 2A3, 1 mo. LIBOR + .16%, 0.42%, due 04/25/36
    705,080  
  146,687    
Fremont Home Loan Trust, Series 06-B, Class 2A2, 1 mo. LIBOR + .10%, 0.36%, due 08/25/36
    48,865  
  2,662,239    
Fremont Home Loan Trust, Series 06-B, Class 2A3, 1 mo. LIBOR + .16%, 0.42%, due 08/25/36
    745,427  
  426,660    
Fremont Home Loan Trust, Series 06-A, Class 1A2, 1 mo. LIBOR + .20%, 0.45%, due 05/25/36
    228,596  
  407,525    
Household Home Equity Loan Trust, Series 05-2, Class A2, 1 mo. LIBOR + .31%, 0.56%, due 01/20/35
    350,089  
  391,725    
Household Home Equity Loan Trust, Series 05-3, Class A2, 1 mo. LIBOR + .29%, 0.54%, due 01/20/35
    344,596  
  876,133    
Household Home Equity Loan Trust, Series 06-1, Class A1, 1 mo. LIBOR + .16%, 0.41%, due 01/20/36
    770,997  
  3,902,775    
J.P. Morgan Mortgage Acquisition Corp., Series 06-WMC4, Class A3, 1 mo. LIBOR + .12%, 0.38%, due 12/25/36
    1,232,886  
  1,978,025    
Master Asset-Backed Securities Trust, Series 06-NC3, Class A4, 1 mo. LIBOR + .16%, 0.42%, due 10/25/36
    593,407  
  2,255,555    
Master Asset-Backed Securities Trust, Series 06-FRE2, Class A4, 1 mo. LIBOR + .15%, 0.41%, due 03/25/36
    789,444  
  228,804    
Master Asset-Backed Securities Trust, Series 05-FRE1, Class A4, 1 mo. LIBOR + .25%, 0.51%, due 10/25/35
    215,075  
  1,600,000    
Master Asset-Backed Securities Trust, Series 06-HE2, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 06/25/36
    480,000  
  226,639    
Master Asset-Backed Securities Trust, Series 06-AM3, Class A2, 1 mo. LIBOR + .13%, 0.39%, due 10/25/36
    219,840  
  3,069,552    
Master Asset-Backed Securities Trust, Series 06-HE3, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 08/25/36
    813,431  
  876,736    
Master Second Lien Trust, Series 06-1, Class A, 1 mo. LIBOR + .16%, 0.58%, due 03/25/36
    105,208  
  599,864    
Merrill Lynch Mortgage Investors, Series 07-HE2, Class A2A, 1 mo. LIBOR + .12%, 0.38%, due 02/25/37
    272,938  
  261,049    
Merrill Lynch Mortgage Trust, Series 06-SD1, Class A, 1 mo. LIBOR + .28%, 0.54%, due 01/25/47
    161,198  
  235,014    
Morgan Stanley Capital, Inc., Series 04-SD1, Class A, 1 mo. LIBOR + .40%, 0.66%, due 08/25/34
    168,623  
  3,600,000    
Morgan Stanley Capital, Inc., Series 07-HE4, Class A2C, 1 mo. LIBOR + .23%, 0.49%, due 02/25/37
    756,000  
  458,109    
Morgan Stanley Home Equity Loans, Series 07-2, Class A1, 1 mo. LIBOR + .10%, 0.36%, due 04/25/37
    374,504  
  1,065,573    
Morgan Stanley IXIS Real Estate Capital Trust, Series 06-2, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 11/25/36
    261,065  
  1,000,000    
Nationstar Home Equity Loan Trust, Series 06-B, Class AV3, 1 mo. LIBOR + .17%, 0.43%, due 09/25/36
    777,969  
  900,000    
Nomura Home Equity Loan, Inc., Series 06-HE3, Class 2A3, 1 mo. LIBOR + .15%, 0.41%, due 07/25/36
    353,672  
  740,750    
People’s Choice Home Loan Securities Trust, Series 05-4, Class 1A2, 1 mo. LIBOR + .26%, 0.52%, due 12/25/35
    426,524  
  611,622    
RAAC Series Trust, Series 06-SP1, Class A2, 1 mo. LIBOR + .19%, 0.45%, due 09/25/45
    507,035  
  137,226    
Residential Asset Mortgage Products, Inc., Series 05-RS8, Class A2, 1 mo. LIBOR + .29%, 0.55%, due 10/25/33
    125,740  
  41,108    
Residential Asset Securities Corp., Series 07-KS3, Class AI1, 1 mo. LIBOR + .11%, 0.37%, due 04/25/37
    40,812  
  26,092    
Saxon Asset Securities Trust, Series 04-1, Class A, 1 mo. LIBOR + .27%, 0.80%, due 03/25/35
    16,259  
  378,402    
Saxon Asset Securities Trust, Series 06-3, Class A2, 1 mo. LIBOR + .11%, 0.37%, due 10/25/46
    346,238  
  48,948    
Securitized Asset Backed Receivables LLC, Series 06-NC1, Class A2, 1 mo. LIBOR + .16%, 0.42%, due 03/25/36
    45,032  
  800,000    
Securitized Asset-Backed Receivables LLC Trust, Series 06-HE1, Class A2C, 1 mo. LIBOR + .16%, 0.42%, due 07/25/36
    256,000  
  51,139    
Security National Mortgage Loan Trust, Series 06-2A, Class A1, 144A, 1 mo. LIBOR + .29%, 0.55%, due 10/25/36
    50,756  
  2,200,000    
Specialty Underwriting & Residential Finance, Series 06-BC3, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 06/25/37
    924,000  
  774,775    
Structured Asset Investment Loan Trust, Series 06-1, Class A3, 1 mo. LIBOR + .20%, 0.46%, due 01/25/36
    557,838  

 


 

                 
  342,580    
Structured Asset Securities Corp., Series 05-S6, Class A2, 1 mo. LIBOR + .29%, 0.84%, due 11/25/35
    264,643  
  1,546,934    
Yale Mortgage Loan Trust, Series 07-1, Class A, 144A, 1 mo. LIBOR + .40%, 0.66%, due 06/25/37
    123,755  
       
 
     
       
Total Residential Asset-Backed Securities (United States)
    36,665,213  
       
 
     
       
 
       
       
Residential Mortgage-Backed Securities (Australian) — 4.3%
       
  766,706    
Crusade Global Trust, Series 06-1, Class A1, 144A, 3 mo. LIBOR + .06%, 0.47%, due 07/20/38
    746,818  
  954,302    
Crusade Global Trust, Series 07-1, Class A1, 3 mo. LIBOR + .06%, 0.47%, due 04/19/38
    917,004  
  199,939    
Interstar Millennium Trust, Series 03-3G, Class A2, 3 mo. LIBOR + .25%, 0.86%, due 09/27/35
    183,512  
  1,983,998    
Interstar Millennium Trust, Series 04-2G, Class A, 3 mo. LIBOR + .20%, 0.74%, due 03/14/36
    1,824,604  
  371,209    
Interstar Millennium Trust, Series 05-1G, Class A, 3 mo. LIBOR + .12%, 0.74%, due 12/08/36
    330,376  
  168,026    
Interstar Millennium Trust, Series 06-2GA, Class A2, 144A, 3 mo. LIBOR + .08%, 0.81%, due 05/27/38
    153,663  
  411,396    
Medallion Trust, Series 05-1G, Class A1, 3 mo. LIBOR + .08%, 0.52%, due 05/10/36
    396,661  
  691,446    
Medallion Trust, Series 06-1G, Class A1, 3 mo. LIBOR + .05%, 0.39%, due 06/14/37
    672,765  
  1,154,340    
Puma Finance Ltd., Series G5, Class A1, 144A, 3 mo. LIBOR + .07%, 0.55%, due 02/21/38
    1,056,337  
  93,463    
Superannuation Members Home Loans Global Fund, Series 7, Class A1, 3 mo. LIBOR + .14%, 0.62%, due 03/09/36
    90,639  
  100,522    
Superannuation Members Home Loans Global Fund, Series 8, Class A1, 3 mo. LIBOR + .07%, 0.53%, due 01/12/37
    98,486  
  955,002    
Superannuation Members Home Loans Global Fund, Series 07-1, Class A1, 3 mo. LIBOR + .06%, 0.40%, due 06/12/40
    899,786  
       
 
     
       
Total Residential Mortgage-Backed Securities (Australian)
    7,370,651  
       
 
     
       
 
       
       
Residential Mortgage-Backed Securities (European) — 7.6%
       
  1,862,343    
Aire Valley Mortgages, Series 06-1A, Class 1A, 144A, 3 mo. LIBOR + .11%, 0.46%, due 09/20/66
    1,527,121  
  3,032,383    
Brunel Residential Mortgages, Series 07-1A, Class A4C, 144A, 3 mo. LIBOR + .10%, 0.50%, due 01/13/39
    2,686,631  
  403,491    
Granite Master Issuer Plc, Series 06-2, Class A4, 1 mo. LIBOR + .04%, 0.33%, due 12/20/54
    386,544  
  254,838    
Granite Master Issuer Plc, Series 06-3, Class A3, 1 mo. LIBOR + .04%, 0.29%, due 12/20/54
    243,371  
  210,079    
Granite Mortgages Plc, Series 04-3, Class 2A1, 3 mo. LIBOR + .14%, 0.63%, due 09/20/44
    201,886  
  1,461,789    
Kildare Securities Ltd., Series 07-1A, Class A2, 144A, 3 mo. LIBOR + .06%, 0.40%, due 12/10/43
    1,300,993  
  369,666    
Leek Finance Plc, Series 17A, Class A2B, 144A, 3 mo. LIBOR + .28%, 0.63%, due 12/21/37
    330,851  
  737,343    
Paragon Mortgages Plc, Series 7A, Class A1A, 144A, 3 mo. LIBOR + .42%, 0.88%, due 05/15/34
    592,381  
  1,472,010    
Paragon Mortgages Plc, Series 12A, Class A2C, 144A, 3 mo. LIBOR + .11%, 0.68%, due 11/15/38
    1,090,244  
  1,004,304    
Paragon Mortgages Plc, Series 14A, Class A2C, 144A, 3 mo. LIBOR + .10%, 0.45%, due 09/15/39
    750,516  
  3,300,000    
Permanent Master Issuer Plc, Series 06-1, Class 5A, 3 mo. LIBOR + .11%, 0.51%, due 07/15/33
    3,267,990  
  600,000    
Permanent Master Issuer Plc, Series 07-1, Class 4A, 3 mo. LIBOR + .08%, 0.48%, due 10/15/33
    596,940  
       
 
     
       
Total Residential Mortgage-Backed Securities (European)
    12,975,468  
       
 
     
       
 
       
       
Residential Mortgage-Backed Securities (United States) — 0.1%
       
  61,847    
Chevy Chase Mortgage Funding Corp., Series 04-3A, Class A2, 144A, 1 mo. LIBOR + .30%, 0.56%, due 08/25/35
    38,654  
  273,048    
Mellon Residential Funding Corp., Series 04-TBC1, Class A, 144A, 1 mo. LIBOR + .25%, 0.51%, due 02/26/34
    221,169  
       
 
     
       
Total Residential Mortgage-Backed Securities (United States)
    259,823  
       
 
     
       
 
       
       
Student Loans — 2.4%
       
  2,600,000    
College Loan Corp. Trust, Series 07-2, Class A1, 3 mo. LIBOR + .25%, 0.67%, due 01/25/24
    2,535,000  
  44,672    
Goal Capital Funding Trust, Series 07-1, Class A1, 3 mo. LIBOR + .02%, 0.38%, due 06/25/21
    44,587  
  122,873    
National Collegiate Student Loan Trust, Series 06-1, Class A2, 1 mo. LIBOR + .14%, 0.40%, due 08/25/23
    119,187  
  1,100,000    
Nelnet Student Loan Trust, Series 05-2, Class A4, 3 mo. LIBOR + .08%, 0.44%, due 12/23/19
    1,085,744  
  351,713    
SLM Student Loan Trust, Series 07-A, Class A1, 3 mo. LIBOR + .03%, 0.38%, due 09/15/22
    350,834  
       
 
     
       
Total Student Loans
    4,135,352  
       
 
     

 


 

                 
       
Time Share — 1.5%
       
  1,768,966    
Marriott Vacation Club Owner Trust, Series 09-2A, Class A, 144A, 4.81%, due 07/20/31
    1,804,345  
  209,166    
Sierra Receivables Funding Co., Series 08-1A, Class A2, 144A, 1 mo. LIBOR + 4.00%, 4.25%, due 02/20/20
    214,951  
  457,744    
Sierra Receivables Funding Co. LLC, Series 11-1A, Class B, 144A, 4.23%, due 04/20/26
    455,590  
       
 
     
       
Total Time Share
    2,474,886  
       
 
     
       
Total Asset-Backed Securities
    161,380,285  
       
 
     
       
 
       
       
Corporate Debt — 0.8%
       
  1,290,000    
Health Care Property Investors, Inc., Series G, MTN, 5.63%, due 02/28/13
    1,330,575  
       
 
     
       
 
       
       
U.S. Government Agency — 3.3%
       
  250,000    
Agency for International Development Floater (Support of Belize), 6 mo. U.S. Treasury Bill + .50%, 0.57%, due 01/01/14(a)
    246,711  
  1,355,035    
Agency for International Development Floater (Support of Jamaica), 3 mo. LIBOR + .30%, 0.82%, due 10/01/18(a)
    1,310,407  
  3,773,204    
Agency for International Development Floater (Support of Jamaica), 6 mo. U.S. Treasury Bill + 0.75%, 0.82%, due 03/30/19(a)
    3,636,723  
  36,240    
Agency for International Development Floater (Support of Morocco), 6 mo. U.S. Treasury Bill + .45%, 0.52%, due 11/15/14(a)
    35,462  
  47,506    
Agency for International Development Floater (Support of Peru), Series A, 6 mo. U.S. Treasury Bill + .35%, 0.42%, due 05/01/14(a)
    46,592  
  74,879    
Agency for International Development Floater (Support of Peru), Series B, 6 mo. U.S. Treasury Bill +.35%, 0.42%, due 05/01/14(a)
    73,438  
  50,001    
Agency for International Development Floater (Support of Zimbabwe), 3 mo. U.S. Treasury Bill x 115%, 0.04%, due 01/01/12(a)
    49,924  
  200,000    
U.S. Department of Transportation, 144A, 6.00%, due 12/07/21
    219,406  
       
 
     
       
Total U.S. Government Agency
    5,618,663  
       
 
     
 
       
TOTAL DEBT OBLIGATIONS (COST $170,327,872)
    168,329,523  
       
 
     
 
                 
Shares     Description   Value ($)  
 
       
SHORT-TERM INVESTMENTS — 1.3%
       
       
 
       
       
Money Market Funds
       
  2,202,247    
State Street Institutional Liquid Reserve Fund-Institutional Class, 0.17%(b)
    2,202,247  
       
 
     
       
 
       
       
TOTAL SHORT-TERM INVESTMENTS (COST $2,202,247)
    2,202,247  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 99.9%
(Cost $172,530,119)
    170,531,770  
       
 
       
       
Other Assets and Liabilities (net) — 0.1%
    113,975  
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 170,645,745  
       
 
     
 
Notes to Schedule of Investments:
 
144A — Securities exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional investors.
 
AMBAC — Insured as to the payment of principal and interest by AMBAC Assurance Corporation.
 
CapMAC — Insured as to the payment of principal and interest by Capital Markets Assurance Corporation.
 
CDO — Collateralized Debt Obligation
 
CMBS — Commercial Mortgage Backed Security
 
FGIC — Insured as to the payment of principal and interest by Financial Guaranty Insurance Corporation.
 
FSA — Insured as to the payment of principal and interest by Financial Security Assurance.
 
LIBOR — London Interbank Offered Rate
 
MBIA — Insured as to the payment of principal and interest by MBIA Insurance Corp.
 
MTN — Medium Term Note
 
XL — Insured as to the payment of principal and interest by XL Capital Assurance.

 


 

The rates shown on variable rate notes are the current interest rates at November 30, 2011, which are subject to change based on the terms of the security.
 
  These securities were categorized as “high yield” as a result of being rated below investment grade at issuance.
 
  These securities are primarily backed by subprime mortgages.
 
(a)   Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust.
 
(b)   Rate disclosed, the 7 day net yield, is as of November 30, 2011.
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                         
    Gross     Gross     Net Unrealized  
    Unrealized     Unrealized     Appreciation  
    Aggregate Cost       Appreciation     (Depreciation)     (Depreciation)  
$            173,407,257
  $ 12,967,812     $ (15,843,299 )   $ (2,875,487 )

 


 

Debt Opportunities Fund (the “Fund”) commenced operations on October 3, 2011.
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 4.1% of net assets. The Fund classifies such securities (levels defined below) as Level 3. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Typically the Fund values debt instruments based on the most recent quoted price supplied by a single pricing source chosen by the Manager. Although the Manager normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and may change a pricing source at any time. The Manager monitors erratic or unusual movements (including unusual inactivity) in the prices supplied for a security and has discretion to override a price supplied by a source (e.g., by taking a price supplied by another) when it believes that the price supplied is not reliable. Although alternative prices may be available for securities held by the Fund, those alternative sources are not typically part of the valuation process and do not necessarily provide greater certainty about the prices used by the Fund. As of November 30, 2011, the total value of securities held directly for which no alternative pricing source was available represented 12.4% of the net assets of the Fund.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit risk, yield curves and similar data.
Level 3 — Valuations based primarily on inputs that are unobservable and significant. The Fund utilized a number of fair value techniques on Level 3 investments, including the following: The Fund valued certain debt securities using quoted prices. The Fund valued certain other debt securities by using an estimated specified spread above the LIBOR Rate.

 


 

The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Debt Obligations
                               
Asset-Backed Securities
  $     $ 16,276,366     $ 145,103,919     $ 161,380,285  
Corporate Debt
          1,330,575             1,330,575  
U.S. Government Agency
          219,406       5,399,257       5,618,663  
 
                       
TOTAL DEBT OBLIGATIONS
          17,826,347       150,503,176       168,329,523  
 
                       
Short-Term Investments
    2,202,247                   2,202,247  
 
                       
Total Investments
    2,202,247       17,826,347       150,503,176       170,531,770  
 
                       
Total
  $ 2,202,247     $ 17,826,347     $ 150,503,176     $ 170,531,770  
 
                       

 


 

The aggregate net values of the Fund’s direct investments in securities using Level 3 inputs were 88.2% of total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant unobservable inputs (Level 3) were used in determining value:
                                                                                 
                                                                            Net Change in  
                                                                            Unrealized  
                                                                            Appreciation  
                                                                            (Depreciation)  
                                                                            from  
                                            Change in                             Investments Still  
    Balances as of                     Accrued     Total     Unrealized     Transfer     Transfer     Balances as of     Held as of  
    February 28,                     Discounts/     Realized     Appreciation     into     out of     November 30,     November 30,  
    2011     Purchases     Sales     Premiums     Gain/(Loss)     (Depreciation)     level 3 *     level 3 *     2011     2011  
Debt Obligations
                                                                               
Asset-Backed Securities
  $     $ 152,648,992     $ (6,683,665 )   $ 265,951     $ 678,865     $ (1,806,224 )   $     $     $ 145,103,919     $ (1,806,224 )
U.S. Government Agency
          5,441,111       (30,517 )     3,982       492       (15,811 )                 5,399,257       (15,811 )
 
                                                           
Total
  $     $ 158,090,103     $ (6,714,182 )   $ 269,933     $ 679,357     $ (1,822,035 )   $     $     $ 150,503,176     $ (1,822,035 )
 
                                                           
 
*   The Fund accounts for investments and derivatives transferred into Level 3 at the value at the beginning of the period and transferred out of Level 3 at the value at the end of the period.

 


 

Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase the security at an agreed upon price and date. The Fund, through its custodian, takes possession of securities it acquired under the repurchase agreement. The value of the securities acquired is required by contract to be marked to market daily and additional collateral is required to be transferred so that the market value is at least equal to the amount owed to the Fund by the seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings and/or the value of the securities subject to the repurchase agreement is insufficient, the Fund’s recovery of cash from the seller may be delayed and the Fund may incur a loss equal to the difference between the cash it paid and the value of the securities. The Fund had no repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same assets at an agreed upon price and date. The Fund can use the proceeds received from entering into a reverse repurchase agreement to make additional investments, which generally causes the Fund’s portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the securities it sold and as a result would realize a loss equal to the difference between the value of those securities and the payment it received for them. The size of this loss will depend upon the difference between what the buyer paid for the securities the Fund sold to it and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of $100). In the event of a buyer’s bankruptcy or insolvency, the Fund’s use of proceeds from the sale of its securities may be restricted while the other party or its trustee or receiver determines whether to honor the Fund’s right to repurchase the securities. The Fund had no reverse repurchase agreements outstanding at the end of the period.
Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income securities whose principal value is adjusted periodically according to the rate of inflation. Two structures are common. The U.S. Treasury and some other issuers use a structure that reflects inflation in the principal value of the bond. Most other issuers pay out any inflation related accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real interest rates. Real interest rates, in turn, are tied to the relationship between nominal interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e. nominal interest rate minus inflation) might decline, leading to an increase in value of inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than inflation, real interest rates might rise, leading to a decrease in value of inflation indexed bonds. There can be no assurance, however, that the value of inflation indexed bonds will be directly correlated to changes in nominal interest rates, and short term increases in inflation may lead to a decline in their value. Coupon payments received by the Fund from inflation indexed bonds are included in the Fund’s gross income for the period in which they accrue. In addition, any increase or decrease in the principal amount of an inflation indexed bond will increase or decrease taxable ordinary income to the Fund, even though principal is not paid until maturity. The Fund had no inflation-indexed bonds outstanding at the end of the period.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) as amended, and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.

 


 

Market Risk — Fixed Income Securities — Typically, the market value of fixed income securities will decline during periods of rising interest rates and widening credit spreads.
 
Market Risk — Asset-Backed Securities — Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
 
Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating. The Fund’s investments in below investment grade securities have speculative characteristics, and changes in economic conditions or other circumstances are more likely to impair the capacity of issuers to make principal and interest payments than is the case with issuers of investment grade securities.
 
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
 
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
 
Leveraging Risk — The Fund’s use of reverse repurchase agreements and other derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
 
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations. The risk of counterparty default is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions.
 
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies or in industries with high positive correlations to one another creates additional risk.
 
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
 
Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in underlying funds, including the risk that the underlying funds in which it invests will not perform as expected.
 
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
 
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds, or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
 
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to

 


 

the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
 
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of foreign currency holdings and investments denominated in foreign currencies.
The Fund invests in asset-backed securities, which may be backed by many types of assets, including pools of residential and commercial mortgages, automobile loans, educational loans, home equity loans, or credit card receivables, which expose the Fund to additional types of market risk. They also may be backed by pools of corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds and loans (commonly referred to as “collateralized debt obligations” or “collateralized loan obligations”) and by the fees earned by service providers. Payment of interest on asset backed securities and repayment of principal largely depend on the cash flows generated by the assets backing the securities. The market risk of a particular asset-backed security depends on many factors, including the deal structure (e.g., determination as to the amount of underlying assets or other support needed to produce the cash flows necessary to service interest and make principal payments), the quality of the underlying assets and, if any, the level of credit support and the credit quality of the credit-support provider. Asset-backed securities involve risk of loss of principal if obligors of the underlying obligations default and the value of the defaulted obligations exceeds whatever credit support the securities may have. The obligations of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and other laws affecting the rights and remedies of creditors. Many asset-backed securities in which the Fund has invested are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal and/or interest will be paid because the insurer could default on its obligations. In recent years, a significant number of asset-backed security insurers have defaulted on their obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about the creditworthiness of those securities (and underlying assets) caused credit spreads (the difference between yields on the asset-backed securities and U.S. Government securities) to widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions to make markets in many fixed income securities. These events reduced liquidity and contributed to substantial declines in the value of asset-backed and other fixed income securities. There can be no assurance these conditions will not occur again. Also, government actions and proposals affecting the terms of underlying home and consumer loans, changes in demand for products (e.g., automobiles) financed by those loans, and the inability of borrowers to refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying assets and is, therefore, subject to risks associated with the negligence or defalcation of its servicer. In some circumstances, the mishandling of related documentation also may affect the rights of security holders in and to the underlying assets. The insolvency of entities that generate receivables or that utilize the assets may result in a decline in the value of the underlying assets, as well as costs and delays. The obligations underlying asset-backed securities, in particular securities backed by pools of residential and commercial mortgages, also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as high a yield as is provided by the asset-backed security. The risk of investing in asset-backed securities has increased because performance of the various sectors in which the assets underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime mortgages, and credit card receivables) has become more highly correlated since the deterioration in worldwide economic and liquidity conditions.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. In particular, the Fund may use swaps or other derivatives on an index, a single security or a basket of securities to gain investment exposures (e.g., by selling protection under a credit default swap). The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.

 


 

The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). For example, the Fund may use credit default swaps to take a short position with respect to the likelihood of default by an issuer. The Fund also may use currency derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For instance, the Manager may alter the interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is designed to maintain the Fund’s exposure to the credit of an issuer through the debt instrument but adjust the Fund’s interest rate exposure through the swap. With these swaps, the Fund and its counterparties exchange interest rate exposure, such as fixed versus variable rates and shorter duration versus longer duration exposure. In adjusting its investment exposures, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund is not limited in the extent to which it uses derivatives or in the absolute face value of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate exposure of its assets, and its net long exposure may exceed 100% of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.

 


 

When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk that it will be required to pay the full notional value of the swap contract in the event of a default.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself.
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. The Fund had no forward currency contracts outstanding at the end of the period.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded. The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC

 


 

options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.

 


 

The Fund prices its swap agreements daily using models that may incorporate quotations from market makers and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Developed World Stock Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares     Description   Value ($)  
 
       
COMMON STOCKS — 93.6%
       
       
 
       
       
Australia — 0.5%
       
  12,203    
BHP Billiton Ltd
    457,206  
  327,592    
Telstra Corp Ltd
    1,076,361  
       
 
     
       
Total Australia
    1,533,567  
       
 
     
       
 
       
       
Austria — 0.3%
       
  20,578    
OMV AG
    683,361  
  9,268    
Voestalpine AG
    269,518  
       
 
     
       
Total Austria
    952,879  
       
 
     
       
 
       
       
Belgium — 0.0%
       
  143,879    
Dexia SA *
    72,968  
       
 
     
       
 
       
       
Canada — 0.9%
       
  10,800    
Canadian Pacific Railway Ltd
    650,785  
  40,800    
EnCana Corp
    822,040  
  49,600    
Husky Energy, Inc.
    1,235,198  
  14,200    
Research In Motion Ltd *
    255,891  
       
 
     
       
Total Canada
    2,963,914  
       
 
     
       
 
       
       
Finland — 0.1%
       
  59,699    
Nokia Oyj
    345,036  
       
 
     
       
 
       
       
France — 5.1%
       
  55,504    
AXA
    803,678  
  31,946    
BNP Paribas
    1,271,708  
  19,689    
Bouygues SA
    641,739  
  7,768    
Casino Guichard-Perrachon SA
    691,291  
  31,309    
CNP Assurances
    421,394  
  7,895    
Compagnie de Saint-Gobain
    334,771  
  11,268    
EADS NV
    338,061  
  5,283    
Lafarge SA
    193,105  
  4,319    
LVMH Moet Hennessy Louis Vuitton SA
    680,036  
  22,018    
Peugeot SA
    412,249  
  21,858    
Renault SA
    819,029  
  57,866    
Sanofi
    4,047,495  
  10,071    
Schneider Electric SA
    572,677  
  61,855    
Total SA
    3,191,258  
  1,988    
Unibail-Rodamco SE REIT
    370,588  
  7,706    
Vinci SA
    344,504  
  52,457    
Vivendi SA
    1,209,976  
       
 
     
       
Total France
    16,343,559  
       
 
     
       
 
       
       
Germany — 3.6%
       
  16,059    
Allianz SE (Registered)
    1,668,917  
  21,533    
BASF AG
    1,573,059  
  11,421    
Bayerische Motoren Werke AG
    865,793  
  98,877    
E.ON AG
    2,447,570  
  8,417    
Hannover Rueckversicherung AG (Registered)
    439,413  
  4,463    
K+S AG
    243,025  
  3,188    
Linde AG
    491,306  
  7,969    
Muenchener Rueckversicherungs-Gesellschaft AG (Registered)
    1,007,115  
  17,760    
RWE AG
    736,228  
  3,797    
Siemens AG (Registered)
    384,253  
  22,486    
Suedzucker AG
    716,345  

 


 

                 
  6,297    
Volkswagen AG
    959,068  
       
 
     
       
Total Germany
    11,532,092  
       
 
     
       
 
       
       
Hong Kong — 0.1%
       
  32,500    
CLP Holdings Ltd
    289,429  
  37    
Esprit Holdings Ltd
    54  
       
 
     
       
Total Hong Kong
    289,483  
       
 
     
       
 
       
       
Ireland — 0.5%
       
  79,376    
CRH Plc
    1,515,341  
       
 
     
       
 
       
       
Italy — 3.5%
       
  649,254    
Enel SPA
    2,766,407  
  228,155    
ENI SPA
    4,831,931  
  71,236    
Finmeccanica SPA
    309,055  
  57,445    
Mediaset SPA
    169,815  
  19,976    
Mediobanca SPA
    129,078  
  128,256    
Parmalat SPA
    260,601  
  16,884    
Saipem SPA
    755,464  
  844,992    
Telecom Italia SPA
    956,637  
  668,670    
Telecom Italia SPA-Di RISP
    653,364  
  487,518    
UniCredit SPA
    509,159  
       
 
     
       
Total Italy
    11,341,511  
       
 
     
       
 
       
       
Japan — 9.4%
       
  36,500    
Aeon Co Ltd
    498,756  
  13,200    
Astellas Pharma Inc
    508,813  
  23,200    
Bridgestone Corp
    537,591  
  126,000    
Cosmo Oil Co Ltd
    348,446  
  10,300    
Credit Saison Co Ltd
    188,608  
  10,000    
Daito Trust Construction Co Ltd
    891,891  
  1,700    
Fast Retailing Co Ltd
    275,870  
  29,000    
Fuji Heavy Industries Ltd
    167,614  
  11,300    
Gree Inc
    379,375  
  151,000    
Hitachi Ltd
    837,885  
  14,400    
Honda Motor Co Ltd
    456,975  
  89    
INPEX Corp
    600,828  
  129,000    
Itochu Corp
    1,310,948  
  137,820    
JX Holdings, Inc.
    876,483  
  157,000    
Kawasaki Kisen Kaisha Ltd
    272,980  
  209    
KDDI Corp
    1,384,792  
  20,700    
Komatsu Ltd
    529,751  
  144,000    
Marubeni Corp
    889,593  
  198,000    
Mazda Motor Corp *
    361,100  
  74,000    
Mitsubishi Chemical Holdings Corp
    429,898  
  25,400    
Mitsubishi Corp
    525,105  
  29,000    
Mitsubishi Electric Corp
    274,527  
  40,600    
Mitsui & Co Ltd
    640,582  
  80,000    
Mitsui OSK Lines Ltd
    254,309  
  195,000    
Mizuho Financial Group, Inc.
    256,704  
  5,200    
Murata Manufacturing Co Ltd
    308,147  
  1,300    
Nintendo Co Ltd
    197,909  
  51,000    
Nippon Telegraph & Telephone Corp
    2,515,242  
  170,000    
Nippon Yusen Kabushiki Kaisha
    378,699  
  94,200    
Nissan Motor Co Ltd
    865,068  
  7,000    
Nitto Denko Corp
    290,968  
  98    
NTT Data Corp
    304,659  
  325    
NTT Docomo Inc
    574,452  
  7,710    
ORIX Corp
    650,530  

 


 

                 
  231,100    
Resona Holdings Inc
    1,035,084  
  20,000    
Ricoh Company Ltd
    180,234  
  12,600    
Sankyo Co Ltd
    629,823  
  14,100    
Seven & I Holdings Co Ltd
    393,679  
  15,000    
Shizuoka Bank Ltd (The)
    155,503  
  64,500    
Showa Shell Sekiyu KK
    431,812  
  321,000    
Sojitz Corp
    503,707  
  139,800    
Sumitomo Corp
    1,866,058  
  180,000    
Taisei Corp
    466,512  
  40,700    
Takeda Pharmaceutical Co Ltd
    1,671,711  
  52,000    
TonenGeneral Sekiyu KK
    593,048  
  68,000    
Toray Industries Inc
    509,790  
  22,100    
Toyota Motor Corp
    727,765  
  48,100    
Toyota Tsusho Corp
    809,357  
  8,650    
Yamada Denki Co Ltd
    625,681  
       
 
     
       
Total Japan
    30,384,862  
       
 
     
       
 
       
       
Singapore — 1.6%
       
  39,000    
DBS Group Holdings Ltd
    387,834  
  2,786,000    
Golden Agri-Resources Ltd
    1,573,653  
  115,100    
Keppel Corp Ltd
    855,004  
  133,050    
Oversea-Chinese Banking Corp Ltd
    847,548  
  106,000    
Sembcorp Industries Ltd
    356,554  
  476,600    
Singapore Telecommunications
    1,161,701  
       
 
     
       
Total Singapore
    5,182,294  
       
 
     
       
 
       
       
Spain — 2.7%
       
  168,371    
Banco Bilbao Vizcaya Argentaria SA
    1,418,311  
  161,229    
Banco Popular Espanol SA
    688,487  
  262,848    
Banco Santander SA
    1,972,997  
  19,281    
Ferrovial SA
    239,099  
  52,753    
Gas Natural SDG SA
    918,366  
  5,274    
Inditex SA
    448,465  
  12,957    
Indra Sistemas SA
    182,674  
  146,793    
Mapfre SA
    491,382  
  36,316    
Repsol YPF SA
    1,096,415  
  69,703    
Telefonica SA
    1,308,907  
       
 
     
       
Total Spain
    8,765,103  
       
 
     
       
 
       
       
Sweden — 0.2%
       
  40,274    
Svenska Cellulosa AB Class B
    599,278  
       
 
     
       
 
       
       
Switzerland — 0.7%
       
  6,922    
Nestle SA (Registered)
    388,482  
  26,477    
Novartis AG (Registered)
    1,429,871  
  2,678    
Zurich Financial Services AG *
    589,798  
       
 
     
       
Total Switzerland
    2,408,151  
       
 
     
       
 
       
       
United Kingdom — 9.9%
       
  24,945    
Antofagasta Plc
    465,830  
  68,373    
ARM Holdings Plc
    642,486  
  80,154    
AstraZeneca Plc
    3,691,713  
  216,006    
Aviva Plc
    1,060,232  
  221,666    
BAE Systems Plc
    956,998  
  281,683    
Barclays Plc
    811,451  
  21,969    
BHP Billiton Plc
    675,598  
  264,414    
BP Plc
    1,914,982  
  28,992    
British American Tobacco Plc
    1,345,434  
  557,553    
BT Group Plc
    1,668,432  

 


 

                 
  13,768    
Burberry Group Plc
    275,822  
  25,174    
Diageo Plc
    539,177  
  144,250    
GlaxoSmithKline Plc
    3,196,873  
  13,357    
Imperial Tobacco Group Plc
    480,545  
  573,329    
Legal & General Group Plc
    957,727  
  73,747    
Marks & Spencer Group Plc
    383,719  
  9,361    
Next Plc
    395,663  
  570,002    
Old Mutual Plc
    1,018,571  
  13,524    
Pearson Plc
    245,674  
  2,417    
Randgold Resources Ltd
    257,142  
  22,797    
Rio Tinto Plc
    1,200,163  
  622,747    
Royal Bank of Scotland Group Plc *
    207,288  
  81,181    
Royal Dutch Shell Plc A Shares (London)
    2,839,272  
  66,116    
Royal Dutch Shell Plc B Shares (London)
    2,382,461  
  40,095    
SSE Plc
    830,237  
  31,409    
Tate & Lyle Plc
    332,657  
  985,189    
Vodafone Group Plc
    2,667,014  
  11,599    
Weir Group Plc (The)
    377,019  
       
 
     
       
Total United Kingdom
    31,820,180  
       
 
     
       
 
       
       
United States — 54.5%
       
  34,800    
3M Co.
    2,820,192  
  65,600    
Abbott Laboratories
    3,578,480  
  5,200    
Abercrombie & Fitch Co.-Class A
    249,132  
  44,200    
Accenture Plc.-Class A
    2,560,506  
  12,200    
ACE Ltd.
    848,266  
  3,200    
Affiliated Managers Group, Inc. *
    302,624  
  9,200    
Altera Corp.
    346,564  
  10,800    
Altria Group, Inc.
    309,852  
  2,100    
Amazon.com, Inc. *
    403,809  
  11,200    
Amdocs Ltd. *
    316,288  
  15,700    
Ameren Corp.
    530,817  
  13,400    
American Capital Agency Corp. REIT
    384,446  
  24,000    
American Express Co.
    1,152,960  
  12,400    
Ameriprise Financial, Inc.
    569,284  
  7,300    
Anadarko Petroleum Corp.
    593,271  
  76,000    
Annaly Capital Management, Inc. REIT
    1,221,320  
  9,400    
Apple, Inc. *
    3,592,680  
  10,600    
Assurant, Inc.
    415,944  
  39,500    
Automatic Data Processing, Inc.
    2,018,055  
  1,500    
AutoZone, Inc. *
    492,570  
  5,700    
AvalonBay Communities, Inc. REIT
    711,645  
  16,400    
Baker Hughes, Inc.
    895,604  
  21,500    
Baxter International, Inc.
    1,110,690  
  13,200    
Becton, Dickinson and Co.
    973,896  
  5,900    
Bed Bath & Beyond, Inc. *
    357,009  
  10,200    
Best Buy Co., Inc.
    276,318  
  5,100    
Borg Warner, Inc. *
    336,192  
  4,700    
Boston Properties, Inc. REIT
    448,286  
  19,500    
Bristol—Myers Squibb Co.
    638,040  
  4,100    
Camden Property Trust REIT
    236,693  
  18,000    
Capital One Financial Corp.
    803,880  
  17,500    
Caterpillar, Inc.
    1,712,900  
  18,000    
CBRE Group, Inc. *
    302,580  
  31,500    
CBS Corp.-Class B (Non Voting)
    820,260  
  9,100    
Celanese Corp.-Class A
    423,059  
  17,600    
CenterPoint Energy, Inc.
    350,240  
  3,500    
CF Industries Holdings, Inc.
    489,300  
  29,400    
Chevron Corp.
    3,022,908  

 


 

                 
  1,700    
Chipotle Mexican Grill, Inc. *
    546,652  
  15,600    
CH Robinson Worldwide, Inc.
    1,068,756  
  38,500    
Cisco Systems, Inc.
    717,640  
  5,400    
Cliffs Natural Resources, Inc.
    366,174  
  22,000    
Coach, Inc.
    1,376,980  
  114,800    
Coca-Cola Co. (The)
    7,718,004  
  13,800    
Cognizant Technology Solutions Corp.-Class A *
    929,430  
  12,600    
Comcast Corp.-Class A (Non-Voting)
    281,736  
  17,400    
Computer Sciences Corp.
    425,082  
  51,053    
ConocoPhillips
    3,641,100  
  11,200    
Covidien Plc
    510,160  
  6,100    
CR Bard, Inc.
    531,859  
  26,300    
CSX Corp.
    570,973  
  9,700    
Danaher Corp.
    469,286  
  9,900    
Deere & Co.
    784,575  
  4,200    
Digital Realty Trust, Inc. REIT
    266,700  
  9,400    
DirectTV — Class A *
    443,868  
  28,900    
Discover Financial Services
    688,398  
  4,500    
Dollar Tree, Inc. *
    366,705  
  6,800    
Dominion Resources, Inc./Virginia
    351,016  
  13,800    
Dow Chemical Co. (The)
    382,398  
  14,100    
Du Pont (E.I.) de Nemours & Co.
    672,852  
  16,800    
Duke Energy Corp.
    350,280  
  7,900    
Eastman Chemical Co.
    312,998  
  22,100    
Ecolab, Inc.
    1,260,142  
  53,900    
Eli Lilly & Co.
    2,040,115  
  18,500    
EMC Corp. *
    425,685  
  6,600    
Equity Residential REIT
    364,254  
  1,700    
Essex Property Trust, Inc. REIT
    225,845  
  18,900    
Expeditors International of Washington, Inc.
    822,339  
  64,200    
Exxon Mobil Corp.
    5,164,248  
  11,100    
FirstEnergy Corp.
    493,617  
  8,800    
FLIR Systems, Inc.
    236,368  
  10,100    
FMC Technologies, Inc. *
    528,836  
  14,300    
Forest Laboratories, Inc. *
    428,428  
  4,200    
Fossil, Inc. *
    376,278  
  24,000    
General Dynamics Corp.
    1,585,440  
  9,500    
Genuine Parts Co.
    555,750  
  12,400    
Google, Inc.-Class A *
    7,432,436  
  3,700    
Green Mountain Coffee Roasters, Inc. *
    193,991  
  31,200    
Halliburton Co.
    1,148,160  
  4,900    
Hansen Natural Corp. *
    451,780  
  30,700    
Hartford Financial Services Group, Inc. (The)
    545,232  
  17,400    
Hewlett-Packard Co.
    486,330  
  6,800    
Honeywell International, Inc.
    368,220  
  17,100    
Hormel Foods Corp.
    514,881  
  8,700    
Hospitality Properties Trust REIT
    191,661  
  12,300    
International Business Machines Corp.
    2,312,400  
  13,300    
Intuit, Inc.
    708,092  
  195,600    
Johnson & Johnson
    12,659,232  
  4,000    
Joy Global, Inc.
    365,120  
  32,900    
Kimberly—Clark Corp.
    2,351,363  
  12,200    
Kraft Foods, Inc.-Class A
    441,030  
  18,700    
Las Vegas Sands Corp. *
    873,477  
  12,200    
Leucadia National Corp.
    285,724  
  3,300    
Liberty Media Corp. Capital-Class A *
    251,724  
  9,700    
Limited Brands, Inc.
    410,601  
  4,900    
Lululemon Athletica, Inc. *
    243,530  
  21,400    
Macy’s, Inc.
    691,862  
  31,500    
Marathon Oil Corp.
    880,740  

 


 

                 
  1,300    
MasterCard, Inc.-Class A
    486,915  
  5,800    
McDonald’s Corp.
    554,016  
  23,100    
Medtronic, Inc.
    841,533  
  162,800    
Merck & Co., Inc.
    5,820,100  
  218,700    
Microsoft Corp.
    5,594,346  
  7,800    
Motorola Solutions, Inc.
    364,026  
  10,300    
NASDAQ OMX Group, Inc. (The) *
    270,375  
  10,400    
National Oilwell Varco, Inc.
    745,680  
  23,500    
Nike, Inc.-Class B
    2,260,230  
  19,500    
NiSource, Inc.
    446,745  
  9,300    
Norfolk Southern Corp.
    702,522  
  5,100    
Occidental Petroleum Corp.
    504,390  
  73,500    
Oracle Corp.
    2,304,225  
  38,100    
Paychex, Inc.
    1,109,091  
  18,800    
Pepco Holdings, Inc.
    371,864  
  67,300    
PepsiCo, Inc.
    4,307,200  
  185,673    
Pfizer, Inc.
    3,726,457  
  15,700    
Philip Morris International, Inc.
    1,196,968  
  5,200    
PPG Industries, Inc.
    456,300  
  2,100    
Precision Castparts Corp.
    345,975  
  1,900    
Priceline.com, Inc. *
    923,191  
  13,800    
ProLogis, Inc. REIT
    383,916  
  8,200    
Prudential Financial, Inc.
    415,248  
  3,300    
Public Storage REIT
    435,270  
  88,200    
Qualcomm, Inc.
    4,833,360  
  20,100    
Reynolds American, Inc.
    841,386  
  5,000    
Rockwell Automation, Inc.
    375,150  
  10,000    
Rockwell Collins, Inc.
    549,000  
  20,600    
RR Donnelley & Sons Co.
    309,412  
  4,800    
Schlumberger Ltd.
    361,584  
  8,700    
Sigma—Aldrich Corp.
    563,847  
  4,200    
Simon Property Group, Inc. REIT
    522,228  
  32,700    
SLM Corp.
    421,176  
  9,200    
Southern Co.
    403,972  
  20,600    
Starbucks Corp.
    895,688  
  22,800    
Stryker Corp.
    1,113,324  
  7,800    
St Jude Medical, Inc.
    299,832  
  30,542    
Supervalu, Inc.
    224,484  
  40,900    
Sysco Corp.
    1,167,286  
  8,400    
T. Rowe Price Group, Inc.
    476,784  
  22,200    
TD Ameritrade Holding Corp.
    361,638  
  13,300    
Teradata Corp. *
    721,259  
  6,100    
Tiffany & Co.
    408,944  
  4,000    
Time Warner Cable, Inc.
    241,920  
  10,600    
TJX Cos., Inc. (The)
    654,020  
  16,800    
Travelers Cos., Inc. (The)
    945,000  
  20,215    
UnitedHealth Group, Inc.
    985,885  
  19,700    
United Technologies Corp.
    1,509,020  
  44,800    
Valero Energy Corp.
    997,696  
  7,700    
Varian Medical Systems, Inc. *
    479,171  
  3,300    
VF Corp.
    457,677  
  19,300    
Viacom, Inc.-Class B
    863,868  
  13,900    
Virgin Media, Inc.
    308,024  
  6,000    
Visa, Inc.-Class A
    581,820  
  105,600    
Wal—Mart Stores, Inc.
    6,219,840  
  12,000    
WellPoint, Inc.
    846,600  
  9,100    
Western Digital Corp. *
    264,537  
  4,600    
Whole Foods Market, Inc.
    313,260  
  19,200    
Williams Cos., Inc.
    619,776  
  4,800    
WW Grainger, Inc.
    897,120  

 


 

                 
  5,200    
Wynn Resorts Ltd.
    626,912  
       
 
     
       
Total United States
    175,934,196  
       
 
     
       
TOTAL COMMON STOCKS (COST $299,737,804)
    301,984,414  
       
 
     
       
 
       
       
PREFERRED STOCKS — 0.3%
       
       
 
       
       
Germany — 0.3%
       
  12,089    
Porsche Automobil Holding SE 1.24%
    740,798  
  1,702    
Volkswagen AG 1.95%
    294,100  
       
 
     
       
Total Germany
    1,034,898  
       
 
     
       
TOTAL PREFERRED STOCKS (COST $975,526)
    1,034,898  
       
 
     
       
 
       
       
RIGHTS/WARRANTS — 0.0%
       
       
 
       
       
United States — 0.0%
       
  6,727    
American International Group, Inc., Warrants, Strike 45.00, Expires 01/19/21*
    41,169  
       
 
     
       
TOTAL RIGHTS/WARRANTS (COST $125,109)
    41,169  
       
 
     
       
 
       
       
MUTUAL FUNDS — 4.3%
       
       
 
       
       
United States — 4.3%
       
       
 
       
       
Affiliated Issuers
       
  549,062    
GMO U.S. Treasury Fund
    13,732,028  
       
 
     
       
TOTAL MUTUAL FUNDS (COST $13,732,028)
    13,732,028  
       
 
     
 
Par Value     Description   Value ($)  
 
       
SHORT-TERM INVESTMENTS — 0.8%
       
       
 
       
       
Time Deposits — 0.8%
       
USD  2,103,373    
Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11
    2,103,373  
AUD  9,892    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 3.78%, due 12/01/11
    10,173  
CAD  13,154    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.25%, due 12/01/11
    12,897  
CHF  9,068    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.01%, due 12/01/11
    9,925  
DKK  52,423    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.14%, due 12/01/11
    9,473  
HKD  77,826    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.01%, due 12/01/11
    10,018  
NOK  59,276    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.95%, due 12/01/11
    10,263  
SEK  66,813    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 1.06%, due 12/01/11
    9,873  
SGD  12,698    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.01%, due 12/01/11
    9,908  
JPY  9,323,720    
Citibank (New York) Time Deposit, 0.01%, due 12/01/11
    120,213  
EUR  108,276    
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11
    145,490  
GBP  24,182    
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11
    37,939  
       
 
     
       
Total Time Deposits
    2,489,545  
       
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $2,489,545)
    2,489,545  
       
 
     

 


 

                 
       
TOTAL INVESTMENTS — 99.0%
(Cost $317,060,012)
    319,282,054  
       
 
       
       
Other Assets and Liabilities (net) — 1.0%
    3,347,202  
       
 
     
 
       
TOTAL NET ASSETS — 100.0%
  $ 322,629,256  
       
 
     
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
                                         
                                    Net Unrealized  
Settlement                 Units of             Appreciation  
Date     Counterparty   Deliver/Receive     Currency     Value     (Depreciation)  
Buys †  
 
                               
  12/16/11    
Barclays Bank PLC
  CAD     3,146,071     $ 3,083,377     $ 4,367  
  12/16/11    
Morgan Stanley Capital Services Inc.
  EUR     1,625,728       2,184,716       (39,198 )
  12/16/11    
Brown Brothers Harriman & Co.
  GBP     1,287,643       2,019,902       2,835  
  12/16/11    
JPMorgan Chase Bank, N.A.
  GBP     1,327,209       2,081,968       (6,658 )
  12/16/11    
Morgan Stanley Capital Services Inc.
  GBP     2,031,850       3,187,326       5,668  
  12/16/11    
Bank of America N.A.
  HKD     7,800,772       1,004,184       740  
  12/16/11    
Deutsche Bank AG
  HKD     37,993,622       4,890,872       3,604  
  12/16/11    
Royal Bank of Scotland PLC
  HKD     20,189,866       2,599,016       1,985  
  12/16/11    
State Street Bank and Trust Company
  HKD     7,703,303       991,637       195  
  12/16/11    
JPMorgan Chase Bank, N.A.
  JPY     47,721,000       615,484       (4,629 )
  12/16/11    
Bank of America N.A.
  SEK     12,141,987       1,792,936       (26,123 )
  12/16/11    
Bank of New York Mellon
  SEK     5,162,681       762,343       (7,387 )
  12/16/11    
Brown Brothers Harriman & Co.
  SEK     4,003,522       591,177       (6,533 )
  12/16/11    
Bank of America, N.A.
  SGD     1,544,058       1,204,761       (11,579 )
  12/16/11    
Bank of New York Mellon
  SGD     3,066,619       2,392,749       (11,805 )
  12/16/11    
JPMorgan Chase Bank N.A.
  SGD     3,392,840       2,647,285       (14,413 )
  12/16/11    
Morgan Stanley Capital Services Inc.
  SGD     1,646,540       1,284,723       (3,902 )

 


 

                                         
  12/16/11    
Royal Bank of Scotland PLC
  SGD     1,943,689       1,516,576       (11,359 )
  12/16/11    
State Street Bank and Trust Company
  SGD     4,005,840       3,125,582       (24,183 )
       
 
                           
       
 
                  $ 37,976,614     $ (148,375 )
       
 
                           
Sales #  
 
                               
  12/16/11    
Barclays Bank PLC
  CAD     1,169,601     $ 1,146,294     $ 3,870  
  12/16/11    
JPMorgan Chase Bank, N.A.
  CHF     1,297,087       1,420,240       18,945  
  12/16/11    
Royal Bank of Scotland PLC
  CHF     214,708       235,094       2,857  
  12/16/11    
Bank of America, N.A.
  EUR     2,827,242       3,799,357       77,380  
  12/16/11    
Brown Brothers Harriman & Co.
  EUR     1,803,658       2,423,825       42,280  
  12/16/11    
Deutsche Bank AG
  EUR     624,763       839,581       16,657  
  12/16/11    
Morgan Stanley Capital Services Inc.
  EUR     3,356,248       4,510,255       79,840  
  12/16/11    
Bank of New York Mellon
  JPY     56,992,510       735,064       8,077  
  12/16/11    
JPMorgan Chase Bank, N.A.
  JPY     164,686,939       2,124,060       23,041  
       
 
                           
       
 
                  $ 17,233,770     $ 272,947  
       
 
                           
 
  Fund buys foreign currency; sells USD.
 
#   Fund sells foreign currency; buys USD.
Futures Contracts
                         
                    Net Unrealized  
Number of       Expiration           Appreciation  
Contracts   Type   Date   Value     (Depreciation)  
Buys  
 
                   
1  
Amsterdam Exchanges Index
  December 2011   $ 80,995     $ 3,544  
9  
CAC 40
  December 2011     382,355       21,128  
2  
DAX
  December 2011     410,845       21,122  
7  
FTSE 100
  December 2011     605,825       17,064  
56  
FTSE/MIB
  December 2011     5,765,200       707,874  
1  
IBEX 35
  December 2011     113,665       3,105  
2  
MSCI Singapore
  December 2011     97,969       3,466  
33  
S&P 500 E-Mini Index
  December 2011     2,055,900       49,088  
81  
TOPIX
  December 2011     7,780,866       1,825  
   
 
               
   
 
      $ 17,293,620     $ 828,216  
   
 
               
   
 
                   
Sales  
 
                   
2  
Hang Seng
  December 2011   $ 240,595     $ (14,355 )
30  
OMXS 30
  December 2011     438,605       (15,319 )
5  
S&P Toronto 60
  December 2011     680,916       14,664  
12  
SPI 200
  December 2011     1,310,747       (45,507 )
   
 
               
   
 
      $ 2,670,863     $ (60,517 )
   
 
               
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.

 


 

 
Notes to Schedule of Investments:
REIT — Real Estate Investment Trust
*   Non-income producing security.
Currency Abbreviations:
AUD — Australian Dollar
CAD — Canadian Dollar
CHF — Swiss Franc
DKK — Danish Krone
EUR — Euro
GBP — British Pound
HKD — Hong Kong Dollar
JPY — Japanese Yen
NOK — Norwegian Krone
SEK — Swedish Krona
SGD — Singapore Dollar
USD — United States Dollar

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                             
        Gross     Gross     Net Unrealized  
        Unrealized     Unrealized     Appreciation  
Aggregate Cost     Appreciation     (Depreciation)     (Depreciation)  
$ 323,542,525     $ 21,215,745     $ (25,476,216 )   $ (4,260,471 )

 


 

Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO U.S. Treasury Fund
  $ 11,923,000     $ 32,535,000     $ 30,731,304     $ 4,115     $ 543     $ 13,732,028  
 
                                   

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivative contracts based on the creditworthiness of its counterparties. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below.
     
Security Type   Percentage of Net Assets of the Fund
Equity Securities
  38.5%
Futures Contracts
  0.2%
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include: fair value adjustments provided by an independent pricing service applied to equity securities (including the fair value of equity securities that

 


 

underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) due to market events that have occurred since the local market close but prior to the close of the NYSE.
Level 3 — Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Common Stocks
                               
Australia
  $     $ 1,533,567     $     $ 1,533,567  
Austria
          952,879             952,879  
Belgium
          72,968             72,968  
Canada
    2,963,914                   2,963,914  
Finland
          345,036             345,036  
France
          16,343,559             16,343,559  
Germany
          11,532,092             11,532,092  
Hong Kong
          289,483             289,483  
Ireland
          1,515,341             1,515,341  
Italy
          11,341,511             11,341,511  
Japan
          30,384,862             30,384,862  
Singapore
          5,182,294             5,182,294  
Spain
          8,765,103             8,765,103  
Sweden
          599,278             599,278  
Switzerland
          2,408,151             2,408,151  
United Kingdom
          31,820,180             31,820,180  
United States
    175,934,196                   175,934,196  
 
                       
TOTAL COMMON STOCKS
    178,898,110       123,086,304             301,984,414  
 
                       
Preferred Stocks
                               
Germany
          1,034,898             1,034,898  
 
                       
TOTAL PREFERRED STOCKS
          1,034,898             1,034,898  
 
                       
Rights/Warrants
                               
United States
          41,169             41,169  
 
                       
TOTAL RIGHTS/WARRANTS
          41,169             41,169  
 
                       
Mutual Funds
                               
United States
    13,732,028                   13,732,028  
 
                       
TOTAL MUTUAL FUNDS
    13,732,028                   13,732,028  
 
                       
Short-Term Investments
    2,489,545                   2,489,545  
 
                       
Total Investments
    195,119,683       124,162,371             319,282,054  
 
                       
Derivatives*
                               
Forward Currency Contracts
                               
Foreign Currency Risk
          292,341             292,341  
Futures Contracts
                               
Equity Risk
    63,752       779,128             842,880  
 
                       
Total Derivatives
    63,752       1,071,469             1,135,221  
 
                       
Total
  $ 195,183,435     $ 125,233,840     $     $ 320,417,275  
 
                       
 
LIABILITY VALUATION INPUTS
 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Liabilities     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Derivatives*
                               
Forward Currency Contracts
                               
Foreign Currency Risk
  $     $ (167,769 )   $     $ (167,769 )
Futures Contracts
                               
Equity Risk
          (75,181 )           (75,181 )
 
                       
Total Derivatives
          (242,950 )           (242,950 )
 
                       
Total
  $     $ (242,950 )   $     $ (242,950 )
 
                       

 


 

The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
 
* Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If the Fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of the value of those investments. The Fund also may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Because the Fund normally does not take temporary defensive positions, declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating

 


 

brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Leveraging Risk — The Fund’s use of derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies or in industries with high positive correlations to one another creates additional risk.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Among other trading agreements, the Fund is party to International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Agreements”) or other similar types of agreements with selected counterparties that generally govern over-the-counter derivative transactions entered into by the Fund. The ISDA Agreements typically include representations and warranties as well as contractual terms related to collateral, events of default, termination events, and other provisions. Termination events may include the decline in the net assets of the Fund below a certain level over a specified period of time and entitle a counterparty to elect to terminate early with respect to some or all the transactions under the ISDA Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse effect on the Fund’s operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. For example, the Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives, to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives. The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For example, if the Fund holds a large proportion of stocks of companies in a particular sector and the Manager believes that stocks of companies in another sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that

 


 

index). In adjusting its investment exposure, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net long exposures in excess of its net assets. The Fund’s foreign currency exposure may differ significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.

 


 

Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most forward currency contracts are not collateralized. During the period ended November 30, 2011, the Fund used forward currency contracts to manage against anticipated currency exchange rate changes and adjust exposure to foreign currencies. Forward currency contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded (unless otherwise adjusted due to the time at which foreign markets close). The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. During the period ended November 30, 2011, the Fund used futures contracts to adjust exposure to certain securities markets and maintain the diversity and liquidity of the portfolio. Futures contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.

 


 

Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers (unless otherwise adjusted due to the time at which foreign markets close) and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market

 


 

disruptions. During the period ended November 30, 2011, the Fund used total return swap agreements to achieve returns comparable to holding and lending a direct equity position. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. During the period ended November 30, 2011, the Fund held rights and/or warrants received as a result of corporate actions. Rights and/or warrants held by the Fund at the end of the period are listed in the Fund’s Schedule of Investments.

 


 

The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Assets:
                                               
Investments, at value (rights and/or warrants)
  $     $     $     $ 41,169     $     $ 41,169  
Unrealized appreciation on forward currency contracts
          292,341                         292,341  
Unrealized appreciation on futures contracts*
                      842,880             842,880  
 
                                   
Total
  $     $ 292,341     $     $ 884,049     $     $ 1,176,390  
 
                                   
 
                                               
Liabilities:
                                               
Unrealized depreciation on forward currency contracts
  $     $ (167,769 )   $     $     $     $ (167,769 )
Unrealized depreciation on futures contracts*
                      (75,181 )           (75,181 )
 
                                   
Total
  $     $ (167,769 )   $     $ (75,181 )   $     $ (242,950 )
 
                                   
 
*   The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of futures contracts as reported in the Schedule of Investments.
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts, futures contracts and rights and/or warrants), or notional amounts (swap agreements) outstanding at each month-end, was as follows for the period ended November 30, 2011:
                                 
    Forward                    
    Currency     Futures     Rights and/or     Swap  
    Contracts     Contracts     Warrants     Agreements  
Average amount outstanding
  $ 61,961,392     $ 16,643,284     $ 72,825     $ 92,570  

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Domestic Bond Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Par Value ($) /            
Shares     Description   Value ($)  
 
       
DEBT OBLIGATIONS — 11.0%
       
       
 
       
       
Corporate Debt — 2.8%
       
  9,312,000    
Health Care Property Investors, Inc., Series G, MTN, 5.63%, due 02/28/13
    9,604,900  
       
 
     
       
 
       
       
U.S. Government — 8.0%
       
  27,168,858    
U.S. Treasury Inflation Indexed Note, 2.00%, due 04/15/12(a)
    27,260,118  
       
 
     
       
 
       
       
U.S. Government Agency — 0.2%
       
  471,650    
Agency for International Development Floater (Support of Jamaica), 6 mo. U.S. Treasury Bill + 0.75%, 0.82%, due 03/30/19(b)
    454,590  
  233,336    
Agency for International Development Floater (Support of Zimbabwe), 3 mo. U.S. Treasury Bill x 115%, 0.04%, due 01/01/12(b)
    232,979  
       
 
     
       
Total U.S. Government Agency
    687,569  
       
 
     
       
TOTAL DEBT OBLIGATIONS (COST $37,498,148)
    37,552,587  
       
 
     
 
       
MUTUAL FUNDS — 88.9%
       
       
 
       
       
Affiliated Issuers — 88.9%
       
  45,578,624    
GMO Short-Duration Collateral Fund
    301,274,708  
  1,483    
GMO Special Purpose Holding Fund(c)
    578  
  28,812    
GMO U.S. Treasury Fund
    720,599  
       
 
     
       
 
    301,995,885  
       
 
     
       
TOTAL MUTUAL FUNDS (COST $327,957,777)
    301,995,885  
       
 
     
 
       
SHORT-TERM INVESTMENTS — 0.0%
       
       
 
       
       
Money Market Funds — 0.0%
       
  30,184    
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00%(d)
    30,184  
       
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $30,184)
    30,184  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 99.9%
       
       
(Cost $365,486,109)
    339,578,656  
 
       
Other Assets and Liabilities (net) — 0.1%
    173,479  
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 339,752,135  
       
 
     

 


 

A summary of outstanding financial instruments at November 30, 2011 is as follows:
Swap Agreements
Credit Default Swaps
                                                     
                                        Maximum Potential        
                            Implied         Amount of Future     Net Unrealized  
Notional   Expiration       Receive     Annual     Credit     Reference   Payments by the Fund     Appreciation/  
Amount   Date   Counterparty   (Pay)^     Premium     Spread (1)     Entity   Under the Contract (2)     (Depreciation)  
11,500,000 USD
  3/20/2013   Barclays Bank PLC   (Pay)     0.61 %     1.20 %   Health Care Properties   NA   $ 74,725  
 
                                               
Premiums to (Pay) Receive     $  
 
                                               
 
^   Receive — Fund receives premium and sells credit protection. If a credit event occurs, as defined under the terms of that particular swap agreement, the Fund will either (i) pay to the buyer of protection an amount equal to the notional amount of the swap and take delivery of the referenced obligation or underlying securities comprising the referenced index or (ii) pay a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation or underlying securities comprising the referenced index.
 
    (Pay) — Fund pays premium and buys credit protection. If a credit event occurs, as defined under the terms of that particular swap agreement, the Fund will either (i) receive from the seller of protection an amount equal to the notional amount of the swap and deliver the referenced obligation or underlying securities comprising the referenced index or (ii) receive a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation or underlying securities comprising the referenced index.
 
(1)   Implied credit spreads, represented in absolute terms, utilized in determining the market value of credit default swap agreements on the reference security, as of November 30, 2011, serve as an indicator of the current status of the payment/performance risk and reflect the likelihood or risk of default for the reference entity. The implied credit spread of a particular referenced entity reflects the cost of buying/selling protection. Wider (i.e.higher) credit spreads represent a deterioration of the referenced entity’s credit soundness and a greater likelihood or risk of default or other credit event occurring as defined under the terms of the agreement.
 
(2)   The maximum potential amount the Fund could be required to pay as a seller of credit protection if a credit event occurs as defined under the terms of that particular swap agreement.
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
 
Notes to Schedule of Investments:
MTN — Medium Term Note

The rates shown on variable rate notes are the current interest rates at November 30, 2011, which are subject to change based on the terms of the security.
(a)      Indexed security in which price and/or coupon is linked to the prices of a specific instrument or financial statistic.
(b)      Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust.
(c)      Underlying investment represents interests in defaulted claims. See “Other Matters” for additional information.
(d)      Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.
Currency Abbreviations:
USD — United States Dollar

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                             
        Gross     Gross     Net Unrealized  
        Unrealized     Unrealized     Appreciation  
Aggregate Cost     Appreciation     (Depreciation)     (Depreciation)  
$ 381,961,238     $ 305,861     $ (42,688,443 )   $ (42,382,582 )
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                         
    Value,                             Distributions                
    beginning of             Sales     Dividend     of Realized     Return of     Value, end  
Affiliate   period     Purchases     Proceeds     Income*     Gains*     Capital*     of period  
GMO Short-Duration Collateral Fund
  $ 473,106,122     $     $     $ 3,583,799     $     $ 157,848,603     $ 301,274,708  
GMO Special Purpose Holding Fund
    741                                     578  
GMO U.S. Treasury Fund
    14,663,527       13,710,000       27,653,000       492       30             720,599  
 
                                         
Totals
  $ 487,770,390     $ 13,710,000     $ 27,653,000     $ 3,584,291     $ 30     $ 157,848,603     $ 301,995,885  
 
                                         
 
*   The table above includes estimated sources of all distributions paid by the underlying funds during the period March 1, 2011 through November 30, 2011 for tax purposes. The actual tax characterization of distributions paid by the underlying funds will be determined at the end of the fiscal year ending February 29, 2012.

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly and indirectly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 3.2% of net assets. The Fund and the underlying funds classify such securities (levels defined below) as Level 3. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivatives contracts based on the creditworthiness of its counterparties. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Typically the Fund and the underlying funds value debt instruments based on the most recent quoted price supplied by a single pricing source chosen by the Manager. Although the Manager normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and may change a pricing source at any time. The Manager monitors erratic or unusual movements (including unusual inactivity) in the prices supplied for a security and has discretion to override a price supplied by a source (e.g., by taking a price supplied by another) when it believes that the price supplied is not reliable. Although alternative prices may be available for securities held by the Fund and the underlying funds, those alternative sources are not typically part of the valuation process and do not necessarily provide greater certainty about the prices used by the Fund and the underlying funds. As of November 30, 2011, the total value of securities held indirectly for which no alternative pricing source was available represented 9.8% of the net assets of the Fund.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit risk, yield curves and similar data. The Fund also used third party valuation services (which use industry models and market data from pricing vendors) to value credit default swaps.
Level 3 — Valuations based primarily on inputs that are unobservable and significant. The Fund used the following fair value technique on Level 3 investments: The Fund valued certain debt securities by using a specified spread above the LIBOR rate.

 


 

The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Debt Obligations
                               
Corporate Debt
  $     $ 9,604,900     $     $ 9,604,900  
U.S. Government
          27,260,118             27,260,118  
U.S. Government Agency
                687,569       687,569  
 
                       
TOTAL DEBT OBLIGATIONS
          36,865,018       687,569       37,552,587  
 
                       
Mutual Funds
    301,995,307       578             301,995,885  
Short-Term Investments
    30,184                   30,184  
 
                       
Total Investments
    302,025,491       36,865,596       687,569       339,578,656  
 
                       
Derivatives*
                               
Swap Agreements
                               
Credit Risk
          74,725             74,725  
 
                       
Total
  $ 302,025,491     $ 36,940,321     $ 687,569     $ 339,653,381  
 
                       

 


 

The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
 
*   Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as either Level 1 or Level 2. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net values of the Fund’s investments (both direct and indirect) in securities and derivative financial instruments using Level 3 inputs were 63.9% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant unobservable inputs (Level 3) were used in determining value:
                                                                                   
                                                                              Net Change in  
                                                                              Unrealized  
                                                                              Appreciation  
                                            Change in                               (Depreciation)  
    Balances as                     Accrued     Total     Unrealized                     Balances as       from Investments  
    of February                     Discounts/     Realized     Appreciation     Transfers     Transfers out     of November       Still Held as of  
    28, 2011     Purchases     Sales     Premiums     Gain/(Loss)     (Depreciation)     into level 3 *     of level 3 *     30, 2011       November 30, 2011  
Debt Obligations
                                                                                 
U.S. Government Agency
  $ 983,567     $     $ (296,234 )   $ 16     $ (34 )   $ 254     $     $     $ 687,569       $ 254  
 
                                                             
Total
  $ 983,567     $     $ (296,234 )   $ 16     $ (34 )   $ 254     $     $     $ 687,569       $ 254  
 
                                                             
 
*   The Fund accounts for investments and derivatives transferred into Level 3 at the value at the beginning of the period and transferred out of Level 3 at the value at the end of the period.

 


 

Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase the security at an agreed upon price and date. The Fund, through its custodian, takes possession of securities it acquired under the repurchase agreement. The value of the securities acquired is required by contract to be marked to market daily and additional collateral is required to be transferred so that the market value is at least equal to the amount owed to the Fund by the seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings and/or the value of the securities subject to the repurchase agreement is insufficient, the Fund’s recovery of cash from the seller may be delayed and the Fund may incur a loss equal to the difference between the cash it paid and the value of the securities. The Fund had no repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same assets at an agreed upon price and date. The Fund can use the proceeds received from entering into a reverse repurchase agreement to make additional investments, which generally causes the Fund’s portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the securities it sold and as a result would realize a loss equal to the difference between the value of those securities and the payment it received for them. The size of this loss will depend upon the difference between what the buyer paid for the securities the Fund sold to it and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of $100). In the event of a buyer’s bankruptcy or insolvency, the Fund’s use of proceeds from the sale of its securities may be restricted while the other party or its trustee or receiver determines whether to honor the Fund’s right to repurchase the securities. The Fund had no reverse repurchase agreements outstanding at the end of the period.
Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income securities whose principal value is adjusted periodically according to the rate of inflation. Two structures are common. The U.S. Treasury and some other issuers use a structure that reflects inflation in the principal value of the bond. Most other issuers pay out any inflation related accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real interest rates. Real interest rates, in turn, are tied to the relationship between nominal interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e. nominal interest rate minus inflation) might decline, leading to an increase in value of inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than inflation, real interest rates might rise, leading to a decrease in value of inflation indexed bonds. There can be no assurance, however, that the value of inflation indexed bonds will be directly correlated to changes in nominal interest rates, and short term increases in inflation may lead to a decline in their value. Coupon payments received by the Fund from inflation indexed bonds are included in the Fund’s gross income for the period in which they accrue. In addition, any increase or decrease in the principal amount of an inflation indexed bond will increase or decrease taxable ordinary income to the Fund, even though principal is not paid until maturity. Inflation-indexed bonds outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Other matters
GMO Special Purpose Holding Fund (“SPHF”), an investment of the Fund, has litigation pending against various entities related to the 2002 fraud and related default of securities previously held by SPHF. The outcome of the lawsuits against the remaining defendants is not known and any potential recoveries are not reflected in the net asset value of SPHF. For the period ended November 30, 2011, the Fund received no distributions from SPHF in connection with the defaulted securities or the related litigation.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Asset-Backed Securities — Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or

 


 

to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating. The Fund’s investments in below investment grade securities have speculative characteristics, and changes in economic conditions or other circumstances are more likely to impair the capacity of issuers to make principal and interest payments than is the case with issuers of investment grade securities.
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies with high positive correlations to one another, such as the Fund’s investments in asset-backed securities secured by different types of consumer debt (e.g., credit-card receivables, automobile loans and home equity loans), creates additional risk.
Market Risk Fixed Income Securities — Typically, the market value of the Fund’s fixed income securities will decline during periods of widening of credit spreads.
Derivatives Risk — The use of derivatives involves the risk that their value may or may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in underlying funds, including the risk that the underlying funds in which it invests will not perform as expected.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations. The risk of counterparty default is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions.
Leveraging Risk — The Fund’s use of reverse repurchase agreements and other derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
The Fund invests (including through investment in underlying funds) in asset-backed securities, which may be backed by many types of assets, including pools of residential and commercial mortgages, automobile loans, educational loans, home equity loans, or credit card receivables, which expose the Fund to additional types of market risk. They also may be backed by pools of corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds and loans (commonly referred to as “collateralized debt obligations” or “collateralized loan obligations”) and by the fees earned by service providers. Payment of interest on asset backed securities and repayment of principal largely depend on the cash flows generated by the assets backing the securities. The market risk of a particular asset-backed security depends on many factors, including the deal structure (e.g., determination as to the amount of underlying assets or other support needed to produce the cash flows necessary to service interest and make principal payments), the quality of the underlying assets and, if any, the level of credit support and the credit quality of the credit-support provider. Asset-backed securities involve risk of loss of principal if obligors of the underlying obligations default and the value of the defaulted

 


 

obligations exceeds whatever credit support the securities may have. The obligations of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and other laws affecting the rights and remedies of creditors. Many asset-backed securities in which the Fund has invested are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal and/or interest will be paid because the insurer could default on its obligations. In recent years, a significant number of asset-backed security insurers have defaulted on their obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about the creditworthiness of those securities (and underlying assets) caused credit spreads (the difference between yields on the asset-backed securities and U.S. Government securities) to widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions to make markets in many fixed income securities. These events reduced liquidity and contributed to substantial declines in the value of asset-backed and other fixed income securities. There can be no assurance these conditions will not occur again. Also, government actions and proposals affecting the terms of underlying home and consumer loans, changes in demand for products (e.g., automobiles) financed by those loans, and the inability of borrowers to refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying assets and is, therefore, subject to risks associated with the negligence or defalcation of its servicer. In some circumstances, the mishandling of related documentation also may affect the rights of security holders in and to the underlying assets. The insolvency of entities that generate receivables or that utilize the assets may result in a decline in the value of the underlying assets, as well as costs and delays. The obligations underlying asset-backed securities, in particular securities backed by pools of residential and commercial mortgages, also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as high a yield as is provided by the asset-backed security. The risk of investing in asset-backed securities has increased because performance of the various sectors in which the assets underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime mortgages, and credit card receivables) has become more highly correlated since the deterioration in worldwide economic and liquidity conditions.
Among other trading agreements, the Fund is party to International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Agreements”) or other similar types of agreements with selected counterparties that generally govern over-the-counter derivative transactions entered into by the Fund. The ISDA Agreements typically include representations and warranties as well as contractual terms related to collateral, events of default, termination events, and other provisions. Termination events may include the decline in the net assets of the Fund below a certain level over a specified period of time and entitle a counterparty to elect to terminate early with respect to some or all the transactions under the ISDA Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse effect on the Fund’s operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. In particular, the Fund may use swaps or other derivatives on an index, a single security or a basket of securities to gain investment exposures (e.g., by selling protection under a credit default swap). The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). For example, the Fund may use credit default swaps to take a short position with respect to the likelihood of default by an issuer. The Fund also may use currency derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For instance, the Manager may alter the interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is designed to maintain the Fund’s exposure to the credit of an issuer through the debt instrument but adjust the Fund’s interest rate exposure through the swap. With these swaps, the Fund and its counterparties exchange interest rate exposure, such as fixed versus variable rates and shorter duration versus longer duration exposure. In adjusting its investment exposures, the Fund also may use currency derivatives in an

 


 

attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund is not limited in the extent to which it uses derivatives or in the absolute face value of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate exposure of its assets, and its net long exposure may exceed 100% of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk that it will be required to pay the full notional value of the swap contract in the event of a default.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by

 


 

making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded. The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other

 


 

relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. During the period ended November 30, 2011, the Fund used credit default swap agreements to provide a measure of protection against default loss. Swap agreements outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.

 


 

The following is a summary of the fair valuations of derivative instruments categorized by risk exposure.
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Assets:
                                               
Unrealized appreciation on swap agreements
  $     $     $ 74,725     $     $     $ 74,725  
 
                                   
Total
  $     $     $ 74,725     $     $     $ 74,725  
 
                                   
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The derivative financial instruments outstanding as of period end (as disclosed in the Schedule of Investments) serve as indicators of the volume of derivative activity for the Fund during the period.
Subsequent Events
On November 17, 2011, the Fund’s Board of Trustees approved a reverse stock split for Class III and Class VI of the Fund of one new share for every nine current shares. The reverse splits were effective for shareholders of record after the close of the NYSE on January 13, 2012. Transactions in shares were effected at the relevant class’s post-split price starting January 17, 2012. The ticker symbols and cusips for the share classes did not change.
The reverse splits reduced the number of shares outstanding for the share classes, and resulted in a proportionate increase in the price per share of each share class. The reverse splits did not change the value of a shareholder’s investment. Every nine pre-split shares held by a shareholder resulted in the receipt of one post-split share, which is priced nine times higher than the pre-split shares.

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Emerging Countries Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares     Description   Value ($)  
 
       
COMMON STOCKS — 85.3%
       
       
 
       
       
Brazil — 11.7%
       
  6,300    
Banco Bradesco ADR
    103,950  
  172,000    
Banco do Brasil SA
    2,301,767  
  29,600    
Banco Santander Brasil SA ADR
    228,512  
  19,000    
BM&F BOVESPA SA
    103,807  
  39,600    
BR Malls Participacoes SA
    400,960  
  18,000    
Brasil Brokers Participacoes SA
    60,619  
  17,660    
Brasil Telecom SA ADR
    314,701  
  11,700    
BRF — Brasil Foods SA
    235,755  
  7,070    
Centrais Eletricas Brasileiras SA Sponsored ADR
    65,680  
  21,200    
CETIP SA
    308,325  
  14,709    
Cia de Saneamento Basico do Estado de Sao Paulo
    406,615  
  18,100    
Cielo SA
    481,939  
  4,200    
Companhia de Bebidas das Americas
    115,199  
  2,700    
Companhia de Bebidas das Americas ADR
    92,826  
  3,600    
Companhia de Concessoes Rodoviarias
    22,993  
  20,300    
Companhia de Saneamento de Minas Gerais-Copasa MG *
    362,253  
  10,100    
Cosan SA Industria e Comercio
    150,242  
  25,200    
Cyrela Brazil Realty SA
    209,448  
  27,300    
Electrobras (Centro)
    250,151  
  2,100    
Embraer SA ADR
    53,592  
  5,700    
Fleury SA *
    64,932  
  9,600    
Gafisa SA ADR
    57,792  
  64,500    
Gerdau SA
    413,391  
  44,900    
Gerdau SA Sponsored ADR
    344,832  
  500    
HRT Participacoes em Petroleo SA *
    183,869  
  110,690    
Itau Unibanco Holding SA ADR
    1,970,282  
  74,100    
JBS SA *
    243,811  
  35,800    
Light SA
    542,637  
  5,200    
LPS Brasil Consultoria de Imoveis SA
    77,669  
  2,500    
MPX Mineracao e Energia SA *
    59,723  
  2,000    
Multiplan Empreendimentos Imobiliarios SA
    40,037  
  22,100    
Multiplus SA
    387,408  
  3,200    
OdontoPrev SA
    44,416  
  18,800    
PDG Realty SA Empreendimentos e Participacoes
    69,863  
  96,530    
Petroleo Brasileiro SA (Petrobras) ADR
    2,605,345  
  65,200    
Redecard SA
    1,099,677  
  4,600    
Souza Cruz SA
    58,354  
  2,600    
Sul America SA
    18,979  
  25,060    
Telefonica Brasil SA ADR
    675,868  
  2,838    
Tim Participacoes SA ADR
    67,573  
  12,200    
Ultrapar Participacoes SA
    214,673  
  10,800    
Ultrapar Participacoes SA Sponsored ADR
    191,916  
  7,700    
Usinas Siderurgicas de Minas Gerais SA
    75,793  
  5,500    
Usinas Siderurgicas de Minas Gerais SA Sponsored ADR
    32,835  
  15,900    
Vale SA
    366,210  
  109,400    
Vale SA Sponsored ADR
    2,543,550  
       
 
     
       
Total Brazil
    18,720,769  
       
 
     
       
 
       
       
Chile — 0.2%
       
  500    
Compania Cervecerias Unidas ADR
    28,615  
  560    
Embotelladora Andina SA ADR Class B
    15,232  
  14,272    
Empresa National de Telecomunicaciones SA
    289,232  
       
 
     
       
Total Chile
    333,079  
       
 
     

 


 

                 
       
China — 12.2%
       
  94,000    
Air China Ltd Class H
    72,170  
  300    
Baidu Inc Sponsored ADR *
    39,297  
  2,344,000    
Bank of China Ltd Class H
    764,253  
  693,100    
Bank of Communications Co Ltd Class H
    452,549  
  93,000    
Belle International Holdings Ltd
    178,935  
  563,000    
China CITIC Bank Corp Class H
    303,279  
  92,900    
China Coal Energy Co Class H
    110,972  
  333,200    
China Communication Services Corp Ltd Class H
    160,873  
  879,000    
China Communications Construction Co Ltd Class H
    677,797  
  303,000    
China Construction Bank Class H
    215,481  
  81,000    
China Life Insurance Co Ltd Class H
    217,831  
  106,000    
China Mengniu Dairy Co Ltd
    381,920  
  489,464    
China Mobile Ltd
    4,833,160  
  4,082    
China Mobile Ltd Sponsored ADR
    202,753  
  84,000    
China National Building Material Co Ltd Class H
    102,249  
  162,000    
China Overseas Land & Investment Ltd
    285,960  
  82,600    
China Pacific Insurance Group Co Ltd
    237,703  
  1,977,083    
China Petroleum & Chemical Corp Class H
    2,093,409  
  24,000    
China Resources Cement Holdings Ltd
    17,929  
  149,000    
China Shenhua Energy Co Ltd Class H
    657,687  
  2,221,900    
China Telecom Corp Ltd Class H
    1,357,050  
  308,000    
China Unicom Hong Kong Ltd
    668,686  
  10,300    
China Unicom Hong Kong Ltd ADR
    222,171  
  31,000    
China Yurun Food Group Ltd
    44,807  
  141,200    
Citic Pacific Ltd
    268,243  
  37,000    
CNOOC Ltd
    71,774  
  780    
CNOOC Ltd ADR
    150,790  
  32,000    
Cosco Pacific Ltd
    37,745  
  499,000    
Country Garden Holdings Co
    178,621  
  244,000    
Dongfeng Motor Group Co Ltd Class H
    366,471  
  79,000    
Evergrande Real Estate Group Ltd
    33,041  
  67,000    
Foxconn International Holdings Ltd *
    42,802  
  749,000    
GOME Electrical Appliances Holdings Ltd
    192,388  
  82,500    
Great Wall Motor Co Ltd Class H
    118,818  
  46,000    
Guangzhou R&F Properties Co Ltd Class H
    38,231  
  45,000    
Haitian International Holdings Ltd
    39,020  
  38,500    
Hengan International Group Co Ltd
    362,718  
  1,000    
Home Inns & Hotels Management Inc ADR *
    31,060  
  318,000    
Hopson Development Holdings Ltd
    191,179  
  1,144,000    
Industrial and Commercial Bank of China Ltd Class H
    667,022  
  3,400    
Inner Mongolia Yitai Coal Co Class B
    18,089  
  67,000    
Intime Department Store Group Co Ltd
    78,672  
  12,000    
Jiangxi Copper Co Ltd Class H
    28,508  
  244,000    
Kingdee International Software Group Co Ltd
    83,003  
  112,000    
Kunlun Energy Company Ltd
    151,590  
  32,000    
Lenovo Group Ltd
    22,811  
  18,500    
Longfor Properties
    21,931  
  1,200    
Netease.Com Inc ADR *
    54,108  
  6,000    
New Oriental Education & Technology Group Inc Sponsored ADR *
    151,440  
  1,000    
PetroChina Co Ltd ADR
    130,750  
  463,553    
PetroChina Co Ltd Class H
    601,952  
  406,000    
PICC Property & Casualty Co Ltd Class H
    550,214  
  25,000    
Shanghai Industrial Holdings Ltd
    67,917  
  102,251    
Sino-Ocean Land Holdings Ltd
    40,824  
  90,000    
Tingyi (Cayman Islands) Holding Corp
    292,805  
  240,000    
Yangzijiang Shipbuilding Holdings Ltd
    172,871  
  64,000    
Zijin Mining Group Co Ltd Class H
    28,607  
       
 
     
       
Total China
    19,584,936  
       
 
     

 


 

                 
       
 
       
       
Czech Republic — 1.6%
       
  40,558    
CEZ AS
    1,601,264  
  3,116    
Komercni Banka AS
    515,102  
  3,575    
Pegas Nonwovens SA
    85,292  
  356    
Philip Morris CR AS
    231,286  
  8,365    
Telefonica 02 Czech Republic AS
    175,048  
       
 
     
       
Total Czech Republic
    2,607,992  
       
 
     
       
 
       
       
Egypt — 1.4%
       
  14,835    
Alexandria Mineral Oils Co
    159,529  
  59,003    
Commercial International Bank
    235,782  
  2,693    
EFG-Hermes Holding GDR *
    9,702  
  10,010    
EFG-Hermes Holding SAE *
    18,365  
  8,394    
Egyptian Co for Mobile Services
    136,507  
  60,139    
Egyptian Kuwaiti Holding Co SAE
    62,380  
  36,806    
ElSwedy Electric Co
    134,228  
  10,381    
Orascom Construction Industries
    382,182  
  136,655    
Orascom Telecom Holding SAE *
    67,744  
  104,741    
Orascom Telecom Holding SAE GDR (Registered Shares) *
    273,307  
  19,791    
Oriental Weavers Co
    99,700  
  40,877    
Sidi Kerir Petrochemicals Co
    84,941  
  131,908    
South Valley Cement
    76,402  
  188,467    
Talaat Moustafa Group *
    117,517  
  181,129    
Telecom Egypt
    423,721  
       
 
     
       
Total Egypt
    2,282,007  
       
 
     
       
 
       
       
Hungary — 1.2%
       
  1,327    
Egis Gyogyszergyar Nyrt
    108,774  
  123,215    
Magyar Telekom Nyrt
    282,078  
  2,489    
MOL Hungarian Oil and Gas Nyrt *
    207,180  
  79,889    
OTP Bank Nyrt
    1,186,633  
  441    
Richter Gedeon Nyrt
    66,481  
       
 
     
       
Total Hungary
    1,851,146  
       
 
     
       
 
       
       
India — 5.0%
       
  3,256    
ACC Ltd
    72,280  
  24,159    
Ambuja Cements Ltd
    70,200  
  1,493    
Asian Paints Ltd
    83,043  
  30,368    
Aurobindo Pharma Ltd
    54,479  
  2,417    
Bajaj Auto Ltd
    78,902  
  4,253    
Bank of Baroda (a)
    58,171  
  7,966    
Bank of India
    50,691  
  2,359    
Bharat Petroleum Corp Ltd
    24,339  
  29,275    
Bharti Airtel Ltd
    215,810  
  9,683    
Cairn India Ltd *
    57,154  
  11,777    
Canara Bank Ltd
    98,602  
  20,228    
Coal India Ltd
    128,869  
  10,740    
Coromandel International Ltd
    59,556  
  39,899    
Dish TV India Ltd *
    49,896  
  24,902    
Essar Oil Ltd *
    33,567  
  17,981    
GAIL India Ltd
    138,384  
  7,560    
Grasim Industries Ltd (a)
    354,366  
  4,278    
HCL Technologies Ltd
    32,677  
  13,917    
HDFC Bank Ltd
    120,880  
  3,100    
HDFC Bank Ltd ADR
    85,746  
  5,575    
Hero Honda Motors Ltd
    218,089  
  13,048    
Hindalco Industries Ltd
    31,781  
  9,596    
Hindustan Petroleum Corp Ltd
    51,155  
  2,397    
Hindustan Unilever Ltd
    18,280  
  38,197    
Hindustan Zinc Ltd
    89,638  

 


 

                 
  110,349    
Idea Cellular Ltd *
    203,650  
  11,609    
Indian Oil Corp Ltd
    58,095  
  13,773    
Indraprastha Gas Ltd
    106,809  
  14,642    
IndusInd Bank Ltd (a)
    70,865  
  9,423    
Infosys Technologies Ltd
    482,827  
  7,960    
Infosys Technologies Ltd Sponsored ADR
    410,895  
  2,737    
JSW Steel Ltd
    31,508  
  3,955    
Jubilant Foodworks Ltd *
    59,456  
  2,540    
Kotak Mahindra Bank Ltd
    23,152  
  2,204    
Lupin Ltd
    20,260  
  12,017    
Mahindra & Mahindra Ltd
    171,293  
  2,415    
Maruti Suzuki India Ltd
    45,874  
  24,090    
Mphasis Ltd
    151,013  
  1,021    
Nestle India Ltd
    82,979  
  67,909    
NHPC Ltd
    29,561  
  38,117    
NTPC Ltd
    121,076  
  102,832    
Oil & Natural Gas Corp Ltd
    534,714  
  29,699    
Petronet LNG Ltd
    94,154  
  66,557    
Power Grid Corp of India Ltd
    127,955  
  4,152    
Punjab National Bank Ltd (a)
    72,006  
  16,249    
Rallis India Ltd
    47,597  
  13,124    
Reliance Industries Ltd
    201,181  
  1,402    
Reliance Industries Ltd Sponsored GDR, 144A
    42,233  
  26,977    
Rural Electrification Corp Ltd
    97,143  
  106,932    
Sesa Goa Ltd
    387,309  
  74,708    
Shree Renuka Sugars Ltd
    44,244  
  2,732    
State Bank of India
    92,878  
  48,007    
Steel Authority of India Ltd
    75,637  
  100,275    
Sterlite Industries India Ltd
    197,666  
  2,200    
Sterlite Industries India Ltd ADR
    17,732  
  8,768    
Sun TV Network Ltd
    44,677  
  26,707    
Tata Consultancy Services Ltd
    582,353  
  69,520    
Tata Motors Ltd
    238,317  
  4,800    
Tata Motors Ltd Sponsored ADR
    82,560  
  73,428    
Tata Power Co Ltd
    131,979  
  28,073    
Tata Steel Ltd
    210,389  
  2,051    
Ultratech Cement Ltd
    45,423  
  12,498    
Union Bank of India
    51,114  
  16,547    
Wipro Ltd
    123,290  
  7,900    
Wipro Ltd ADR
    75,840  
       
 
     
       
Total India
    7,964,259  
       
 
     
       
 
       
       
Indonesia — 6.4%
       
  498,500    
Astra International Tbk PT
    4,004,063  
  285,000    
Bank Central Asia Tbk PT
    254,057  
  664,621    
Bank Danamon Indonesia Tbk PT
    328,689  
  1,556,672    
Bank Mandiri Tbk PT
    1,133,817  
  465,000    
Bank Negara Indonesia (Persero) Tbk PT
    200,123  
  1,321,500    
Bank Rakyat Tbk PT
    978,644  
  83,500    
Bumi Resources Tbk PT
    19,292  
  3,000    
Gudang Garam Tbk PT
    21,947  
  392,500    
Indofood Sukses Makmur Tbk PT
    209,663  
  90,500    
Indosat Tbk PT
    54,632  
  116,000    
Jasa Marga PT
    50,517  
  661,000    
Kalbe Farma Tbk PT
    261,554  
  948,000    
Perusahaan Gas Negara PT
    329,270  
  139,500    
Tambang Batubara Bukit Asam Tbk PT
    268,585  
  935,000    
Telekomunikasi Indonesia Tbk PT
    766,223  
  9,800    
Telekomunikasi Indonesia Tbk PT Sponsored ADR
    320,950  
  399,575    
United Tractors Tbk PT
    1,053,842  
       
 
     
       
Total Indonesia
    10,255,868  
       
 
     

 


 

                 
       
Malaysia — 0.5%
       
  25,000    
AirAsia Berhad
    29,915  
  156,680    
AMMB Holdings Berhad
    298,014  
  40,160    
Genting Berhad
    141,536  
  39,800    
Genting Malaysia Berhad
    50,138  
  56,083    
Hong Leong Bank Berhad
    186,379  
  64,900    
Landmarks Berhad *
    22,984  
  33,200    
Petronas Chemicals Group Bhd
    63,971  
  16,500    
Sime Darby Berhad
    47,359  
  19    
UMW Holdings Berhad
    40  
       
 
     
       
Total Malaysia
    840,336  
       
 
     
       
 
       
       
Mexico — 1.3%
       
  202,100    
America Movil SAB de CV Class L
    240,550  
  61,140    
America Movil SAB de CV Class L ADR
    1,456,355  
  220    
Grupo Elektra SA de CV
    21,458  
  15,900    
Grupo Financiero Banorte SAB de CV Class O
    53,814  
  10,300    
Grupo Financiero Inbursa, SAB de CV
    19,254  
  1,400    
Grupo Televisa SA Sponsored ADR
    29,064  
  59,000    
Grupo Televisa SA-Series CPO
    245,766  
       
 
     
       
Total Mexico
    2,066,261  
       
 
     
       
 
       
       
Morocco — 0.3%
       
  537    
Attijariwafa Bank
    23,198  
  27,286    
Maroc Telecom
    463,060  
       
 
     
       
Total Morocco
    486,258  
       
 
     
       
 
       
       
Philippines — 1.2%
       
  281,000    
Alliance Global Group Inc
    67,084  
  76,380    
BDO Unibank Inc
    98,157  
  2,118,500    
Lopez Holding Corp
    225,283  
  107,617    
Metropolitan Bank & Trust Co
    166,420  
  15,345    
Philippine Long Distance Telephone Co
    852,577  
  7,390    
Philippine Long Distance Telephone Co Sponsored ADR
    407,928  
  60,000    
Universal Robina Corp
    69,385  
  315,000    
Vista Land & Lifescapes Inc
    21,206  
       
 
     
       
Total Philippines
    1,908,040  
       
 
     
       
 
       
       
Poland — 1.8%
       
  4,932    
Asseco Poland SA
    73,215  
  14,125    
Grupa Lotos SA *
    106,314  
  39,011    
KGHM Polska Miedz SA
    1,550,366  
  29,648    
PGE SA
    189,854  
  8,632    
Polski Koncern Naftowy Orlen SA *
    104,016  
  91,363    
Polskie Gornictwo Naftowe i Gazownictwo SA
    112,425  
  187,714    
Tauron Polska Energia SA
    304,713  
  83,774    
Telekomunikacja Polska SA
    462,956  
       
 
     
       
Total Poland
    2,903,859  
       
 
     
       
 
       
       
Russia — 11.2%
       
  1,625    
Eurasia Drilling Co Ltd GDR
    42,546  
  66,025    
Gazprom Neft Class S
    308,517  
  6,614    
Gazprom Neft JSC Sponsored ADR
    151,521  
  417,668    
Gazprom OAO Sponsored ADR
    4,829,635  
  46,022    
KamAZ *
    60,685  
  63,111    
Lukoil OAO ADR
    3,553,646  
  26,176    
Magnit OJSC Sponsored GDR
    582,088  
  21,347    
Magnitogorsk Iron & Steel Works Sponsored GDR (Registered Shares)
    133,659  
  12,347    
Mail.ru Group Ltd GDR (Registered Shares) *
    382,219  
  24,490    
Mechel Sponsored ADR
    266,696  

 


 

                 
  22,901    
MMC Norilsk Nickel JSC ADR
    404,368  
  22,400    
Mobile Telesystems Sponsored ADR
    387,072  
  4,392    
NovaTek OAO Sponsored GDR (Registered Shares)
    672,885  
  36,018    
OAO Tatneft Sponsored GDR (Registered Shares)
    1,166,372  
  241,202    
Rosneft OJSC GDR (Registered Shares)
    1,765,249  
  37,343    
Rostelecom *
    196,573  
  58,663    
Sberbank Sponsored ADR *(a)
    713,672  
  7,823    
Sistema JSFC Sponsored GDR (Registered Shares)
    156,869  
  184,231    
Surgutneftegas Sponsored ADR
    1,770,849  
  10,005    
Uralkali Sponsored GDR (Registered Shares)
    406,492  
       
 
     
       
Total Russia
    17,951,613  
       
 
     
       
 
       
       
South Africa — 3.6%
       
  23,064    
Absa Group Ltd
    409,282  
  4,200    
African Rainbow Minerals Ltd
    93,661  
  3,747    
AngloGold Ashanti Ltd
    177,519  
  70,253    
Aveng Ltd
    308,747  
  6,399    
Bidvest Group Ltd
    124,769  
  12,743    
Exxaro Resources Ltd
    284,400  
  173,951    
FirstRand Ltd
    432,233  
  916    
Gold Fields Ltd
    15,435  
  3,200    
Gold Fields Ltd Sponsored ADR
    54,208  
  68,039    
Growthpoint Properties Ltd
    154,478  
  4,362    
Kumba Iron Ore Ltd
    274,772  
  19,606    
MTN Group Ltd
    353,186  
  14,408    
Murray & Roberts Holdings Ltd *
    44,738  
  13,324    
Nedbank Group Ltd
    236,399  
  18,793    
Remgro Ltd
    283,569  
  46,523    
RMB Holdings Ltd
    151,042  
  30,981    
Sanlam Ltd
    114,867  
  11,833    
Sasol Ltd
    567,673  
  800    
Sasol Ltd Sponsored ADR
    38,328  
  20,736    
Shoprite Holdings Ltd
    350,019  
  2,840    
Standard Bank Group Ltd
    34,636  
  19,457    
Steinhoff International Holdings Ltd *
    56,999  
  97,361    
Telkom South Africa Ltd
    348,906  
  5,617    
Tiger Brands Ltd
    170,130  
  35,585    
Vodacom Group Ltd
    402,392  
  9,670    
Wilson Bayly Holmes-Ovcon Ltd
    125,807  
  42,121    
Woolworths Holdings Ltd
    210,606  
       
 
     
       
Total South Africa
    5,818,801  
       
 
     
       
 
       
       
South Korea — 12.7%
       
  9    
BS Financial Group Inc *
    94  
  14,187    
Celltrion Inc
    470,480  
  609    
CJ CheilJedang Corp
    156,120  
  1,200    
Daewoo International Corp
    29,876  
  1,920    
Daewoo Shipbuilding & Marine Engineering Co Ltd
    51,517  
  21,162    
DGB Financial Group Inc *
    249,256  
  5,318    
Dongbu Insurance Co Ltd
    245,084  
  548    
Doosan Heavy Industries and Construction Co
    32,597  
  312    
E-Mart Co Ltd *
    80,954  
  259    
GLOVIS Co Ltd
    51,501  
  895    
GS Home Shopping Inc
    85,636  
  17,932    
Hana Financial Group Inc
    648,722  
  12,547    
Hanwha Corp
    410,551  
  3,149    
Hyosung Corp
    177,282  
  1,841    
Hyundai Heavy Industries Co Ltd
    459,316  
  7,167    
Hyundai Hysco
    271,054  
  2,306    
Hyundai Mobis
    639,479  
  4,362    
Hyundai Motor Co
    848,479  

 


 

                 
  3,491    
Hyundai Steel Co
    309,903  
  42,525    
Industrial Bank of Korea
    565,329  
  9,737    
INTOPS Co Ltd
    179,412  
  10,558    
Kangwon Land Inc
    260,240  
  3,324    
Kia Motors Corp
    211,463  
  86,960    
Korea Exchange Bank
    635,508  
  1,216    
Korea Investment Holdings Co Ltd
    40,861  
  642    
Korea Zinc Co Ltd
    197,887  
  6,000    
KT Corp
    192,152  
  21,100    
KT Corp Sponsored ADR
    338,655  
  18,627    
KT&G Corp
    1,260,614  
  59,208    
LG Uplus Corp
    353,980  
  133    
Lotte Shopping Co Ltd
    41,932  
  1,128    
NCSoft Corp
    306,939  
  1,000    
NHN Corp *
    221,854  
  444    
OCI Company Ltd
    93,664  
  150    
ORION Corp
    81,060  
  5,474    
POSCO
    1,844,885  
  577    
POSCO ADR
    49,420  
  47,580    
Samho International Co Ltd *
    78,719  
  718    
Samsung C&T Corp
    43,354  
  4,442    
Samsung Electronics Co Ltd
    4,042,752  
  3,041    
Samsung Fire & Marine Insurance Co Ltd
    599,911  
  2,078    
Samsung Life Insurance Co Ltd
    154,776  
  17,657    
Shinhan Financial Group Co Ltd
    658,306  
  595    
Shinsegae Co Ltd
    127,992  
  3,763    
SK C&C Co Ltd
    462,463  
  3,018    
SK Telecom Co Ltd
    404,406  
  72,839    
SK Telecom Co Ltd ADR
    1,077,289  
  226    
SK Holdings Co Ltd
    29,438  
  68,986    
Woori Finance Holdings Co Ltd
    618,063  
       
 
     
       
Total South Korea
    20,391,225  
       
 
     
       
 
       
       
Sri Lanka — 0.1%
       
  131,522    
Hatton National Bank Plc
    177,701  
  10,386    
Hatton National Bank Plc (Non Voting)
    7,751  
       
 
     
       
Total Sri Lanka
    185,452  
       
 
     
       
 
       
       
Taiwan — 6.6%
       
  130,660    
Asia Cement Corp
    144,455  
  131,871    
Asustek Computer Inc
    921,398  
  78,400    
Catcher Technology Co Ltd
    383,103  
  371,594    
Chunghwa Telecom Co Ltd
    1,231,791  
  4,289    
Chunghwa Telecom Co Ltd ADR
    143,381  
  1,308,577    
Compal Electronics Inc
    1,193,644  
  325,314    
Far Eastone Telecommunications Co Ltd
    619,760  
  46,000    
Formosa Chemicals & Fibre Co
    120,968  
  17,092    
Fubon Financial Holding Co Ltd
    17,815  
  28,091    
Hon Hai Precision Industry Co Ltd
    76,393  
  4,772    
HTC Corp
    78,564  
  263,000    
Innolux Display Corp *
    113,396  
  287,353    
Lite-On Technology Corp
    314,907  
  52,000    
MediaTek Inc
    496,248  
  117,289    
Nan Ya Plastics Corp
    218,433  
  50,793    
Novatek Microelectronics Corp Ltd
    127,930  
  147,100    
Powertech Technology Inc
    335,283  
  830,200    
ProMOS Technologies Inc *
    9,306  
  542,715    
Quanta Computer Inc
    1,092,341  
  134,880    
Taishin Financial Holding Co Ltd
    50,289  
  12,000    
Taiwan Cement Corp
    13,349  
  186,928    
Taiwan Mobile Co Ltd
    601,534  

 


 

                 
  295,660    
Taiwan Semiconductor Manufacturing Co Ltd
    741,223  
  13,289    
TPK Holding Co Ltd *
    182,028  
  1,202,000    
United Microelectronics Corp
    533,361  
  20,400    
United Microelectronics Corp Sponsored ADR
    46,716  
  581,395    
Wistron Corp
    732,054  
  13,000    
Yungtay Engineering Co Ltd
    19,726  
       
 
     
       
Total Taiwan
    10,559,396  
       
 
     
       
 
       
       
Thailand — 3.7%
       
  199,890    
Advanced Info Service Pcl (Foreign Registered) (a)
    912,071  
  500,488    
Asian Property Development Pcl (Foreign Registered) (a)
    79,796  
  13,000    
Bangkok Bank Pcl (Foreign Registered) (a)
    67,515  
  34,950    
Bangkok Bank Pcl NVDR
    166,578  
  211,200    
Bangkok Dusit Medical Service Pcl (Foreign Registered) (a)
    515,402  
  6,950    
Banpu Pcl (Foreign Registered) (a)
    124,561  
  91,200    
BEC World Pcl (Foreign Registered) (a)
    116,675  
  248,500    
Charoen Pokphand Foods Pcl (Foreign Registered) (a)
    268,634  
  102,700    
CP ALL Pcl (Foreign Registered) (a)
    168,115  
  121,900    
Electricity Generating Pcl (Foreign Registered) (a)
    348,575  
  1,463,400    
Hemaraj Land and Development Pcl (Foreign Registered) (a)
    107,273  
  716,200    
Home Product Center Pcl (Foreign Registered) (a)
    238,682  
  620,300    
IRPC Pcl (Foreign Registered) (a)
    79,742  
  57,910    
Kasikornbank Pcl (Foreign Registered) (a)
    225,343  
  69,900    
Kasikornbank Pcl NVDR
    269,694  
  222,000    
Land & Houses Pcl NVDR
    43,597  
  25,297    
PTT Global Chemical Pcl NVDR * (a)
    53,159  
  98,922    
PTT Pcl (Foreign Registered) (a)
    995,790  
  32,500    
Robinson Department Store Pcl (Foreign Registered) (a)
    38,665  
  46,939    
Siam Cement Pcl (Foreign Registered) (a)
    549,412  
  2,800    
Siam Cement Pcl NVDR
    28,999  
  64,450    
Siam Commercial Bank Pcl (Foreign Registered) (a)
    230,334  
  8,000    
Siam Makro Pcl (Foreign Registered) (a)
    59,316  
  202,200    
Thai Tap Water Supply Pcl (Foreign Registered) (a)
    34,460  
  65,300    
Thanachart Capital Pcl (Foreign Registered) (a)
    53,702  
  23,100    
Tisco Financial Group Pcl (Foreign Registered) (a)
    29,375  
  50,050    
Total Access Communication Pcl (Foreign Registered) (a)
    129,884  
       
 
     
       
Total Thailand
    5,935,349  
       
 
     
       
 
       
       
Turkey — 2.6%
       
  13,109    
Akbank TAS
    46,390  
  102,737    
Arcelik AS
    348,028  
  32,902    
Enka Insaat ve Sanayi AS
    81,633  
  267,558    
Eregli Demir ve Celik Fabrikalari TAS
    500,593  
  49,107    
Haci Omer Sabanci Holding AS
    154,980  
  118,803    
Koc Holding AS
    411,387  
  18,689    
Tupras-Turkiye Petrol Rafineriler AS
    427,864  
  136,620    
Turk Telekomunikasyon AS
    562,279  
  81,324    
Turkcell Iletisim Hizmet AS *
    406,554  
  141,044    
Turkiye Garanti Bankasi
    483,173  
  44,808    
Turkiye IS Bankasi Class C
    92,802  
  63,636    
Turkiye Sise ve Cam Fabrikalari AS
    107,638  
  76,671    
Turkiye Vakiflar Bankasi TAO Class D
    113,835  
  54,724    
Turkiye Halk Bankasi AS
    331,042  
  36,579    
Yapi ve Kredi Bankasi AS *
    61,536  
       
 
     
       
Total Turkey
    4,129,734  
       
 
     
       
TOTAL COMMON STOCKS (COST $149,184,453)
    136,776,380  
       
 
     

 


 

                 
       
PREFERRED STOCKS — 11.7%
       
       
 
       
       
Brazil — 8.5%
       
  12,900    
AES Tiete SA 11.00%
    175,843  
  93,949    
Banco Bradesco SA 0.62%
    1,539,364  
  37,500    
Banco do Estado do Rio Grande do Sul SA Class B 0.59%
    400,019  
  23,700    
Bradespar SA 0.03%
    434,460  
  10,200    
Brasil Telecom SA 2.70%
    60,917  
  42,100    
Centrais Eletricas Brasileiras SA Class B 6.98%
    548,032  
  3,700    
Companhia Paranaense de Energia Class B 0.85%
    74,661  
  23,900    
Eletropaulo Metropolitana SA 10.99%
    432,839  
  116,952    
Itausa-Investimentos Itau SA 0.51%
    682,304  
  46,800    
Klabin SA 2.65%
    186,853  
  2,000    
Lojas Americanas SA 0.43%
    16,700  
  49,600    
Metalurgica Gerdau SA 4.34%
    469,573  
  10,524    
Petroleo Brasileiro SA (Petrobras) 0.56%
    128,324  
  124,690    
Petroleo Brasileiro SA Sponsored ADR 0.60%
    3,125,978  
  45,500    
Tele Norte Leste Participacoes ADR 5.35%
    430,430  
  54,900    
Usinas Siderrurgicas de Minas Gerais SA Class A 3.15%
    314,521  
  11,100    
Vale Fertilizantes SA 0.44%
    151,859  
  10,756    
Vale SA Class A 0.98%
    232,149  
  194,130    
Vale SA Sponsored ADR 2.10%
    4,245,623  
       
 
     
       
Total Brazil
    13,650,449  
       
 
     
       
 
       
       
Chile — 0.0%
       
  3,380    
Embotelladora Andina SA B Shares 1.86%
    15,076  
       
 
     
       
 
       
       
Russia — 1.9%
       
  2,932,141    
Surgutneftegaz Class S 7.78%
    1,604,051  
  845    
Transneft 0.70%
    1,393,464  
       
 
     
       
Total Russia
    2,997,515  
       
 
     
       
 
       
       
South Korea — 1.3%
       
  6,794    
Hyundai Motor Co 2.29%
    423,550  
  3,032    
Samsung Electronics Co Ltd (Non Voting) 0.86%
    1,690,682  
       
 
     
       
Total South Korea
    2,114,232  
       
 
     
       
TOTAL PREFERRED STOCKS (COST $19,763,586)
    18,777,272  
       
 
     
       
 
       
       
INVESTMENT FUNDS — 1.6%
       
       
 
       
       
United States — 1.6%
       
  61,234    
Vanguard Emerging Markets ETF (b)
    2,498,347  
       
 
     
       
TOTAL INVESTMENT FUNDS (COST $2,391,343)
    2,498,347  
       
 
     
       
 
       
       
MUTUAL FUNDS — 1.2%
       
       
 
       
       
United States — 1.2%
       
       
 
       
       
Affiliated Issuers
       
  78,090    
GMO U.S. Treasury Fund
    1,953,022  
       
 
     
       
TOTAL MUTUAL FUNDS (COST $1,953,021)
    1,953,022  
       
 
     
       
 
       
                 
   Par Value     Description   Value ($)  
 
       
SHORT-TERM INVESTMENTS — 0.6%
       
       
 
       
       
Time Deposits — 0.6%
       
USD 200,000  
Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11
    200,000  

 


 

                 
  EUR 7  
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.10%, due 12/01/11
    9  
  HKD 18,087  
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.01%, due 12/01/11
    2,328  
  USD 5,605  
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.03%, due 12/01/11
    5,605  
  ZAR 1,373,305  
Brown Brothers Harriman (Grand Cayman) Time Deposit, 4.85%, due 12/01/11
    169,257  
  USD 200,000  
Citibank (New York) Time Deposit, 0.03%, due 12/01/11
    200,000  
  USD 200,000  
HSBC Bank (New York) Time Deposit, 0.03%, due 12/01/11
    200,000  
  USD 200,000  
JPMorgan Chase (New York) Time Deposit, 0.03%, due 12/01/11
    200,000  
       
 
     
       
Total Time Deposits
    977,199  
       
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $977,199)
    977,199  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 100.4%
(Cost $174,269,602)
    160,982,220  
       
 
       
       
Other Assets and Liabilities (net) — (0.4%)
    (671,561 )
       
 
     
 
       
TOTAL NET ASSETS — 100.0%
  $ 160,310,659  
       
 
     
       
 
       
 
Notes to Schedule of Investments:
 
144A — Securities exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional investors.
 
ADR — American Depositary Receipt
 
CPO — Ordinary Participation Certificate (Certificado de Participacion Ordinares), representing a bundle of shares of the multiple series of one issuer that trade together as a unit.
 
ETF — Exchange-Traded Fund
 
Foreign Registered — Shares issued to foreign investors in markets that have foreign ownership limits.
 
GDR — Global Depository Receipt
 
NVDR — Non-Voting Depository Receipt
 
*   Non-income producing security.
 
(a)   Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust.
 
(b)   Represents an investment to obtain exposure in Emerging Markets. The Vanguard Emerging Markets ETF is a separate investment portfolio of Vanguard, Inc., a registered investment company. The Vanguard Emerging Markets ETF prospectus states that the fund invests substantially all (normally about 95%) of its assets in the common stocks included in the MSCI Emerging Market Index, while employing a form of sampling to reduce risk.
 
Currency Abbreviations:
 
EUR — Euro
 
HKD — Hong Kong Dollar
 
USD — United States Dollar
 
ZAR — South African Rand

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                     
    Gross   Gross   Net Unrealized  
    Unrealized   Unrealized   Appreciation  
Aggregate Cost   Appreciation   (Depreciation)   (Depreciation)  
$179,081,907
  $ 7,683,373   $ (25,783,060 ) $ (18,099,687 )
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO U.S. Treasury Fund
  $ 14     $ 24,100,653     $ 22,148,591     $ 539     $ 82     $ 1,953,022  
 
                                   

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 4.1% of net assets. The Fund classifies such securities (levels defined below) as Level 3. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below.
     
Security Type   Percentage of Net Assets of the Fund
Equity Securities
  65.5%
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include: fair value adjustments provided by an independent pricing service applied to equity securities (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) due to market events that have occurred since the local market close but prior to the close of the NYSE.

 


 

Level 3 — Valuations based primarily on inputs that are unobservable and significant. The Fund utilized a number of fair value techniques on Level 3 investments: Certain of the Fund’s securities in Thailand and India were valued at the local price as adjusted by applying a premium or discount when the holdings exceed foreign ownership limitations. The Fund values certain securities using a price from a comparable security related to the same issuer that trades on a different exchange.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Common Stocks
                               
Brazil
  $ 18,720,769     $     $     $ 18,720,769  
Chile
    333,079                   333,079  
China
    982,369       18,602,567             19,584,936  
Czech Republic
          2,607,992             2,607,992  
Egypt
    99,700       2,182,307             2,282,007  
Hungary
          1,851,146             1,851,146  
India
    782,023       6,626,828       555,408       7,964,259  
Indonesia
    320,950       9,934,918             10,255,868  
Malaysia
          840,336             840,336  
Mexico
    2,066,261                   2,066,261  
Morocco
          486,258             486,258  
Philippines
    407,928       1,500,112             1,908,040  
Poland
          2,903,859             2,903,859  
Russia
    2,990,392       14,247,549       713,672       17,951,613  
South Africa
    270,055       5,548,746             5,818,801  
South Korea
    1,465,364       18,925,861             20,391,225  
Sri Lanka
    7,751       177,701             185,452  
Taiwan
    190,097       10,369,299             10,559,396  
Thailand
          562,027       5,373,322       5,935,349  
Turkey
          4,129,734             4,129,734  
 
                       
TOTAL COMMON STOCKS
    28,636,738       101,497,240       6,642,402       136,776,380  
 
                       
Preferred Stocks
                               
Brazil
    13,650,449                   13,650,449  
Chile
    15,076                   15,076  
Russia
    1,604,051       1,393,464             2,997,515  
South Korea
          2,114,232             2,114,232  
 
                       
TOTAL PREFERRED STOCKS
    15,269,576       3,507,696             18,777,272  
 
                       
Investment Funds
                               
United States
    2,498,347                   2,498,347  
 
                       
TOTAL INVESTMENT FUNDS
    2,498,347                   2,498,347  
 
                       
Mutual Funds
                               
United States
    1,953,022                   1,953,022  
 
                       
TOTAL MUTUAL FUNDS
    1,953,022                   1,953,022  
 
                       
Short-Term Investments
    977,199                   977,199  
 
                       
Total Investments
    49,334,882       105,004,936       6,642,402       160,982,220  
 
                       
Total
  $ 49,334,882     $ 105,004,936     $ 6,642,402     $ 160,982,220  
 
                       

 


 

The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net value of the Fund’s direct investments in securities using Level 3 inputs was 4.1% of total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant unobservable inputs (Level 3) were used in determining value:
                                                                                 
                                                                            Net Change in  
                                                                            Unrealized  
                                                                            Appreciation  
                                                                            (Depreciation)  
                                            Change in                             from  
    Balances as                     Accrued             Unrealized                     Balances as     Investments  
    of February                     Discounts/     Total Realized     Appreciation     Transfers     Transfers out     of November     Still Held as of  
    28, 2011     Purchases     Sales     Premiums     Gain/(Loss)     (Depreciation)     into Level 3 *     of Level 3 *     30, 2011     November 30, 2011  
Common Stocks
                                                                               
Egypt
  $ 2,848,899     $ 794,300     $ (1,366,801 )   $     $ (528,905 )   $ 189,125     $     $ (1,936,618) **   $     $  
India
    526,696       901,030       (657,336 )           (34,188 )     (83,651 )           (97,143) **     555,408       (63,299 )
Russia
    2,973,126       4,120,423       (5,132,550 )           240,948       (714,705 )           (773,570) **     713,672       29,381  
Thailand
    8,703,006       4,575,899       (8,200,063 )           1,534,035       (1,239,555 )                 5,373,322       523,638  
Preferred Stocks
                                                                               
Russia
    2,878,315       440,923       (441,968 )             608       119,637             (2,997,515) **            
 
                                                           
Total
  $ 17,930,042     $ 10,832,575     $ (15,798,718 )   $     $ 1,212,498     $ (1,729,149 )   $     $ (5,804,846 )   $ 6,642,402     $ 489,720  
 
                                                           
 
*   The Fund accounts for investments and derivatives transferred into Level 3 at the value at the beginning of the period and transferred out of Level 3 at the value at the end of the period.
 
**   Financial assets transferred between Level 2 and Level 3 were due to a change in observable and/or unobservable inputs.

 


 

Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If the Fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of value of those investments. Because the Fund normally does not take temporary defensive positions, declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies.
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind. In addition, the Fund may buy securities that are less liquid than those in its benchmark.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations. The Fund may buy securities that have smaller market capitalizations than those in its benchmark.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the

 


 

desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Focused Investment Risk — Focusing investments in a limited number of countries and geographic regions creates additional risk.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in underlying funds, including the risk that the underlying funds (including ETFs) in which it invests will not perform as expected.
Leveraging Risk — The Fund’s use of reverse repurchase agreements and other derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. For example, the Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives, to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives. The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For example, if the Fund holds a large proportion of stocks of companies in a particular sector and the Manager believes that stocks of companies in another sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index). In adjusting its investment exposure, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net long exposures in excess of its net assets. The Fund’s foreign currency exposure may differ significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC

 


 

derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of

 


 

the contracts. Most forward currency contracts are not collateralized. The Fund had no forward currency contracts outstanding at the end of the period.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded (unless otherwise adjusted due to the time at which foreign markets close). The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other

 


 

relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers (unless otherwise adjusted due to the time at which foreign markets close) and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. During the period ended November 30, 2011, the Fund held rights and/or warrants received as a result of corporate actions. The Fund held no rights or warrants at the end of the period.

 


 

The volume of derivative activity, based on absolute values (rights and/or warrants), outstanding at each month-end, was as follows for the period ended November 30, 2011:
         
    Right and/or  
    Warrants  
Average amount outstanding   $ 3,908  

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Emerging Country Debt Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                     
Par Value     Description   Value ($)  
 
           
DEBT OBLIGATIONS — 99.7%
       
           
 
       
           
Albania — 0.1%
       
           
 
       
           
Foreign Government Obligations
       
EUR     1,613,000    
Albania Government International Bond, 7.50%, due 11/04/15
    1,863,953  
           
 
     
           
 
       
           
Argentina — 11.6%
       
           
 
       
           
Foreign Government Obligations — 10.1%
       
USD     9,000,000    
Province of Buenos Aires, Reg S, Step Up, 4.00%, due 05/15/35
    3,262,500  
EUR     19,000,000    
Republic of Argentina, Step Up, 2.26%, due 12/31/38
    6,637,876  
DEM     3,830,000    
Republic of Argentina Discount Bond, Series DM, 6 mo. DEM LIBOR + .81%, 1.00%, due 03/31/23(b)
    1,578,778  
USD     10,240,448    
Republic of Argentina Discount Bond, 5.77%, due 12/31/33
    7,065,909  
EUR     35,562,828    
Republic of Argentina Discount Bond, 5.45%, due 12/31/33
    28,193,595  
EUR     351,220,524    
Republic of Argentina GDP Linked, due 12/15/35(c)
    44,833,811  
ARS     28,000,000    
Republic of Argentina GDP Linked, due 12/15/35(c)(d)
    487,907  
USD     24,331,990    
Republic of Argentina GDP Linked, due 12/15/35(c)
    2,596,223  
ARS     28,000,000    
Republic of Argentina Global Par Bond, Step Up, due 12/31/38
    2,317,079  
USD     7,500,000    
Republic of Argentina Par Bond, Step Up, 2.50%, due 12/31/38
    2,388,750  
EUR     181,000,000    
Republic of Argentina Par Bond, Step Up, 2.26%, due 12/31/38
    65,666,596  
           
 
     
           
 
    165,029,024  
           
 
     
           
 
       
           
Judgments — 1.5%
       
USD     32,000,000    
Republic of Argentina Discount Bond, Series L-GL, 6 mo. LIBOR + .81%, 6.17%, due 03/31/23(b)(d)(e)
    16,320,000  
USD     15,000,000    
Republic of Argentina Global Par Bond, Series L-GP, Step Up, due 03/31/23(b)(d)(e)
    8,542,500  
           
 
     
           
 
    24,862,500  
           
 
     
           
Total Argentina
    189,891,524  
           
 
     
           
 
       
           
Bahamas — 0.2%
       
           
 
       
           
Foreign Government Obligations
       
USD     2,500,000    
Commonwealth of Bahamas, Reg S, 6.95%, due 11/20/29
    2,775,000  
           
 
     
           
 
       
           
Barbados — 0.3%
       
           
 
       
           
Foreign Government Obligations
       
USD     4,800,000    
Government of Barbados, Reg S, 7.00%, due 08/04/22
    4,800,000  
           
 
     
           
 
       
           
Belize — 0.5%
       
           
 
       
           
Foreign Government Obligations
       
USD     12,925,000    
Government of Belize, Reg S, Step Up, 6.00%, due 02/20/29
    7,755,000  
           
 
     
           
 
       
           
Bosnia & Herzegovina — 0.6%
       
           
 
       
           
Foreign Government Obligations
       
DEM     18,428,120    
Bosnia & Herzegovina, Series A, Reg S, 6 mo. DEM LIBOR + .81%, 2.51%, due 12/11/17
    9,622,007  
           
 
     
           
 
       
           
Brazil — 5.2%
       
           
 
       
           
Corporate Debt — 0.6%
       
USD     9,000,000    
Petrobras International Finance Co., 6.88%, due 01/20/40
    9,881,100  
           
 
     
           
 
       
           
Foreign Government Agency — 0.6%
       
USD     9,000,000    
Banco Nacional de Desenvolvimento Economico e Social, Reg S, 5.50%, due 07/12/20
    9,585,000  
           
 
     


 

                     
           
Foreign Government Obligations — 4.0%
       
USD     3,366,904    
Brazilian Government International Exit Bonds, 6.00%, due 09/15/13
    3,484,745  
USD     131,825    
Brazilian Government International Exit Bonds, Odd Lot, 6.00%, due 09/15/13
    128,529  
USD     42,000,000    
Republic of Brazil, 8.25%, due 01/20/34(g)
    61,425,000  
           
 
     
           
 
    65,038,274  
           
 
     
           
Total Brazil
    84,504,374  
           
 
     
           
 
       
           
Chile — 0.1%
       
           
 
       
           
Foreign Government Agency
       
USD     1,700,000    
Empresa Nacional del Petroleo, Reg. S, 5.25%, due 08/10/20
    1,785,000  
           
 
     
           
 
       
           
Colombia — 1.6%
       
           
 
       
           
Foreign Government Agency — 0.6%
       
USD     8,000,000    
Ecopetrol SA, 7.63%, due 07/23/19
    9,600,000  
           
 
     
           
 
       
           
Foreign Government Obligations — 1.0%
       
USD     8,000,000    
Republic of Colombia, 8.70%, due 02/15/16
    9,440,000  
USD     3,800,000    
Republic of Colombia, 11.85%, due 03/09/28
    6,400,302  
           
 
     
           
 
    15,840,302  
           
 
     
           
Total Colombia
    25,440,302  
           
 
     
           
 
       
           
Congo Republic (Brazzaville) — 4.7%
       
           
 
       
           
Foreign Government Obligations
       
USD     108,440,600    
Republic of Congo, Reg S, Series INTL, Step Up, 3.00%, due 06/30/29
    75,908,420  
           
 
     
           
 
       
           
Croatia — 0.4%
       
           
 
       
           
Foreign Government Obligations
       
USD     8,000,000    
Croatia Government International Bond, Reg. S, 6.38%, due 03/24/21
    7,100,000  
           
 
     
           
 
       
           
Dominican Republic — 3.9%
       
           
 
       
           
Asset-Backed Securities — 1.4%
       
USD     27,052,008    
Autopistas Del Nordeste Ltd., Reg S, 9.39%, due 04/15/24
    23,129,467  
           
 
     
           
 
       
           
Foreign Government Obligations — 2.5%
       
USD     8,000,000    
Dominican Republic, Reg S, 8.63%, due 04/20/27
    8,480,000  
USD     42,557,000    
Dominican Republic Discount Bond, 6 mo. LIBOR + .81%, 1.55%, due 08/30/24
    32,343,320  
           
 
     
           
 
    40,823,320  
           
 
     
           
Total Dominican Republic
    63,952,787  
           
 
     
           
 
       
           
Ecuador — 0.2%
       
           
 
       
           
Foreign Government Obligations
       
USD     11,587,000    
Republic of Ecuador, Step Up, Reg S, due 08/15/30(b)
    2,896,750  
USD     1,375,909    
Republic of Ecuador PDI (Global Bearer Capitalization Bond), PIK, 6 mo. LIBOR + .81%, 1.31%, due 02/27/15
    983,775  
           
 
     
           
Total Ecuador
    3,880,525  
           
 
     
           
 
       
           
Egypt — 0.2%
       
           
 
       
           
Foreign Government Agency
       
USD     3,000,000    
African Export-Import Bank, 8.75%, due 11/13/14
    3,236,250  
           
 
     


 

                     
           
El Salvador — 1.2%
       
           
 
       
           
Foreign Government Obligations
       
USD     19,000,000    
El Salvador Government International Bond, Reg S, 7.63%, due 02/01/41
    19,627,000  
           
 
     
           
 
       
           
Gabon — 0.5%
       
           
 
       
           
Foreign Government Obligations
       
USD     7,000,000    
Gabonese Republic, Reg S, 8.20%, due 12/12/17
    8,050,000  
           
 
     
           
 
       
           
Grenada — 0.3%
       
           
 
       
           
Foreign Government Obligations
       
USD     9,000,000    
Republic of Grenada, Reg S, Step Up, 4.50%, due 09/15/25
    5,130,000  
           
 
     
           
 
       
           
Iceland — 0.4%
       
           
 
       
           
Foreign Government Obligations
       
USD     6,000,000    
Iceland Government International Bond, Reg S, 4.88%, due 06/16/16
    5,880,000  
           
 
     
           
 
       
           
Indonesia — 2.9%
       
           
 
       
           
Foreign Government Agency
       
USD     10,600,000    
Majapahit Holding BV, Reg. S, 7.75%, due 01/20/20
    12,208,550  
USD     31,000,000    
Majapahit Holding BV, Reg S, 7.88%, due 06/29/37
    35,650,000  
           
 
     
           
Total Indonesia
    47,858,550  
           
 
     
           
 
       
           
Iraq — 0.7%
       
           
 
       
           
Foreign Government Obligations
       
USD     15,000,000    
Republic of Iraq, Reg S, 5.80%, due 01/15/28(g)
    12,150,000  
           
 
     
           
 
       
           
Israel — 0.2%
       
           
 
       
           
Foreign Government Agency
       
USD     3,000,000    
Israel Electric Corp Ltd, Reg. S, 7.88%, due 12/15/26
    3,146,250  
           
 
     
           
 
       
           
Ivory Coast — 2.0%
       
           
 
       
           
Foreign Government Obligations
       
USD     65,439,000    
Ivory Coast Government International Bond, Reg S, Step Up, 2.50%, due 12/31/32(b)
    32,392,305  
           
 
     
           
 
       
           
Jamaica — 0.2%
       
           
 
       
           
Corporate Debt
       
USD     4,000,000    
National Road Operating & Constructing Co. Ltd., 144A, 9.38%, due 11/10/24
    4,030,000  
           
 
     
           
 
       
           
Latvia — 0.2%
       
           
 
       
           
Foreign Government Obligations
       
USD     4,000,000    
Republic of Latvia, Reg. S, 5.25%, due 06/16/21
    3,680,000  
           
 
     
           
 
       
           
Lithuania — 1.1%
       
           
 
       
           
Foreign Government Obligations
       
USD     1,000,000    
Republic of Lithuania, Reg S, 5.13%, due 09/14/17
    960,880  
USD     4,000,000    
Republic of Lithuania, Reg S, 7.38%, due 02/11/20
    4,240,000  
USD     6,000,000    
Republic of Lithuania, Reg S, 6.13%, due 03/09/21(g)
    5,790,000  
USD     7,000,000    
Republic of Lithuania, 144A, 6.13%, due 03/09/21
    6,755,000  
           
 
     
           
Total Lithuania
    17,745,880  
           
 
     


 

                     
           
Malaysia — 0.9%
       
           
 
       
           
Asset-Backed Securities
       
MYR     50,000,000    
Transshipment Megahub Berhad, Series F, 6.70%, due 11/02/12
    14,472,235  
           
 
     
           
 
       
           
Mexico — 9.4%
       
           
 
       
           
Foreign Government Agency — 2.9%
       
EUR     37,500,000    
Pemex Project Funding Master Trust, Reg S, 5.50%, due 02/24/25
    46,893,266  
           
 
     
           
 
       
           
Foreign Government Obligations — 6.5%
       
GBP     29,994,000    
United Mexican States, GMTN, 6.75%, due 02/06/24
    50,116,350  
USD     55,000,000    
United Mexican States, 5.75%, due 10/12/2110
    56,375,000  
           
 
     
           
 
    106,491,350  
           
 
     
           
Total Mexico
    153,384,616  
           
 
     
           
 
       
           
Nigeria — 0.4%
       
           
 
       
           
Foreign Government Obligations
       
USD     6,100,000    
Nigeria Government International Bond, Reg S, 6.75%, due 01/28/21
    6,344,000  
           
 
     
           
 
       
           
Pakistan — 0.8%
       
           
 
       
           
Foreign Government Obligations
       
USD     20,000,000    
Islamic Republic of Pakistan, Reg S, 7.88%, due 03/31/36
    12,600,000  
           
 
     
           
 
       
           
Peru — 1.4%
       
           
 
       
           
Foreign Government Obligations
       
USD     12,452,000    
Peru Enhanced Pass-Through Finance Ltd., Reg S, Zero Coupon, due 06/02/25
    6,786,340  
USD     8,600,000    
Peru Par Bond, Series 30 Yr., Step Up, 3.00%, due 03/07/27
    7,310,000  
USD     3,784,333    
Peru Trust, Series 97-I-P, Class A3, Zero Coupon, due 12/31/15(d)(f)
    567,650  
USD     1,253,404    
Peru Trust, Series 98-I-P, Zero Coupon, due 03/10/16(d)(f)
    188,010  
USD     1,356,611    
Peru Trust II, Series 98-A LB, Zero Coupon, due 02/28/16(d)(f)
    203,492  
USD     8,000,000    
Republic of Peru, Series 30 Yr., 5.63%, due 11/18/50(g)
    8,480,000  
           
 
     
           
Total Peru
    23,535,492  
           
 
     
           
 
       
           
Philippines — 9.1%
       
           
 
       
           
Foreign Government Agency — 8.4%
       
USD     35,651,000    
Central Bank of Philippines, Series A, 8.60%, due 06/15/27
    45,276,770  
USD     55,450,000    
National Power Corp., Global Bond, 9.63%, due 05/15/28
    73,194,000  
USD     8,500,000    
National Power Corp., Global Bond, 8.40%, due 12/15/16
    10,370,000  
USD     6,296,000    
Power Sector Assets & Liabilities Management Corp, Reg. S, 7.39%, due 12/02/24
    7,696,860  
           
 
     
           
 
    136,537,630  
           
 
     
           
 
       
           
Foreign Government Obligations — 0.7%
       
USD     3,000,000    
Republic of Philippines, 6.50%, due 01/20/20
    3,577,500  
USD     8,000,000    
Republic of Philippines, 5.50%, due 03/30/26
    8,880,000  
           
 
     
           
 
    12,457,500  
           
 
     
           
Total Philippines
    148,995,130  
           
 
     
           
 
       
           
Qatar — 2.1%
       
           
 
       
           
Foreign Government Agency — 0.2%
       
USD     3,500,000    
Qtel International Finance Ltd., Reg S, 5.00%, due 10/19/25
    3,325,000  
           
 
     
           
 
       
           
Foreign Government Obligations — 1.9%
       
USD     30,000,000    
Qatar Goverment International Bond, 144A, 5.75%, due 01/20/42
    30,525,000  
           
 
     
           
Total Qatar
    33,850,000  
           
 
     


 

                     
           
Russia — 5.9%
       
           
 
       
           
Corporate Debt — 4.9%
       
USD     36,200,000    
Gaz Capital SA, Reg S, 9.25%, due 04/23/19(g)
    44,073,500  
USD     3,000,000    
Sberbank of Russia Via SB Capital SA, Reg S, 5.72%, due 06/16/21
    2,857,500  
USD     14,900,000    
Transcapital Ltd. (Transneft), Reg S, 8.70%, due 08/07/18
    17,954,500  
USD     7,600,000    
VTB Bank OJSC Via VTB Capital SA, Reg S, 6.55%, due 10/13/20
    7,220,000  
USD     9,000,000    
VTB Capital SA, Reg S, 6.25%, due 06/30/35
    8,932,500  
           
 
     
           
 
    81,038,000  
           
 
     
           
 
       
           
Foreign Government Agency — 1.0%
       
USD     15,000,000    
RSHB Capital SA, Reg S, 6.30%, due 05/15/17
    15,225,000  
           
 
     
           
Total Russia
    96,263,000  
           
 
     
           
 
       
           
Senegal — 0.4%
       
           
 
       
           
Foreign Government Obligations
       
USD     5,900,000    
Republic of Senegal, Reg S, 8.75%, due 05/13/21
    5,767,250  
           
 
     
           
 
       
           
Serbia — 1.5%
       
           
 
       
           
Foreign Government Obligations
       
USD     12,000,000    
Republic of Serbia, 144A, 7.25%, due 09/28/21
    11,490,000  
USD     12,970,558    
Republic of Serbia, Reg S, Step Up, 6.75%, due 11/01/24
    12,419,309  
           
 
     
           
Total Serbia
    23,909,309  
           
 
     
           
 
       
           
South Africa — 0.8%
       
           
 
       
           
Foreign Government Agency — 0.3%
       
ZAR     163,000,000    
Eskom Holdings Ltd., Zero Coupon, due 12/31/32
    2,034,047  
ZAR     20,000,000    
Transnet Ltd., 13.50%, due 04/18/28
    2,908,889  
           
 
     
           
 
    4,942,936  
           
 
     
           
 
       
           
Foreign Government Obligations — 0.5%
       
USD     7,500,000    
South Africa Government International Bond, 6.25%, due 03/08/41
    8,456,250  
           
 
     
           
Total South Africa
    13,399,186  
           
 
     
           
 
       
           
South Korea — 1.3%
       
           
 
       
           
Foreign Government Agency
       
USD     8,000,000    
Export-Import Bank of Korea, 5.13%, due 06/29/20
    8,332,800  
USD     4,000,000    
Korea Gas Corp., Reg S, 6.00%, due 07/15/14
    4,298,800  
USD     8,000,000    
Korea Hydro & Nuclear Power Co Ltd., Reg S, 4.75%, due 07/13/21
    8,079,760  
           
 
     
           
Total South Korea
    20,711,360  
           
 
     
           
 
       
           
Sri Lanka — 0.7%
       
           
 
       
           
Foreign Government Obligations
       
USD     1,500,000    
Republic of Sri Lanka, Reg S, 8.25%, due 10/24/12
    1,520,445  
USD     1,000,000    
Republic of Sri Lanka, Reg S, 7.40%, due 01/22/15
    1,056,200  
USD     6,500,000    
Republic of Sri Lanka, Reg S, 6.25%, due 10/04/20
    6,532,500  
USD     2,000,000    
Republic of Sri Lanka, Reg S, 6.25%, due 07/27/21
    1,990,000  
           
 
     
           
Total Sri Lanka
    11,099,145  
           
 
     
           
 
       
           
Thailand — 0.3%
       
           
 
       
           
Foreign Government Agency
       
USD     4,000,000    
PTTEP Canada International Finance Ltd., Reg S, 5.69%, due 04/05/21
    4,146,040  
           
 
     


 

                     
           
Trinidad And Tobago — 1.4%
       
           
 
       
           
Corporate Debt — 0.5%
       
USD     8,000,000    
First Citizens St Lucia Ltd, Reg S, 4.90%, due 02/09/16
    8,080,000  
           
 
       
           
 
       
           
Foreign Government Agency — 0.9%
       
USD     11,500,000    
Petroleum Company of Trinidad and Tobago Ltd., Reg S, 9.75%, due 08/14/19
    13,455,000  
USD     1,312,500    
Petroleum Company of Trinidad and Tobago Ltd., Reg. S, 6.00%, due 05/08/22
    1,286,250  
           
 
       
           
 
    14,741,250  
           
 
       
           
Total Trinidad And Tobago
    22,821,250  
           
 
       
           
 
       
           
Tunisia — 0.3%
       
           
 
       
           
Foreign Government Agency
       
JPY     360,000,000    
Banque Centrale De Tunisie, Series 6BR, 4.35%, due 08/15/17
    4,838,835  
           
 
       
           
 
       
           
Turkey — 4.5%
       
           
 
       
           
Corporate Debt — 0.1%
       
USD     2,000,000    
Export Credit Bank of Turkey, 144A, 5.38%, due 11/04/16
    1,992,500  
           
 
       
           
 
       
           
Foreign Government Obligations — 4.4%
       
USD     41,000,000    
Republic of Turkey, 6.75%, due 05/30/40(g)
    43,357,500  
USD     30,000,000    
Republic of Turkey, 6.00%, due 01/14/41(g)
    28,837,500  
           
 
       
           
 
    72,195,000  
           
 
       
           
Total Turkey
    74,187,500  
           
 
       
           
 
       
           
Ukraine — 0.6%
       
           
 
       
           
Foreign Government Obligations
       
USD     4,000,000    
City of Kyiv Via Kyiv Finance PLC, Reg. S, 9.38%, due 07/11/16
    3,040,000  
USD     8,000,000    
Ukraine Government International Bond, Reg. S, 7.95%, due 02/23/21(g)
    7,040,000  
           
 
       
           
Total Ukraine
    10,080,000  
           
 
       
           
 
       
           
United States — 6.8%
       
           
 
       
           
Asset-Backed Securities — 2.8%
       
USD     3,278,241    
Aircraft Finance Trust, Series 99-1A, Class A1, 144A, 1 mo. LIBOR + .48%, 0.73%, due 05/15/24
    1,573,556  
USD     150,112    
Chevy Chase Mortgage Funding Corp., Series 03-4A, Class A1, 144A, AMBAC, 1 mo. LIBOR + .34%, 0.60%, due 10/25/34
    95,921  
USD     1,119,855    
CNL Commercial Mortgage Loan Trust, Series 03-2A, Class A1, 144A, AMBAC, 1 mo. LIBOR + .44%, 0.70%, due 10/25/30
    811,895  
USD     17,399,785    
Countrywide Home Equity Loan Trust, Series 05-F, Class 2A, AMBAC, 1 mo. LIBOR + .24%, 0.49%, due 12/15/35
    8,177,899  
USD     12,778,105    
Countrywide Home Equity Loan Trust, Series 05-H, Class 2A, FGIC, 1 mo. LIBOR + .24%, 0.49%, due 12/15/35
    5,782,092  
USD     7,614,489    
Countrywide Home Equity Loan Trust, Series 06-D, Class 2A, XL, 1 mo. LIBOR + .20%, 0.45%, due 05/15/36
    2,855,433  
USD     3,789,097    
First Franklin Mortgage Loan Asset Backed Certificates, Series 05-FF10, Class A6M, 1 mo. LIBOR + .35%, 0.61%, due 11/25/35
    947,274  
USD     1,261,840    
GSAMP Trust, Series 05-HE6, Class A2B, 1 mo. LIBOR + .19%, 0.45%, due 11/25/35
    1,165,688  
USD     9,250,000    
Home Equity Asset Trust, Series 07-1, Class 2A4, 1 mo. LIBOR + .23%, 0.49%, due 05/25/37
    416,250  
USD     8,608,688    
IXIS Real Estate Capital Trust, Series 06-HE2, Class A3, 1 mo. LIBOR + .16%, 0.42%, due 08/25/36
    1,850,868  
USD     12,857,159    
Master Asset-Backed Securities Trust, Series 06-NC3, Class A4, 1 mo. LIBOR + .16%, 0.42%, due 10/25/36 ¨
    3,857,148  
USD     6,280,768    
Morgan Stanley ABS Capital I, Series 06-NC3, Class A2C, 1 mo. LIBOR + .17%, 0.43%, due 03/25/36
    3,391,615  


 

                     
USD     14,530,541    
Morgan Stanley IXIS Real Estate Capital Trust, Series 06-2, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 11/25/36 ¨
    3,559,983  
USD     14,724,282    
Morgan Stanley IXIS Real Estate Capital Trust, Series 06-2, Class A4, 1 mo. LIBOR + .22%, 0.48%, due 11/25/36 ¨
    3,754,692  
USD     12,868,000    
Option One Mortgage Loan Trust, Series 06-3, Class 2A4, 1 mo. LIBOR + .22%, 0.48%, due 02/25/37
    3,860,400  
USD     8,000,000    
Wamu Asset-Backed Certificates, Series 07-HE2, Class 2A4, 1 mo. LIBOR + .36%, 0.62%, due 04/25/37
    2,740,000  
           
 
       
           
 
    44,840,714  
           
 
       
           
 
       
           
U.S. Government — 4.0%
       
USD     9,639,573    
Republic of Albania Par Bond, Zero Coupon, due 08/31/25(a)
    4,723,391  
USD     60,470,275    
U.S. Treasury Inflation Indexed Note, 2.00%, due 04/15/12(c)(g)(h)
    60,673,395  
           
 
       
           
 
    65,396,786  
           
 
       
           
Total United States
    110,237,500  
           
 
       
           
 
       
           
Uruguay — 2.4%
       
           
 
       
           
Foreign Government Obligations
       
USD     29,851,571    
Republic of Uruguay, 7.63%, due 03/21/36
    39,702,590  
           
 
       
           
 
       
           
Venezuela — 8.3%
       
           
 
       
           
Corporate Debt — 0.7%
       
USD     20,000,000    
Electricidad de Caracas Finance BV, 8.50%, due 04/10/18
    12,000,000  
           
 
       
           
 
       
           
Foreign Government Agency — 1.3%
       
USD     29,000,000    
Petroleos de Venezuela SA, Reg S, 8.50%, due 11/02/17
    21,677,500  
           
 
       
           
 
       
           
Foreign Government Obligations — 6.3%
       
USD     23,100,000    
Republic of Venezuela, Reg S, 8.25%, due 10/13/24
    14,610,750  
USD     30,000,000    
Republic of Venezuela, Reg S, 9.00%, due 05/07/23
    20,250,000  
USD     18,500,000    
Republic of Venezuela, Reg S, 12.75%, due 08/23/22
    16,233,750  
USD     64,500,000    
Republic of Venezuela, Reg. S, 11.95%, due 08/05/31
    51,277,500  
           
 
       
           
 
    102,372,000  
           
 
       
           
Total Venezuela
    136,049,500  
           
 
       
           
 
       
           
Vietnam — 1.1%
       
           
 
       
           
Foreign Government Obligations
       
USD     4,000,000    
Socialist Republic of Vietnam, Series 30 Yr., 6 mo. LIBOR + .81%, 1.38%, due 03/13/28
    3,160,000  
USD     19,750,000    
Socialist Republic of Vietnam, Series 30 Yr., Step Up, 4.00%, due 03/12/28
    15,010,000  
           
 
       
           
Total Vietnam
    18,170,000  
           
 
       
           
 
       
           
TOTAL DEBT OBLIGATIONS (COST $1,677,998,133)
    1,626,769,065  
           
 
       
           
 
       
           
LOAN ASSIGNMENTS — 1.9%
       
           
 
       
           
Angola — 0.3%
       
USD     2,300,000    
Angolan Ministry of Finance Loan Agreement, 6 mo. LIBOR + 5.50%, 5.94%, due 03/07/13
    2,139,000  
USD     2,300,000    
Angolan Ministry of Finance Loan Agreement, 6 mo. LIBOR + 5.50%, 5.94%, due 07/08/13
    2,116,000  
           
 
       
           
Total Angola
    4,255,000  
           
 
       
           
 
       
           
Dominican Republic — 0.1%
       
USD     3,200,135    
Dominican Republic, 6 mo. LIBOR + 1.75%, 2.20%, due 08/15/15
    2,598,190  
           
 
       
           
 
       
           
Indonesia — 1.0%
       
EUR     1,828,570    
Republic of Indonesia, Indonesia Paris Club Debt, 4.00%, due 06/01/21(i)
    1,824,359  


 

                     
USD     3,213,600    
Republic of Indonesia Loan Agreement, dated June 14, 1995, 6 mo. LIBOR + .88%, 1.25%, due 12/14/19
    2,892,240  
USD     3,213,600    
Republic of Indonesia Loan Agreement, dated June 14, 1995, 6 mo. LIBOR + .88%, 1.25%, due 12/14/19
    2,892,240  
USD     4,284,800    
Republic of Indonesia Loan Agreement, dated June 14, 1995, 6 mo. LIBOR + .88%, 1.25%, due 12/14/19
    3,856,320  
USD     717,901    
Republic of Indonesia Loan Agreement, dated September 29, 1994, 7.24%, due 12/01/11
    656,879  
USD     2,335,068    
Republic of Indonesia Loan Agreement, dated September 29, 1994, 6 mo. LIBOR + .88%, 1.31%, due 12/01/19
    2,136,587  
JPY     48,600,000    
Republic of Indonesia Loan Agreement, 6 mo. JPY TIBOR + .88%, 1.20%, due 03/28/13
    589,015  
USD     989,999    
Republic of Indonesia Loan Agreement, 6 mo. LIBOR +.88%, 1.31%, due 03/29/13
    930,599  
           
 
       
           
Total Indonesia
    15,778,239  
           
 
       
           
 
       
           
Vietnam — 0.5%
       
USD     18,000,000    
Vietnam Shipbuilding Industry Group Loan Agreement, 6 mo. LIBOR + 1.50%, 4.63%, due
06/26/15(b)
    8,280,000  
           
 
       
           
 
       
           
TOTAL LOAN ASSIGNMENTS (COST $36,775,632)
    30,911,429  
           
 
       
           
 
       
           
LOAN PARTICIPATIONS — 6.3%
       
           
 
       
           
Egypt — 0.2%
       
CHF     3,708,432    
Paris Club Loan Agreement (Participation with Standard Chartered Bank), due 01/03/24
    3,186,949  
           
 
       
           
 
       
           
Indonesia — 1.7%
       
USD     395,520    
Republic of Indonesia Loan Agreement (Participation with Citibank), 6 mo. LIBOR +.88%, 1.25%, due 12/14/19
    355,968  
USD     527,360    
Republic of Indonesia Loan Agreement (Participation with Citibank), 6 mo. LIBOR +.88%, 1.25%, due 12/14/19
    474,624  
USD     395,520    
Republic of Indonesia Loan Agreement (Participation with Citibank), 6 mo. LIBOR +.88%, 1.25%, due 12/14/19
    355,968  
JPY     287,323,957    
Republic of Indonesia Loan Agreement (Participation with Deutsche Bank), 6 mo. JPY TIBOR +.88%, 1.20%, due 03/28/13
    3,482,266  
USD     9,513,696    
Republic of Indonesia Loan Agreement (Participation with Deutsche Bank), 3 mo. LIBOR + 1.25%, 1.70%, due 02/12/13
    8,942,874  
USD     8,604,627    
Republic of Indonesia Loan Agreement (Participation with Deutsche Bank), 6 mo. LIBOR +.88%, 1.42%, due 09/29/19
    7,873,234  
USD     6,477,988    
Republic of Indonesia Loan Agreement (Participation with Morgan Stanley), 6 mo. LIBOR + .88%, 1.25%, due 12/14/19
    5,830,189  
           
 
       
           
Total Indonesia
    27,315,123  
           
 
       
           
 
       
           
Iraq — 2.7%
       
JPY     4,781,786,145    
Republic of Iraq Paris Club Loan Agreement (Participation with Deutsche Bank), due 01/01/28
    38,187,267  
JPY     624,805,614    
Republic of Iraq Paris Club Loan, T Chatani (Participation with Deutsche Bank), due 01/01/28
    4,900,751  
           
 
       
           
Total Iraq
    43,088,018  
           
 
       
           
 
       
           
Russia — 0.4%
       
EUR     57,042,402    
Russian Foreign Trade Obligations (Participation with GML International Ltd) (b)(d)
    6,835,440  
           
 
       
           
 
       
           
Vietnam — 1.3%
       
JPY     1,972,198,951    
Socialist Republic of Vietnam Loan Agreement (Participation with Deutsche Bank), 6 mo. JPY LIBOR + .60%, 0.93%, due 09/01/17
    21,868,117  
           
 
       
           
 
       
           
TOTAL LOAN PARTICIPATIONS (COST $90,818,731)
    102,293,647  
           
 
       


 

                     
           
PROMISSORY NOTES — 0.0%
       
           
 
       
           
Ghana — 0.0%
       
USD     3,312,500    
Republic of Ghana Promissory Notes, 0.00%, due (b)(d)(j)
    331,250  
           
 
       
           
 
       
           
TOTAL PROMISSORY NOTES (COST $3,312,500)
    331,250  
           
 
       
           
 
       
Principal Amount   Description   Value ($)
 
           
OPTIONS PURCHASED — 0.0%
       
           
 
       
           
Options on Interest Rate Swaps — 0.0%
       
           
 
       
ILS     200,000,000    
ILS Swaption Put, Expires 02/16/12, Strike 4.38% Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of 200,000,000 ILS in which it will receive 3 month ILS TELBOR and will pay 4.38%, maturing on February 20, 2013. (OTC) (CP — JP Morgan Chase Bank, N.A.)
    0  
           
 
       
ILS     300,000,000    
ILS Swaption Put, Expires 03/01/12 ,Strike 4.44% Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of 300,000,000 ILS in which it will receive 3 month ILS TELBOR and will pay 4.44%, maturing on March 5, 2013. (OTC) (CP — JP Morgan Chase Bank, N.A.)
    0  
           
 
       
ZAR     800,000,000    
ZAR Swaption Put, Expires 02/14/12, Strike 7.24% Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of 800,000,000 ZAR in which it will receive 3 month ZAR JIBAR and will pay 7.24%, maturing on February 14, 2013. (OTC) (CP — JP Morgan Chase Bank, N.A.)
    0  
           
 
       
           
Total Options on Interest Rate Swaps
    0  
           
 
       
           
 
       
           
TOTAL OPTIONS PURCHASED (COST $1,188,216)
    0  
           
 
       
           
 
       
Shares   Description   Value ($)
 
           
MUTUAL FUNDS — 3.8%
       
           
 
       
           
United States — 3.8%
       
           
 
       
           
Affiliated Issuers — 3.8%
       
      3,976,082    
GMO Short-Duration Collateral Fund
    26,281,902  
      21,409    
GMO Special Purpose Holding Fund(k)
    8,349  
      1    
GMO U.S. Treasury Fund
    31  
      1,515,449    
GMO World Opportunity Overlay Fund
    35,764,589  
           
 
       
           
Total United States
    62,054,871  
           
 
       
           
 
       
           
TOTAL MUTUAL FUNDS (COST $64,643,226)
    62,054,871  
           
 
       
           
 
       
           
RIGHTS/WARRANTS — 0.6%
       
           
 
       
           
Nigeria — 0.3%
       
      25,000    
Central Bank of Nigeria Oil Warrants, Expires 11/15/20*
    4,500,000  
           
 
       
           
 
       
           
Uruguay — 0.0%
       
      4,000,000    
Banco Central Del Uruguay Value Recovery Rights, VRRB, Expires 01/02/21*(d)
     
           
 
       


 

                     
           
Venezuela — 0.3%
       
      205,145    
Republic of Venezuela Oil Warrants, Expires 04/15/20*
    5,590,201  
      6,660    
Republic of Venezuela Oil Warrants, Expires 04/15/20*
    181,485  
           
 
       
           
Total Venezuela
    5,771,686  
           
 
       
           
 
       
           
Total RIGHTS/WARRANTS (COST $0)
    10,271,686  
           
 
       
                     
           
SHORT-TERM INVESTMENTS — 0.2%
       
           
 
       
           
Money Market Funds — 0.2%
       
      3,125,102    
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00%(l)
    3,125,102  
           
 
     
           
 
       
           
TOTAL SHORT-TERM INVESTMENTS (COST $3,125,102)
    3,125,102  
           
 
     
           
 
       
           
TOTAL INVESTMENTS — 112.5%
(Cost $1,877,861,540)
    1,835,757,050  
           
Other Assets and Liabilities (net) — (12.5%)
    (203,457,503 )
           
 
     
           
 
       
           
TOTAL NET ASSETS — 100.0%
  $ 1,632,299,547  
           
 
     
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
                                         
                                    Net Unrealized  
Settlement                                   Appreciation  
Date   Counterparty     Deliver/Receive     Units of Currency     Value     (Depreciation)  
Buys †
                                       
2/07/12
  Deutsche Bank AG   EUR     10,000,000     $ 13,445,702     $ (57,298 )
 
                                   
Sales #
                                       
2/07/12
  Deutsche Bank AG   EUR     280,000,000     $ 376,479,656       4,740,344  
1/10/12
  Credit Suisse International   GBP     30,000,000       47,050,418     $ (721,118 )
2/14/12
  Deutsche Bank AG   JPY     4,600,000,000       59,402,725       461,928  
 
                                   
 
                          $ 482,932,799     $ 4,481,154  
 
                                   
 
  Fund buys foreign currency; sells USD.
 
#   Fund sells foreign currency; buys USD.
Reverse Repurchase Agreements
                     
Face Value   Description   Market Value
USD
    27,875,000     Barclays Bank PLC, 0.19%, dated 11/14/11, to be repurchased on demand at face value plus accrued interest with a stated maturity date of 12/14/11.   $ (27,877,501 )
USD
    16,706,250     Barclays Bank PLC, 0.19%, dated 11/18/11, to be repurchased on demand at face value plus accrued interest with a stated maturity date of 12/19/11.     (16,707,396 )
USD
    1,640,606     Barclays Bank PLC, 0.25%, dated 11/09/11, to be repurchased on demand at face value plus accrued interest. (m)     (1,640,845 )


 

                     
USD
    1,102,969     Barclays Bank PLC, 0.35%, dated 11/18/11, to be repurchased on demand at face value plus accrued interest. (m)     (1,103,076 )
USD
    7,554,267     JPMorgan Chase Bank, N.A., 0.00%, dated 11/07/11, to be repurchased on demand at face value plus accrued interest. (m)     (7,554,267 )
USD
    13,060,583     JPMorgan Chase Bank, N.A., 0.55%, dated 11/04/11, to be repurchased on demand at face value plus accrued interest. (m)     (13,065,173 )
USD
    19,965,000     JPMorgan Chase Bank, N.A., 0.70%, dated 03/04/11, to be repurchased on demand at face value plus accrued interest. (m)     (20,069,040 )
USD
    36,015,188     JPMorgan Chase Bank, N.A., 0.75%, dated 02/04/11, to be repurchased on demand at face value plus accrued interest. (m)     (36,238,031 )
USD
    33,223,125     JPMorgan Chase Bank, N.A., 0.75%, dated 11/02/11, to be repurchased on demand at face value plus accrued interest. (m)     (33,242,505 )
USD
    29,922,500     JPMorgan Chase Bank, N.A., 0.90%, dated 11/16/11, to be repurchased on demand at face value plus accrued interest. (m)     (29,929,981 )
USD
    30,617,361     JPMorgan Chase Bank, N.A., 0.95%, dated 11/16/11, to be repurchased on demand at face value plus accrued interest. (m)     (30,625,441 )
 
                   
 
              $ (218,053,256 )
 
                   
         
Average balance outstanding
  $ (279,217,889 )
Average interest rate
    0.51 %
Maximum balance outstanding
  $ (351,205,903 )
Average balance outstanding was calculated based on daily face value balances outstanding during the period that the Fund has entered into reverse repurchase agreements.
Swap Agreements
Credit Default Swaps
                                                         
                                        Maximum Potential   Net
                            Implied       Amount of Future   Unrealized
Notional   Expiration       Receive   Annual   Credit   Reference   Payments by the Fund   Appreciation/
Amount   Date   Counterparty   (Pay)^   Premium   Spread (1)   Entity   Under the Contract (2)   (Depreciation)
1,000,100
  USD   12/20/2011   Deutsche Bank AG   Receive     1.60 %     2.4 %   Stemcor UK Ltd.     1,000,100     USD   $ 2,711  
8,500,000
  EUR   1/20/2012   Deutsche Bank AG   (Pay)     0.42 %     1.41 %   Republic of Kazakhstan     N/A           (1,685 )
4,100,000,000
  KZT   1/20/2012   Deutsche Bank AG   Receive     0.32 %     1.06 %   Republic of Kazakhstan     4,100,000,000     KZT     3,006  
20,000,000
  USD   6/20/2012   Goldman Sachs International   (Pay)     5.00 %     N/A     Republic of Argentina     N/A           (362,684 )
5,000,000
  USD   7/30/2012   JP Morgan Chase Bank, N.A.   Receive     3.05 %     0.57 %   Republic of Chile     5,000,000     USD     135,851  
5,000,000
  USD   8/20/2012   JP Morgan Chase Bank, N.A.   Receive     3.50 %     4.65 %   Republic of Jamaica     5,000,000     USD     7,300  
15,000,000
  USD   9/20/2012   JP Morgan Chase Bank, N.A.   (Pay)     1.15 %     0.66 %   Republic of Peru     N/A           (93,828 )
10,000,000
  USD   9/20/2012   JP Morgan Chase Bank, N.A.   (Pay)     1.25 %     1.72 %   Gazprom OAO     N/A           13,589  


 

                                                         
85,000,000
  PEN   9/20/2012   JP Morgan Chase Bank, N.A.   Receive     0.92 %     0.62 %   Republic of Peru     85,000,000     PEN     133,264  
2,000,000
  USD   9/20/2012   Goldman Sachs International   (Pay)     9.20 %     4.24 %   Republic of Argentina     N/A           (115,869 )
10,000,000
  USD   10/4/2012   JP Morgan Chase Bank, N.A.   Receive     2.95 %     0.57 %   Republic of Chile     10,000,000     USD     249,802  
4,000,000
  USD   10/20/2012   UBS AG   (Pay)     3.90 %     6.79 %   Petroleos de Venezuela     N/A           81,079  
4,000,000
  USD   10/20/2012   UBS AG   (Pay)     4.13 %     6.79 %   Petroleos de Venezuela     N/A           72,161  
42,000,000
  USD   12/20/2012   Morgan Stanley Capital Services Inc.   (Pay)     1.20 %     0.05 %   Reference security within CDX IG Index     N/A           (614,198 )
125,384,851
  USD   12/20/2012   Morgan Stanley Capital Services Inc.   Receive     0.71 %     0.01 %   Reference security within CDX IG Index     125,384,851     USD     1,113,029  
20,000,000
  USD   12/20/2012   JP Morgan Chase Bank, N.A.   (Pay)     5.00 %     5.02 %   Republic of Argentina     N/A           (192,532 )
10,000,000
  USD   12/20/2012   Goldman Sachs International   (Pay)     5.00 %     5.02 %   Republic of Argentina     N/A           (96,266 )
22,000,000
  USD   6/20/2013   Deutsche Bank AG   (Pay)     5.79 %     7.07 %   Republic of Argentina     N/A           (158,061 )
82,046,951
  RUB   6/21/2013   Deutsche Bank AG   Receive     2.35 %     10.34 %   VTB Leasing     82,046,951     RUB     (42,878 )
16,938,484
  USD   6/24/2013   JP Morgan Chase Bank, N.A.   Receive     1.37 %     4.32 %   VTB Leasing     16,938,484     USD     (381,538 )
277,250,000
  PEN   8/20/2013   JP Morgan Chase Bank, N.A.   Receive     0.96 %     0.89 %   Republic of Peru     277,250,000     PEN     393,636  
50,000,000
  USD   8/20/2013   JP Morgan Chase Bank, N.A.   (Pay)     1.20 %     1.07 %   Republic of Peru     N/A           (280,864 )
130,000,000
  USD   10/20/2013   Deutsche Bank AG   Receive     3.30 %     1.14 %   Republic of Brazil     130,000,000     USD     5,772,647  
80,000,000
  USD   10/20/2013   Deutsche Bank AG   Receive     4.05 %     1.14 %   Republic of Brazil     80,000,000     USD     4,748,564  
11,850,000,000
  JPY   10/20/2013   Deutsche Bank AG   (Pay)     3.20 %     0.98 %   Republic of Brazil     N/A           (6,914,746 )
7,110,000,000
  JPY   10/20/2013   Deutsche Bank AG   (Pay)     3.95 %     0.98 %   Republic of Brazil     N/A           (5,506,221 )
10,000,000
  USD   12/24/2013   JP Morgan Chase Bank, N.A.   Receive     3.80 %     2.04 %   Republic of Turkey     10,000,000     USD     525,067  
14,000,000
  USD   3/20/2014   Deutsche Bank AG   (Pay)     1.68 %     5.01 %   Italy Government International Bond     N/A           936,715  
39,000,000
  USD   3/20/2014   Deutsche Bank AG   (Pay)     1.49 %     1.48 %   Republic of Austria     N/A           (126,988 )
28,000,000
  USD   3/20/2014   Deutsche Bank AG   (Pay)     1.70 %     5.01 %   Republic of Italy     N/A           1,860,532  


 

                                                         
14,000,000
  USD   3/20/2014   Deutsche Bank AG   (Pay)     1.45 %     0.50 %   United Kingdom Government     N/A           (344,005 )
10,000,000
  USD   3/20/2014   Deutsche Bank AG   (Pay)     1.85 %     5.01 %   Italy Government
International Bond
    N/A           629,926  
39,000,000
  USD   3/20/2014   Deutsche Bank AG   (Pay)     2.39 %     89.29 %   Hellenic Republic of Greece     N/A           21,734,124  
39,000,000
  USD   3/20/2014   Deutsche Bank AG   (Pay)     1.28 %     0.50 %   United Kingdom Government     N/A           (793,077 )
14,000,000
  USD   3/20/2014   Deutsche Bank AG   (Pay)     2.80 %     89.29 %   Hellenic Republic of Greece     N/A           7,753,554  
2,000,000
  USD   8/24/2014   Deutsche Bank AG   (Pay)     4.25 %     3.73 %   Lebanese Republic     N/A           (49,271 )
15,000,000
  USD   9/20/2014   Deutsche Bank AG   Receive     3.77 %     1.99 %   Russian Federation     15,000,000     USD     841,809  
15,000,000
  USD   9/20/2014   Deutsche Bank AG   (Pay)     4.03 %     2.62 %   Sberbank     N/A           (680,984 )
5,000,000
  USD   3/20/2015   JP Morgan Chase Bank, N.A.   Receive     5.00 %     8.64 %   Government of Ukraine     5,000,000     USD     (457,383 )
25,000,000
  USD   3/20/2015   JP Morgan Chase Bank, N.A.   Receive     5.00 %     8.64 %   Government of Ukraine     25,000,000     USD     (2,286,915 )
8,000,000
  USD   3/20/2015   JP Morgan Chase Bank, N.A.   Receive     5.00 %     8.64 %   Government of Ukraine     8,000,000     USD     (731,813 )
575,500,000
  EUR   3/20/2015   Deutsche Bank AG   (Pay)     3.72 %     8.82 %   Venezuela Eurobond     N/A           103,265,374  
765,000,000
  USD   3/20/2015   Deutsche Bank AG   Receive     3.80 %     8.90 %   Bolivarian Republic of Venezuela     765,000,000     USD     (103,351,103 )
412,500,000
  USD   4/20/2015   Deutsche Bank AG   Receive     4.40 %     8.92 %   Bolivarian Republic of Venezuela     412,500,000     USD     (51,190,774 )
300,000,000
  EUR   4/20/2015   Deutsche Bank AG   (Pay)     4.32 %     8.85 %   Bolivarian Republic of Venezuela     N/A           49,429,850  
30,000,000
  USD   6/20/2015   Barclays Bank PLC   (Pay)     5.00 %     N/A     CDX 13 Emerging Sovereign     N/A           (2,599,833 )
40,000,000
  USD   6/20/2015   Barclays Bank PLC   (Pay)     5.00 %     N/A     CDX 13 Emerging Sovereign     N/A           (3,466,444 )
11,000,000
  USD   6/20/2015   Deutsche Bank AG   (Pay)     5.00 %     N/A     CDX 13 Emerging Sovereign     N/A           (953,272 )
15,000,000
  USD   9/20/2015   Barclays Bank PLC   (Pay)     1.00 %     1.43 %   Republic of Colombia     N/A           208,572  
56,950,000,000
  COP   11/20/2015   Citibank N.A.   Receive     1.81 %     1.16 %   Republic of Colombia     56,950,000,000     COP     699,513  
15,000,000
  USD   2/20/2016   Citibank N.A.   (Pay)     2.16 %     1.50 %   Republic of Colombia     N/A           (490,077 )
56,700,000,000
  COP   2/20/2016   Citibank N.A.   Receive     1.46 %     1.19 %   Republic of Colombia     56,700,000,000     COP     413,669  


 

                                                         
114,800,000,000
  COP   4/20/2016   Citibank N.A.   Receive     1.33 %     1.21 %   Republic of Colombia   114,800,000,000COP         359,565  
25,000,000
  USD   4/20/2016   Citibank N.A.   (Pay)     1.90 %     1.53 %   Republic of Colombia     N/A           (442,052 )
18,333,333
  EUR   6/17/2016   Deutsche Bank AG   Receive     5.60 %     11.49 %   Republic of Angola     18,333,333     EUR     343,183  
20,000,000
  USD   8/20/2016   Citibank N.A.   (Pay)     2.15 %     1.58 %   Republic of Colombia     N/A           (628,944 )
97,680,000,000
  COP   8/20/2016   Citibank N.A.   Receive     1.51 %     1.26 %   Republic of Colombia     97,680,000,000     COP     726,397  
32,500,000
  USD   2/20/2017   Deutsche Bank AG   Receive     2.43 %     9.51 %   Bolivarian Republic of Venezuela     32,500,000     USD     (8,702,498 )
32,000,000
  PEN   5/20/2017   Deutsche Bank AG   Receive     0.79 %     1.37 %   Republic of Peru     32,000,000     PEN     (327,684 )
2,500,000
  USD   5/20/2017   Deutsche Bank AG   (Pay)     1.05 %     1.70 %   Republic of Peru     N/A           81,174  
35,000,000
  USD   7/20/2017   UBS AG   Receive     2.26 %     2.84 %   Republic of Turkey     35,000,000     USD     (739,479 )
4,500,000
  USD   7/20/2017   JP Morgan Chase Bank, N.A.   Receive     3.30 %     5.58 %   Republic of Jamaica     4,500,000     USD     (411,989 )
10,000,000
  USD   12/20/2018   Deutsche Bank AG   Receive     0.44 %     1.02 %   United Kingdom Government     10,000,000     USD     (365,000 )
10,000,000
  USD   3/20/2019   Deutsche Bank AG   Receive     1.62 %     4.75 %   Italy Government International Bond     10,000,000     USD     (1,651,339 )
30,000,000
  USD   3/20/2019   Deutsche Bank AG   Receive     1.46 %     2.00 %   Republic of Austria     30,000,000     USD     (936,286 )
20,000,000
  USD   3/20/2019   Deutsche Bank AG   Receive     1.66 %     4.75 %   Republic of Italy     20,000,000     USD     (3,258,071 )
10,000,000
  USD   3/20/2019   Deutsche Bank AG   Receive     1.70 %     4.75 %   Italy Government International Bond     10,000,000     USD     (1,606,732 )
30,000,000
  USD   3/20/2019   Deutsche Bank AG   Receive     2.25 %     55.21 %   Hellenic Republic of Greece     30,000,000     USD     (17,010,710 )
30,000,000
  USD   3/20/2019   Deutsche Bank AG   Receive     1.25 %     1.03 %   United Kingdom Government     30,000,000     USD     512,410  
10,000,000
  USD   3/20/2019   Deutsche Bank AG   Receive     2.61 %     55.21 %   Hellenic Republic of Greece     10,000,000     USD     (5,624,296 )
10,000,000
  USD   3/20/2019   Deutsche Bank AG   Receive     1.35 %     1.03 %   United Kingdom Government     10,000,000     USD     239,130  
6,000,000
  USD   3/20/2020   Barclays Bank PLC   Receive     1.00 %     5.79 %   Republic of Croatia     6,000,000     USD     (1,564,774 )


 

                                                         
20,000,000
  USD   8/15/2031   Goldman Sachs International   (Pay)     1.84 %     1.98 %   United Mexican States     N/A           240,168  
 
                                                       
 
                                                  $ (22,025,792 )
 
                                                       
 
                                        Premiums to (Pay) Receive   $ 19,845,518  
 
                                                       
 
^   Receive — Fund receives premium and sells credit protection. If a credit event occurs, as defined under the terms of that particular swap agreement, the Fund will either (i) pay to the buyer of protection an amount equal to the notional amount of the swap and take delivery of the referenced obligation or underlying securities comprising the referenced index or (ii) pay a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation or underlying securities comprising the referenced index. (Pay) — Fund pays premium and buys credit protection. If a credit event occurs, as defined under the terms of that particular swap agreement, the Fund will either (i) receive from the seller of protection an amount equal to the notional amount of the swap and deliver the referenced obligation or underlying securities comprising the referenced index or (ii) receive a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation or underlying securities comprising the referenced index.
 
(1)   Implied credit spreads, represented in absolute terms, utilized in determining the market value of credit default swap agreements on the reference security, as of November 30, 2011, serve as an indicator of the current status of the payment/performance risk and reflect the likelihood or risk of default for the reference entity. The implied credit spread of a particular referenced entity reflects the cost of buying/selling protection. Wider (i.e.higher) credit spreads represent a deterioration of the referenced entity’s credit soundness and a greater likelihood or risk of default or other credit event occurring as defined under the terms of the agreement.
 
(2)   The maximum potential amount the Fund could be required to pay as a seller of credit protection if a credit event occurs as defined under the terms of that particular swap agreement.
Interest Rate Swaps
                                                         
                                                    Net Unrealized  
Notional     Expiration             Receive                     Appreciation/  
Amount     Date     Counterparty     (Pay)#     Fixed Rate     Variable Rate     (Depreciation)  
46,800,000
  PEN     4/21/2014     JP Morgan Chase Bank, N.A.   Receive     5.03 %   6 month LIBOR   $ 1,018,993  
51,000,000
  BRL     1/2/2013     JP Morgan Chase Bank, N.A.   Receive     13.80 %   Floating Rate CDI     947,317  
43,000,000
  PEN     2/16/2012     JP Morgan Chase Bank, N.A.   (Pay)     1.41 %   6 month LIBOR     (335,425 )
 
                                                     
 
                                                  $ 1,630,885  
 
                                                     
                                    Premiums to (Pay) Receive   $  
 
                                                     
 
#   Receive — Fund receives fixed rate and pays variable rate.
 
    (Pay) — Fund pays fixed rate and receives variable rate.
Total Return Swaps
                                                 
                                            Net Unrealized  
Notional     Expiration                             Appreciation/  
Amount     Date     Counterparty     Fund Pays     Fund Receives     (Depreciation)  
5,000,000
  USD     12/12/2011     Barclays Bank PLC   0.85% of notional amount   Total Return on Venezuela 11.75% Bond   $ 324,689  
 
                                             
 
                              Premiums to (Pay) Receive   $  
 
                                             
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.


 

 
Notes to Schedule of Investments:
144A — Securities exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional investors.

AMBAC — Insured as to the payment of principal and interest by AMBAC Assurance Corporation.

CDI — Certificado de Deposito Interbancario

CP — Counterparty

DEM LIBOR — London Interbank Offered Rate denominated in Deutsche Marks

FGIC — Insured as to the payment of principal and interest by Financial Guaranty Insurance Corporation.

GDP — Gross Domestic Product

GMTN — Global Medium Term Note

ILS TELBOR — Tel Aviv Interbank Offered Rate denominated in Israeli Shekel

JPY LIBOR — London Interbank Offered Rate denominated in Japanese Yen

JPY TIBOR — Tokyo Interbank Offered Rate

LIBOR — London Interbank Offered Rate

MTN — Medium Term Note

OTC — Over-the-Counter

PDI — Past Due Interest

PIK — Payment In Kind

Reg S — Security exempt from registration under Regulation S of the Securities Act of 1933, which exempts from registration securities offered and sold outside the United States. Security may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act of 1933.

VRRB — Variable Rate Reduction Bond

XL — Insured as to the payment of principal and interest by XL Capital Assurance.

ZAR Jibar — Johannesburg Interbank Offered Rate denominated in South African Rand

The rates shown on variable rate notes are the current interest rates at November 30, 2011, which are subject to change based on the terms of the security.

¨ These securities are primarily backed by subprime mortgages.
 
* Non-income producing security.
 
(a) Security is backed by the U.S. Government.
 
(b) Security is in default.
 
(c) Indexed security in which price and/or coupon is linked to the prices of a specific instrument or financial statistic.
 
(d) Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust.
 
(e) Security represents a judgment against the Government of Argentina (“Argentina”) relating to Argentina’s failure to make payments on sovereign debt held by the Fund. See “Other matters” for additional information.
 
(f) These Peru Trust securities are currently in default. See “Other matters” for additional information.
 
(g) All or a portion of this security has been pledged to cover collateral requirements on reverse repurchase agreements.
 
(h) All or a portion of this security has been pledged to cover margin requirements on futures contracts, collateral on open swap contracts, forward currency contracts, and/or written options, if any.
 
(i) Non-performing. Borrower not currently paying interest.
 
(j) Republic of Ghana promissory notes are currently in default. See “Other matters” for additional information.
 
(k) Underlying investment represents interests in defaulted claims. See “Other matters” for additional information.
 
(l) Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.
 
(m) These Reverse Repurchase Agreements have an open maturity date and can be closed on demand.
Currency Abbreviations:
ARS — Argentine Peso
BRL — Brazilian Real
CHF — Swiss Franc
COP — Colombian Peso


 

DEM — Deutsche Mark
EUR — Euro
GBP — British Pound
ILS — Israeli Shekel
JPY — Japanese Yen
KZT — Kazakhstan Tenge
MYR — Malaysian Ringgit
PEN — Peruvian Sol
RUB — Russian Ruble
USD — United States Dollar
ZAR — South African Rand
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                         
    Gross   Gross   Net Unrealized
    Unrealized   Unrealized   Appreciation
Aggregate Cost   Appreciation   (Depreciation)   (Depreciation)
$  1,885,658,404
  $ 177,271,527     $ (227,172,881 )   $ (49,901,354)
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                         
    Value,                             Distributions              
    beginning of             Sales     Dividend     of Realized     Returm of     Value, end of  
Affiliate   period     Purchases     Proceeds     Income*     Gains*     Capital*     period  
GMO Short-Duration Collateral Fund
  $ 41,271,731     $     $     $ 312,635     $     $ 13,770,029     $ 26,281,902  
GMO Special Purpose Holding Fund
    10,705                                     8,349  
GMO U.S. Treasury Fund
    31                                     31  
GMO World Opportunity Overlay Fund
    34,370,376                                     35,764,589  
 
                                         
Totals
  $ 75,652,843     $     $     $ 312,635     $     $ 13,770,029     $ 62,054,871  
 
                                         
 
*   The table above includes estimated sources of all distributions paid by the underlying funds during the period March 1, 2011 through November 31, 2011 for tax purposes. The actual tax characterization of distributions paid by the underlying funds will be determined through fiscal year ending February 29, 2012.


 

    Basis of presentation
 
    The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
 
    Portfolio valuation
 
    Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly and indirectly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 2.3% of net assets. The Fund and the underlying funds classify such securities (levels defined below) as Level 3. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivatives contracts based on the creditworthiness of its counterparties. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
 
    Typically the Fund and the underlying funds value debt instruments based on the most recent quoted price supplied by a single pricing source chosen by the Manager. Although the Manager normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and may change a pricing source at any time. The Manager monitors erratic or unusual movements (including unusual inactivity) in the prices supplied for a security and has discretion to override a price supplied by a source (e.g., by taking a price supplied by another) when it believes that the price supplied is not reliable. Although alternative prices may be available for securities held by the Fund and the underlying funds, those alternative sources are not typically part of the valuation process and do not necessarily provide greater certainty about the prices used by the Fund and the underlying funds. As of November 30, 2011, the total value of securities held directly and indirectly for which no alternative pricing source was available represented 21.7% of the net assets of the Fund.
 
    “Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
 
    In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
 
    During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
 
    The three levels are defined as follows:
 
    Level 1 — Valuations based on quoted prices for identical securities in active markets.
 
    Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit risk, yield curves and similar data. The Fund also used third party valuation services (which use industry models and market data from pricing vendors) to value certain credit default swaps.
 
    Level 3 — Valuations based primarily on inputs that are unobservable and significant. The Fund utilized a number of fair value techniques on Level 3 investments, including the following: The Fund valued certain debt securities using quoted prices. In some


 

    cases, quoted prices or prices calculated by using industry models are adjusted by a specified discount for liquidity or other considerations (including the Argentine judgment described in Other Matters below). In addition, the Fund valued certain sovereign debt securities using comparable securities issued by the sovereign adjusted by a specified spread. The Fund valued certain other debt securities by using a specified spread above the LIBOR rate. The Fund deemed certain defaulted securities to be worthless. The Fund also used third party valuation services to value certain credit default swaps using unobservable inputs.
 
    The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Debt Obligations
                               
Asset-Backed Securities
  $     $ 1,573,556     $ 80,868,860     $ 82,442,416  
Corporate Debt
          112,991,600       4,030,000       117,021,600  
Foreign Government Agency
          308,151,672       40,098,195       348,249,867  
Foreign Government Obligations
          622,725,934       366,069,962       988,795,896  
Judgments
                24,862,500       24,862,500  
U.S. Government
          65,396,786             65,396,786  
 
                       
TOTAL DEBT OBLIGATIONS
          1,110,839,548       515,929,517       1,626,769,065  
 
                       
Loan Assignments
                30,911,429       30,911,429  
Loan Participations
                102,293,647       102,293,647  
Promissory Notes
                331,250       331,250  
Options Purchased
          0 *            
Mutual Funds
    62,046,522       8,349             62,054,871  
Rights/Warrants
                10,271,686       10,271,686  
Short-Term Investments
    3,125,102                   3,125,102  
 
                       
Total Investments
    65,171,624       1,110,847,897       659,737,529       1,835,757,050  
 
                       
Derivatives**
                               
Forward Currency Contracts
                               
Foreign Currency Risk
          5,202,272             5,202,272  
Swap Agreements
                               
Credit Risk
          50,829,141       152,698,230       203,527,371  
Interest Rate Risk
          1,966,310             1,966,310  
Equity Risk
          324,689             324,689  
 
                       
Total
  $ 65,171,624     $ 1,169,170,309     $ 812,435,759     $ 2,046,777,692  
 
                       
LIABILITY VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Liabilities     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Derivatives**
                               
Forward Currency Contracts
                               
Foreign Currency Risk
  $     $ (778,416 )   $     $ (778,416 )
Swap Agreements
                               
Credit Risk
          (62,308,788 )     (163,244,375 )     (225,553,163 )
Interest Rate Risk
          (335,425 )           (335,425 )
 
                       
Total
  $     $ (63,422,629 )   $ (163,244,375 )   $ (226,667,004 )
 
                       
 
*   Represents the investment in securities that were determined to have a fair value of zero at November 30, 2011.


 

      The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
 
**   Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
    The underlying funds held at period end are classified above as either Level 1 or Level 2. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net values of the Fund’s investments (both direct and indirect) in securities and derivative financial instruments using Level 3 inputs were 42.1% and (0.6)% of total net assets, respectively.
 
    For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
 
    The following is a reconciliation of investments and derivatives, if any, in which significant unobservable inputs (Level 3) were used in determining value:


 

                                                                                   
                                                                              Net Change in  
                                                                              Unrealized  
                                                                              Appreciation  
                                            Change in                               (Depreciation)  
    Balances as of                     Accrued           Unrealized                     Balances as of       from Investments  
    February 28,                     Discounts/     Total Realized     Appreciation     Transfers into     Transfers out of     November 30,       Still Held as of  
    2011     Purchases     Sales     Premiums     Gain/(Loss)     (Depreciation)     level 3 *     level 3 *     2011       November 30, 2011  
Debt Obligations
                                                                                 
Asset-Backed Securities
  $ 96,820,133     $ 503,783     $ (9,378,111 )   $ 10,308     $ 268,242     $ (7,355,495 )   $     $     $ 80,868,860       $ (7,355,494 )
Corporate Debt
    8,020,000       4,000,000       (8,000,000 )                 10,000                   4,030,000         4,030,000  
Foreign Government Agency
    137,425,667       27,840,937       (17,550,306 )     698,575       444,476       1,423,282             (110,184,436 )     40,098,195         163,980  
Foreign Government Obligations
    523,408,255       54,268,789       (68,374,293 )     8,742,561       8,054,743       (53,608,549 )           (106,421,544 )     366,069,962         (48,769,800 )
Judgments
    28,170,000                   481,588             (3,789,088 )                 24,862,500         (3,789,088 )
 
                                                             
 
                                                                                 
Total Debt Obligations
    793,844,055       86,613,509       (103,302,710 )     9,933,032       8,767,461       (63,319,850 )           (216,605,980 )     515,929,517         (55,720,402 )
 
                                                             
Loan Assignments
    33,280,252       970,000       (2,659,041 )     721,968       614,511       (2,016,261 )                 30,911,429         (2,016,261 )
Loan Participations
    117,371,965             (11,617,259 )     1,533,602       3,326,096       (8,320,757 )                 102,293,647         (8,320,757 )
Promissory Notes
    1,071,677             (817,249 )     42,241             34,581                   331,250          
Rights and Warrants
    10,377,589                               (105,903 )                 10,271,686         (105,903 )
 
                                                             
Total Investments
    955,945,538       87,583,509       (118,396,259 )     12,230,843       12,708,068       (73,728,190 )           (216,605,980 )     659,737,529         (66,163,323 )
 
                                                             
Derivatives
                                                                                 
Swap Agreements
    (10,713,914 )           1,124,209             (1,124,209 )     167,769                   (10,546,145 )       (10,546,145 )
 
                                                             
Total
  $ 945,231,624     $ 87,583,509     $ (117,272,050 )   $ 12,230,843     $ 11,583,859     $ (73,560,421 )   $     $ (216,605,980 )   $ 649,191,384       $ (76,709,468 )
 
                                                             
 
*   The Fund accounts for investments and derivatives transferred into Level 3 at the value at the beginning of the period and transferred out of Level 3 at the value at the end of the period.


 

    Foreign currency translation
 
    The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
 
    Loan agreements
 
    The Fund may invest in loans to corporate, governmental, or other borrowers. The Fund’s investments in loans may be in the form of participations in loans or assignments of all or a portion of loans. A loan is often administered by a bank or other financial institution that acts as agent for all holders. The agent administers the terms of the loan, as specified in the loan agreement. When investing in a loan participation, (i) the Fund has the right to receive payments of principal, interest and any fees to which it is entitled only from the party from whom the Fund has purchased the participation and only upon receipt by that party of payments from the borrower and (ii) the Fund generally has no right to enforce compliance by the borrower with the terms of the loan agreement or to vote on matters arising under the loan agreement. Thus, the Fund may be subject to credit risk both of the party from whom it purchased the loan participation and the borrower and the Fund may have minimal control over the terms of any loan modification. When the Fund purchases assignments of loans, it acquires direct rights against the borrower. Loan agreements outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
 
    Repurchase agreements
 
    The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase the security at an agreed upon price and date. The Fund, through its custodian, takes possession of securities it acquired under the repurchase agreement. The value of the securities acquired is required by contract to be marked to market daily and additional collateral is required to be transferred so that the market value is at least equal to the amount owed to the Fund by the seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings and/or the value of the securities subject to the repurchase agreement is insufficient, the Fund’s recovery of cash from the seller may be delayed and the Fund may incur a loss equal to the difference between the cash it paid and the value of the securities. The Fund had no repurchase agreements outstanding at the end of the period.
 
    Reverse repurchase agreements
 
    The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same assets at an agreed upon price and date. The Fund can use the proceeds received from entering into a reverse repurchase agreement to make additional investments, which generally causes the Fund’s portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the securities it sold and as a result would realize a loss equal to the difference between the value of those securities and the payment it received for them. The size of this loss will depend upon the difference between what the buyer paid for the securities the Fund sold to it and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of $100). In the event of a buyer’s bankruptcy or insolvency, the Fund’s use of proceeds from the sale of its securities may be restricted while the other party or its trustee or receiver determines whether to honor the Fund’s right to repurchase the securities. As of November 30, 2011, the Fund had received $217,682,849 from reverse repurchase agreements relating to securities with a market value, plus accrued interest, of $221,928,239. Reverse repurchase agreements outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
 
    Inflation-indexed bonds
 
    The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income securities whose principal value is adjusted periodically according to the rate of inflation. Two structures are common. The U.S. Treasury and some other issuers use a structure that reflects inflation in the principal value of the bond. Most other issuers pay out any inflation related accruals as part of a semiannual coupon.
 
    The value of inflation indexed bonds is expected to change in response to changes in real interest rates. Real interest rates, in turn, are tied to the relationship between nominal interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e. nominal interest rate minus inflation) might decline, leading to an increase in value of inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than inflation, real interest rates might rise, leading to a decrease in value of inflation indexed bonds. There can be no assurance, however, that the value of inflation indexed bonds will be directly correlated to changes in nominal interest rates, and short term increases in inflation may lead to a decline in their value. Coupon payments received by the Fund from inflation indexed bonds are included in the Fund’s


 

    gross income for the period in which they accrue. In addition, any increase or decrease in the principal amount of an inflation indexed bond will increase or decrease taxable ordinary income to the Fund, even though principal is not paid until maturity. Inflation-indexed bonds outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
 
    Other matters
 
    In December 2005, the Fund entered into litigation against the Government of Argentina (“Argentina”) relating to Argentina’s failure to make payments on sovereign debt held by the Fund. A judgment was awarded in the Fund’s favor on September 24, 2007; however, the Fund’s ability to collect on this judgment remains uncertain, and the Fund is not able to transfer or sell the judgment without court consent. In late May 2010, Argentina commenced a public debt exchange in which certain defaulted debts, including legal judgments on those debts, were eligible to be exchanged for currently performing Argentina Bonds. The eligible portion of the Fund’s judgment was tendered in the debt exchange and the Fund received new bonds in June 2010. The remaining portion of the Fund’s judgment, which continues to be valued according to the Fund’s valuation policy, represented 1.5% of the net assets of the Fund as of November 30, 2011.
 
    Peru Trust, Series 1998 I-P; Peru Trust, Series 97-I-P; and Peru Trust II, Series 98-A LB (the “Peru Trusts”) held by the Fund are currently in default. The Peru Trusts hold obligations of Istituto per i Servizi Assicurativi e il Credito all’Espotazione (“SACE”), the Italian Agency for Insurance of Export Credits. The obligations are payable only to the extent SACE recovers amounts from the Government of Peru (“Peru”) in relation to certain export insurance policies. Peru fully paid all of its obligations to SACE on August 24, 2009; however, payments to the Peru Trusts by SACE remain outstanding. Litigation between the Peru Trusts and SACE is pending in Italy with respect to the outstanding payments. The Peru Trusts’ ability to recover such payments, and the Fund’s corresponding ability to receive payment with respect to its investment in the Peru Trusts, remains uncertain. The Peru Trusts, which continue to be valued according to the Fund’s valuation policy, represented 0.1% of the net assets of the Fund as of November 30, 2011. Costs associated with this action are borne by the Fund.
 
    In July 2008, the Fund entered into litigation against GNPA Limited (“GNPA”) (an entity wholly owned by the government of Ghana) seeking payment on an unconditional promissory note issued by GNPA. A judgment was awarded in the Fund’s favor in February 2010; however, the Fund’s ability to collect on this judgment remains uncertain. The defaulted promissory note, which continues to be valued according to the Fund’s valuation policy, represented less than 0.1% of the net assets of the Fund as of November 30, 2011. Costs associated with this action are borne by the Fund.
 
    In connection with the Fund’s purchase of Venezuelan bonds between 2000 and 2002, the Fund acquired warrants which (along with related payments on those warrants) have not been received in custody. The Fund’s trading counterparties have acknowledged their delivery obligations but have not necessarily accepted legal liability for payment. Because there can be no assurance that the Fund will receive the warrants (or related payments), the Fund values the warrants at fair value using methods determined in good faith by or at the discretion of the Trustees of GMO Trust. The value of any possible recovery is carried at $1,015,199 representing 0.1% of the net assets of the Fund as of November 30, 2011.
 
    GMO Special Purpose Holding Fund (“SPHF”), an investment of the Fund, has litigation pending against various entities related to the 2002 fraud and related default of securities previously held by SPHF. The outcome of the lawsuits against the remaining defendants is not known and any potential recoveries are not reflected in the net asset value of SPHF. For the period ended November 30, 2011, the Fund received no distributions from SPHF in connection with the defaulted securities or the related litigation.
 
    Investment and other risks
 
    The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
  Market Risk — Fixed Income Securities — Typically, the market value of the Fund’s fixed income securities will decline during periods of rising interest rates and widening of credit spreads.
 
  Market Risk — Asset-Backed Securities — Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
 
  Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s


 

      failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating. The Fund’s investments in below investment grade securities have speculative characteristics, and changes in economic conditions or other circumstances are more likely to impair the capacity of issuers to make principal and interest payments than is the case with issuers of investment grade securities. Because the Fund typically invests in securities that are of lesser quality than those in its benchmark, in rapidly declining markets, the percentage decline in the value of the Fund is likely to exceed that of its benchmark.
  Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind. Sovereign debt of emerging countries is not widely traded and may be subject to purchase and sale restrictions. In addition, because the Fund typically invests in securities that are less liquid than those in its benchmark, in rapidly declining markets the percentage decline in the Fund’s investments is likely to exceed that of its benchmark.
 
  Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
 
  Leveraging Risk — The Fund’s use of reverse repurchase agreements and other derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
 
  Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
 
  Currency Risk — Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies.
 
  Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
 
  Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations. The risk of counterparty default is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions.
 
  Focused Investment Risk — Focusing investments in a limited number of countries, regions, sectors or companies creates additional risk.
 
  Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.


 

  Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
    The Fund invests (including through investment in underlying funds) in asset-backed securities, which may be backed by many types of assets, including pools of residential and commercial mortgages, automobile loans, educational loans, home equity loans, or credit card receivables, which expose the Fund to additional types of market risk. They also may be backed by pools of corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds and loans (commonly referred to as “collateralized debt obligations” or “collateralized loan obligations”) and by the fees earned by service providers. Payment of interest on asset backed securities and repayment of principal largely depend on the cash flows generated by the assets backing the securities. The market risk of a particular asset-backed security depends on many factors, including the deal structure (e.g., determination as to the amount of underlying assets or other support needed to produce the cash flows necessary to service interest and make principal payments), the quality of the underlying assets and, if any, the level of credit support and the credit quality of the credit-support provider. Asset-backed securities involve risk of loss of principal if obligors of the underlying obligations default and the value of the defaulted obligations exceeds whatever credit support the securities may have. The obligations of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and other laws affecting the rights and remedies of creditors. Many asset-backed securities in which the Fund has invested are now rated below investment grade.
    The existence of insurance on an asset-based security does not guarantee that the principal and/or interest will be paid because the insurer could default on its obligations. In recent years, a significant number of asset-backed security insurers have defaulted on their obligations.
    With the deterioration of worldwide economic and liquidity conditions that occurred and became acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about the creditworthiness of those securities (and underlying assets) caused credit spreads (the difference between yields on the asset-backed securities and U.S. Government securities) to widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions to make markets in many fixed income securities. These events reduced liquidity and contributed to substantial declines in the value of asset-backed and other fixed income securities. There can be no assurance these conditions will not occur again. Also, government actions and proposals affecting the terms of underlying home and consumer loans, changes in demand for products (e.g., automobiles) financed by those loans, and the inability of borrowers to refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse valuation and liquidity effects on asset-backed securities.
    The market value of an asset-backed security may depend on the servicing of its underlying assets and is, therefore, subject to risks associated with the negligence or defalcation of its servicer. In some circumstances, the mishandling of related documentation also may affect the rights of security holders in and to the underlying assets. The insolvency of entities that generate receivables or that utilize the assets may result in a decline in the value of the underlying assets, as well as costs and delays. The obligations underlying asset-backed securities, in particular securities backed by pools of residential and commercial mortgages, also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as high a yield as is provided by the asset-backed security. The risk of investing in asset-backed securities has increased because performance of the various sectors in which the assets underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime mortgages, and credit card receivables) has become more highly correlated since the deterioration in worldwide economic and liquidity conditions.
    Among other trading agreements, the Fund is party to International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Agreements”) or other similar types of agreements with selected counterparties that generally govern over-the-counter derivative transactions entered into by the Fund. The ISDA Agreements typically include representations and warranties as well as contractual terms related to collateral, events of default, termination events, and other provisions. Termination events may include the decline in the net assets of the Fund below a certain level over a specified period of time and entitle a counterparty to elect to terminate early with respect to some or all the transactions under the ISDA Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse effect on the Fund’s operations.
    Derivative financial instruments
    Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
    The Fund may use derivatives as a substitute for direct investment in securities or other assets. In particular, the Fund may use swaps or other derivatives on an index, a single security or a basket of securities to gain investment exposures (e.g., by selling protection under a credit default swap). The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.


 

    The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). For example, the Fund may use credit default swaps to take a short position with respect to the likelihood of default by an issuer. The Fund also may use currency derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
    The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For instance, the Manager may alter the interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is designed to maintain the Fund’s exposure to the credit of an issuer through the debt instrument but adjust the Fund’s interest rate exposure through the swap. With these swaps, the Fund and its counterparties exchange interest rate exposure, such as fixed versus variable rates and shorter duration versus longer duration exposure. In adjusting its investment exposures, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
    The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
    The Fund is not limited in the extent to which it uses derivatives or in the absolute face value of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate exposure of its assets, and its net long exposure may exceed 100% of its net assets.
    The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
    The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
    Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
    The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
    Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.


 

    When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk that it will be required to pay the full notional value of the swap contract in the event of a default.
    Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
    The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
    Forward currency contracts
    The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.
    These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. During the period ended November 30, 2011, the Fund used forward currency contracts to adjust exposure to foreign currencies and otherwise adjust currency exchange rate risk. Forward currency contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
    Futures contracts
    The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded. The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. The Fund had no futures contracts outstanding at the end of the period.
    Options
    The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. During the period ended November 30, 2011, the Fund used purchased option contracts to adjust interest rate exposure. Option contracts purchased by the Fund and outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
    The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When


 

    the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.
 
    When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
 
    Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
 
    Swap agreements
 
    The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
 
    Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
 
    Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
 
    Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
 
    In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
 
    For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
 
    Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment


 

    when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
 
    The Fund prices its swap agreements daily using models that may incorporate quotations from market makers and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
 
    Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. During the period ended November 30, 2011, the Fund used swap agreements to adjust interest rate exposure, adjust exposure to certain markets, achieve exposure to a reference entity’s credit, and/or provide a measure of protection against default loss. Swap agreements outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
 
    Rights and warrants
 
    The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. Additionally, the Fund owns warrants linked to the price of oil. During the period ended November 30, 2011, the Fund held rights and/or warrants received to adjust exposure to certain markets. Rights and/or warrants held by the Fund at the end of the period are listed in the Fund’s Schedule of Investments.


 

The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Assets:
                                               
Investments, at value (purchased options, rights and/or warrants)
  $     $     $     $     $ 10,271,686     $ 10,271,686  
Unrealized appreciation on forward currency contracts
          5,202,272                         5,202,272  
Unrealized appreciation on swap agreements
    1,966,310             203,527,371       324,689             205,818,370  
 
                                   
Total
  $ 1,966,310     $ 5,202,272     $ 203,527,371     $ 324,689     $ 10,271,686     $ 221,292,328  
 
                                   
 
Liabilities:
                                               
Unrealized depreciation on forward currency contracts
  $     $ (778,416 )   $     $     $     $ (778,416 )
Unrealized depreciation on swap agreements
    (335,425 )           (225,553,163 )                 (225,888,588 )
 
                                   
Total
  $ (335,425 )   $ (778,416 )   $ (225,553,163 )   $     $     $ (226,667,004 )
 
                                   
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts, and rights and/or warrants), notional amounts (swap agreements), or principal amounts (options) outstanding at each month-end, was as follows for the period ended November 30, 2011:
                                 
    Forward                
    Currency   Swap           Rights and/or
    Contracts   Agreements   Options   Warrants
Average amount outstanding
  $ 539,499,784     $ 4,565,788,786     $ 401,027,019     $ 10,306,987  


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.


 

GMO Emerging Domestic Opportunities Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares     Description   Value ($)  
 
       
COMMON STOCKS — 83.0%
       
       
 
       
       
Brazil — 10.3%
       
  138,500    
Arcos Dorados Holdings Inc Class A
    3,035,920  
  533,400    
Brasil Brokers Participacoes SA
    1,796,337  
  95,912    
Companhia de Bebidas das Americas
    2,630,705  
  146,600    
Fleury SA
    1,670,008  
  231,400    
Gafisa SA ADR
    1,393,028  
  331,200    
Itau Unibanco Holding SA ADR
    5,895,360  
  409,100    
Light SA
    6,200,918  
  155,300    
LPS Brasil Consultoria de Imoveis SA
    2,319,602  
  305,400    
Multiplus SA
    5,353,599  
  285,100    
PDG Realty SA Empreendimentos e Participacoes
    1,059,459  
  290,400    
Redecard SA
    4,897,946  
  202,800    
Telefonica Brasil SA ADR
    5,469,516  
       
 
     
       
Total Brazil
    41,722,398  
       
 
     
       
 
       
       
China — 11.8%
       
  9,531    
Baidu Inc Sponsored ADR *
    1,248,466  
  1,678,000    
China Mengniu Dairy Co Ltd
    6,045,864  
  207,500    
China Mobile Ltd
    2,048,937  
  2,144,000    
Dah Chong Hong Holdings Ltd
    2,971,178  
  1,912,000    
Dongfeng Motor Group Co Ltd Class H
    2,871,691  
  710,000    
Galaxy Entertainment Group Ltd *
    1,417,254  
  1,669,000    
Haitian International Holdings Ltd
    1,447,221  
  532,500    
Hengan International Group Co Ltd
    5,016,811  
  36,000    
Home Inns & Hotels Management Inc ADR *
    1,118,160  
  2,257,500    
Intime Department Store Group Co Ltd
    2,650,763  
  6,974,450    
Kingdee International Software Group Co Ltd
    2,372,535  
  1,920,000    
Kunlun Energy Company Ltd
    2,598,688  
  170,700    
New Oriental Education & Technology Group Inc Sponsored ADR *
    4,308,468  
  4,245,500    
Sun Art Retail Group Ltd *
    5,803,663  
  1,430,000    
Tingyi (Cayman Islands) Holding Corp
    4,652,341  
  1,974,000    
Trinity Ltd
    1,444,343  
       
 
     
       
Total China
    48,016,383  
       
 
     
       
 
       
       
Hong Kong — 0.5%
       
  707,000    
Chow Sang Sang Holdings International Ltd
    1,961,573  
       
 
     
       
 
       
       
India — 6.0%
       
  18,378    
Asian Paints Ltd
    1,022,213  
  375,442    
Coromandel International Ltd
    2,081,917  
  1,485,240    
Dish TV India Ltd *
    1,857,364  
  31,191    
Glaxo SmithKline Consumer Healthcare Ltd
    1,502,147  
  33,985    
Hero Honda Motors Ltd
    1,329,464  
  914,220    
Idea Cellular Ltd *
    1,687,204  
  394,039    
Indraprastha Gas Ltd
    3,055,754  
  299,602    
IndusInd Bank Ltd (a)
    1,450,022  
  66,894    
Jubilant Foodworks Ltd *
    1,005,625  
  81,990    
Kotak Mahindra Bank Ltd
    747,325  
  139,725    
Mahindra & Mahindra Ltd
    1,991,673  
  36,062    
Nestle India Ltd
    2,930,854  
  398,058    
Petronet LNG Ltd
    1,261,953  
  473,846    
Rallis India Ltd
    1,388,002  
  187,993    
Sun TV Network Ltd
    957,922  
       
 
     
       
Total India
    24,269,439  
       
 
     

 


 

                 
       
Indonesia — 9.2%
       
  10,158,500    
ACE Hardware Indonesia Tbk PT
    4,306,727  
  1,350,500    
Astra International Tbk PT
    10,847,518  
  2,967,500    
Bank Central Asia Tbk PT
    2,645,313  
  4,750,855    
Bank Danamon Indonesia Tbk PT
    2,349,542  
  13,194,500    
Bank Mandiri Tbk PT
    9,610,337  
  1,564,500    
Indomobil Sukses Internasional Tbk PT *
    2,298,063  
  4,412,500    
Kalbe Farma Tbk PT
    1,745,999  
  11,000    
Sumber Alfaria Trijaya Tbk PT
    5,117  
  1,310,287    
United Tractors Tbk PT
    3,455,762  
       
 
     
       
Total Indonesia
    37,264,378  
       
 
     
       
 
       
       
Macau — 0.3%
       
  354,400    
Wynn Macau Ltd *
    1,038,780  
       
 
     
       
 
       
       
Malaysia — 1.8%
       
  1,294,700    
AMMB Holdings Berhad
    2,462,590  
  1,522,400    
Hong Leong Bank Berhad
    5,059,359  
       
 
     
       
Total Malaysia
    7,521,949  
       
 
     
       
 
       
       
Mexico — 1.9%
       
  139,770    
First Cash Financial Services, Inc. *
    5,073,651  
  105,400    
Grupo Televisa SA Sponsored ADR
    2,188,104  
  142,700    
Grupo Televisa SA-Series CPO
    594,420  
       
 
     
       
Total Mexico
    7,856,175  
       
 
     
       
 
       
       
Nigeria — 0.6%
       
  963,551    
Nestle Nigeria Plc
    2,290,071  
       
 
     
       
 
       
       
Philippines — 0.9%
       
  10,070,645    
Puregold Price Club Inc *
    3,532,345  
       
 
     
       
 
       
       
Russia — 3.3%
       
  276,647    
Magnit OJSC Sponsored GDR (Registered Shares)
    6,151,930  
  606,727    
Sberbank Sponsored ADR *(a)
    7,381,208  
       
 
     
       
Total Russia
    13,533,138  
       
 
     
       
 
       
       
South Africa — 5.0%
       
  1,282,280    
Growthpoint Properties Ltd
    2,911,323  
  304,198    
Shoprite Holdings Ltd
    5,134,797  
  92,715    
Tiger Brands Ltd
    2,808,183  
  450,500    
Vodacom Group Ltd
    5,094,220  
  111,703    
Wilson Bayly Holmes-Ovcon Ltd
    1,453,257  
  614,307    
Woolworths Holdings Ltd
    3,071,549  
       
 
     
       
Total South Africa
    20,473,329  
       
 
     
       
 
       
       
South Korea — 5.2%
       
  8,135    
E-Mart Co Ltd *
    2,110,769  
  28,330    
GS Home Shopping Inc
    2,710,698  
  23,046    
Hyundai Mobis
    6,390,912  
  31,557    
Hyundai Motor Co
    6,138,345  
  113,155    
Kangwon Land Inc
    2,789,112  
  2,097    
ORION Corp
    1,133,213  
       
 
     
       
Total South Korea
    21,273,049  
       
 
     
       
 
       
       
Taiwan — 1.4%
       
  1,461,000    
Chunghwa Telecom Co Ltd
    4,843,046  

 


 

                 
  6,900    
Chunghwa Telecom Co Ltd ADR
    230,667  
  100    
Taiwan Mobile Co Ltd
    322  
  400,000    
Yungtay Engineering Co Ltd
    606,943  
       
 
     
       
Total Taiwan
    5,680,978  
       
 
     
       
 
       
       
Thailand — 10.8%
       
  997,800    
Advanced Info Service Pcl (Foreign Registered) (a)
    4,552,825  
  1,940,100    
Bangkok Dusit Medical Service Pcl (Foreign Registered) (a)
    4,734,522  
  2,003,300    
BEC World Pcl (Foreign Registered) (a)
    2,562,875  
  1,955,100    
Charoen Pokphand Foods Pcl (Foreign Registered) (a)
    2,113,506  
  3,192,900    
CP ALL Pcl (Foreign Registered) (a)
    5,226,630  
  48,180,600    
Hemaraj Land and Development Pcl (Foreign Registered) (a)
    3,531,837  
  668,100    
Hemaraj Land and Development Pcl NVDR
    48,975  
  21,746,886    
Home Product Center Pcl (Foreign Registered) (a)
    7,247,397  
  14,110,800    
Land & Houses Pcl NVDR
    2,771,117  
  1,264,100    
Robinson Department Store Pcl (Foreign Registered) (a)
    1,503,897  
  291,100    
Siam Makro Pcl (Foreign Registered) (a)
    2,158,381  
  9,802,700    
Thai Tap Water Supply Pcl (Foreign Registered) (a)
    1,670,636  
  2,375,900    
Thanachart Capital Pcl (Foreign Registered) (a)
    1,953,915  
  123,300    
Tisco Financial Group Pcl (Foreign Registered) (a)
    156,794  
  744,500    
Tisco Financial Group Pcl NVDR
    946,742  
  1,068,600    
Total Access Communication Pcl NVDR
    2,799,261  
       
 
     
       
Total Thailand
    43,979,310  
       
 
     
       
 
       
       
Turkey — 1.4%
       
  2,164,603    
Dogus Otomotiv Servis ve Ticaret AS *
    3,894,476  
  549,702    
Turkiye Garanti Bankasi
    1,883,109  
       
 
     
       
Total Turkey
    5,777,585  
       
 
     
       
 
       
       
United States — 12.6%
       
  190,200    
Colgate—Palmolive Co.
    17,403,300  
  233,700    
Domino’s Pizza, Inc. *
    7,698,078  
  463,800    
Yum! Brands, Inc.
    25,991,352  
       
 
     
       
Total United States
    51,092,730  
       
 
     
       
TOTAL COMMON STOCKS (COST $322,855,513)
    337,283,610  
       
 
     
       
 
       
       
PREFERRED STOCKS — 1.3%
       
       
 
       
       
Brazil — 1.3%
       
  393,100    
AES Tiete SA 11.00%
    5,358,429  
       
 
     
       
TOTAL PREFERRED STOCKS (COST $5,094,419)
    5,358,429  
       
 
     
 
       
INVESTMENT FUNDS — 8.8%
       
 
       
United States — 8.8%
       
 
  826,119    
Vanguard Emerging Markets ETF (b)
    33,705,655  
  47,784    
iShares MSCI Emerging Markets Index Fund (c)
    1,913,272  
       
 
     
       
Total United States
    35,618,927  
       
 
     
       
TOTAL INVESTMENT FUNDS (COST $34,467,517)
    35,618,927  
       
 
     
       
 
       
       
MUTUAL FUNDS — 3.2%
       
       
 
       
       
United States — 3.2%
       
       
 
       
       
Affiliated Issuers
       
  509,802    
GMO U.S. Treasury Fund
    12,750,143  
       
 
     
       
TOTAL MUTUAL FUNDS (COST $12,750,143)
    12,750,143  
       
 
     

 


 

                 
Par Value     Description   Value ($)  
 
       
SHORT-TERM INVESTMENTS — 1.0%
       
       
 
       
       
Time Deposits — 1.0%
       
USD  1,750,000    
Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11
    1,750,000  
ZAR 16,132    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 4.85%, due 12/01/11
    1,988  
USD  1,750,000    
Citibank (New York) Time Deposit, 0.03%, due 12/01/11
    1,750,000  
USD 641,740    
JPMorgan Chase (New York) Time Deposit, 0.03%, due 12/01/11
    641,740  
       
 
     
       
Total Time Deposits
    4,143,728  
       
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $4,143,728)
    4,143,728  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 97.3%
(Cost $379,311,320)
    395,154,837  
       
 
       
       
Other Assets and Liabilities (net) — 2.7%
    11,125,441  
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 406,280,278  
       
 
     
 
Notes to Schedule of Investments:
 
ADR — American Depositary Receipt
 
CP — Counterparty
 
CPO — Ordinary Participation Certificate (Certificado de Participacion Ordinares), representing a bundle of shares of the multiple series of one issuer that trade together as a unit.
 
ETF — Exchange-Traded Fund
 
Foreign Registered — Shares issued to foreign investors in markets that have foreign ownership limits.
 
GDR — Global Depository Receipt
 
MSCI — Morgan Stanley Capital International
 
NVDR — Non-Voting Depository Receipt
 
*   Non-income producing security.
 
(a)   Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust.
 
(b)   Represents an investment to equitize cash in the Vanguard Emerging Markets ETF, which is a separate investment portfolio of Vanguard, Inc., a registered investment company. The Vanguard Emerging Markets ETF prospectus states that the fund invests substantially all (normally about 95%) of its assets in the common stocks included in the MSCI Emerging Market Index, while employing a form of sampling to reduce risk.
 
(c)   Represents an investment to equitize cash in the iShares® MSCI Emerging Markets Index Fund, which is a separate investment portfolio of iShares, Inc., a registered investment company. The iShares® MSCI Emerging Markets Index Fund’s prospectus states that it invests in global emerging markets and seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI Emerging Markets Index. iShares® is a registered trademark of BlackRock. Neither BlackRock nor the iShares® Funds make any representations regarding the advisability of investing in the iShares® MSCI Emerging Markets Index Fund.
 
Currency Abbreviations:
 
HKD — Hong Kong Dollar
 
SGD — Singapore Dollar
 
USD — United States Dollar
 
ZAR — South African Rand

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
               
    Gross   Gross   Net Unrealized
    Unrealized   Unrealized   Appreciation
Aggregate Cost   Appreciation   (Depreciation)   (Depreciation)
$381,264,390
  $22,041,542   $ (8,151,095 ) $13,890,447

 


 

Investments In Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period March 1, 2011 (commencement of operations) through November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO U.S Treasury Fund
  $     $ 143,790,376     $ 131,040,493     $ 632     $ 12     $ 12,750,143  
 
                                   

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 11.4% of net assets. The Fund classifies such securities (levels defined below) as Level 3. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below.
       
Security Type   Percentage of Net Assets of the Fund    
Equity Securities
  42.9%
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include: fair value adjustments provided by an independent pricing service applied to equity securities (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) due to market events that have occurred since the local market close but prior to the close of the NYSE.

 


 

Level 3 — Valuations based primarily on inputs that are unobservable and significant. The Fund used the following fair value techniques on Level 3 investments: Certain of the Fund’s securities in Thailand and India were valued at the local price as adjusted by applying a premium or discount when the holdings exceed foreign ownership limitations. The Fund also valued certain securities using a price from a comparable security related to the same issuer that trades on a different exchange.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Common Stocks
                               
Brazil
  $ 41,722,398     $     $     $ 41,722,398  
China
    12,478,757       35,537,626             48,016,383  
Hong Kong
          1,961,573             1,961,573  
India
          22,819,417       1,450,022       24,269,439  
Indonesia
          37,264,378             37,264,378  
Macau
          1,038,780             1,038,780  
Malaysia
          7,521,949             7,521,949  
Mexico
    7,856,175                   7,856,175  
Nigeria
          2,290,071             2,290,071  
Philippines
    3,532,345                   3,532,345  
Russia
          6,151,930       7,381,208       13,533,138  
South Africa
          20,473,329             20,473,329  
South Korea
          21,273,049             21,273,049  
Taiwan
    230,667       5,450,311             5,680,978  
Thailand
          6,566,095       37,413,215       43,979,310  
Turkey
          5,777,585             5,777,585  
United States
    51,092,730                   51,092,730  
 
                       
TOTAL COMMON STOCKS
    116,913,072       174,126,093       46,244,445       337,283,610  
 
                       
Preferred Stocks
                               
Brazil
    5,358,429                   5,358,429  
 
                       
TOTAL PREFERRED STOCKS
    5,358,429                   5,358,429  
 
                       
Investment Funds
                               
United States
    35,618,927                   35,618,927  
 
                       
TOTAL INVESTMENT FUNDS
    35,618,927                   35,618,927  
 
                       
Mutual Funds
                               
United States
    12,750,143                   12,750,143  
 
                       
TOTAL MUTUAL FUNDS
    12,750,143                   12,750,143  
 
                       
Short-Term Investments
    4,143,728                   4,143,728  
 
                       
Total Investments
    174,784,299       174,126,093       46,244,445       395,154,837  
 
                       
Total
  $ 174,784,299     $ 174,126,093     $ 46,244,445     $ 395,154,837  
 
                       

 


 

The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net values of the Fund’s direct investments in securities using Level 3 inputs were 11.4% of total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant unobservable inputs (Level 3) were used in determining value:

 


 

                                                                                 
                                                                            Net Change in  
                                                                            Unrealized  
                                                                            Appreciation  
                                                                          (Depreciation)  
                                            Change in                             from Investments  
    Balances as                     Accrued             Unrealized                     Balances as     Still Held as  
    of February                     Discounts/     Total Realized     Appreciation     Transfers     Transfers out     of November     November 30,  
    28, 2011 **     Purchases     Sales     Premiums     Gain/(Loss)     (Depreciation)     into level 3 *     of level 3 *     30, 2011     2011  
Common Stocks
                                                                               
India
  $     $ 3,084,067     $ (1,253,166 )   $     $ (158,913 )   $ (221,966 )   $     $     $ 1,450,022     $ (221,966 )
Russia
          5,951,644       (514,229 )           (102,138 )     2,045,931                   7,381,208       2,045,931  
Thailand
          35,377,315       (1,735,771 )           (36,759 )     3,808,430                   37,413,215       3,808,430  
 
                                                           
Total
  $     $ 44,413,026     $ (3,503,166 )   $     $ (297,810 )   $ 5,632,395     $     $     $ 46,244,445     $ 5,632,395  
 
                                                           
 
*   The Fund accounts for investments and derivatives transferred into Level 3 at the value at the beginning of the period and transferred out of Level 3 at the value at the end of the period.
 
**   Note: Fund commenced operation on March 1, 2011.

 


 

Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If the Fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of value of those investments. Because the Fund normally does not take temporary defensive positions, declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments related to emerging markets, the economies of which tend to be more volatile than the economies of developed markets.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies.
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Focused Investment Risk — The Fund’s investments in companies whose prospects are linked to the internal development and growth of emerging markets create additional risk because the performance of those companies is likely to be highly correlated.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.

 


 

Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations. The Fund is also subject to risk because the Fund does not seek to control risk relative to a particular securities market index or benchmark.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in underlying funds, including the risk that the underlying funds (including ETFs) in which it invests will not perform as expected.
Leveraging Risk — The Fund’s use of reverse repurchase agreements and other derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. For example, the Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives, to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives. The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For example, if the Fund holds a large proportion of stocks of companies in a particular sector and the Manager believes that stocks of companies in another sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index). In adjusting its investment exposure, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net long exposures in excess of its net assets. The Fund’s foreign currency exposure may differ significantly from the currency exposure represented by its investments.

 


 

The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.

 


 

These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most forward currency contracts are not collateralized. The Fund had no forward currency contracts outstanding at the end of the period.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded (unless otherwise adjusted due to the time at which foreign markets close). The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated

 


 

terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers (unless otherwise adjusted due to the time at which foreign markets close) and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Emerging Markets Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares     Description   Value ($)  
 
       
COMMON STOCKS — 85.7%
       
       
 
       
       
Brazil — 11.9%
       
  231,100    
Arcos Dorados Holdings Inc Class A
    5,065,712  
  2,742,010    
Banco Bradesco ADR
    45,243,165  
  10,920,200    
Banco do Brasil SA
    146,138,104  
  1,851,200    
Banco Santander Brasil SA ADR
    14,291,264  
  1,004,500    
BM&FBOVESPA SA
    5,488,130  
  2,339,100    
BR Malls Participacoes SA
    23,683,978  
  1,583,900    
Brasil Brokers Participacoes SA
    5,334,117  
  680,165    
Brasil Telecom SA ADR
    12,120,540  
  727,800    
BRF — Brasil Foods SA
    14,665,170  
  390,180    
Centrais Eletricas Brasileiras SA ADR
    5,228,412  
  886,270    
Centrais Eletricas Brasileiras SA Sponsored ADR
    8,233,448  
  1,228,763    
CETIP SA
    17,870,693  
  6,200    
Cia de Bebidas das Americas ADR
    170,376  
  1,040,302    
Cia de Saneamento Basico do Estado de Sao Paulo
    28,758,093  
  36,282    
Cia de Saneamento Basico do Estado de Sao Paulo ADR
    2,003,492  
  254,800    
Cia Paranaense de Energia Sponsored ADR
    5,134,220  
  1,329,800    
Cielo SA
    35,407,897  
  608,060    
Companhia de Bebidas das Americas
    16,678,063  
  716,200    
Companhia de Bebidas das Americas ADR
    24,622,956  
  1,076,800    
Companhia de Saneamento de Minas Gerais-Copasa MG
    19,215,493  
  18,300    
Companhia Energetica de Minas Gerais Sponsored ADR
    321,165  
  605,300    
Cosan SA Industria e Comercio
    9,004,103  
  1,470,000    
Cyrela Brazil Realty SA
    12,217,823  
  1,280,592    
Electrobras (Centro)
    11,734,128  
  693,300    
Fleury SA
    7,897,796  
  838,400    
Gafisa SA ADR
    5,047,168  
  3,055,100    
Gerdau SA
    19,580,617  
  2,663,300    
Gerdau SA Sponsored ADR
    20,454,144  
  15,500    
HRT Participacoes em Petroleo SA *
    5,699,947  
  7,257,650    
Itau Unibanco Holding SA ADR
    129,186,170  
  1,980,300    
Light SA
    30,016,326  
  1,013,800    
LPS Brasil Consultoria de Imoveis SA
    15,142,388  
  1,180,300    
Multiplus SA
    20,690,414  
  1,058,200    
PDG Realty SA Empreendimentos e Participacoes
    3,932,372  
  6,650,790    
Petroleo Brasileiro SA (Petrobras) ADR
    179,504,822  
  4,077,000    
Redecard SA
    68,763,514  
  1,332,860    
Telefonica Brasil SA ADR
    35,947,234  
  321,103    
Tim Participacoes SA ADR
    7,645,462  
  911,100    
Ultrapar Participacoes SA
    16,031,853  
  105,100    
Ultrapar Participacoes SA Sponsored ADR
    1,867,627  
  22,700    
Usinas Siderurgicas de Minas Gerais SA Sponsored ADR
    135,519  
  1,723,800    
Vale SA
    39,702,641  
  6,998,200    
Vale SA Sponsored ADR
    162,708,150  
       
 
     
       
Total Brazil
    1,238,584,706  
       
 
     
       
 
       
       
Chile — 0.2%
       
  826,614    
Empresa National de Telecomunicaciones SA
    16,751,898  
  52,949,871    
Madeco SA *
    2,341,234  
       
 
     
       
Total Chile
    19,093,132  
       
 
     
       
 
       
       
China — 12.7%
       
  61,800    
Baidu Inc Sponsored ADR *
    8,095,182  
  133,249,640    
Bank of China Ltd Class H
    43,445,600  
  30,572,480    
Bank of Communications Co Ltd Class H
    19,961,839  
  4,786,000    
Belle International Holdings Ltd
    9,208,402  

 


 

                 
  9,315,400    
Changsha Zoomlion Heavy Industry Science and Technology Development Co Ltd Class H
    9,990,166  
  26,906,000    
China CITIC Bank Corp Class H
    14,493,806  
  12,361,700    
China Coal Energy Co Class H
    14,766,420  
  17,669,700    
China Communication Services Corp Ltd Class H
    8,531,128  
  34,459,150    
China Communications Construction Co Ltd Class H
    26,571,459  
  25,124,099    
China Construction Bank Class H
    17,867,205  
  4,038,000    
China Everbright Ltd
    6,069,149  
  44,600    
China Life Insurance Co Ltd ADR
    1,795,596  
  9,329,000    
China Life Insurance Co Ltd Class H
    25,088,238  
  6,646,000    
China Mengniu Dairy Co Ltd
    23,945,658  
  10,177,000    
China Minsheng Banking Corp Ltd
    8,351,659  
  30,297,237    
China Mobile Ltd
    299,166,850  
  546,800    
China Mobile Ltd Sponsored ADR
    27,159,556  
  8,466,000    
China National Building Material Co Ltd Class H
    10,305,198  
  947,080    
China Ocean Resources Co Ltd
    4,272,165  
  5,929,400    
China Pacific Insurance Group Co Ltd
    17,063,424  
  40,100    
China Petroleum & Chemical Corp ADR
    4,264,635  
  119,449,351    
China Petroleum & Chemical Corp Class H
    126,477,424  
  24,211,000    
China Railway Group Ltd Class H
    7,755,666  
  9,388,500    
China Shenhua Energy Co Ltd Class H
    41,440,896  
  7,878,000    
China Southern Airlines Co Ltd Class H *
    4,197,165  
  41,500    
China Telecom Corp Ltd ADR
    2,568,020  
  128,558,000    
China Telecom Corp Ltd Class H
    78,518,237  
  4,268,400    
China Ting Group Holding Ltd
    232,058  
  24,077,900    
China Unicom Hong Kong Ltd
    52,274,518  
  1,458,500    
China Unicom Hong Kong Ltd ADR
    31,459,845  
  9,826,400    
Citic Pacific Ltd
    18,667,570  
  5,283,000    
CNOOC Ltd
    10,248,111  
  820    
CNOOC Ltd ADR
    158,522  
  3,602,000    
Dah Chong Hong Holdings Ltd
    4,991,691  
  13,834,000    
Dongfeng Motor Group Co Ltd Class H
    20,777,709  
  6,988,000    
Galaxy Entertainment Group Ltd *
    13,948,979  
  35,140,000    
GOME Electrical Appliances Holdings Ltd
    9,026,073  
  4,188,525    
Great Wall Motor Co Ltd Class H
    6,032,397  
  17,237,500    
Haitian International Holdings Ltd
    14,946,958  
  2,289,000    
Hengan International Group Co Ltd
    21,565,220  
  97,400    
Home Inns & Hotels Management Inc ADR *
    3,025,244  
  12,902,440    
Hopson Development Holdings Ltd
    7,756,828  
  92,276,000    
Industrial and Commercial Bank of China Ltd Class H
    53,802,559  
  3,769,500    
Intime Department Store Group Co Ltd
    4,426,158  
  11,654,000    
Kingdee International Software Group Co Ltd
    3,964,402  
  6,210,000    
Kunlun Energy Company Ltd
    8,405,133  
  4,656,160    
Lianhua Supermarket Holdings Co Ltd
    5,751,118  
  7,536,700    
Minth Group Ltd
    7,024,999  
  285,400    
New Oriental Education & Technology Group Inc Sponsored ADR *
    7,203,496  
  6,356,172    
Peace Mark Holdings Ltd * (a)(b)
     
  63,100    
PetroChina Co Ltd ADR
    8,250,325  
  41,484,301    
PetroChina Co Ltd Class H
    53,869,913  
  15,908,000    
PICC Property & Casualty Co Ltd Class H
    21,558,651  
  3,299,000    
Ping An Insurance (Group) Co of China Ltd Class H
    22,983,821  
  13,568,000    
Sun Art Retail Group Ltd *
    18,547,663  
  348,700    
Suntech Power Holdings Co Ltd ADR *
    864,776  
  5,044,000    
Tingyi (Cayman Islands) Holding Corp
    16,410,074  
  3,143,600    
Weichai Power Co Ltd Class H
    14,756,116  
       
 
     
       
Total China
    1,324,301,670  
       
 
     
       
 
       
       
Czech Republic — 1.5%
       
  2,557,442    
CEZ AS
    100,969,986  
  176,400    
Komercni Banka AS
    29,160,442  

 


 

                 
  196,730    
Pegas Nonwovens SA
    4,693,580  
  10,667    
Philip Morris CR AS
    6,930,136  
  599,330    
Telefonica 02 Czech Republic AS
    12,541,701  
       
 
     
       
Total Czech Republic
    154,295,845  
       
 
     
       
 
       
       
Egypt — 1.4%
       
  1,403,439    
Alexandria Mineral Oils Co
    15,091,928  
  9,183,853    
Arab Cotton Ginning
    3,985,172  
  4,313,370    
Commercial International Bank
    17,236,673  
  59,608    
EFG-Hermes Holding GDR *
    214,760  
  1,697,999    
EFG-Hermes Holding SAE *
    3,115,246  
  448,823    
Egyptian Co for Mobile Services
    7,298,953  
  1,751,207    
ElSwedy Electric Co
    6,386,498  
  526,146    
Orascom Construction Industries
    19,370,357  
  34,261    
Orascom Construction Industries GDR
    1,234,767  
  14,449,944    
Orascom Telecom Holding SAE *
    7,163,255  
  4,705,236    
Orascom Telecom Holding SAE GDR (Registered Shares) *
    12,277,641  
  6,195,288    
Sidi Kerir Petrochemicals Co
    12,873,555  
  9,875,104    
South Valley Cement
    5,719,755  
  11,433,399    
Talaat Moustafa Group *
    7,129,225  
  9,866,090    
Telecom Egypt
    23,080,060  
       
 
     
       
Total Egypt
    142,177,845  
       
 
     
       
 
       
       
Hong Kong — 0.0%
       
  1,185,000    
Chow Sang Sang Holdings International Ltd
    3,287,784  
       
 
     
       
 
       
       
Hungary — 1.0%
       
  55,072    
Egis Gyogyszergyar Nyrt
    4,514,260  
  6,697,748    
Magyar Telekom Nyrt
    15,333,235  
  119,203    
MOL Hungarian Oil and Gas Nyrt *
    9,922,244  
  4,637,155    
OTP Bank Nyrt
    68,878,058  
  37,195    
Richter Gedeon Nyrt
    5,607,212  
       
 
     
       
Total Hungary
    104,255,009  
       
 
     
       
 
       
       
India — 5.1%
       
  996,097    
Aban Offshore Ltd
    6,767,815  
  11,840,176    
Alok Industries Ltd
    4,347,961  
  105,319    
Asian Paints Ltd
    5,858,007  
  1,408,103    
Aurobindo Pharma Ltd
    2,526,095  
  156,860    
Bayer Cropscience Ltd
    2,330,641  
  1,718,215    
Bharti Airtel Ltd
    12,666,369  
  1,587,014    
Canara Bank Ltd
    13,287,114  
  1,823,810    
Coal India Ltd
    11,619,177  
  832,320    
Coromandel International Ltd
    4,615,416  
  4,197,855    
Dish TV India Ltd *
    5,249,620  
  1,048,356    
GAIL India Ltd
    8,068,285  
  1,218,069    
Gitanjali Gems Ltd
    7,973,527  
  90,829    
Glaxo SmithKline Consumer Healthcare Ltd
    4,374,292  
  490,883    
Grasim Industries Ltd (a)
    23,009,567  
  1,018,207    
HDFC Bank Ltd
    8,843,943  
  392,500    
HDFC Bank Ltd ADR
    10,856,550  
  278,224    
Hero Honda Motors Ltd
    10,883,887  
  8,736,910    
Hexaware Technologies Ltd
    14,442,926  
  947,250    
HSIL Ltd
    2,743,645  
  5,827,143    
Idea Cellular Ltd *
    10,754,062  
  2,604,877    
Indraprastha Gas Ltd
    20,200,696  
  1,665,626    
IndusInd Bank Ltd (a)
    8,061,341  
  302,308    
Infosys Technologies Ltd
    15,490,011  
  733,490    
Infosys Technologies Ltd Sponsored ADR
    37,862,754  

 


 

                 
  1,369,784    
Ipca Laboratories Ltd
    6,783,875  
  426,834    
Jubilant Foodworks Ltd *
    6,416,645  
  1,227,170    
Kiri Industries Ltd (c)
    1,895,901  
  276,979    
Kotak Mahindra Bank Ltd
    2,524,618  
  717,709    
Mahindra & Mahindra Ltd
    10,230,392  
  1,135,425    
Mphasis Ltd
    7,117,657  
  104,083    
Nestle India Ltd
    8,459,099  
  2,576,042    
NTPC Ltd
    8,182,634  
  4,738,139    
Oil & Natural Gas Corp Ltd
    24,637,745  
  5,116,997    
Petronet LNG Ltd
    16,222,290  
  4,174,275    
Power Grid Corp of India Ltd
    8,025,013  
  1,305,020    
Rallis India Ltd
    3,822,699  
  1,316,394    
Reliance Industries Ltd
    20,179,333  
  46,756    
Reliance Industries Ltd Sponsored GDR, 144A
    1,408,441  
  5,644,438    
Satyam Computer Services Ltd *
    7,333,130  
  7,898,140    
Sesa Goa Ltd
    28,607,142  
  9,442,568    
Shree Renuka Sugars Ltd
    5,592,077  
  5,433,778    
Sterlite Industries India Ltd
    10,711,277  
  612,700    
Sterlite Industries India Ltd ADR
    4,938,362  
  807,650    
Sun TV Network Ltd
    4,115,397  
  1,736,803    
Tata Consultancy Services Ltd
    37,871,453  
  3,865,735    
Tata Motors Ltd
    13,251,859  
  270,800    
Tata Motors Ltd Sponsored ADR
    4,657,760  
  4,088,793    
Tata Power Co Ltd
    7,349,179  
  2,365,200    
Tata Steel Ltd
    17,725,608  
  710,993    
Torrent Pharmaceuticals Ltd
    7,584,071  
  2,827,962    
Welspun Corp Ltd
    3,849,303  
  428,574    
Whirlpool of India Ltd *
    1,555,665  
       
 
     
       
Total India
    533,882,326  
       
 
     
       
 
       
       
Indonesia — 6.3%
       
  15,102,500    
ACE Hardware Indonesia Tbk PT
    6,402,751  
  25,416,000    
AKR Corporindo Tbk PT
    8,184,642  
  27,013,500    
Astra International Tbk PT
    216,978,473  
  178,985,775    
Bakrie Telecom Tbk PT *
    5,610,651  
  15,598,500    
Bank Central Asia Tbk PT
    13,904,943  
  36,788,668    
Bank Danamon Indonesia Tbk PT
    18,193,886  
  90,617,202    
Bank Mandiri Tbk PT
    66,001,886  
  21,896,500    
Bank Negara Indonesia (Persero) Tbk PT
    9,423,653  
  75,642,500    
Bank Rakyat Tbk PT
    56,017,452  
  60,980,000    
Gajah Tunggal Tbk PT
    19,438,006  
  72,212,500    
Global Mediacom Tbk PT
    7,917,792  
  7,236,000    
Harum Energy Tbk PT
    5,521,399  
  24,703,550    
Indofood Sukses Makmur Tbk PT
    13,195,995  
  1,564,500    
Indomobil Sukses Internasional Tbk PT *
    2,298,063  
  55,192,000    
Kalbe Farma Tbk PT
    21,839,136  
  10,530,000    
Matahari Putra Prima Tbk PT
    1,107,071  
  61,017,000    
Media Nusantara Citra Tbk PT
    7,695,614  
  61,051,500    
Perusahaan Gas Negara PT
    21,205,064  
  7,111,000    
Straits Asia Resources Ltd
    10,939,216  
  6,572,500    
Tambang Batubara Bukit Asam Tbk PT
    12,654,282  
  64,257,000    
Telekomunikasi Indonesia Tbk PT
    52,657,963  
  470,300    
Telekomunikasi Indonesia Tbk PT Sponsored ADR
    15,402,325  
  22,602,112    
United Tractors Tbk PT
    59,611,005  
       
 
     
       
Total Indonesia
    652,201,268  
       
 
     
       
 
       
       
Kazakhstan — 0.2%
       
  972,711    
KazMunaiGas Exploration Production GDR
    15,669,332  
       
 
     

 


 

                 
       
Macau — 0.1%
       
  3,330,000    
Wynn Macau Ltd *
    9,760,544  
       
 
     
       
 
       
       
Malaysia — 0.5%
       
  8,327,930    
AMMB Holdings Berhad
    15,840,181  
  1,952,000    
Genting Berhad
    6,879,413  
  3,349,913    
Hong Leong Bank Berhad
    11,132,693  
  11,727,819    
Lion Industries Corp Berhad
    5,046,962  
  2,037,027    
Shangri-La Hotels Berhad
    1,344,449  
  3,844,400    
UMW Holdings Berhad
    8,173,976  
       
 
     
       
Total Malaysia
    48,417,674  
       
 
     
       
 
       
       
Mexico — 1.5%
       
  43,381,400    
America Movil SAB de CV Class L
    51,634,866  
  3,122,600    
America Movil SAB de CV Class L ADR
    74,380,332  
  234,000    
First Cash Financial Services Inc *
    8,494,200  
  1,801,000    
Grupo Financiero Banorte SAB de CV Class O
    6,095,458  
  262,400    
Grupo Televisa SA Sponsored ADR
    5,447,424  
  2,900,800    
Grupo Televisa SA-Series CPO
    12,083,343  
       
 
     
       
Total Mexico
    158,135,623  
       
 
     
       
 
       
       
Morocco — 0.1%
       
  749,424    
Maroc Telecom
    12,718,173  
       
 
     
       
 
       
       
Nigeria — 0.1%
       
  1,732,376    
Nestle Nigeria Plc
    4,117,336  
       
 
     
       
 
       
       
Philippines — 1.2%
       
  4,235,830    
BDO Unibank Inc
    5,443,517  
  98,766,400    
Lopez Holding Corp
    10,502,926  
  7,179,552    
Metropolitan Bank & Trust Co
    11,102,535  
  848,220    
Philippine Long Distance Telephone Co
    47,127,570  
  443,300    
Philippine Long Distance Telephone Co Sponsored ADR
    24,470,160  
  51,350,600    
Puregold Price Club Inc *
    18,011,558  
  10,608,100    
Universal Robina Corp
    12,267,457  
       
 
     
       
Total Philippines
    128,925,723  
       
 
     
       
 
       
       
Poland — 1.5%
       
  524,825    
Asseco Poland SA
    7,790,941  
  1,065,854    
Grupa Lotos SA *
    8,022,305  
  2,246,638    
KGHM Polska Miedz SA
    89,285,344  
  2,783,621    
PGE SA
    17,825,214  
  794,260    
Polski Koncern Naftowy Orlen SA *
    9,570,895  
  5,316,338    
Synthos SA
    6,789,119  
  9,716,593    
Tauron Polska Energia SA
    15,772,772  
  712,388    
Telekomunikacja Polska SA
    3,936,840  
       
 
     
       
Total Poland
    158,993,430  
       
 
     
       
 
       
       
Russia — 11.5%
       
  138,966    
Bashneft OAO Class S
    6,611,925  
  2,694,062    
Gazprom Neft Class S
    12,588,624  
  394,348    
Gazprom Neft JSC Sponsored ADR
    9,034,193  
  30,676,111    
Gazprom OAO Sponsored ADR
    354,718,179  
  4,383,257    
Lukoil OAO ADR
    246,811,852  
  1,407,798    
Magnit OJSC Sponsored GDR
    31,305,870  
  892,861    
Magnitogorsk Iron & Steel Works Sponsored GDR (Registered Shares)
    5,590,414  
  9,196    
Mail.ru Group Ltd GDR *, 144A
    283,237  
  700,752    
Mail.ru Group Ltd GDR (Registered Shares) *
    21,692,763  

 


 

                 
  1,136,270    
Mechel Sponsored ADR
    12,373,980  
  1,406,980    
MMC Norilsk Nickel JSC ADR
    24,843,357  
  1,625,260    
Mobile Telesystems Sponsored ADR
    28,084,493  
  353,986    
NovaTek OAO Sponsored GDR (Registered Shares)
    54,233,097  
  2,039,222    
OAO Tatneft Sponsored GDR (Registered Shares)
    66,036,206  
  18,610,649    
Rosneft OJSC GDR (Registered Shares)
    136,202,947  
  2,745,787    
Rostelecom *
    14,453,817  
  135,000    
RUSIA Petroleum Class S * (a)
    1,350  
  2,782,198    
Sberbank Sponsored ADR * (a)
    33,847,152  
  523,492    
Sistema JSFC Sponsored GDR (Registered Shares)
    10,497,208  
  9,852,907    
Surgutneftegas Sponsored ADR
    94,707,255  
  643,121    
Tatneft
    3,466,211  
  508,707    
TNK-BP Holding Class S
    1,401,451  
  586,554    
Uralkali Sponsored GDR (Registered Shares)
    23,831,024  
  107,800    
Yandex NV *
    2,369,444  
       
 
     
       
Total Russia
    1,194,986,049  
       
 
     
       
 
       
       
South Africa — 3.3%
       
  1,463,950    
Absa Group Ltd
    25,978,483  
  198,735    
AngloGold Ashanti Ltd
    9,415,342  
  2,825,762    
Blue Label Telecoms Ltd
    2,030,684  
  885,888    
Exxaro Resources Ltd
    19,771,337  
  13,014,594    
FirstRand Ltd
    32,338,601  
  8,694    
Gold Fields Ltd
    146,499  
  256,800    
Gold Fields Ltd Sponsored ADR
    4,350,192  
  3,559,591    
Growthpoint Properties Ltd
    8,081,792  
  502,263    
Impala Platinum Holdings Ltd
    10,681,735  
  1,241,476    
Investec Ltd
    7,288,163  
  267,284    
Kumba Iron Ore Ltd
    16,836,807  
  1,351,057    
MTN Group Ltd
    24,338,186  
  614,756    
Nedbank Group Ltd
    10,907,228  
  1,016,289    
Remgro Ltd
    15,334,843  
  2,788,254    
Sanlam Ltd
    10,337,879  
  724,545    
Sasol Ltd
    34,759,116  
  65,900    
Sasol Ltd Sponsored ADR
    3,157,269  
  1,047,345    
Shoprite Holdings Ltd
    17,678,958  
  645,516    
Standard Bank Group Ltd
    7,872,527  
  1,530,084    
Steinhoff International Holdings Ltd *
    4,482,375  
  5,345,735    
Telkom South Africa Ltd
    19,157,137  
  371,704    
Tiger Brands Ltd
    11,258,295  
  2,122,279    
Vodacom Group Ltd
    23,998,570  
  992,236    
Wilson Bayly Holmes-Ovcon Ltd
    12,909,002  
  2,290,709    
Woolworths Holdings Ltd
    11,453,596  
       
 
     
       
Total South Africa
    344,564,616  
       
 
     
       
 
       
       
South Korea — 12.6%
       
  329,245    
BS Financial Group Inc *
    3,428,430  
  471,263    
Celltrion Inc
    15,628,386  
  310,470    
Cheil Worldwide Inc
    5,424,822  
  33,596    
CJ CheilJedang Corp
    8,612,468  
  63,917    
Daum Communications Corp
    8,397,222  
  1,019,672    
DGB Financial Group Inc *
    12,010,183  
  46,398    
Dong-A Pharmaceutical Co Ltd
    3,913,188  
  295,563    
Dongbu Insurance Co Ltd
    13,621,258  
  312,250    
Dongkuk Steel Mill Co Ltd
    6,378,722  
  23,676    
E-Mart Co Ltd *
    6,143,154  
  289,126    
Edu Ark Co Ltd * (a)
     
  427,229    
Finetex EnE Inc *
    681,319  
  676,820    
Foosung Co Ltd *
    5,036,700  

 


 

                 
  71,169    
GS Home Shopping Inc
    6,809,660  
  1,033,609    
Hana Financial Group Inc
    37,392,649  
  697,615    
Hanwha Corp
    22,826,723  
  373,710    
Hynix Semiconductor Inc
    7,870,125  
  211,806    
Hyosung Corp
    11,924,238  
  131,426    
Hyundai Heavy Industries Co Ltd
    32,789,804  
  380,364    
Hyundai Hysco
    14,385,285  
  445,880    
Hyundai Marine & Fire Insurance Co Ltd
    13,378,617  
  110,782    
Hyundai Mobis
    30,721,083  
  205,320    
Hyundai Motor Co
    39,938,046  
  209,965    
Hyundai Steel Co
    18,639,043  
  3,457,522    
In the F Co Ltd * (c)
    1,887,120  
  2,325,464    
Industrial Bank of Korea
    30,914,805  
  677,465    
Kangwon Land Inc
    16,698,563  
  17,733    
KCC Corp
    3,725,003  
  136,124    
Kia Motors Corp
    8,659,798  
  1,112,955    
KleanNara Co Ltd *
    3,653,603  
  241,320    
Kolon Corp
    4,568,681  
  171,210    
Kolon Industries Inc
    9,247,764  
  4,396,328    
Korea Exchange Bank
    32,128,570  
  246,831    
Korea Investment Holdings Co Ltd
    8,294,212  
  24,737    
Korea Zinc Co Ltd
    7,624,803  
  911,126    
KT Corp
    29,179,181  
  944,900    
KT Corp Sponsored ADR
    15,165,645  
  941,985    
KT&G Corp
    63,750,461  
  186,513    
LG International Corp
    8,536,995  
  3,389,382    
LG Uplus Corp
    20,263,719  
  18,710    
Lotte Shopping Co Ltd
    5,898,816  
  62,307    
NCSoft Corp
    16,954,291  
  61,322    
NHN Corp *
    13,604,539  
  11,557    
ORION Corp
    6,245,369  
  300,539    
POSCO
    101,289,697  
  74,900    
POSCO ADR
    6,415,185  
  489,930    
Pumyang Construction Co Ltd *
    367,649  
  1,870,110    
RNL BIO Co Ltd *
    10,859,388  
  295,999    
Samsung Electronics Co Ltd
    269,394,526  
  154,007    
Samsung Fire & Marine Insurance Co Ltd
    30,381,595  
  87,031    
Samsung Life Insurance Co Ltd
    6,482,333  
  88,113    
Seah Besteel Corp
    4,511,893  
  1,223,587    
Shinhan Financial Group Co Ltd
    45,619,028  
  36,935    
Shinsegae Co Ltd
    7,945,159  
  643,724    
Simm Tech Co Ltd
    7,047,047  
  197,794    
SK C&C Co Ltd
    24,308,378  
  156,024    
SK Chemicals Co Ltd
    9,254,038  
  444,682    
SK Telecom Co Ltd
    59,586,527  
  2,289,700    
SK Telecom Co Ltd ADR
    33,864,663  
  60,415    
SK Holdings Co Ltd
    7,869,443  
  162,250    
SM Entertainment Co *
    6,483,430  
  1,691,940    
Tong Yang Securities Inc
    6,387,265  
  3,849,940    
Woori Finance Holdings Co Ltd
    34,492,606  
  499,262    
Youngone Corp
    12,975,350  
       
 
     
       
Total South Korea
    1,318,488,263  
       
 
     
       
 
       
       
Sri Lanka — 0.1%
       
  20,990,000    
Anilana Hotel & Properties (a)(d)
    1,842,925  
  5,731,554    
Hatton National Bank Plc
    7,743,956  
  268,616    
Hatton National Bank Plc (Non Voting)
    200,469  
       
 
     
       
Total Sri Lanka
    9,787,350  
       
 
     

 


 

                 
       
Taiwan — 6.2%
       
  3,989,600    
Advantech Co Ltd
    11,143,747  
  5,315,070    
Asustek Computer Inc
    37,137,016  
  5,189,229    
Catcher Technology Co Ltd
    25,357,234  
  30,681,329    
Chunghwa Telecom Co Ltd
    101,705,063  
  228,500    
Chunghwa Telecom Co Ltd ADR
    7,638,755  
  57,471,311    
Compal Electronics Inc
    52,423,565  
  6,540,000    
E Ink Holdings Inc
    12,126,383  
  16,972,994    
Far Eastone Telecommunications Co Ltd
    32,335,496  
  5,455,732    
Gintech Energy Corp
    5,182,896  
  829,000    
Global Unichip Corp
    2,706,926  
  330,000    
Grand Pacific Petrochemical Corp
    138,091  
  7,801,312    
Hon Hai Precision Industry Co Ltd
    21,215,495  
  257,188    
HTC Corp
    4,234,194  
  13,284,349    
Lite-On Technology Corp
    14,558,147  
  37,422,000    
Macronix International Co Ltd
    15,507,872  
  2,355,000    
MediaTek Inc
    22,474,320  
  9,928,000    
Neo Solar Power Corp
    6,011,230  
  3,605,658    
Novatek Microelectronics Corp Ltd
    9,081,429  
  7,700,749    
Powertech Technology Inc
    17,552,231  
  27,746,290    
Quanta Computer Inc
    55,845,908  
  3,130,660    
Radiant Opto-Electronics Corp
    9,513,257  
  1,385,000    
Senao International Co Ltd
    4,550,285  
  16,058,923    
Taishin Financial Holding Co Ltd
    5,987,459  
  7,575,676    
Taiwan Mobile Co Ltd
    24,378,498  
  28,446,044    
Taiwan Semiconductor Manufacturing Co Ltd
    71,314,518  
  28,700    
TPK Holding Co Ltd *
    393,123  
  60,140,000    
United Microelectronics Corp
    26,685,793  
  1,119,400    
United Microelectronics Corp Sponsored ADR
    2,563,426  
  28,283,212    
Wistron Corp
    35,612,354  
  9,221,570    
Yungtay Engineering Co Ltd
    13,992,412  
       
 
     
       
Total Taiwan
    649,367,123  
       
 
     
       
 
       
       
Thailand — 3.9%
       
  11,764,090    
Advanced Info Service Pcl (Foreign Registered) (a)
    53,677,940  
  7,865,105    
Airports of Thailand Pcl (Foreign Registered) (a)
    11,114,488  
  35,542,571    
Asian Property Development Pcl (Foreign Registered) (a)
    5,666,768  
  62,000    
Bangkok Bank Pcl (Foreign Registered) (a)
    321,996  
  2,202,890    
Bangkok Bank Pcl NVDR
    10,499,364  
  10,881,886    
Bangkok Dusit Medical Service Pcl (Foreign Registered) (a)
    26,555,604  
  352,700    
Banpu Pcl (Foreign Registered) (a)
    6,321,248  
  8,008,300    
BEC World Pcl (Foreign Registered) (a)
    10,245,232  
  10,022,600    
Charoen Pokphand Foods Pcl (Foreign Registered) (a)
    10,834,652  
  5,363,000    
CP ALL Pcl (Foreign Registered) (a)
    8,778,983  
  5,378,850    
Electricity Generating Pcl (Foreign Registered) (a)
    15,380,903  
  34,388,100    
Esso Thailand Pcl (Foreign Registered) (a)
    10,008,836  
  10,303,800    
Glow Energy Pcl (Foreign Registered) (a)
    17,391,773  
  81,144,700    
Hemaraj Land and Development Pcl (Foreign Registered) (a)
    5,948,242  
  36,543,071    
Home Product Center Pcl (Foreign Registered) (a)
    12,178,394  
  3,766,120    
Kasikornbank Pcl (Foreign Registered) (a)
    14,654,980  
  2,305,200    
Kasikornbank Pcl NVDR
    8,894,132  
  10,423,000    
Land & Houses Pcl NVDR
    2,046,897  
  6,101,570    
PTT Pcl (Foreign Registered) (a)
    61,420,920  
  13,489,950    
Robinson Department Store Pcl (Foreign Registered) (a)
    16,048,959  
  12,577,500    
Saha Pathana Inter-Holding Pcl (Foreign Registered) (a)
    9,342,832  
  2,400,828    
Siam Cement Pcl (Foreign Registered) (a)
    28,101,251  
  3,288,480    
Siam Commercial Bank Pcl (Foreign Registered) (a)
    11,752,498  
  507,800    
Siam Makro Pcl (Foreign Registered) (a)
    3,765,118  
  3,108,050    
Star Block Co Ltd (Foreign Registered) * (a)(b)(c)
     

 


 

                 
  34,575,402    
Thai Tap Water Supply Pcl (Foreign Registered) (a)
    5,892,553  
  7,508,900    
Thanachart Capital Pcl (Foreign Registered) (a)
    6,175,241  
  4,113,400    
Tisco Financial Group Pcl (Foreign Registered) (a)
    5,230,797  
  2,322,900    
Total Access Communication Pcl (Foreign Registered) (a)
    6,028,104  
  2,991,710    
Total Access Communication Pcl NVDR
    7,836,960  
  35,383,800    
TPI Polene Pcl (Foreign Registered) (a)
    17,739,179  
       
 
     
       
Total Thailand
    409,854,844  
       
 
     
       
 
       
       
Turkey — 2.9%
       
  1,467,164    
Akbank TAS
    5,191,938  
  4,002,484    
Akenerji Elektrik Uretim AS *
    4,596,478  
  1,818,232    
Aksa Akrilik Kimya Sanayii
    4,375,394  
  2,511,551    
Aygaz AS
    12,453,280  
  7,680,438    
Dogus Otomotiv Servis ve Ticaret AS *
    13,818,367  
  5,875,122    
Eregli Demir ve Celik Fabrikalari TAS
    10,992,185  
  1,447,052    
Ford Otomotiv Sanayi AS
    11,607,945  
  3,323,616    
Haci Omer Sabanci Holding AS
    10,489,187  
  1,881,526    
Ipek Dogal Enerji Kaynaklari Ve Uretim AS *
    2,632,638  
  4,027,195    
Izmir Demir Celik Sanayii AS *
    7,907,304  
  12,498,000    
Kardemir Karabuk Demir Celik Sanayi ve Ticaret AS Class D *
    5,355,636  
  5,166,367    
Koc Holding AS
    17,889,913  
  4,205,336    
Koza Anadolu Metal Madencilik Isletmeleri AS *
    7,062,966  
  42,150    
Medya Holding AS (a)(b)
     
  1,162,838    
Tupras-Turkiye Petrol Rafineriler AS
    26,621,919  
  6,040,518    
Turk Hava Yollari Anonim Ortakligi *
    7,952,278  
  8,878,382    
Turk Telekomunikasyon AS
    36,540,265  
  232,817    
Turk Traktor ve Ziraat Makineleri AS
    3,989,617  
  5,768,575    
Turkcell Iletisim Hizmet AS *
    28,838,197  
  80,300    
Turkcell Iletisim Hizmetleri AS ADR *
    1,011,780  
  9,656,274    
Turkiye Garanti Bankasi
    33,079,414  
  3,243,082    
Turkiye IS Bankasi Class C
    6,716,761  
  10,832,428    
Turkiye Sise ve Cam Fabrikalari AS
    18,322,592  
  4,731,241    
Turkiye Vakiflar Bankasi TAO Class D
    7,024,564  
  3,318,559    
Turkiye Halk Bankasi AS
    20,074,993  
       
 
     
       
Total Turkey
    304,545,611  
       
 
     
 
       
TOTAL COMMON STOCKS (COST $9,630,316,420)
    8,940,411,276  
       
 
     
       
 
       
       
PREFERRED STOCKS — 10.9%
       
       
 
       
       
Brazil — 8.3%
       
  1,839,100    
AES Tiete SA 11.00%
    25,069,160  
  4,593,571    
Banco Bradesco SA 0.62%
    75,266,131  
  1,930,900    
Banco do Estado do Rio Grande do Sul SA Class B 0.59%
    20,597,263  
  1,348,900    
Bradespar SA 0.03%
    24,727,533  
  1,884,600    
Brasil Telecom SA 2.70%
    11,255,388  
  1,739,300    
Centrais Eletricas Brasileiras SA Class B 6.98%
    22,641,149  
  585,180    
Cia Energetica de Minas Gerais 5.76%
    10,038,037  
  183,600    
Companhia Paranaense de Energia Class B 0.85%
    3,704,794  
  1,486,500    
Eletropaulo Metropolitana SA 10.99%
    26,921,157  
  912,900    
Gerdau SA 3.47%
    6,815,135  
  7,123,341    
Itausa-Investimentos Itau SA 0.51%
    41,557,911  
  1,134,400    
Klabin SA 2.65%
    4,529,194  
  2,721,500    
Metalurgica Gerdau SA 4.35%
    25,764,968  
  1,615,404    
Petroleo Brasileiro SA (Petrobras) 0.56%
    19,697,325  
  7,674,860    
Petroleo Brasileiro SA Sponsored ADR 0.60%
    192,408,740  
  1,004,700    
Randon Participacoes SA 1.08%
    5,505,890  
  3,085,000    
Tele Norte Leste Participacoes ADR 5.35%
    29,184,100  
  5,950,100    
Usinas Siderrurgicas de Minas Gerais SA Class A 3.15%
    34,088,001  

 


 

                     
  530,200    
Vale Fertilizantes SA 0.44%
    7,253,656  
  592,008    
Vale SA Class A 0.98%
    12,777,434  
  12,421,110    
Vale SA Sponsored ADR 2.10%
    271,649,676  
       
 
     
       
Total Brazil
    871,452,642  
       
 
     
       
 
       
       
Russia — 1.6%
       
  2,409,658    
Sberbank 1.80%
    5,318,392  
  132,951,696    
Surgutneftegaz Class S 7.78%
    72,732,289  
  12,100    
Surgutneftegaz Sponsored ADR 7.51%
    65,945  
  2,622,835    
TNK BP Holding 9.77%
    6,319,199  
  48,063    
Transneft 0.70%
    79,259,203  
       
 
     
       
Total Russia
    163,695,028  
       
 
     
       
 
       
       
South Korea — 1.0%
       
  272,070    
Hyundai Motor Co 2.29%
    16,961,339  
  162,679    
Samsung Electronics Co Ltd (Non Voting) 0.86%
    90,711,887  
       
 
     
       
Total South Korea
    107,673,226  
       
 
     
 
       
TOTAL PREFERRED STOCKS (COST $1,224,441,741)
    1,142,820,896  
       
 
     
       
 
       
       
INVESTMENT FUNDS — 1.1%
       
       
 
       
       
China — 0.1%
       
  199,464    
Martin Currie China A Share Fund Ltd Class B * (a)(d)
    7,248,933  
  25,045    
Martin Currie China A Share Fund Ltd Class S * (a)(d)
    1,589,993  
  245,374    
Martin Currie China A Share Fund Ltd Class S * (a)(d)
    2,208,732  
       
 
     
       
Total China
    11,047,658  
       
 
     
       
 
       
       
India — 0.1%
       
  11,806    
Fire Capital Mauritius Private Fund * (a)(d)
    11,162,634  
  1,371,900    
TDA India Technology Fund II LP * (a)(d)
    905,255  
       
 
     
       
Total India
    12,067,889  
       
 
     
       
 
       
       
Poland — 0.0%
       
  1,749,150    
Templeton EE FD * (a)(d)
    235,581  
       
 
     
       
 
       
       
Russia — 0.1%
       
  9,500,000    
NCH Eagle Fund LP * (a)(d)
    8,880,315  
  2,769    
Steep Rock Russia Fund LP * (a)(d)
    735,170  
       
 
     
       
Total Russia
    9,615,485  
       
 
     
       
 
       
       
Ukraine — 0.0%
       
  16,667    
Societe Generale Thalmann Ukraine Fund * (a)(e)
    4,000  
       
 
     
       
 
       
       
United States — 0.8%
       
  2,005,771    
Vanguard Emerging Markets ETF (f)
    81,835,457  
       
 
     
 
       
TOTAL INVESTMENT FUNDS (COST $110,003,265)
    114,806,070  
       
 
     
       
 
       
       
DEBT OBLIGATIONS — 0.3%
       
       
 
       
       
Poland — 0.2%
       
PLN 100,677,888    
TRI Media Secured Term Note, 5.93% , due 02/07/13(a)(d)
    25,417,698  
       
 
     
       
 
       
       
United States — 0.1%
       
  7,994,487    
U.S. Treasury Inflation Indexed Note, 2.00% , due 04/15/12(g)
    8,021,972  
       
 
     
 
       
TOTAL DEBT OBLIGATIONS (COST $37,592,749)
    33,439,670  
       
 
     

 


 

                 
       
MUTUAL FUNDS — 1.6%
       
       
 
       
       
United States — 1.6%
       
       
 
       
       
Affiliated Issuers
       
  8,064    
GMO Special Purpose Holding Fund (h)
    3,145  
  6,473,460    
GMO U.S. Treasury Fund
    161,901,238  
       
 
     
 
       
TOTAL MUTUAL FUNDS (COST $161,901,238)
    161,904,383  
       
 
     
                     
Par Value     Description   Value ($)  
 
 
          SHORT-TERM INVESTMENTS — 0.5%        
 
                   
 
          Time Deposits — 0.5%        
USD
    31,779     Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11     31,779  
USD
    1,700,000     Bank of Montreal Time Deposit, 0.03%, due 12/01/11     1,700,000  
USD
    12,500,000     Barclays Plc Time Deposit, 0.12%, due 12/01/11     12,500,000  
EUR
    17     Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.10%, due 12/01/11     23  
GBP
    225     Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.10%, due 12/01/11     353  
ZAR
    719,200     Brown Brothers Harriman (Grand Cayman) Time Deposit, 4.85%, due 12/01/11     88,640  
HKD
    429,468     Citibank (New York) Time Deposit, 0.01%, due 12/01/11     55,281  
USD
    12,500,000     Deutsche Bank Time Deposit, 0.06%, due 12/01/11     12,500,000  
USD
    12,500,000     HSBC Bank USA (Grand Cayman) Time Deposit, 0.05%, due 12/01/11     12,500,000  
USD
    12,500,000     Royal Bank of Canada (Grand Cayman) Time Deposit, 0.03%, due 12/01/11     12,500,000  
 
                 
 
          Total Time Deposits     51,876,076  
 
                 
 
 
          TOTAL SHORT-TERM INVESTMENTS (COST $51,876,076)     51,876,076  
 
                 
 
 
          TOTAL INVESTMENTS — 100.1%        
 
             (Cost $11,216,131,489)     10,445,258,371  
 
 
          Other Assets and Liabilities (net) — (0.1%)     (9,939,029 )
 
                 
 
 
          TOTAL NET ASSETS — 100.0%   $ 10,435,319,342  
 
                 

 


 

A summary of outstanding financial instruments at November 30, 2011 is as follows:
Swap Agreements
Total Return Swaps
                         
                    Net Unrealized
Notional   Expiration               Appreciation/
Amount   Date   Counterparty   Fund Pays   Fund (Pays)/Receives   (Depreciation)
15,025,840 USD
  12/27/2011   Morgan Stanley Capital Services Inc.   Daily Fed Funds Rate minus 8.00%   Total Return on TPK Holding Co Ltd   $ (2,986,216 )
2,972,590 USD
  1/19/2012   Morgan Stanley Capital Services Inc.   Monthly Fed Funds Rate minus 15.00%   Total Return on Suntech Power Holdings Co Ltd     338,996  
9,859,800 USD
  1/30/2012   Goldman Sachs International   Daily Fed Funds Rate minus 16.25%   Total Return on JBS SA     172,943  
18,598,751 USD
  2/9/2012   Morgan Stanley Capital Services Inc.   Daily Fed Funds Rate minus 2.50%   Total Return on Asustek Computer Inc.     (21,389 )
 
                     
 
                  $ (2,495,666 )
 
              Premiums to (Pay) Receive   $  
 
                     
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
Notes to Schedule of Investments:
144A — Securities exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional investors.
ADR — American Depositary Receipt
CPO — Ordinary Participation Certificate (Certificado de Participacion Ordinares), representing a bundle of shares of the multiple series of one issuer that trade together as a unit.
ETF — Exchange-Traded Fund
Foreign Registered — Shares issued to foreign investors in markets that have foreign ownership limits.
GDR — Global Depository Receipt
NVDR — Non-Voting Depository Receipt
* Non-income producing security.
(a)   Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust.
 
(b)   Bankrupt issuer.

 


 

(c)   Affiliated company.
 
(d)   Private placement securities are restricted as to resale.
 
(e)   The security is currently in full liquidation.
 
(f)   Represents an investment to obtain exposure to equitize cash. The Vanguard Emerging Markets ETF is a separate investment portfolio of Vanguard, Inc., a registered investment company. The Vanguard Emerging Markets ETF prospectus states that the fund invests substantially all (normally about 95%) of its assets in the common stocks included in the MSCI Emerging Market Index, while employing a form of sampling to reduce risk.
 
(g)   Indexed security in which price and/or coupon is linked to the prices of a specific instrument or financial statistic.
 
(h)   Underlying investment represents interests in defaulted claims. See “Other matters” for additional information.
Currency Abbreviations:
EUR — Euro
GPB — British Pound
HKD — Hong Kong Dollar
PLN — Polish Zloty
USD — United States Dollar
ZAR — South African Rand
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                         
    Gross     Gross     Net Unrealized  
    Unrealized     Unrealized     Appreciation  
Aggregate Cost   Appreciation     (Depreciation)     (Depreciation)  
$11,418,700,634
  $ 555,903,331     $ (1,529,345,594 )   $ (973,442,263 )

 


 

Additional information on each restricted security is as follows:
                                 
                    Value as a        
                    Percentage     Value as of  
    Acquisition     Acquisition     of Fund’s     November 30,  
Issuer Description   Date     Cost     Net Assets     2011  
Anilana Hotel & Properties
    2/10/11     $ 1,890,310       0.02 %   $ 1,842,925  
Fire Capital Mauritius Private Fund **
    9/06/06-10/26/09       12,180,554       0.11 %     11,162,634  
Martin Currie China A Share Fund Ltd Class B
    1/20/06       2,159,084       0.07 %     7,248,933  
Martin Currie China A Share Fund Ltd Class S
    10/14/08             0.02 %     1,589,993  
Martin Currie China A Share Fund Ltd Class S
    4/23/10       2,453,738       0.02 %     2,208,732  
NCH Eagle Fund LP
    1/08/03       9,500,000       0.09 %     8,880,315  
Societe Generale Thalmann Ukraine Fund
    7/15/97       199,943       0.00 %     4,000  
Steep Rock Russia Fund LP
    12/22/06-5/13/09       2,250,000       0.01 %     735,170  
TDA India Technology Fund II LP
    2/23/00-3/23/04       787,800       0.01 %     905,255  
TRI Media Secured Term Note
    8/7/09       29,505,475       0.24 %     25,417,698  
Templeton EE FD
    12/05/97-6/24/02       471,720       0.00 %     235,581  
 
                             
 
                          $ 60,231,236  
 
                             
 
** GMO Emerging Markets Fund has committed an additional $7,724,246 to this investment.
                   
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO Special Purpose Holding Fund
  $ 4,032     $     $     $     $     $ 3,145  
GMO U.S. Treasury Fund
    110,007,196       976,581,843       924,714,708       34,549       4,587       161,901,238  
 
                                   
Totals
  $ 110,011,228     $ 976,581,843     $ 924,714,708     $ 34,549     $ 4,587     $ 161,904,383  
 
                                   

 


 

Investments in Other Affiliated Issuers
An affiliated company is a company in which the Fund has or had owndership of at least 5% of the voting securities. A summary of the Fund’s transactions with companies that are or were affiliates during the period ended November 30, 2011 is set forth below:
                                         
Affiliate   Value,
beginning of
period
    Purchases     Sales
Proceeds
    Dividend
Income
    Value, end
of period
 
In the F Co Ltd
  $ 2,759,050     $     $ 21,203     $     $ 1,887,120  
Kiri Industries Ltd
    7,389,591       833,078       486,923       1,834,005       1,895,901  
Medquist Holdings, Inc*
    24,003,561             26,805,264              
Pumyang Constduction Co Ltd*
    2,075,101             267,571             367,649  
Star Block Co Ltd (Foreign Registered)
                             
 
                             
Total
  $ 36,227,303     $ 833,078     $ 27,580,961     $ 1,834,005     $ 4,150,670  
 
                             
 
*   No longer an affiliate as of November 30, 2011.

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 4.8% of net assets. The Fund classifies such securities (levels defined below) as Level 3. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivatives contracts based on the creditworthiness of its counterparties. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below.
     
Security Type   Percentage of Net Assets of the Fund
Equity Securities
  65.2%
Swap Agreements
  (0.0)^
 
^   Rounds to 0.0%.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.

 


 

Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include: fair value adjustments provided by an independent pricing service applied to equity securities (including the fair value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) due to market events that have occurred since the local market close but prior to the close of the NYSE.
Level 3 — Valuations based primarily on inputs that are unobservable and significant. The Fund utilized a number of fair value techniques on Level 3 investments, including the following: Certain of the Fund’s securities in Thailand and India were valued at the local price as adjusted by applying a premium or discount when the holdings exceed foreign ownership limitations. The Fund valued various third-party investment funds based on valuations provided by fund sponsors and adjusted the values for liquidity considerations as well as the timing of the receipt of information. The Fund valued certain equity securities based on the last traded exchange price adjusted for the movement in a securities index. The Fund valued certain debt securities by using an estimated specified spread above the Warsaw Interbank Offered Rate (WIBOR) and adjusted the values for liquidity considerations. The Fund values certain securities using a price from a comparable security related to the same issuer that trades on a different exchange.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Common Stocks
                               
Brazil
  $ 1,238,584,706     $     $     $ 1,238,584,706  
Chile
    19,093,132                   19,093,132  
China
    113,392,860       1,210,908,810       0  *     1,324,301,670  
Czech Republic
          154,295,845             154,295,845  
Egypt
          142,177,845             142,177,845  
Hong Kong
          3,287,784             3,287,784  
Hungary
          104,255,009             104,255,009  
India
    58,315,426       444,495,992       31,070,908       533,882,326  
Indonesia
    15,402,325       636,798,943             652,201,268  
Kazakhstan
          15,669,332             15,669,332  
Macau
          9,760,544             9,760,544  
Malaysia
          48,417,674             48,417,674  
Mexico
    158,135,623                   158,135,623  
Morocco
          12,718,173             12,718,173  
Nigeria
          4,117,336             4,117,336  
Philippines
    42,481,718       86,444,005             128,925,723  
Poland
          158,993,430             158,993,430  
Russia
    73,336,569       1,087,800,978       33,848,502       1,194,986,049  
South Africa
    16,922,803       327,641,813             344,564,616  
South Korea
    55,445,493       1,263,042,770       0  *     1,318,488,263  
Sri Lanka
    200,469       7,743,956       1,842,925       9,787,350  
Taiwan
    10,202,181       639,164,942             649,367,123  
Thailand
          29,277,353       380,577,491       409,854,844  
Turkey
    1,011,780       303,533,831       0  *     304,545,611  
 
                       
TOTAL COMMON STOCKS
    1,802,525,085       6,690,546,365       447,339,826       8,940,411,276  
 
                       
Preferred Stocks
                               
Brazil
    871,452,642                   871,452,642  
Russia
    78,116,626       85,578,402             163,695,028  
South Korea
          107,673,226             107,673,226  
 
                       
TOTAL PREFERRED STOCKS
    949,569,268       193,251,628             1,142,820,896  
 
                       
Investment Funds
                               
China
                11,047,658       11,047,658  
India
                12,067,889       12,067,889  
Poland
                235,581       235,581  
Russia
                9,615,485       9,615,485  
Ukraine
                4,000       4,000  
United States
    81,835,457                   81,835,457  
 
                       
TOTAL INVESTMENT FUNDS
    81,835,457             32,970,613       114,806,070  
 
                       
Debt Obligations
                               
Poland
                25,417,698       25,417,698  
United States
          8,021,972             8,021,972  
 
                       
TOTAL DEBT OBLIGATIONS
          8,021,972       25,417,698       33,439,670  
 
                       
Mutual Funds
                               
United States
    161,901,238       3,145             161,904,383  
 
                       
Total Mutual Funds
    161,901,238       3,145             161,904,383  
 
                       
Short-Term Investments
    51,876,076                   51,876,076  
 
                       
Total Investments
    3,047,707,124       6,891,823,110       505,728,137       10,445,258,371  
 
                       
Derivatives **
                               
Swap Agreements
                               
Equity risk
          511,939             511,939  
 
                       
Total Derivatives **
          511,939             511,939  
 
                       
Total
  $ 3,047,707,124     $ 6,892,335,049     $ 505,728,137     $ 10,445,770,310  
 
                       

 


 

LIABILITY VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Liabilities     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Derivatives**
                               
Swap Agreements
                               
Equity risk
  $     $ (3,007,605 )   $     $ (3,007,605 )
 
                       
Total Derivatives
          (3,007,605 )           (3,007,605 )
 
                       
Total
  $     $ (3,007,605 )   $     $ (3,007,605 )
 
                       

 


 

*    Represents the investment in securities that were determined to have a fair value of zero at November 30, 2011.
The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
**  Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as either Level 1 or Level 2. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net values of the Fund’s investments (both direct and indirect) in securities using Level 3 inputs were 4.9% of total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant unobservable inputs (Level 3) were used in determining value:
                                                                                   
                                                                              Net Change in  
                                                                              Unrealized  
                                                                              Appreciation  
                                                                              (Depreciation)  
                                            Change in                               from  
    Balances as of                     Accrued     Total     Unrealized     Transfers                     Investments  
    February 28,                     Discounts/     Realized     Appreciation     into Level     Transfers out     Balances as of       Still Held as of  
    2011     Purchase     Sales     Premiums     Gain/(Loss)     (Depreciation)     3 *     of Level 3 *     November 30, 2011       November 30, 2011  
Common Stocks
                                                                                 
Egypt
  $ 138,391,206     $ 49,010,099     $ (38,941,819 )   $     $ (10,480,910 )   $ (9,527,899 )   $     $ (128,450,677 )**   $       $  
India
    25,524,840       31,551,437       (19,866,520 )           (706,936 )     (5,431,913 )                 31,070,908         (4,137,405 )
Russia
    151,244,856       130,720,230       (191,848,241 )           22,573,351       (40,008,262 )           (38,833,432 )**     33,848,502         (3,073,986 )
Sri Lanka
    1,894,404                               (51,479 )                 1,842,925         (51,479 )
Thailand
    408,898,018       278,979,528       (342,303,776 )           67,568,580       (32,564,859 )                 380,577,491         41,080,885  
 
                                                             
 
    725,953,324       490,261,294       (592,960,356 )           78,954,085       (87,584,412 )           (167,284,109 )     447,339,826         33,818,015  
 
                                                             
Preferred Stocks
                                                                                 
Russia
    134,030,568       20,033,123       (11,320,881 )           769,278       8,479,405             (151,991,493 )**              
 
                                                             
Investment Funds
                                                                                 
China
    12,771,635                               (1,723,977 )                 11,047,658         (1,723,977 )
India
    11,624,316             (274,014 )           (75,154 )     792,741                   12,067,889         1,241,632  
Poland
    252,509                               (16,928 )                 235,581         (16,928 )
Russia
    10,315,309                               (699,824 )                 9,615,485         (699,824 )
Ukraine
    4,000                                                 4,000          
 
                                                             
 
    34,967,769             (274,014 )           (75,154 )     (1,647,988 )                 32,970,613         (1,199,097 )
 
                                                             
Debt Obligations
                                                                                 
Poland
    27,902,437                               (2,484,739 )                 25,417,698         (2,484,739 )
 
                                                                               
 
                                                             
 
  $ 922,854,098     $ 510,294,417     $ (604,555,251 )   $     $ 79,648,209     $ (83,237,734 )   $     $ (319,275,602 )   $ 505,728,137       $ 30,134,179  
 
                                                             
 
*   The Fund accounts for investments and derivatives transferred into Level 3 at the value at the beginning of the period and transferred out of Level 3 at the value at the end of the period.
 
**   Financial assets transferred between Level 2 and Level 3 were due to a change in observable and/or unobservable inputs.

 


 

Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Other matters
GMO Special Purpose Holding Fund (“SPHF”), an investment of the Fund, has litigation pending against various entities related to the 2002 fraud and related default of securities previously held by SPHF. The outcome of the lawsuits against the remaining defendants is not known and any potential recoveries are not reflected in the net asset value of SPHF. For the period ended November 30, 2011, the Fund received no distributions from SPHF in connection with the defaulted securities or the related litigation.
In addition, Indian regulators alleged in 2002 that the Fund violated some conditions under which it was granted permission to operate in India and have restricted the Fund’s locally held assets pending resolution of the dispute. Although these locally held assets remain the property of the Fund, a portion of the assets are not permitted to be withdrawn from the Fund’s local custodial account located in India. The amount of restricted assets is small relative to the size of the Fund, representing approximately 0.6% of the Fund’s total net assets as of November 30, 2011. The effect of this claim on the value of the restricted assets, and all matters relating to the Fund’s response to these allegations are subject to the supervision and control of the Trust’s Board of Trustees. The Fund’s costs in respect of this matter are being borne by the Fund.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If the Fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of value of those investments. Because the Fund normally does not take temporary defensive positions, declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging markets, the economies of which tend to be more volatile than the economies of developed markets.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies.
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund

 


 

holds, the more likely it is to honor a redemption request in-kind. In addition, the Fund may buy securities that are less liquid than those in its benchmark.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations. The Fund may buy securities that have smaller market capitalizations than those in its benchmark.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Focused Investment Risk — Focusing investments in a limited number of countries and geographic regions creates additional risk.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in underlying funds, including the risk that the underlying funds (including ETFs) in which it invests will not perform as expected.
Leveraging Risk — The Fund’s use of reverse repurchase agreements and other derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. For example, the Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives, to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives. The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For example, if the Fund

 


 

holds a large proportion of stocks of companies in a particular sector and the Manager believes that stocks of companies in another sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index). In adjusting its investment exposure, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net long exposures in excess of its net assets. The Fund’s foreign currency exposure may differ significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by

 


 

making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most forward currency contracts are not collateralized. The Fund had no forward currency contracts outstanding at the end of the period.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded (unless otherwise adjusted due to the time at which foreign markets close). The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.

 


 

Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers (unless otherwise adjusted due to the time at which foreign markets close) and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market

 


 

disruptions. During the period ended November 30, 2011, the Fund used total return swap agreements as a substitute for direct investment in securities and/or to achieve returns comparable to holding and lending a direct equity position. Swap agreements outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. During the period ended November 30, 2011, the Fund held rights and/or warrants as a result of corporate actions. The Fund held no rights or warrants at the end of the period.
The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Assets:
                                               
Unrealized appreciation on swap agreements
  $     $     $     $ 511,939     $     $ 511,939  
 
                                   
Total
  $     $     $     $ 511,939     $     $ 511,939  
 
                                   
Liabilities:
                                               
Unrealized depreciation on swap agreements
  $     $     $     $ (3,007,605 )   $     $ (3,007,605 )
 
                                   
Total
  $     $     $     $ (3,007,605 )   $     $ (3,007,605 )
 
                                   
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (rights and/or warrants), or notional amounts (swap agreements) outstanding at each month-end, was as follows for the period ended November 30, 2011:
                   
    Rights and/or   Swap
    Warrants   Agreements
Average amount outstanding
  $ 179,656     $ 38,550,960  

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Flexible Equities Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares     Description   Value ($)  
 
       
COMMON STOCKS — 93.4%
       
       
 
       
       
Japan — 93.4%
       
  66,700    
ABC-Mart Inc
    2,479,916  
  1,400    
Accordia Golf Co Ltd
    1,086,842  
  4,482    
Advance Residence Investment Corp (REIT)
    8,362,329  
  567,000    
Aeon Co Ltd
    7,747,798  
  197,000    
Aichi Machine Industry Co Ltd
    575,869  
  50,600    
Aisan Industry Co Ltd
    418,398  
  109,400    
Aisin Seiki Co Ltd
    3,305,700  
  59,800    
Alfresa Holdings Corp
    2,205,733  
  11,400    
Alpen Co Ltd
    194,572  
  557,700    
Alps Electric Co Ltd
    3,904,513  
  215,900    
AOC Holdings Inc
    1,304,997  
  11,700    
AOKI Holdings Inc
    174,610  
  41,000    
Aoyama Trading Co Ltd
    667,922  
  45,500    
Arc Land Sakamoto Co Ltd
    778,046  
  52,000    
Arcs Co Ltd
    989,380  
  93,000    
Arnest One Corp
    949,534  
  27,700    
Asatsu–DK Inc
    689,729  
  290,000    
Astellas Pharma Inc
    11,178,462  
  37,400    
Axell Corp
    784,108  
  119,000    
Bando Chemical Industries Ltd
    473,228  
  187,800    
Belluna Co Ltd
    1,411,391  
  326,500    
Best Denki Co Ltd *
    875,942  
  3,013    
BIC Camera Inc
    1,651,858  
  145,900    
Brother Industries Ltd
    1,972,902  
  615,000    
Calsonic Kansei Corp
    3,550,171  
  107,600    
Canon Inc
    4,827,174  
  84,600    
Cawachi Ltd
    1,650,852  
  184,000    
Central Glass Co Ltd
    900,652  
  334,420    
Century Tokyo Leasing Corp
    6,635,934  
  2,090,000    
Chiba Bank Ltd
    13,632,407  
  20,600    
Chiyoda Integre Co Ltd
    266,636  
  107,800    
Chubu Electric Power Co Inc
    2,052,202  
  142,000    
Chuetsu Pulp & Paper Co Ltd
    230,381  
  85,000    
Chugoku Marine Paints Ltd
    574,226  
  55,300    
Circle K Sunkus Co Ltd
    901,841  
  13,700    
Coca–Cola Central Japan Co Ltd
    178,287  
  83,900    
Cocokara fine Inc
    2,247,780  
  144,400    
COMSYS Holdings Corp
    1,474,473  
  2,521,000    
Cosmo Oil Co Ltd
    6,971,682  
  12,224    
Dai-ichi Life Insurance Co Ltd (The)
    13,636,580  
  775,750    
Daiei Inc *
    2,819,384  
  62,000    
Daifuku Co Ltd
    328,395  
  68,000    
Daihatsu Diesel Manufacturing Co Ltd
    325,936  
  117,000    
Daihatsu Motor Co Ltd
    2,049,909  
  81,000    
Daiichi Jitsugyo Co Ltd
    322,959  
  78,500    
Daiichikosho Co Ltd
    1,456,513  
  8,400    
Daikoku Denki Co Ltd
    74,593  
  74,000    
Dainichiseika Color & Chemicals Manufacturing Co Ltd
    331,528  
  190,000    
Daio Paper Corp
    1,337,320  
  414,100    
Daito Trust Construction Co Ltd
    36,933,200  
  93,000    
Daiwa Industries Ltd
    495,643  
  853,000    
Daiwabo Holdings Co Ltd
    2,003,542  
  602    
Daiwa Office Investment Corp (REIT)
    1,259,733  
  195,200    
DCM Holdings Co Ltd
    1,489,465  
  74,912    
Dena Co Ltd
    2,325,632  

 


 

                 
  1,284,000    
DIC Corp
    2,168,338  
  740    
Digital Garage Inc *
    2,417,364  
  21,800    
Doshisha Co Ltd
    575,004  
  14,900    
DTS Corp
    176,791  
  462,000    
Edion Corp
    3,618,192  
  104,200    
Electric Power Development Co Ltd
    2,629,363  
  148,100    
Elpida Memory Inc *
    737,990  
  18,500    
Fanuc Ltd
    3,039,522  
  10,300    
Fast Retailing Co Ltd
    1,671,449  
  233    
Fields Corp
    349,891  
  89,800    
Foster Electric Co Ltd
    1,338,625  
  1,192    
Fuji Media Holdings Inc
    1,638,293  
  347,000    
Fujikura Ltd
    1,071,832  
  2,000    
Fujitsu General Ltd
    11,041  
  624,000    
Fuji Electric Co Ltd
    1,845,743  
  190,000    
Fuji Heavy Industries Ltd
    1,098,159  
  32,300    
Fuji Soft Inc
    544,437  
  349,000    
Furukawa-Sky Aluminum Corp
    790,410  
  354,000    
Futaba Industrial Co Ltd
    2,170,410  
  85,700    
Fuyo General Lease Co Ltd
    2,941,474  
  972    
Geo Corp
    1,045,647  
  139    
Global One Real Estate Investment Co Ltd (REIT)
    882,392  
  207,000    
Godo Steel Ltd
    518,131  
  10,500    
Gulliver International Co Ltd
    444,655  
  190,000    
Gunze Ltd
    547,032  
  84,000    
H2O Retailing Corp
    630,582  
  20,200    
Hajime Construction Co Ltd
    449,218  
  19,900    
Hakuto Co Ltd
    180,780  
  214    
Hankyu Reit Inc (REIT)
    931,573  
  1,156,000    
Hanwa Co Ltd
    5,011,394  
  1,775,500    
Haseko Corp *
    1,150,461  
  18,100    
Heiwa Corp
    325,217  
  117,600    
Heiwado Co Ltd
    1,522,300  
  22,100    
Hikari Tsushin Inc
    561,886  
  470,000    
Hino Motors Ltd
    2,890,574  
  67,100    
Hisamitsu Pharmaceutical Co Inc
    2,677,128  
  80,300    
Hitachi Chemical Co Ltd
    1,550,239  
  48,300    
Hitachi Koki Co Ltd
    356,398  
  608,000    
Hitachi Ltd
    3,373,737  
  12,600    
Hogy Medical Co Ltd
    517,104  
  70,300    
Hokkaido Electric Power Co Inc
    948,317  
  226,000    
Hokuetsu Kishu Paper Co Ltd
    1,434,794  
  147,300    
Honda Motor Co Ltd
    4,674,472  
  86,200    
Hosiden Corp
    606,959  
  209,700    
Hoya Corp
    4,466,491  
  71,400    
Idemitsu Kosan Co Ltd
    7,635,404  
  1,257,000    
IHI Corporation
    2,952,160  
  26,400    
Inaba Denki Sangyo Co Ltd
    759,673  
  312,600    
Inabata & Co Ltd
    1,828,108  
  1,028    
INPEX Corp
    6,939,903  
  152,000    
Isetan Mitsukoshi Holdings Ltd
    1,487,905  
  188,500    
IT Holdings Corp
    2,127,103  
  160,800    
Itochu Enex Co Ltd
    907,830  
  41,300    
Itochu Techno-Solutions Corp
    1,784,022  
  5,500    
Itochu-Shokuhin Co Ltd
    189,760  
  2,069,400    
Itochu Corp
    21,030,051  
  20,100    
Itoki Corp
    44,142  
  48,600    
Ito En Ltd
    846,288  
  567,000    
Iwatani Corp
    2,000,767  
  206,675    
Izumiya Co Ltd
    1,032,583  

 


 

                 
  174,400    
Izumi Co Ltd
    2,612,418  
  7,900    
Japan Drilling Co Ltd
    258,007  
  1,485    
Japan Prime Realty Investment Corp (REIT)
    3,615,414  
  51,000    
Japan Pulp & Paper Co Ltd
    182,484  
  347    
Japan Excellent Inc (REIT)
    1,395,162  
  4,913    
Japan Retail Fund Investment Corp (REIT)
    7,513,543  
  770,000    
JFE Shoji Holdings Inc
    3,239,107  
  131,800    
JFE Holdings Inc
    2,426,045  
  166,489    
Joshin Denki Co Ltd
    1,864,266  
  22,600    
JSP Corp
    315,594  
  162,400    
JSR Corp
    3,166,347  
  343,800    
JVC Kenwood Holdings Inc *
    1,447,409  
  2,537,000    
JX Holdings Inc
    16,134,359  
  206,000    
J–Oil Mills Inc
    575,004  
  162,840    
K’s Holdings Corp
    6,418,625  
  32,700    
Kaga Electronics Co Ltd
    336,819  
  2,773,000    
Kajima Corp
    8,350,536  
  35,000    
Kaken Pharmaceutical Co Ltd
    424,363  
  89,000    
Kandenko Co Ltd
    380,235  
  199,000    
Kaneka Corp.
    1,070,624  
  2,432,000    
Kanematsu Corp *
    2,351,416  
  253,200    
Kansai Electric Power Co Inc (The)
    3,792,828  
  183,900    
Kanto Auto Works Ltd
    1,516,159  
  111,600    
Kao Corp
    2,953,440  
  90,000    
Kasumi Co Ltd
    577,669  
  80,900    
Kato Sangyo Co Ltd
    1,674,136  
  2,564,000    
Kawasaki Kisen Kaisha Ltd
    4,458,100  
  2,254    
KDDI Corp
    14,934,549  
  95,700    
Keiyo Co Ltd
    577,090  
  1,181    
Kenedix Realty Investment Corp (REIT)
    3,375,132  
  15,700    
Keyence Corp
    4,017,207  
  1,910,000    
Kobe Steel Ltd
    3,049,946  
  192,300    
Kohnan Shoji Co Ltd
    3,091,893  
  172,700    
Kojima Co Ltd
    1,152,245  
  140,000    
Krosaki Harima Corp
    472,178  
  670,000    
Kurabo Industries Ltd
    1,302,835  
  39,100    
Kuroda Electric Co Ltd
    419,010  
  426,000    
KYB Co Ltd
    2,040,977  
  136,000    
Kyodo Printing Co Ltd
    336,581  
  72,100    
Kyoei Steel Ltd
    1,450,446  
  66,000    
Kyoritsu Maintenance Co Ltd
    1,106,648  
  199,400    
Kyowa Exeo Corp
    1,937,366  
  119,000    
Kyudenko Corp
    718,197  
  110,800    
Lawson Inc
    6,561,874  
  384    
M3 Inc
    1,904,607  
  417,000    
Maeda Corp
    1,530,763  
  53,000    
Maeda Road Construction Co Ltd
    525,338  
  15,900    
Mars Engineering Corp
    269,606  
  2,822,000    
Marubeni Corp
    17,433,545  
  400,300    
Marudai Food Co Ltd
    1,401,342  
  152,074    
Maruetsu Inc (The)
    548,272  
  1,295,000    
Maruha Nichiro Holdings Inc
    2,284,073  
  38,000    
Maruzen Showa Unyu Co Ltd
    118,667  
  46,600    
Matsumotokiyoshi Holdings Co Ltd
    915,592  
  2,184,000    
Mazda Motor Corp *
    3,983,038  
  367,900    
Medipal Holdings Corp
    3,615,880  
  82,600    
Megane TOP Co Ltd
    1,004,764  
  1,327    
MID REIT Inc (REIT)
    3,259,985  
  85,900    
Mikuni Coca–Cola Bottling Co Ltd
    763,602  
  16,800    
Ministop Co Ltd
    313,030  

 


 

                 
  242,500    
Mirait Holdings Corp
    1,892,808  
  110,000    
Mitsuba Corp
    734,192  
  400,000    
Mitsubishi Materials Corp
    1,125,725  
  45,400    
Mitsubishi Shokuhin Co Ltd
    1,144,959  
  125,000    
Mitsubishi Steel Manufacturing Co Ltd
    338,519  
  1,816,000    
Mitsubishi Chemical Holdings Corp
    10,549,936  
  418,100    
Mitsubishi Corp
    8,643,560  
  243,000    
Mitsubishi Gas Chemical Co Inc
    1,447,097  
  1,267,392    
Mitsubishi Paper Mills Ltd *
    1,182,006  
  9,927,000    
Mitsubishi UFJ Financial Group Inc
    43,480,434  
  152,260    
Mitsubishi UFJ Lease & Finance Co Ltd
    5,829,141  
  2,324,000    
Mitsui Chemicals Inc
    7,556,414  
  1,455,000    
Mitsui Engineer & Shipbuilding Co Ltd
    2,234,303  
  343,000    
Mitsui Matsushima Co Ltd
    625,931  
  188,200    
Mitsui & Co Ltd
    2,969,398  
  73,000    
Mitsui Home Co Ltd
    364,907  
  770,000    
Mitsui Mining & Smelting Co Ltd
    1,995,193  
  1,776,000    
Mitsui OSK Lines Ltd
    5,645,654  
  32,592,600    
Mizuho Financial Group Inc
    42,905,863  
  517    
Mori Hills REIT Investment Corp (REIT)
    1,667,349  
  417,000    
Morinaga Milk Industry Co Ltd
    1,591,593  
  57,250    
Moshi Moshi Hotline Inc
    530,851  
  3,400    
Nafco Co Ltd
    57,681  
  400,000    
Nakayama Steel Works Ltd *
    332,138  
  134,300    
Namco Bandai Holdings Inc
    1,936,318  
  104,600    
Namura Shipbuilding Co Ltd
    405,805  
  24,000    
NEC Capital Solutions Ltd
    354,987  
  2,028,000    
NEC Corp *
    4,363,053  
  26,000    
NEC Mobiling Ltd
    858,205  
  22,800    
NEC Fielding Ltd
    280,783  
  25,100    
NEC Networks & System Integration Corp
    384,678  
  663    
Net One Systems Co Ltd
    1,710,331  
  65,000    
Nichias Corp
    354,459  
  26,600    
Nichiha Corp
    287,853  
  278,200    
Nichirei Corp
    1,297,356  
  89,300    
Nihon Unisys Ltd
    563,021  
  213,000    
Nihon Yamamura Glass Co Ltd
    508,687  
  47,100    
Nintendo Co Ltd
    7,170,380  
  221,000    
Nippon Carbide Industries Co Inc
    296,865  
  302,000    
Nippon Coke & Engineering Co Ltd
    404,931  
  210,000    
Nippon Corp
    1,827,935  
  238,000    
Nippon Formula Feed Manufacturing Co Ltd *
    329,926  
  288,000    
Nippon Road Co Ltd (The)
    744,132  
  18,000    
Nippon Seiki Co Ltd
    178,844  
  138,000    
Nippon Shokubai Co Ltd
    1,511,491  
  238,000    
Nippon Soda Co Ltd
    1,009,762  
  150,000    
Nippon Steel Trading Co Ltd
    365,059  
  90,000    
Nippon Densetsu Kogyo Co Ltd
    822,966  
  396,000    
Nippon Express Co Ltd
    1,500,770  
  42,000    
Nippon Flour Mills Co Ltd
    186,706  
  1,168,000    
Nippon Light Metal Co Ltd
    1,552,749  
  331,800    
Nippon Paper Group Inc
    7,112,224  
  558,000    
Nippon Sheet Glass Co Ltd
    1,073,155  
  431,800    
Nippon Suisan Kaisha Ltd
    1,457,276  
  514,100    
Nippon Telegraph & Telephone Corp
    25,354,626  
  3,715,000    
Nippon Yusen Kabushiki Kaisha
    8,275,694  
  56,500    
Nishimatsuya Chain Co Ltd
    428,895  
  2,085,984    
Nishimatsu Construction Co Ltd
    3,386,811  
  190,000    
Nissan Shatai Co Ltd
    1,860,832  
  260,000    
Nissan Chemical Industries Ltd
    2,460,613  

 


 

                 
  570,700    
Nissan Motor Co Ltd
    5,240,916  
  138,300    
Nissen Holdings Co Ltd
    783,676  
  798,000    
Nisshin Steel Co Ltd
    1,144,325  
  55,000    
Nisshin Oillio Group Ltd (The)
    222,741  
  166,000    
Nissin Corp
    391,300  
  28,100    
Nitori Holdings Co Ltd
    2,626,647  
  104,000    
Nittetsu Mining Co Ltd
    417,442  
  54,100    
Nitto Denko Corp
    2,248,767  
  541    
Nomura Real Estate Office Fund (REIT)
    2,773,513  
  96,300    
Nomura Research Institute Ltd
    2,124,979  
  70,000    
NS United Kaiun Kaisha Ltd
    97,063  
  144,000    
NTN Corp
    572,182  
  7,328    
NTT Docomo Inc
    12,952,576  
  570,000    
Obayashi Corp
    2,396,067  
  4,520    
Obic Co Ltd
    828,044  
  320,000    
OJI Paper Co Ltd
    1,595,121  
  3,000    
Okamura Corp
    20,707  
  790,000    
Oki Electric Industry Co Ltd *
    648,553  
  145    
Okinawa Cellular Telephone Co
    297,649  
  31,900    
Okinawa Electric Power Co
    1,358,506  
  63,000    
Okuwa Co Ltd
    1,051,836  
  10,000    
Onoken Co Ltd
    81,881  
  45,200    
Ono Pharmaceutical Co Ltd
    2,354,878  
  68,200    
ORIX Corp
    5,754,368  
  897,132    
Osaka Gas Co Ltd
    3,422,597  
  279,000    
Pacific Metals Co Ltd
    1,426,254  
  26,600    
Paltac Corp
    504,113  
  27,800    
Parco Co Ltd
    208,986  
  314    
Pasona Group Inc
    327,500  
  2,109,000    
Penta Ocean Construction Co Ltd
    6,656,553  
  3,766    
PGM Holdings KK
    2,637,840  
  63,620    
Point Inc
    2,645,196  
  302    
Premier Investment Corp (REIT)
    972,432  
  220,000    
Press Kogyo Co Ltd
    1,033,096  
  666,000    
Prima Meat Packers Ltd
    1,019,387  
  100,900    
Raito Kogyo Co Ltd
    488,653  
  434,000    
Rengo Co Ltd
    3,088,281  
  589,000    
Ricoh Company Ltd
    5,307,900  
  88,600    
Right On Co Ltd
    661,389  
  46,000    
Riken Corp
    176,393  
  28,700    
Riso Kagaku Corp
    478,384  
  513,200    
Round One Corp
    3,066,541  
  93,000    
Ryobi Ltd
    360,483  
  49,200    
Ryohin Keikaku Co Ltd
    2,238,551  
  14,500    
S Foods Inc
    113,910  
  23,000    
Saint Marc Holdings Co Ltd
    891,237  
  155,000    
San-Ai Oil Co Ltd
    644,640  
  235,000    
Sanden Corp
    715,360  
  32,000    
Sanki Engineering
    157,681  
  194,000    
Sankyo–Tateyama Holdings Inc *
    260,506  
  100,300    
Sankyo Co Ltd
    5,013,592  
  189,418    
Sankyu Inc
    717,573  
  50,300    
Sanshin Electronics Co Ltd
    416,529  
  159    
Sanwa Holdings Corp
    492  
  3,200    
San–A Co Ltd
    123,810  
  180,000    
Sasebo Heavy Industries Co Ltd
    267,454  
  5,500    
Secom Co Ltd
    248,056  
  74,000    
Seika Corp
    203,554  
  374,000    
Seikitokyu Kogyo Co Ltd *
    218,762  
  85,000    
Seiko Holdings Corp
    169,828  

 


 

                 
  127,000    
Seino Holdings Co Ltd
    922,690  
  23,800    
Seiren Co Ltd
    143,652  
  278    
Sekisui House SI Investment Co (REIT)
    1,027,879  
  393,516    
Senko Co Ltd
    1,477,705  
  34,700    
Senshukai Co Ltd
    235,794  
  50,400    
Shimachu Co Ltd
    1,116,411  
  25,700    
Shimamura Co Ltd
    2,442,734  
  538,000    
Shimizu Corp
    2,218,162  
  32,700    
Shinko Plantech Co Ltd
    292,145  
  40,000    
Shinko Shoji Co Ltd
    312,217  
  86,000    
ShinMaywa Industries Ltd
    305,346  
  6,759,000    
Shinsei Bank Ltd
    6,849,364  
  166,000    
Shinsho Corp
    391,322  
  53,888    
Ship Healthcare Holdings Inc
    1,281,824  
  883,000    
Shizuoka Bank Ltd (The)
    9,153,943  
  104,500    
Shizuoka Gas Co Ltd
    700,642  
  54,300    
Showa Corp *
    299,732  
  1,690,000    
Showa Denko KK
    3,449,520  
  68,000    
Showa Sangyo Co Ltd
    209,221  
  676,000    
Showa Shell Sekiyu KK
    4,525,662  
  74,000    
Sinanen Co Ltd
    336,152  
  2,104    
SKY Perfect JSAT Holdings Inc
    1,075,333  
  101,900    
Sodick Co Ltd
    552,499  
  4,706,200    
Sojitz Corp
    7,384,873  
  123,600    
Stanley Electric Co Ltd
    1,823,469  
  407,000    
Sumikin Bussan Corp
    979,747  
  25,120    
Sumisho Computer Systems Corp
    409,254  
  1,938,000    
Sumitomo Light Metal Industries Ltd *
    1,826,361  
  58,000    
Sumitomo Seika Chemicals Co Ltd
    259,651  
  1,562,600    
Sumitomo Corp
    20,857,667  
  71,400    
Sumitomo Forestry Co Ltd
    610,840  
  90,000    
Sumitomo Metal Mining Co Ltd
    1,214,402  
  1,403,500    
Sumitomo Mitsui Financial Group Inc
    39,037,903  
  505,000    
Sumitomo Osaka Cement Co Ltd
    1,467,745  
  69,500    
Suzuken Co Ltd
    1,792,936  
  278,000    
SWCC Showa Holdings Co Ltd *
    257,300  
  82,000    
T RAD Co Ltd
    273,982  
  51,200    
Tachi-S Co Ltd
    874,977  
  3,118,000    
Taiheiyo Cement Co Ltd
    6,057,078  
  497,400    
Taihei Kogyo Co Ltd
    2,710,180  
  2,397,836    
Taisei Corp
    6,214,546  
  283,000    
Takashimaya Co Ltd
    2,016,620  
  557,900    
Takeda Pharmaceutical Co Ltd
    22,915,171  
  47,000    
Takiron Co Ltd
    158,178  
  402,000    
Takuma Co Ltd *
    1,737,792  
  56,800    
Teikoku Piston Ring Co Ltd
    605,581  
  253,000    
Tekken Corp
    287,679  
  648,098    
TOA Corp
    1,157,772  
  222,000    
Tohoku Electric Power Co Inc
    2,312,354  
  201,200    
Toho Holdings Co Ltd
    2,572,552  
  110,000    
Tohto Suisan Co Ltd
    188,380  
  61,300    
Tokai Rika Co Ltd
    951,099  
  38,940    
Token Corp
    1,452,007  
  693,900    
Tokio Marine Holdings Inc
    16,866,067  
  459,000    
Tokuyama Corp
    1,566,583  
  644,000    
Tokyo Gas Co Ltd
    2,762,461  
  69,400    
Tokyo Steel Manufacturing Co
    591,143  
  520    
Tokyu REIT Inc (REIT)
    2,372,430  
  103,810    
Tokyu Construction Co Ltd
    258,002  
  252,000    
TonenGeneral Sekiyu KK
    2,874,000  

 


 

                 
  38,100    
Toppan Forms Co Ltd
    280,690  
  281,000    
Toppan Printing Co Ltd
    2,071,781  
  224,000    
Topy Industries Ltd
    573,607  
  89,000    
Toshiba TEC Corp
    336,039  
  1,337,000    
Tosoh Corp
    3,912,659  
  33,000    
Touei Housing Corp
    337,140  
  100,000    
Toyo Ink SC Holdings Co Ltd
    372,015  
  199,000    
Toyo Kanetsu KK
    382,069  
  951,000    
Toyo Tire & Rubber Co Ltd
    2,227,748  
  75,800    
Toyota Auto Body Co Ltd
    1,125,874  
  210,900    
Toyota Motor Corp
    6,945,048  
  669,800    
Toyota Tsusho Corp
    11,270,420  
  1,170,000    
Toyo Construction Co Ltd
    1,162,183  
  115,000    
Toyo Engineering Corp
    421,670  
  69,000    
Toyo Suisan Kaisha Ltd
    1,697,804  
  19,700    
Transcosmos Inc
    228,597  
  61,900    
Tsumura & Co
    1,717,111  
  17,800    
Tsuruha Holdings Inc
    927,209  
  543    
T–Gaia Corp
    1,053,424  
  259,000    
Uchida Yoko Co Ltd
    717,521  
  67,000    
Uniden Corp
    256,112  
  45,900    
Unipres Corp
    1,273,018  
  5,270    
United Urban Investment Corp (REIT)
    5,625,469  
  1,235,000    
Unitika Ltd *
    669,739  
  311,100    
UNY Co Ltd
    2,857,063  
  159,230    
Usen Corp *
    101,859  
  26,220    
USS Co Ltd
    2,279,859  
  131,800    
Valor Co Ltd
    2,099,743  
  21,600    
Vital KSK Holdings Inc
    173,433  
  645,000    
Wakachiku Construction Co Ltd *
    924,053  
  65,200    
Xebio Co Ltd
    1,509,264  
  9,585    
Yahoo Japan Corp
    3,037,175  
  166,660    
Yamada Denki Co Ltd
    12,055,034  
  67,400    
Yamato Holdings Co Ltd
    1,082,336  
  81,000    
Yamato Kogyo Co Ltd
    2,243,914  
  116,800    
Yamazen Corp
    841,280  
  283,000    
Yokohama Rubber Co Ltd
    1,573,058  
  43,600    
Yokohama Reito Co Ltd
    335,662  
  71,500    
Yonekyu Corp
    628,769  
  37,000    
Yorozu Corp
    790,353  
  854,000    
Yuasa Trading Co Ltd
    1,171,706  
  86,000    
Yurtec Corp
    421,840  
     
 
     
       
Total Japan
    1,052,093,863  
     
 
     
       
TOTAL COMMON STOCKS (COST $1,085,481,383)
    1,052,093,863  
     
 
     
                 
Par Value     Description   Value ($)  
       
SHORT-TERM INVESTMENTS — 6.0%
       
       
 
       
       
Time Deposits — 6.0%
       
USD     10,000,000  
Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11
    10,000,000  
USD     27,529,993  
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.03%, due 12/01/11
    27,529,993  
JPY   222,107,166  
Citibank (New York) Time Deposit, 0.01%, due 12/01/11
    2,863,682  
USD     7,139,084  
Citibank (New York) Time Deposit, 0.03%, due 12/01/11
    7,139,084  
USD     10,000,000  
HSBC Bank (New York) Time Deposit, 0.03%, due 12/01/11
    10,000,000  
USD     10,000,000  
JPMorgan Chase (New York) Time Deposit, 0.03%, due 12/01/11
    10,000,000  
     
 
     
       
Total Time Deposits
    67,532,759  
     
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $67,532,759)
    67,532,759  
     
 
     

 


 

                 
       
TOTAL INVESTMENTS — 99.4%
       
       
(Cost $1,153,014,142)
    1,119,626,622  
       
Other Assets and Liabilities (net) — 0.6%
    6,270,035  
       
 
     
       
TOTAL NET ASSETS — 100.0%
  $ 1,125,896,657  
       
 
     

 


 

A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
                                         
                                    Net Unrealized  
Settlement                                   Appreciation  
Date   Counterparty     Deliver/Receive     Units of Currency     Value     (Depreciation)  
Buys †
                                       
12/07/11
  Bank of New York Mellon   JPY     5,038,305,916     $ 64,964,175     $ 58,045  
12/07/11
  Barclays Bank PLC   JPY     12,530,211,951       161,565,197       155,794  
12/07/11
  Brown Brothers Harriman & Co.   JPY     11,788,471,519       152,001,158       146,572  
12/07/11
  Deutsche Bank AG   JPY     7,570,598,233       97,615,683       94,129  
12/07/11
  Morgan Stanley Capital Services Inc.   JPY     11,331,250,000       146,105,720       129,604  
 
                                   
 
                          $ 622,251,933     $ 584,144  
 
                                   
Sales #
                                       
12/07/11
  Bank of New York Mellon   JPY     5,038,305,916     $ 64,964,175     $ (316,637 )
12/07/11
  Barclays Bank PLC   JPY     12,530,211,951       161,565,197       (788,504 )
12/07/11
  Brown Brothers Harriman & Co.   JPY     11,788,471,519       152,001,158       (744,739 )
12/07/11
  Deutsche Bank AG   JPY     7,570,598,233       97,615,683       (478,274 )
12/07/11
  Morgan Stanley Capital Services Inc.   JPY     11,331,250,000       146,105,720       (713,988 )
1/10/12
  Bank of New York Mellon   JPY     16,369,555,916       211,276,630       (214,510 )
1/10/12
  Barclays Bank PLC   JPY     12,530,211,951       161,723,444       (180,862 )
1/10/12
  Brown Brothers Harriman & Co.   JPY     11,788,471,519       152,150,037       (158,398 )
1/10/12
  Deutsche Bank AG   JPY     7,570,598,233       97,711,293       (109,274 )
 
                                   
 
                          $ 1,245,113,337     $ (3,705,186 )
 
                                   
 
  Fund buys foreign currency; sells USD.
 
#   Fund sells foreign currency; buys USD.
Futures Contracts
                                 
                            Net Unrealized  
            Expiration             Appreciation  
Number of Contracts   Type     Date     Value     (Depreciation)  
Buys
                               
468
  TOPIX   December 2011   $ 44,956,118     $ 1,458,746  
 
                           

 


 

As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
 
Notes to Schedule of Investments:
 
REIT  —  Real Estate Investment Trust
*   Non-income producing security.
Currency Abbreviations:
 
JPY  —  Japanese Yen
USD  —  United States Dollar

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                         
      Gross       Gross       Net Unrealized  
      Unrealized       Unrealized       Appreciation  
 Aggregate Cost      Appreciation       (Depreciation)       (Depreciation)  
$1,168,451,770
    $45,191,664       $(94,016,812)       $(48,825,148)  

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivatives contracts based on the creditworthiness of its counterparties. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below.
     
Security Type   Percentage of Net Assets of the Fund  
Equity Securities
  93.4%    
Futures Contracts
  0.1%    
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 – Valuations based on quoted prices for identical securities in active markets.
Level 2 – Valuations determined using other significant direct or indirect observable inputs. These inputs may include: fair value adjustments provided by an independent pricing service applied to equity securities (including the value of equity securities that

 


 

underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) due to market events that have occurred since the local market close but prior to the close of the NYSE.
Level 3 – Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices in                    
    Active Markets for     Significant Other     Significant        
    Identical Assets     Observable Inputs     Unobservable Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
 
Common Stocks
                               
Japan
  $     $ 1,052,093,863     $     $ 1,052,093,863  
 
                       
TOTAL COMMON STOCKS
          1,052,093,863             1,052,093,863  
 
                       
Short-Term Investments
    67,532,759                   67,532,759  
 
                       
Total Investments
    67,532,759       1,052,093,863             1,119,626,622  
 
                       
Derivatives*
                               
Forward Currency Contracts
                               
Foreign Currency Risk
          584,144             584,144  
Futures Contracts
                               
Equity risk
          1,458,746             1,458,746  
 
                       
Total
  $ 67,532,759     $ 1,054,136,753     $     $ 1,121,669,512  
 
                       
 
LIABILITY VALUATION INPUTS
 
    Quoted Prices in                    
    Active Markets for                    
    Identical     Significant Other     Significant        
    Liabilities     Observable Inputs     Unobservable Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
 
Derivatives*
                               
Forward Currency Contracts
                               
Foreign Currency Risk
  $     $ (3,705,186 )   $     $ (3,705,186 )
 
                       
Total
  $     $ (3,705,186 )   $     $ (3,705,186 )
 
                       

 


 

The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
 
  Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011 whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the [Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. Declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies with high positive correlations to one another creates additional risk.

 


 

Currency Risk — Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies.
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Leveraging Risk — The Fund’s use of reverse repurchase agreements and other derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Short Sales Risk — The Fund runs the risk that the Fund’s loss on a short sale of securities that the Fund does not own is unlimited.
Among other trading agreements, the Fund is party to International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Agreements”) or other similar types of agreements with selected counterparties that generally govern over-the-counter derivative transactions entered into by the Fund. The ISDA Agreements typically include representations and warranties as well as contractual terms related to collateral, events of default, termination events, and other provisions. Termination events may include the decline in the net assets of the Fund below a certain level over a specified period of time and entitle a counterparty to elect to terminate early with respect to some or all the transactions under the ISDA Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse effect on the Fund’s operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. For example, the Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives, to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives. The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.

 


 

The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For example, if the Fund holds a large proportion of stocks of companies in a particular sector and the Manager believes that stocks of companies in another sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index). In adjusting its investment exposure, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net long exposures in excess of its net assets. The Fund’s foreign currency exposure may differ significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).

 


 

The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most forward currency contracts are not collateralized. During the period ended November 30, 2011, the Fund used forward currency contracts to manage against anticipated currency exchange rate changes and adjust exposure to foreign currencies. Forward currency contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded (unless otherwise adjusted due to the time at which foreign markets close). The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. During the period ended November 30, 2011, the Fund used futures contracts to maintain the diversity and liquidity of the portfolio. Futures contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.

 


 

When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers (unless otherwise adjusted due to the time at which foreign markets close) and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves

 


 

counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. During the period ended November 30, 2011, the Fund used swap agreements to manage against anticipated currency exchange rates and to adjust exposure to foreign currencies. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.

 


 

The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Assets:
                                               
Unrealized appreciation on forward currency contracts
  $     $ 584,144     $     $     $     $ 584,144  
Unrealized appreciation on futures contracts*
                      1,458,746             1,458,746  
 
                                   
 
  $     $ 584,144     $     $ 1,458,746     $     $ 2,042,890  
 
                                   
 
                                               
Liabilities:
                                               
Unrealized depreciation on forward currency contracts
  $     $ (3,705,186 )   $     $     $     $ (3,705,186 )
 
                                   
Total
  $     $ (3,705,186 )   $     $     $     $ (3,705,186 )
 
                                   
 
*   The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of futures contracts as reported in the Schedule of Investments.
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts and futures contracts), or notional amounts (swap agreements), outstanding at each month-end, was as follows for the period ended November 30, 2011:
                         
    Forward        
    Currency   Futures   Swap
    Contracts   Contracts   Agreements
Average amount outstanding
  $ 929,190,447     $ 29,787,405     $ 46,103,998  

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Foreign Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares     Description   Value ($)  
 
       
COMMON STOCKS — 93.5%
       
       
 
       
       
Australia — 2.6%
       
  1,913,063    
Asciano Group
    3,111,030  
  53,715    
Australia and New Zealand Banking Group Ltd
    1,141,244  
  34,000    
Commonwealth Bank of Australia
    1,702,522  
  202,016    
Crown Ltd
    1,745,821  
  1,542,683    
Dexus Property Group (REIT)
    1,395,572  
  1,009,457    
Incitec Pivot Ltd
    3,491,060  
  145,735    
James Hardie Industries SE *
    1,046,988  
  100,207    
Macquarie Group Ltd
    2,509,975  
  508,638    
Myer Holdings Ltd
    1,279,056  
  202,427    
Santos Ltd
    2,830,691  
  1,237,720    
Telstra Corp Ltd
    4,066,746  
  296,123    
Westpac Banking Corp
    6,469,400  
       
 
     
       
Total Australia
    30,790,105  
       
 
     
       
 
       
       
Austria — 0.1%
       
  21,523    
Telekom Austria AG
    249,345  
  44,547    
Wienerberger AG
    472,821  
       
 
     
       
Total Austria
    722,166  
       
 
     
       
 
       
       
Belgium — 0.7%
       
  162,214    
Belgacom SA
    5,151,403  
  81,407    
Umicore SA
    3,504,846  
       
 
     
       
Total Belgium
    8,656,249  
       
 
     
       
 
       
       
Brazil — 1.2%
       
  144,200    
Cia Hering
    3,054,088  
  175,000    
EDP-Energias Do Brasil SA
    3,735,449  
  348,200    
OGX Petroleo e Gas Participacoes SA *
    2,688,015  
  213,100    
Sonae Sierra Brasil SA
    2,762,222  
  237,600    
T4F Entretenimento SA *
    1,773,772  
       
 
     
       
Total Brazil
    14,013,546  
       
 
     
       
 
       
       
Denmark — 0.5%
       
  289,300    
H Lundbeck A/S
    5,606,863  
       
 
     
       
 
       
       
Finland — 3.1%
       
  87,529    
Amer Sports Oyj Class A
    1,085,588  
  127,688    
Elisa Oyj
    2,776,617  
  111,582    
Fortum Oyj
    2,566,974  
  230,058    
Neste Oil Oyj
    2,877,633  
  133,203    
Nokian Renkaat Oyj
    4,412,251  
  1,362,392    
Nokia Oyj
    7,874,074  
  142,471    
Orion Oyj Class B
    2,898,190  
  203,979    
Sampo Oyj Class A
    5,328,573  
  477,558    
UPM–Kymmene Oyj
    5,590,656  
  53,629    
Wartsila Oyj
    1,762,515  
       
 
     
       
Total Finland
    37,173,071  
       
 
     
       
 
       
       
France — 8.4%
       
  100,918    
Accor SA
    2,823,762  
  336,603    
AXA
    4,873,889  
  81,872    
BNP Paribas
    3,259,165  
  109,610    
Carrefour SA
    2,918,413  
  26,544    
Christian Dior SA
    3,437,666  

 


 

                 
  78,074    
Compagnie de Saint-Gobain
    3,310,564  
  88,005    
Compagnie Generale des Etablissements Michelin-Class B
    5,610,165  
  118,452    
European Aeronautic Defense and Space Co NV
    3,553,776  
  15,019    
L’Oreal SA
    1,625,580  
  101,400    
Legrand SA
    3,282,228  
  53,135    
Pernod-Ricard SA
    5,012,668  
  74,958    
Publicis Groupe SA
    3,580,617  
  33,731    
Renault SA
    1,263,916  
  251,534    
Sanofi
    17,593,798  
  32,531    
Societe BIC SA
    2,888,145  
  81,181    
Sodexo
    5,904,239  
  418,668    
Total SA
    21,600,157  
  33,791    
Vallourec SA
    2,319,828  
  285,322    
Vivendi SA
    6,581,252  
       
 
     
       
Total France
    101,439,828  
       
 
     
       
 
       
       
Germany — 6.5%
       
  88,222    
Allianz SE (Registered)
    9,168,391  
  32,983    
Axel Springer AG
    1,482,886  
  140,365    
Bayer AG
    9,236,178  
  78,617    
Beiersdorf AG
    4,503,772  
  67,829    
Continental AG *
    4,815,799  
  201,074    
Daimler AG (Registered)
    9,147,515  
  721,105    
Deutsche Telekom AG (Registered)
    9,363,287  
  398,696    
E.ON AG
    9,869,196  
  64,956    
HeidelbergCement AG
    2,740,548  
  73,323    
RWE AG
    3,039,553  
  173,393    
SAP AG
    10,382,661  
  40,843    
Siemens AG (Registered)
    4,133,278  
       
 
     
       
Total Germany
    77,883,064  
       
 
     
       
 
       
       
Hong Kong — 1.6%
       
  2,033,853    
CITIC Securities Co Ltd *
    3,324,851  
  626,000    
Hutchison Whampoa Ltd
    5,498,005  
  845,000    
Power Assets Holdings Ltd
    6,331,351  
  280,000    
Swire Pacific Ltd
    3,418,110  
       
 
     
       
Total Hong Kong
    18,572,317  
       
 
     
       
 
       
       
India — 0.1%
       
  764,411    
Housing Development & Infrastructure Ltd *
    909,503  
       
 
     
       
 
       
       
Ireland — 0.3%
       
  240,782    
C&C Group Plc
    986,453  
  30,607    
DCC Plc
    741,020  
  61,992    
Kerry Group Plc Class A
    2,315,205  
       
 
     
       
Total Ireland
    4,042,678  
       
 
     
       
 
       
       
Italy — 4.8%
       
  221,378    
Assicurazioni Generali SPA
    3,676,343  
  341,686    
Autogrill SPA
    3,563,703  
  441,625    
Enel SPA
    1,881,720  
  1,289,697    
ENI SPA
    27,313,567  
  387,705    
Fiat Industrial SPA *
    3,475,656  
  3,580,501    
Intesa San Paolo
    5,947,106  
  1,023,726    
Intesa Sanpaolo SPA-Di RISP
    1,319,607  
  222,863    
Italcementi SPA-Di RISP
    611,009  
  180,045    
Lottomatica SPA *
    2,778,089  
  988,001    
Mediaset SPA
    2,920,659  
  85,477    
Prysmian SPA
    1,168,396  

 


 

                 
  1,201,957    
Saras SPA *
    1,893,648  
  217,011    
Unione di Banche Italiane ScpA
    885,018  
       
 
     
       
Total Italy
    57,434,521  
       
 
     
       
 
       
       
Japan — 25.7%
       
  804,800    
Aeon Co Ltd
    10,997,228  
  248,400    
Aisin Seiki Co Ltd
    7,505,813  
  347,600    
Alps Electric Co Ltd
    2,433,582  
  664,000    
Asahi Glass Co Ltd
    5,684,085  
  1,194,000    
Asahi Kasei Corp
    7,242,764  
  177,400    
Astellas Pharma Inc
    6,838,135  
  286,200    
Canon Inc
    12,839,566  
  713,000    
Chiba Bank Ltd
    4,650,673  
  244,700    
Chugai Pharmaceutical Co Ltd
    3,738,331  
  272,700    
Daikin Industries Ltd
    8,030,714  
  84,700    
Daito Trust Construction Co Ltd
    7,554,316  
  1,326,000    
Ebara Corp
    4,847,712  
  3,078,000    
Hitachi Ltd
    17,079,546  
  588,600    
Honda Motor Co Ltd
    18,678,846  
  250,800    
Hoya Corp
    5,341,897  
  751,800    
Itochu Corp
    7,640,085  
  3,923    
Japan Retail Fund Investment Corp (REIT)
    5,999,517  
  1,346    
Japan Tobacco Inc
    6,459,140  
  320,400    
JSR Corp
    6,246,906  
  256,400    
JS Group Corp
    4,862,701  
  1,928,600    
JX Holdings Inc
    12,265,166  
  166,800    
Lawson Inc
    9,878,345  
  99,600    
Miraca Holdings Inc
    3,824,712  
  1,652,500    
Mitsubishi Chemical Holdings Corp
    9,600,093  
  1,221,000    
Mitsubishi Electric Corp
    11,558,538  
  593,900    
Mitsui & Co Ltd
    9,370,487  
  1,633,200    
Nissan Motor Co Ltd
    14,998,185  
  1,049,000    
NSK Ltd
    6,942,771  
  9,326    
NTT Docomo Inc
    16,484,132  
  706,000    
Sekisui Chemical Co Ltd
    5,305,225  
  68,800    
Shimamura Co Ltd
    6,539,303  
  4,499,000    
Shinsei Bank Ltd
    4,559,149  
  395,600    
Sumitomo Rubber Industries
    4,745,044  
  358,300    
Sumitomo Electric Industries Ltd
    3,890,783  
  467,300    
Sumitomo Mitsui Financial Group Inc
    12,997,800  
  1,838,000    
Sumitomo Mitsui Trust Holdings Inc
    5,631,946  
  273,500    
Sumitomo Realty & Development Co Ltd
    5,424,979  
  1,410,000    
Teijin Ltd
    4,314,483  
  258,900    
Tokio Marine Holdings Inc
    6,292,873  
       
 
     
       
Total Japan
    309,295,571  
       
 
     
       
 
       
       
Malaysia — 0.2%
       
  1,357,000    
Petronas Chemicals Group Bhd
    2,614,737  
       
 
     
       
 
       
       
Mexico — 0.2%
       
  55,500    
Grupo Aeroportuario del Sureste SAB de CV ADR
    3,128,535  
       
 
     
       
 
       
       
Netherlands — 0.6%
       
  116,940    
Arcadis NV
    2,099,372  
  98,397    
Imtech NV
    2,530,000  
  173,664    
Koninklijke KPN NV
    2,125,482  
       
 
     
       
Total Netherlands
    6,754,854  
       
 
     

 


 

                 
       
New Zealand — 0.0%
       
  52,286    
Sky Network Television Ltd
    225,695  
       
 
     
       
 
       
       
Norway — 0.9%
       
  506,992    
ProSafe ASA
    3,823,206  
  268,330    
Statoil ASA
    6,938,971  
       
 
     
       
Total Norway
    10,762,177  
       
 
     
       
 
       
       
Philippines — 0.3%
       
  10,723,400    
Alliance Global Group Inc
    2,560,019  
  657,030    
Cebu Air Inc
    1,068,945  
       
 
     
       
Total Philippines
    3,628,964  
       
 
     
       
 
       
       
Russia — 1.8%
       
  132,063    
Lukoil OAO ADR
    7,436,186  
  51,908    
Magnit OJSC Sponsored GDR
    1,154,303  
  240,520    
Phosagro OAO GDR
    2,453,304  
  889,900    
VimpelCom Ltd Sponsored ADR
    10,607,608  
       
 
     
       
Total Russia
    21,651,401  
       
 
     
       
 
       
       
Singapore — 1.0%
       
  487,554    
DBS Group Holdings Ltd
    4,848,461  
  2,308,000    
Global Logistic Properties Ltd *
    3,355,863  
  551,100    
Keppel Corp Ltd
    4,093,769  
       
 
     
       
Total Singapore
    12,298,093  
       
 
     
       
 
       
       
South Korea — 2.0%
       
  69,694    
Doosan Heavy Industries and Construction Co
    4,145,679  
  10,822    
Hyundai Mobis
    3,001,061  
  83,960    
Kangwon Land Inc
    2,069,496  
  4,732    
LG Chem Ltd
    1,416,245  
  30,134    
LG Corp
    1,696,072  
  181,970    
LG Display Co Ltd
    4,339,015  
  38,786    
LG Electronics Inc
    2,597,662  
  56,490    
Shinhan Financial Group Co Ltd
    2,106,118  
  16,986    
SK Holdings Co Ltd
    2,212,536  
       
 
     
       
Total South Korea
    23,583,884  
       
 
     
       
 
       
       
Spain — 1.0%
       
  299,171    
Banco Santander SA
    2,245,646  
  217,988    
Enagas
    4,090,321  
  297,130    
Telefonica SA
    5,579,612  
       
 
     
       
Total Spain
    11,915,579  
       
 
     
       
 
       
       
Sweden — 1.6%
       
  444,038    
Ericsson LM B Shares
    4,737,092  
  135,575    
Getinge AB Class B
    3,494,735  
  513,941    
Svenska Cellulosa AB Class B
    7,647,451  
  438,101    
TeliaSonera AB
    2,988,480  
       
 
     
       
Total Sweden
    18,867,758  
       
 
     
       
 
       
       
Switzerland — 4.3%
       
  50,218    
Adecco SA *
    2,184,111  
  417,564    
Novartis AG (Registered)
    22,550,230  
  40,492    
Roche Holding AG (Non Voting)
    6,441,236  
  39,800    
Sulzer AG
    4,442,966  
  11,394    
Swisscom AG (Registered)
    4,302,884  

 


 

                 
  9,011    
Syngenta AG (Registered) *
    2,651,696  
  43,304    
Zurich Financial Services AG *
    9,537,202  
       
 
     
       
Total Switzerland
    52,110,325  
       
 
     
       
 
       
       
Taiwan — 0.3%
       
  570,416    
Asustek Computer Inc
    3,985,563  
       
 
     
       
 
       
       
Thailand — 0.6%
       
  952,900    
Bangkok Bank Pcl NVDR
    4,541,690  
  13,666,800    
Land & Houses Pcl NVDR
    2,683,923  
       
 
     
       
Total Thailand
    7,225,613  
       
 
     
       
 
       
       
United Kingdom — 23.1%
       
  221,089    
AMEC Plc
    3,025,585  
  466,159    
BG Group Plc
    9,998,563  
  3,409,003    
BP Plc
    24,689,230  
  502,494    
British American Tobacco Plc
    23,319,269  
  1,314,289    
BT Group Plc
    3,932,904  
  620,183    
Centrica Plc
    2,948,021  
  47,509    
Charter International Plc
    697,349  
  474,879    
Diageo Plc
    10,170,970  
  251,269    
GlaxoSmithKline Plc
    5,568,631  
  2,428,608    
HSBC Holdings Plc
    18,944,239  
  249,694    
Imperial Tobacco Group Plc
    8,983,242  
  549,484    
Inchcape Plc
    2,822,276  
  385,946    
International Power Plc
    2,039,557  
  169,010    
John Wood Group Plc
    1,736,787  
  30,820    
Johnson Matthey Plc
    929,081  
  177,109    
Land Securities Group Plc (REIT)
    1,915,283  
  819,972    
National Express Group Plc
    2,709,728  
  279,170    
National Grid Plc
    2,743,489  
  823,017    
Premier Oil Plc *
    4,727,550  
  496,272    
Prudential Plc
    4,884,619  
  174,628    
Reckitt Benckiser Group Plc
    8,859,355  
  292,703    
Rio Tinto Plc
    15,409,541  
  276,990    
Rolls-Royce Holdings Plc *
    3,183,860  
  708,588    
Royal Dutch Shell Plc A Shares (London)
    24,782,572  
  612,778    
Royal Dutch Shell Plc B Shares (London)
    22,081,190  
  1,508,782    
Tesco Plc
    9,632,997  
  188,829    
Travis Perkins Plc
    2,479,057  
  144,487    
Ultra Electronics Holdings Plc
    3,284,866  
  240,668    
Unilever Plc
    8,084,507  
  8,983,184    
Vodafone Group Plc
    24,318,455  
  1,639,965    
WM Morrison Supermarkets Plc
    8,314,364  
  688,159    
Xstrata Plc
    11,047,458  
       
 
     
       
Total United Kingdom
    278,264,595  
       
 
     
       
TOTAL COMMON STOCKS (COST $1,163,498,516)
    1,123,557,255  
       
 
     
       
 
       
       
PREFERRED STOCKS — 1.0%
       
       
 
       
       
Brazil — 0.5%
       
  214,100    
Telefonica Brasil SA 0.72%
    5,777,687  
       
 
     
       
 
       
       
Germany — 0.1%
       
  30,672    
Porsche Automobil Holding SE 1.12%
    1,879,540  
       
 
     
       
 
       
       
South Korea — 0.4%
       
  38,888    
Hyundai Motor Co 2.29%
    2,424,349  

 


 

                 
  10,785    
LG Chem Ltd 3.40%
    1,167,341  
  33,070    
LG Electronics Inc 1.04%
    717,464  
       
 
     
       
Total South Korea
    4,309,154  
       
 
     
       
TOTAL PREFERRED STOCKS (COST $10,694,429)
    11,966,381  
       
 
     
       
 
       
       
RIGHTS/WARRANTS — 0.0%
       
       
 
       
       
South Korea — 0.0%
       
  7,448    
LG Electronics Inc Rights, Expires 12/21/11*
    141,438  
       
 
     
       
 
       
       
United Kingdom — 0.0%
       
  20,989,248    
Rolls-Royce Holdings Plc Rights, Expires 2/09/12*
    32,930  
       
 
     
       
TOTAL RIGHTS/WARRANTS (COST $177,079)
    174,368  
       
 
     
                 
Par Value     Description   Value ($)  
 
       
SHORT-TERM INVESTMENTS — 4.9%
       
       
 
       
       
Time Deposits — 4.9%
       
USD 15,000,000  
Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11
    15,000,000  
AUD 124  
Brown Brothers Harriman (Grand Cayman) Time Deposit, 3.78%, due 12/01/11
    127  
GBP 144,194  
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.10%, due 12/01/11
    226,226  
NOK 120  
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.95%, due 12/01/11
    21  
SEK 146  
Brown Brothers Harriman (Grand Cayman) Time Deposit, 1.06%, due 12/01/11
    21  
EUR 5,186,899  
Citibank (New York) Time Deposit, 0.10%, due 12/01/11
    6,969,636  
JPY 69,997,496  
Citibank (New York) Time Deposit, 0.01%, due 12/01/11
    902,498  
USD 7,116,033  
Citibank (New York) Time Deposit, 0.03%, due 12/01/11
    7,116,033  
USD 13,370,406  
HSBC Bank (New York) Time Deposit, 0.03%, due 12/01/11
    13,370,406  
EUR 11,142,889  
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11
    14,972,699  
       
 
     
       
Total Time Deposits
    58,557,667  
       
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $58,557,667)
    58,557,667  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 99.4%
(Cost $1,232,927,691)
    1,194,255,671  
       
 
       
       
Other Assets and Liabilities (net) — 0.6%
    7,120,105  
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 1,201,375,776  
       
 
     

 


 

     A summary of outstanding financial instruments at November 30, 2011 is as follows:
     Forward Currency Contracts
                                         
                                    Net Unrealized  
Settlement                                 Appreciation  
Date     Counterparty   Deliver/Receive     Units of Currency     Value     (Depreciation)  
Sales #  
 
                               
  12/06/11    
Deutsche Bank AG
  EUR     13,853,500     $ 18,615,017     $ 707,072  
  12/06/11    
HSBC Bank USA
  EUR     13,853,500       18,615,016       721,022  
       
 
                           
       
 
                  $ 37,230,033     $ 1,428,094  
       
 
                           
 
#   Fund sells foreign currency; buys USD.
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
 
Notes to Schedule of Investments:
ADR — American Depositary Receipt
GDR — Global Depository Receipt
NVDR — Non-Voting Depository Receipt
REIT — Real Estate Investment Trust
* Non-income producing security.
Currency Abbreviations:
AUD — Australian Dollar
EUR — Euro
GBP — British Pound
JPY — Japanese Yen
NOK — Norwegian Krone
SEK — Swedish Krona
USD — United States Dollar

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                             
    Gross     Gross     Net Unrealized      
    Unrealized     Unrealized     Appreciation      
Aggregate Cost   Appreciation     (Depreciation)     (Depreciation)      
$1,275,599,746
  $ 66,712,881     $ (148,056,956 )   $ (81,344,075 )    

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivatives contracts based on the creditworthiness of its counterparties. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below.
     
Security Type  
Percentage of Net Assets of the Fund
Equity Securities
  91.3%
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 – Valuations based on quoted prices for identical securities in active markets.
Level 2 – Valuations determined using other significant direct or indirect observable inputs. These inputs may include: fair value adjustments provided by an independent pricing service applied to equity securities (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) due to market events that have occurred since the local market close but prior to the close of the NYSE.

 


 

Level 3 – Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Common Stocks
                               
Australia
  $     $ 30,790,105     $     $ 30,790,105  
Austria
          722,166             722,166  
Belgium
          8,656,249             8,656,249  
Brazil
    14,013,546                   14,013,546  
Denmark
          5,606,863             5,606,863  
Finland
          37,173,071             37,173,071  
France
          101,439,828             101,439,828  
Germany
          77,883,064             77,883,064  
Hong Kong
    3,324,851       15,247,466             18,572,317  
India
          909,503             909,503  
Ireland
          4,042,678             4,042,678  
Italy
          57,434,521             57,434,521  
Japan
          309,295,571             309,295,571  
Malaysia
          2,614,737             2,614,737  
Mexico
    3,128,535                   3,128,535  
Netherlands
          6,754,854             6,754,854  
New Zealand
          225,695             225,695  
Norway
          10,762,177             10,762,177  
Philippines
          3,628,964             3,628,964  
Russia
    13,060,912       8,590,489             21,651,401  
Singapore
          12,298,093             12,298,093  
South Korea
          23,583,884             23,583,884  
Spain
          11,915,579             11,915,579  
Sweden
          18,867,758             18,867,758  
Switzerland
          52,110,325             52,110,325  
Taiwan
          3,985,563             3,985,563  
Thailand
          7,225,613             7,225,613  
United Kingdom
          278,264,595             278,264,595  
 
                       
TOTAL COMMON STOCKS
    33,527,844       1,090,029,411             1,123,557,255  
 
                       
Preferred Stocks
                               
Brazil
    5,777,687                   5,777,687  
Germany
          1,879,540             1,879,540  
South Korea
          4,309,154             4,309,154  
 
                       
TOTAL PREFERRED STOCKS
    5,777,687       6,188,694             11,966,381  
 
                       
Rights/Warrants
                               
South Korea
          141,438             141,438  
United Kingdom
          32,930             32,930  
 
                       
TOTAL RIGHTS/WARRANTS
          174,368             174,368  
 
                       
Total Short-Term Investments
    58,557,667                   58,557,667  
 
                       
Total Investments
    97,863,198       1,096,392,473             1,194,255,671  
 
                       
Derivatives*
                               
Forward Currency Contracts
                               
Foreign Currency Risk
          1,428,094             1,428,094  
 
                       
Total Derivatives
          1,428,094             1,428,094  
 
                       
Total
  $ 97,863,198     $ 1,097,820,567     $     $ 1,195,683,765  
 
                       

 


 

The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
 
*    Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant unobservable inputs (Level 3) were used in determining value:
                                                                                   
                                                                              Net Change in  
                                                                              Unrealized  
                                                                              Appreciation  
                                            Change in                               (Depreciation)  
    Balances as                     Accrued     Total     Unrealized                               from Investments  
    of February                     Discounts/     Realized     Appreciation     Transfers     Transfers out     Balances as       Still Held as of  
    28, 2011     Purchases     Sales     Premiums     Gain/(Loss)     (Depreciation)     into Level 3*     of Level 3*     of November 30, 2011       November 30, 2011  
Common Stocks
         
Thailand
  $ 3,966,670         $ (3,910,885 )   $     $ (33,316 )   $ (22,469 )   $     $     $       $  
 
                                                             
Total
  $ 3,966,670         $ (3,910,885 )   $     $ (33,316 )   $ (22,469 )   $     $     $       $  
 
                                                             
 
*   The Fund accounts for investments and derivatives transferred into Level 3 at the value at the beginning of the period and transferred out of Level 3 at the value at the end of the period.

 


 

Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If the Fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of value of those investments. Declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.

 


 

Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
Leveraging Risk — The Fund’s use of derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies or in industries with high positive correlations to one another creates additional risk.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Among other trading agreements, the Fund is party to International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Agreements”) or other similar types of agreements with selected counterparties that generally govern over-the-counter derivative transactions entered into by the Fund. The ISDA Agreements typically include representations and warranties as well as contractual terms related to collateral, events of default, termination events, and other provisions. Termination events may include the decline in the net assets of the Fund below a certain level over a specified period of time and entitle a counterparty to elect to terminate early with respect to some or all the transactions under the ISDA Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse effect on the Fund’s operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. For example, the Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives, to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives. The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For example, if the Fund holds a large proportion of stocks of companies in a particular sector and the Manager believes that stocks of companies in another sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index). In adjusting its investment exposure, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.

 


 

The Fund does not employ leverage as a principal investment strategy, but the Fund may have net long exposures in excess of its net assets. The Fund’s foreign currency exposure may differ significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency

 


 

exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most forward currency contracts are not collateralized. During the period ended November 30, 2011, the Fund used forward currency contracts to manage against anticipated currency exchange rate changes. Forward currency contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded (unless otherwise adjusted due to the time at which foreign markets close). The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of

 


 

available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers (unless otherwise adjusted due to the time at which foreign markets close) and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and

 


 

may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. During the period ended November 30, 2011, the Fund held rights and/or warrants received as a result of corporate actions. Rights and/or warrants held by the Fund at the end of the period are listed in the Fund’s Schedule of Investments.
The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Assets:
                                               
Investments, at value (rights and/or warrants)
  $     $     $     $ 174,368     $     $ 174,368  
Unrealized appreciation on forward currency contracts
          1,428,094                         1,428,094  
 
                                   
Total
  $     $ 1,428,094     $     $ 174,368     $     $ 1,602,462  
 
                                   
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts and rights and/or warrants) outstanding at each month-end, was as follows for the period ended November 30, 2011:
                 
    Forward        
    Currency     Rights and/or  
    Contracts     Warrants  
Average amount outstanding
  $ 27,874,005     $ 1,955,774  

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Foreign Small Companies Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares     Description   Value ($)  
 
       
COMMON STOCKS — 95.7%
       
       
 
       
       
Australia — 3.6%
       
  249,244    
Aquarius Platinum Ltd
    670,684  
  1,288,353    
Asciano Group
    2,095,124  
  243,908    
Billabong International Ltd
    954,847  
  3,407,775    
Dexus Property Group (REIT)
    3,082,807  
  511,521    
Iress Market Technology Ltd
    4,081,095  
  347,519    
Nufarm Ltd *
    1,755,271  
  1,527,883    
Pacific Brands Ltd
    851,959  
  198,843    
PanAust Ltd *
    692,526  
  391,677    
Primary Health Care Ltd
    1,328,056  
  197,476    
Seven West Media Ltd
    696,931  
  3,348,485    
Ten Network Holdings Ltd
    3,165,289  
       
 
     
       
Total Australia
    19,374,589  
       
 
     
       
 
       
       
Austria — 0.4%
       
  16,047    
Flughafen Wien AG
    617,936  
  8,600    
Lenzing AG
    782,813  
  58,311    
Wienerberger AG
    618,912  
       
 
     
       
Total Austria
    2,019,661  
       
 
     
       
 
       
       
Belgium — 1.6%
       
  40,914    
CMB Cie Maritime Belge SA
    877,977  
  38,030    
Compagnie d’Entreprises CFE
    1,986,188  
  41,011    
Mobistar SA
    2,242,581  
  50,893    
SA D’Ieteren NV
    2,405,299  
  26,961    
Umicore SA
    1,160,762  
       
 
     
       
Total Belgium
    8,672,807  
       
 
     
       
 
       
       
Brazil — 3.4%
       
  204,400    
Aliansce Shopping Centers SA
    1,593,740  
  480,000    
Brasil Brokers Participacoes SA
    1,616,501  
  129,500    
Brasil Insurance Participacoes e Administracao SA
    1,278,279  
  220,000    
Brazil Pharma SA *
    2,109,547  
  423,600    
Cia Hering
    8,971,648  
  207,000    
Iochpe-Maxion SA
    2,552,659  
       
 
     
       
Total Brazil
    18,122,374  
       
 
     
       
 
       
       
Canada — 4.3%
       
  151,340    
Alamos Gold Inc
    2,559,552  
  657,000    
Canaco Resources Inc *
    908,250  
  700,000    
Chinook Energy Inc *
    1,029,462  
  87,100    
Corus Entertainment Inc Class B
    1,617,407  
  113,200    
Flint Energy Services Ltd *
    1,429,497  
  625,000    
Gran Colombia Gold Corp *(a)
    324,771  
  128,250    
Gran Colombia Gold Corp *
    66,643  
  475,100    
Guide Exploration Ltd Class A *
    1,457,976  
  166,300    
Just Energy Group Inc
    1,671,234  
  123,700    
Karnalyte Resources Inc *
    1,597,264  
  172,300    
Karnalyte Resources Inc (a)
    2,224,806  
  349,500    
NuVista Energy Ltd *
    1,548,841  
  224,800    
Precision Drilling Corp *
    2,598,551  
  763,100    
RMP Energy Inc *
    1,645,983  
  332,550    
Western Energy Services Corp *
    2,523,591  
       
 
     
       
Total Canada
    23,203,828  
       
 
     

 


 

                 
       
China — 0.4%
       
  4,605,000    
361 Degrees International Ltd
    1,979,821  
       
 
     
       
 
       
       
Denmark — 0.9%
       
  141,931    
H Lundbeck A/S
    2,750,735  
  1,527,788    
Ossur hf *
    2,113,212  
       
 
     
       
Total Denmark
    4,863,947  
       
 
     
       
 
       
       
Finland — 1.6%
       
  45,070    
Amer Sports Oyj Class A
    558,985  
  113,100    
Elisa Oyj
    2,459,396  
  72,000    
Huhtamaki Oyj
    837,906  
  593,200    
M-real Oyj B shares *
    1,135,177  
  479,518    
Oriola-KD Oyj Class B
    1,366,320  
  79,700    
Orion Oyj Class B
    1,621,282  
  147,630    
Talvivaara Mining Co Plc *
    556,686  
       
 
     
       
Total Finland
    8,535,752  
       
 
     
       
 
       
       
France — 5.1%
       
  139,127    
Boursorama *
    1,129,652  
  85,896    
Cap Gemini SA
    3,262,331  
  64,262    
Compagnie Generale des Etablissements Michelin-Class B
    4,096,590  
  107,428    
Faurecia
    2,263,795  
  112,191    
Legrand SA
    3,631,523  
  50,296    
Societe BIC SA
    4,465,346  
  62,421    
Sodexo
    4,539,837  
  25,932    
Virbac SA
    4,170,918  
       
 
     
       
Total France
    27,559,992  
       
 
     
       
 
       
       
Germany — 3.3%
       
  48,332    
Bauer AG
    1,312,371  
  62,218    
Cat Oil AG
    395,517  
  28,123    
Continental AG *
    1,996,708  
  45,917    
Gerresheimer AG
    1,931,834  
  41,970    
GSW Immobilien AG *
    1,342,724  
  36,818    
HeidelbergCement AG
    1,553,382  
  78,172    
KUKA AG *
    1,530,170  
  100,954    
NORMA Group *
    1,888,030  
  170,000    
Prime Office REIT-AG *
    1,043,840  
  61,797    
Rhoen-Klinikum AG
    1,170,204  
  112,974    
Tom Tailor Holding AG *
    2,012,634  
  38,287    
Wincor Nixdorf AG
    1,838,163  
       
 
     
       
Total Germany
    18,015,577  
       
 
     
       
 
       
       
Hong Kong — 1.3%
       
  7,073,900    
PCCW Ltd
    2,621,932  
  1,425,000    
Yue Yuen Industrial Holdings
    4,106,539  
       
 
     
       
Total Hong Kong
    6,728,471  
       
 
     
       
 
       
       
India — 0.3%
       
  302,200    
Housing Development & Infrastructure Ltd *
    359,560  
  277,400    
Orchid Chemicals & Pharmaceuticals Ltd
    833,719  
  254,100    
Rolta India Ltd
    296,239  
       
 
     
       
Total India
    1,489,518  
       
 
     
       
 
       
       
Indonesia — 0.2%
       
  4,011,000    
Borneo Lumbung Energi & Metal Tbk PT *
    370,752  

 


 

                 
  381,500    
Tambang Batubara Bukit Asam Tbk PT
    734,516  
       
 
     
       
Total Indonesia
    1,105,268  
       
 
     
       
 
       
       
Ireland — 0.8%
       
  329,129    
C&C Group Plc
    1,348,400  
  83,494    
DCC Plc
    2,021,456  
  30,100    
Kerry Group Plc Class A
    1,124,140  
       
 
     
       
Total Ireland
    4,493,996  
       
 
     
       
 
       
       
Italy — 3.5%
       
  464,323    
Autogrill SPA
    4,842,777  
  109,100    
Buzzi Unicem SPA *
    1,003,278  
  427,232    
Credito Emiliano SPA
    1,661,087  
  335,758    
Italcementi SPA-Di RISP
    920,526  
  151,165    
Lottomatica SPA *
    2,332,471  
  790,054    
Mediaset SPA
    2,335,502  
  488,436    
Mediolanum SPA
    1,784,782  
  200,000    
Piaggio & C SPA
    590,954  
  1,339,325    
Prelios SPA *
    155,610  
  115,821    
Prysmian SPA
    1,583,172  
  1,202,408    
Saras SPA *
    1,894,359  
       
 
     
       
Total Italy
    19,104,518  
       
 
     
       
 
       
       
Japan — 25.7%
       
  438,000    
Air Water Inc
    5,722,051  
  475,900    
Alps Electric Co Ltd
    3,331,823  
  1,827,000    
Aozora Bank Ltd
    4,894,226  
  230,300    
Avex Group Holding Inc
    2,613,366  
  226,900    
Century Tokyo Leasing Corp
    4,502,402  
  224,600    
Circle K Sunkus Co Ltd
    3,662,810  
  170,200    
Cosmos Pharmaceutical Corp
    8,292,320  
  400,500    
Fuji Oil Co Ltd
    5,732,866  
  155,200    
Hitachi Chemical Co Ltd
    2,996,228  
  324,700    
Hitachi Transport System Ltd
    5,457,247  
  151,400    
IRISO Electronics Co Ltd
    2,337,762  
  256,500    
Izumi Co Ltd
    3,842,232  
  507,000    
Japan Aviation Electronics Industry Ltd
    3,683,760  
  120,040    
K’s Holdings Corp
    4,731,587  
  276,900    
Keihin Corp
    4,358,624  
  1,224    
Kenedix Realty Investment Corp (REIT)
    3,498,020  
  121,500    
Kintetsu World Express Inc
    3,621,439  
  157,000    
Kyorin Co Ltd
    2,647,029  
  114,420    
Mitsubishi UFJ Lease & Finance Co Ltd
    4,380,469  
  315,300    
Nabtesco Corp
    6,943,398  
  643,500    
NHK Spring Co Ltd
    5,873,264  
  331,300    
Nihon Kohden Corp
    7,662,639  
  69,000    
Nippon Soda Co Ltd
    292,746  
  489,000    
Nissin Electric Co Ltd
    2,807,393  
  760,200    
Pioneer Corp *
    3,730,072  
  638,000    
Rengo Co Ltd
    4,539,915  
  170,200    
Saizeriya Co Ltd
    2,790,620  
  764,000    
Sanken Electric Co Ltd
    2,635,428  
  2,085,000    
Shinsei Bank Ltd
    2,112,875  
  217,200    
Sumitomo Rubber Industries
    2,605,216  
  231,300    
Takata Corp
    5,013,164  
  741,000    
Tsubakimoto Chain Co
    4,028,440  
  1,418,000    
Ube Industries Ltd
    4,011,688  

 


 

                 
  173,900    
United Arrows Ltd
    3,114,656  
       
 
     
       
Total Japan
    138,467,775  
       
 
     
       
 
       
       
Mexico — 0.4%
       
  1,221,200    
Fibra Uno Administracion SA de CV (REIT)
    2,238,967  
       
 
     
       
 
       
       
Netherlands — 2.4%
       
  131,030    
AerCap Holdings NV *
    1,409,883  
  144,481    
Arcadis NV
    2,593,804  
  76,500    
CSM NV
    1,005,482  
  99,032    
Imtech NV
    2,546,326  
  50,723    
Koninklijke Ten Cate NV
    1,471,036  
  30,762    
Nutreco Holding NV
    2,017,247  
  90,472    
SBM Offshore NV
    1,948,443  
       
 
     
       
Total Netherlands
    12,992,221  
       
 
     
       
 
       
       
New Zealand — 0.6%
       
  1,056,738    
Fisher & Paykel Appliances Holdings Ltd *
    294,827  
  170,048    
Pumpkin Patch Ltd
    79,506  
  1,120,349    
Sky City Entertainment Group Ltd
    3,004,710  
       
 
     
       
Total New Zealand
    3,379,043  
       
 
     
       
 
       
       
Norway — 2.2%
       
  729,820    
BWG Homes ASA
    1,228,635  
  88,623    
Fred Olsen Energy ASA
    2,974,693  
  78,085    
Kongsberg Gruppen ASA
    1,575,596  
  530,407    
ProSafe ASA
    3,999,778  
  295,810    
SpareBank 1 SR Bank
    2,129,580  
       
 
     
       
Total Norway
    11,908,282  
       
 
     
       
 
       
       
Philippines — 1.3%
       
  12,352,000    
Alliance Global Group Inc
    2,948,818  
  1,061,100    
Cebu Air Inc
    1,726,341  
  5,938,800    
Puregold Price Club Inc *
    2,083,073  
       
 
     
       
Total Philippines
    6,758,232  
       
 
     
       
 
       
       
Russia — 0.3%
       
  99,423    
Cherkizovo Group GDR (Registered) *
    1,488,461  
       
 
     
       
 
       
       
Singapore — 1.1%
       
  605,000    
ComfortDelgro Corp Ltd
    672,754  
  3,725,000    
First Ship Lease Trust
    859,050  
  2,587,640    
Mapletree Logistics Trust (REIT)
    1,693,134  
  854,000    
MobileOne Ltd
    1,629,966  
  985,000    
Petra Foods Ltd
    1,312,389  
       
 
     
       
Total Singapore
    6,167,293  
       
 
     
       
 
       
       
South Korea — 5.7%
       
  209,083    
CrucialTec Co Ltd *
    3,344,599  
  20,750    
Daelim Industrial Co Ltd
    1,846,115  
  290,330    
DGB Financial Group Inc *
    3,419,645  
  42,990    
Golfzon Co Ltd *
    2,079,603  
  442,142    
Kortek Corp
    4,164,128  
  250,000    
Magnachip Semiconductor Corp *
    2,002,500  
  13,095    
Mando Corp
    2,391,495  
  27,560    
Mirae Asset Securities Co Ltd
    838,579  
  10,467    
Nong Shim Co Ltd
    2,168,688  
  35,140    
S1 Corp
    1,781,593  

 


 

                 
  17,730    
Sindoh Co Ltd
    783,447  
  5,600    
SK Holdings Co Ltd
    729,436  
  81,600    
Tong Yang Life Insurance Co Ltd
    1,096,565  
  79,520    
Youngone Holding Co Ltd
    4,317,971  
       
 
     
       
Total South Korea
    30,964,364  
       
 
     
       
 
       
       
Spain — 1.2%
       
  146,205    
Banco Espanol de Credito SA
    704,785  
  2,662    
Construcciones y Auxiliar de Ferrocarriles SA
    1,425,855  
  150,968    
Enagas
    2,832,760  
  33,034    
Red Electrica de Espana
    1,452,157  
       
 
     
       
Total Spain
    6,415,557  
       
 
     
       
 
       
       
Sweden — 2.2%
       
  103,561    
Elekta AB Class B
    4,409,272  
  205,781    
Getinge AB Class B
    5,304,444  
  1,994,403    
Trigon Agri A/S *
    2,399,163  
       
 
     
       
Total Sweden
    12,112,879  
       
 
     
       
 
       
       
Switzerland — 2.9%
       
  7,227    
Alpiq Holding AG (Registered)
    1,229,214  
  100,479    
Aryzta AG
    4,850,775  
  10,921    
Kaba Holding AG Class B (Registered)
    3,847,718  
  29,275    
Sulzer AG
    3,268,036  
  13,617    
Valora Holding AG
    2,582,221  
       
 
     
       
Total Switzerland
    15,777,964  
       
 
     
       
 
       
       
Taiwan — 0.2%
       
  640,982    
Altek Corp
    523,855  
  434,500    
Coretronic Corp
    320,627  
       
 
     
       
Total Taiwan
    844,482  
       
 
     
       
 
       
       
Thailand — 0.4%
       
  15,969,100    
Quality Houses PCL (Foreign Registered) (b)
    725,347  
  10,770,200    
SVI PCL (Foreign Registered) (b)
    1,180,166  
       
 
     
       
Total Thailand
    1,905,513  
       
 
     
       
 
       
       
United Kingdom — 18.4%
       
  401,205    
Babcock International Group Plc
    4,581,378  
  228,267    
Berkeley Group Holdings Plc (Unit Shares) *
    4,595,993  
  983,386    
Centaur Media Plc
    599,404  
  214,443    
Charter International Plc
    3,147,647  
  516,156    
Diploma Plc
    2,708,553  
  497,482    
Euromoney Institutional Investor Plc
    5,443,531  
  1,482,352    
F&C Asset Management Plc
    1,610,849  
  878,781    
Filtrona Plc
    5,423,953  
  589,351    
Great Portland Estates Plc (REIT)
    3,271,115  
  682,417    
Inchcape Plc
    3,505,051  
  1,320,418    
ITE Group Plc
    4,187,869  
  503,032    
James Fisher & Sons Plc
    3,912,294  
  383,282    
John Wood Group Plc
    3,938,697  
  1,016,645    
Jupiter Fund Management Plc
    3,564,978  
  3,073,885    
KCOM Group Plc
    3,629,449  
  119,354    
Kier Group Plc
    2,658,687  
  1,683,237    
Lupus Capital Plc
    2,613,149  
  1,122,251    
Metric Property Investments Plc (REIT)
    1,589,723  
  613,952    
N Brown Group
    2,569,332  
  811,850    
National Express Group Plc
    2,682,887  

 


 

                 
  537,139    
Premier Oil Plc *
    3,085,418  
  447,287    
PZ Cussons Plc
    2,524,956  
  662,329    
Restaurant Group Plc
    3,179,392  
  1,039,336    
RPS Group Plc
    3,082,487  
  1,698,286    
Senior Plc
    4,700,172  
  163,885    
Travis Perkins Plc
    2,151,578  
  138,786    
Ultra Electronics Holdings Plc
    3,155,256  
  94,826    
Weir Group Plc (The)
    3,082,264  
  834,233    
WM Morrison Supermarkets Plc
    4,229,430  
  890,880    
WSP Group Plc
    2,883,521  
  70,000    
XP Power Ltd
    1,044,938  
       
 
     
       
Total United Kingdom
    99,353,951  
       
 
     
       
TOTAL COMMON STOCKS (COST $519,994,487)
    516,045,103  
       
 
     
       
 
       
       
PREFERRED STOCKS — 1.1%
       
       
 
       
       
Brazil — 0.5%
       
  628,000    
Marcopolo SA 2.96%
    2,833,788  
       
 
     
       
 
       
       
Chile — 0.4%
       
  1,100,000    
Coca-Cola Embonor SA Class B 2.97%
    1,883,642  
       
 
     
       
 
       
       
South Korea — 0.2%
       
  63,170    
Daelim Industrial Co Ltd 0.68%
    1,228,526  
       
 
     
       
TOTAL PREFERRED STOCKS (COST $5,189,216)
    5,945,956  
       
 
     
       
 
       
       
RIGHTS/WARRANTS — 0.0%
       
       
 
       
       
Canada — 0.0%
       
  312,500    
Gran Colombia Gold Corp Warrants, Expires 08/24/15*
    52,086  
       
 
     
       
TOTAL RIGHTS/WARRANTS (COST $114,573)
    52,086  
       
 
     
                 
Par Value     Description   Value ($)  
 
       
SHORT-TERM INVESTMENTS — 3.2%
       
       
 
       
       
Time Deposits — 3.2%
       
USD 7,000,000    
Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11
    7,000,000  
CAD 19,978    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.25%, due 12/01/11
    19,587  
NZD 87    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 1.75%, due 12/01/11
    68  
JPY 23,796,441    
Citibank (New York) Time Deposit, 0.01%, due 12/01/11
    306,826  
SGD 41,144    
Citibank (New York) Time Deposit, 0.01%, due 12/01/11
    32,102  
USD 4,333,293    
Citibank (New York) Time Deposit, 0.03%, due 12/01/11
    4,333,293  
AUD 176,136    
JPMorgan Chase (New York) Time Deposit, 3.78%, due 12/01/11
    181,138  
EUR 3,981,814    
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11
    5,350,363  
GBP 113,996    
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11
    178,848  
       
 
     
       
Total Time Deposits
    17,402,225  
       
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $17,402,225)
    17,402,225  
       
 
     

 


 

                 
       
TOTAL INVESTMENTS — 100.0%
(Cost $542,700,501)
    539,445,370  
 
       
Other Assets and Liabilities (net) — (0.0%)
    (211,376 )
       
 
     
 
       
TOTAL NET ASSETS — 100.0%
  $ 539,233,994  
       
 
     
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
                                         
                                    Net Unrealized  
Settlement                                   Appreciation  
Date   Counterparty   Deliver/Receive   Units of Currency   Value   (Depreciation)  
Sales #
                                       
12/06/11
  Deutsche Bank AG   EUR     1,913,500     $ 2,571,179     $ 48,689  
12/06/11
  HSBC Bank   EUR     1,913,500       2,571,179       48,689  
                                   
 
                          $ 5,142,358     $ 97,378  
                                   
 
#   Fund sells foreign currency; buys USD.
Notes to Schedule of Investments:
Foreign Registered — Shares issued to foreign investors in markets that have foreign ownership limits.
GDR — Global Depository Receipt
REIT — Real Estate Investment Trust
     
*   Non-income producing security.
 
(a)   144A — Securities exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional investors.
 
(b)   Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust.
Currency Abbreviations:
AUD — Australian Dollar
CAD — Canadian Dollar
EUR — Euro
GBP — British Pound
JPY — Japanese Yen
NZD — New Zealand Dollar
SGD — Singapore Dollar
USD — United States Dollar

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                         
    Gross     Gross     Net Unrealized  
    Unrealized     Unrealized     Appreciation  
Aggregate Cost   Appreciation     (Depreciation)     (Depreciation)  
$546,447,334
  $ 62,346,310     $ (69,348,274 )   $ (7,001,964 )

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivatives contracts based on the creditworthiness of its counterparties. As of November 30, 2011, the total value of securities held directly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 0.4% of net assets. The Fund classifies such securities (levels defined below) as Level 3. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below.
       
Security Type     Percentage of Net Assets of the Fund
Equity Securities
    86.5 %
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include: fair value adjustments provided by an independent pricing service applied to equity securities (including the value of equity securities that

 


 

underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) due to market events that have occurred since the local market close but prior to the close of the NYSE.
Level 3 — Valuations based primarily on inputs that are unobservable and significant. The Fund used the following fair value technique on Level 3 investments: Certain of the Fund’s securities in Thailand were valued at the local price as adjusted by applying a premium or discount when the holdings exceed foreign ownership limitations.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assests     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
 
Common Stocks
                               
Australia
  $     $ 19,374,589     $     $ 19,374,589  
Austria
          2,019,661             2,019,661  
Belgium
          8,672,807             8,672,807  
Brazil
    18,122,374                   18,122,374  
Canada
    23,203,828                   23,203,828  
China
          1,979,821             1,979,821  
Denmark
          4,863,947             4,863,947  
Finland
          8,535,752             8,535,752  
France
          27,559,992             27,559,992  
Germany
          18,015,577             18,015,577  
Hong Kong
          6,728,471             6,728,471  
India
          1,489,518             1,489,518  
Indonesia
          1,105,268             1,105,268  
Ireland
          4,493,996             4,493,996  
Italy
          19,104,518             19,104,518  
Japan
          138,467,775             138,467,775  
Mexico
    2,238,967                   2,238,967  
Netherlands
    1,409,883       11,582,338             12,992,221  
New Zealand
          3,379,043             3,379,043  
Norway
          11,908,282             11,908,282  
Philippines
    2,083,073       4,675,159             6,758,232  
Russia
          1,488,461             1,488,461  
Singapore
          6,167,293             6,167,293  
South Korea
    2,002,500       28,961,864             30,964,364  
Spain
          6,415,557             6,415,557  
Sweden
          12,112,879             12,112,879  
Switzerland
          15,777,964             15,777,964  
Taiwan
          844,482             844,482  
Thailand
                1,905,513       1,905,513  
United Kingdom
          99,353,951             99,353,951  
                         
TOTAL COMMON STOCKS
    49,060,625       465,078,965       1,905,513       516,045,103  
                         
Preferred Stocks
                               
Brazil
    2,833,788                   2,833,788  
Chile
    1,883,642                   1,883,642  
South Korea
          1,228,526             1,228,526  
                         
TOTAL PREFERRED STOCKS
    4,717,430       1,228,526             5,945,956  
                         
Rights/Warrants
                               
Canada
          52,086             52,086  
                         
TOTAL RIGHTS/WARRANTS
          52,086             52,086  
                         
Short-Term Investments
    17,402,225                   17,402,225  
                         
Total Investments
    71,180,280       466,359,577       1,905,513       539,445,370  
                         
Derivatives*
                               
Forward Currency Contracts
                               
Foreign currency risk
          97,378             97,378  
                         
Total
  $ 71,180,280     $ 466,456,955     $ 1,905,513     $ 539,542,748  
                         

 


 

The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
* Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
The aggregate net value of the Fund’s direct investments in securities using Level 3 inputs was 0.4% of total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant unobservable inputs (Level 3) were used in determining value:

 


 

                                                                                   
                                                                              Net Change in  
                                                                              Unrealized  
                                                                              Appreciation  
                                                                              (Depreciation)  
                                                                              from  
                                            Change in                               Investments  
    Balances as of                     Accrued     Total     Unrealized                     Balances as       Still Held as of  
    February 28,                     Discounts/     Realized     Appreciation     Transfers into     Transfers out of     of November 30,       November 30,  
    2011     Purchases     Sales     Premiums     Gain/(Loss)     (Depreciation)     level 3 *     level 3 *     2011       2011  
Common Stocks
Thailand
  $ 921,051     $ 2,468,778     $ (433,494 )   $     $ (275,209 )   $ (775,613 )   $     $     $ 1,905,513       $ (775,613 )
 
                                                             
 
                                                                           
Total
  $ 921,051     $ 2,468,778     $ (433,494 )   $     $ (275,209 )   $ (775,613 )   $     $     $ 1,905,513       $ (775,613 )
 
                                                             
 
*   The Fund accounts for investments and derivatives transferred into Level 3 at the value at the beginning of the period and transferred out of Level 3 at the value at the end of the period.

 


 

Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Smaller Company Risk— Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If the Fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of value of those investments. Declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies.
Liquidity Risk — Shares of small- and mid-cap companies often have lower trading volumes and a limited number or no market makers. Thus, a large position may limit or prevent the Fund from selling those shares or unwinding derivative positions on them at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include

 


 

the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Leveraging Risk — The Fund’s use of derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies or in industries with high positive correlations to one another creates additional risk.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Among other trading agreements, the Fund is party to International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Agreements”) or other similar types of agreements with selected counterparties that generally govern over-the-counter derivative transactions entered into by the Fund. The ISDA Agreements typically include representations and warranties as well as contractual terms related to collateral, events of default, termination events, and other provisions. Termination events may include the decline in the net assets of the Fund below a certain level over a specified period of time and entitle a counterparty to elect to terminate early with respect to some or all the transactions under the ISDA Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse effect on the Fund’s operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. For example, the Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives, to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives. The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For example, if the Fund holds a large proportion of stocks of companies in a particular sector and the Manager believes that stocks of companies in another sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index). In adjusting their investment exposure, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net long exposures in excess of its net assets. The Fund’s foreign currency exposure may differ significantly from the currency exposure represented by its investments.

 


 

The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.

 


 

These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most forward currency contracts are not collateralized. During the period ended November 30, 2011, the Fund used forward currency contracts to manage against anticipated currency exchange rate changes. Forward currency contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded (unless otherwise adjusted due to the time at which foreign markets close). The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.

 


 

Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers (unless otherwise adjusted due to the time at which foreign markets close) and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. During the

 


 

period ended November 30, 2011, the Fund held rights and/or warrants received as a result of corporate actions. Rights and/or warrants held by the Fund at the end of the period are listed in the Fund’s Schedule of Investments.

 


 

The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Assets:
                                               
Investments, at value (rights and/or warrants)
  $     $     $     $ 52,086     $     $ 52,086  
Unrealized appreciation on forward currency contracts
          97,378                         97,378  
 
                                   
Total
  $     $ 97,378     $     $ 52,086     $     $ 149,464  
 
                                   
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
 
The volume of derivative activity, based on absolute values (forward currency contracts and rights and/or warrants) outstanding at each month-end, was as follows for the period ended November 30, 2011:
                 
    Forward        
    Currency     Rights and /or  
    Contracts     Warrants  
Average amount outstanding
  $ 1,350,135     $ 199,333  

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Global Asset Allocation Fund
(formerly GMO Global Balanced Asset Allocation Fund)
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
             
Shares / Par Value ($)   Description   Value ($)  
 
       
MUTUAL FUNDS — 98.9%
       
       
 
       
       
Affiliated Issuers — 98.9%
       
  19,982,387    
GMO Alpha Only Fund, Class IV
    497,361,623  
  1,463,575    
GMO Asset Allocation Bond Fund, Class VI
    35,886,863  
  23,737,369    
GMO Domestic Bond Fund, Class VI
    70,262,611  
  1,652,011    
GMO Emerging Country Debt Fund, Class IV
    15,644,547  
  30,412,253    
GMO Emerging Markets Fund, Class VI
    355,519,234  
  6,481,654    
GMO Flexible Equities Fund, Class VI
    111,095,552  
  11,694,720    
GMO International Core Equity Fund, Class VI
    308,857,556  
  6,881,116    
GMO International Growth Equity Fund, Class IV
    147,255,885  
  12,448,686    
GMO International Intrinsic Value Fund, Class IV
    242,749,374  
  37,507,629    
GMO Quality Fund, Class VI
    819,166,611  
  356,591    
GMO Short-Duration Investment Fund, Class III
    2,945,445  
  4,698,916    
GMO Special Situations Fund, Class VI
    124,239,343  
  22,084,117    
GMO Strategic Fixed Income Fund, Class VI
    375,871,669  
  1,016,189    
GMO World Opportunity Overlay Fund
    23,982,062  
       
 
     
       
TOTAL MUTUAL FUNDS (COST $2,892,791,213)
    3,130,838,375  
       
 
     
       
 
       
       
DEBT OBLIGATIONS — 1.1%
       
       
 
       
       
Asset-Backed Securities — 1.1%
       
       
 
       
       
Airlines — 0.0%
       
  491,736    
Aircraft Finance Trust, Series 99-1A, Class A1, 144A, 1 mo. LIBOR + .48%, 0.73%, due 05/15/24
    236,033  
       
 
     
       
 
       
       
Auto Financing — 0.1%
       
  133,660    
Capital Auto Receivable Asset Trust, Series 08-1, Class A4B, 1 mo. LIBOR + 1.35%, 1.60%, due 07/15/14
    134,078  
  612,695    
Carmax Auto Owner Trust, Series 08-2, Class A4B, 1 mo. LIBOR + 1.65%, 1.90%, due 08/15/13
    616,426  
  309,607    
Daimler Chrysler Auto Trust, Series 08-B, Class A4A, 5.32%, due 11/10/14
    311,309  
  265,377    
Daimler Chrysler Auto Trust, Series 08-B, Class A4B, 1 mo. LIBOR + 1.85%, 2.10%, due 11/10/14
    266,041  
  548,833    
Ford Credit Auto Owner Trust, Series 08-B, Class A4B, 1 mo. LIBOR + 2.00%, 2.25%, due 03/15/13
    551,275  
  20,400    
Franklin Auto Trust, Series 08-A, Class A4B, 1 mo. LIBOR + 1.95%, 2.20%, due 05/20/16
    20,420  
  258,720    
Wachovia Auto Owner Trust, Series 08-A, Class A4B, 1 mo. LIBOR + 1.15%, 1.40%, due 03/20/14
    259,598  
       
 
     
       
Total Auto Financing
    2,159,147  
       
 
     
       
 
       
       
Business Loans — 0.1%
       
  120,015    
ACAS Business Loan Trust, Series 07-1A, Class A, 144A, 3 mo. LIBOR + .14%, 0.60%, due 08/16/19
    117,015  
  74,746    
Bayview Commercial Asset Trust, Series 04-1, Class A, 144A, 1 mo. LIBOR + .36%, 0.62%, due 04/25/34
    56,807  
  53,927    
Bayview Commercial Asset Trust, Series 04-3, Class A1, 144A, 1 mo. LIBOR + .37%, 0.63%, due 01/25/35
    40,445  
  265,509    
Bayview Commercial Asset Trust, Series 05-4A, Class A2, 144A, 1 mo. LIBOR + .39%, 0.65%, due 01/25/36
    167,271  
  242,471    
Bayview Commercial Asset Trust, Series 07-3, Class A1, 144A, 1 mo. LIBOR + .24%, 0.50%, due 07/25/37
    152,757  
  954,830    
Bayview Commercial Asset Trust, Series 07-6A, Class A2, 144A, 1 mo. LIBOR + 1.30%, 1.56%, due 12/25/37
    668,381  
  72,678    
GE Business Loan Trust, Series 04-1, Class A, 144A, 1 mo. LIBOR + .29%, 0.54%, due 05/15/32
    64,320  
  119,474    
GE Business Loan Trust, Series 05-2A, Class A, 144A, 1 mo. LIBOR + .24%, 0.49%, due 11/15/33
    97,969  
  199,686    
Lehman Brothers Small Balance Commercial, Series 05-1A, Class A, 144A, 1 mo. LIBOR + .25%, 0.51%, due 02/25/30
    153,670  

 


 

                 
  159,280    
Lehman Brothers Small Balance Commercial, Series 05-2A, Class 1A, 144A, 1 mo. LIBOR + .25%, 0.51%, due 09/25/30
    125,656  
  388,984    
Lehman Brothers Small Balance Commercial, Series 07-3A, Class 1A2, 144A, 1 mo. LIBOR + .85%, 1.11%, due 10/25/37
    311,040  
       
 
     
       
Total Business Loans
    1,955,331  
       
 
     
       
 
       
       
CMBS — 0.1%
       
  341,936    
Citigroup/Deutsche Bank Commercial Mortgage, Series 05-CD1, Class A2FL, 1 mo. LIBOR + .12%, 0.37%, due 07/15/44
    337,662  
  1,100,000    
Commercial Mortgage Pass-Through Certificates, Series 06-FL12, Class AJ, 144A, 1 mo. LIBOR + .13%, 0.38%, due 12/15/20
    995,500  
  292,800    
GE Capital Commercial Mortgage Corp., Series 05-C4, Class A2, 5.31%, due 11/10/45
    292,800  
  383,390    
GE Capital Commercial Mortgage Corp., Series 06-C1, Class A2, 5.33%, due 03/10/44
    383,390  
  491,883    
GS Mortgage Securities Corp., Series 06-GG6, Class A2, 5.51%, due 04/10/38
    496,648  
  194,890    
GS Mortgage Securities Corp., Series 07-EOP, Class A1, 144A, 1 mo. LIBOR + .39%, 1.14%, due 03/06/20
    192,941  
  300,000    
GS Mortgage Securities Corp., Series 07-EOP, Class A2, 144A, 1 mo. LIBOR + .57%, 1.32%, due 03/06/20
    297,000  
  123,417    
J.P. Morgan Chase Commercial Mortgage Securities Corp., Series 06-LDP7, Class A2, 5.86%, due 04/15/45
    123,491  
  618,019    
Merrill Lynch Mortgage Trust, Series 06-C1, Class A2, 5.62%, due 05/12/39
    630,132  
  257,619    
Morgan Stanley Capital I, Series 06-IQ11, Class A3, 5.69%, due 10/15/42
    262,640  
  516,025    
Wachovia Bank Commercial Mortgage Trust, Series 06-WL7A, Class A1, 144A, 1 mo. LIBOR + .09%, 0.34%, due 09/15/21
    490,223  
       
 
     
       
Total CMBS
    4,502,427  
       
 
     
       
 
       
       
CMBS Collateralized Debt Obligations — 0.0%
       
  499,812    
American Capital Strategies Ltd. Commercial Real Estate CDO Trust, Series 07-1A, Class A, 144A, 3 mo. LIBOR + .80%, 1.30%, due 11/23/52
    4,998  
  297,845    
G-Force LLC, Series 05-RR2, Class A2, 144A, 5.16%, due 12/25/39
    279,975  
  133,000    
Guggenheim Structured Real Estate Funding, Series 05-2A, Class A, 144A, 1 mo. LIBOR + .32%, 0.58%, due 08/26/30
    122,692  
  766,126    
Marathon Real Estate CDO, Series 06-1A, Class A1, 144A, 1 mo. LIBOR + .33%, 0.59%, due 05/25/46
    559,272  
       
 
     
       
Total CMBS Collateralized Debt Obligations
    966,937  
       
 
     
       
 
       
       
Corporate Collateralized Debt Obligations — 0.0%
       
  1,000,000    
Morgan Stanley ACES SPC, Series 06-13A, Class A, 144A, 3 mo. LIBOR + .29%, 0.64%, due 06/20/13
    880,900  
       
 
     
       
 
       
       
Credit Cards — 0.1%
       
  1,300,000    
Charming Shoppes Master Trust, Series 07-1A, Class A1, 144A, 1 mo. LIBOR + 1.25%, 1.50%, due 09/15/17
    1,302,145  
  400,000    
World Financial Network Credit Card Master Trust, Series 06-A, Class A, 144A, 1 mo. LIBOR + .13%, 0.38%, due 02/15/17
    396,876  
       
 
     
       
Total Credit Cards
    1,699,021  
       
 
     
       
 
       
       
Insured Auto Financing — 0.1%
       
  208,280    
AmeriCredit Automobile Receivables Trust, Series 07-AX, Class A4, XL, 1 mo. LIBOR + .04%, 0.29%, due 10/06/13
    207,760  
  172,187    
AmeriCredit Automobile Receivables Trust, Series 07-BF, Class A4, FSA, 1 mo. LIBOR + .05%, 0.30%, due 12/06/13
    172,183  
  228,701    
AmeriCredit Automobile Receivables Trust, Series 07-DF, Class A4B, FSA, 1 mo. LIBOR + .80%, 1.05%, due 06/06/14
    228,583  
  413,132    
AmeriCredit Prime Automobile Receivable Trust, Series 07-2M, Class A4B, MBIA, 1 mo. LIBOR + .50%, 0.75%, due 03/08/16
    411,562  

 


 

                 
  1,258,896    
Triad Auto Receivables Owner Trust, Series 07-B, Class A4B, FSA, 1 mo. LIBOR + 1.20%, 1.45%, due 07/14/14
    1,265,027  
       
 
     
       
Total Insured Auto Financing
    2,285,115  
       
 
     
       
 
       
       
Insured Business Loans — 0.0%
       
  223,971    
CNL Commercial Mortgage Loan Trust, Series 03-2A, Class A1, 144A, AMBAC, 1 mo. LIBOR + .44%, 0.70%, due 10/25/30
    162,379  
       
 
     
       
 
       
       
Insured High Yield Collateralized Debt Obligations § — 0.0%
       
  14,332    
GSC Partners CDO Fund Ltd., Series 03-4A, Class A3, 144A, AMBAC, 3 mo. LIBOR + .46%, 0.87%, due 12/16/15
    14,117  
       
 
     
       
 
       
       
Insured Other — 0.1%
       
  1,500,000    
Dominos Pizza Master Issuer LLC, Series 07-1, Class A2, 144A, MBIA, 5.26%, due 04/25/37
    1,505,775  
  598,060    
Henderson Receivables LLC, Series 06-3A, Class A1, 144A, MBIA, 1 mo. LIBOR + .20%, 0.45%, due 09/15/41
    529,914  
  592,807    
Henderson Receivables LLC, Series 06-4A, Class A1, 144A, MBIA, 1 mo. LIBOR + .20%, 0.45%, due 12/15/41
    527,390  
  300,497    
TIB Card Receivables Fund, Series 2005-B,144A, FGIC, 3 mo. LIBOR + .25%, 0.63%, due 01/05/14
    240,398  
  100,000    
Toll Road Investment Part II, Series B, 144A, MBIA, Zero Coupon, due 02/15/30
    13,533  
  900,000    
Toll Road Investment Part II, Series C, 144A, MBIA, Zero Coupon, due 02/15/37
    56,331  
       
 
     
       
Total Insured Other
    2,873,341  
       
 
     
       
 
       
       
Insured Residential Asset-Backed Securities (United States) — 0.0%
       
  71,166    
Ameriquest Mortgage Securities, Inc., Series 04-R6, Class A1, XL, 1 mo. LIBOR + .21%, 0.68%, due 07/25/34
    56,221  
  85,059    
Citigroup Mortgage Loan Trust, Inc., Series 03-HE3, Class A, AMBAC, 1 mo. LIBOR + .38%, 0.64%, due 12/25/33
    68,472  
  23,574    
Quest Trust, Series 04-X1, Class A, 144A, AMBAC, 1 mo. LIBOR + .33%, 0.59%, due 03/25/34
    17,681  
  350,433    
Residential Asset Mortgage Products, Inc., Series 05-RS9, Class AI3, FGIC, 1 mo. LIBOR + .22%, 0.48%, due 11/25/35
    245,303  
       
 
     
       
Total Insured Residential Asset-Backed Securities (United States)
    387,677  
       
 
     
       
 
       
       
Insured Residential Mortgage-Backed Securities (United States) — 0.0%
       
  12,867    
Chevy Chase Mortgage Funding Corp., Series 03-4A, Class A1, 144A, AMBAC, 1 mo. LIBOR + .34%, 0.60%, due 10/25/34
    8,222  
  35,123    
Chevy Chase Mortgage Funding Corp., Series 04-1A, Class A2, 144A, AMBAC, 1 mo. LIBOR + .33%, 0.59%, due 01/25/35
    21,952  
  271,862    
Countrywide Home Equity Loan Trust, Series 07-E, Class A, MBIA, 1 mo. LIBOR + .15%, 0.40%, due 06/15/37
    160,398  
  176,410    
GMAC Mortgage Corp. Loan Trust, Series 04-HE3, Class A3, FSA, 1 mo. LIBOR + .23%, 0.49%, due 10/25/34
    123,769  
  8,154    
GreenPoint Home Equity Loan Trust, Series 04-1, Class A, AMBAC, 1 mo. LIBOR + .23%, 0.72%, due 07/25/29
    5,489  
  11,538    
GreenPoint Home Equity Loan Trust, Series 04-4, Class A, AMBAC, 1 mo. LIBOR + .28%, 0.81%, due 08/15/30
    7,127  
  18,600    
Lehman ABS Corp., Series 04-2, Class A, AMBAC, 1 mo. LIBOR + .22%, 0.70%, due 06/25/34
    12,276  
  5,030    
Residential Funding Mortgage Securities II, Series 03-HS1, Class AII, FGIC, 1 mo. LIBOR + .29%, 0.55%, due 12/25/32
    1,459  
  125,526    
SBI Heloc Trust, Series 05-HE1, Class 1A, 144A, FSA, 1 mo. LIBOR + .19%, 0.45%, due 11/25/35
    113,714  
       
 
     
       
Total Insured Residential Mortgage-Backed Securities (United States)
    454,406  
       
 
     
       
 
       
       
Insured Time Share — 0.0%
       
  65,367    
Sierra Receivables Funding Co., Series 06-1A, Class A2, 144A, MBIA, 1 mo. LIBOR + .15%, 0.40%, due 05/20/18
    64,693  
  86,705    
Sierra Receivables Funding Co., Series 07-1A, Class A2, 144A, FGIC, 1 mo. LIBOR + .15%, 0.40%, due 03/20/19
    83,508  

 


 

                 
  252,571    
Sierra Receivables Funding Co., Series 07-2A, Class A2, 144A, MBIA, 1 mo. LIBOR + 1.00%, 1.25%, due 09/20/19
    245,194  
       
 
     
       
Total Insured Time Share
    393,395  
       
 
     
       
 
       
       
Insured Transportation — 0.0%
       
  96,667    
GE Seaco Finance SRL, Series 04-1A, Class A, 144A, AMBAC, 1 mo. LIBOR + .30%, 0.55%, due 04/17/19
    94,008  
       
 
     
       
 
       
       
Residential Asset-Backed Securities (United States) — 0.3%
       
  37,311    
Accredited Mortgage Loan Trust, Series 04-4, Class A1B, 1 mo. LIBOR + .39%, 0.65%, due 01/25/35
    29,243  
  84,050    
ACE Securities Corp., Series 06-ASL1, Class A, 1 mo. LIBOR + .14%, 0.40%, due 02/25/36
    17,440  
  189,289    
ACE Securities Corp., Series 06-ASP2, Class A2C, 1 mo. LIBOR + .18%, 0.44%, due 03/25/36
    156,636  
  65,871    
ACE Securities Corp., Series 06-ASP4, Class A2B, 1 mo. LIBOR + .10%, 0.36%, due 08/25/36
    60,848  
  700,000    
ACE Securities Corp., Series 06-ASP5, Class A2C, 1 mo. LIBOR + .18%, 0.44%, due 10/25/36
    196,000  
  219,011    
ACE Securities Corp., Series 06-CW1, Class A2B, 1 mo. LIBOR + .10%, 0.36%, due 07/25/36
    204,775  
  182,810    
ACE Securities Corp., Series 06-HE2, Class A2C, 1 mo. LIBOR + .16%, 0.42%, due 05/25/36
    89,577  
  63,024    
ACE Securities Corp., Series 06-HE3, Class A2B, 1 mo. LIBOR + .09%, 0.35%, due 06/25/36
    57,352  
  389,446    
ACE Securities Corp., Series 06-OP1, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 04/25/36
    227,826  
  114,561    
ACE Securities Corp., Series 06-SL1, Class A, 1 mo. LIBOR + .16%, 0.58%, due 09/25/35
    20,048  
  257,318    
ACE Securities Corp., Series 06-SL3, Class A1, 1 mo. LIBOR + .10%, 0.36%, due 06/25/36
    41,814  
  329,312    
ACE Securities Corp., Series 06-SL3, Class A2, 1 mo. LIBOR + .17%, 0.43%, due 06/25/36
    40,341  
  139,952    
ACE Securities Corp., Series 07-HE1, Class A2A, 1 mo. LIBOR + .09%, 0.35%, due 01/25/37
    41,286  
  123,917    
ACE Securities Corp., Series 07-WM1, Class A2A, 1 mo. LIBOR + .07%, 0.33%, due 11/25/36
    41,512  
  367,392    
Alliance Bancorp Trust, Series 07-S1, Class A1, 144A, 1 mo. LIBOR + .20%, 0.46%, due 05/25/37
    18,370  
  130,475    
Argent Securities, Inc., Series 04-W8, Class A5, 1 mo. LIBOR + .52%, 1.30%, due 05/25/34
    112,800  
  1,360,354    
Argent Securities, Inc., Series 06-M1, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 07/25/36
    353,267  
  256,406    
Argent Securities, Inc., Series 06-M2, Class A2B, 1 mo. LIBOR + .11%, 0.37%, due 09/25/36
    74,999  
  338,813    
Argent Securities, Inc., Series 06-W2, Class A2B, 1 mo. LIBOR + .19%, 0.45%, due 03/25/36
    98,256  
  257,557    
Argent Securities, Inc., Series 06-W5, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 06/25/36
    67,770  
  283,571    
Asset Backed Funding Certificates, Series 06-OPT2, Class A3C, 1 mo. LIBOR + .15%, 0.41%, due 10/25/36
    164,471  
  542,634    
Asset Backed Funding Certificates, Series 07-NC1, Class A1, 144A, 1 mo. LIBOR + .22%, 0.48%, due 05/25/37
    427,324  
  222,899    
Bayview Financial Acquisition Trust, Series 04-B, Class A1, 144A, 1 mo. LIBOR + .50%, 1.26%, due 05/28/39
    72,442  
  222,899    
Bayview Financial Acquisition Trust, Series 04-B, Class A2, 144A, 1 mo. LIBOR + .65%, 1.56%, due 05/28/39
    62,969  
  299,776    
Bayview Financial Acquisition Trust, Series 05-A, Class A1, 144A, 1 mo. LIBOR + .50%, 1.26%, due 02/28/40
    180,165  
  122,708    
Bear Stearns Asset Backed Securities, Inc., Series 07-AQ1, Class A1, 1 mo. LIBOR + .11%, 0.37%, due 11/25/36
    74,471  
  300,000    
Bear Stearns Asset Backed Securities, Inc., Series 07-AQ1, Class A2, 1 mo. LIBOR + .20%, 0.46%, due 11/25/36
    40,050  
  70,981    
Bear Stearns Mortgage Funding Trust, Series 07-SL2, Class 1A, 1 mo. LIBOR + .16%, 0.58%, due 02/25/37
    11,222  
  29,733    
Carrington Mortgage Loan Trust, Series 07-FRE1, Class A1, 1 mo. LIBOR + .12%, 0.38%, due 02/25/37
    28,960  
  1,300,000    
Carrington Mortgage Loan Trust, Series 07-FRE1, Class A2, 1 mo. LIBOR + .20%, 0.46%, due 02/25/37
    801,190  
  343,847    
Centex Home Equity, Series 06-A, Class AV3, 1 mo. LIBOR + .16%, 0.42%, due 06/25/36
    261,324  
  5,978    
Chase Funding Mortgage Loan Trust, Series 03-3, Class 2A2, 1 mo. LIBOR + .27%, 0.80%, due 04/25/33
    5,021  
  2,843    
Citigroup Mortgage Loan Trust, Inc., Series 04-OPT1, Class A1B, 1 mo. LIBOR + .41%, 0.67%, due 10/25/34
    2,644  
  400,000    
Citigroup Mortgage Loan Trust, Inc., Series 06-HE3, Class A2C, 1 mo. LIBOR + .16%, 0.42%, due 12/25/36
    120,000  
  1,000,000    
Countrywide Asset-Backed Certificates, Series 06-BC3, Class 2A2, 1 mo. LIBOR + .14%, 0.40%, due 02/25/37
    727,500  

 


 

                 
  27,847    
Countrywide Asset-Backed Certificates, Series 06-BC5, Class 2A1, 1 mo. LIBOR + .08%, 0.34%, due 03/25/37
    27,485  
  17,934    
Equity One ABS, Inc., Series 04-1, Class AV2, 1 mo. LIBOR + .30%, 0.56%, due 04/25/34
    12,884  
  395,834    
First Franklin Mortgage Loan Asset Backed Certificates, Series 06-FF5, Class 2A3, 1 mo. LIBOR + .16%, 0.42%, due 04/25/36
    235,027  
  127,998    
Fremont Home Loan Trust, Series 06-A, Class 1A2, 1 mo. LIBOR + .20%, 0.45%, due 05/25/36
    68,579  
  48,896    
Fremont Home Loan Trust, Series 06-B, Class 2A2, 1 mo. LIBOR + .10%, 0.36%, due 08/25/36
    16,288  
  570,480    
Fremont Home Loan Trust, Series 06-B, Class 2A3, 1 mo. LIBOR + .16%, 0.42%, due 08/25/36
    159,734  
  107,243    
Household Home Equity Loan Trust, Series 05-2, Class A2, 1 mo. LIBOR + .31%, 0.56%, due 01/20/35
    92,129  
  97,931    
Household Home Equity Loan Trust, Series 05-3, Class A2, 1 mo. LIBOR + .29%, 0.54%, due 01/20/35
    86,149  
  281,614    
Household Home Equity Loan Trust, Series 06-1, Class A1, 1 mo. LIBOR + .16%, 0.41%, due 01/20/36
    247,820  
  907,622    
J.P. Morgan Mortgage Acquisition Corp., Series 06-WMC4, Class A3, 1 mo. LIBOR + .12%, 0.38%, due 12/25/36
    286,718  
  62,401    
Master Asset-Backed Securities Trust, Series 05-FRE1, Class A4, 1 mo. LIBOR + .25%, 0.51%, due 10/25/35
    58,657  
  64,754    
Master Asset-Backed Securities Trust, Series 06-AM3, Class A2, 1 mo. LIBOR + .13%, 0.39%, due 10/25/36
    62,812  
  544,444    
Master Asset-Backed Securities Trust, Series 06-FRE2, Class A4, 1 mo. LIBOR + .15%, 0.41%, due 03/25/36
    190,556  
  400,000    
Master Asset-Backed Securities Trust, Series 06-HE2, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 06/25/36
    120,000  
  722,248    
Master Asset-Backed Securities Trust, Series 06-HE3, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 08/25/36
    191,396  
  494,506    
Master Asset-Backed Securities Trust, Series 06-NC3, Class A4, 1 mo. LIBOR + .16%, 0.42%, due 10/25/36
    148,352  
  194,830    
Master Second Lien Trust, Series 06-1, Class A, 1 mo. LIBOR + .16%, 0.58%, due 03/25/36
    23,380  
  149,966    
Merrill Lynch Mortgage Investors, Series 07-HE2, Class A2A, 1 mo. LIBOR + .12%, 0.38%, due 02/25/37
    68,234  
  78,338    
Morgan Stanley Capital, Inc., Series 04-SD1, Class A, 1 mo. LIBOR + .40%, 0.66%, due 08/25/34
    56,208  
  1,000,000    
Morgan Stanley Capital, Inc., Series 07-HE4, Class A2C, 1 mo. LIBOR + .23%, 0.49%, due 02/25/37
    210,000  
  142,172    
Morgan Stanley Home Equity Loans, Series 07-2, Class A1, 1 mo. LIBOR + .10%, 0.36%, due 04/25/37
    116,226  
  290,611    
Morgan Stanley IXIS Real Estate Capital Trust, Series 06-2, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 11/25/36
    71,200  
  191,162    
People’s Choice Home Loan Securities Trust, Series 05-4, Class 1A2, 1 mo. LIBOR + .26%, 0.52%, due 12/25/35
    110,071  
  186,146    
RAAC Series Trust, Series 06-SP1, Class A2, 1 mo. LIBOR + .19%, 0.45%, due 09/25/45
    154,315  
  49,900    
Residential Asset Mortgage Products, Inc., Series 05-RS8, Class A2, 1 mo. LIBOR + .29%, 0.55%, due 10/25/33
    45,724  
  150,842    
Residential Asset Securities Corp., Series 05-KS12, Class A2, 1 mo. LIBOR + .25%, 0.51%, due 01/25/36
    135,758  
  12,511    
Residential Asset Securities Corp., Series 07-KS3, Class AI1, 1 mo. LIBOR + .11%, 0.37%, due 04/25/37
    12,421  
  9,319    
Saxon Asset Securities Trust, Series 04-1, Class A, 1 mo. LIBOR + .27%, 0.80%, due 03/25/35
    5,807  
  12,237    
Securitized Asset Backed Receivables LLC, Series 06-NC1, Class A2, 1 mo. LIBOR + .16%, 0.42%, due 03/25/36
    11,258  
  10,654    
Security National Mortgage Loan Trust, Series 06-2A, Class A1, 144A, 1 mo. LIBOR + .29%, 0.55%, due 10/25/36
    10,574  
  34,104    
SG Mortgage Securities Trust, Series 05-OPT1, Class A2, 1 mo. LIBOR + .26%, 0.52%, due 10/25/35
    31,591  
  28,190    
Soundview Home Equity Loan Trust, Series 07-NS1, Class A1, 1 mo. LIBOR + .12%, 0.38%, due 01/25/37
    26,965  
  500,000    
Specialty Underwriting & Residential Finance, Series 06-BC3, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 06/25/37
    210,000  
  154,955    
Structured Asset Investment Loan Trust, Series 06-1, Class A3, 1 mo. LIBOR + .20%, 0.46%, due 01/25/36
    111,568  

 


 

                 
  88,092    
Structured Asset Securities Corp., Series 05-S6, Class A2, 1 mo. LIBOR + .29%, 0.84%, due 11/25/35
    68,051  
  488,506    
Yale Mortgage Loan Trust, Series 07-1, Class A, 144A, 1 mo. LIBOR + .40%, 0.66%, due 06/25/37
    39,080  
       
 
     
       
Total Residential Asset-Backed Securities (United States)
    8,452,930  
       
 
     
       
 
       
       
Residential Mortgage-Backed Securities (Australian) — 0.1%
       
  173,127    
Crusade Global Trust, Series 06-1, Class A1, 144A, 3 mo. LIBOR + .06%, 0.47%, due 07/20/38
    168,636  
  272,658    
Crusade Global Trust, Series 07-1, Class A1, 3 mo. LIBOR + .06%, 0.47%, due 04/19/38
    262,001  
  58,315    
Interstar Millennium Trust, Series 03-3G, Class A2, 3 mo. LIBOR + .25%, 0.86%, due 09/27/35
    53,524  
  453,856    
Interstar Millennium Trust, Series 04-2G, Class A, 3 mo. LIBOR + .20%, 0.74%, due 03/14/36
    417,393  
  39,075    
Interstar Millennium Trust, Series 05-1G, Class A, 3 mo. LIBOR + .12%, 0.74%, due 12/08/36
    34,777  
  56,009    
Interstar Millennium Trust, Series 06-2GA, Class A2, 144A, 3 mo. LIBOR + .08%, 0.81%, due 05/27/38
    51,221  
  32,153    
Medallion Trust, Series 05-1G, Class A1, 3 mo. LIBOR + .08%, 0.52%, due 05/10/36
    31,001  
  207,434    
Medallion Trust, Series 06-1G, Class A1, 3 mo. LIBOR + .05%, 0.39%, due 06/14/37
    201,830  
  209,070    
National RMBS Trust, Series 06-3, Class A1, 144A, 3 mo. LIBOR + .07%, 0.48%, due 10/20/37
    202,577  
  256,520    
Puma Finance Ltd., Series G5, Class A1, 144A, 3 mo. LIBOR + .07%, 0.55%, due 02/21/38
    234,741  
  272,858    
Superannuation Members Home Loans Global Fund, Series 07-1, Class A1, 3 mo. LIBOR + .06%, 0.40%, due 06/12/40
    257,082  
  31,154    
Superannuation Members Home Loans Global Fund, Series 7, Class A1, 3 mo. LIBOR + .14%, 0.62%, due 03/09/36
    30,213  
  28,721    
Superannuation Members Home Loans Global Fund, Series 8, Class A1, 3 mo. LIBOR + .07%, 0.53%, due 01/12/37
    28,139  
  201,524    
Westpac Securitization Trust, Series 07-1G, Class A2A, 3 mo. LIBOR + .05%, 0.53%, due 05/21/38
    195,505  
       
 
     
       
Total Residential Mortgage-Backed Securities (Australian)
    2,168,640  
       
 
     
       
 
       
       
Residential Mortgage-Backed Securities (European) — 0.1%
       
  344,878    
Aire Valley Mortgages, Series 06-1A, Class 1A, 144A, 3 mo. LIBOR + .11%, 0.46%, due 09/20/66
    282,800  
  775,726    
Brunel Residential Mortgages, Series 07-1A, Class A4C, 144A, 3 mo. LIBOR + .10%, 0.50%, due 01/13/39
    687,278  
  115,283    
Granite Master Issuer Plc, Series 06-2, Class A4, 1 mo. LIBOR + .08%, 0.33%, due 12/20/54
    110,441  
  60,023    
Granite Mortgages Plc, Series 04-3, Class 2A1, 3 mo. LIBOR + .28%, 0.63%, due 09/20/44
    57,682  
  278,436    
Kildare Securities Ltd., Series 07-1A, Class A2, 144A, 3 mo. LIBOR + .06%, 0.40%, due 12/10/43
    247,808  
  82,148    
Leek Finance Plc, Series 17A, Class A2B, 144A, 3 mo. LIBOR + .28%, 0.63%, due 12/21/37
    73,522  
  194,038    
Paragon Mortgages Plc, Series 7A, Class A1A, 144A, 3 mo. LIBOR + .42%, 0.88%, due 05/15/34
    155,890  
  306,669    
Paragon Mortgages Plc, Series 12A, Class A2C, 144A, 3 mo. LIBOR + .22%, 0.68%, due 11/15/38
    227,134  
  215,208    
Paragon Mortgages Plc, Series 14A, Class A2C, 144A, 3 mo. LIBOR + .10%, 0.45%, due 09/15/39
    160,825  
  1,000,000    
Permanent Master Issuer Plc, Series 06-1, Class 5A, 3 mo. LIBOR + .11%, 0.51%, due 07/15/33
    990,300  
  100,000    
Permanent Master Issuer Plc, Series 07-1, Class 4A, 3 mo. LIBOR + .08%, 0.48%, due 10/15/33
    99,490  
       
 
     
       
Total Residential Mortgage-Backed Securities (European)
    3,093,170  
       
 
     
       
 
       
       
Residential Mortgage-Backed Securities (United States) — 0.0%
       
  20,616    
Chevy Chase Mortgage Funding Corp., Series 04-3A, Class A2, 144A, 1 mo. LIBOR + .30%, 0.56%, due 08/25/35
    12,885  
  71,855    
Mellon Residential Funding Corp., Series 04-TBC1, Class A, 144A, 1 mo. LIBOR + .25%, 0.51%, due 02/26/34
    58,202  
       
 
     
       
Total Residential Mortgage-Backed Securities (United States)
    71,087  
       
 
     
       
 
       
       
Student Loans — 0.0%
       
  700,000    
College Loan Corp. Trust, Series 07-2, Class A1, 3 mo. LIBOR + .25%, 0.67%, due 01/25/24
    682,500  
  14,891    
Goal Capital Funding Trust, Series 07-1, Class A1, 3 mo. LIBOR + .02%, 0.38%, due 06/25/21
    14,863  
  36,862    
National Collegiate Student Loan Trust, Series 06-1, Class A2, 1 mo. LIBOR + .14%, 0.40%, due 08/25/23
    35,756  
  400,000    
Nelnet Student Loan Trust, Series 05-2, Class A4, 3 mo. LIBOR + .08%, 0.44%, due 12/23/19
    394,816  
  97,698    
SLM Student Loan Trust, Series 07-A, Class A1, 3 mo. LIBOR + .03%, 0.38%, due 09/15/22
    97,454  
       
 
     
       
Total Student Loans
    1,225,389  
       
 
     

 


 

                 
       
Time Share — 0.0%
       
  95,076    
Sierra Receivables Funding Co., Series 08-1A, Class A2, 144A, 1 mo. LIBOR + 4.00%, 4.25%, due 02/20/20
    97,705  
       
 
     
       
Total Asset-Backed Securities
    34,173,155  
       
 
     
       
 
       
       
Corporate Debt — 0.0%
       
  598,000    
Health Care Property Investors, Inc., Series G, MTN, 5.63%, due 02/28/13
    616,809  
       
 
     
       
 
       
       
U.S. Government Agency — 0.0%
       
  67,600    
Agency for International Development Floater (Support of C.A.B.E.I.), 6 mo. U.S. Treasury Bill + .40%, 0.47%, due 10/01/12(a)
    66,814  
  471,651    
Agency for International Development Floater (Support of Jamaica), 6 mo. U.S. Treasury Bill + 0.75%, 0.82%, due 03/30/19(a)
    454,591  
  37,439    
Agency for International Development Floater (Support of Peru), Series B, 6 mo. U.S. Treasury Bill +.35%, 0.42%, due 05/01/14(a)
    36,719  
  100,001    
Agency for International Development Floater (Support of Zimbabwe), 3 mo. U.S. Treasury Bill x 115%, 0.04%, due 01/01/12(a)
    99,848  
       
 
     
       
Total U.S. Government Agency
    657,972  
       
 
     
       
TOTAL DEBT OBLIGATIONS (COST $35,414,813)
    35,447,936  
       
 
     
       
 
       
Shares     Description   Value ($)  
 
       
SHORT-TERM INVESTMENTS — 0.0%
       
       
 
       
       
Money Market Funds — 0.0%
       
  33,889    
State Street Institutional U.S. Government Money Market Fund-Institutional Class, 0.00%(b)
    33,889  
       
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $33,889)
    33,889  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 100.0%
(Cost $2,928,239,915)
    3,166,320,200  
       
Other Assets and Liabilities (net) — (0.0%)
    (115,431 )
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 3,166,204,769  
       
 
     
Notes to Schedule of Investments:
144A — Securities exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional investors.

AMBAC — Insured as to the payment of principal and interest by AMBAC Assurance Corporation.

C.A.B.E.I. — Central American Bank for Economic Integration

CDO — Collateralized Debt Obligation

CMBS — Commercial Mortgage Backed Security

FGIC — Insured as to the payment of principal and interest by Financial Guaranty Insurance Corporation.

FSA — Insured as to the payment of principal and interest by Financial Security Assurance.

LIBOR — London Interbank Offered Rate

MBIA — Insured as to the payment of principal and interest by MBIA Insurance Corp.

MTN — Medium Term Note

NPGC — Insured as to the payment of principal and interest by National Public Guarantee Corp.

 


 

RMBS — Residential Mortgage Backed Security

XL — Insured as to the payment of principal and interest by XL Capital Assurance.

The rates shown on variable rate notes are the current interest rates at November 30, 2011, which are subject to change based on the terms of the security.
§   These securities were categorized as “high yield” as a result of being rated below investment grade at issuance.
 
  These securities are primarily backed by subprime mortgages.
 
(a)   Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust.
 
(b)   Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
             
Aggregate Cost
  Gross
Unrealized
Appreciation
  Gross
Unrealized
(Depreciation)
  Net Unrealized
Appreciation
(Depreciation)
             
$3,244,438,964   $ —   $(78,118,764)   $(78,118,764)

 


 

Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                         
    Value,                             Distributions              
    beginning of             Sales     Dividend     of Realized     Return of     Value, end  
Affiliate   period     Purchases     Proceeds     Income*     Gains*     Capital*     of period  
GMO Alpha Only Fund, Class IV
  $ 444,489,793     $ 227,499,578     $ 207,369,629     $     $     $     $ 497,361,623  
GMO Asset Allocation Bond Fund, Class VI
    108,350,120       84,828,322       154,102,537       1,843,725       5,937,562             35,886,863  
GMO Domestic Bond Fund, Class VI
    112,619,380             2,985,073       1,102,707             36,025,475       70,262,611  
GMO Emerging Country Debt Fund, Class IV
    15,394,798       317,038       724,696       201,418                   15,644,547  
GMO Emerging Markets Fund, Class VI
    407,920,924       80,837,617       51,055,857       143,487       30,272,350             355,519,234  
GMO Flexible Equities Fund, Class VI
    40,832,080       87,342,567       8,628,790                         111,095,552  
GMO International Core Equity Fund, Class VI
    547,460,836       52,771,405       241,152,977       4,890,400                   308,857,556  
GMO International Growth Equity Fund, Class IV
    150,549,756       28,010,427       14,677,806       1,057,734                   147,255,885  
GMO International Intrinsic Value Fund, Class IV
    155,598,926       116,478,011       5,982,606       2,939,296                   242,749,374  
GMO Quality Fund, Class VI
    877,962,197       171,628,715       269,652,239       13,240,406                   819,166,611  
GMO Short-Duration Investment Fund, Class III
    3,023,794       5,662       48,076       5,662                   2,945,445  
GMO Special Situations Fund, Class VI
    147,372,218       4,195,689       21,513,311                         124,239,343  
GMO Strategic Fixed Income Fund, Class VI
    365,706,603       13,096,298       41,758,546                         375,871,669  
GMO World Opportunity Overlay Fund
    23,422,041             378,657                         23,982,062  
 
                                         
Totals
  $ 3,400,703,466     $ 867,011,329     $ 1,020,030,800     $ 25,424,835     $ 36,209,912     $ 36,025,475     $ 3,130,838,375  
 
                                         
 
*   The table above includes estimated sources of all distributions paid by the underlying funds during the period March 1, 2011 through November 30, 2011 for tax purposes. The actual tax characterization of distributions paid by the underlying funds will be determined at the end of fiscal year ending February 29, 2012.

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Shares of the underlying funds and other investment funds are generally valued at their net asset value. Investments held by the underlying funds are valued as follows: Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly and indirectly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 0.8% of net assets. The Fund and the underlying funds classify such securities (levels defined below) as Level 3.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund, either directly or through investments in the underlying funds, that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below and as described in the disclosures of the underlying funds.
                     
Security Type
 
Percentage of Net Assets of the Fund
               
Equity Securities
  41.8%                
Futures Contracts
  0.1%                
Swap Agreements
  0.8%                
Typically the Fund and the underlying funds value debt instruments based on the most recent quoted price supplied by a single pricing source chosen by the Manager. Although the Manager normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and may change a pricing source at any time. The Manager monitors erratic or unusual movements (including unusual inactivity) in the prices supplied for a security and has discretion to override a price supplied by a source (e.g., by taking a price supplied by another) when it believes that the price supplied is not reliable. Although alternative prices may be available for securities held by the Fund and the underlying funds, those alternative sources are not typically part of the valuation process and do not necessarily provide greater certainty about the prices used by the Fund and the underlying funds. As of November 30, 2011, the total value of securities held directly and indirectly for which no alternative pricing source was available represented 1.0% of the net assets of the Fund.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the

 


 

valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit risk, yield curves and similar data.
Level 3 — Valuations based primarily on inputs that are unobservable and significant. The Fund utilized a number of fair value techniques on Level 3 investments, including the following: The Fund valued certain debt securities using quoted prices. The Fund valued certain other debt securities by using an estimated specified spread above the LIBOR Rate.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Mutual Funds
  $ 3,130,838,375     $     $     $ 3,130,838,375  
Debt Obligations
                               
Asset-Backed Securities
          4,959,949       29,213,206       34,173,155  
Corporate Debt
          616,809             616,809  
U.S. Government Agency
                657,972       657,972  
 
                       
TOTAL DEBT OBLIGATIONS
          5,576,758       29,871,178       35,447,936  
 
                       
Short-Term Investments
    33,889                   33,889  
 
                       
Total Investments
    3,130,872,264       5,576,758       29,871,178       3,166,320,200  
 
                       
Total
  $ 3,130,872,264     $ 5,576,758     $ 29,871,178     $ 3,166,320,200  
 
                       

 


 

The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net values of the Fund’s investments (both direct and indirect) in securities and derivative financial instruments using Level 3 inputs were 6.5% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant unobservable inputs (Level 3) were used in determining value:

 


 

                                                                                   
                                                                              Net Change in  
                                                                              Unrealized  
                                                                              Appreciation  
                                            Change in                               (Depreciation) from  
    Balances as of                           Total     Unrealized     Transfers     Transfers     Balances as of       Investments Still Held as  
    February 28,                     Accrued     Realized     Appreciation     into Level     out of     November 30,       of November 30,  
    2011     Purchases     Sales     Discounts/Premiums     Gain/(Loss)     (Depreciation)     3*     Level 3*     2011       2011  
Debt Obligations
                                                                                 
Asset-Backed Securities
  $ 44,061,730     $     $ (13,253,275 )   $ 565,156     $ 1,988,081     $ (4,148,486 )   $     $     $ 29,213,206       $ (3,572,405 )
U.S. Government Agency
  $ 971,897     $     $ (312,290 )   $ 1,758     $ 6,473     $ (9,866 )   $     $     $ 657,972       $ (9,599 )
 
                                                             
Total Debt Obligations
  $ 45,033,627     $     $ (13,565,565 )   $ 566,914     $ 1,994,554     $ (4,158,352 )   $     $     $ 29,871,178       $ (3,582,004 )
 
                                                             
 
*   The Fund accounts for investments transferred into Level 3 at the value at the beginning of the period and transferred out of Level 3 at the value at the end of the period.

 


 

Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. References to investments include those held directly by the Fund and indirectly through the Fund’s investments in the underlying funds. Some of the underlying funds are non-diversified investment companies under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by those funds may affect their performance more than if they were diversified. Selected risks of investing in the Fund are summarized below, including those risks to which the Fund is exposed as a result of its investments in the underlying funds. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If an underlying fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of the value of those investments. An underlying fund also may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Declines in stock market prices generally are likely to reduce the net asset value of the Fund’s             shares.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Market Risk — Fixed Income Securities — Typically, the market value of fixed income securities will decline during periods of rising interest rates and widening of credit spreads.
Market Risk — Asset-Backed Securities — Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund or an underlying fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.

 


 

Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in the underlying funds, including the risk that the underlying funds in which it invests do not perform as expected. Because the Fund bears the fees and expenses of the underlying funds in which it invests, new investments in underlying funds with higher fees or expenses than those of the underlying funds in which the Fund is currently invested will increase the Fund’s total expenses. The fees and expenses associated with an investment in the Fund are less predictable and may be higher than fees and expenses associated with an investment in funds that charge a fixed management fee.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
Commodities Risk — To the extent an underlying fund has exposure to global commodity markets, the value of its shares is affected by factors particular to the commodity markets and may fluctuate more than the value of shares of a fund with a broader range of investments.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of foreign currency holdings and investments denominated in foreign currencies, or that the U.S. dollar will decline in value relative to the foreign currency being hedged.
Leveraging Risk — The use of reverse repurchase agreements and other derivatives and securities lending may cause the Fund’s portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating. Below investment grade securities have speculative characteristics, and changes in economic conditions or other circumstances are more likely to impair the capacity of issuers to make principal and interest payments than is the case with issuers of investment grade securities.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Real Estate Risk — To the extent an underlying fund concentrates its assets in real estate-related investments, the value of its portfolio is subject to factors affecting the real estate industry and may fluctuate more than the value of a portfolio that consists of securities of companies in a broader range of industries.
Short Sales Risk — The Fund runs the risk that an underlying fund’s loss on a short sale of securities that the underlying fund does not own is unlimited.
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies or in industries with high positive correlations to one another creates additional risk.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.

 


 

Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
The Fund invests (including through investment in underlying funds) in asset-backed securities, which may be backed by many types of assets, including pools of residential and commercial mortgages, automobile loans, educational loans, home equity loans, or credit card receivables, which expose the Fund to additional types of market risk. They also may be backed by pools of corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds and loans (commonly referred to as “collateralized debt obligations” or “collateralized loan obligations”) and by the fees earned by service providers. Payment of interest on asset backed securities and repayment of principal largely depend on the cash flows generated by the assets backing the securities. The market risk of a particular asset-backed security depends on many factors, including the deal structure (e.g., determination as to the amount of underlying assets or other support needed to produce the cash flows necessary to service interest and make principal payments), the quality of the underlying assets and, if any, the level of credit support and the credit quality of the credit-support provider. Asset-backed securities involve risk of loss of principal if obligors of the underlying obligations default and the value of the defaulted obligations exceeds whatever credit support the securities may have. The obligations of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and other laws affecting the rights and remedies of creditors. Many asset-backed securities in which the Fund has invested are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal and/or interest will be paid because the insurer could default on its obligations. In recent years, a significant number of asset-backed security insurers have defaulted on their obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about the creditworthiness of those securities (and underlying assets) caused credit spreads (the difference between yields on the asset-backed securities and U.S. Government securities) to widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions to make markets in many fixed income securities. These events reduced liquidity and contributed to substantial declines in the value of asset-backed and other fixed income securities. There can be no assurance these conditions will not occur again. Also, government actions and proposals affecting the terms of underlying home and consumer loans, changes in demand for products (e.g., automobiles) financed by those loans, and the inability of borrowers to refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying assets and is, therefore, subject to risks associated with the negligence or defalcation of its servicer. In some circumstances, the mishandling of related documentation also may affect the rights of security holders in and to the underlying assets. The insolvency of entities that generate receivables or that utilize the assets may result in a decline in the value of the underlying assets, as well as costs and delays. The obligations underlying asset-backed securities, in particular securities backed by pools of residential and commercial mortgages, also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as high a yield as is provided by the asset-backed security. The risk of investing in asset-backed securities has increased because performance of the various sectors in which the assets underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime mortgages, and credit card receivables) has become more highly correlated since the deterioration in worldwide economic and liquidity conditions.
Derivative financial instruments
At November 30, 2011, the Fund held no derivative financial instruments directly. For a listing of derivative financial instruments held by the underlying funds, if any, please refer to the underlying funds’ Schedule of Investments.

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Global Bond Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Par Value   Description   Value ($)  
 
       
DEBT OBLIGATIONS — 39.5%
       
       
 
       
       
Canada — 2.7%
       
       
 
       
       
Foreign Government Obligations
       
CAD 1,500,000    
Government of Canada, 8.00%, due 06/01/23
    2,316,952  
CAD 2,000,000    
Government of Canada, 3.50%, due 06/01/20
    2,182,401  
       
 
     
       
Total Canada
    4,499,353  
       
 
     
       
 
       
       
France — 2.4%
       
       
 
       
       
Foreign Government Obligations
       
EUR 3,000,000    
Government of France, 4.00%, due 10/25/38
    4,047,908  
       
 
     
 
       
Germany — 1.0%
       
 
       
Foreign Government Obligations
       
EUR 1,000,000    
Republic of Deutschland, 4.75%, due 07/04/34
    1,709,992  
       
 
     
       
 
       
       
Italy — 1.4%
       
       
 
       
       
Foreign Government Obligations
       
EUR 2,400,000    
Buoni Poliennali Del Tesoro, 5.00%, due 08/01/34
    2,427,367  
       
 
     
       
 
       
       
Japan — 18.1%
       
       
 
       
       
Foreign Government Obligations
       
JPY 2,200,000,000    
Japan Government Twenty Year Bond, 2.20%, due 06/20/26
    30,864,105  
       
 
     
       
 
       
       
Spain — 1.2%
       
       
 
       
       
Foreign Government Obligations
       
EUR 2,000,000    
Government of Spain, 4.70%, due 07/30/41
    2,074,565  
       
 
     
       
 
       
       
United Kingdom — 6.1%
       
       
 
       
       
Foreign Government Obligations
       
GBP 5,500,000    
U.K. Treasury Gilt, 4.25%, due 12/07/27
    10,328,857  
       
 
     
       
 
       
       
United States — 6.6%
       
       
 
       
       
U.S. Government
       
USD 3,242,374    
U.S. Treasury Inflation Indexed Note, 2.00%, due 04/15/12(a)(b)
    3,253,265  
USD 10,000,000    
U.S. Treasury Principal Strip Bond, due 11/15/21
    8,043,440  
       
 
     
       
Total United States
    11,296,705  
       
 
     
       
 
       
       
TOTAL DEBT OBLIGATIONS (COST $60,270,946)
    67,248,852  
       
 
     
                 
Shares   Description   Value ($)  
 
       
MUTUAL FUNDS — 59.7%
       
       
 
       
       
United States — 59.7%
       
       
 
       
       
Affiliated Issuers
       
                638,217    
GMO Emerging Country Debt Fund, Class IV
    6,043,919  
  7,873,225    
GMO Short-Duration Collateral Fund
    52,042,020  
  45,838    
GMO Special Purpose Holding Fund(c)
    17,877  
  319,010    
GMO U.S. Treasury Fund
    7,978,452  
  1,501,007    
GMO World Opportunity Overlay Fund
    35,423,765  
       
 
     

 


 

                 
                     
Total United States
    101,506,033  
       
 
     
       
 
       
       
TOTAL MUTUAL FUNDS (COST $111,935,780)
    101,506,033  
       
 
     
                 
Shares/Par   Description   Value ($)  
 
       
SHORT-TERM INVESTMENTS — 1.0%
       
       
 
       
       
Money Market Funds — 0.0%
       
          70,064    
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00%(d)
    70,064  
       
 
       
       
U.S. Government — 1.0%
       
  1,750,000    
U.S. Treasury Bill, 0.10%, due 10/18/12 (a)(e)
    1,748,435  
       
 
     
       
 
       
       
TOTAL SHORT-TERM INVESTMENTS (COST $1,818,374)
    1,818,499  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 100.2%
(Cost $174,025,100)
    170,573,384  
       
 
       
       
Other Assets and Liabilities (net) — (0.2%)
    (396,742 )
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 170,176,642  
       
 
     
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
                                     
                                Net Unrealized  
Settlement                             Appreciation  
Date     Counterparty   Deliver/Receive   Units of Currency     Value     (Depreciation)  
  Buys †    
 
                           
  12/06/11    
Barclays Bank PLC
  AUD     1,200,000     $ 1,233,506     $ (4,417 )
  12/06/11    
Citibank N.A.
  AUD     300,000       308,376       (4,512 )
  12/06/11    
Credit Suisse International
  AUD     1,100,000       1,130,713       52,735  
  12/06/11    
Deutsche Bank AG
  AUD     10,700,000       10,998,757       573,626  
  12/06/11    
Royal Bank of Scotland PLC
  AUD     600,000       616,753       14,058  
  12/13/11    
Barclays Bank PLC
  CAD     700,000       686,105       (17,133 )
  12/13/11    
Citibank N.A.
  CAD     600,000       588,090       (14,967 )
  12/13/11    
Credit Suisse International
  CAD     3,800,000       3,724,571       (17,546 )
  12/13/11    
Deutsche Bank AG
  CAD     3,800,000       3,724,571       22,400  
  12/13/11    
Royal Bank of Scotland PLC
  CAD     2,700,000       2,646,405       (41,349 )
  1/31/12    
Deutsche Bank AG
  CHF     400,000       438,568       1,452  
  2/07/12    
Citibank N.A.
  EUR     600,000       806,742       (4,146 )
  2/07/12    
Credit Suisse International
  EUR     1,300,000       1,747,941       12,935  
  2/07/12    
Deutsche Bank AG
  EUR     16,700,000       22,454,322       (282,728 )

 


 

                                     
  1/10/12    
Citibank N.A.
  GBP     800,000       1,254,678       (27,148 )
  1/10/12    
Credit Suisse International
  GBP     3,300,000       5,175,546       (47,901 )
  1/10/12    
Deutsche Bank AG
  GBP     800,000       1,254,678       (27,722 )
  1/10/12    
Royal Bank of Scotland PLC
  GBP     1,000,000       1,568,347       (8,488 )
  2/14/12    
Credit Suisse International
  JPY     160,000,000       2,066,182       1,746  
  2/14/12    
Deutsche Bank AG
  JPY     730,000,000       9,426,954       (73,306 )
  2/21/12    
Deutsche Bank AG
  NOK     21,400,000       3,692,112       43,970  
  2/21/12    
Royal Bank of Scotland PLC
  NOK     3,700,000       638,356       9,931  
  1/24/12    
Credit Suisse International
  NZD     1,100,000       855,736       (7,434 )
  12/20/11    
Barclays Bank PLC
  SEK     10,500,000       1,550,263       (31,339 )
  12/20/11    
Citibank N.A.
  SEK     6,800,000       1,003,980       (8,016 )
  12/20/11    
Credit Suisse International
  SEK     14,700,000       2,170,368       42,849  
  12/20/11    
Deutsche Bank AG
  SEK     9,200,000       1,358,325       (78,872 )
       
 
                       
       
 
              $ 83,120,945     $ 78,678  
       
 
                       
       
 
                           
  Sales #    
 
                           
  12/06/11    
Citibank N.A.
  AUD     1,100,000     $ 1,130,713     $ 5,684  
  12/06/11    
Credit Suisse International
  AUD     2,800,000       2,878,180       (14,953 )
  12/06/11    
Deutsche Bank AG
  AUD     1,100,000       1,130,713       (9,813 )
  12/06/11    
Royal Bank of Scotland PLC
  AUD     1,500,000       1,541,882       (74,074 )
  12/13/11    
Citibank N.A.
  CAD     900,000       882,135       3,831  
  12/13/11    
Credit Suisse International
  CAD     1,100,000       1,078,165       (41,212 )
  12/13/11    
Deutsche Bank AG
  CAD     13,500,000       13,232,027       (210,600 )
  1/31/12    
Barclays Bank PLC
  CHF     800,000       877,135       13,029  
  1/31/12    
Credit Suisse International
  CHF     3,900,000       4,276,035       113,094  
  1/31/12    
Royal Bank of Scotland PLC
  CHF     1,600,000       1,754,271       29,950  
  2/07/12    
Citibank N.A.
  EUR     1,100,000       1,479,027       1,958  
  1/10/12    
Citibank N.A.
  GBP     1,300,000       2,038,851       (15,271 )
  1/10/12    
Credit Suisse International
  GBP     2,200,000       3,450,364       (16,961 )
  1/10/12    
Deutsche Bank AG
  GBP     400,000       627,339       4,821  
  1/10/12    
Royal Bank of Scotland PLC
  GBP     800,000       1,254,678       5,750  
  2/14/12    
Barclays Bank PLC
  JPY     50,000,000       645,682       5,631  
  2/14/12    
Citibank N.A.
  JPY     60,000,000       774,818       536  
  2/14/12    
Credit Suisse International
  JPY     110,000,000       1,420,500       13,154  
  2/14/12    
Royal Bank of Scotland PLC
  JPY     100,000,000       1,291,364       10,279  

 


 

                                     
  1/24/12    
Citibank N.A.
  NZD     400,000       311,177       (9,137 )
  1/24/12    
Deutsche Bank AG
  NZD     700,000       544,559       7,076  
  1/24/12    
Royal Bank of Scotland PLC
  NZD     800,000       622,354       (15,786 )
  12/20/11    
Barclays Bank PLC
  SEK     6,300,000       930,158       350  
  12/20/11    
Credit Suisse International
  SEK     26,200,000       3,868,274       179,620  
       
 
                       
       
 
              $ 48,040,401     $ (13,044 )
       
 
                       
 
  Fund buys foreign currency; sells USD.
 
#   Fund sells foreign currency; buys USD.
Futures Contracts
                             
                        Net Unrealized  
Number of         Expiration           Appreciation  
Contracts     Type   Date   Value     (Depreciation)  
Buys  
 
                   
  11    
Australian Government Bond 3 Yr.
  December 2011   $ 1,222,846     $ 12,678  
  67    
Euro BOBL
  December 2011     11,040,117       5,212  
  96    
Euro Bund
  December 2011     17,262,132       (392,365 )
  4    
Japanese Government Bond 10 Yr. (TSE)
  December 2011     7,311,501       (40,776 )
  47    
U.S. Treasury Bond 30 Yr. (CBT)
  March 2012     6,644,625       (171,047 )
  80    
U.S. Treasury Note 10 Yr. (CBT)
  March 2012     10,347,500       (97,737 )
  111    
U.S. Treasury Note 2 Yr. (CBT)
  March 2012     24,475,500       5,283  
  112    
U.S. Treasury Note 5 Yr. (CBT)
  March 2012     13,735,750       (17,836 )
       
 
               
       
 
      $ 92,039,971     $ (696,588 )
       
 
               
       
 
                   
Sales  
 
                   
  46    
Australian Government Bond 10 Yr.
  December 2011   $ 5,519,037     $ (123,289 )
  46    
Canadian Government Bond 10 Yr.
  March 2012     5,954,135       (14,829 )
  7    
Euro SCHATZ
  December 2011     1,036,624       (4,600 )
  56    
UK Gilt Long Bond
  March 2012     9,971,932       111,230  
       
 
               
       
 
      $ 22,481,728     $ (31,488 )
       
 
               
Swap Agreements
Credit Default Swaps
                                                                                 
                                                            Maximum Potential     Net  
                                            Implied             Amount of Future     Unrealized  
Notional     Expiration           Receive   Annual     Credit     Reference   Payments by the Fund     Appreciation/  
Amount     Date   Counterparty   (Pay)^   Premium     Spread (1)     Entity   Under the Contract (2)     (Depreciation)  
21,000,000
  USD       3/20/2014     Deutsche Bank AG   (Pay)     1.70 %     5.01 %   Italy Government International Bond     N/A             $ 1,395,399  

 


 

                                                                                 
15,000,000
  USD       3/20/2019     Deutsche Bank AG     Receive     1.66 %     4.75 %   Italy Government International Bond     15,000,000     USD     (2,443,553 )
 
                                                                             
 
                                                                          $ (1,048,154 )
 
                                                                             
 
                                                      Premiums to (Pay) Receive   $  
 
                                                                             
 
^   Receive — Fund receives premium and sells credit protection. If a credit event occurs, as defined under the terms of that particular swap agreement, the Fund will either (i) pay to the buyer of protection an amount equal to the notional amount of the swap and take delivery of the referenced obligation or underlying securities comprising the referenced index or (ii) pay a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation or underlying securities comprising the referenced index. (Pay) — Fund pays premium and buys credit protection. If a credit event occurs, as defined under the terms of that particular swap agreement, the Fund will either (i) receive from the seller of protection an amount equal to the notional amount of the swap and deliver the referenced obligation or underlying securities comprising the referenced index or (ii) receive a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation or underlying securities comprising the referenced index.
 
(1)   Implied credit spreads, represented in absolute terms, utilized in determining the market value of credit default swap agreements on the reference security, as of November 30, 2011, serve as an indicator of the current status of the payment/performance risk and reflect the likelihood or risk of default for the reference entity. The implied credit spread of a particular referenced entity reflects the cost of buying/selling protection. Wider (i.e. higher) credit spreads represent a deterioration of the referenced entity’s credit soundness and a greater likelihood or risk of default or other credit event occurring as defined under the terms of the agreement.
 
(2)   The maximum potential amount the Fund could be required to pay as a seller of credit protection if a credit event occurs as defined under the terms of that particular swap agreement.
Interest Rate Swaps
                                                 
                                            Net Unrealized  
Notional     Expiration         Receive               Appreciation/  
Amount     Date     Counterparty   (Pay)#   Fixed Rate     Variable Rate   (Depreciation)  
3,300,000     CHF       3/21/2022    
Barclays Bank PLC
  Receive     1.80 %   6 Month CHF LIBOR   $ 118,134  
3,100,000     CHF       3/21/2022    
Citibank N.A.
  Receive     1.80 %   6 Month CHF LIBOR     110,974  
3,100,000     CHF       3/21/2022    
Deutsche Bank AG
  Receive     1.80 %   6 Month CHF LIBOR     110,974  
12,000,000     EUR       8/11/2014    
Merrill Lynch Capital Services, Inc.
  Receive     1.86 %   6 Month EUR LIBOR     94,280  
33,700,000     SEK       3/21/2022    
Barclays Bank PLC
  (Pay)     2.90 %   3 Month SEK STIBOR     (226,416 )
34,600,000     SEK       3/21/2022    
JPMorgan Chase Bank, N.A.
  (Pay)     2.90 %   3 Month SEK STIBOR     (232,463 )
                       
 
                     
                       
 
                  $ (24,517 )
                       
 
                     
                       
 
        Premiums to (Pay) Receive   $ 38,865  
                       
 
                     
 
#   Receive — Fund receives fixed rate and pays variable rate.
    (Pay) — Fund pays fixed rate and receives variable rate.
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
Notes to Schedule of Investments:
BOBL — Bundesobligationen
CHF LIBOR — London Interbank Offered Rate denominated in Swiss Franc.

 


 

EUR LIBOR — London Interbank Offered Rate denominated in Euros.
SEK STIBOR — Stockholm Interbank Offered Rate denominated in Swedish Krona.
(a)   All or a portion of this security has been pledged to cover margin requirements on futures contracts, collateral on swap contracts, forward currency contracts, and/or written options, if any.
 
(b)   Indexed security in which price and/or coupon is linked to the prices of a specific instrument or financial statistic.
 
(c)   Underlying investment represents interests in defaulted claims. See “Other matters” for additional information.
 
(d)   Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.
 
(e)   Rate shown represents yield-to-maturity.
Currency Abbreviations:
AUD — Australian Dollar
CAD — Canadian Dollar
CHF — Swiss Franc
EUR — Euro
GBP — British Pound
JPY — Japanese Yen
NOK — Norwegian Krone
NZD — New Zealand Dollar
SEK — Swedish Krona
USD — United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                           
      Gross     Gross     Net Unrealized  
      Unrealized     Unrealized     Appreciation  
Aggregate Cost   Appreciation     (Depreciation)     (Depreciation)  
$ 183,303,068   $ 8,986,902     $ (21,716,586 )   $ (12,729,684 )

 


 

Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                         
    Value,                             Distributions              
    beginning of             Sales     Dividend     of Realized     Return of     Value, end  
Affiliate   period     Purchases     Proceeds     Income*     Gains*     Capital*     of period  
GMO Emerging Country Debt Fund, Class IV
  $ 7,020,716     $ 1,008,841     $ 2,275,000     $ 93,841     $     $     $ 6,043,919  
GMO Short-Duration Collateral Fund
    81,724,080                   619,064             27,266,677       52,042,020  
GMO Special Purpose Holding Fund
    22,919                                     17,877  
GMO U.S. Treasury Fund
    4,227,972       44,395,088       40,650,000       4,170       918             7,978,452  
GMO World Opportunity Overlay Fund
    41,828,178       600,000       8,500,000                         35,423,765  
 
                                         
Totals
  $ 134,823,865     $ 46,003,929     $ 51,425,000     $ 717,075     $ 918     $ 27,266,677     $ 101,506,033  
 
                                         
 
*   The table above includes estimated sources of all distributions paid by the underlying funds during the period March 1, 2011 through November 30, 2011 for tax purposes. The actual tax characterization of distributions paid by the underlying funds will be determined at the end of the fiscal year ending February 29, 2012.

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly and indirectly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 1.5% of net assets. The underlying funds classify such securities (levels defined below) as Level 3. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivatives contracts based on the creditworthiness of its counterparties. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Typically the Fund and the underlying funds value debt instruments based on the most recent quoted price supplied by a single pricing source chosen by the Manager. Although the Manager normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and may change a pricing source at any time. The Manager monitors erratic or unusual movements (including unusual inactivity) in the prices supplied for a security and has discretion to override a price supplied by a source (e.g., by taking a price supplied by another) when it believes that the price supplied is not reliable. Although alternative prices may be available for securities held by the Fund and the underlying funds, those alternative sources are not typically part of the valuation process and do not necessarily provide greater certainty about the prices used by the Fund and the underlying funds. As of November 30, 2011, the total value of securities held directly and indirectly for which no alternative pricing source was available represented 6.3% of the net assets of the Fund.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit risk, yield curves and similar data. The Fund also used third party valuation services (which use industry models and inputs from pricing vendors) to value credit default swaps.
Level 3 — Valuations based primarily on inputs that are unobservable and significant.

 


 

The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Debt Obligations
                               
Foreign Government Obligations
  $     $ 55,952,147     $     $ 55,952,147  
U.S. Government
          11,296,705             11,296,705  
 
                       
TOTAL DEBT OBLIGATIONS
          67,248,852             67,248,852  
 
                       
Mutual Funds
    101,488,156       17,877             101,506,033  
Short-Term Investments
    1,818,499                   1,818,499  
 
                       
Total Investments
    103,306,655       67,266,729             170,573,384  
 
                       
Derivatives *
                               
Forward Currency Contracts
                               
Foreign currency risk
          1,170,465             1,170,465  
Futures Contracts
                               
Interest rate risk
    134,403                   134,403  
Swap Agreements
                               
Credit risk
          1,395,399             1,395,399  
Interest rate risk
          434,362             434,362  
 
                       
Total Derivatives
    134,403       3,000,226             3,134,629  
 
                       
Total
  $ 103,441,058     $ 70,266,955     $     $ 173,708,013  
 
                       
LIABILITY VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Liabilities     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Derivatives *
                               
Forward Currency Contracts
                               
Foreign currency risk
  $     $ (1,104,831 )   $     $ (1,104,831 )
Futures Contracts
                               
Interest rate risk
    (862,479 )                 (862,479 )
Swap Agreements
                               
Credit risk
          (2,443,553 )           (2,443,553 )
Interest rate risk
          (458,879 )           (458,879 )
 
                       
Total Derivatives
    (862,479 )     (4,007,263 )           (4,869,742 )
 
                       
Total
  $ (862,479 )   $ (4,007,263 )   $     $ (4,869,742 )
 
                       
The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
 
*   Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as either Level 1 or Level 2. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net values of the Fund’s indirect investments in securities and derivative financial instruments using Level 3 inputs were 28.7% and (0.1)% of total net assets, respectively.

 


 

For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011 whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase the security at an agreed upon price and date. The Fund, through its custodian, takes possession of securities it acquired under the repurchase agreement. The value of the securities acquired is required by contract to be marked to market daily and additional collateral is required to be transferred so that the market value is at least equal to the amount owed to the Fund by the seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings and/or the value of the securities subject to the repurchase agreement is insufficient, the Fund’s recovery of cash from the seller may be delayed and the Fund may incur a loss equal to the difference between the cash it paid and the value of the securities. The Fund had no repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same assets at an agreed upon price and date. The Fund can use the proceeds received from entering into a reverse repurchase agreement to make additional investments, which generally causes the Fund’s portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the securities it sold and as a result would realize a loss equal to the difference between the value of those securities and the payment it received for them. The size of this loss will depend upon the difference between what the buyer paid for the securities the Fund sold to it and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of $100). In the event of a buyer’s bankruptcy or insolvency, the Fund’s use of proceeds from the sale of its securities may be restricted while the other party or its trustee or receiver determines whether to honor the Fund’s right to repurchase the securities.
The Fund had no reverse repurchase agreements outstanding at the end of the period.
Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income securities whose principal value is adjusted periodically according to the rate of inflation. Two structures are common. The U.S. Treasury and some other issuers use a structure that reflects inflation in the principal value of the bond. Most other issuers pay out any inflation related accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real interest rates. Real interest rates, in turn, are tied to the relationship between nominal interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e. nominal interest rate minus inflation) might decline, leading to an increase in value of inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than inflation, real interest rates might rise, leading to a decrease in value of inflation indexed bonds. There can be no assurance, however, that the value of inflation indexed bonds will be directly correlated to changes in nominal interest rates, and short term increases in inflation may lead to a decline in their value. Coupon payments received by the Fund from inflation indexed bonds are included in the Fund’s gross income for the period in which they accrue. In addition, any increase or decrease in the principal amount of an inflation indexed bond will increase or decrease taxable ordinary income to the Fund, even though principal is not paid until maturity. Inflation-indexed bonds outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Other matters
GMO Special Purpose Holding Fund (“SPHF”), an investment of the Fund, has litigation pending against various entities related to the 2002 fraud and related default of securities previously held by SPHF. The outcome of the lawsuits against the remaining

 


 

defendants is not known and any potential recoveries are not reflected in the net asset value of SPHF. For the period ended November 30, 2011, the Fund received no distributions from SPHF in connection with the defaulted securities or the related litigation.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies.
Market Risk Fixed Income Securities — Typically, the market value of the Fund’s fixed income securities will decline during periods of rising interest rates and widening of credit spreads.
Market Risk Asset-Backed Securities — Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating. The Fund’s investments in below investment grade securities have speculative characteristics, and changes in economic conditions or other circumstances are more likely to impair the capacity of issuers to make principal and interest payments than is the case with issuers of investment grade securities.
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Derivatives Risk — The use of derivatives involves the risk that their value may or may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Leveraging Risk — The Fund’s use of reverse repurchase agreements and other derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations. The risk of counterparty default is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions.
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies with high positive correlations to one another, such as the Fund’s investments in asset-backed securities secured by different types of consumer debt (e.g., credit-card receivables, automobile loans and home equity loans), creates additional risk.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.

 


 

Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in underlying funds, including the risk that the underlying funds in which it invests will not perform as expected.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
The Fund invests (including through investment in underlying funds) in asset-backed securities, which may be backed by many types of assets, including pools of residential and commercial mortgages, automobile loans, educational loans, home equity loans, or credit card receivables, which expose the Fund to additional types of market risk. They also may be backed by pools of corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds and loans (commonly referred to as “collateralized debt obligations” or “collateralized loan obligations”) and by the fees earned by service providers. Payment of interest on asset backed securities and repayment of principal largely depend on the cash flows generated by the assets backing the securities. The market risk of a particular asset-backed security depends on many factors, including the deal structure (e.g., determination as to the amount of underlying assets or other support needed to produce the cash flows necessary to service interest and make principal payments), the quality of the underlying assets and, if any, the level of credit support and the credit quality of the credit-support provider. Asset-backed securities involve risk of loss of principal if obligors of the underlying obligations default and the value of the defaulted obligations exceeds whatever credit support the securities may have. The obligations of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and other laws affecting the rights and remedies of creditors. Many asset-backed securities in which the Fund has invested are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal and/or interest will be paid because the insurer could default on its obligations. In recent years, a significant number of asset-backed security insurers have defaulted on their obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about the creditworthiness of those securities (and underlying assets) caused credit spreads (the difference between yields on the asset-backed securities and U.S. Government securities) to widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions to make markets in many fixed income securities. These events reduced liquidity and contributed to substantial declines in the value of asset-backed and other fixed income securities. There can be no assurance these conditions will not occur again. Also, government actions and proposals affecting the terms of underlying home and consumer loans, changes in demand for products (e.g., automobiles) financed by those loans, and the inability of borrowers to refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying assets and is, therefore, subject to risks associated with the negligence or defalcation of its servicer. In some circumstances, the mishandling of related documentation also may affect the rights of security holders in and to the underlying assets. The insolvency of entities that generate receivables or that utilize the assets may result in a decline in the value of the underlying assets, as well as costs and delays. The obligations underlying asset-backed securities, in particular securities backed by pools of residential and commercial mortgages, also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as high a yield as is provided by the asset-backed security. The risk of investing in asset-backed securities has increased because performance of the various sectors in which the assets

 


 

underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime mortgages, and credit card receivables) has become more highly correlated since the deterioration in worldwide economic and liquidity conditions.
Among other trading agreements, the Fund is party to International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Agreements”) or other similar types of agreements with selected counterparties that generally govern over-the-counter derivative transactions entered into by the Fund. The ISDA Agreements typically include representations and warranties as well as contractual terms related to collateral, events of default, termination events, and other provisions. Termination events may include the decline in the net assets of the Fund below a certain level over a specified period of time and entitle a counterparty to elect to terminate early with respect to some or all the transactions under the ISDA Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse effect on the Fund’s operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. In particular, the Fund may use swaps or other derivatives on an index, a single security or a basket of securities to gain investment exposures (e.g., by selling protection under a credit default swap). The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). For example, the Fund may use credit default swaps to take a short position with respect to the likelihood of default by an issuer. The Fund also may use currency derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For instance, the Manager may alter the interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is designed to maintain the Fund’s exposure to the credit of an issuer through the debt instrument but adjust the Fund’s interest rate exposure through the swap. With these swaps, the Fund and its counterparties exchange interest rate exposure, such as fixed versus variable rates and shorter duration versus longer duration exposure. In adjusting its investment exposures, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund is not limited in the extent to which it uses derivatives or in the absolute face value of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate exposure of its assets, and its net long exposure may exceed 100% of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During

 


 

these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk that it will be required to pay the full notional value of the swap contract in the event of a default.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. During the period ended November 30, 2011, the Fund used forward currency contracts to adjust exposure to foreign currencies and otherwise adjust currency exchange risk. Forward currency contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded. The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses

 


 

are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. During the period ended November 30, 2011, the Fund used futures contracts to adjust interest rate exposure and maintain the diversity and liquidity of the portfolio. Futures contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. During the period ended November 30, 2011, the Fund used purchased option contracts to adjust exposure to foreign currencies and otherwise manage currency exchange rate risk. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. During the period ended November 30, 2011, the Fund used written option contracts to adjust exposure to foreign currencies and otherwise manage currency exchange rate risk. The Fund had no written option contracts outstanding at the end of the period.
For the period ended November 30, 2011, investment activity in options contracts written by the Fund was as follows:
                                                 
    Puts     Calls  
    Principal     Number             Principal     Number        
    Amount of     of             Amount of     of        
    Contracts     Contracts     Premiums     Contracts     Contracts     Premiums  
Outstanding, beginning of period
    (11,600,00 )         $ (228,729 )               $  
Options written
                                   
Options exercised
                                       
Options expired
    11,600,000             228,729                      
Options sold
                                   
 
                                   
Outstanding, end of period
              $                 $  
 
                                   
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.

 


 

Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. During the period ended November 30, 2011, the Fund used swap agreements to adjust interest rate exposure, achieve exposure to a reference entity’s credit, and/or provide a measure of protection against default loss. Swap agreements outstanding at the end of the period are listed in the Fund’s Schedule of Investments.

 


 

Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.
The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Assets:
                                               
Unrealized appreciation on forward currency contracts
  $     $ 1,170,465     $     $     $     $ 1,170,465  
Unrealized appreciation on futures contracts*
    134,403                               134,403  
Unrealized appreciation on swap agreements
    434,362             1,395,399                   1,829,761  
 
                                     
Total
  $ 568,765     $ 1,170,465     $ 1,395,399     $     $     $ 3,134,629  
 
                                   
 
                                               
Liabilities:
                                               
Unrealized depreciation on forward currency contracts
  $     $ (1,104,831 )   $     $     $     $ (1,104,831 )
Unrealized depreciation on futures contracts*
    (862,479 )                             (862,479 )
Unrealized depreciation on swap agreements
    (458,879 )           (2,443,553 )                 (2,902,432 )
 
                                     
Total
  $ (1,321,358 )   $ (1,104,831 )   $ (2,443,553 )   $     $     $ (4,869,742 )
 
                                   
 
*   The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of futures contracts as reported in the Schedule of Investments.
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts, and futures contracts), notional amounts (swap agreements), or principal amounts (options) outstanding at each month-end, was as follows for the period ended November 30, 2011:
                                 
    Forward                    
    Currency     Futures     Swap        
    Contracts     Contracts     Agreements     Options  
Average amount outstanding
  $ 162,585,149     $ 146,586,214     $ 81,216,535     $ 5,491,824  

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Global Equity Allocation Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                         
        Shares/            
        Par Value ($)     Description   Value ($)  
 
               
MUTUAL FUNDS — 100.0%
       
               
 
       
               
Affilliated Issuers — 100.0%
       
          665,102    
GMO Alpha Only Fund, Class IV
    16,554,387  
          19,177,879    
GMO Emerging Markets Fund, Class VI
    224,189,410  
          2,984,061    
GMO Flexible Equities Fund, Class VI
    51,146,806  
          10,553,104    
GMO International Core Equity Fund, Class VI
    278,707,487  
          3,633,108    
GMO International Growth Equity Fund, Class IV
    77,748,499  
          9,205,992    
GMO International Intrinsic Value Fund, Class IV
    179,516,845  
          26,833,208    
GMO Quality Fund, Class VI
    586,037,257  
          17,113    
GMO Short-Duration Investment Fund, Class III
    141,353  
          6,385,343    
GMO U.S. Core Equity Fund, Class VI
    77,518,065  
               
 
     
               
TOTAL MUTUAL FUNDS (COST $1,400,783,184)
    1,491,560,109  
               
 
     
               
 
       
               
PRIVATE INVESTMENT FUNDS — 0.0%
       
               
 
       
               
Affilliated Issuers — 0.0%
       
          175    
GMO SPV I, LLC (a)
    16  
               
 
     
 
               
TOTAL PRIVATE INVESTMENT FUNDS (COST $-)
    16  
               
 
     
               
 
       
               
SHORT-TERM INVESTMENTS — 0.0%
       
               
 
       
               
Time Deposits — 0.0%
       
          15,708    
State Street Eurodollar Time Deposit , 0.01%, due 12/01/11
    15,708  
               
 
     
 
               
TOTAL SHORT-TERM INVESTMENTS (COST $15,708)
    15,708  
               
 
     
               
 
       
               
TOTAL INVESTMENTS — 100.0%
(Cost $1,400,798,892)
    1,491,575,833  
               
 
       
               
Other Assets and Liabilities (net) — (0.0%)
    (64,984 )
               
 
     
               
 
       
               
TOTAL NET ASSETS — 100.0%
  $ 1,491,510,849  
               
 
     
Notes to Schedule of Investments:
(a)   Underlying investment represents interests in defaulted claims. See “Other matters” for additional information.
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                         
    Gross     Gross     Net Unrealized  
    Unrealized     Unrealized     Appreciation  
Aggregate Cost   Appreciation     (Depreciation)     (Depreciation)  
$1,508,084,485
  $—     $(16,508,652)     $(16,508,652)  
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.

 


 

A summary of the Fund’s transactions in the shares of other funds managed by GMO during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO Alpha Only Fund, Class IV
  $ 14,851,414     $ 1,071,856     $ 273,687     $     $     $ 16,554,387  
GMO Emerging Markets Fund, Class VI
    238,829,624       45,621,106       9,720,252       90,279       18,478,317       224,189,410  
GMO Flexible Equities Fund, Class VI
    18,160,575       38,584,066       811,170                   51,146,806  
GMO International Core Equity Fund, Class VI
    359,986,618       42,300,949       77,962,774       4,254,964             278,707,487  
GMO International Growth Equity Fund, Class IV
    127,710,937       12,000,163       46,436,562       907,572             77,748,499  
GMO International Intrinsic Value Fund, Class IV
    131,550,402       73,103,442       4,257,106       2,478,307             179,516,845  
GMO Quality Fund, Class VI
    519,733,118       101,511,135       60,308,582       8,536,981             586,037,257  
GMO Short-Duration Investment Fund, Class III
    142,792       270             270             141,353  
GMO SPV I, LLC
    26                               16  
GMO U.S. Core Equity Fund, Class VI
    74,768,699       6,785,775       5,197,374       1,175,818             77,518,065  
 
                                   
Totals
  $ 1,485,734,205     $ 320,978,762     $ 204,967,507     $ 17,444,191     $ 18,478,317     $ 1,491,560,125  
 
                                   

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Shares of the underlying funds and other investment funds are generally valued at their net asset value. Investments held by the underlying funds are valued as follows: Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly and indirectly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 0.7% of net assets. The underlying funds classify such securities (levels defined below) as Level 3.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund, either directly or through investments in the underlying funds, that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below and as described in the disclosures of the underlying funds.
             
Security Type             Percentage of Net Assets of the Fund  
Equity Securities
  52.6%    
Futures Contracts
  0.2%    
Swap Agreements
  0.1%    
Typically the Fund and the underlying funds value debt instruments based on the most recent quoted price supplied by a single pricing source chosen by the Manager. Although the Manager normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and may change a pricing source at any time. The Manager monitors erratic or unusual movements (including unusual inactivity) in the prices supplied for a security and has discretion to override a price supplied by a source (e.g., by taking a price supplied by another) when it believes that the price supplied is not reliable. Although alternative prices may be available for securities held by the Fund and the underlying funds, those alternative sources are not typically part of the valuation process and do not necessarily provide greater certainty about the prices used by the Fund and the underlying funds. As of November 30, 2011, the total value of securities held directly and indirectly for which no alternative pricing source was available represented 0.0% of the net assets of the Fund.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

 


 

During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs.
Level 3 — Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Mutual Funds
  $ 1,491,560,109     $     $     $ 1,491,560,109  
Private Investment Fund
          16             16  
Short-Term Investments
    15,708                   15,708  
 
                       
Total Investments
    1,491,575,817       16             1,491,575,833  
 
                       
Total
  $ 1,491,575,817     $ 16     $     $ 1,491,575,833  
 
                       
The underlying funds held at period end are classified above as either Level 1 or Level 2. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net values of the Fund’s indirect investments in securities and derivative financial instruments using Level 3 inputs were 0.7% and 0.0% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011 whose fair value was categorized using Level 3 inputs.
Other matters
GMO SPV I, LLC (“SPV”), an investment of the Fund, has litigation pending against various entities related to the 2002 fraud and related default of asset-backed securities issued by NPF VI, Inc. and NPF XII, Inc. The outcome of the lawsuits against the remaining defendants is not known and any potential recoveries are not reflected in the net asset value of SPV. For the period ended November 30, 2011, the Fund received no distributions from SPV in connection with the defaulted securities or the related litigation.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. References to investments include those held directly by the Fund and indirectly through the Fund’s investments in the underlying funds. Some of the underlying funds are non-diversified investment companies under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by those funds may affect their performance more than if they were diversified. Selected risks of investing in the Fund are summarized below, including those risks to which the Fund is exposed as a result of its investments in the underlying funds. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If an underlying fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will

 


 

not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of the value of those investments. An underlying fund also may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Because the Fund and the underlying funds normally do not take temporary defensive positions, declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund or an underlying fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in the underlying funds, including the risk that the underlying funds in which it invests do not perform as expected. Because the Fund bears the fees and expenses of the underlying funds in which it invests, new investments in underlying funds with higher fees or expenses than those of the underlying funds in which the Fund is currently invested will increase the Fund’s total expenses. The fees and expenses associated with an investment in the Fund are less predictable and may be higher than fees and expenses associated with an investment in funds that charge a fixed management fee.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
Commodities Risk — To the extent an underlying fund has exposure to global commodity markets, the value of its shares is affected by factors particular to the commodity markets and may fluctuate more than the value of shares of a fund with a broader range of investments.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of foreign currency holdings and investments denominated in foreign currencies, or that the U.S. dollar will decline in value relative to the foreign currency being hedged.
Leveraging Risk — The use of reverse repurchase agreements and other derivatives and securities lending may cause the Fund’s portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.

 


 

Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Real Estate Risk — To the extent an underlying fund concentrates its assets in real estate-related investments, the value of its portfolio is subject to factors affecting the real estate industry and may fluctuate more than the value of a portfolio that consists of securities of companies in a broader range of industries.
Short Sales Risk — The Fund runs the risk that an underlying fund’s loss on a short sale of securities that the underlying fund does not own is unlimited.
Market Risk — Fixed Income Securities — Typically, the market value of fixed income securities will decline during periods of rising interest rates and widening of credit spreads.
Market Risk — Asset-Backed Securities — Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating.
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies or in industries with high positive correlations to one another creates additional risk.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Derivative financial instruments
At November 30, 2011, the Fund held no derivative financial instruments directly. For a listing of derivative financial instruments held by the underlying funds, if any, please refer to the underlying funds’ Schedule of Investments.

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Inflation Indexed Plus Bond Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                         
        Par Value ($) /            
        Shares     Description   Value ($)  
 
               
DEBT OBLIGATIONS — 40.3%
       
               
 
       
               
U.S. Government — 40.3%
       
          1,259,616    
U.S. Treasury Inflation Indexed Bond, 2.13%, due 02/15/40(a)
    1,675,782  
          2,166,498    
U.S. Treasury Inflation Indexed Bond, 2.38%, due 01/15/25(a)
    2,734,357  
          5,033,150    
U.S. Treasury Inflation Indexed Bond, 0.63%, due 07/15/21(a) (e)
    5,332,778  
          2,236,120    
U.S. Treasury Inflation Indexed Note, 2.00%, due 04/15/12(a)
    2,243,631  
               
 
     
               
Total U.S. Government
    11,986,548  
               
 
     
               
TOTAL DEBT OBLIGATIONS (COST $11,652,765)
    11,986,548  
               
 
     
               
 
       
               
MUTUAL FUNDS — 55.0%
       
               
 
       
               
Affiliated Issuers — 55.0%
       
          108,656    
GMO Emerging Country Debt Fund, Class IV
    1,028,976  
          1,338,468    
GMO Short-Duration Collateral Fund
    8,847,273  
          28,918    
GMO Special Purpose Holding Fund(b)
    11,278  
          16,275    
GMO U.S. Treasury Fund
    407,043  
          257,374    
GMO World Opportunity Overlay Fund
    6,074,038  
               
 
     
               
TOTAL MUTUAL FUNDS (COST $15,535,537)
    16,368,608  
               
 
     
               
 
       
               
SHORT-TERM INVESTMENTS — 4.1%
       
               
 
       
               
Money Market Funds — 0.5%
       
          153,776    
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00% (c)
    153,776  
 
               
U.S. Government — 3.6%
       
 
          1,050,000    
U.S. Treasury Bill, 0.10%, due 10/18/12 (d)(e)
    1,049,061  
               
 
     
               
TOTAL SHORT-TERM INVESTMENTS (COST $1,202,762)
    1,202,837  
               
 
     
               
 
       
               
TOTAL INVESTMENTS — 99.4%
(Cost $28,391,064)
    29,557,993  
               
 
       
               
Other Assets and Liabilities (net) — 0.6%
    190,606  
               
 
     
 
               
TOTAL NET ASSETS — 100.0%
  $ 29,748,599  
               
 
     
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
                                 
                            Net Unrealized  
Settlement                           Appreciation  
Date   Counterparty   Deliver/Receive   Units of Currency     Value     (Depreciation)  
Buys †  
 
                           
12/06/11  
Barclays Bank PLC
  AUD     100,000     $ 102,792     $ (1,150 )
12/06/11  
Citibank N.A.
  AUD     100,000       102,792       (1,504 )
12/06/11  
Credit Suisse International
  AUD     200,000       205,584       9,588  

 


 

                                 
12/06/11  
Deutsche Bank AG
  AUD     1,600,000       1,644,674       83,259  
12/06/11  
Royal Bank of Scotland PLC
  AUD     100,000       102,792       933  
12/13/11  
Barclays Bank PLC
  CAD     200,000       196,030       (4,895 )
12/13/11  
Citibank N.A.
  CAD     100,000       98,015       (2,495 )
12/13/11  
Credit Suisse International
  CAD     600,000       588,090       (2,867 )
12/13/11  
Deutsche Bank AG
  CAD     700,000       686,105       3,582  
12/13/11  
Royal Bank of Scotland PLC
  CAD     500,000       490,075       (7,888 )
1/31/12  
Deutsche Bank AG
  CHF     100,000       109,642       363  
2/07/12  
Citibank N.A.
  EUR     100,000       134,457       (691 )
2/07/12  
Credit Suisse International
  EUR     200,000       268,914       1,990  
1/10/12  
Citibank N.A.
  GBP     200,000       313,670       (6,503 )
1/10/12  
Credit Suisse International
  GBP     500,000       784,174       (10,786 )
1/10/12  
Deutsche Bank AG
  GBP     100,000       156,835       (3,465 )
1/10/12  
Royal Bank of Scotland PLC
  GBP     100,000       156,835       (2,325 )
2/14/12  
Credit Suisse International
  JPY     30,000,000       387,409       327  
2/21/12  
Deutsche Bank AG
  NOK     3,700,000       638,356       7,602  
2/21/12  
Royal Bank of Scotland PLC
  NOK     600,000       103,517       1,611  
1/24/12  
Credit Suisse International
  NZD     200,000       155,588       (1,352 )
12/20/11  
Barclays Bank PLC
  SEK     1,800,000       265,759       (5,392 )
12/20/11  
Citibank N.A.
  SEK     1,300,000       191,937       (1,217 )
12/20/11  
Credit Suisse International
  SEK     2,100,000       310,053       6,238  
12/20/11  
Deutsche Bank AG
  SEK     1,600,000       236,231       (13,717 )
   
 
                       
   
 
              $ 8,430,326     $ 49,246  
   
 
                       
   
 
                           
Sales #  
 
                           
12/06/11  
Citibank N.A.
  AUD     200,000     $ 205,584     $ 2,481  
12/06/11  
Credit Suisse International
  AUD     500,000       513,961       (2,591 )
12/06/11  
Deutsche Bank AG
  AUD     200,000       205,584       (1,784 )
12/06/11  
Royal Bank of Scotland PLC
  AUD     200,000       205,584       (10,007 )
12/13/11  
Citibank N.A.
  CAD     200,000       196,030       851  
12/13/11  
Credit Suisse International
  CAD     200,000       196,030       (7,493 )
12/13/11  
Deutsche Bank AG
  CAD     2,100,000       2,058,315       (31,543 )
1/31/12  
Barclays Bank PLC
  CHF     200,000       219,284       3,257  
1/31/12  
Credit Suisse International
  CHF     600,000       657,852       18,500  
1/31/12  
Royal Bank of Scotland PLC
  CHF     300,000       328,926       5,616  
2/07/12  
Citibank N.A.
  EUR     100,000       134,457       178  
2/07/12  
Deutsche Bank AG
  EUR     1,400,000       1,882,398       23,702  
1/10/12  
Citibank N.A.
  GBP     200,000       313,670       (2,349 )
1/10/12  
Credit Suisse International
  GBP     400,000       627,339       (3,706 )
1/10/12  
Deutsche Bank AG
  GBP     100,000       156,835       1,205  

 


 

                                 
1/10/12  
Royal Bank of Scotland PLC
  GBP     100,000       156,835       719  
2/14/12  
Barclays Bank PLC
  JPY     10,000,000       129,136       1,126  
2/14/12  
Citibank N.A.
  JPY     10,000,000       129,136       89  
2/14/12  
Credit Suisse International
  JPY     20,000,000       258,273       2,392  
2/14/12  
Deutsche Bank AG
  JPY     60,000,000       774,818       6,025  
2/14/12  
Royal Bank of Scotland PLC
  JPY     20,000,000       258,273       2,056  
1/24/12  
Deutsche Bank AG
  NZD     100,000       77,794       1,011  
1/24/12  
Royal Bank of Scotland PLC
  NZD     200,000       155,588       (3,946 )
12/20/11  
Barclays Bank PLC
  SEK     1,100,000       162,409       61  
12/20/11  
Credit Suisse International
  SEK     5,000,000       738,220       35,557  
   
 
                       
   
 
              $ 10,742,331     $ 41,407  
   
 
                       
 
  Fund buys foreign currency; sells USD.
 
#   Fund sells foreign currency; buys USD.
Futures Contracts
                         
                    Net Unrealized  
Number of       Expiration           Appreciation  
Contracts   Type   Date   Value     (Depreciation)  
Buys  
 
                   
13  
Euro Bund
  December 2011   $ 2,341,844     $ (52,758 )
1  
U.S. Treasury Note 10 Yr. (CBT)
  March 2012     129,344       (1,222 )
3  
U.S. Treasury Note 2 Yr. (CBT)
  March 2012     661,500       137  
   
 
               
   
 
      $ 3,132,688     $ (53,843 )
   
 
               
   
 
                   
Sales  
 
                   
9  
Australian Government Bond 10 Yr.
  December 2011   $ 1,078,657     $ (20,529 )
5  
Canadian Government Bond 10 Yr.
  March 2012     649,225       (2,837 )
1  
U.S. Treasury Bond 30 Yr. (CBT)
  March 2012     141,375       3,794  
8  
UK Gilt Long Bond
  March 2012     1,428,102       15,890  
   
 
               
   
 
      $ 3,297,359     $ (3,682 )
   
 
               
Swap Agreements
Interest Rate Swaps
                                         
                                    Net Unrealized  
Notional   Expiration       Receive                   Appreciation/  
Amount   Date   Counterparty   (Pay)#   Fixed Rate     Variable Rate     (Depreciation)  
1,400,000   CHF   3/21/2022  
Barclays Bank PLC
  Receive     1.80 %   6 Month CHF LIBOR     $ 50,117  
6,300,000   SEK   3/21/2022  
Barclays Bank PLC
  (Pay)     2.90 %   3 Month SEK STIBOR       (42,327 )
6,300,000   SEK   3/21/2022  
JPMorgan Chase Bank, N.A.
  (Pay)     2.90 %   3 Month SEK STIBOR       (42,327 )
           
 
                       
           
 
                      $ (34,537 )
           
 
                         
           
 
              Premiums to (Pay) Receive     $ 38,501  
           
 
                       
 
#   Receive — Fund receives fixed rate and pays variable rate.
  (Pay) — Fund pays fixed rate and receives variable rate.

 


 

Total Return Swaps
                                     
                                Net Unrealized  
Notional   Expiration                       Appreciation/  
Amount   Date   Counterparty   Fund Pays     Fund Receives   (Depreciation)  
16,000,000   USD   1/4/2012  
Barclays Bank PLC
  0.19% of notional amount     Barclays TIPS Total Return Index (a)   $ 187,641  
           
 
                 
           
 
                     
           
 
          Premiums to (Pay) Receive   $  
           
 
                 
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
Notes to Schedule of Investments:
CHF LIBOR — London Interbank Offered Rate denominated in Swiss Franc.
SEK STIBOR — Stockholm Interbank Offered Rate denominated in Swedish Krona.
TIPS — Treasury Inflation Protected Securities
(a)   Indexed security in which price and/or coupon is linked to the prices of a specific instrument or financial statistic.
 
(b)   Underlying investment represents interests in defaulted claims. See “Other Matters” for additional information.
 
(c)   Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.
 
(d)   Rate shown represents yield-to-maturity.
 
(e)   All or a portion of this security has been pledged to cover margin requirements on futures contracts, collateral on swap contracts, forward currency contracts, and/or written options, if any.
Currency Abbreviations:
AUD — Australian Dollar
CAD — Canadian Dollar
CHF — Swiss Franc
EUR — Euro
GBP — British Pound
JPY — Japanese Yen
NOK — Norwegian Krone
NZD — New Zealand Dollar
SEK — Swedish Krona
USD — United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                         
    Gross     Gross     Net Unrealized  
    Unrealized     Unrealized     Appreciation  
Aggregate Cost   Appreciation     (Depreciation)     (Depreciation)  
$49,085,840
  $     $ (19,527,847 )   $ (19,527,847 )

 


 

Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                         
    Value,                             Distributions              
    beginning of             Sales     Dividend     of Realized     Return of     Value, end  
Affiliate   period     Purchases     Proceeds     Income*     Gains*     Capital*     of period  
GMO Emerging Country Debt Fund, Class IV
  $ 4,686,583     $ 207,642     $ 4,050,000     $ 62,642     $     $       1,028,976  
GMO Short-Duration Collateral Fund
    68,106,389             37,500,000       458,027             20,173,802       8,847,273  
GMO Special Purpose Holding Fund
    14,459                                     11,278  
GMO U.S. Treasury Fund
    6,501,391       39,903,410       46,000,000       2,613       797             407,043  
GMO World Opportunity Overlay Fund
    31,160,332       700,000       26,425,000                         6,074,038  
 
                                         
Totals
  $ 110,469,154     $ 40,811,052     $ 113,975,000     $ 523,282     $ 797     $ 20,173,802       16,368,608  
 
                                         
 
*   The table above includes estimated sources of all distributions paid by the underlying funds during the period March 1, 2011 through November 30, 2011 for tax purposes. The actual tax characterization of distributions paid by the underlying funds will be determined at the end of the fiscal year ending February 29, 2012.

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly and indirectly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 1.4% of net assets. The Fund and the underlying funds classify such securities (levels defined below) as Level 3. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivatives contracts based on the creditworthiness of its counterparties. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Typically the Fund and the underlying funds value debt instruments based on the most recent quoted price supplied by a single pricing source chosen by the Manager. Although the Manager normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and may change a pricing source at any time. The Manager monitors erratic or unusual movements (including unusual inactivity) in the prices supplied for a security and has discretion to override a price supplied by a source (e.g., by taking a price supplied by another) when it believes that the price supplied is not reliable. Although alternative prices may be available for securities held by the Fund and the underlying funds, those alternative sources are not typically part of the valuation process and do not necessarily provide greater certainty about the prices used by the Fund and the underlying funds. As of November 30, 2011, the total value of securities held directly and indirectly for which no alternative pricing source was available represented 4.8% of the net assets of the Fund.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit risk, yield curves and similar data.
Level 3 — Valuations based primarily on inputs that are unobservable and significant.

 


 

The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Debt Obligations
                               
U.S. Government
  $     $ 11,986,548     $     $ 11,986,548  
 
                       
TOTAL DEBT OBLIGATIONS
          11,986,548             11,986,548  
 
                       
Mutual Funds
    16,357,330       11,278             16,368,608  
Short-Term Investments
    1,202,837                   1,202,837  
 
                       
Total Investments
    17,560,167       11,997,826             29,557,993  
 
                       
Derivatives *
                               
Forward Currency Contracts
                               
Foreign Currency risk
          220,319             220,319  
Futures Contracts
                               
Interest Rate risk
    19,821                   19,821  
Swap Agreements
                               
Interest Rate risk
          237,758             237,758  
 
                       
Total Derivatives
    19,821       458,077             477,898  
 
                       
Total
  $ 17,579,988     $ 12,455,903     $     $ 30,035,891  
 
                       
LIABILITY VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Liabilities     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Derivatives *
                               
Forward Currency Contracts
                               
Foreign Currency risk
          (129,666 )           (129,666 )
Futures Contracts
                               
Interest Rate risk
    (77,346 )                 (77,346 )
Swap Agreements
                               
Interest Rate risk
          (84,654 )           (84,654 )
 
                       
Total Derivatives
    (77,346 )     (214,320 )           (291,666 )
 
                       
Total
  $ (77,346 )   $ (214,320 )   $     $ (291,666 )
 
                       

 


 

The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
* Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as either Level 1 or Level 2. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net values of the Fund’s investments (both direct and indirect) in securities and derivative financial instruments using Level 3 inputs were 27.9% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase the security at an agreed upon price and date. The Fund, through its custodian, takes possession of securities it acquired under the repurchase agreement. The value of the securities acquired is required by contract to be marked to market daily and additional collateral is required to be transferred so that the market value is at least equal to the amount owed to the Fund by the seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings and/or the value of the securities subject to the repurchase agreement is insufficient, the Fund’s recovery of cash from the seller may be delayed and the Fund may incur a loss equal to the difference between the cash it paid and the value of the securities. The Fund had no repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same assets at an agreed upon price and date. The Fund can use the proceeds received from entering into a reverse repurchase agreement to make additional investments, which generally causes the Fund’s portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the securities it sold and as a result would realize a loss equal to the difference between the value of those securities and the payment it received for them. The size of this loss will depend upon the difference between what the buyer paid for the securities the Fund sold to it and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of $100). In the event of a buyer’s bankruptcy or insolvency, the Fund’s use of proceeds from the sale of its securities may be restricted while the other party or its trustee or receiver determines whether to honor the Fund’s right to repurchase the securities. The Fund had no reverse repurchase agreements outstanding at the end of the period.
Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income securities whose principal value is adjusted periodically according to the rate of inflation. Two structures are common. The U.S. Treasury and some other issuers use a structure that reflects inflation in the principal value of the bond. Most other issuers pay out any inflation related accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real interest rates. Real interest rates, in turn, are tied to the relationship between nominal interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e. nominal interest rate minus inflation) might decline, leading to an increase in value of inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than inflation,

 


 

real interest rates might rise, leading to a decrease in value of inflation indexed bonds. There can be no assurance, however, that the value of inflation indexed bonds will be directly correlated to changes in nominal interest rates, and short term increases in inflation may lead to a decline in their value. Coupon payments received by the Fund from inflation indexed bonds are included in the Fund’s gross income for the period in which they accrue. In addition, any increase or decrease in the principal amount of an inflation indexed bond will increase or decrease taxable ordinary income to the Fund, even though principal is not paid until maturity. Inflation-indexed bonds outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Other matters
GMO Special Purpose Holding Fund (“SPHF”), an investment of the Fund, has litigation pending against various entities related to the 2002 fraud and related default of securities previously held by SPHF. The outcome of the lawsuits against the remaining defendants is not known and any potential recoveries are not reflected in the net asset value of SPHF. For the period ended November 30, 2011, the Fund received no distributions from SPHF in connection with the defaulted securities or the related litigation.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk Fixed Income Securities — Typically, the market value of fixed income securities will decline during periods of rising interest rates and widening of credit spreads. In addition, increases in real interest rates may not be accompanied by increases in nominal interest rates. In such instances, the value of inflation indexed bonds may experience greater declines than non-inflation indexed (or nominal) fixed income investments with similar maturities. There can be no assurance that the value of the Fund’s inflation indexed bond investments will change in the same proportion as changes in nominal interest rates, and short-term increases in inflation may lead to a decline in their value.
Market Risk Asset-Backed Securities — Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating. The Fund’s investments in below investment grade securities have speculative characteristics, and changes in economic conditions or other circumstances are more likely to impair the capacity of issuers to make principal and interest payments than is the case with issuers of investment grade securities.
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Derivatives Risk — The use of derivatives involves the risk that their value may or may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Leveraging Risk — The Fund’s use of reverse repurchase agreements and other derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations. The risk of counterparty default is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions.
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies with high positive correlations to one another, such as the Fund’s investments in asset-backed securities secured by different types of consumer debt (e.g., credit-card receivables, automobile loans and home equity loans), creates additional risk.

 


 

Currency Risk — Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in underlying funds, including the risk that the underlying funds in which it invests will not perform as expected.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
The Fund invests (including through investment in underlying funds) in asset-backed securities, which may be backed by many types of assets, including pools of residential and commercial mortgages, automobile loans, educational loans, home equity loans, or credit card receivables, which expose the Fund to additional types of market risk. They also may be backed by pools of corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds and loans (commonly referred to as “collateralized debt obligations” or “collateralized loan obligations”) and by the fees earned by service providers. Payment of interest on asset backed securities and repayment of principal largely depend on the cash flows generated by the assets backing the securities. The market risk of a particular asset-backed security depends on many factors, including the deal structure (e.g., determination as to the amount of underlying assets or other support needed to produce the cash flows necessary to service interest and make principal payments), the quality of the underlying assets and, if any, the level of credit support and the credit quality of the credit-support provider. Asset-backed securities involve risk of loss of principal if obligors of the underlying obligations default and the value of the defaulted obligations exceeds whatever credit support the securities may have. The obligations of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and other laws affecting the rights and remedies of creditors. Many asset-backed securities in which the Fund has invested are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal and/or interest will be paid because the insurer could default on its obligations. In recent years, a significant number of asset-backed security insurers have defaulted on their obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about the creditworthiness of those securities (and underlying assets) caused credit spreads (the difference between yields on the asset-backed securities and U.S. Government securities) to widen dramatically.

 


 

Concurrently, systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions to make markets in many fixed income securities. These events reduced liquidity and contributed to substantial declines in the value of asset-backed and other fixed income securities. There can be no assurance these conditions will not occur again. Also, government actions and proposals affecting the terms of underlying home and consumer loans, changes in demand for products (e.g., automobiles) financed by those loans, and the inability of borrowers to refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying assets and is, therefore, subject to risks associated with the negligence or defalcation of its servicer. In some circumstances, the mishandling of related documentation also may affect the rights of security holders in and to the underlying assets. The insolvency of entities that generate receivables or that utilize the assets may result in a decline in the value of the underlying assets, as well as costs and delays. The obligations underlying asset-backed securities, in particular securities backed by pools of residential and commercial mortgages, also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as high a yield as is provided by the asset-backed security. The risk of investing in asset-backed securities has increased because performance of the various sectors in which the assets underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime mortgages, and credit card receivables) has become more highly correlated since the deterioration in worldwide economic and liquidity conditions.
Among other trading agreements, the Fund is party to International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Agreements”) or other similar types of agreements with selected counterparties that generally govern over-the-counter derivative transactions entered into by the Fund. The ISDA Agreements typically include representations and warranties as well as contractual terms related to collateral, events of default, termination events, and other provisions. Termination events may include the decline in the net assets of the Fund below a certain level over a specified period of time and entitle a counterparty to elect to terminate early with respect to some or all the transactions under the ISDA Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse effect on the Fund’s operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. In particular, the Fund may use swaps or other derivatives on an index, a single security or a basket of securities to gain investment exposures (e.g., by selling protection under a credit default swap). The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). For example, the Fund may use credit default swaps to take a short position with respect to the likelihood of default by an issuer. The Fund also may use currency derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For instance, the Manager may alter the interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is designed to maintain the Fund’s exposure to the credit of an issuer through the debt instrument but adjust the Fund’s interest rate exposure through the swap. With these swaps, the Fund and its counterparties exchange interest rate exposure, such as fixed versus variable rates and shorter duration versus longer duration exposure. In adjusting its investment exposures, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund is not limited in the extent to which it uses derivatives or in the absolute face value of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate exposure of its assets, and its net long exposure may exceed 100% of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated,

 


 

the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk that it will be required to pay the full notional value of the swap contract in the event of a default.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.

 


 

These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. During the period ended November 30, 2011, the Fund used forward currency contracts to adjust exposure to foreign currencies and otherwise adjust currency exchange rate risk. Forward currency contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded. The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. During the period ended November 30, 2011, the Fund used futures contracts to adjust interest rate exposure and enhance the diversity and liquidity of the portfolio. Futures contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. During the period ended November 30, 2011, the Fund used purchased option contracts to adjust exposure to currencies and otherwise adjust currency exchange rate risk, as well as to enhance the diversity and liquidity of the portfolio and to adjust interest rate exposure. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. During the period ended November 30, 2011, the Fund used written option contracts to adjust exposure to currencies and otherwise adjust currency exchange rate risk, as well as to maintain the diversity and liquidity of the portfolio and to adjust interest rate exposure. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
For the period ended November 30, 2011, investment activity in options contracts written by the Fund was as follows:

 


 

                                                 
    Puts     Calls  
    Principal     Number             Principal              
    Amount of     of             Amount of     Number of        
    Contracts     Contracts     Premiums     Contracts     Contracts     Premiums  
Outstanding, beginning of period
    (20,900,000 )         $ (412,106 )               $  
Options written
                                       
Options bought back
                                   
Options expired
    20,900,000             412,106                    
Options sold
                                   
 
                                   
Outstanding, end of period
              $                   $    
 
                                   
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a

 


 

payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. During the period ended November 30, 2011, the Fund used swap agreements to adjust interest rate exposure and adjust its exposure to certain markets. Swap agreements outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.
The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Assets:
                                               
Unrealized appreciation on forward currency contracts
  $     $ 220,319     $     $     $     $ 220,319  
Unrealized appreciation on futures contracts*
    19,821                               19,821  
Unrealized appreciation on swap agreements
    237,758                               237,758  
 
                                   
Total
  $ 257,579     $ 220,319     $     $     $     $ 477,898  
 
                                   
 
                                               
Liabilities:
                                               
Unrealized depreciation on forward currency contracts
  $     $ (129,666 )   $     $     $     $ (129,666 )
Unrealized depreciation on futures contracts*
    (77,346 )                             (77,346 )
Unrealized depreciation on swap agreements
    (84,654 )                             (84,654 )
 
                                   
Total
  $ (162,000 )   $ (129,666 )   $     $     $     $ (291,666 )
 
                                   
 
*   The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of futures contracts as reported in the Schedule of Investments.
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts, futures contracts), notional amounts (swap agreements), or principal amounts (options) outstanding at each month-end, was as follows for the period ended November 30, 2011:
                                 
    Forward                    
    Currency     Futures     Swap        
    Contracts     Contracts     Agreements     Options  
Average amount outstanding
  $ 56,609,095     $ 45,756,722     $ 98,765,921     $ 9,894,753  

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO International Bond Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                     
Par Value     Description   Value ($)  
 
           
DEBT OBLIGATIONS — 37.6%
       
           
 
       
           
Canada — 4.5%
       
           
 
       
           
Foreign Government Obligations
       
CAD     3,000,000    
Government of Canada, 3.50%, due 06/01/20
    3,273,602  
           
 
     
           
 
       
           
France — 3.7%
       
           
 
       
           
Foreign Government Obligations
       
EUR     2,000,000    
Government of France, 4.00%, due 10/25/38
    2,698,605  
           
 
     
           
 
       
           
Italy — 0.3%
       
           
 
       
           
Foreign Government Obligations
       
EUR     250,000    
Italy Buoni Poliennali Del Tesoro, 5.00%, due 08/01/34
    252,851  
           
 
     
           
 
       
           
Japan — 16.3%
       
           
 
       
           
Foreign Government Obligations
       
JPY     848,400,000    
Japan Government Twenty Year Bond, 2.20%, due 06/20/26
    11,902,321  
           
 
     
           
 
       
           
Spain — 1.6%
       
           
 
       
           
Foreign Government Obligations
       
EUR     1,100,000    
Government of Spain, 4.70%, due 07/30/41
    1,141,010  
           
 
     
           
United Kingdom — 6.0%
       
           
 
       
           
Foreign Government Obligations
       
GBP     2,350,000    
U.K. Treasury Gilt, 4.25%, due 12/07/27
    4,413,239  
           
 
     
           
Total Foreign Government Obligations
    23,681,628  
           
 
     
           
United States — 5.2%
       
           
 
       
           
U.S. Government — 5.2%
       
USD     3,790,223    
U.S. Treasury Inflation Indexed Note, 2.00%, due 04/15/12(a)(b)(c)
    3,802,955  
           
 
     
           
 
       
           
TOTAL DEBT OBLIGATIONS (COST $26,178,138)
    27,484,583  
           
 
     
                     
Shares     Description   Value ($)  
 
           
MUTUAL FUNDS — 64.1%
       
           
 
       
           
United States — 64.1%
       
           
 
       
           
Affiliated Issuers
       
      279,624    
GMO Emerging Country Debt Fund, Class IV
    2,648,036  
      3,980,527    
GMO Short-Duration Collateral Fund
    26,311,285  
      37,466    
GMO Special Purpose Holding Fund(d)
    14,612  
      56,089    
GMO U.S. Treasury Fund
    1,402,795  
      701,891    
GMO World Opportunity Overlay Fund
    16,564,627  
           
 
     
           
Total United States
    46,941,355  
           
 
     
           
 
       
           
TOTAL MUTUAL FUNDS (COST $46,524,518)
    46,941,355  
           
 
     

 


 

                     
Shares/            
Par Value ($)     Description   Value ($)  
 
           
SHORT-TERM INVESTMENTS — 2.1%
       
           
 
       
           
Money Market Funds — 0.7%
       
      528,078    
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00%(e)
    528,078  
           
 
       
           
U.S. Government — 1.4%
       
      1,000,000    
U.S. Treasury Bill, 0.10%, due 10/18/12 (a)(f)
    999,106  
           
 
     
           
TOTAL SHORT-TERM INVESTMENTS (COST $1,527,112)
    1,527,184  
           
 
     
           
 
       
           
TOTAL INVESTMENTS — 103.8% (Cost $74,229,768)
    75,953,122  
           
Other Assets and Liabilities (net) — (3.8%)
    (2,777,746 )
           
 
     
           
 
       
           
TOTAL NET ASSETS — 100.0%
  $ 73,175,376  
           
 
     
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
                                 
                            Net Unrealized  
Settlement                           Appreciation  
Date   Counterparty   Deliver/Receive   Units of Currency     Value     (Depreciation)  
Buys †  
 
                           
12/06/11  
Barclays Bank PLC
  AUD     300,000     $ 308,377     $ (3,451 )
12/06/11  
Citibank N.A.
  AUD     200,000       205,584       (3,008 )
12/06/11  
Credit Suisse International
  AUD     600,000       616,753       28,765  
12/06/11  
Deutsche Bank AG
  AUD     5,100,000       5,242,398       283,631  
12/06/11  
Royal Bank of Scotland PLC
  AUD     200,000       205,584       1,865  
12/13/11  
Barclays Bank PLC
  CAD     300,000       294,045       (7,343 )
12/13/11  
Citibank N.A.
  CAD     300,000       294,045       (7,484 )
12/13/11  
Credit Suisse International
  CAD     1,600,000       1,568,240       (5,689 )
12/13/11  
Deutsche Bank AG
  CAD     1,700,000       1,666,255       10,228  
12/13/11  
Royal Bank of Scotland PLC
  CAD     1,400,000       1,372,210       (17,967 )
1/31/12  
Deutsche Bank AG
  CHF     200,000       219,284       726  
2/07/12  
Citibank N.A.
  EUR     400,000       537,828       (2,764 )

 


 

                                 
2/07/12  
Credit Suisse International
  EUR     400,000       537,828       3,980  
2/07/12  
Deutsche Bank AG
  EUR     14,500,000       19,496,268       (245,482 )
1/10/12  
Citibank N.A.
  GBP     300,000       470,504       (10,323 )
1/10/12  
Credit Suisse International
  GBP     2,800,000       4,391,373       8,449  
1/10/12  
Deutsche Bank AG
  GBP     400,000       627,339       (13,861 )
1/10/12  
Royal Bank of Scotland PLC
  GBP     600,000       941,008       811  
2/14/12  
Credit Suisse International
  JPY     50,000,000       645,682       546  
2/14/12  
Deutsche Bank AG
  JPY     1,350,000,000       17,433,409       (135,566 )
2/21/12  
Deutsche Bank AG
  NOK     9,300,000       1,604,516       19,109  
2/21/12  
Royal Bank of Scotland PLC
  NOK     1,500,000       258,793       4,026  
1/24/12  
Credit Suisse International
  NZD     500,000       388,971       (3,379 )
12/20/11  
Barclays Bank PLC
  SEK     4,400,000       649,634       (12,714 )
12/20/11  
Citibank N.A.
  SEK     2,800,000       413,403       (3,498 )
12/20/11  
Credit Suisse International
  SEK     6,900,000       1,018,744       20,107  
12/20/11  
Deutsche Bank AG
  SEK     4,100,000       605,341       (35,225 )
   
 
                       
   
 
              $ 62,013,416     $ (125,511 )
   
 
                       
   
 
                           
Sales #  
 
                           
12/06/11  
Citibank N.A.
  AUD     500,000     $ 513,961     $ 3,548  
12/06/11  
Credit Suisse International
  AUD     1,200,000       1,233,506       (5,771 )
12/06/11  
Deutsche Bank AG
  AUD     500,000       513,961       (4,461 )
12/06/11  
Royal Bank of Scotland PLC
  AUD     700,000       719,545       (34,047 )
12/13/11  
Citibank N.A.
  CAD     400,000       392,060       1,703  
12/13/11  
Credit Suisse International
  CAD     500,000       490,075       (18,733 )
12/13/11  
Deutsche Bank AG
  CAD     6,800,000       6,665,021       (106,272 )
1/31/12  
Barclays Bank PLC
  CHF     300,000       328,926       4,886  
1/31/12  
Credit Suisse International
  CHF     1,700,000       1,863,913       51,621  
1/31/12  
Royal Bank of Scotland PLC
  CHF     700,000       767,493       13,103  
2/07/12  
Citibank N.A.
  EUR     700,000       941,199       1,246  
1/10/12  
Citibank N.A.
  GBP     600,000       941,008       (7,048 )
1/10/12  
Credit Suisse International
  GBP     600,000       941,008       (8,980 )
1/10/12  
Deutsche Bank AG
  GBP     500,000       784,174       5,326  
1/10/12  
Royal Bank of Scotland PLC
  GBP     300,000       470,504       2,156  
2/14/12  
Barclays Bank PLC
  JPY     20,000,000       258,273       2,253  
2/14/12  
Citibank N.A.
  JPY     40,000,000       516,545       357  

 


 

                                 
2/14/12  
Credit Suisse International
  JPY     50,000,000       645,682       5,979  
2/14/12  
Royal Bank of Scotland PLC
  JPY     60,000,000       774,818       6,167  
1/24/12  
Citibank N.A.
  NZD     200,000       155,588       (4,568 )
1/24/12  
Deutsche Bank AG
  NZD     300,000       233,383       3,032  
1/24/12  
Royal Bank of Scotland PLC
  NZD     400,000       311,177       (7,893 )
12/20/11  
Barclays Bank PLC
  SEK     2,700,000       398,639       150  
12/20/11  
Credit Suisse International
  SEK     10,700,000       1,579,791       72,580  
   
 
              $ 22,440,250     $ (23,666 )
 
  Fund buys foreign currency; sells USD.
 
#   Fund sells foreign currency; buys USD.
Futures Contracts
                         
                    Net Unrealized  
Number of       Expiration           Appreciation  
Contracts   Type   Date   Value     (Depreciation)  
Buys  
 
                   
7  
Australian Government Bond 3 Yr.
  December 2011   $ 778,175     $ 8,059  
46  
Euro BOBL
  December 2011     7,579,782       5,753  
70  
Euro Bund
  December 2011     12,586,971       (318,900 )
67  
Euro SCHATZ
  December 2011     9,921,971       26,621  
10  
Japanese Government Bond 10 Yr. (TSE)
  December 2011     18,278,752       (90,790 )
2  
U.S. Treasury Note 10 Yr. (CBT)
  March 2012     258,687       (2,443 )
6  
U.S. Treasury Note 2 Yr. (CBT)
  March 2012     1,323,000       225  
   
 
               
   
 
      $ 50,727,338     $ (371,475 )
   
 
               
   
 
                   
Sales  
 
                   
19  
Australian Government Bond 10 Yr.
  December 2011   $ 2,279,602     $ (49,250 )
24  
Canadian Government Bond 10 Yr.
  March 2012     3,106,505       (4,200 )
3  
U.S. Treasury Bond 30 Yr. (CBT)
  March 2012     424,125       11,382  
9  
UK Gilt Long Bond
  March 2012     1,602,632       17,876  
   
 
               
   
 
      $ 7,412,864     $ (24,192 )
   
 
               

 


 

Reverse Repurchase Agreements
                     
Face Value     Description   Market Value  
USD     2,195,000    
Barclays Bank PLC, 0.15%, dated 11/28/11, to be repurchased on demand at face value plus accrued interest with a stated maturity date of 12/28/11.
    (2,195,027 )
         
Average balance outstanding
  $ (2,194,348 )
Average interest rate
    0.23 %
Maximum balance outstanding
  $ (3,704,250 )
Average balance outstanding was calculated based on daily face value balances outstanding during the period that the Fund has entered into reverse repurchase agreements.
Swap Agreements
Credit Default Swaps
                                                                 
                                                    Maximum Potential        
                                    Implied             Amount of Future     Net Unrealized  
Notional     Expiration           Receive     Annual     Credit     Reference     Payments by the Fund     Appreciation/  
Amount     Date   Counterparty     (Pay)^     Premium     Spread (1)     Entity     Under the Contract (2)     (Depreciation)  
14,000,000 USD  
3/20/2014
  Deutsche Bank AG   (Pay)     1.70 %     5.01 %   Republic of Italy     N/A     $ 930,266  
10,000,000 USD  
3/20/2019
  Deutsche Bank AG   Receive     1.66 %     4.75 %   Republic of Italy     10,000,000 USD     (1,629,036)
       
 
                                                     
       
 
                                                  $ (698,770 )
       
 
                                                     
       
 
                                  Premiums to (Pay) Receive           $  
       
 
                                                     
 
^   Receive — Fund receives premium and sells credit protection. If a credit event occurs, as defined under the terms of that particular swap agreement, the Fund will either (i) pay to the buyer of protection an amount equal to the notional amount of the swap and take delivery of the referenced obligation or underlying securities comprising the referenced index or (ii) pay a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation or underlying securities comprising the referenced index.
 
    (Pay) — Fund pays premium and buys credit protection. If a credit event occurs, as defined under the terms of that particular swap agreement, the Fund will either (i) receive from the seller of protection an amount equal to the notional amount of the swap and deliver the referenced obligation or underlying securities comprising the referenced index or (ii) receive a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation or underlying securities comprising the referenced index.
 
(1)   Implied credit spreads, represented in absolute terms, utilized in determining the market value of credit default swap agreements on the reference security, as of November 30, 2011, serve as an indicator of the current status of the payment/performance risk and reflect the likelihood or risk of default for the reference entity. The implied credit spread of a particular referenced entity reflects the cost of buying/selling protection. Wider (i.e. higher) credit spreads represent a deterioration of the referenced entity’s credit soundness and a greater likelihood or risk of default or other credit event occurring as defined under the terms of the agreement.
 
(2)   The maximum potential amount the Fund could be required to pay as a seller of credit protection if a credit event occurs as defined under the terms of that particular swap agreement.

 


 

Interest Rate Swaps
                                             
                                Net Unrealized          
Notional     Expiration         Receive           Appreciation/          
Amount     Date     Counterparty   (Pay)#     Fixed Rate     Variable Rate     (Depreciation)  
100,000   CHF     3/21/2022    
Citibank N.A.
  Receive     1.80 %   6 Month CHF LIBOR   $ 3,580  
2,200,000   CHF     3/21/2022    
Deutsche Bank AG
  Receive     1.80 %   6 Month CHF LIBOR     78,756  
1,900,000   CHF     3/21/2022    
Barclays Bank PLC
  Receive     1.80 %   6 Month CHF LIBOR     68,016  
17,000,000   SEK     3/21/2022    
Barclays Bank PLC
  (Pay)     2.90 %   3 Month SEK STIBOR     (114,216 )
12,000,000   SEK     3/21/2022    
JPMorgan Chase Bank, N.A.
  (Pay)     2.90 %   3 Month SEK STIBOR     (80,623 )
               
 
                         
               
 
                      $ (44,487 )
               
 
                         
               
 
              Premiums to (Pay) Receive   $ 24,030  
               
 
                         
 
#   Receive — Fund receives fixed rate and pays variable rate.
 
    (Pay) — Fund pays fixed rate and receives variable rate.
As of November 30, 2011, for the above contracts and/ or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
Notes to Schedule of Investments:
CHF LIBOR — London Interbank Offered Rate denominated in Swiss Franc.
SEK STIBOR — Stockholm Interbank Offered Rate denominated in Swedish Krona.
(a)   All or a portion of this security has been pledged to cover margin requirements on futures contracts, collateral on swap contracts, forward currency contracts, and/or written options, if any.
 
(b)   Indexed security in which price and/or coupon is linked to the prices of a specific instrument or financial statistic.
 
(c)   All or a portion of this security has been pledged to cover collateral requirements on reverse repurchase agreements.
 
(d)   Underlying investment represents interests in defaulted claims. See “Other matters” for additional information.
 
(e)   Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.
 
(f)   Rate shown represents yield-to-maturity.
Currency Abbreviations:
AUD — Australian Dollar
CAD — Canadian Dollar
CHF — Swiss Franc
EUR — Euro
GBP — British Pound
JPY — Japanese Yen
NOK — Norwegian Krone
NZD — New Zealand Dollar
SEK — Swedish Krona
USD — United States Dollar

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                         
    Gross     Gross     Net Unrealized  
    Unrealized     Unrealized     Appreciation  
Aggregate Cost   Appreciation     (Depreciation)     (Depreciation)  
$87,404,626
  $     $ (11,451,504 )   $ (11,451,504 )
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                         
    Value,                             Distributions              
    beginning of             Sales     Dividend     of Realized     Return of     Value, end  
Affiliate   period     Purchases     Proceeds     Income*     Gains*     Capital*     of period  
GMO Emerging Country Debt Fund, Class IV
  $ 3,312,292     $ 259,273     $ 1,050,000     $ 44,273     $     $     $ 2,648,036  
GMO Short-Duration Collateral Fund
    41,317,873                   312,985             13,785,424       26,311,285  
GMO Special Purpose Holding Fund
    18,733                                     14,612  
GMO U.S. Treasury Fund
    1,600,199       23,051,676       23,250,000       1,302       374             1,402,795  
GMO World Opportunity Overlay Fund
    22,044,168       375,000       6,600,000                         16,564,627  
 
                                         
Totals
  $ 68,293,265     $ 23,685,949     $ 30,900,000     $ 358,560     $ 374     $ 13,785,424       46,941,355  
 
                                         
 
*   The table above includes estimated sources of all distributions paid by the underlying funds during the period March 1, 2011 through November 30, 2011 for tax purposes. The actual tax characterization of all distributions paid by the underlying funds will be determined at the end of the fiscal year ending February 29, 2012.

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly and indirectly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 1.7% of net assets. The underlying funds classify such securities (levels defined below) as Level 3. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivatives contracts based on the creditworthiness of its counterparties. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Typically the Fund and the underlying funds value debt instruments based on the most recent quoted price supplied by a single pricing source chosen by the Manager. Although the Manager normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and may change a pricing source at any time. The Manager monitors erratic or unusual movements (including unusual inactivity) in the prices supplied for a security and has discretion to override a price supplied by a source (e.g., by taking a price supplied by another) when it believes that the price supplied is not reliable. Although alternative prices may be available for securities held by the Fund and the underlying funds, those alternative sources are not typically part of the valuation process and do not necessarily provide greater certainty about the prices used by the Fund and the underlying funds. As of November 30, 2011, the total value of securities held directly and indirectly for which no alternative pricing source was available represented 5.9% of the net assets of the Fund.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit risk, yield curves and similar data. The Fund also used third party valuation services (which use industry models and inputs from pricing vendors) to value credit default swaps.
Level 3 — Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Debt Obligations
                               
Foreign Government Obligations
  $     $ 23,681,628     $     $ 23,681,628  
U.S. Government
          3,802,955             3,802,955  
 
                       
TOTAL DEBT OBLIGATIONS
          27,484,583             27,484,583  
 
                       
Mutual Funds
    46,926,743       14,612             46,941,355  
Short-Term Investments
    1,527,184                   1,527,184  
 
                       
Total Investments
    48,453,927       27,499,195             75,953,122  
 
                       
Derivatives*
                               
Forward Currency Contracts
                               
Foreign Currency risk
          556,350             556,350  
Futures Contracts
                               
Interest Rate risk
    69,916                   69,916  
Swap Agreements
                               
Credit risk
          930,266             930,266  
Interest Rate risk
          150,352             150,352  
 
                       
Total
  $ 48,523,843     $ 29,136,163     $     $ 77,660,006  
 
                       
LIABILITY VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Liabilities     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Derivatives*
                               
Forward Currency Contracts
                               
Foreign Currency risk
  $     $ (705,527 )   $     $ (705,527 )
Futures Contracts
                               
Interest Rate risk
    (465,583 )                 (465,583 )
Swap Agreements
                               
Credit risk
          (1,629,036 )           (1,629,036 )
Interest Rate risk
          (194,839 )           (194,839 )
 
                       
Total
  $ (465,583 )   $ (2,529,402 )   $     $ (2,994,985 )
 
                       

 


 

The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
* Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as either Level 1 or Level 2. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net values of the Fund’s investments (both direct and indirect) in securities and derivative financial instruments using Level 3 inputs were 33.0% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011 whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase the security at an agreed upon price and date. The Fund, through its custodian, takes possession of securities it acquired under the repurchase agreement. The value of the securities acquired is required by contract to be marked to market daily and additional collateral is required to be transferred so that the market value is at least equal to the amount owed to the Fund by the seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings and/or the value of the securities subject to the repurchase agreement is insufficient, the Fund’s recovery of cash from the seller may be delayed and the Fund may incur a loss equal to the difference between the cash it paid and the value of the securities. The Fund had no repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same assets at an agreed upon price and date. The Fund can use the proceeds received from entering into a reverse repurchase agreement to make additional investments, which generally causes the Fund’s portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the securities it sold and as a result would realize a loss equal to the difference between the value of those securities and the payment it received for them. The size of this loss will depend upon the difference between what the buyer paid for the securities the Fund sold to it and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of $100). In the event of a buyer’s bankruptcy or insolvency, the Fund’s use of proceeds from the sale of its securities may be restricted while the other party or its trustee or receiver determines whether to honor the Fund’s right to repurchase the securities. As of November 30, 2011, the Fund had received $2,195,000 from reverse repurchase agreements relating to securities with a market value, plus accrued interest, of $2,249,374. Reverse repurchase agreements outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income securities whose principal value is adjusted periodically according to the rate of inflation. Two structures are common. The U.S. Treasury and some other issuers use a structure that reflects inflation in the principal value of the bond. Most other issuers pay out any inflation related accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real interest rates. Real interest rates, in turn, are tied to the relationship between nominal interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate of

 


 

inflation rises at a faster rate than nominal interest rates, real interest rates (i.e. nominal interest rate minus inflation) might decline, leading to an increase in value of inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than inflation, real interest rates might rise, leading to a decrease in value of inflation indexed bonds. There can be no assurance, however, that the value of inflation indexed bonds will be directly correlated to changes in nominal interest rates, and short term increases in inflation may lead to a decline in their value. Coupon payments received by the Fund from inflation indexed bonds are included in the Fund’s gross income for the period in which they accrue. In addition, any increase or decrease in the principal amount of an inflation indexed bond will increase or decrease taxable ordinary income to the Fund, even though principal is not paid until maturity. Inflation-indexed bonds outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Other matters
GMO Special Purpose Holding Fund (“SPHF”), an investment of the Fund, has litigation pending against various entities related to the 2002 fraud and related default of securities previously held by SPHF. The outcome of the lawsuits against the remaining defendants is not known and any potential recoveries are not reflected in the net asset value of SPHF. For the period ended November 30, 2011, the Fund received no distributions from SPHF in connection with the defaulted securities or the related litigation.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies.
Market Risk Fixed Income Securities — Typically, the market value of the Fund’s fixed income securities will decline during periods of rising interest rates and widening of credit spreads.
Market Risk Asset-Backed Securities — Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating. The Fund’s investments in below investment grade securities have speculative characteristics, and changes in economic conditions or other circumstances are more likely to impair the capacity of issuers to make principal and interest payments than is the case with issuers of investment grade securities.
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Derivatives Risk — The use of derivatives involves the risk that their value may or may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Leveraging Risk — The Fund’s use of reverse repurchase agreements and other derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations. The risk of counterparty default is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions.

 


 

Focused Investment Risk — Focusing investments in countries, regions, sectors or companies with high positive correlations to one another, such as the Fund’s investments in asset-backed securities secured by different types of consumer debt (e.g., credit-card receivables, automobile loans and home equity loans), creates additional risk.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in underlying funds, including the risk that the underlying funds in which it invests will not perform as expected.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
The Fund invests (including through investment in underlying funds) in asset-backed securities, which may be backed by many types of assets, including pools of residential and commercial mortgages, automobile loans, educational loans, home equity loans, or credit card receivables, which expose the Fund to additional types of market risk. They also may be backed by pools of corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds and loans (commonly referred to as “collateralized debt obligations” or “collateralized loan obligations”) and by the fees earned by service providers. Payment of interest on asset backed securities and repayment of principal largely depend on the cash flows generated by the assets backing the securities. The market risk of a particular asset-backed security depends on many factors, including the deal structure (e.g., determination as to the amount of underlying assets or other support needed to produce the cash flows necessary to service interest and make principal payments), the quality of the underlying assets and, if any, the level of credit support and the credit quality of the credit-support provider. Asset-backed securities involve risk of loss of principal if obligors of the underlying obligations default and the value of the defaulted obligations exceeds whatever credit support the securities may have. The obligations of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and other laws affecting the rights and remedies of creditors. Many asset-backed securities in which the Fund has invested are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal and/or interest will be paid because the insurer could default on its obligations. In recent years, a significant number of asset-backed security insurers have defaulted on their obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about the creditworthiness of those securities (and underlying assets) caused

 


 

credit spreads (the difference between yields on the asset-backed securities and U.S. Government securities) to widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions to make markets in many fixed income securities. These events reduced liquidity and contributed to substantial declines in the value of asset-backed and other fixed income securities. There can be no assurance these conditions will not occur again. Also, government actions and proposals affecting the terms of underlying home and consumer loans, changes in demand for products (e.g., automobiles) financed by those loans, and the inability of borrowers to refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying assets and is, therefore, subject to risks associated with the negligence or defalcation of its servicer. In some circumstances, the mishandling of related documentation also may affect the rights of security holders in and to the underlying assets. The insolvency of entities that generate receivables or that utilize the assets may result in a decline in the value of the underlying assets, as well as costs and delays. The obligations underlying asset-backed securities, in particular securities backed by pools of residential and commercial mortgages, also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as high a yield as is provided by the asset-backed security. The risk of investing in asset-backed securities has increased because performance of the various sectors in which the assets underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime mortgages, and credit card receivables) has become more highly correlated since the deterioration in worldwide economic and liquidity conditions.
Among other trading agreements, the Fund is party to International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Agreements”) or other similar types of agreements with selected counterparties that generally govern over-the-counter derivative transactions entered into by the Fund. The ISDA Agreements typically include representations and warranties as well as contractual terms related to collateral, events of default, termination events, and other provisions. Termination events may include the decline in the net assets of the Fund below a certain level over a specified period of time and entitle a counterparty to elect to terminate early with respect to some or all the transactions under the ISDA Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse effect on the Fund’s operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. In particular, the Fund may use swaps or other derivatives on an index, a single security or a basket of securities to gain investment exposures (e.g., by selling protection under a credit default swap). The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). For example, the Fund may use credit default swaps to take a short position with respect to the likelihood of default by an issuer. The Fund also may use currency derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For instance, the Manager may alter the interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is designed to maintain the Fund’s exposure to the credit of an issuer through the debt instrument but adjust the Fund’s interest rate exposure through the swap. With these swaps, the Fund and its counterparties exchange interest rate exposure, such as fixed versus variable rates and shorter duration versus longer duration exposure. In adjusting its investment exposures, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund is not limited in the extent to which it uses derivatives or in the absolute face value of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate exposure of its assets, and its net long exposure may exceed 100% of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have

 


 

contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk that it will be required to pay the full notional value of the swap contract in the event of a default.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see ‘Leveraging Risk’ above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.

 


 

These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. During the period ended November 30, 2011, the Fund used forward currency contracts to adjust exposure to foreign currencies and otherwise adjust currency exchange rate risk. Forward currency contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded. The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. During the period ended November 30, 2011, the Fund used futures contracts to adjust interest-rate exposure and maintain the diversity and liquidity of the portfolio. Futures contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. During the period ended November 30, 2011, the Fund used purchased currency option contracts to adjust exposure to currencies and otherwise manage currency exchange rate risk. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. During the period ended November 30, 2011, the Fund used written currency option contracts to adjust exposure to currencies and otherwise manage currency exchange rate risk. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.

 


 

For the period ended November 30, 2011, investment activity in options contracts written by the Fund was as follows:
                                                 
    Puts     Calls  
    Principal Amount of     Number of Futures             Principal Amount of     Number of Futures        
    Contracts     Contracts     Premiums     Contracts     Contracts     Premiums  
Outstanding, beginning of period
    (8,000,000 )         $ (157,744 )               $  
Options written
                                   
Options exercised
                                   
Options expired
    8,000,000             157,744                    
Options sold
                                   
 
                                   
Outstanding, end of period
              $                 $  
 
                                   
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.

 


 

The Fund prices its swap agreements daily using models that may incorporate quotations from market makers and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. During the period ended November 30, 2011, the Fund used swap agreements to adjust interest rate exposure, achieve exposure to a reference entity’s credit, and/or provide a measure of protection against default loss. Swap agreements outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.

 


 

The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Assets:
                                               
Unrealized appreciation on forward currency contracts
  $     $ 556,350     $     $     $     $ 556,350  
Unrealized appreciation on futures contracts*
    69,916                               69,916  
Unrealized appreciation on swap agreements
    150,352             930,266                   1,080,618  
 
                                   
Total
  $ 220,268     $ 556,350     $ 930,266     $     $     $ 1,706,884  
 
                                   
 
                                               
Liabilities:
                                               
Unrealized depreciation on forward currency contracts
  $     $ (705,527 )   $     $     $     $ (705,527 )
Unrealized depreciation on futures contracts*
    (465,583 )                             (465,583 )
Unrealized depreciation on swap agreements
    (194,839 )           (1,629,036 )                 (1,823,875 )
 
                                     
Total
  $ (660,422 )   $ (705,527 )   $ (1,629,036 )   $     $     $ (2,994,985 )
 
                                   
 
*   The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of futures contracts as reported in the Schedule of Investments.
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts and futures contracts), notional amounts (swap agreements), or principal amounts (options) outstanding at each month-end, was as follows for the period ended November 30, 2011:
                                 
    Forward                    
    Currency     Futures     Swap        
    Contracts     Contracts     Agreements     Options  
Average amount outstanding
  $ 113,320,038     $ 60,842,830     $ 80,446,094     $ 3,787,465  

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO International Core Equity Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares     Description   Value ($)  
 
       
COMMON STOCKS — 95.2%
       
       
 
       
       
Australia — 5.5%
       
  237,770    
BHP Billiton Ltd
    8,908,451  
  1,255,557    
Billabong International Ltd
    4,915,231  
  4,355,114    
BlueScope Steel Ltd
    1,776,077  
  877,367    
Boart Longyear Group
    2,837,976  
  2,003,355    
Charter Hall Office (REIT)
    7,195,760  
  305,181    
Commonwealth Bank of Australia
    15,281,689  
  7,985,316    
Dexus Property Group (REIT)
    7,223,830  
  7,016,917    
Goodman Fielder Ltd
    3,844,797  
  12,346,449    
Goodman Group (REIT)
    7,778,033  
  4,437,857    
GPT Group (REIT)
    14,563,872  
  351,085    
Iluka Resources Ltd
    5,665,432  
  9,727,652    
Investa Office Fund (REIT)
    6,065,545  
  3,719,347    
Mirvac Group (REIT)
    4,970,909  
  345,819    
National Australia Bank Ltd
    8,659,159  
  1,508,014    
OneSteel Ltd
    1,352,165  
  3,612,133    
Pacific Brands Ltd
    2,014,153  
  1,627,792    
Qantas Airways Ltd *
    2,611,783  
  1,580,214    
QBE Insurance Group Ltd
    22,634,352  
  838,876    
Resolute Mining Ltd *
    1,745,726  
  4,134,828    
Stockland (REIT)
    14,821,552  
  1,353,486    
TABCORP Holdings Ltd
    4,016,706  
  10,075,216    
Telstra Corp Ltd
    33,103,887  
  592,575    
Wesfarmers Ltd
    19,026,587  
  330,897    
Westfield Group (REIT)
    2,857,916  
  1,034,807    
Westpac Banking Corp
    22,607,432  
  75    
Woolworths Ltd
    1,931  
       
 
     
       
Total Australia
    226,480,951  
       
 
     
       
 
       
       
Austria — 0.7%
       
  49,777    
Andritz AG
    4,395,160  
  341,440    
Immofinanz AG *
    1,056,469  
  435,716    
OMV AG
    14,469,410  
  98,205    
Raiffeisen International Bank Holding
    2,334,528  
  175,753    
Voestalpine AG
    5,110,976  
       
 
     
       
Total Austria
    27,366,543  
       
 
     
       
 
       
       
Belgium — 0.5%
       
  2,872,054    
Ageas
    5,065,041  
  249,113    
Belgacom SA
    7,911,040  
  96,436    
Colruyt SA
    3,652,134  
  36,324    
Delhaize Group
    2,142,232  
       
 
     
       
Total Belgium
    18,770,447  
       
 
     
       
 
       
       
Canada — 2.4%
       
  271,900    
BCE Inc
    10,663,268  
  447,300    
Canadian Natural Resources Ltd
    16,800,885  
  119,700    
Canadian National Railway Co
    9,256,080  
  1,024,300    
EnCana Corp
    20,637,644  
  277,200    
Manulife Financial Corp
    2,986,841  
  180,400    
Methanex Corp
    4,421,785  
  108,200    
Metro Inc Class A
    5,468,611  
  55,900    
National Bank of Canada
    3,635,870  
  148,200    
Potash Corp of Saskatchewan Inc
    6,460,093  
  485,000    
Research In Motion Ltd *
    8,739,938  
  278,500    
Sherritt International Corp
    1,518,173  

 


 

                 
  542,300    
Sun Life Financial Inc
    9,815,048  
  3,172,400    
Yellow Media Inc
    606,518  
       
 
     
       
Total Canada
    101,010,754  
       
 
     
       
 
       
       
Denmark — 0.7%
       
  11    
Carlsberg A/S Class B
    810  
  241,491    
Novo-Nordisk A/S Class B
    27,414,128  
       
 
     
       
Total Denmark
    27,414,938  
       
 
     
       
 
       
       
Finland — 0.6%
       
  226,691    
Neste Oil Oyj
    2,835,518  
  2,632,817    
Nokia Oyj
    15,216,616  
  137,300    
Sampo Oyj Class A
    3,586,708  
  80,474    
Tieto Oyj
    1,242,725  
       
 
     
       
Total Finland
    22,881,567  
       
 
     
       
 
       
       
France — 11.3%
       
  553,724    
Air France—KLM *
    3,226,744  
  1,299,876    
Alcatel-Lucent *
    2,175,476  
  129,767    
Archos *
    975,113  
  113,214    
Arkema
    8,246,981  
  287,308    
BNP Paribas
    11,437,174  
  13,233    
Casino Guichard-Perrachon SA
    1,177,633  
  223,516    
Compagnie de Saint-Gobain
    9,477,727  
  75,975    
Compagnie Generale des Etablissements Michelin-Class B
    4,843,273  
  31,981    
Essilor International SA
    2,286,191  
  275,687    
European Aeronautic Defense and Space Co NV
    8,271,113  
  719,263    
France Telecom SA
    12,414,871  
  239,511    
Lagardere SCA
    5,832,976  
  59,750    
LVMH Moet Hennessy Louis Vuitton SA
    9,407,771  
  203,080    
Peugeot SA
    3,802,327  
  37,837    
Rallye SA
    1,148,927  
  234,945    
Renault SA
    8,803,493  
  206,597    
Safran SA
    6,130,272  
  2,229,417    
Sanofi
    155,938,807  
  170,123    
Societe Generale
    4,156,499  
  133    
STMicroelectronics NV
    843  
  2,933,437    
Total SA
    151,343,549  
  48,893    
Unibail-Rodamco SE (REIT)
    9,114,256  
  156,829    
Valeo SA
    6,944,384  
  195,211    
Vinci SA
    8,727,086  
  956,719    
Vivendi SA
    22,067,730  
  144,324    
Wendel
    10,398,578  
       
 
     
       
Total France
    468,349,794  
       
 
     
       
 
       
       
Germany — 6.8%
       
  127,147    
Aareal Bank AG *
    2,302,794  
  135,636    
Adidas AG
    9,565,162  
  166,985    
Aixtron AG
    2,185,652  
  172,634    
Aurubis AG
    9,851,059  
  585,548    
BASF AG
    42,776,279  
  213,556    
Bayerische Motoren Werke AG
    16,189,052  
  171,735    
Deutsche Lufthansa AG (Registered)
    2,226,568  
  3,224,307    
E.ON AG
    79,813,489  
  83,984    
Fresenius SE & Co KGaA
    8,088,331  
  92,204    
Fresenius Medical Care AG & Co
    6,321,093  
  213,700    
GEA Group AG
    6,325,579  
  1,071,155    
Infineon Technologies AG
    8,904,617  
  253,534    
Kloeckner & Co SE
    3,339,373  

 


 

                 
  165,624    
Lanxess AG
    9,291,042  
  195,138    
Leoni AG
    7,261,597  
  61,370    
Linde AG
    9,457,790  
  10    
MTU Aero Engines Holding AG
    642  
  253,360    
RWE AG
    10,502,859  
  110,628    
Salzgitter AG
    5,743,547  
  146,856    
SAP AG
    8,793,642  
  27,539    
SGL Carbon SE *
    1,659,575  
  79,889    
Siemens AG (Registered)
    8,084,700  
  210,228    
Software AG
    9,062,196  
  243,706    
Suedzucker AG
    7,763,833  
  141,786    
ThyssenKrupp AG
    3,662,324  
  25,110    
Volkswagen AG
    3,824,393  
       
 
     
       
Total Germany
    282,997,188  
       
 
     
       
 
       
       
Greece — 0.3%
       
  131,488    
Hellenic Telecommunications Organization SA
    556,236  
  562,648    
Marfin Investment Group SA *
    322,722  
  882,223    
National Bank of Greece SA *
    2,349,768  
  815,245    
OPAP SA
    7,314,726  
  198,835    
Public Power Corp SA
    1,135,916  
       
 
     
       
Total Greece
    11,679,368  
       
 
     
       
 
       
       
Hong Kong — 1.6%
       
  2,176,800    
AIA Group Ltd
    6,856,413  
  2,228,221    
CLP Holdings Ltd
    19,843,451  
  3,063,200    
Esprit Holdings Ltd
    4,420,973  
  4,406,000    
Melco International Development Ltd
    3,502,956  
  5,496,000    
Pacific Basin Shipping Ltd
    2,460,443  
  2,204,500    
Power Assets Holdings Ltd
    16,517,708  
  1,482,000    
SJM Holdings Ltd
    2,573,868  
  526,500    
Swire Pacific Ltd
    6,427,268  
  1,488,500    
Yue Yuen Industrial Holdings
    4,289,532  
       
 
     
       
Total Hong Kong
    66,892,612  
       
 
     
       
 
       
       
Ireland — 1.0%
       
  719,786    
C&C Group Plc
    2,948,873  
  1,139,802    
CRH Plc
    21,759,582  
  169,925    
DCC Plc
    4,114,020  
  259,848    
Kerry Group Plc Class A
    9,704,500  
  75,714    
Paddy Power Plc
    4,110,901  
       
 
     
       
Total Ireland
    42,637,876  
       
 
     
       
 
       
       
Israel — 0.1%
       
  1,714,366    
Bezeq Israeli Telecommunication Corp Ltd
    3,240,179  
  88,342    
Israel Chemicals Ltd
    951,363  
  214,666    
Partner Communications Co Ltd
    2,065,641  
       
 
     
       
Total Israel
    6,257,183  
       
 
     
       
 
       
       
Italy — 5.5%
       
  2,937,259    
Banco Popolare Scarl
    3,529,646  
  578,607    
Campari
    4,137,619  
  13,831,701    
Enel SPA
    58,935,506  
  4,068,840    
ENI SPA
    86,171,042  
  1,086,593    
Finmeccanica SPA
    4,714,141  
  517,754    
Fondiaria—Sai SPA *
    699,085  
  1,059,883    
Intesa Sanpaolo SPA-Di RISP
    1,366,214  
  295,699    
Mediobanca SPA
    1,910,707  

 


 

                 
  745,195    
Pirelli & C SPA
    7,049,909  
  294,520    
Recordati SPA
    2,262,727  
  253,453    
Saipem SPA
    11,340,603  
  1,703,817    
Snam Rete Gas SPA
    7,909,871  
  9,899,300    
Telecom Italia SPA
    11,207,245  
  13,861,075    
Telecom Italia SPA-Di RISP
    13,543,801  
  1,777,635    
Terna SPA
    6,378,694  
  41,009    
Tod’s SPA
    3,819,441  
  2,833,259    
UniCredit SPA
    2,959,026  
       
 
     
       
Total Italy
    227,935,277  
       
 
     
       
 
       
       
Japan — 23.0%
       
  1,847    
Advance Residence Investment Corp (REIT)
    3,446,056  
  1,144,300    
Aeon Co Ltd
    15,636,341  
  837,600    
Alps Electric Co Ltd
    5,864,120  
  602,000    
Anritsu Corp
    6,798,076  
  672,600    
Astellas Pharma Inc
    25,926,322  
  504,200    
Bridgestone Corp
    11,683,344  
  134,300    
Canon Inc
    6,024,996  
  99,900    
Capcom
    2,562,531  
  1,740    
CyberAgent Inc
    5,776,011  
  645,700    
Daiei Inc *
    2,346,731  
  812,000    
Daiichi Chuo Kisen Kaisha *
    1,070,476  
  2,386,000    
Daikyo Inc *
    4,610,736  
  350,900    
Daito Trust Construction Co Ltd
    31,296,450  
  1,160,000    
Daiwabo Holdings Co Ltd
    2,724,629  
  272,200    
Dena Co Ltd
    8,450,410  
  1,365,000    
DIC Corp
    2,305,126  
  210,300    
Don Quijote Co Ltd
    7,248,200  
  241,900    
Eisai Co Ltd
    9,338,917  
  66,300    
Fanuc Ltd
    10,892,991  
  60,100    
Fast Retailing Co Ltd
    9,752,825  
  1,176,000    
Fuji Electric Co Ltd
    3,478,515  
  1,159,000    
Fuji Heavy Industries Ltd
    6,698,771  
  193,300    
Fuji Oil Co Ltd
    2,766,949  
  178,500    
Gree Inc
    5,992,781  
  589,000    
Gunze Ltd
    1,695,800  
  686,000    
Hanwa Co Ltd
    2,973,889  
  1,487,500    
Haseko Corp *
    963,847  
  95,900    
Hikari Tsushin Inc
    2,438,228  
  3,459,000    
Hitachi Ltd
    19,193,681  
  157,600    
Honda Motor Co Ltd
    5,001,336  
  1,524    
INPEX Corp
    10,288,339  
  1,475,000    
Itochu Corp
    14,989,526  
  478,500    
JFE Holdings Inc
    8,807,758  
  114,000    
JGC Corp
    2,873,156  
  624,000    
Juki Corp
    1,504,810  
  5,712,830    
JX Holdings Inc
    36,331,435  
  292,420    
K’s Holdings Corp
    11,526,248  
  3,874,000    
Kajima Corp
    11,666,057  
  157,220    
Kakaku.com Inc
    6,028,402  
  636,400    
Kao Corp
    16,842,021  
  3,169,000    
Kawasaki Kisen Kaisha Ltd
    5,510,031  
  5,489    
KDDI Corp
    36,369,005  
  436,000    
Kinugawa Rubber Industrial Co Ltd
    3,923,314  
  216,400    
Komatsu Ltd
    5,538,071  
  255,400    
Konami Corp
    7,681,787  
  125,000    
Lawson Inc
    7,402,836  
  1,412,500    
Leopalace21 Corp *
    3,260,471  

 


 

                 
  2,052,000    
Marubeni Corp
    12,676,696  
  3,926,000    
Mazda Motor Corp *
    7,159,985  
  50,904    
Meiji Holdings Co Ltd
    2,211,531  
  896,000    
Mitsubishi Heavy Industries Ltd
    3,762,224  
  2,051,500    
Mitsubishi Chemical Holdings Corp
    11,918,058  
  242,900    
Mitsubishi Corp
    5,021,575  
  491,000    
Mitsubishi Electric Corp
    4,648,028  
  156,140    
Mitsubishi UFJ Lease & Finance Co Ltd
    5,977,683  
  614,600    
Mitsui & Co Ltd
    9,697,089  
  1,924,000    
Mitsui OSK Lines Ltd
    6,116,125  
  8,160,400    
Mizuho Financial Group Inc
    10,742,592  
  341,000    
Nachi-Fujikoshi Corp
    1,604,689  
  2,060    
Net One Systems Co Ltd
    5,314,149  
  105,900    
Nikon Corp
    2,479,592  
  32,900    
Nintendo Co Ltd
    5,008,609  
  747,000    
Nippon Chemi-Con Corp
    2,767,726  
  3,365,000    
Nippon Light Metal Co Ltd
    4,473,460  
  127,500    
Nippon Paper Group Inc
    2,732,998  
  4,215,000    
Nippon Steel Corp
    10,232,109  
  767,500    
Nippon Telegraph & Telephone Corp
    37,851,927  
  2,823,000    
Nippon Yusen Kabushiki Kaisha
    6,288,637  
  1,392,900    
Nissan Motor Co Ltd
    12,791,435  
  113,450    
Nitori Holdings Co Ltd
    10,604,738  
  101,300    
Nitto Denko Corp
    4,210,723  
  584,000    
NSK Ltd
    3,865,184  
  12,883    
NTT Docomo Inc
    22,771,293  
  1,876,000    
Obayashi Corp
    7,886,003  
  681,000    
OKUMA Corp
    5,228,565  
  100    
Omron Corp
    2,141  
  125,100    
Ono Pharmaceutical Co Ltd
    6,517,593  
  134,750    
ORIX Corp
    11,369,517  
  1,773,000    
Osaka Gas Co Ltd
    6,764,071  
  1,853,500    
Penta Ocean Construction Co Ltd
    5,850,128  
  115,630    
Point Inc
    4,807,671  
  566,100    
Promise Co Ltd *
    5,904,675  
  5,894,700    
Resona Holdings Inc
    26,402,021  
  514,000    
Ricoh Company Ltd
    4,632,022  
  768,400    
Round One Corp
    4,591,446  
  119,500    
Ryohin Keikaku Co Ltd
    5,437,132  
  193,700    
Sankyo Co Ltd
    9,682,280  
  80,600    
Secom Co Ltd
    3,635,148  
  223,100    
Seven & I Holdings Co Ltd
    6,229,060  
  4,952,800    
Sojitz Corp
    7,771,833  
  1,907,000    
Sumitomo Corp
    25,454,736  
  6,697,000    
Taiheiyo Cement Co Ltd
    13,009,703  
  3,943,000    
Taisei Corp
    10,219,196  
  51,300    
Taisho Pharmaceutical Holdings Co Ltd *
    3,432,787  
  1,454,100    
Takeda Pharmaceutical Co Ltd
    59,725,668  
  393,280    
Takefuji Corp * (a) (b)
    5,071  
  162,500    
Tokyo Steel Manufacturing Co
    1,384,160  
  2,066,000    
Tokyo Tatemono Co Ltd
    6,049,631  
  356,000    
TonenGeneral Sekiyu KK
    4,060,095  
  1,498,000    
Toray Industries Inc
    11,230,378  
  282,700    
Toyota Motor Corp
    9,309,460  
  782,800    
Toyota Tsusho Corp
    13,171,820  
  970,500    
UNY Co Ltd
    8,912,825  
  58,670    
USS Co Ltd
    5,101,423  
  279,020    
Yamada Denki Co Ltd
    20,182,381  
  208,900    
Yamato Holdings Co Ltd
    3,354,599  

 


 

                 
  672,000    
Zeon Corp
    5,714,036  
       
 
     
       
Total Japan
    951,460,482  
       
 
     
       
 
       
       
Malta — 0.0%
       
  15,998,662    
BGP Holdings Plc *
     
       
 
     
       
 
       
       
Netherlands — 1.3%
       
  53    
ASML Holding NV
    2,092  
  208,241    
CSM
    2,737,027  
  21    
Heineken NV
    983  
  2,889,569    
ING Groep NV *
    22,536,261  
  909,990    
Koninklijke BAM Groep NV
    3,152,432  
  611,950    
Unilever NV
    20,842,923  
  71,650    
Wereldhave NV (REIT)
    4,986,209  
       
 
     
       
Total Netherlands
    54,257,927  
       
 
     
       
 
       
       
New Zealand — 0.6%
       
  1,884,358    
Chorus Ltd *
    4,840,909  
  1,123,857    
Fletcher Building Ltd
    5,318,769  
  9,421,793    
Telecom Corp of New Zealand
    14,934,723  
       
 
     
       
Total New Zealand
    25,094,401  
       
 
     
       
 
       
       
Norway — 0.2%
       
  163,421    
Acergy SA *
    3,229,870  
  108,680    
Frontline Ltd
    325,438  
  186,323    
TGS Nopec Geophysical Co ASA
    4,145,815  
       
 
     
       
Total Norway
    7,701,123  
       
 
     
       
 
       
       
Portugal — 0.2%
       
  1,418,618    
EDP — Energias de Portugal SA
    4,546,768  
  223,116    
Jeronimo Martins SGPS SA
    4,070,716  
       
 
     
       
Total Portugal
    8,617,484  
       
 
     
       
 
       
       
Singapore — 1.8%
       
  1,487,000    
Ezra Holdings Ltd
    1,051,695  
  35,619,000    
Golden Agri-Resources Ltd
    20,119,142  
  2,793,000    
Jaya Holdings Ltd *
    1,056,413  
  779,200    
MobileOne Ltd
    1,487,201  
  4,164    
Oversea-Chinese Banking Corp Ltd
    26,525  
  1,346,000    
SembCorp Marine Ltd
    4,047,580  
  2,450,000    
Singapore Exchange Ltd
    12,036,469  
  2,147,000    
Singapore Press Holdings Ltd
    6,627,977  
  9,983,000    
Singapore Telecommunications
    24,333,322  
  1,432,000    
Suntec Real Estate Investment Trust (REIT)
    1,285,078  
  305,000    
Venture Corp Ltd
    1,577,906  
  2,415,000    
Yangzijiang Shipbuilding Holdings Ltd
    1,739,516  
       
 
     
       
Total Singapore
    75,388,824  
       
 
     
       
 
       
       
Spain — 4.4%
       
  2,186,305    
Banco Popular Espanol SA
    9,336,058  
  3,314,232    
Banco Santander SA
    24,877,385  
  224,981    
Ferrovial SA
    2,789,934  
  135,108    
Fomento de Construcciones y Contratas SA
    3,496,860  
  991,708    
Gas Natural SDG SA
    17,264,439  
  323,799    
Grifols SA *
    5,235,493  
  1,958,473    
Iberdrola SA
    13,051,034  
  167,306    
Inditex SA
    14,226,553  
  788,351    
Jazztel Plc *
    4,387,236  

 


 

                 
  977,345    
Repsol YPF SA
    29,506,980  
  3,000,126    
Telefonica SA
    56,337,419  
       
 
     
       
Total Spain
    180,509,391  
       
 
     
       
 
       
       
Sweden — 0.6%
       
  338,316    
Boliden AB
    4,905,050  
  2    
Ericsson LM B Shares
    21  
  382,968    
Investor AB B Shares
    7,142,928  
  144,597    
NCC Class B
    2,356,187  
  125    
Sandvik AB
    1,602  
  804,793    
Swedbank AB Class A
    10,766,464  
  119,835    
Trelleborg AB Class B
    1,010,986  
       
 
     
       
Total Sweden
    26,183,238  
       
 
     
       
 
       
       
Switzerland — 3.8%
       
  65,434    
Compagnie Financiere Richemont SA Class A
    3,550,823  
  673,440    
Nestle SA (Registered)
    37,795,330  
  1,418,659    
Novartis AG (Registered)
    76,613,612  
  133,702    
Roche Holding AG (Non Voting)
    21,268,550  
  21,925    
Swatch Group AG
    8,551,422  
  6,534    
Swisscom AG (Registered)
    2,467,531  
  25,440    
Syngenta AG (Registered) *
    7,486,311  
       
 
     
       
Total Switzerland
    157,733,579  
       
 
     
 
       
United Kingdom — 22.3%
       
  1,902,924    
3i Group Plc
    5,700,727  
  324,415    
Aggreko Plc
    9,671,028  
  1,839,498    
ARM Holdings Plc
    17,285,359  
  135,137    
ASOS Plc *
    2,893,163  
  2,742,407    
AstraZeneca Plc
    126,309,116  
  1,010,596    
Aviva Plc
    4,960,355  
  4,056,818    
BAE Systems Plc
    17,514,483  
  9,271,194    
Barclays Plc
    26,707,758  
  260,668    
BBA Aviation Plc
    725,109  
  1,156,049    
BG Group Plc
    24,795,893  
  177,936    
BHP Billiton Plc
    5,471,944  
  5,435,345    
BP Plc
    39,364,729  
  995,869    
British American Tobacco Plc
    46,215,353  
  12,176,757    
BT Group Plc
    36,437,964  
  1,061,846    
Burberry Group Plc
    21,272,560  
  256,909    
Capita Group Plc
    2,547,803  
  266    
Centrica Plc
    1,264  
  312,926    
Diageo Plc
    6,702,257  
  5,879,076    
Dixons Retail Plc *
    1,044,056  
  1,172,083    
Drax Group Plc
    10,322,856  
  65    
Eurasian Natural Resources Corp
    683  
  1,119,421    
FirstGroup Plc
    5,754,383  
  1,429,769    
Game Group Plc
    166,918  
  5,570,875    
GlaxoSmithKline Plc
    123,461,890  
  4,571,420    
Home Retail Group Plc
    6,461,941  
  103,359    
ICAP Plc
    578,118  
  587,863    
IMI Plc
    7,401,881  
  330,605    
Imperial Tobacco Group Plc
    11,894,177  
  3,084,613    
ITV Plc
    3,154,648  
  49    
Kazakhmys Plc
    715  
  2,500,018    
Kesa Electricals Plc
    3,496,644  
  340,669    
Lancashire Holdings Ltd
    3,923,059  
  14,681,268    
Lloyds Banking Group Plc *
    5,745,231  
  424,491    
Next Plc
    17,942,054  

 


 

                 
  451,387    
Pearson Plc
    8,199,807  
  82,467    
Petrofac Ltd
    1,885,458  
  655,960    
Prudential Plc
    6,456,368  
  70,972    
Randgold Resources Ltd
    7,550,624  
  157,419    
Reckitt Benckiser Group Plc
    7,986,296  
  363,104    
Rio Tinto Plc
    19,115,848  
  268,392    
Rolls-Royce Holdings Plc *
    3,085,031  
  10,457,116    
Royal Bank of Scotland Group Plc *
    3,480,766  
  581,634    
Royal Dutch Shell Group Class A (Amsterdam)
    20,315,589  
  1,084,553    
Royal Dutch Shell Plc A Shares (London)
    37,931,793  
  1,724,787    
Royal Dutch Shell Plc B Shares (London)
    62,151,952  
  159,424    
SABMiller Plc
    5,628,877  
  527,846    
Scottish & Southern Energy Plc
    10,929,978  
  298,938    
Shire Plc
    10,052,684  
  635,403    
Smith & Nephew Plc
    5,805,333  
  239,262    
Spectris Plc
    4,721,814  
  276,441    
Standard Chartered Plc
    6,018,343  
  289,576    
Travis Perkins Plc
    3,801,723  
  897,287    
Trinity Mirror Plc *
    677,932  
  749,774    
Tullett Prebon Plc
    3,609,305  
  25,466,497    
Vodafone Group Plc
    68,940,575  
  449,763    
Weir Group Plc (The)
    14,619,287  
  338,595    
WH Smith Plc
    2,797,600  
  2,427,575    
William Hill Plc
    7,730,738  
  186,704    
Wolseley Plc
    5,597,676  
       
 
     
       
Total United Kingdom
    925,017,516  
       
 
     
       
TOTAL COMMON STOCKS (COST $4,172,798,103)
    3,942,638,463  
       
 
     
       
 
       
       
PREFERRED STOCKS — 1.1%
       
       
 
       
       
Germany — 1.1%
       
  401,654    
Porsche Automobil Holding SE 1.12%
    24,612,838  
  229,262    
ProSiebenSat.1 Media AG 7.61%
    4,535,376  
  94,603    
Volkswagen AG 1.74%
    16,347,053  
       
 
     
       
Total Germany
    45,495,267  
       
 
     
       
TOTAL PREFERRED STOCKS (COST $38,757,457)
    45,495,267  
       
 
     
       
 
       
       
RIGHTS/WARRANTS — 0.0%
       
       
 
       
       
Australia — 0.0%
       
  3,484,091    
BlueScope Steel Ltd, Expires 12/14/11*
    39,413  
       
 
     
       
TOTAL RIGHTS/WARRANTS (COST $770,472)
    39,413  
       
 
     
       
 
       
       
MUTUAL FUNDS — 1.6%
       
       
 
       
       
United States — 1.6%
       
       
 
       
       
Affiliated Issuers
       
  2,699,282    
GMO U.S. Treasury Fund
    67,509,049  
       
 
     
       
TOTAL MUTUAL FUNDS (COST $67,509,049)
    67,509,049  
       
 
     
                 
Par Value     Description   Value ($)  
 
       
SHORT-TERM INVESTMENTS — 1.0%
       
       
 
       
       
Time Deposits — 1.0%
       
USD  25,000,000    
Barclays Plc Time Deposit, 0.12%, due 12/01/11
    25,000,000  

 


 

                 
CHF  9,068    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.01%, due 12/01/11
    9,926  
DKK  54,827    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.14%, due 12/01/11
    9,907  
NOK  57,463    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.95%, due 12/01/11
    9,949  
NZD  12,744    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 1.75%, due 12/01/11
    9,952  
SEK  68,003    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 1.06%, due 12/01/11
    10,049  
USD  807    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.03%, due 12/01/11
    807  
HKD  2,186,423    
Citibank (New York) Time Deposit, 0.01%, due 12/01/11
    281,438  
JPY  115,224,480    
Citibank (New York) Time Deposit, 0.01%, due 12/01/11
    1,485,617  
SGD  281,846    
Citibank (New York) Time Deposit, 0.01%, due 12/01/11
    219,909  
USD  9,800,000    
Deutsche Bank Time Deposit, 0.06%, due 12/01/11
    9,800,000  
AUD  205,387    
JPMorgan Chase (New York) Time Deposit, 3.78%, due 12/01/11
    211,220  
CAD  27,843    
JPMorgan Chase (New York) Time Deposit, 0.25%, due 12/01/11
    27,299  
EUR  2,174,120    
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11
    2,921,365  
GBP  480,441    
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11
    753,763  
       
 
     
       
Total Time Deposits
    40,751,201  
       
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $40,751,201)
    40,751,201  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 98.9%
(Cost $4,320,586,282)
    4,096,433,393  
 
       
Other Assets and Liabilities (net) — 1.1%
    47,145,467  
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 4,143,578,860  
       
 
     
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
                                     
                                Net Unrealized  
Settlement                             Appreciation  
Date     Counterparty   Deliver/Receive   Units of Currency     Value     (Depreciation)  
Buys †  
 
                           
  12/16/11    
Royal Bank of Scotland PLC
  CHF     14,666,613     $ 16,059,150     $ (195,187 )
  12/16/11    
Brown Brothers Harriman & Co.
  CHF     6,931,983       7,590,147       (91,571 )
  12/16/11    
Bank of America N.A.
  CHF     7,734,631       8,469,004       (117,875 )
  12/16/11    
Bank of New York Mellon
  CHF     6,931,983       7,590,147       (89,274 )
  12/16/11    
Brown Brothers Harriman & Co.
  EUR     9,952,393       13,374,409       (109,542 )
  12/16/11    
Royal Bank of Scotland PLC
  GBP     10,579,539       16,595,928       44,292  
  12/16/11    
Brown Brothers Harriman & Co.
  GBP     16,512,165       25,902,329       36,353  
  12/16/11    
Morgan Stanley Capital Services Inc.
  GBP     3,074,371       4,822,709       8,576  

 


 

                                     
  12/16/11    
Deutsche Bank AG
  GBP     14,697,355       23,055,470       (37,014 )
  12/16/11    
Barclays Bank PLC
  GBP     16,573,977       25,999,293       53,063  
  12/16/11    
Bank of America, N.A.
  GBP     11,797,412       18,506,383       41,321  
  12/16/11    
JPMorgan Chase Bank, N.A.
  GBP     10,773,188       16,899,702       (20,667 )
  12/16/11    
Bank of New York Mellon
  GBP     17,876,578       28,042,659       58,306  
  12/16/11    
Brown Brothers Harriman & Co.
  HKD     191,759,640       24,684,980       10,888  
  12/16/11    
Barclays Bank PLC
  HKD     184,129,190       23,702,722       17,404  
  12/16/11    
Morgan Stanley Capital Services Inc.
  HKD     184,129,190       23,702,722       13,985  
  12/16/11    
State Street Bank and Trust Company
  HKD     154,537,940       19,893,477       14,146  
  12/16/11    
JPMorgan Chase Bank, N.A.
  HKD     60,254,935       7,756,543       5,690  
  12/16/11    
Royal Bank of Scotland PLC
  SEK     48,779,995       7,203,057       (74,676 )
  12/16/11    
Deutsche Bank AG
  SEK     88,995,030       13,141,376       (158,045 )
  12/16/11    
JPMorgan Chase Bank, N.A.
  SEK     94,627,767       13,973,130       (106,669 )
  12/16/11    
Bank of New York Mellon
  SEK     40,268,668       5,946,239       (57,616 )
  12/16/11    
Barclays Bank PLC
  SGD     21,021,261       16,401,973       (112,620 )
  12/16/11    
Morgan Stanley Capital Services Inc.
  SGD     19,020,196       14,840,630       (115,529 )
  12/16/11    
State Street Bank and Trust Company
  SGD     14,692,589       11,463,986       (88,698 )
  12/16/11    
Bank of America, N.A.
  SGD     58,447,243       45,603,835       (438,281 )
  12/16/11    
Bank of New York Mellon
  SGD     14,822,079       11,565,022       (57,057 )
       
 
                       
       
 
              $ 452,787,022     $ (1,566,297 )
       
 
                       
 
Sales #  
 
                           
  12/16/11    
Bank of America, N.A.
  AUD     10,821,675     $ 11,109,774     $ (600,564 )
  12/16/11    
Brown Brothers Harriman & Co.
  AUD     13,072,046       13,420,055       (170,883 )
  12/16/11    
Royal Bank of Scotland PLC
  CAD     15,935,808       15,618,242       (63,813 )
  12/16/11    
State Street Bank and Trust Company
  CAD     34,650,473       33,959,965       43,394  
  12/16/11    
Brown Brothers Harriman & Co.
  CAD     15,803,254       15,488,330       501  
  12/16/11    
Morgan Stanley Capital Services Inc.
  CAD     12,007,266       11,767,988       6,532  

 


 

                                 
12/16/11  
Barclays Bank PLC
  CAD     12,307,889       12,062,620       (17,083 )
12/16/11  
Deutsche Bank AG
  CAD     7,813,987       7,658,271       (16,230 )
12/16/11  
Royal Bank of Scotland PLC
  CHF     12,998,677       14,232,850       555,313  
12/16/11  
Royal Bank of Scotland PLC
  DKK     37,184,648       6,720,353       107,410  
12/16/11  
State Street Bank and Trust Company
  DKK     89,495,296       16,174,417       266,477  
12/16/11  
Royal Bank of Scotland PLC
  EUR     24,908,163       33,472,550       554,192  
12/16/11  
Bank of America, N.A.
  EUR     17,275,058       23,214,889       472,809  
12/16/11  
Morgan Stanley Capital Services Inc.
  EUR     16,823,205       22,607,672       400,198  
12/16/11  
Deutsche Bank AG
  EUR     34,806,000       46,773,645       927,978  
12/16/11  
Brown Brothers Harriman & Co.
  JPY     410,698,269       5,297,006       59,625  
12/16/11  
JPMorgan Chase Bank, N.A.
  JPY     3,203,470,130       41,316,950       448,194  
12/16/11  
Bank of America, N.A.
  JPY     1,811,172,000       23,359,701       254,200  
12/16/11  
Deutsche Bank, AG
  JPY     1,074,552,130       13,859,101       150,522  
12/16/11  
Morgan Stanley Capital Services Inc.
  NZD     10,386,611       8,102,329       88,967  
12/16/11  
Bank of America N.A.
  NZD     12,464,049       9,722,886       122,180  
   
 
                       
   
 
              $ 385,939,594     $ 3,589,919  
   
 
                       
 
  Fund buys foreign currency; sells USD.
 
#   Fund sells foreign currency; buys USD.
Futures Contracts
                             
                        Net Unrealized  
Number of         Expiration           Appreciation  
Contracts     Type   Date   Value     (Depreciation)  
Buys  
 
                   
  5    
OMXS 30
  December 2011   $ 73,101     $ 2,409  
  256    
FTSE 100
  December 2011     22,155,902       1,531,046  
  707    
TOPIX
  December 2011     67,914,477       475,671  
  797    
FTSE/MIB
  December 2011     82,051,145       9,856,670  
  25    
MSCI Singapore
  December 2011     1,224,617       43,327  
  184    
DAX
  December 2011     37,797,726       5,499,815  
       
 
               
       
 
      $ 211,216,968     $ 17,408,938  
       
 
               
       
 
                   
Sales  
 
                   
  461    
S&P Toronto 60
  December 2011   $ 62,780,431     $ (603,702 )
  427    
SPI 200
  December 2011     46,640,756       (1,567,811 )
       
 
               
       
 
      $ 109,421,187     $ (2,171,513 )
       
 
               

 


 

Swap Agreements
Total Return Swaps
                                         
                                    Net Unrealized  
Notional   Expiration                       Appreciation/  
Amount   Date   Counterparty   Fund Pays     Fund (Pays)/Receives     (Depreciation)  
  589,094     EUR   11/27/12  
Goldman Sachs International
  1 Month Euribor Floating Rate -10.0%   Total Return on Dexia SA   $ (24,961 )
  678,631     EUR   11/27/12  
Bank of America Merrill Lynch
  3 Month Euribor Floating Rate -10.0%   Total Return on Alpha Bank A.E.     (1,587 )
               
 
                   
               
 
                  $ (26,548 )
               
 
                     
               
 
          Premiums to (Pay) Receive   $  
               
 
                     
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
Notes to Schedule of Investments:
REIT — Real Estate Investment Trust
 
*   Non-income producing security.
 
(a)   Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust.
 
(b)   Bankrupt issuers.
Currency Abbreviations:
AUD — Australian Dollar
CAD — Canadian Dollar
CHF — Swiss Franc
DKK — Danish Krone
EUR — Euro
GBP — British Pound
HKD — Hong Kong Dollar
JPY — Japanese Yen
NZD — New Zealand Dollar
SEK — Swedish Krona
SGD — Singapore Dollar
USD — United States Dollar

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
             
    Gross   Gross   Net Unrealized
    Unrealized   Unrealized   Appreciation
Aggregate Cost   Appreciation   (Depreciation)   (Depreciation)
$4,390,760,242
  $350,645,151   $(644,972,000)   $(294,326,849)

 


 

Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO U.S. Treasury Fund
  $ 52,104,000     $ 109,839,000     $ 94,442,925     $ 20,646     $ 2,873     $ 67,509,049  
 
                                   

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented less than 0.1% of net assets. The Fund classifies such securities (levels defined below) as Level 3. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivatives contracts based on the creditworthiness of its counterparties. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below.
     
Security Type
Percentage of Net Assets of the Fund  
Equity Securities
93.3%  
Futures Contracts
0.4%  
Swap Agreements
(0.0%)^  
 
^   Rounds to 0.0%.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.

 


 

The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include: fair value adjustments provided by an independent pricing service applied to equity securities (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) due to market events that have occurred since the local market close but prior to the close of the NYSE.
Level 3 — Valuations based primarily on inputs that are unobservable and significant. The Fund used the following fair value technique on Level 3 investments: The Fund considered certain bankrupt securities to be near worthless.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Common Stocks
                               
Australia
  $     $ 226,480,951     $     $ 226,480,951  
Austria
          27,366,543             27,366,543  
Belgium
          18,770,447             18,770,447  
Canada
    101,010,754                   101,010,754  
Denmark
          27,414,938             27,414,938  
Finland
          22,881,567             22,881,567  
France
          468,349,794             468,349,794  
Germany
          282,997,188             282,997,188  
Greece
          11,679,368             11,679,368  
Hong Kong
          66,892,612             66,892,612  
Ireland
          42,637,876             42,637,876  
Israel
          6,257,183             6,257,183  
Italy
          227,935,277             227,935,277  
Japan
    3,432,787       948,022,624       5,071       951,460,482  
Malta
          0 *           0 *
Netherlands
          54,257,927             54,257,927  
New Zealand
    19,775,632       5,318,769             25,094,401  
Norway
          7,701,123             7,701,123  
Portugal
          8,617,484             8,617,484  
Singapore
          75,388,824             75,388,824  
Spain
          180,509,391             180,509,391  
Sweden
          26,183,238             26,183,238  
Switzerland
          157,733,579             157,733,579  
United Kingdom
          925,017,516             925,017,516  
 
                       
TOTAL COMMON STOCKS
    124,219,173       3,818,414,219       5,071       3,942,638,463  
 
                       
Preferred Stocks
                               
Germany
          45,495,267             45,495,267  
 
                       
TOTAL PREFERRED STOCKS
          45,495,267             45,495,267  
 
                       
Rights/Warrants
                               
Australia
          39,413             39,413  
 
                       
TOTAL RIGHTS/WARRANTS
          39,413             39,413  
 
                       
Mutual Funds
    67,509,049                   67,509,049  
 
                       
Short-Term Investments
    40,751,201                   40,751,201  
 
                       
Total Investments
    232,479,423       3,863,948,899       5,071       4,096,433,393  
 
                       
Derivatives**
                               
Forward Currency Contracts
                               
Foreign exchange risk
          4,762,516             4,762,516  
Futures Contracts
                               
Equity risk
          17,408,938             17,408,938  
 
                       
Total Derivatives
          22,171,454             22,171,454  
 
                       
Total
  $ 232,479,423     $ 3,886,120,353     $ 5,071     $ 4,118,604,847  
 
                       
LIABILITY VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Liabilities     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Derivatives**
                               
Forward Currency Contracts
                               
Foreign exchange risk
  $     $ (2,738,894 )   $     $ (2,738,894 )
Futures Contracts
                               
Equity risk
    (603,702 )     (1,567,811 )           (2,171,513 )
Swap Agreements
                               
Equity risk
          (26,548 )           (26,548 )
 
                       
Total Derivatives
    (603,702 )     (4,333,253 )           (4,936,955 )
 
                       
Total
  $ (603,702 )   $ (4,333,253 )   $     $ (4,936,955 )
 
                       
 
*   Represents the interest in securities that were determined to have a fair value of zero at November 30, 2011.

 


 

The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
** Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net value of the Fund’s direct investments in securities using Level 3 inputs was less than 0.1% of total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant unobservable inputs (Level 3) were used in determining value:

 


 

                                                                                   
                                                                              Net Change in  
                                                                              Unrealized  
                                                                              Appreciation  
                                                                              (Depreciation)  
                                            Change in                               from  
    Balances as of                     Accrued     Total     Unrealized                 Balances as of       Investments Still  
    February 28,                     Discounts/     Realized     Appreciation     Transfer     Transfer     November 30,       Held as of November  
    2011     Purchases     Sales     Premiums     Gain/(Loss)     (Depreciation)     into level 3 *     out of level 3 *     2011       30, 2011  
Common Stocks
                                                                                 
Japan
  $ 4,808     $     $     $     $     $ 263     $     $     $ 5,071       $ 263  
 
                                                             
Total
  $ 4,808     $     $     $     $     $ 263     $     $     $ 5,071       $ 263  
 
                                                             
 
*   The Fund accounts for investments and derivatives transferred into Level 3 at the value at the beginning of the period and transferred out of Level 3 at the value at the end of the period.

 


 

Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If the Fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of the value of those investments. The Fund also may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Because the Fund normally does not take temporary defensive positions, declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.

 


 

Leveraging Risk — The Fund’s use of derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies or in industries with high positive correlations to one another creates additional risk.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Among other trading agreements, the Fund is party to International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Agreements”) or other similar types of agreements with selected counterparties that generally govern over-the-counter derivative transactions entered into by the Fund. The ISDA Agreements typically include representations and warranties as well as contractual terms related to collateral, events of default, termination events, and other provisions. Termination events may include the decline in the net assets of the Fund below a certain level over a specified period of time and entitle a counterparty to elect to terminate early with respect to some or all the transactions under the ISDA Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse effect on the Fund’s operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. For example, the Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives, to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives. The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For example, if the Fund holds a large proportion of stocks of companies in a particular sector and the Manager believes that stocks of companies in another sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index). In adjusting their investment exposure, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net long exposures in excess of its net assets. The Fund’s foreign currency exposure may differ significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC

 


 

derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most forward currency contracts are not collateralized. During the period ended November 30, 2011, the Fund used

 


 

forward currency contracts to manage against anticipated currency exchange rate changes and adjust exposure to foreign currencies. Forward currency contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded (unless otherwise adjusted due to the time at which foreign markets close). The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. During the period ended November 30, 2011, the Fund used futures contracts to adjust exposure to certain securities markets and maintain the diversity and liquidity of the portfolio. Futures contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated

 


 

terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers (unless otherwise adjusted due to the time at which foreign markets close) and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. During the period ended November 30, 2011, the Fund used swap agreements to achieve returns comparable to holding and lending a direct equity position. Swap agreements outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. During the period ended November 30, 2011, the Fund held rights and/or warrants received as a result of corporate actions. Rights and/or warrants held by the Fund at the end of the period are listed in the Fund’s Schedule of Investments.

 


 

The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Assets:
                                               
Investments, at value (rights and/or warrants)
  $     $     $     $ 39,413     $     $ 39,413  
Unrealized appreciation on forward currency contracts
          4,762,516                         4,762,516  
Unrealized appreciation on futures contracts*
                      17,408,938             17,408,938  
Unrealized appreciation on swap agreements
                                   
 
                                   
Total
  $     $ 4,762,516     $     $ 17,448,351     $     $ 22,210,867  
 
                                   
 
                                               
Liabilities:
                                               
Unrealized depreciation on forward currency contracts
  $     $ (2,738,894 )   $     $     $     $ (2,738,894 )
Unrealized depreciation on futures contracts*
                      (2,171,513 )         $ (2,171,513 )
Unrealized depreciation on swap agreements
                      (26,548 )           (26,548 )
 
                                   
Total
  $     $ (2,738,894 )   $     $ (2,198,061 )   $     $ (4,936,955 )
 
                                   
 
*   The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of futures contracts as reported in the Schedule of Investments.
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts, futures contracts and rights and/or warrants), or notional amounts (swap agreements) outstanding at each month-end, was as follows for the period ended November 30, 2011:
                                 
    Forward                    
    Currency     Futures     Rights and/or     Swap  
    Contracts     Contracts     Warrants     Agreements  
Average amount outstanding
  $948,437,538     $385,081,487     $539,285     $277,482  

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO International Equity Allocation Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares/Par Value ($)     Description   Value ($)  
 
       
MUTUAL FUNDS — 100.1%
       
       
 
       
       
Affiliated Issuers — 100.1%
       
  22,366,402    
GMO Emerging Markets Fund, Class VI
    261,463,245  
  2,441,904    
GMO Flexible Equities Fund, Class VI
    41,854,243  
  13,803,848    
GMO International Growth Equity Fund, Class IV
    295,402,351  
  21,948,029    
GMO International Intrinsic Value Fund, Class IV
    427,986,569  
       
 
     
       
TOTAL MUTUAL FUNDS (COST $972,732,788)
    1,026,706,408  
       
 
     
       
 
       
       
SHORT-TERM INVESTMENTS — 0.0%
       
       
 
       
       
Time Deposits — 0.0%
       
  20,858    
State Street Eurodollar Time Deposit, 0.01%, due 12/01/11
    20,858  
       
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $20,858)
    20,858  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 100.1%
(Cost $972,753,646)
    1,026,727,266  
       
 
       
       
Other Assets and Liabilities (net) — (0.1%)
    (527,593 )
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 1,026,199,673  
       
 
     

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
             
    Gross   Gross   Net Unrealized
    Unrealized   Unrealized   Appreciation
Aggregate Cost   Appreciation   (Depreciation)   (Depreciation)
$1,115,916,108
  $—   $(89,188,842)   $(89,188,842)
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO Emerging Markets Fund, Class VI
  $ 331,226,965     $ 47,472,044     $ 58,186,266     $ 106,511     $ 24,815,381     $ 261,463,245  
 
                                               
GMO Flexible Equities Fund, Class VI
    22,278,407       26,532,449       2,776,196                   41,854,243  
 
                                               
GMO International Growth Equity Fund, Class IV
    461,803,642       32,980,814       160,014,706       2,914,653             295,402,351  
 
                                               
GMO International Intrinsic Value Fund, Class IV
    462,273,821       118,648,077       88,684,636       8,067,662             427,986,569  
 
                                   
 
                                               
Totals
  $ 1,277,582,835     $ 225,633,384     $ 309,661,804     $ 11,088,826     $ 24,815,381     $ 1,026,706,408  
 
                                   

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Shares of the underlying funds and other investment funds are generally valued at their net asset value. Investments held by the underlying funds are valued as follows: Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly and indirectly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 1.2% of net assets. The underlying funds classify such securities (levels defined below) as Level 3.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund, either directly or through investments in the underlying funds, that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below and as described in the disclosures of the underlying funds.
     
Security Type
Percentage of Net Assets of the Fund  
Equity Securities
84.3%  
Futures Contracts
0.3%  
Swap Agreements
(0.0)% ^  
 
^   Rounds to 0.0%.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:

 


 

Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs.
Level 3 — Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Mutual Funds
  $ 1,026,706,408     $     $     $ 1,026,706,408  
Short-Term Investments
    20,858                   20,858  
 
                       
Total Investments
    1,026,727,266                   1,026,727,266  
 
                       
Total
  $ 1,026,727,266     $     $     $ 1,026,727,266  
 
                       

 


 

The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net values of the Fund’s indirect investments in securities using Level 3 inputs were 1.2% of total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011 whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. References to investments include those held directly by the Fund and indirectly through the Fund’s investments in the underlying funds. Some of the underlying funds are non-diversified investment companies under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by those funds may affect their performance more than if they were diversified. Selected risks of investing in the Fund are summarized below, including those risks to which the Fund is exposed as a result of its investments in the underlying funds. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If an underlying fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of the value of those investments. An underlying fund also may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Because the Fund and the underlying funds normally do not take temporary defensive positions, declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of foreign currency holdings and investments denominated in foreign currencies.
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund or an underlying fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in the underlying funds, including the risk that the underlying funds in which it invests do not perform as expected. Because the Fund bears the fees and expenses of the underlying funds in which it invests, new investments in underlying funds with higher fees or expenses than those of the underlying funds in which the Fund is currently invested will increase the Fund’s total expenses. The fees and expenses

 


 

associated with an investment in the Fund are less predictable and may be higher than fees and expenses associated with an investment in funds that charge a fixed management fee.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
Commodities Risk — To the extent an underlying fund has exposure to global commodity markets, the value of its shares is affected by factors particular to the commodity markets and may fluctuate more than the value of shares of a fund with a broader range of investments.
Leveraging Risk — The use of reverse repurchase agreements and other derivatives and securities lending may cause the Fund’s portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Short Sales Risk — The Fund runs the risk that an underlying fund’s loss on a short sale of securities that the underlying fund does not own is unlimited.
Market Risk — Fixed Income Securities — Typically, the market value of fixed income securities will decline during periods of rising interest rates and widening of credit spreads.
Market Risk — Asset-Backed Securities — Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating.
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies or in industries with high positive correlations to one another creates additional risk.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.

 


 

Derivative financial instruments
At November 30, 2011, the Fund held no derivative financial instruments directly. For a listing of derivative financial instruments held by the underlying funds, if any, please refer to the underlying funds’ Schedule of Investments.
For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO International Growth Equity Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares     Description   Value ($)  
 
       
COMMON STOCKS — 94.5%
       
       
 
       
       
Australia — 4.6%
       
  846,748    
BHP Billiton Ltd
    31,724,830  
  1,366,831    
BlueScope Steel Ltd
    557,413  
  176,810    
Coca Cola Amatil Ltd
    2,157,419  
  42,780    
Cochlear Ltd
    2,526,245  
  181,726    
CSL Ltd
    5,925,480  
  220,319    
Iluka Resources Ltd
    3,555,271  
  338,700    
National Australia Bank Ltd
    8,480,903  
  601,383    
Qantas Airways Ltd *
    964,916  
  26,397    
Rio Tinto Ltd
    1,797,499  
  2,713,296    
Telstra Corp Ltd
    8,915,009  
  499,826    
Wesfarmers Ltd
    16,048,573  
  361,502    
Westpac Banking Corp
    7,897,736  
  172,933    
Woodside Petroleum Ltd
    6,028,111  
  908,952    
Woolworths Ltd
    23,399,020  
       
 
     
       
Total Australia
    119,978,425  
       
 
     
       
 
       
       
Austria — 0.2%
       
  36,331    
Andritz AG
    3,207,919  
  946,419    
Immofinanz AG (Entitlement Shares) *
     
  40,044    
Raiffeisen International Bank Holding
    951,925  
  72,261    
Voestalpine AG
    2,101,382  
       
 
     
       
Total Austria
    6,261,226  
       
 
     
       
 
       
       
Belgium — 0.3%
       
  46,742    
Bekaert NV
    1,857,448  
  87,822    
Colruyt SA
    3,325,912  
  63,760    
Mobistar SA
    3,486,551  
       
 
     
       
Total Belgium
    8,669,911  
       
 
     
       
 
       
       
Canada — 3.8%
       
  29,500    
Agrium Inc
    2,070,597  
  73,500    
BCE Inc
    2,882,494  
  270,900    
Canadian National Railway Co
    20,947,971  
  77,400    
Cenovus Energy Inc
    2,588,474  
  361,900    
Enbridge Inc
    12,823,242  
  78,300    
IGM Financial Inc
    3,324,842  
  140,600    
Imperial Oil Ltd
    6,013,012  
  39,000    
Metro Inc Class A
    1,971,126  
  296,800    
Potash Corp of Saskatchewan Inc
    12,937,623  
  136,200    
Research In Motion Ltd *
    2,454,391  
  172,900    
Rogers Communications Inc Class B
    6,411,175  
  75,200    
Saputo Inc
    2,800,969  
  82,800    
Shoppers Drug Mart Corp
    3,446,110  
  268,900    
Suncor Energy Inc
    8,099,032  
  222,196    
Valeant Pharmaceuticals International Inc *
    10,282,515  
       
 
     
       
Total Canada
    99,053,573  
       
 
     
       
 
       
       
Denmark — 1.5%
       
  295,425    
Novo-Nordisk A/S Class B
    33,536,732  
  131,820    
Novozymes A/S B Shares
    4,227,749  
       
 
     
       
Total Denmark
    37,764,481  
       
 
     
       
 
       
       
Finland — 0.5%
       
  112,595    
Kone Oyj Class B
    6,341,687  

 


 

                 
  97,887    
Nokian Renkaat Oyj
    3,242,435  
  50,846    
Sampo Oyj Class A
    1,328,257  
  58,434    
Wartsila Oyj
    1,920,432  
       
 
     
       
Total Finland
    12,832,811  
       
 
     
       
 
       
       
France — 6.5%
       
  113,985    
Air France—KLM *
    664,231  
  17,760    
Air Liquide SA
    2,247,176  
  1,663,315    
Alcatel-Lucent *
    2,783,728  
  57,460    
Arkema
    4,185,627  
  67,471    
BNP Paribas
    2,685,890  
  70,374    
Bureau Veritas SA
    5,214,356  
  262,849    
Carrefour SA
    6,998,466  
  203,955    
Compagnie de Saint-Gobain
    8,648,284  
  68,800    
Michelin (CGDE)
    4,385,880  
  168,226    
Credit Agricole SA
    1,081,380  
  122,139    
Danone SA
    8,063,926  
  50,819    
Dassault Systemes SA
    4,161,005  
  124,827    
Essilor International SA
    8,923,371  
  195,383    
EADS NV
    5,861,846  
  78,337    
Eutelsat Communications
    3,044,053  
  16,696    
ICADE REIT
    1,334,670  
  27,889    
Iliad SA
    3,407,515  
  89,947    
L’Oreal SA
    9,735,405  
  79,198    
Legrand SA
    2,563,569  
  43,629    
LVMH Moet Hennessy Louis Vuitton SA
    6,869,483  
  18,862    
Neopost SA
    1,336,446  
  83,954    
Renault SA
    3,145,793  
  86,312    
Safran SA
    2,561,102  
  398,648    
Sanofi
    27,883,834  
  85,368    
Schneider Electric SA
    4,854,360  
  200,684    
SES SA Class A FDR
    4,945,876  
  50,479    
Societe Generale
    1,233,319  
  31,467    
Sodexo
    2,288,574  
  205,333    
STMicroelectronics NV
    1,301,335  
  40,664    
Technip SA
    3,874,361  
  49,001    
Total SA
    2,528,087  
  20,320    
Unibail-Rodamco SE REIT
    3,787,898  
  76,225    
Valeo SA
    3,375,241  
  154,119    
Vinci SA
    6,890,031  
  37,559    
Wendel
    2,706,135  
  45,517    
Zodiac Aerospace
    3,740,592  
       
 
     
       
Total France
    169,312,845  
       
 
     
       
 
       
       
Germany — 8.0%
       
  95,489    
Adidas AG
    6,733,963  
  141,551    
Aixtron AG
    1,852,748  
  71,570    
Aurubis AG
    4,084,018  
  482,598    
BASF AG
    35,255,430  
  146,716    
Bayerische Motoren Werke AG
    11,122,108  
  54,250    
Beiersdorf AG
    3,107,847  
  43,522    
Bilfinger & Berger SE
    3,975,980  
  21,962    
Brenntag AG
    2,108,859  
  44,754    
Continental AG *
    3,177,495  
  35,575    
Deutsche Boerse AG *
    2,182,748  
  153,500    
Deutsche Lufthansa AG (Registered)
    1,990,149  
  17,145    
Fielmann AG
    1,737,866  
  50,896    
Fraport AG
    2,898,605  
  52,636    
Fresenius SE & Co KGaA
    5,069,268  

 


 

                 
  80,839    
Fresenius Medical Care AG & Co
    5,541,959  
  199,955    
GEA Group AG
    5,918,724  
  29,594    
Hochtief AG
    1,698,236  
  943,465    
Infineon Technologies AG
    7,843,117  
  50,591    
K+S AG
    2,754,844  
  61,372    
Kabel Deutschland Holding AG *
    3,411,555  
  137,317    
Kloeckner & Co SE
    1,808,644  
  75,358    
Lanxess AG
    4,227,373  
  52,638    
Leoni AG
    1,958,798  
  49,059    
Linde AG
    7,560,530  
  39,670    
Merck KGaA
    3,948,748  
  63,902    
Metro AG
    3,153,322  
  33,214    
MTU Aero Engines Holding AG
    2,133,472  
  28,174    
Rheinmetall AG
    1,367,607  
  629,883    
SAP AG
    37,716,987  
  39,542    
SGL Carbon SE *
    2,382,908  
  97,702    
Siemens AG (Registered)
    9,887,361  
  61,251    
Software AG
    2,640,317  
  47,305    
Stada Arzneimittel AG
    1,320,784  
  127,216    
Suedzucker AG
    4,052,768  
  104,456    
ThyssenKrupp AG
    2,698,092  
  36,983    
Volkswagen AG
    5,632,716  
       
 
     
       
Total Germany
    204,955,946  
       
 
     
       
 
       
       
Greece — 0.1%
       
  8    
Alpha Bank A.E. *
    7  
  226,711    
OPAP SA
    2,034,148  
       
 
     
       
Total Greece
    2,034,155  
       
 
     
       
 
       
       
Hong Kong — 3.4%
       
  3,493,400    
AIA Group Ltd
    11,003,396  
  182,000    
Cheung Kong Holdings Ltd
    2,101,006  
  1,334,000    
CLP Holdings Ltd
    11,879,954  
  1,272,574    
Esprit Holdings Ltd
    1,836,647  
  1,910,000    
Galaxy Entertainment Group Ltd *
    3,812,614  
  412,800    
Hang Seng Bank Ltd
    5,093,106  
  4,556,374    
Hong Kong & China Gas
    10,550,887  
  66,800    
Hong Kong Aircraft Engineering Co Ltd
    869,898  
  174,400    
Hong Kong Exchanges & Clearing Ltd
    2,881,853  
  641,000    
Hutchison Whampoa Ltd
    5,629,746  
  84,400    
Jardine Matheson Holdings Ltd
    4,268,704  
  1,263,000    
Power Assets Holdings Ltd
    9,463,309  
  2,109,600    
Sands China Ltd *
    6,312,806  
  2,440,000    
SJM Holdings Ltd
    4,237,677  
  121,000    
Sun Hung Kai Properties Ltd
    1,496,391  
  78,000    
Swire Pacific Ltd
    952,188  
  1,286,000    
Wynn Macau Ltd *
    3,769,387  
  2,320,000    
Xinyi Glass Holdings Ltd
    1,358,048  
       
 
     
       
Total Hong Kong
    87,517,617  
       
 
     
       
 
       
       
Ireland — 0.3%
       
  375,608    
CRH Plc
    7,170,608  
  32,135    
DCC Plc
    778,014  
       
 
     
       
Total Ireland
    7,948,622  
       
 
     
       
 
       
       
Italy — 0.3%
       
  61,142    
Assicurazioni Generali SPA
    1,015,363  
  1,165,452    
Enel SPA
    4,965,875  
  139,898    
Mediobanca SPA
    903,974  

 


 

                 
  51,775    
Saipem SPA
    2,316,641  
       
 
     
       
Total Italy
    9,201,853  
       
 
     
       
 
       
       
Japan — 20.0%
       
  37,700    
ABC-Mart Inc
    1,401,692  
  288,000    
Asahi Glass Co Ltd
    2,465,386  
  78,600    
Astellas Pharma Inc
    3,029,749  
  432,900    
Bridgestone Corp
    10,031,178  
  686,850    
Canon Inc
    30,813,613  
  408    
Central Japan Railway Co
    3,269,129  
  269,200    
Chugai Pharmaceutical Co Ltd
    4,112,622  
  227,000    
Daihatsu Motor Co Ltd
    3,977,175  
  146,800    
Daiichi Sankyo Co Ltd
    2,647,032  
  133,800    
Daito Trust Construction Co Ltd
    11,933,499  
  107,000    
Dena Co Ltd
    3,321,800  
  529,000    
DIC Corp
    893,342  
  162,900    
Eisai Co Ltd
    6,289,002  
  91,800    
Fanuc Ltd
    15,082,603  
  50,700    
Fast Retailing Co Ltd
    8,227,425  
  76,600    
Gree Inc
    2,571,692  
  24,800    
Hirose Electric Co Ltd
    2,294,821  
  110,100    
Hisamitsu Pharmaceutical Co Inc
    4,392,724  
  2,634,000    
Hitachi Ltd
    14,615,830  
  243,100    
Honda Motor Co Ltd
    7,714,624  
  390,800    
Hoya Corp
    8,323,818  
  21,400    
Idemitsu Kosan Co Ltd
    2,288,482  
  997,000    
IHI Corporation
    2,341,530  
  2,124    
INPEX Corp
    14,338,866  
  345,600    
Itochu Corp
    3,512,122  
  80,100    
Ito En Ltd
    1,394,808  
  819    
Japan Tobacco Inc
    3,930,190  
  126,000    
JGC Corp
    3,175,593  
  69,500    
K’s Holdings Corp
    2,739,465  
  54,629    
Kakaku.com Inc
    2,094,680  
  561,500    
Kao Corp
    14,859,828  
  762,000    
Kawasaki Heavy Industries Ltd
    1,982,993  
  701,000    
Kawasaki Kisen Kaisha Ltd
    1,218,849  
  2,425    
KDDI Corp
    16,067,560  
  39,630    
Keyence Corp
    10,140,249  
  1,012,000    
Kintetsu Corp
    3,755,222  
  1,000,000    
Kobe Steel Ltd
    1,596,830  
  405,500    
Komatsu Ltd
    10,377,484  
  61,500    
Konami Corp
    1,849,765  
  129,700    
Kuraray Co Ltd
    1,861,352  
  103,500    
Lawson Inc
    6,129,548  
  95,100    
Makita Corp
    3,326,857  
  959,000    
Marubeni Corp
    5,924,440  
  799,000    
Mazda Motor Corp *
    1,457,164  
  149,000    
Mitsubishi Estate Co Ltd
    2,487,299  
  1,228,000    
Mitsubishi Heavy Industries Ltd
    5,156,263  
  986,500    
Mitsubishi Chemical Holdings Corp
    5,731,009  
  283,100    
Mitsubishi Corp
    5,852,647  
  599,000    
Mitsubishi Electric Corp
    5,670,405  
  579,000    
Mitsui Engineer & Shipbuilding Co Ltd
    889,114  
  577,000    
Mitsui & Co Ltd
    9,103,840  
  288,000    
Mitsui OSK Lines Ltd
    915,511  
  67,900    
Murata Manufacturing Co Ltd
    4,023,691  
  78,900    
Nabtesco Corp
    1,737,501  
  126,100    
Namco Bandai Holdings Inc
    1,818,092  

 


 

                 
  36,600    
Nidec Corp
    3,342,714  
  59,900    
Nintendo Co Ltd
    9,119,018  
  47,000    
Nippon Telegraph & Telephone Corp
    2,317,968  
  360,600    
Nissan Motor Co Ltd
    3,311,502  
  83,150    
Nitori Holdings Co Ltd
    7,772,446  
  113,300    
Nitto Denko Corp
    4,709,525  
  135,300    
Nomura Research Institute Ltd
    2,985,562  
  7,061    
NTT Docomo Inc
    12,480,641  
  509,000    
Odakyu Electric Railway Co Ltd
    4,817,522  
  67,000    
Olympus Corp
    905,094  
  49,900    
Ono Pharmaceutical Co Ltd
    2,599,743  
  33,300    
Oriental Land Co Ltd
    3,466,966  
  11,630    
ORIX Corp
    981,280  
  18,420    
Point Inc
    765,868  
  4,009    
Rakuten Inc
    4,301,311  
  708,500    
Resona Holdings Inc
    3,173,331  
  308,000    
Ricoh Company Ltd
    2,775,608  
  47,800    
Sankyo Co Ltd
    2,389,329  
  39,100    
Sanrio Co Ltd
    2,033,881  
  65,700    
Santen Pharmaceutical Co Ltd
    2,478,366  
  26,900    
Sawai Pharmaceuticals Co Ltd
    2,851,462  
  86,500    
Secom Co Ltd
    3,901,244  
  149,100    
Sega Sammy Holdings Inc
    3,049,113  
  121,000    
Seven & I Holdings Co Ltd
    3,378,379  
  645,000    
Seven Bank Ltd
    1,274,906  
  25,600    
Shimamura Co Ltd
    2,433,229  
  330,000    
Shimizu Corp
    1,360,583  
  99,700    
Shin-Etsu Chemical Co Ltd
    5,012,333  
  171,000    
Shionogi & Co Ltd
    2,011,656  
  259,400    
Shiseido Co Ltd
    4,820,873  
  33,200    
SMC Corp
    5,514,354  
  177,100    
SoftBank Corp
    5,981,452  
  185,800    
Stanley Electric Co Ltd
    2,741,104  
  112,000    
Sumitomo Metal Mining Co Ltd
    1,511,255  
  100,400    
Sysmex Corp
    3,456,122  
  490,100    
Takeda Pharmaceutical Co Ltd
    20,130,355  
  585,000    
Teijin Ltd
    1,790,052  
  173,300    
Terumo Corp
    8,441,753  
  342,000    
Tobu Railway Co Ltd
    1,732,503  
  1,461,000    
Toray Industries Inc
    10,952,992  
  628,000    
Toshiba Corp
    2,902,598  
  84,400    
Toyota Tsusho Corp
    1,420,160  
  98,000    
Toyo Suisan Kaisha Ltd
    2,411,374  
  144,700    
Trend Micro Inc
    4,442,049  
  106,400    
Tsumura & Co
    2,951,545  
  129,700    
Unicharm Corp
    6,152,193  
  52,136    
West Japan Railway Co
    2,152,177  
  20,478    
Yahoo Japan Corp
    6,488,812  
  106,410    
Yamada Denki Co Ltd
    7,696,965  
  236,500    
Yamato Holdings Co Ltd
    3,797,811  
  56,400    
Yamato Kogyo Co Ltd
    1,562,429  
       
 
     
       
Total Japan
    518,209,513  
       
 
     
       
 
       
       
Netherlands — 2.1%
       
  206,827    
Aegon NV *
    902,885  
  73,893    
ASML Holding NV
    2,917,252  
  313,613    
ING Groep NV *
    2,445,924  
  860,694    
Koninklijke KPN NV
    10,534,075  
  162,248    
Reed Elsevier NV
    1,912,535  

 


 

                 
  1,037,675    
Unilever NV
    35,343,051  
       
 
     
       
Total Netherlands
    54,055,722  
       
 
     
       
 
       
       
New Zealand — 0.1%
       
  188,686    
Chorus Ltd *
    484,734  
  943,433    
Telecom Corp of New Zealand Ltd
    1,495,459  
       
 
     
       
Total New Zealand
    1,980,193  
       
 
     
       
 
       
       
Norway — 0.2%
       
  927,653    
Golden Ocean Group Ltd
    676,052  
  112,512    
Telenor ASA
    1,924,928  
  94,732    
TGS Nopec Geophysical Co ASA
    2,107,852  
  30,717    
Yara International ASA
    1,250,377  
       
 
     
       
Total Norway
    5,959,209  
       
 
     
       
 
       
       
Singapore — 2.2%
       
  1,424,000    
Ezra Holdings Ltd
    1,007,137  
  6,261,000    
Golden Agri-Resources Ltd
    3,536,482  
  1,271,000    
Hyflux Ltd
    1,192,733  
  1,254,900    
Keppel Corp Ltd
    9,321,849  
  998,000    
SATS Ltd
    1,720,449  
  817,000    
Sembcorp Industries Ltd
    2,748,161  
  976,000    
SembCorp Marine Ltd
    2,934,947  
  861,000    
Singapore Exchange Ltd
    4,229,959  
  2,292,000    
Singapore Press Holdings Ltd
    7,075,605  
  2,130,000    
Singapore Technologies Engineering Ltd
    4,512,176  
  3,950,500    
Singapore Telecommunications
    9,629,249  
  1,644,000    
SMRT Corp Ltd
    2,299,972  
  1,284,000    
StarHub Ltd
    2,868,307  
  391,000    
Wilmar International Ltd
    1,586,392  
  1,834,000    
Yangzijiang Shipbuilding Holdings Ltd
    1,321,024  
       
 
     
       
Total Singapore
    55,984,442  
       
 
     
       
 
       
       
Spain — 1.3%
       
  14,702    
Acciona SA
    1,367,450  
  60,178    
Enagas
    1,129,179  
  119,508    
Gas Natural SDG SA
    2,080,490  
  196,680    
Inditex SA
    16,724,316  
  104,866    
Red Electrica de Espana
    4,609,853  
  230,203    
Repsol YPF SA
    6,950,049  
       
 
     
       
Total Spain
    32,861,337  
       
 
     
       
 
       
       
Sweden — 2.5%
       
  197,854    
Atlas Copco AB
    3,776,207  
  184,727    
Atlas Copco AB Class A
    3,963,682  
  185,372    
Boliden AB
    2,687,602  
  37,135    
Elekta AB Class B
    1,581,081  
  711,858    
Ericsson LM B Shares
    7,594,252  
  597,840    
Hennes & Mauritz AB Class B
    18,993,401  
  297,448    
Investor AB B Shares
    5,547,852  
  67,049    
Kinnevik Investment AB
    1,365,042  
  110,861    
Lundin Petroleum AB *
    2,857,156  
  46,295    
Millicom International Cellular SA SDR
    5,030,392  
  131,192    
Scania AB Class B
    2,008,883  
  441,458    
Swedbank AB Class A
    5,905,794  
  97,369    
Swedish Match AB
    3,193,801  
       
 
     
       
Total Sweden
    64,505,145  
       
 
     

 


 

                 
       
Switzerland — 9.8%
       
  27,339    
Actelion Ltd (Registered) *
    955,988  
  19,237    
Geberit AG (Registered) *
    3,691,693  
  23,290    
Kuehne & Nagel International AG (Registered)
    2,843,512  
  1,258,866    
Nestle SA (Registered)
    70,651,068  
  65,998    
Nobel Biocare Holding AG *
    837,843  
  932,719    
Novartis AG (Registered)
    50,370,788  
  718,802    
Roche Holding AG (Non Voting)
    114,342,914  
  2,469    
SGS SA (Registered)
    4,177,815  
  5,456    
Swisscom AG (Registered)
    2,060,430  
  14,294    
Syngenta AG (Registered) *
    4,206,342  
       
 
     
       
Total Switzerland
    254,138,393  
       
 
     
       
 
       
       
United Kingdom — 26.8%
       
  751,740    
Aberdeen Asset Management Plc
    2,376,807  
  303,240    
Admiral Group Plc
    4,391,942  
  417,212    
Aggreko Plc
    12,437,369  
  177,605    
AMEC Plc
    2,430,510  
  701,931    
ARM Holdings Plc
    6,595,891  
  465,084    
Ashmore Group Plc
    2,470,484  
  138,537    
ASOS Plc *
    2,965,954  
  349,514    
AstraZeneca Plc
    16,097,831  
  149,322    
Babcock International Group Plc
    1,705,114  
  779,398    
BAE Systems Plc
    3,364,892  
  615,678    
Balfour Beatty Plc
    2,437,412  
  1,489,822    
Barclays Plc
    4,291,767  
  1,354,895    
BG Group Plc
    29,060,906  
  327,259    
BHP Billiton Plc
    10,063,971  
  631,761    
BP Plc
    4,575,441  
  1,951,857    
British American Tobacco Plc
    90,579,945  
  805,040    
British Sky Broadcasting Group Plc
    9,693,601  
  3,620,033    
BT Group Plc
    10,832,657  
  234,959    
Bunzl Plc
    3,069,839  
  600,095    
Burberry Group Plc
    12,022,042  
  597,195    
Capita Group Plc
    5,922,467  
  664,750    
Centrica Plc
    3,159,869  
  222,163    
Chemring Group Plc
    1,373,863  
  1,349,787    
Cobham Plc
    3,755,127  
  250,681    
Cookson Group Plc
    1,964,380  
  303,265    
Croda International Plc
    8,706,521  
  1,637,027    
Diageo Plc
    35,061,885  
  298,683    
Drax Group Plc
    2,630,583  
  642,775    
Experian Plc
    8,547,843  
  84,129    
Fresnillo Plc
    2,275,053  
  1,122,782    
GKN Plc
    3,448,973  
  3,940,530    
GlaxoSmithKline Plc
    87,330,138  
  1,020,315    
HSBC Holdings Plc
    7,958,918  
  302,289    
ICAP Plc
    1,690,793  
  307,393    
IMI Plc
    3,870,436  
  266,183    
Imperial Tobacco Group Plc
    9,576,467  
  468,898    
Inchcape Plc
    2,408,368  
  241,906    
Inmarsat Plc
    1,665,500  
  149,534    
InterContinental Hotels Group Plc
    2,599,899  
  392,792    
International Power Plc
    2,075,735  
  145,771    
Intertek Group Plc
    4,418,121  
  167,401    
Investec Plc
    953,049  
  2,584,919    
ITV Plc
    2,643,609  
  304,759    
John Wood Group Plc
    3,131,776  
  75,204    
Johnson Matthey Plc
    2,267,054  

 


 

                 
  563,075    
Kingfisher Plc
    2,269,224  
  90,431    
Lancashire Holdings Ltd
    1,041,381  
  295,812    
Land Securities Group Plc REIT
    3,198,955  
  21    
Legal & General Group Plc
    35  
  658,793    
LG Group Holdings Plc
    4,994,029  
  21,779,541    
Lloyds Banking Group Plc *
    8,523,003  
  203,967    
London Stock Exchange Group Plc
    2,772,621  
  940,839    
Man Group Plc
    2,108,710  
  1,245,947    
Marks & Spencer Group Plc
    6,482,894  
  281,219    
Micro Focus International Plc
    1,603,813  
  300,274    
Mondi Plc
    2,165,735  
  443,326    
National Grid Plc
    4,356,700  
  240,118    
Next Plc
    10,149,120  
  390,913    
Pearson Plc
    7,101,249  
  319,932    
Pennon Group Plc
    3,614,879  
  182,348    
Petrofac Ltd
    4,169,056  
  750,442    
Prudential Plc
    7,386,319  
  42,791    
Randgold Resources Ltd
    4,552,482  
  414,160    
Reckitt Benckiser Group Plc
    21,011,467  
  726,504    
Reed Elsevier Plc
    6,041,877  
  516,202    
Resolution Ltd
    1,915,999  
  414,042    
Rexam Plc
    2,245,105  
  220,397    
Rightmove Plc
    4,412,094  
  395,589    
Rio Tinto Plc
    20,826,042  
  217,965    
Rolls-Royce Holdings Plc *
    2,505,398  
  30    
Royal Bank of Scotland Group Plc *
    10  
  79,376    
Royal Dutch Shell Plc A Shares (London)
    2,776,143  
  514,053    
Royal Dutch Shell Plc B Shares (London)
    18,523,677  
  127,725    
SABMiller Plc
    4,509,661  
  601,470    
Sage Group Plc (The)
    2,748,839  
  145,678    
Schroders Plc
    3,081,311  
  342,379    
SSE Plc
    7,089,558  
  525,540    
Shire Plc
    17,672,854  
  283,191    
Smiths Group Plc
    4,231,328  
  737,283    
Smith & Nephew Plc
    6,736,155  
  157,992    
Spectris Plc
    3,117,958  
  312,945    
Standard Chartered Plc
    6,813,065  
  304,320    
Tate & Lyle Plc
    3,223,098  
  894,201    
Tesco Plc
    5,709,132  
  316,559    
Tullett Prebon Plc
    1,523,870  
  179,440    
Unilever Plc
    6,027,739  
  264,684    
Weir Group Plc (The)
    8,603,401  
  734,001    
William Hill Plc
    2,337,464  
  208,903    
Wolseley Plc
    6,263,237  
  436,245    
Xstrata Plc
    7,003,321  
       
 
     
       
Total United Kingdom
    694,340,810  
       
 
     
       
TOTAL COMMON STOCKS (COST $2,480,812,927)
    2,447,566,229  
       
 
     
       
 
       
       
PREFERRED STOCKS — 0.8%
       
       
 
       
       
Germany — 0.8%
       
  23,744    
Bayerische Motoren Werke AG 3.40%
    1,251,052  
  34,528    
Hugo Boss AG 2.95%
    3,143,298  
  103,100    
Porsche Automobil Holding SE 1.24%
    6,317,835  
  153,801    
ProSiebenSat.1 Media AG 7.61%
    3,042,568  
  53,806    
Volkswagen AG 1.95%
    9,297,480  
       
 
     
       
Total Germany
    23,052,233  
       
 
     
       
TOTAL PREFERRED STOCKS (COST $21,800,510)
    23,052,233  
       
 
     

 


 

                 
       
RIGHTS/WARRANTS — 0.0%
       
       
 
       
       
Australia — 0.0%
       
  1,093,464    
BlueScope Steel Ltd, Expires 12/14/11*
    12,370  
       
 
     
 
       
Canada — 0.0%
       
  19,162    
Kinross Gold Corp, Warrants, Strike 21.30, Expires 09/17/14*
    37,950  
       
 
     
       
TOTAL RIGHTS/WARRANTS (COST $177,130)
    50,320  
       
 
     
       
 
       
       
MUTUAL FUNDS — 2.5%
       
       
 
       
       
United States — 2.5%
       
       
 
       
       
Affiliated Issuers
       
  2,596,126    
GMO U.S. Treasury Fund
    64,929,120  
       
 
     
       
TOTAL MUTUAL FUNDS (COST $64,929,120)
    64,929,120  
       
 
     
                     
    Par Value     Description   Value ($)  
 
           
SHORT-TERM INVESTMENTS — 1.4%
       
           
 
       
           
Time Deposits — 1.4%
       
USD     91,940    
Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11
    91,940  
USD     25,000,000    
Barclays Plc Time Deposit, 0.12%, due 12/01/11
    25,000,000  
AUD     9,899    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 3.78%, due 12/01/11
    10,180  
CAD     16,520    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.25%, due 12/01/11
    16,196  
CHF     9,068    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.01%, due 12/01/11
    9,926  
DKK     54,824    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.14%, due 12/01/11
    9,907  
NOK     57,437    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.95%, due 12/01/11
    9,944  
NZD     12,616    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 1.75%, due 12/01/11
    9,851  
HKD     1,715,546    
Citibank (New York) Time Deposit, 0.01%, due 12/01/11
    220,826  
JPY     85,722,560    
Citibank (New York) Time Deposit, 0.01%, due 12/01/11
    1,105,242  
SGD     421,923    
Citibank (New York) Time Deposit, 0.01%, due 12/01/11
    329,203  
USD     8,300,000    
Deutsche Bank Time Deposit, 0.06%, due 12/01/11
    8,300,000  
EUR     712,028    
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11
    956,752  
GBP     348,711    
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11
    547,093  
SEK     1,017,866    
JPMorgan Chase (New York) Time Deposit, 1.06%, due 12/01/11
    150,415  
           
 
     
           
Total Time Deposits
    36,767,475  
           
 
     
           
TOTAL SHORT-TERM INVESTMENTS (COST $36,767,475)
    36,767,475  
           
 
     
           
 
       
           
TOTAL INVESTMENTS — 99.2%
(Cost $2,604,487,162)
    2,572,365,377  
           
 
       
           
Other Assets and Liabilities (net) — 0.8%
    19,728,069  
           
 
     
           
 
       
           
TOTAL NET ASSETS — 100.0%
  $ 2,592,093,446  
           
 
     

 


 

A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
                                     
                                Net Unrealized  
Settlement                             Appreciation  
Date     Counterparty   Deliver/Receive   Units of Currency     Value     (Depreciation)  
Buys †                                
  12/16/11    
Bank of New York Mellon
  CAD     10,357,635     $ 10,151,230     $ 4,276  
  12/16/11    
Royal Bank of Scotland PLC
  DKK     69,679,199       12,593,069       (258,652 )
  12/16/11    
Brown Brothers & Harriman & Co.
  EUR     15,867,809       21,323,773       (395,817 )
  12/16/11    
Deutsche Bank AG
  EUR     3,666,048       4,926,577       (97,742 )
  12/16/11    
JPMorgan Chase Bank, N.A.
  EUR     3,666,048       4,926,577       (93,204 )
  12/16/11    
Morgan Stanley Capital Services Inc.
  EUR     5,535,000       7,438,146       (131,669 )
  12/16/11    
Royal Bank of Scotland PLC
  EUR     7,477,617       10,048,710       (125,826 )
  12/16/11    
State Street Bank and Trust Company
  EUR     11,783,460       15,835,068       (405,839 )
  12/16/11    
Bank of America, N.A.
  GBP     6,689,070       10,493,021       23,429  
  12/16/11    
Bank of New York Mellon
  GBP     4,542,455       7,125,665       14,816  
  12/16/11    
JPMorgan Chase Bank, N.A.
  GBP     8,886,908       13,940,729       (17,049 )
  12/16/11    
Morgan Stanley Capital Services Inc.
  GBP     6,913,181       10,844,580       19,285  
  12/16/11    
Royal Bank of Scotland PLC
  GBP     2,567,058       4,026,897       10,747  
  12/16/11    
State Street Bank and Trust Company
  GBP     7,110,070       11,153,436       43,169  
  12/16/11    
Barclays Bank PLC
  HKD     114,596,892       14,751,915       10,832  
  12/16/11    
Brown Brothers Harriman & Co.
  HKD     136,659,856       17,592,053       7,760  
  12/16/11    
JPMorgan Chase Bank, N.A.
  HKD     86,921,174       11,189,255       8,208  
  12/16/11    
Morgan Stanley Capital Services Inc.
  HKD     114,596,892       14,751,915       8,704  
  12/16/11    
State Street Bank and Trust Company
  HKD     27,881,121       3,589,102       2,552  
  12/16/11    
Bank of New York Mellon
  JPY     1,048,626,376       13,524,722       (148,602 )

 


 

                                     
  12/16/11    
Barclays Bank PLC
  JPY     423,543,931       5,462,684       (61,418 )
  12/16/11    
Deutsche Bank AG
  JPY     1,219,187,662       15,724,547       (170,783 )
  12/16/11    
JPMorgan Chase Bank, N.A.
  JPY     913,030,250       11,775,863       (127,741 )
  12/16/11    
Morgan Stanley Capital Services Inc.
  JPY     607,020,455       7,829,083       (87,663 )
  12/16/11    
Barclays Bank PLC
  NOK     22,173,139       3,836,319       (105,362 )
  12/16/11    
Royal Bank of Scotland PLC
  NOK     9,316,546       1,611,916       (44,655 )
  12/16/11    
Brown Brothers Harriman & Co.
  SEK     85,581,248       12,637,283       (138,898 )
  12/16/11    
JPMorgan Chase Bank, N.A.
  SEK     79,170,463       11,690,640       (332,250 )
  12/16/11    
Bank of America, N.A.
  SGD     14,891,566       11,619,240       (111,668 )
  12/16/11    
Bank of New York Mellon
  SGD     14,413,175       11,245,972       (55,483 )
  12/16/11    
Barclays Bank PLC
  SGD     28,088,454       21,916,196       (150,482 )
  12/16/11    
Brown Brothers Harriman & Co.
  SGD     8,493,082       6,626,782       (54,897 )
  12/16/11    
Morgan Stanley Capital Services Inc.
  SGD     20,027,257       15,626,395       (121,646 )
  12/16/11    
Royal Bank of Scotland PLC
  SGD     12,129,880       9,464,416       (70,888 )
  12/16/11    
State Street Bank and Trust Company
  SGD     14,413,175       11,245,972       (87,011 )
       
 
                       
       
 
              $ 378,539,748     $ (3,241,467 )
       
 
                       
            Sales #                            
  12/16/11    
Bank of America, N.A.
  AUD     5,395,172     $ 5,538,805     $ (295,695 )
  12/16/11    
Bank of New York Mellon
  CAD     31,287,488       30,663,997       (122,008 )
  12/16/11    
Deutsche Bank AG
  CAD     14,418,569       14,131,239       (29,949 )
  12/16/11    
Royal Bank of Scotland PLC
  CAD     21,864,996       21,429,275       (87,556 )
  12/16/11    
State Street Bank and Trust Company
  CAD     22,994,946       22,536,707       51,290  
  12/16/11    
Bank of America, N.A.
  CHF     12,132,955       13,284,931       184,905  
  12/16/11    
Bank of New York Mellon
  CHF     13,664,951       14,962,384       175,984  
  12/16/11    
Barclays Bank PLC
  CHF     8,039,076       8,802,355       105,702  
  12/16/11    
Brown Brothers Harriman & Co.
  CHF     14,758,791       16,160,080       211,311  
  12/16/11    
Deutsche Bank AG
  CHF     7,892,767       8,642,154       120,480  
  12/16/11    
JPMorgan Chase Bank, N.A.
  CHF     5,885,390       6,444,185       85,959  

 


 

                                     
  12/16/11    
Royal Bank of Scotland PLC
  CHF     3,444,919       3,772,000       45,846  
  12/16/11    
State Street Bank and Trust Company
  CHF     12,733,524       13,942,522       175,250  
  12/16/11    
Royal Bank of Scotland PLC
  DKK     69,679,199       12,593,069       201,273  
  12/16/11    
Brown Brothers Harriman & Co.
  EUR     1,188,903       1,597,694       35,435  
  12/16/11    
Deutsche Bank AG
  EUR     3,666,048       4,926,577       108,872  
  12/16/11    
JPMorgan Chase Bank, N.A.
  EUR     3,666,048       4,926,577       108,968  
  12/16/11    
Morgan Stanley Capital Services Inc.
  EUR     5,535,000       7,438,146       165,172  
  12/16/11    
JPMorgan Chase Bank, N.A.
  JPY     655,240,000       8,450,998       83,340  
  12/16/11    
Barclays Bank PLC
  NOK     22,173,139       3,836,319       71,944  
  12/16/11    
Royal Bank of Scotland PLC
  NOK     9,316,546       1,611,916       30,261  
  12/16/11    
Bank of New York Mellon
  SEK     48,727,046       7,195,238       69,718  
  12/16/11    
Barclays Bank PLC
  SEK     46,389,309       6,850,038       68,782  
  12/16/11    
Brown Brothers Harriman & Co.
  SEK     165,313,119       24,410,823       269,776  
  12/16/11    
JPMorgan Chase Bank, N.A.
  SEK     99,880,716       14,748,802       112,591  
  12/16/11    
State Street Bank and Trust Company
  SEK     66,282,770       9,787,590       114,524  
       
 
                       
       
 
              $ 288,684,421     $ 2,062,175  
       
 
                       
 
  Fund buys foreign currency; sells USD.
 
#   Fund sells foreign currency; buys USD.
Futures Contracts
                             
                        Net Unrealized  
Number of         Expiration           Appreciation  
Contracts     Type   Date   Value     (Depreciation)  
Buys  
 
                   
  324    
DAX
  December 2011   $ 66,556,866     $ 8,186,933  
  595    
FTSE 100
  December 2011     51,495,162       3,798,210  
  102    
CAC 40
  December 2011     4,333,353       176,403  
       
 
               
       
 
      $ 122,385,381     $ 12,161,546  
       
 
               
       
 
                   
Sales  
 
                   
  77    
FTSE/MIB
  December 2011   $ 7,927,149     $ (915,687 )
  446    
SPI 200
  December 2011     48,716,106       (1,686,399 )
       
 
               
       
 
      $ 56,643,255     $ (2,602,086 )
       
 
               
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.

 


 

Notes to Schedule of Investments:
FDR — Fiduciary Depositary Receipt
REIT — Real Estate Investment Trust
SDR — Swedish Depository Receipt
*      Non-income producing security.
Currency Abbreviations:
AUD — Australian Dollar
CAD — Canadian Dollar
CHF — Swiss Franc
DKK — Danish Krone
EUR — Euro
GBP — British Pound
HKD — Hong Kong Dollar
JPY — Japanese Yen
NOK — Norwegian Krone
NZD — New Zealand Dollar
SEK — Swedish Krona
SGD — Singapore Dollar
USD — United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                         
    Gross   Gross   Net Unrealized
    Unrealized   Unrealized   Appreciation
Aggregate Cost   Appreciation   (Depreciation)   (Depreciation)
$2,621,664,582
  $212,791,591   $(262,090,796)   $(49,299,205)
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                           Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO U.S. Treasury Fund
  $ 52,104,025     $ 143,991,000     $ 131,171,000     $ 20,362     $ 2,934     $ 64,929,120  
 
                                   

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivatives contracts based on the creditworthiness of its counterparties. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below.
     
Security Type   Percentage of Net Assets of the Fund
Equity Securities
  91.4%
Futures Contracts
  0.4%
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include: fair value adjustments provided by an independent pricing service applied to equity securities (including the value of equity securities that

 


 

underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) due to market events that have occurred since the local market close but prior to the close of the NYSE.
Level 3 — Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Common Stocks
                               
Australia
  $     $ 119,978,425     $     $ 119,978,425  
Austria
          6,261,226             6,261,226  
Belgium
          8,669,911             8,669,911  
Canada
    99,053,573                   99,053,573  
Denmark
          37,764,481             37,764,481  
Finland
          12,832,811             12,832,811  
France
          169,312,845             169,312,845  
Germany
          204,955,946             204,955,946  
Greece
          2,034,155             2,034,155  
Hong Kong
          87,517,617             87,517,617  
Ireland
          7,948,622             7,948,622  
Italy
          9,201,853             9,201,853  
Japan
          518,209,513             518,209,513  
Netherlands
          54,055,722             54,055,722  
New Zealand
    1,980,193                   1,980,193  
Norway
          5,959,209             5,959,209  
Singapore
          55,984,442             55,984,442  
Spain
          32,861,337             32,861,337  
Sweden
          64,505,145             64,505,145  
Switzerland
          254,138,393             254,138,393  
United Kingdom
          694,340,810             694,340,810  
 
                       
TOTAL COMMON STOCKS
    101,033,766       2,346,532,463             2,447,566,229  
 
                       
Preferred Stocks
                               
Germany
          23,052,233             23,052,233  
 
                       
TOTAL PREFERRED STOCKS
          23,052,233             23,052,233  
 
                       
RIGHTS AND WARRANTS
                               
Australia
          12,370             12,370  
Canada
          37,950             37,950  
 
                       
Total RIGHTS AND WARRANTS
          50,320             50,320  
 
                       
Mutual Funds
                               
United States
    64,929,120                   64,929,120  
 
                       
TOTAL MUTUAL FUNDS
    64,929,120                   64,929,120  
 
                       
Short-Term Investments
    36,767,475                   36,767,475  
 
                       
Total Investments
    202,730,361       2,369,635,016             2,572,365,377  
 
                       
Derivatives*
                               
Forward Currency Contracts
                               
Foreign currency risk
          2,751,161             2,751,161  
Futures Contracts
                               
Equity risk
          12,161,546             12,161,546  
 
                       
Total Derivatives
          14,912,707             14,912,707  
 
                       
Total
  $ 202,730,361     $ 2,384,547,723     $     $ 2,587,278,084  
 
                       
LIABILITY VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Liabilities     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Derivatives*
                               
Forward Currency Contracts
                               
Foreign currency risk
  $     $ (3,930,453 )   $     $ (3,930,453 )
Futures Contracts
                               
Equity risk
          (2,602,086 )           (2,602,086 )
 
                       
Total Derivatives
          (6,532,539 )           (6,532,539 )
 
                       
Total
  $     $ (6,532,539 )   $     $ (6,532,539 )
 
                       

 


 

The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
 
*   Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011 whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. The Fund may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Because the Fund normally does not take temporary defensive positions, declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to

 


 

be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Leveraging Risk — The Fund’s use of derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies or in industries with high positive correlations to one another creates additional risk.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Among other trading agreements, the Fund is party to International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Agreements”) or other similar types of agreements with selected counterparties that generally govern over-the-counter derivative transactions entered into by the Fund. The ISDA Agreements typically include representations and warranties as well as contractual terms related to collateral, events of default, termination events, and other provisions. Termination events may include the decline in the net assets of the Fund below a certain level over a specified period of time and entitle a counterparty to elect to terminate early with respect to some or all the transactions under the ISDA Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse effect on the Fund’s operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. For example, the Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives, to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives. The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For example, if the Fund holds a large proportion of stocks of companies in a particular sector and the Manager believes that stocks of companies in another

 


 

sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index). In adjusting its investment exposure, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net long exposures in excess of its net assets. The Fund’s foreign currency exposure may differ significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives

 


 

transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most forward currency contracts are not collateralized. During the period ended November 30, 2011, the Fund used forward currency contracts to manage against anticipated currency exchange rate changes and adjust exposure to foreign currencies. Forward currency contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded (unless otherwise adjusted due to the time at which foreign markets close). The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. During the period ended November 30, 2011, the Fund used futures contracts to adjust exposure to certain securities markets and maintain the diversity and liquidity of the portfolio. Futures contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.

 


 

Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses on the Statement of Operations. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses in the Statement of Operations.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers (unless otherwise adjusted due to the time at which foreign markets close) and records the change in value, if any, as unrealized gain or loss in the Statement of Operations. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services

 


 

firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. During the period ended November 30, 2011, the Fund held rights and/or warrants received as a result of corporate actions. Rights and/or warrants held by the Fund at the end of the period are listed in the Fund’s Schedule of Investments.
 

 


 

The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Assets:
                                               
Investments, at value (rights and/or warrants)
  $     $     $     $ 50,320     $     $ 50,320  
Unrealized appreciation on forward currency contracts
          2,751,161                         2,751,161  
Unrealized appreciation on futures contracts*
                      12,161,546             12,161,546  
 
                                   
Total
  $     $ 2,751,161     $     $ 12,211,866     $     $ 14,963,027  
 
                                   
 
                                               
Liabilities:
                                               
Unrealized depreciation on forward currency contracts
  $     $ (3,930,453 )   $     $     $     $ (3,930,453 )
Unrealized depreciation on futures contracts*
                      (2,602,086 )           (2,602,086 )
 
                                   
Total
  $     $ (3,930,453 )   $     $ (2,602,086 )   $     $ (6,532,539 )
 
                                   
 
*   The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of futures contracts as reported in the Schedule of Investments.
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts, futures contracts and rights and/or warrants) outstanding at each month-end, was as follows for the period ended November 30, 2011:
                           
    Forward        
    Currency   Futures   Rights and/or
    Contracts   Contracts   Warrants
Average amount outstanding
  $ 700,896,661     $ 260,301,637     $ 131,826  

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO International Intrinsic Value Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares     Description   Value ($)  
 
       
COMMON STOCKS — 94.2%
       
       
 
       
       
Australia — 4.6%
       
  204,280    
BHP Billiton Ltd
    7,653,692  
  4,906,332    
BlueScope Steel Ltd
    2,000,871  
  1,910,199    
Charter Hall Office (REIT)
    6,861,157  
  412,473    
Commonwealth Bank of Australia
    20,654,249  
  7,831,544    
Dexus Property Group (REIT)
    7,084,722  
  7,260,431    
Goodman Group (REIT)
    4,573,936  
  3,060,505    
GPT Group (REIT)
    10,043,767  
  8,221,532    
Investa Office Fund (REIT)
    5,126,424  
  879,555    
Macquarie Atlas Roads Group *
    1,261,474  
  7,500,352    
Mirvac Group (REIT)
    10,024,223  
  659,398    
National Australia Bank Ltd
    16,511,043  
  4,632,663    
Pacific Brands Ltd
    2,583,209  
  2,848,070    
QBE Insurance Group Ltd
    40,794,612  
  1,400,092    
Resolute Mining Ltd *
    2,913,634  
  5,525,670    
Stockland (REIT)
    19,807,113  
  2,262,015    
TABCORP Holdings Ltd
    6,712,924  
  1,126,117    
Tatts Group Ltd
    2,709,191  
  16,850,389    
Telstra Corp Ltd
    55,364,904  
  684,056    
Wesfarmers Ltd
    21,963,888  
  2,017,905    
Westpac Banking Corp
    44,085,178  
  1,509    
Woodside Petroleum Ltd
    52,601  
       
 
     
       
Total Australia
    288,782,812  
       
 
     
       
 
       
       
Austria — 0.7%
       
  66,623    
Andritz AG
    5,882,612  
  1,167,625    
Immofinanz AG (Entitlement Shares) *
     
  671,050    
OMV AG
    22,284,464  
  206,242    
Raiffeisen International Bank Holding
    4,902,781  
  337,435    
Voestalpine AG
    9,812,762  
       
 
     
       
Total Austria
    42,882,619  
       
 
     
       
 
       
       
Belgium — 0.4%
       
  2,767,178    
Ageas
    4,880,086  
  328,465    
Belgacom SA
    10,431,008  
  55,449    
Colruyt SA
    2,099,913  
  103,283    
KBC Groep NV
    1,156,975  
  65,258    
Mobistar SA
    3,568,465  
  37,341    
Solvay SA
    3,505,096  
       
 
     
       
Total Belgium
    25,641,543  
       
 
     
       
 
       
       
Canada — 4.3%
       
  188,400    
Alimentation Couche Tard Inc
    5,412,148  
  197,000    
Bank of Montreal
    11,523,134  
  535,300    
BCE Inc
    20,993,186  
  741,200    
Canadian Natural Resources Ltd
    27,839,965  
  295,000    
Canadian Oil Sands Ltd
    6,203,981  
  103,500    
Canadian Tire Corp Ltd
    6,555,321  
  87,900    
Canadian Western Bank
    2,372,555  
  235,800    
Canadian National Railway Co
    18,233,782  
  116,400    
Canadian Pacific Railway Ltd
    7,014,014  
  132,900    
Enbridge Inc
    4,709,060  
  1,247,400    
EnCana Corp
    25,132,673  
  473,300    
First Quantum Minerals Ltd
    9,559,273  
  615,700    
Husky Energy Inc
    15,332,889  
  162,700    
IGM Financial Inc
    6,908,708  

 


 

                 
  943,400    
Manulife Financial Corp
    10,165,171  
  177,500    
Methanex Corp
    4,350,703  
  173,900    
Metro Inc Class A
    8,789,200  
  115,000    
National Bank of Canada
    7,479,876  
  662,921    
Precision Drilling Corp *
    7,662,962  
  899,000    
Research In Motion Ltd *
    16,200,422  
  269,800    
RONA Inc
    2,454,771  
  259,000    
Shoppers Drug Mart Corp
    10,779,499  
  292,700    
Suncor Energy Inc
    8,815,867  
  1,147,600    
Sun Life Financial Inc
    20,770,328  
  262,500    
Yamana Gold Inc
    4,426,688  
       
 
     
       
Total Canada
    269,686,176  
       
 
     
       
 
       
       
Denmark — 0.2%
       
  10,789    
Greentech Energy Systems A/S *
    40,606  
  88,804    
Novo-Nordisk A/S Class B
    10,081,056  
  154,730    
Pandora A/S
    1,611,941  
       
 
     
       
Total Denmark
    11,733,603  
       
 
     
       
 
       
       
Finland — 0.5%
       
  4,314,125    
Nokia Oyj
    24,933,895  
  186,674    
Sampo Oyj Class A
    4,876,512  
  37,913    
Stockmann Oyj ABP A Shares
    734,717  
  82,652    
Tieto Oyj
    1,276,359  
       
 
     
       
Total Finland
    31,821,483  
       
 
     
       
 
       
       
France — 13.0%
       
  653,722    
Air France–KLM *
    3,809,468  
  1,928,994    
Alcatel-Lucent *
    3,228,369  
  178,036    
APERAM
    2,872,220  
  101,723    
Arkema
    7,409,929  
  596,677    
BNP Paribas
    23,752,553  
  14,541    
Bongrain SA
    874,356  
  105,595    
Bouygues SA
    3,441,742  
  15,686    
Casino Guichard-Perrachon SA
    1,395,931  
  106,196    
CNP Assurances
    1,429,313  
  235,915    
Compagnie de Saint-Gobain
    10,003,481  
  107,187    
Compagnie Generale des Etablissements Michelin-Class B
    6,832,984  
  51,407    
Dassault Systemes SA
    4,209,150  
  100,870    
Essilor International SA
    7,210,783  
  280,365    
European Aeronautic Defense and Space Co NV
    8,411,461  
  50,797    
Eutelsat Communications
    1,973,892  
  1,531,474    
France Telecom SA
    26,434,076  
  3,499    
Fromageries Bel
    801,540  
  217,371    
Lagardere SCA
    5,293,785  
  57,516    
LVMH Moet Hennessy Louis Vuitton SA
    9,056,022  
  564,595    
PagesJaunes Groupe
    1,961,977  
  399,782    
Peugeot SA
    7,485,236  
  18,372    
PPR
    2,753,132  
  379,403    
Renault SA
    14,216,397  
  181,199    
Safran SA
    5,376,647  
  3,907,574    
Sanofi
    273,319,180  
  74,116    
Schneider Electric SA
    4,214,527  
  102,016    
SES SA Class A FDR
    2,514,194  
  436,874    
Societe Generale
    10,673,845  
  30,971    
Sodexo
    2,252,500  
  501,096    
Technicolor *
    833,839  
  63,033    
Technip SA
    6,005,622  
  5,476,084    
Total SA
    282,525,238  

 


 

                 
  43,651    
Unibail-Rodamco (REIT)
    8,137,083  
  100,885    
Valeo SA
    4,467,185  
  149,289    
Vinci SA
    6,674,101  
  1,645,512    
Vivendi SA
    37,955,465  
  69,070    
Wendel
    4,976,510  
  27,234    
Zodiac Aerospace
    2,238,093  
       
 
     
       
Total France
    807,021,826  
       
 
     
       
 
       
       
Germany — 6.1%
       
  279,923    
Aareal Bank AG *
    5,069,761  
  114,921    
Adidas AG
    8,104,323  
  196,356    
Aurubis AG
    11,204,714  
  609,516    
BASF AG
    44,527,223  
  155,127    
Bayerische Motoren Werke AG
    11,759,722  
  29,041    
Beiersdorf AG
    1,663,686  
  53,718    
Bilfinger & Berger SE
    4,907,442  
  2,934,670    
Commerzbank AG *
    5,515,788  
  68,390    
Continental AG *
    4,855,630  
  498,428    
Deutsche Post AG (Registered)
    7,533,938  
  5,560,736    
E.ON AG
    137,648,723  
  63,200    
Fraport AG
    3,599,336  
  82,055    
Fresenius Medical Care AG & Co
    5,625,323  
  96,327    
Fresenius SE & Co KGaA
    9,277,061  
  234,336    
GEA Group AG
    6,936,411  
  170,103    
Gildemeister AG *
    2,322,352  
  603,565    
Heidelberger Druckmaschinen AG *
    1,196,625  
  925,062    
Infineon Technologies AG
    7,690,131  
  30,663    
Lanxess AG
    1,720,108  
  179,719    
Leoni AG
    6,687,816  
  53,453    
Linde AG
    8,237,694  
  56,724    
Merck KGaA
    5,646,301  
  61,088    
MTU Aero Engines Holding AG
    3,923,934  
  11,545    
Puma AG Rudolf Dassler Sport
    3,646,683  
  638,855    
RWE AG
    26,483,281  
  99,772    
Salzgitter AG
    5,179,928  
  226,112    
SAP AG
    13,539,441  
  97,401    
Siemens AG (Registered)
    9,856,900  
  189,092    
Suedzucker AG
    6,023,974  
  112,235    
ThyssenKrupp AG
    2,899,024  
  41,675    
Volkswagen AG
    6,347,334  
       
 
     
       
Total Germany
    379,630,607  
       
 
     
       
 
       
       
Greece — 0.3%
       
  439,940    
EFG Eurobank Ergasias *
    283,486  
  1,751,518    
National Bank of Greece SA *
    4,665,104  
  1,048,216    
OPAP SA
    9,405,040  
  1,911,055    
Piraeus Bank SA *
    749,820  
  440,336    
Public Power Corp SA
    2,515,576  
       
 
     
       
Total Greece
    17,619,026  
       
 
     
       
 
       
       
Hong Kong — 1.1%
       
  2,428,598    
CLP Holdings Ltd
    21,627,911  
  4,272,690    
Esprit Holdings Ltd
    6,166,574  
  55,000    
Guoco Group
    517,604  
  71,500    
Hong Kong Aircraft Engineering Co Ltd
    931,103  
  540,700    
Hong Kong Ferry Co Ltd
    428,284  
  6,582,983    
Hong Kong & China Gas
    15,243,768  
  7,622,000    
Pacific Basin Shipping Ltd
    3,412,208  
  1,259,969    
Power Assets Holdings Ltd
    9,440,599  

 


 

                 
  1,202,000    
SJM Holdings Ltd
    2,087,577  
  331,000    
Swire Pacific Ltd
    4,040,695  
  2,168,400    
Yue Yuen Industrial Holdings
    6,248,855  
       
 
     
       
Total Hong Kong
    70,145,178  
       
 
     
       
 
       
       
Ireland — 0.7%
       
  803,758    
C&C Group Plc
    3,292,895  
  875,728    
CRH Plc
    16,718,233  
  211,452    
DCC Plc
    5,119,422  
  547,037    
Greencore Group Plc
    542,387  
  1,492,286    
Irish Life & Permanent Group Holdings Plc *
    64,509  
  191,572    
Kerry Group Plc Class A
    7,154,607  
  212,731    
Kingspan Group Plc
    1,898,759  
  119,273    
Paddy Power Plc
    6,475,943  
  336,350    
Smurfit Kappa Group Plc *
    2,037,057  
       
 
     
       
Total Ireland
    43,303,812  
       
 
     
       
 
       
       
Israel — 0.1%
       
  1,042,805    
Bezeq Israeli Telecommunication Corp Ltd
    1,970,918  
  206,569    
Discount Investment Corp (Registered)
    1,480,238  
  208,096    
Mizrahi Tefahot Bank Ltd
    1,722,597  
  330,942    
Partner Communications Co Ltd
    3,184,516  
       
 
     
       
Total Israel
    8,358,269  
       
 
     
       
 
       
       
Italy — 6.0%
       
  1,113,746    
A2A SPA
    1,167,046  
  4,622,432    
Banca Monte dei Paschi di Siena SPA
    1,553,144  
  2,974,107    
Banco Popolare Scarl
    3,573,926  
  645,560    
Campari
    4,616,400  
  633,704    
CIR-Compagnie Industriali Riunite SPA
    1,084,120  
  25,525,138    
Enel SPA
    108,760,082  
  6,947,835    
ENI SPA
    147,143,211  
  61,811    
Exor SPA
    1,314,886  
  1,792,604    
Finmeccanica SPA
    7,777,142  
  712,561    
Fondiaria–Sai SPA *
    962,119  
  201,979    
Indesit Company SPA
    1,076,937  
  3,349,671    
Intesa San Paolo
    5,563,704  
  212,430    
Italcementi SPA-Di RISP
    582,406  
  1,264,372    
Mediaset SPA
    3,737,647  
  2,518,606    
Milano Assicurazioni SPA *
    849,153  
  94,800    
Natuzzi SPA ADR *
    223,728  
  573,594    
Parmalat SPA
    1,165,476  
  615,861    
Pirelli & C SPA
    5,826,346  
  443,475    
Recordati SPA
    3,407,112  
  182,832    
Saipem SPA
    8,180,708  
  1,166,964    
Snam Rete Gas SPA
    5,417,562  
  22,963,148    
Telecom Italia SPA
    25,997,154  
  20,569,668    
Telecom Italia SPA-Di RISP
    20,098,837  
  1,479,342    
Terna SPA
    5,308,328  
  32,718    
Tod’s SPA
    3,047,245  
  4,970,516    
UniCredit SPA
    5,191,155  
       
 
     
       
Total Italy
    373,625,574  
       
 
     
       
 
       
       
Japan — 23.7%
       
  2,529    
Advance Residence Investment Corp (REIT)
    4,718,503  
  1,583,500    
Aeon Co Ltd
    21,637,810  
  320,800    
Aeon Credit Service Co Ltd
    4,922,476  
  1,865,900    
Aiful Corp *
    2,706,938  
  305,000    
Ajinomoto Co Inc
    3,653,517  

 


 

                 
  146,100    
Alfresa Holdings Corp
    5,388,923  
  761,329    
Alps Electric Co Ltd
    5,330,139  
  393,000    
Anritsu Corp
    4,437,946  
  971,000    
Aozora Bank Ltd
    2,601,146  
  140,500    
Asahi Breweries Ltd
    3,118,562  
  705,100    
Astellas Pharma Inc
    27,179,081  
  586,100    
Bridgestone Corp
    13,581,135  
  763,000    
Calsonic Kansei Corp
    4,404,521  
  123,500    
Canon Inc
    5,540,484  
  113,100    
Capcom
    2,901,124  
  505    
Central Japan Railway Co
    4,046,348  
  749,000    
Chiba Bank Ltd
    4,885,489  
  211,000    
Chiyoda Corp
    2,331,135  
  142,500    
Circle K Sunkus Co Ltd
    2,323,911  
  2,767,000    
Cosmo Oil Co Ltd
    7,651,981  
  185,400    
Credit Saison Co Ltd
    3,394,952  
  1,000    
CyberAgent Inc
    3,319,547  
  492,200    
Daiei Inc *
    1,788,851  
  216,000    
Daihatsu Motor Co Ltd
    3,784,448  
  3,506,000    
Daikyo Inc *
    6,775,037  
  481,600    
Daito Trust Construction Co Ltd
    42,953,463  
  264,500    
Dena Co Ltd
    8,211,365  
  1,192,000    
DIC Corp
    2,012,974  
  860    
Digital Garage Inc *
    2,809,369  
  186,300    
Don Quijote Co Ltd
    6,421,016  
  603,300    
Eisai Co Ltd
    23,291,313  
  228,200    
Electric Power Development Co Ltd
    5,758,355  
  29,600    
Fanuc Ltd
    4,863,236  
  50,100    
Fast Retailing Co Ltd
    8,130,059  
  661,000    
Fuji Electric Co Ltd
    1,955,186  
  523,000    
Fuji Heavy Industries Ltd
    3,022,828  
  265,300    
Fuji Oil Co Ltd
    3,797,576  
  850,000    
Gunze Ltd
    2,447,249  
  61,600    
Hamamatsu Photonics KK
    2,269,339  
  865,000    
Hanwa Co Ltd
    3,749,875  
  9,378,500    
Haseko Corp *
    6,076,936  
  128,800    
Hikari Tsushin Inc
    3,274,700  
  2,941,694    
Hitachi Ltd
    16,323,196  
  130,500    
Honda Motor Co Ltd
    4,141,334  
  251,100    
Hosiden Corp
    1,768,067  
  2,301    
INPEX Corp
    15,533,772  
  2,514,800    
Itochu Corp
    25,556,380  
  5,064    
Japan Retail Fund Investment Corp (REIT)
    7,744,470  
  857,100    
JFE Holdings Inc
    15,776,654  
  263,000    
JGC Corp
    6,628,421  
  60,900    
JS Group Corp
    1,154,986  
  145,000    
JTEKT Corp
    1,430,105  
  519,200    
JVC Kenwood Holdings Inc *
    2,185,848  
  7,384,390    
JX Holdings Inc
    46,961,924  
  460,100    
K’s Holdings Corp
    18,135,650  
  4,524,993    
Kajima Corp
    13,626,439  
  988,700    
Kao Corp
    26,165,471  
  2,982,000    
Kawasaki Kisen Kaisha Ltd
    5,184,889  
  9,611    
KDDI Corp
    63,680,544  
  607,000    
Kinugawa Rubber Industrial Co Ltd
    5,462,045  
  4,934,000    
Kobe Steel Ltd
    7,878,761  
  388,300    
Komatsu Ltd
    9,937,305  
  260,000    
Konami Corp
    7,820,144  
  113,000    
Krosaki Harima Corp
    381,115  
  178,000    
KYB Co Ltd
    852,802  

 


 

                 
  291,000    
Kyowa Exeo Corp
    2,827,350  
  186,400    
Lawson Inc
    11,039,110  
  1,582,200    
Leopalace21 Corp *
    3,652,189  
  277,000    
Makino Milling Machine Co Ltd
    1,951,105  
  95,900    
Makita Corp
    3,354,843  
  2,169,000    
Marubeni Corp
    13,399,490  
  3,095,000    
Mazda Motor Corp *
    5,644,461  
  28,100    
Miraca Holdings Inc
    1,079,060  
  4,380,000    
Mitsubishi Chemical Holdings Corp
    25,445,330  
  358,200    
Mitsubishi Corp
    7,405,221  
  536,000    
Mitsubishi Electric Corp
    5,074,018  
  361,000    
Mitsubishi Gas Chemical Co Inc
    2,149,802  
  1,727,000    
Mitsubishi Heavy Industries Ltd
    7,251,520  
  191,080    
Mitsubishi UFJ Lease & Finance Co Ltd
    7,315,330  
  2,092,000    
Mitsui Chemicals Inc
    6,802,073  
  1,706,000    
Mitsui Engineer & Shipbuilding Co Ltd
    2,619,739  
  562,100    
Mitsui & Co Ltd
    8,868,750  
  3,306,000    
Mitsui Mining & Smelting Co Ltd
    8,566,375  
  2,937,000    
Mitsui OSK Lines Ltd
    9,336,310  
  22,092,500    
Mizuho Financial Group Inc
    29,083,221  
  187,000    
Nabtesco Corp
    4,118,032  
  112,000    
Nachi-Fujikoshi Corp
    527,053  
  192,200    
Namco Bandai Holdings Inc
    2,771,112  
  2,110    
Net One Systems Co Ltd
    5,443,133  
  76,500    
Nichicon Corp
    817,871  
  1,113,000    
Nichirei Corp
    5,190,355  
  126,600    
Nikon Corp
    2,964,272  
  70,600    
Nintendo Co Ltd
    10,747,958  
  675,000    
Nippon Chemi-Con Corp
    2,500,958  
  4,478,000    
Nippon Light Metal Co Ltd
    5,953,092  
  180,700    
Nippon Paper Group Inc
    3,873,354  
  7,322,000    
Nippon Steel Corp
    17,774,497  
  1,419,900    
Nippon Telegraph & Telephone Corp
    70,027,298  
  3,680,000    
Nippon Yusen Kabushiki Kaisha
    8,197,727  
  436,000    
Nipro Corp
    3,557,285  
  1,271,900    
Nissan Motor Co Ltd
    11,680,254  
  742,000    
Nisshinbo Holdings Inc
    6,280,797  
  98,750    
Nitori Holdings Co Ltd
    9,230,656  
  111,600    
Nitto Denko Corp
    4,638,861  
  19,534    
NTT Docomo Inc
    34,527,240  
  1,061,247    
Obayashi Corp
    4,461,086  
  524,000    
OJI Paper Co Ltd
    2,612,011  
  49,200    
Okinawa Electric Power Co
    2,095,251  
  533,000    
OKUMA Corp
    4,092,254  
  61,500    
Ono Pharmaceutical Co Ltd
    3,204,093  
  117,110    
ORIX Corp
    9,881,144  
  767    
ORIX JREIT Inc (REIT)
    3,240,694  
  2,298,000    
Osaka Gas Co Ltd
    8,766,969  
  650,000    
Pacific Metals Co Ltd
    3,322,813  
  1,232,500    
Penta Ocean Construction Co Ltd
    3,890,091  
  146,040    
Point Inc
    6,072,060  
  660,350    
Promise Co Ltd *
    6,887,744  
  8,112,700    
Resona Holdings Inc
    36,336,314  
  540,000    
Ricoh Company Ltd
    4,866,326  
  846,000    
Round One Corp
    5,055,132  
  135,000    
Ryohin Keikaku Co Ltd
    6,142,366  
  104,000    
Saizeriya Co Ltd
    1,705,197  
  242,600    
Sankyo Co Ltd
    12,126,594  
  1,183,500    
Sapporo Hokuyo Holdings Inc
    4,120,277  
  90,100    
Secom Co Ltd
    4,063,608  

 


 

                 
  284,400    
Sega Sammy Holdings Inc
    5,816,015  
  398,000    
Seino Holdings Co Ltd
    2,891,579  
  284,700    
Seven & I Holdings Co Ltd
    7,948,962  
  80,200    
Shimamura Co Ltd
    7,622,850  
  670,000    
Shizuoka Bank Ltd (The)
    6,945,801  
  978,600    
Showa Shell Sekiyu KK
    6,551,498  
  5,375,900    
Sojitz Corp
    8,435,753  
  205,080    
Sumisho Computer Systems Corp
    3,341,154  
  3,161,200    
Sumitomo Corp
    42,195,863  
  383,000    
Sumitomo Metal Mining Co Ltd
    5,167,954  
  97,700    
Sumitomo Mitsui Financial Group Inc
    2,717,494  
  468,000    
Sumitomo Osaka Cement Co Ltd
    1,360,207  
  164,200    
Sumitomo Rubber Industries
    1,969,505  
  5,850,716    
Taiheiyo Cement Co Ltd
    11,365,698  
  4,649,000    
Taisei Corp
    12,048,958  
  482,000    
Takashimaya Co Ltd
    3,434,667  
  2,131,600    
Takeda Pharmaceutical Co Ltd
    87,553,287  
  419,650    
Takefuji Corp (a) (b)
    5,411  
  1,087,000    
Toho Zinc Co Ltd
    4,395,086  
  138,100    
Tokai Rika Co Ltd
    2,142,688  
  2,585,000    
Tokyo Tatemono Co Ltd
    7,569,359  
  471    
Tokyu REIT Inc (REIT)
    2,148,874  
  628,000    
TonenGeneral Sekiyu KK
    7,162,190  
  2,044,000    
Toray Industries Inc
    15,323,694  
  2,712,000    
Tosoh Corp
    7,936,524  
  655,000    
Toyo Engineering Corp
    2,401,686  
  77,000    
Toyo Suisan Kaisha Ltd
    1,894,651  
  347,200    
Toyota Motor Corp
    11,433,479  
  771,300    
Toyota Tsusho Corp
    12,978,315  
  71,800    
Trend Micro Inc
    2,204,140  
  1,031,000    
Ube Industries Ltd
    2,916,819  
  100,100    
Unicharm Corp
    4,748,146  
  1,155    
United Urban Investment Corp (REIT)
    1,232,906  
  1,217,200    
UNY Co Ltd
    11,178,455  
  85,190    
USS Co Ltd
    7,407,367  
  106,934    
West Japan Railway Co
    4,414,241  
  19,714    
Yahoo Japan Corp
    6,246,725  
  507,560    
Yamada Denki Co Ltd
    36,713,387  
  382,700    
Yamato Holdings Co Ltd
    6,145,548  
  146,100    
Yamato Kogyo Co Ltd
    4,047,356  
  410,000    
Yokohama Rubber Co Ltd
    2,278,988  
  270,000    
Zeon Corp
    2,295,818  
       
 
     
       
Total Japan
    1,479,017,389  
       
 
     
       
 
       
       
Malta — 0.0%
       
  15,984,486    
BGP Holdings Plc *
     
       
 
     
       
 
       
       
Netherlands — 1.2%
       
  176,239    
Aalberts Industries NV
    2,873,984  
  2,672,637    
Aegon NV *
    11,667,163  
  141,148    
CSM NV
    1,855,186  
  4,669,161    
ING Groep NV *
    36,415,614  
  1,238,093    
Koninklijke BAM Groep NV
    4,289,063  
  494,083    
Unilever NV
    16,828,391  
       
 
     
       
Total Netherlands
    73,929,401  
       
 
     
       
 
       
       
New Zealand — 0.5%
       
  2,283,832    
Chorus Ltd *
    5,867,156  
  1,444,281    
Fletcher Building Ltd
    6,835,209  

 


 

                 
  843,391    
Sky City Entertainment Group Ltd
    2,261,924  
  11,419,160    
Telecom Corp of New Zealand
    18,100,800  
       
 
     
       
Total New Zealand
    33,065,089  
       
 
     
       
 
       
       
Norway — 0.2%
       
  160,122    
DnB NOR ASA
    1,637,475  
  278,030    
Frontline Ltd
    832,550  
  1,547,307    
Golden Ocean Group Ltd
    1,127,640  
  273,467    
Telenor ASA
    4,678,651  
  210,496    
TGS Nopec Geophysical Co ASA
    4,683,681  
       
 
     
       
Total Norway
    12,959,997  
       
 
     
       
 
       
       
Portugal — 0.1%
       
  390,104    
Banco Espirito Santo SA
    600,412  
  2,339,031    
EDP — Energias de Portugal SA
    7,496,754  
       
 
     
       
Total Portugal
    8,097,166  
       
 
     
       
 
       
       
Singapore — 1.8%
       
  3,092,000    
CapitaCommercial Trust (REIT)
    2,628,715  
  4,728,000    
Ezra Holdings Ltd
    3,343,922  
  36,436,000    
Golden Agri-Resources Ltd
    20,580,619  
  2,489,000    
Ho Bee Investment Ltd
    2,369,907  
  4,037,000    
Jaya Holdings Ltd *
    1,526,938  
  870,500    
Keppel Corp Ltd
    6,466,388  
  3,863,000    
Midas Holdings Ltd
    1,066,232  
  487,777    
Oversea-Chinese Banking Corp Ltd
    3,107,212  
  2,183,100    
SembCorp Industries Ltd
    7,343,341  
  1,249,000    
SembCorp Marine Ltd
    3,755,890  
  1,161,000    
Singapore Exchange Ltd
    5,703,812  
  2,840,000    
Singapore Press Holdings Ltd
    8,767,329  
  2,202,000    
Singapore Technologies Engineering Ltd
    4,664,701  
  12,711,000    
Singapore Telecommunications
    30,982,756  
  188,000    
Suntec Real Estate Investment Trust (REIT)
    168,711  
  4,499,000    
Swiber Holdings Ltd *
    1,883,448  
  188,000    
United Overseas Bank Ltd
    2,279,437  
  440,000    
Venture Corp Ltd
    2,276,323  
       
 
     
       
Total Singapore
    108,915,681  
       
 
     
       
 
       
       
Spain — 5.1%
       
  36,898    
Acciona SA
    3,431,926  
  2,005,623    
Banco Bilbao Vizcaya Argentaria SA
    16,894,822  
  4,037,366    
Banco Popular Espanol SA
    17,240,542  
  6,258,056    
Banco Santander SA
    46,974,403  
  439,930    
Ferrovial SA
    5,455,463  
  221,960    
Fomento de Construcciones y Contratas SA
    5,744,760  
  1,689,648    
Gas Natural SDG SA
    29,414,732  
  343,458    
Grifols SA *
    5,553,359  
  3,726,492    
Iberdrola SA
    24,832,905  
  141,766    
Inditex SA
    12,054,807  
  354,812    
Jazztel Plc *
    1,974,557  
  1,598,536    
Mapfre SA
    5,351,016  
  181,789    
Red Electrica de Espana
    7,991,347  
  1,645,741    
Repsol YPF SA
    49,686,495  
  4,500,751    
Telefonica SA
    84,516,681  
       
 
     
       
Total Spain
    317,117,815  
       
 
     
       
 
       
       
Sweden — 0.6%
       
  603,451    
Ericsson LM B Shares
    6,437,744  

 


 

                 
  748,219    
Investor AB B Shares
    13,955,407  
  23,751    
Millicom International Cellular SA SDR
    2,580,772  
  95,699    
NCC Class B
    1,559,401  
  526,828    
Swedbank AB Class A
    7,047,868  
  69,636    
Swedish Match AB
    2,284,130  
       
 
     
       
Total Sweden
    33,865,322  
       
 
     
       
 
       
       
Switzerland — 2.8%
       
  709,441    
Nestle SA (Registered)
    39,815,806  
  2,058,427    
Novartis AG (Registered)
    111,163,802  
  129,156    
Roche Holding AG (Non Voting)
    20,545,399  
  12,550    
Syngenta AG (Registered) *
    3,693,129  
       
 
     
       
Total Switzerland
    175,218,136  
       
 
     
       
 
       
       
United Kingdom — 20.2%
       
  783,918    
Amlin Plc
    4,140,004  
  708,673    
Ashtead Group Plc
    2,064,466  
  4,163,970    
AstraZeneca Plc
    191,783,119  
  3,022,756    
Aviva Plc
    14,836,732  
  6,468,593    
BAE Systems Plc
    27,926,829  
  1,202,092    
Balfour Beatty Plc
    4,758,971  
  17,334,880    
Barclays Plc
    49,937,017  
  698,977    
Barratt Developments Plc *
    1,098,855  
  1,314,778    
BG Group Plc
    28,200,444  
  85,334    
BHP Billiton Plc
    2,624,218  
  11,480,969    
BP Plc
    83,149,319  
  1,121,207    
British American Tobacco Plc
    52,031,921  
  14,542,913    
BT Group Plc
    43,518,495  
  175,911    
Bunzl Plc
    2,298,351  
  427,818    
Burberry Group Plc
    8,570,719  
  466,765    
Cape Plc
    2,394,800  
  764,134    
Catlin Group Ltd
    4,974,097  
  1,963,541    
Cobham Plc
    5,462,599  
  2,618,948    
Debenhams Plc
    2,624,383  
  199,563    
Diageo Plc
    4,274,245  
  10,488,127    
Dixons Retail Plc *
    1,862,571  
  1,721,792    
Drax Group Plc
    15,164,294  
  1,496,500    
FirstGroup Plc
    7,692,757  
  1,352,906    
Game Group Plc
    157,945  
  7,459,162    
GlaxoSmithKline Plc
    165,310,160  
  4,558,648    
Home Retail Group Plc
    6,443,887  
  530,457    
HSBC Holdings Plc
    4,137,804  
  232,780    
IMI Plc
    2,930,972  
  280,887    
Imperial Tobacco Group Plc
    10,105,473  
  1,398,037    
Inchcape Plc
    7,180,640  
  814,646    
Intermediate Capital Group Plc
    3,085,517  
  128,212    
Jardine Lloyd Thompson Group Plc
    1,337,956  
  180,870    
JD Wetherspoon Plc
    1,231,371  
  2,760,984    
Kesa Electricals Plc
    3,861,644  
  417,668    
Lancashire Holdings Ltd
    4,809,761  
  445,256    
Land Securities Group Plc (REIT)
    4,815,065  
  10,013,360    
Legal & General Group Plc
    16,726,976  
  24,918,432    
Lloyds Banking Group Plc *
    9,751,348  
  589,038    
Melrose Plc
    3,176,129  
  691,532    
Micro Focus International Plc
    3,943,858  
  591,268    
National Express Group Plc
    1,953,939  
  322,471    
Next Plc
    13,629,953  
  717,945    
Pearson Plc
    13,042,048  
  640,279    
Prudential Plc
    6,302,026  

 


 

                 
  2,198,990    
Punch Taverns Plc *
    416,076  
  103,497    
Reckitt Benckiser Group Plc
    5,250,685  
  404,072    
Rio Tinto Plc
    21,272,635  
  32,944,241    
Royal Bank of Scotland Group Plc *
    10,965,852  
  2,419,622    
Royal Dutch Shell Plc A Shares (London)
    84,625,279  
  3,312,251    
Royal Dutch Shell Plc B Shares (London)
    119,355,530  
  156,173    
SABMiller Plc
    5,514,092  
  1,274,767    
Sage Group Plc (The)
    5,825,941  
  657,542    
Scottish & Southern Energy Plc
    13,615,562  
  484,962    
Smith & Nephew Plc
    4,430,835  
  41,069    
Spirax-Sarco Engineering Plc
    1,232,860  
  2,198,990    
Spirit Pub Co Plc *
    1,371,373  
  394,626    
Standard Chartered Plc
    8,591,326  
  425,436    
Tate & Lyle Plc
    4,505,855  
  5,350,242    
Taylor Wimpey Plc *
    3,278,207  
  1,562,028    
TUI Travel Plc
    4,239,433  
  548,239    
United Utilities Group Plc
    5,427,373  
  34,706,712    
Vodafone Group Plc
    93,954,841  
  190,980    
Weir Group Plc (The)
    6,207,695  
  2,932,616    
William Hill Plc
    9,339,067  
       
 
     
       
Total United Kingdom
    1,254,744,195  
       
 
     
       
TOTAL COMMON STOCKS (COST $6,456,538,006)
    5,867,182,719  
       
 
     
       
 
       
       
PREFERRED STOCKS — 0.7%
       
       
 
       
       
Germany — 0.7%
       
  48,659    
Hugo Boss AG 2.95%
    4,429,730  
  502,825    
Porsche Automobil Holding SE 1.12%
    30,812,467  
  9,049    
Villeroy & Boch AG 3.22%
    75,223  
  62,985    
Volkswagen AG 1.74%
    10,883,578  
       
 
     
       
Total Germany
    46,200,998  
       
 
     
       
TOTAL PREFERRED STOCKS (COST $39,858,221)
    46,200,998  
       
 
     
       
 
       
       
RIGHTS/WARRANTS — 0.0%
       
       
 
       
       
Australia — 0.0%
       
  3,925,065    
BlueScope Steel Ltd, Expires 12/08/11*
    44,402  
       
 
     
       
TOTAL RIGHTS/WARRANTS (COST $780,398)
    44,402  
       
 
     
       
 
       
       
MUTUAL FUNDS — 1.0%
       
       
 
       
       
United States — 1.0%
       
       
 
       
       
Affiliated Issuers
       
  2,596,141    
GMO U.S. Treasury Fund
    64,929,485  
       
 
     
       
TOTAL MUTUAL FUNDS (COST $64,929,485)
    64,929,485  
       
 
     
                         
Par Value     Description   Value ($)  
 
               
SHORT-TERM INVESTMENTS — 2.6%
       
               
 
       
               
Time Deposits — 2.6%
       
USD     25,000,000    
Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11
    25,000,000  
USD     25,000,000    
Bank of Montreal Time Deposit, 0.03%, due 12/01/11
    25,000,000  
USD     25,000,000    
Barclays Plc Time Deposit, 0.12%, due 12/01/11
    25,000,000  
CHF     102,273    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.01%, due 12/01/11
    111,945  
DKK     48,084    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.14%, due 12/01/11
    8,689  

 


 

                         
NOK     58,531    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.95%, due 12/01/11
    10,134  
NZD     251,636    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 1.75%, due 12/01/11
    196,490  
HKD     3,462,083    
Citibank (New York) Time Deposit, 0.01%, due 12/01/11
    445,642  
JPY     128,862,160    
Citibank (New York) Time Deposit, 0.01%, due 12/01/11
    1,661,451  
SGD     565,957    
Citibank (New York) Time Deposit, 0.01%, due 12/01/11
    441,585  
USD     1,141,418    
Citibank (New York) Time Deposit, 0.03%, due 12/01/11
    1,141,418  
USD     25,000,000    
Deutsche Bank Time Deposit, 0.06%, due 12/01/11
    25,000,000  
USD     25,000,000    
HSBC Bank USA (Grand Cayman) Time Deposit, 0.05%, due 12/01/11
    25,000,000  
AUD     333,488    
JPMorgan Chase (New York) Time Deposit, 3.78%, due 12/01/11
    342,959  
CAD     231,086    
JPMorgan Chase (New York) Time Deposit, 0.25%, due 12/01/11
    226,566  
EUR     3,194,759    
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11
    4,292,798  
GBP     717,334    
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11
    1,125,426  
SEK     1,558,329    
JPMorgan Chase (New York) Time Deposit, 1.06%, due 12/01/11
    230,282  
USD     25,000,000    
Royal Bank of Canada (Grand Cayman) Time Deposit, 0.03%, due 12/01/11
    25,000,000  
               
 
     
               
Total Time Deposits
    160,235,385  
               
 
     
               
TOTAL SHORT-TERM INVESTMENTS (COST $160,235,385)
    160,235,385  
               
 
     
               
 
       
                TOTAL INVESTMENTS — 98.5%
(Cost $6,722,341,495)
    6,138,592,989  
 
               
Other Assets and Liabilities (net) — 1.5%
    92,617,629  
               
 
     
 
               
TOTAL NET ASSETS — 100.0%
  $ 6,231,210,618  
               
 
     

 


 

GMO International Intrinsic Value Fund
(A Series of GMO Trust)
Schedule of Investments — (Continued)
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
                                 
                            Net Unrealized  
Settlement           Units of             Appreciation  
Date   Counterparty   Deliver/Receive   Currency     Value     (Depreciation)  
Buys †
                               
12/16/11
  Bank of America, N.A.   AUD     11,006,486     $ 11,299,504     $ (62,623 )
12/16/11
  Brown Brothers Harriman & Co.   AUD     24,627,912       25,283,565       321,945  
12/16/11
  Brown Brothers Harriman & Co.   EUR     8,736,925       11,741,017       (58,105 )
12/16/11
  Brown Brothers Harriman & Co.   GBP     5,929,000       9,300,713       13,053  
12/16/11
  JPMorgan Chase Bank, N.A.   GBP     8,757,164       13,737,202       (16,800 )
12/16/11
  Morgan Stanley Capital Services Inc.   GBP     13,461,526       21,116,848       37,552  
12/16/11
  Royal Bank of Scotland PLC   GBP     8,757,164       13,737,202       36,663  
12/16/11
  State Street Bank and Trust Company   GBP     6,426,763       10,081,545       39,021  
12/16/11
  Barclays Bank PLC   HKD     186,164,043       23,964,666       17,596  
12/16/11
  Brown Brothers Harriman & Co.   HKD     331,552,057       42,680,284       18,826  
12/16/11
  Deutsche Bank AG   HKD     178,461,542       22,973,133       25,732  
12/16/11
  JPMorgan Chase Bank, N.A.   HKD     281,816,156       36,277,844       26,613  
12/16/11
  Morgan Stanley Capital Services Inc.   HKD     186,164,043       23,964,666       14,139  
12/16/11
  Royal Bank of Scotland PLC   HKD     107,737,008       13,868,851       (1,782 )
12/16/11
  State Street Bank and Trust Company   HKD     472,931,495       60,879,884       43,292  
12/16/11
  Bank of America, N.A.   SEK     109,985,898       16,240,975       (236,626 )
12/16/11
  Brown Brothers Harriman & Co.   SEK     109,985,898       16,240,975       (179,487 )
12/16/11
  Deutsche Bank AG   SEK     109,985,898       16,240,975       (195,322 )
12/16/11
  JPMorgan Chase Bank, N.A.   SEK     109,985,898       16,240,975       (123,982 )
12/16/11
  Bank of America, N.A.   SGD     27,006,408       21,071,922       (202,514 )
12/16/11
  Bank of New York Mellon   SGD     24,705,974       19,276,994       (95,105 )

 


 

                                 
12/16/11
  Barclays Bank PLC   SGD     25,820,548       20,146,648       (138,332 )
12/16/11
  Brown Brothers Harriman & Co.   SGD     24,203,129       18,884,646       (156,443 )
12/16/11
  JPMorgan Chase Bank N.A.   SGD     49,032,796       38,258,153       (208,295 )
12/16/11
  Morgan Stanley Capital Services Inc.   SGD     29,351,703       22,901,854       (178,283 )
12/16/11
  Royal Bank of Scotland PLC   SGD     38,527,603       30,061,409       34,215  
12/16/11
  State Street Bank and Trust Company   SGD     26,756,398       20,876,851       (161,527 )
 
                           
 
                  $ 597,349,301     $ (1,386,579 )
 
                           
Sales #
                               
12/16/11
  Barclays Bank PLC   CAD     23,391,692     $ 22,925,547     $ (32,466 )
12/16/11
  Brown Brothers Harriman & Co.   CAD     15,536,777       15,227,163       492  
12/16/11
  JPMorgan Chase Bank N.A.   CAD     21,501,595       21,073,115       (143,220 )
12/16/11
  Morgan Stanley Capital Services Inc.   CAD     21,746,534       21,313,173       11,829  
12/16/11
  Royal Bank of Scotland PLC   CAD     46,746,090       45,814,543       (187,190 )
12/16/11
  State Street Bank and Trust Company   CAD     28,194,946       27,633,083       (27,786 )
12/16/11
  Bank of America, N.A.   EUR     35,532,164       47,749,492       677,933  
12/16/11
  Brown Brothers Harriman & Co.   EUR     43,729,705       58,765,665       1,482,116  
12/16/11
  JPMorgan Chase Bank, N.A.   EUR     30,145,551       40,510,754       766,403  
12/16/11
  Morgan Stanley Capital Services Inc.   EUR     14,490,513       19,472,910       344,707  
12/16/11
  Royal Bank of Scotland PLC   EUR     8,195,742       11,013,754       182,351  
12/16/11
  State Street Bank and Trust Company   EUR     15,072,775       20,255,376       372,922  
12/16/11
  Barclays Bank PLC   JPY     1,175,265,449       15,158,058       170,426  
12/16/11
  Brown Brothers Harriman & Co.   JPY     2,148,008,999       27,704,077       311,849  
12/16/11
  Deutsche Bank, AG   JPY     627,002,545       8,086,803       87,830  
12/16/11
  JPMorgan Chase Bank, N.A.   JPY     2,036,666,897       26,268,035       284,948  
12/16/11
  Royal Bank of Scotland PLC   JPY     1,136,485,817       14,657,895       162,057  

 


 

                                 
12/16/11
  State Street Bank and Trust Company   JPY     1,059,992,400       13,671,316       146,321  
 
                           
 
                  $ 457,300,759     $ 4,611,522  
 
                           
 
  Fund buys foreign currency; sells USD.
 
#   Fund sells foreign currency; buys USD.
Futures Contracts
                         
                    Net Unrealized  
Number of       Expiration           Appreciation
Contracts   Type   Date   Value     (Depreciation)  
Buys
                       
401
  DAX   December 2011   $ 82,374,392     $ 11,629,690  
217
  FTSE 100   December 2011     18,780,589       (35,752 )
2,039
  FTSE/MIB   December 2011     209,915,037       20,692,654  
597
  IBEX 35   December 2011     67,857,838       1,439,599  
492
  MSCI Singapore   December 2011     24,100,459       852,677  
1,097
  TOPIX   December 2011     105,377,909       (658,479 )
 
                   
 
          $ 508,406,224     $ 33,920,389  
 
                   
Sales
                       
366
  Amesterdam IDX   December 2011   $ 29,644,133     $ (738,863 )
2,007
  OMXS 30   December 2011     29,342,701       (1,024,843 )
1,145
  S&P Toronto 60   December 2011     155,929,702       (1,781,565 )
1,374
  SPI 200   December 2011     150,080,560       (3,787,555 )
 
                   
 
          $ 364,997,096     $ (7,332,826 )
 
                   
Swap Agreements
Total Return Swaps
                                 
                            Net Unrealized  
Notional   Expiration                   Appreciation/  
Amount   Date   Counterparty   Fund Pays   Fund (Pays)/Receives     (Depreciation)  
1,339,625
  EUR   11/27/2012   Bank of America Merrill Lynch   3 Month Euribor Floating Rate minus 10.0%   Total Return on Alpha Bank A.E.   $ (2,487 )
946,168
  EUR   11/27/2012   Goldman Sachs International   1 Month Euribor Floating Rate minus 10.0%   Total Return on Dexia SA     (40,092 )
 
                         
 
                          $ (42,579 )
 
                       
 
                  Premiums to (Pay) Receive   $  
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
 
Notes to Schedule of Investments:
 
ADR — American Depositary Receipt
 
FDR — Fiduciary Depositary Receipt
 

 


 

REIT — Real Estate Investment Trust
 
SDR — Swedish Depository Receipt
 
*   Non-income producing security.
 
(a)    Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust.
 
(b)    Bankrupt issuer.
 
Currency Abbreviations:
 
AUD — Australian Dollar
 
CAD — Canadian Dollar
 
CHF — Swiss Franc
 
DKK — Danish Krone
 
EUR — Euro
 
GBP — British Pound
 
HKD — Hong Kong Dollar
 
JPY — Japanese Yen
 
NOK — Norwegian Krone
 
NZD — New Zealand Dollar
 
SEK — Swedish Krona
 
SGD — Singapore Dollar
 
USD — United States Dollar

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                         
    Gross     Gross     Net Unrealized  
    Unrealized     Unrealized     Appreciation  
Aggregate Cost   Appreciation     (Depreciation)     (Depreciation)  
$6,844,819,905
  $ 333,945,812     $ (1,040,172,728 )   $ (706,226,916 )
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO U.S. Treasury Fund
  $ 30,133,000     $ 91,849,000     $ 57,074,000     $ 20,926     $ 2,934     $ 64,929,485  
 
                                   

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented less than 0.1% of net assets. The Fund classifies such securities (levels defined below) as Level 3. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivatives contracts based on the creditworthiness of its counterparties. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below.
     
Security Type   Percentage of Net Assets of the Fund
Equity Securities
  90.2%
Futures Contracts
  0.5%
Swap Agreements
  (0.0)%^
 
^   Rounds to 0.0%.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:

 


 

Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include: fair value adjustments provided by an independent pricing service applied to equity securities (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) due to market events that have occurred since the local market close but prior to the close of the NYSE.
Level 3 — Valuations based primarily on inputs that are unobservable and significant. The Fund used the following fair value technique on Level 3 investments: The Fund considered certain bankrupt securities to be near worthless.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Common Stocks
                               
Australia
  $     $ 288,782,812     $     $ 288,782,812  
Austria
          42,882,619             42,882,619  
Belgium
          25,641,543             25,641,543  
Canada
    269,686,176                   269,686,176  
Denmark
          11,733,603             11,733,603  
Finland
          31,821,483             31,821,483  
France
          807,021,826             807,021,826  
Germany
          379,630,607             379,630,607  
Greece
          17,619,026             17,619,026  
Hong Kong
          70,145,178             70,145,178  
Ireland
    64,509       43,239,303             43,303,812  
Israel
          8,358,269             8,358,269  
Italy
    223,728       373,401,846             373,625,574  
Japan
          1,479,011,978       5,411       1,479,017,389  
Malta
          0 *           0  
Netherlands
          73,929,401             73,929,401  
New Zealand
    23,967,956       9,097,133             33,065,089  
Norway
          12,959,997             12,959,997  
Portugal
          8,097,166             8,097,166  
Singapore
          108,915,681             108,915,681  
Spain
          317,117,815             317,117,815  
Sweden
          33,865,322             33,865,322  
Switzerland
          175,218,136             175,218,136  
United Kingdom
    1,371,373       1,253,372,822             1,254,744,195  
 
                       
TOTAL COMMON STOCKS
    295,313,742       5,571,863,566       5,411       5,867,182,719  
 
                       
Preferred Stocks
                               
Germany
          46,200,998             46,200,998  
 
                       
TOTAL PREFERRED STOCKS
          46,200,998             46,200,998  
 
                       
Rights/Warrants
                               
Australia
          44,402             44,402  
 
                       
TOTAL RIGHTS/WARRANTS
          44,402             44,402  
 
                       
Mutual Funds
                               
United States
    64,929,485                   64,929,485  
 
                       
TOTAL MUTUAL FUNDS
    64,929,485                   64,929,485  
 
                       
Short-Term Investments
    160,235,385                   160,235,385  
 
                       
Total Investments
    520,478,612       5,618,108,966       5,411       6,138,592,989  
 
                       
Derivatives**
                               
Forward Currency Contracts
                               
Foreign Currency Risk
          5,630,831             5,630,831  
Futures Contracts
                               
Equity Risk
          34,614,620             34,614,620  
 
                       
Total Derivatives
          40,245,451             40,245,451  
 
                       
Total
  $ 520,478,612     $ 5,658,354,417     $ 5,411     $ 6,178,838,440  
 
                       
LIABILITY VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Liabilities     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Derivatives**
                               
Forward Currency Contracts
                               
Foreign Currency Risk
  $     $ (2,405,888 )   $     $ (2,405,888 )
Futures Contracts
                               
Equity Risk
    (1,781,565 )     (6,245,492 )           (8,027,057 )
Swap Agreements
                               
Equity Risk
          (42,579 )           (42,579 )
 
                       

 


 

                                 
Total Derivatives
    (1,781,565 )     (8,693,959 )           (10,475,524 )
 
                       
Total
  $ (1,781,565 )   $ (8,693,959 )   $     $ (10,475,524 )
 
                       
 
*   Represents the interest in securities that were determined to have a fair value of zero as of November 30, 2011.

 


 

The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
** Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net value of the Fund’s direct investments in securities using Level 3 inputs was less than 0.1% of total net assets.
The following is a reconciliation of investments and derivatives, if any, in which significant unobservable inputs (Level 3) were used in determining value:

 


 

                                                                                 
                                                                            Net Change in  
                                                                            Unrealized  
                                                                            Appreciation  
                                                                            (Depreciation)  
                                            Change in                             from  
    Balances as of                     Accrued             Unrealized                     Balances as of     Investments Still  
    February 28,                     Discounts/     Total Realized     Appreciation     Transfer into     Transfer out of     November 30,     Held as of November  
    2011     Purchases     Sales     Premiums     Gain/(Loss)     (Depreciation)     level 3 *     level 3 *     2011     30, 2011  
Common Stocks
                                                                               
Japan
  $ 5,130     $     $     $     $     $ 281     $     $     $ 5,411     $ 281  
 
                                                           
Total
  $ 5,130     $     $     $     $     $ 281     $     $     $ 5,411     $ 281  
 
                                                           
 
*   The Fund accounts for investments and derivatives transferred into Level 3 at the value at the beginning of the period and transferred out of Level 3 at the value at the end of the period.

 


 

Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If the Fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of the value of those investments. The Fund also may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Because the Fund normally does not take temporary defensive positions, declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.

 


 

Leveraging Risk — The Fund’s use of derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies or in industries with high positive correlations to one another creates additional risk.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Among other trading agreements, the Fund is party to International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Agreements”) or other similar types of agreements with selected counterparties that generally govern over-the-counter derivative transactions entered into by the Fund. The ISDA Agreements typically include representations and warranties as well as contractual terms related to collateral, events of default, termination events, and other provisions. Termination events may include the decline in the net assets of the Fund below a certain level over a specified period of time and entitle a counterparty to elect to terminate early with respect to some or all the transactions under the ISDA Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse effect on the Fund’s operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. For example, the Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives, to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives. The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For example, if the Fund holds a large proportion of stocks of companies in a particular sector and the Manager believes that stocks of companies in another sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index). In adjusting its investment exposure, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net long exposures in excess of its net assets. The Fund’s foreign currency exposure may differ significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty

 


 

to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of

 


 

the contracts. Most forward currency contracts are not collateralized. During the period ended November 30, 2011, the Fund used forward currency contracts to manage against anticipated currency exchange rate changes and adjust exposure to foreign currencies. Forward currency contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded (unless otherwise adjusted due to the time at which foreign markets close). The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. During the period ended November 30, 2011, the Fund used futures contracts to adjust exposure to certain securities markets and maintain the diversity and liquidity of the portfolio. Futures contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.

 


 

Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers (unless otherwise adjusted due to the time at which foreign markets close) and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. During the period ended November 30, 2011, the Fund used swap agreements to achieve returns comparable to holding and lending a direct equity position. Swap agreements outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. During the

 


 

period ended November 30, 2011, the Fund held rights and/or warrants received as a result of corporate actions. Rights and/or warrants held by the Fund at the end of the period are listed in the Fund’s Schedule of Investments.

 


 

The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Assets:
                                               
Investments, at value (rights and/or warrants)
  $     $     $     $ 44,402     $     $ 44,402  
Unrealized appreciation on forward currency contracts
          5,630,831                         5,630,831  
Unrealized appreciation on futures contracts*
                      34,614,620             34,614,620  
 
                                   
Total
  $     $ 5,630,831     $     $ 34,659,022     $     $ 40,289,853  
 
                                   
 
                                               
Liabilities:
                                               
Unrealized depreciation on forward currency contracts
  $     $ (2,405,888 )   $     $     $     $ (2,405,888 )
Unrealized depreciation on futures contracts*
                      (8,027,057 )           (8,027,057 )
Unrealized depreciation on swap agreements
                      (42,579 )           (42,579 )
 
                                   
Total
  $     $ (2,405,888 )   $     $ (8,069,636 )   $     $ (10,475,524 )
 
                                   
 
*   The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of futures contracts as reported in the Schedule of Investments.
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts, futures contracts and rights and/or warrants), or notional amounts (swap agreements), outstanding at each month-end, was as follows for the period ended November 30, 2011:
                                 
    Forward             Rights        
    Currency     Futures     and /or     Swap  
    Contracts     Contracts     Warrants     Agreements  
Average amount outstanding
  $ 859,716,115     $ 751,635,739     $ 742,900     $ 757,040  

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO International Opportunities Equity Allocation Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares / Par Value ($)     Description   Value ($)  
 
       
MUTUAL FUNDS — 100.0%
       
       
 
       
       
Affiliated Issuers — 100.0%
       
  1,910,786    
GMO Emerging Markets Fund, Class VI
    22,337,083  
  2,572,161    
GMO Flexible Equities Fund, Class VI
    44,086,840  
  13,340,209    
GMO International Growth Equity Fund, Class IV
    285,480,464  
  20,835,518    
GMO International Intrinsic Value Fund, Class IV
    406,292,602  
       
 
     
       
TOTAL MUTUAL FUNDS (COST $827,701,471)
    758,196,989  
       
 
     
 
       
SHORT-TERM INVESTMENTS — 0.0%
       
       
 
       
       
Time Deposit — 0.0%
       
  21,698    
State Street Eurodollar Time Deposit, 0.01%, due 12/01/11
    21,698  
       
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $21,698)
    21,698  
       
 
     
 
       
TOTAL INVESTMENTS — 100.0%
(Cost $827,723,169)
    758,218,687  
 
       
Other Assets and Liabilities (net) — (0.0%)
    (61,680 )
       
 
     
 
       
TOTAL NET ASSETS — 100.0%
  $ 758,157,007  
       
 
     
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                         
    Gross   Gross   Net Unrealized
    Unrealized   Unrealized   Appreciation
Aggregate Cost   Appreciation   (Depreciation)   (Depreciation)
$976,652,077
  $6,125,403   $(224,558,793)   $(218,433,390)
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO Emerging Markets Fund, Class VI
  $ 22,727,461     $ 5,601,974     $ 1,017,898     $ 8,881       1,768,580     $ 22,337,083  
 
GMO Flexible Equities Fund, Class VI
    11,463,067       37,684,840       1,266,531                   44,086,840  
 
GMO International Growth Equity Fund, Class IV
    381,363,744       55,719,992       108,684,018       2,717,364             285,480,464  
 
GMO International Intrinsic Value Fund, Class IV
    380,486,131       130,820,756       39,998,115       7,505,629             406,292,602  
 
                                   
 
Totals
  $ 796,040,403     $ 229,827,562     $ 150,966,562     $ 10,231,874     $ 1,768,580     $ 758,196,989  
 
                                   

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Shares of the underlying funds and other investment funds are generally valued at their net asset value. Investments held by the underlying funds are valued as follows: Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly and indirectly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 0.1% of net assets. The underlying funds classify such securities (levels defined below) as Level 3.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund, either directly or through investments in the underlying funds, that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below and as described in the disclosures of the underlying funds.
     
Security Type
Percentage of Net Assets of the Fund  
Equity Securities
90.1%  
Futures Contracts
0.4%  
Swap Agreements
(0.0)%^  
 
^   Rounds to 0.0%.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs.

 


 

Level 3 — Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Mutual Funds
  $ 758,196,989     $     $     $ 758,196,989  
Short-Term Investments
    21,698                   21,698  
 
                       
Total Investments
    758,218,687                   758,218,687  
 
                       
Total
  $ 758,218,687     $     $     $ 758,218,687  
 
                       
The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net value of the Fund’s indirect investments in securities using Level 3 inputs was 0.1% of total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. References to investments include those held directly by the Fund and indirectly through the Fund’s investments in the underlying funds. Some of the underlying funds are non-diversified investment companies under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by those funds may affect their performance more than if they were diversified. Selected risks of investing in the Fund are summarized below, including those risks to which the Fund is exposed as a result of its investments in the underlying funds. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If an underlying fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of the value of those investments. An underlying fund also may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Because the Fund and the underlying funds normally do not take temporary defensive positions, declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to

 


 

be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of foreign currency holdings and investments denominated in foreign currencies.
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund or an underlying fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in the underlying funds, including the risk that the underlying funds in which it invests do not perform as expected. Because the Fund bears the fees and expenses of the underlying funds in which it invests, new investments in underlying funds with higher fees or expenses than those of the underlying funds in which the Fund is currently invested will increase the Fund’s total expenses. The fees and expenses associated with an investment in the Fund are less predictable and may be higher than fees and expenses associated with an investment in funds that charge a fixed management fee.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
Commodities Risk — To the extent an underlying fund has exposure to global commodity markets, the value of its shares is affected by factors particular to the commodity markets and may fluctuate more than the value of shares of a fund with a broader range of investments.
Leveraging Risk — The use of reverse repurchase agreements and other derivatives and securities lending may cause the Fund’s portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Short Sales Risk — The Fund runs the risk that an underlying fund’s loss on a short sale of securities that the underlying fund does not own is unlimited.
Market Risk — Fixed Income Securities — Typically, the market value of fixed income securities will decline during periods of rising interest rates and widening of credit spreads.
Market Risk — Asset-Backed Securities — Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating.

 


 

Focused Investment Risk — Focusing investments in countries, regions, sectors or companies or in industries with high positive correlations to one another creates additional risk.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Derivative financial instruments
At November 30, 2011, the Fund held no derivative financial instruments directly. For a listing of derivative financial instruments held by the underlying funds, if any, please refer to the underlying funds’ Schedule of Investments.

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO International Small Companies Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares     Description   Value ($)  
 
       
COMMON STOCKS — 93.8%
       
       
 
       
       
Australia — 3.9%
       
  676,664    
Australian Infrastructure Fund
    1,348,147  
  596,528    
BlueScope Steel Ltd
    243,273  
  17,047    
Campbell Brothers Ltd
    876,100  
  223,405    
Challenger Ltd
    997,436  
  861,238    
Charter Hall Office (REIT)
    3,093,442  
  636,905    
Charter Hall Retail (REIT)
    2,155,848  
  1,610,793    
Goodman Fielder Ltd
    882,606  
  147,206    
GrainCorp Ltd
    1,170,460  
  1,692,981    
Investa Office Fund (REIT)
    1,055,635  
  998,258    
PaperlinX Ltd *
    79,335  
  285,982    
Regis Resources Ltd *
    993,337  
  521,758    
Spark Infrastructure Group
    691,348  
  287,397    
Tatts Group Ltd
    691,414  
       
 
     
       
Total Australia
    14,278,381  
       
 
     
       
 
       
       
Austria — 0.6%
       
  11,804    
Andritz AG
    1,042,258  
  10,478    
Flughafen Wien AG
    403,485  
  1,761,602    
Immofinanz AG (Entitlement Shares) *
     
  18,624    
Strabag SE
    559,503  
  7,493    
Zumtobel AG
    118,423  
       
 
     
       
Total Austria
    2,123,669  
       
 
     
       
 
       
       
Belgium — 0.5%
       
  12,314    
GIMV NV
    600,979  
  19,012    
Omega Pharma SA
    885,323  
  17,833    
Tessenderlo Chemie
    495,352  
  636    
Tessenderlo Chemie NV *
    86  
       
 
     
       
Total Belgium
    1,981,740  
       
 
     
       
 
       
       
Brazil — 0.1%
       
  25,100    
Equatorial Energia SA
    159,621  
  16,500    
Fertilizantes Heringer SA *
    95,075  
       
 
     
       
Total Brazil
    254,696  
       
 
     
       
 
       
       
Canada — 4.0%
       
  34,200    
AltaGas Ltd
    1,035,104  
  41,100    
Davis & Henderson Income Corp
    604,441  
  24,800    
Dorel Industries Inc Class B
    582,342  
  52,600    
Dundee Corp Class A *
    1,237,708  
  6,200    
Empire Co Ltd
    372,018  
  61,400    
Ensign Energy Services Inc
    978,234  
  33,600    
Mullen Group Ltd
    644,361  
  32,400    
Pembina Pipeline Corp
    945,046  
  209,100    
Precision Drilling Corp *
    2,417,069  
  18,871    
Quebecor Inc Class B
    599,276  
  119,900    
RONA Inc
    1,090,908  
  173,800    
Sherritt International Corp
    947,427  
  50,950    
Torstar Corp Class B
    444,586  
  71,325    
Transcontinental Inc
    834,963  
  15,400    
Trilogy Energy Corp
    563,185  
  157,600    
Trinidad Drilling Ltd
    1,229,958  
       
 
     
       
Total Canada
    14,526,626  
       
 
     

 


 

                 
       
Chile — 0.0%
       
  3,721,532    
Madeco SA *
    164,551  
       
 
     
       
 
       
       
China — 0.0%
       
  447,600    
Jiangsu Future Land Co Ltd Class B
    171,223  
       
 
     
       
 
       
       
Czech Republic — 0.0%
       
  4,200    
Pegas Nonwovens SA
    100,204  
       
 
     
       
 
       
       
France — 4.5%
       
  40,031    
Arkema
    2,916,025  
  115,962    
Derichebourg SA *
    380,565  
  14,281    
Eiffage SA
    356,530  
  22,534    
Groupe Steria SCA
    405,210  
  7,588    
ICADE (REIT)
    606,581  
  24,367    
Ingenico SA
    956,856  
  8,468    
Jacquet Metal Service *
    95,659  
  20,921    
Lagardere SCA
    509,503  
  33,104    
Maurel et Prom
    639,382  
  15,095    
Nexans SA
    886,988  
  134,595    
PagesJaunes Groupe
    467,720  
  49,585    
Peugeot SA
    928,395  
  61,895    
Plastic Omnium SA
    1,363,696  
  36,962    
Rallye SA
    1,122,357  
  9,482    
Remy Cointreau SA
    792,884  
  37,770    
SES SA Class A FDR
    930,845  
  5,065    
Societe BIC SA
    449,677  
  16,778    
Teleperformance
    331,046  
  12,278    
Valeo SA
    543,670  
  9,659    
Wendel
    695,933  
  12,455    
Zodiac Aerospace
    1,023,553  
       
 
     
       
Total France
    16,403,075  
       
 
     
       
 
       
       
Germany — 6.2%
       
  62,839    
Aareal Bank AG *
    1,138,094  
  57,489    
Aurubis AG
    3,280,510  
  69,878    
Balda AG *
    360,224  
  26,775    
Bechtle AG
    972,111  
  8,472    
Bertrandt AG
    493,337  
  24,276    
Bilfinger & Berger SE
    2,217,749  
  180,956    
Drillisch AG
    1,634,655  
  130,672    
Freenet AG
    1,725,866  
  168,495    
Gagfah SA
    1,008,908  
  12,769    
Gerresheimer AG
    537,221  
  34,089    
Gerry Weber International AG
    1,063,249  
  28,662    
Hannover Rueckversicherung AG (Registered)
    1,496,311  
  46,791    
Leoni AG
    1,741,216  
  10,237    
Rheinmetall AG
    496,919  
  29,997    
Rhoen-Klinikum AG
    568,031  
  19,801    
Salzgitter AG
    1,028,021  
  15,726    
SGL Carbon SE *
    947,692  
  61,141    
Suedzucker AG
    1,947,792  
       
 
     
       
Total Germany
    22,657,906  
       
 
     
       
 
       
       
Greece — 0.6%
       
  143,182    
Alapis Holding Industrial and Commercial SA *
    6,222  
  268,346    
Intralot SA
    296,600  
  94,916    
Jumbo SA
    486,110  
  1,136,003    
Marfin Investment Group SA *
    651,585  

 


 

                 
  72,262    
Motor Oil (Hellas) Corinth Refineries SA
    592,049  
       
 
     
       
Total Greece
    2,032,566  
       
 
     
       
 
       
       
Hong Kong — 1.9%
       
  2,920,000    
Emperor Watch & Jewellery Ltd
    427,711  
  1,402,000    
First Pacific Co
    1,557,544  
  425,600    
HKR International Ltd
    139,529  
  698,000    
Kowloon Development Co Ltd
    590,084  
  256,000    
Luk Fook Holdings International Ltd
    1,075,530  
  1,722,000    
Melco International Development Ltd
    1,369,063  
  848,000    
Texwinca Holdings Ltd
    1,023,728  
  226,000    
Yue Yuen Industrial Holdings
    651,283  
       
 
     
       
Total Hong Kong
    6,834,472  
       
 
     
       
 
       
       
India — 0.4%
       
  29,368    
Bata India Ltd
    354,086  
  154,409    
Geodesic Ltd
    156,607  
  111,346    
Gitanjali Gems Ltd
    728,875  
  275,905    
Rain Commodities Ltd
    158,082  
       
 
     
       
Total India
    1,397,650  
       
 
     
       
Indonesia — 0.1%
       
  55,384,000    
Bakrie & Brothers Tbk PT *
    313,585  
       
 
     
       
 
       
       
Ireland — 2.2%
       
  1,190,403    
Allied Irish Banks Plc *
    103,970  
  110,781    
DCC Plc
    2,682,097  
  752,322    
Fyffes Plc
    384,142  
  202,464    
Glanbia Plc
    1,264,963  
  718,499    
Irish Life & Permanent Group Holdings Plc *
    31,059  
  39,982    
Paddy Power Plc
    2,170,828  
  177,321    
Smurfit Kappa Group Plc *
    1,073,920  
  551,272    
Total Produce Ltd
    285,103  
       
 
     
       
Total Ireland
    7,996,082  
       
 
     
       
 
       
       
Israel — 0.4%
       
  233,795    
Africa Israel Investments Ltd *
    793,282  
  14,802    
Mellanox Technologies Ltd *
    519,949  
       
 
     
       
Total Israel
    1,313,231  
       
 
     
       
 
       
       
Italy — 4.3%
       
  88,264    
Autostrada Torino-Milano SPA
    868,129  
  241,819    
Benetton Group SPA
    1,187,796  
  49,871    
Brembo SPA
    479,307  
  243,627    
Campari
    1,742,177  
  79,796    
Cementir SPA
    160,024  
  36,568    
Danieli & Co SPA
    821,668  
  137,802    
Danieli & Co SPA-RSP
    1,594,519  
  97,360    
De’Longhi SPA
    1,032,492  
  148,922    
Italcementi SPA-Di RISP
    408,290  
  9,234    
Italmobiliare SPA
    198,730  
  14,836    
Italmobiliare SPA-RSP
    208,800  
  94,855    
Lottomatica SPA *
    1,463,610  
  317,959    
Mediolanum SPA
    1,161,846  
  1,575,844    
Milano Assicurazioni SPA *
    531,299  
  69,509    
Pirelli & C SPA
    657,589  
  243,911    
Recordati SPA
    1,873,910  
  48,396    
Societa Iniziative Autostradali e Servizi SPA
    366,797  

 


 

                 
  4,695    
Tod’s SPA
    437,277  
  1,286,791    
Unipol Gruppo Finanziario SPA *
    431,489  
       
 
     
       
Total Italy
    15,625,749  
       
 
     
       
 
       
       
Japan — 30.9%
       
  1,081    
Advance Residence Investment Corp (REIT)
    2,016,885  
  188,000    
Aichi Steel Corp
    985,905  
  29,500    
Alpen Co Ltd
    503,498  
  87,600    
Alps Electric Co Ltd
    613,296  
  155,000    
Anritsu Corp
    1,750,335  
  112,100    
AOC Holdings Inc
    677,583  
  120,800    
Arnest One Corp
    1,233,373  
  454,000    
Calsonic Kansei Corp
    2,620,776  
  54,700    
Capcom
    1,403,108  
  110,800    
Century Tokyo Leasing Corp
    2,198,617  
  19,400    
Chiba Kogyo Bank Ltd (The) *
    103,996  
  43,000    
Daido Metal Co Ltd
    442,618  
  158,800    
Daiei Inc *
    577,142  
  56,700    
Daiichikosho Co Ltd
    1,052,029  
  107,000    
Dainippon Screen Manufacturing Co Ltd
    816,568  
  335    
Daiwa Office Investment Corp (REIT)
    701,014  
  235,900    
DCM Holdings Co Ltd
    1,800,025  
  700,000    
DIC Corp
    1,182,116  
  138    
Dr Ci:Labo Co Ltd
    851,622  
  227,500    
Edion Corp
    1,781,685  
  84,000    
Fujitsu General Ltd
    463,730  
  22,100    
Fuji Oil Co Ltd
    316,345  
  29,500    
Fuji Soft Inc
    497,241  
  195,100    
Futaba Industrial Co Ltd
    1,196,178  
  47,000    
Fuyo General Lease Co Ltd
    1,613,177  
  402,000    
Godo Steel Ltd
    1,006,225  
  11,060    
Gulliver International Co Ltd
    468,370  
  400,000    
Gunze Ltd
    1,151,647  
  468,000    
Hanwa Co Ltd
    2,028,834  
  34,000    
Hitachi Transport System Ltd
    571,439  
  150,500    
Hokuetsu Kishu Paper Co Ltd
    955,471  
  512,000    
Ishihara Sangyo Kaisha Ltd *
    598,127  
  105,400    
IT Holdings Corp
    1,189,372  
  59,600    
Itochu Enex Co Ltd
    336,484  
  399,000    
JACCS Co Ltd
    1,233,063  
  85    
Japan Excellent Inc (REIT)
    341,754  
  247,000    
JFE Shoji Holdings Inc
    1,039,038  
  365,000    
Juki Corp
    880,218  
  143,000    
J–Oil Mills Inc
    399,153  
  110,500    
K’s Holdings Corp
    4,355,552  
  19,800    
Kaga Electronics Co Ltd
    203,946  
  176,000    
Kaken Pharmaceutical Co Ltd
    2,133,937  
  433    
Kenedix Realty Investment Corp (REIT)
    1,237,453  
  152,000    
Kinugawa Rubber Industrial Co Ltd
    1,367,761  
  127,900    
Kohnan Shoji Co Ltd
    2,056,439  
  57,000    
Kojima Co Ltd
    380,301  
  19,300    
Komeri Co Ltd
    590,161  
  144,000    
Krosaki Harima Corp
    485,669  
  229,000    
Kurabo Industries Ltd
    445,297  
  39,800    
Kyoei Steel Ltd
    800,663  
  52,000    
Kyorin Co Ltd
    876,723  
  30,000    
Kyudenko Corp
    181,058  
  298,500    
Leopalace21 Corp *
    689,027  
  10,600    
Mandom Corp
    270,652  

 


 

                 
  13,300    
Maruwa Co Ltd/Aichi
    592,714  
  303,000    
Mitsubishi Steel Manufacturing Co Ltd
    820,570  
  513,000    
Mitsui Mining & Smelting Co Ltd
    1,329,265  
  303    
Mori Hills REIT Investment Corp (REIT)
    977,189  
  293,000    
Morinaga Milk Industry Co Ltd
    1,118,313  
  283,000    
Nachi-Fujikoshi Corp
    1,331,750  
  150,000    
Nakayama Steel Works Ltd *
    124,552  
  736    
Net One Systems Co Ltd
    1,898,647  
  166,000    
Nichias Corp
    905,233  
  43,800    
Nichii Gakkan Co
    498,577  
  297,000    
Nichirei Corp
    1,385,027  
  93,300    
Nihon Kohden Corp
    2,157,936  
  865,000    
Nippon Coke & Engineering Co Ltd
    1,159,818  
  115,000    
Nippon Corp
    1,001,012  
  97,000    
Nippon Shokubai Co Ltd
    1,062,425  
  210,000    
Nippon Soda Co Ltd
    890,966  
  71,000    
Nippon Synthetic Chemical Industry Co Ltd
    416,858  
  100,000    
Nippon Flour Mills Co Ltd
    444,539  
  1,119,000    
Nippon Light Metal Co Ltd
    1,487,608  
  196,900    
Nippon Suisan Kaisha Ltd
    664,515  
  95,000    
Nipro Corp
    775,096  
  200,000    
Nishimatsu Construction Co Ltd
    324,721  
  123,000    
Nissan Shatai Co Ltd
    1,204,644  
  27,000    
Nisshin Oillio Group Ltd (The)
    109,345  
  16,200    
Noritz Corp
    296,450  
  156,000    
NS United Kaiun Kaisha Ltd
    216,311  
  19,500    
Okinawa Electric Power Co
    830,435  
  1,111,500    
Orient Corp *
    1,000,150  
  236    
ORIX JREIT Inc (REIT)
    997,137  
  26,900    
Osaka Steel Co Ltd
    481,168  
  27,500    
PLENUS Co Ltd
    433,137  
  30,500    
Pola Orbis Holdings Inc
    778,327  
  206    
Premier Investment Corp (REIT)
    663,315  
  270,000    
Press Kogyo Co Ltd
    1,267,891  
  72,750    
Promise Co Ltd *
    758,815  
  294,800    
Round One Corp
    1,761,528  
  299,000    
Ryobi Ltd
    1,158,973  
  32,300    
Ryohin Keikaku Co Ltd
    1,469,618  
  40,700    
Sanrio Co Ltd
    2,117,109  
  142,000    
Seino Holdings Co Ltd
    1,031,669  
  73,800    
Ship Healthcare Holdings Inc
    1,755,468  
  121,000    
Showa Corp *
    667,910  
  1,983    
SKY Perfect JSAT Holdings Inc
    1,013,491  
  99,600    
Sodick Co Ltd
    540,029  
  77,700    
Start Today Co Ltd
    1,505,699  
  479,000    
Taiheiyo Cement Co Ltd
    930,513  
  178,000    
Taihei Kogyo Co Ltd
    969,868  
  22,200    
Tamron Co Ltd.
    596,758  
  93,000    
Tatsuta Electric Wire and Cable Co Ltd
    414,578  
  263,000    
TOA Corp
    469,827  
  298,000    
Toho Zinc Co Ltd
    1,204,909  
  263,000    
Toko Inc *
    526,904  
  259    
Tokyu REIT Inc (REIT)
    1,181,653  
  367,000    
Topy Industries Ltd
    939,793  
  31    
Top REIT Inc (REIT)
    137,901  
  181,000    
Tosoh Corp
    529,687  
  404,000    
Toyo Tire & Rubber Co Ltd
    946,383  
  506    
T–Gaia Corp
    981,643  
  70,000    
Uchida Yoko Co Ltd
    193,925  
  232,000    
Uniden Corp
    886,834  

 


 

                 
  45,100    
Unipres Corp
    1,250,831  
  32,700    
United Arrows Ltd
    585,677  
  14,900    
Xebio Co Ltd
    344,908  
       
 
     
       
Total Japan
    112,191,238  
       
 
     
       
 
       
       
Malaysia — 0.1%
       
  242,966    
Coastal Contracts Berhad
    147,554  
  176,900    
Esso Malaysia Berhad
    195,581  
  679,700    
Scomi Group Berhad *
    61,037  
       
 
     
       
Total Malaysia
    404,172  
       
 
     
       
 
       
       
Netherlands — 1.7%
       
  34,839    
Aalberts Industries NV
    568,130  
  71,962    
Delta Lloyd NV
    1,266,132  
  24,011    
Koninklijke Ten Cate NV
    696,352  
  302,704    
Koninklijke BAM Groep NV
    1,048,642  
  38,655    
Mediq NV
    597,511  
  62,016    
SBM Offshore NV
    1,335,603  
  242,666    
SNS REAAL NV *
    541,771  
       
 
     
       
Total Netherlands
    6,054,141  
       
 
     
       
 
       
       
New Zealand — 0.0%
       
  16,008    
Warehouse Group Ltd (The)
    39,969  
       
 
     
       
 
       
       
Norway — 0.6%
       
  44,636    
Atea ASA
    438,638  
  48,439    
Cermaq ASA *
    560,991  
  55,963    
TGS Nopec Geophysical Co ASA
    1,245,215  
       
 
     
       
Total Norway
    2,244,844  
       
 
     
       
 
       
       
Philippines — 0.1%
       
  1,722,100    
Lopez Holding Corp
    183,130  
       
 
     
 
       
Poland — 0.0%
       
  129,495    
MCI Management SA *
    148,019  
       
 
     
       
 
       
       
Singapore — 2.0%
       
  465,000    
Ho Bee Investment Ltd
    442,751  
  287,000    
Hong Leong Asia Ltd
    356,834  
  2,296,000    
Jaya Holdings Ltd *
    868,430  
  744,000    
Mapletree Industrial Trust (REIT)
    626,074  
  1,232,159    
Mapletree Logistics Trust (REIT)
    806,221  
  331,000    
MobileOne Ltd
    631,755  
  1,473,000    
STX OSV Holdings Ltd
    1,431,789  
  830,000    
Swiber Holdings Ltd *
    347,469  
  161,000    
Venture Corp Ltd
    832,927  
  171,000    
Wheelock Properties Ltd
    214,838  
  630,000    
Wing Tai Holdings Ltd
    535,063  
       
 
     
       
Total Singapore
    7,094,151  
       
 
     
       
 
       
       
South Africa — 0.1%
       
  98,254    
Basil Read Holdings Ltd
    162,737  
  8,176    
Evraz Highveld Steel and Vanadium Ltd *
    37,828  
  400,000    
Simmer & Jack Mines Ltd *
    1,477  
  73,315    
Stefanutti Stocks Holdings Ltd
    97,221  
  1,681,390    
Super Group Ltd *
    186,529  
       
 
     
       
Total South Africa
    485,792  
       
 
     

 


 

                 
       
South Korea — 2.7%
       
  7,301    
AtlasBX Co Ltd
    158,257  
  7,061    
Daum Communications Corp
    927,653  
  1,432    
Dongwon Industries Co Ltd
    208,896  
  22,285    
GemVax & Kael Co Ltd *
    774,078  
  22,480    
Handsome Co Ltd
    536,006  
  5,919    
KCC Engineering & Construction Co
    159,640  
  8,890    
KISCO Corp
    186,734  
  4,407    
KISWIRE Ltd
    177,613  
  11,431    
Kolon Corp
    216,412  
  23,768    
Kolon Industries Inc
    1,283,809  
  21,840    
LG Fashion Corp
    914,910  
  20,220    
LG International Corp
    925,501  
  1,740    
Moorim Paper Co Ltd
    4,033  
  384    
Namyang Dairy Products Co Ltd
    263,466  
  2,305    
Nong Shim Holdings Co Ltd
    101,421  
  94,860    
RNL BIO Co Ltd *
    550,835  
  6,793    
Seah Besteel Corp
    347,841  
  1,341    
SeAH Holdings Corp
    136,225  
  3,828    
SeAH Steel Corp
    238,478  
  4,180    
Silla Co Ltd
    42,526  
  6,533    
SK Gas Co Ltd
    447,012  
  363    
Taekwang Industrial Co Ltd
    410,918  
  25,960    
Youngone Corp
    674,676  
       
 
     
       
Total South Korea
    9,686,940  
       
 
     
       
 
       
       
Spain — 2.1%
       
  16,468    
Acciona SA
    1,531,708  
  61,531    
Cintra Concesiones de Infraestructuras de Transporte SA
    763,031  
  33,212    
Enagas
    623,189  
  84,022    
Fomento de Construcciones y Contratas SA
    2,174,654  
  61,527    
Grifols SA *
    994,828  
  104,223    
Indra Sistemas SA
    1,469,381  
       
 
     
       
Total Spain
    7,556,791  
       
 
     
       
 
       
       
Sweden — 2.2%
       
  31,429    
Axfood AB
    1,147,980  
  63,100    
D Carnegie & Co. AB * (a)
    6,994  
  30,429    
Hoganas AB Class B
    926,902  
  110,218    
Lundin Petroleum AB *
    2,840,584  
  185,616    
Meda AB
    1,810,712  
  67,643    
SAAB AB Class B
    1,211,318  
  81,342    
Vostok Gas Ltd * (a)
    2,645  
       
 
     
       
Total Sweden
    7,947,135  
       
 
     
       
 
       
       
Switzerland — 1.4%
       
  98,449    
OC Oerlikon Corp AG *
    556,100  
  12,587    
PSP Swiss Property AG (Registered) *
    1,090,368  
  24,963    
Swiss Life Holding AG (Registered) *
    2,614,618  
  8,350    
Swiss Prime Site AG (Registered) *
    635,707  
       
 
     
       
Total Switzerland
    4,896,793  
       
 
     
       
 
       
       
Taiwan — 0.7%
       
  54,000    
AV Tech Corp
    160,177  
  76,000    
Chinese Maritime Transport Ltd
    104,630  
  541,000    
Getac Technology Corp
    261,797  
  126,000    
L&K Engineering Co Ltd
    107,365  
  273,000    
Long Bon International Co Ltd
    93,908  

 


 

                 
  86,000    
P-Two Industries Inc
    50,835  
  430,000    
ProMOS Technologies Inc *
    4,820  
  500,000    
Radiant Opto-Electronics Corp
    1,519,369  
  186,000    
Sampo Corp
    47,087  
  106,000    
ThaiLin Semiconductor Corp
    33,275  
       
 
     
       
Total Taiwan
    2,383,263  
       
 
     
       
 
       
       
Thailand — 0.0%
       
  9,246,500    
G J Steel Pcl (Foreign Registered) * (a)
    42,624  
       
 
     
       
 
       
       
Turkey — 0.1%
       
  17,794    
Goodyear Lastikleri Turk AS
    465,399  
       
 
     
       
 
       
       
United Kingdom — 19.4%
       
  152,915    
Aberdeen Asset Management Plc
    483,478  
  115,568    
Amlin Plc
    610,334  
  183,290    
Ashtead Group Plc
    533,950  
  149,128    
Atkins WS Plc
    1,539,532  
  85,760    
Babcock International Group Plc
    979,297  
  660,874    
Balfour Beatty Plc
    2,616,339  
  389,731    
Bodycote Plc
    1,691,585  
  291,069    
Cape Plc
    1,493,368  
  120,308    
Carillion Plc
    589,366  
  393,680    
Catlin Group Ltd
    2,562,643  
  189,115    
Cookson Group Plc
    1,481,938  
  127,197    
Dairy Crest Group Plc
    662,478  
  793,079    
Debenhams Plc
    794,725  
  461,511    
Drax Group Plc
    4,064,654  
  476,762    
DS Smith Plc
    1,506,124  
  332,317    
Elementis Plc
    796,424  
  979,650    
Enterprise Inns Plc *
    555,725  
  215,183    
Fenner Plc
    1,329,492  
  270,174    
Filtrona Plc
    1,667,550  
  517,674    
FirstGroup Plc
    2,661,103  
  838,824    
Game Group Plc
    97,928  
  71,469    
Go–Ahead Group Plc
    1,371,077  
  147,077    
Greene King Plc
    1,117,918  
  143,062    
Halfords Group Plc
    742,109  
  889,326    
Home Retail Group Plc
    1,257,109  
  461,414    
Howden Joinery Group PLC *
    815,446  
  748,040    
Inchcape Plc
    3,842,106  
  356,564    
Intermediate Capital Group Plc
    1,350,506  
  79,675    
Investec Plc
    453,606  
  79,423    
John Wood Group Plc
    816,170  
  964,761    
Johnston Press Plc *
    69,496  
  634,715    
Kesa Electricals Plc
    887,743  
  168,358    
Ladbrokes Plc
    342,338  
  103,475    
Lancashire Holdings Ltd
    1,191,592  
  1,078,337    
Logica Plc
    1,368,112  
  33,950    
London Stock Exchange Group Plc
    461,499  
  774,188    
Marston’s Plc
    1,166,933  
  188,880    
Mcbride Plc *
    374,185  
  110,436    
Melrose Plc
    595,478  
  154,416    
Mondi Plc
    1,113,730  
  418,401    
Morgan Crucible Co Plc
    1,774,768  
  486,124    
National Express Group Plc
    1,606,474  
  24,586    
Next Plc
    1,039,182  
  8,080,027    
Premier Foods Plc *
    747,307  
  1,547,924    
Punch Taverns Plc *
    292,886  
  29,997    
Rightmove Plc
    600,505  

 


 

                 
  78,549    
Savills Plc
    395,292  
  257,135    
Senior Plc
    711,646  
  369,742    
SIG Plc
    486,794  
  70,068    
Smith News Plc
    94,199  
  76,664    
Spectris Plc
    1,512,957  
  1,240,352    
Spirit Pub Co Plc *
    773,530  
  433,117    
Tate & Lyle Plc
    4,587,205  
  36,964    
Telecity Group Plc *
    355,388  
  1,225,247    
Thomas Cook Group Plc
    352,902  
  473,563    
Trinity Mirror Plc *
    357,793  
  296,766    
TUI Travel Plc
    805,440  
  292,074    
Tullett Prebon Plc
    1,406,003  
  20,653    
Weir Group Plc (The)
    671,314  
  42,158    
WH Smith Plc
    348,325  
  999,785    
William Hill Plc
    3,183,867  
  2,546,413    
Yell Group Plc *
    200,964  
       
 
     
       
Total United Kingdom
    70,359,927  
       
 
     
       
TOTAL COMMON STOCKS (COST $369,836,599)
    340,359,734  
       
 
     
       
 
       
       
PREFERRED STOCKS — 3.0%
       
       
 
       
       
Brazil — 0.1%
       
  2,700    
Centrais Eletricas de Santa Catarina SA 6.39%
    48,614  
  11,300    
Eletropaulo Metropolitana SA 10.99%
    204,648  
       
 
     
       
Total Brazil
    253,262  
       
 
     
       
 
       
       
Germany — 2.4%
       
  11,185    
Biotest AG 1.19%
    555,010  
  12,493    
Draegerwerk AG & Co 1.79%
    1,145,080  
  29,860    
Hugo Boss AG 2.95%
    2,718,341  
  35,166    
Jungheinrich AG 2.78%
    970,827  
  54,124    
Porsche Automobil Holding SE 1.12%
    3,316,649  
       
 
     
       
Total Germany
    8,705,907  
       
 
     
       
 
       
       
Russia — 0.5%
       
  1,105    
Transneft 0.70%
    1,822,221  
       
 
     
       
TOTAL PREFERRED STOCKS (COST $8,897,131)
    10,781,390  
       
 
     
       
 
       
       
RIGHTS/WARRANTS — 0.0%
       
       
 
       
       
Australia — 0.0%
       
  477,222    
BlueScope Steel Ltd, Expires 12/14/11*
    5,399  
       
 
     
       
 
       
       
Malaysia — 0.0%
       
  11,833    
Coastal Contracts Warrants, Expires 07/18/16*
    1,861  
       
 
     
       
TOTAL RIGHTS/WARRANTS (COST $25,737)
    7,260  
       
 
     
       
 
       
       
MUTUAL FUNDS — 1.2%
       
       
 
       
       
United States — 1.2%
       
 
       
Affiliated Issuers
       
  178,050    
GMO U.S. Treasury Fund
    4,453,040  
       
 
     
       
TOTAL MUTUAL FUNDS (COST $4,453,039)
    4,453,040  
       
 
     

 


 

                         
Par Value     Description   Value ($)  
               
SHORT-TERM INVESTMENTS — 0.7%
       
               
 
       
               
Time Deposits — 0.7%
       
AUD     9,872    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 3.78%, due 12/01/11
    10,152  
CAD     10,407    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.25%, due 12/01/11
    10,204  
CHF     8,954    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.01%, due 12/01/11
    9,801  
DKK     247,728    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.14%, due 12/01/11
    44,764  
EUR     154,824    
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11
    208,037  
GBP     21,044    
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11
    33,016  
HKD     77,918    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.01%, due 12/01/11
    10,030  
JPY     6,679,686    
Citibank (New York) Time Deposit, 0.01%, due 12/01/11
    86,123  
NOK     56,392    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.95%, due 12/01/11
    9,764  
NZD     805    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 1.75%, due 12/01/11
    629  
SEK     68,344    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 1.06%, due 12/01/11
    10,099  
SGD     81,568    
Citibank (New York) Time Deposit, 0.01%, due 12/01/11
    63,643  
USD     2,106,223    
Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11
    2,106,223  
               
 
     
               
Total Time Deposits
    2,602,485  
               
 
     
               
TOTAL SHORT-TERM INVESTMENTS (COST $2,602,485)
    2,602,485  
               
 
     
               
 
       
               
TOTAL INVESTMENTS — 98.7%
(Cost $385,814,991)
    358,203,909  
               
 
       
               
Other Assets and Liabilities (net) — 1.3%
    4,634,099  
               
 
     
               
 
       
               
TOTAL NET ASSETS — 100.0%
  $ 362,838,008  
               
 
     
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
                                         
                                    Net Unrealized  
Settlement                                 Appreciation  
Date     Counterparty   Deliver/Receive     Units of Currency     Value     (Depreciation)  
Buys †  
 
                               
  12/16/11    
JPMorgan Chase Bank N.A.
  AUD     1,267,478     $ 1,301,221     $ 24,643  
  12/16/11    
Morgan Stanley Capital Services Inc.
  AUD     1,267,478       1,301,221       19,294  
  12/16/11    
Brown Brothers & Harriman & Co.
  EUR     144,291       193,904       1,780  
  12/16/11    
Bank of New York Mellon
  GBP     1,791,725       2,810,646       5,844  

 


 

                                         
  12/16/11    
Deutsche Bank AG
  GBP     2,350,311       3,686,890       (22,346 )
  12/16/11    
Morgan Stanley Capital Services Inc.
  GBP     3,799,689       5,960,502       10,383  
  12/16/11    
State Street Bank and Trust Company
  GBP     1,419,050       2,226,038       10,626  
  12/16/11    
Bank of New York Mellon
  HKD     13,892,673       1,788,386       1,309  
  12/16/11    
Brown Brothers Harriman & Co.
  HKD     21,035,165       2,707,831       1,194  
  12/16/11    
JPMorgan Chase Bank, N.A.
  HKD     12,884,956       1,658,664       1,217  
  12/16/11    
Morgan Stanley Capital Services Inc.
  HKD     9,225,235       1,187,553       701  
  12/16/11    
State Street Bank and Trust Company
  HKD     22,110,191       2,846,217       2,024  
  12/16/11    
Bank of America N.A.
  NOK     4,836,342       836,767       (21,363 )
  12/16/11    
Bank of America N.A.
  SEK     21,536,119       3,180,113       (46,333 )
  12/16/11    
Bank of New York Mellon
  SEK     3,059,439       451,769       (4,377 )
  12/16/11    
Royal Bank of Scotland PLC
  SEK     15,794,643       2,332,303       (24,180 )
  12/16/11    
Bank of America, N.A.
  SGD     12,170,331       9,495,979       (91,262 )
       
 
                           
       
 
                  $ 43,966,004     $ (130,846 )
       
 
                           
Sales #  
 
                               
  12/16/11    
Bank of America, N.A.
  CAD     2,900,553     $ 2,842,751     $ (10,347 )
  12/16/11    
Deutsche Bank AG
  CAD     4,960,106       4,861,262       (10,302 )
  12/16/11    
JPMorgan Chase Bank N.A.
  CAD     2,844,162       2,787,484       (18,945 )
  12/16/11    
Royal Bank of Scotland PLC
  CAD     3,285,282       3,219,813       (6,427 )
  12/16/11    
Bank of America, N.A.
  CHF     883,340       967,210       (9,951 )
  12/16/11    
JPMorgan Chase Bank, N.A.
  CHF     883,340       967,210       13,059  
  12/16/11    
Royal Bank of Scotland PLC
  CHF     610,795       668,788       8,129  
  12/16/11    
Brown Brothers Harriman & Co.
  EUR     1,989,078       2,673,000       46,627  
  12/16/11    
Deutsche Bank AG
  EUR     1,897,000       2,549,262       50,577  
  12/16/11    
JPMorgan Chase Bank, N.A.
  EUR     3,552,916       4,774,546       90,327  
  12/16/11    
Morgan Stanley Capital Services Inc.
  EUR     963,468       1,294,745       22,919  
  12/16/11    
Morgan Stanley Capital Services Inc.
  GBP     1,577,000       2,473,811       (5,178 )

 


 

                                         
  12/16/11    
State Street Bank and Trust Company
  HKD     12,059,000       1,552,340       (4,578 )
  12/16/11    
Bank of New York Mellon
  JPY     162,579,782       2,096,883       17,919  
  12/16/11    
Brown Brothers Harriman & Co.
  JPY     232,289,387       2,995,966       33,724  
  12/16/11    
State Street Bank and Trust Company
  JPY     160,681,000       2,072,393       22,180  
  12/16/11    
Bank of America, N.A.
  NOK     11,674,685       2,019,913       47,410  
       
 
                           
       
 
                  $ 40,817,377     $ 287,143  
       
 
                           
 
  Fund buys foreign currency; sells USD.
 
#   Fund sells foreign currency; buys USD.
Futures Contracts
                                 
                            Net Unrealized  
Number of         Expiration             Appreciation  
Contracts     Type   Date     Value     (Depreciation)  
Buys  
 
                       
  10    
IBEX 35
  December 2011   $ 1,136,647     $ 24,114  
  81    
CAC 40
  December 2011     3,441,192       140,084  
  19    
MSCI Singapore
  December 2011     930,709       32,929  
  80    
FTSE/MIB
  December 2011     8,236,000       966,909  
  57    
FTSE 100
  December 2011     4,933,150       (20,586 )
  70    
TOPIX
  December 2011     6,724,206       (11,168 )
       
 
                   
       
 
          $ 25,401,904     $ 1,132,282  
       
 
                   
Sales  
 
                       
  67    
S&P Toronto 60
  December 2011   $ 9,124,271     $ 791  
  67    
SPI 200
  December 2011     7,318,339       (247,138 )
    312    
OMXS 30
  December 2011     4,561,496       (160,804 )
       
 
                   
       
 
          $ 21,004,106     $ (407,151 )
       
 
                   
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
 
Notes to Schedule of Investments:
Foreign Registered — Shares issued to foreign investors in markets that have foreign ownership limits.
REIT — Real Estate Investment Trust
*   Non-income producing security.
 
(a)   Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust.
Currency Abbreviations:
AUD — Australian Dollar
CAD — Canadian Dollar
CHF — Swiss Franc
DKK — Danish Krone
EUR — Euro
GBP — British Pound

 


 

HKD — Hong Kong Dollar
JPY — Japanese Yen
NOK — Norwegian Krone
SEK — Swedish Krona
SGD — Singapore Dollar
USD — United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
             
    Gross   Gross   Net Unrealized
    Unrealized   Unrealized   Appreciation
Aggregate Cost   Appreciation   (Depreciation)   (Depreciation)
$      401,185,468
  $      24,683,591   $      (67,665,150)   $       (42,981,559)
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO U.S. Treasury Fund
  $ 8,505,000     $ 41,409,001     $ 45,461,236     $ 2,535     $ 409     $ 4,453,040  
 
                                   

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented less than 0.1% of net assets. The Fund classifies such securities (levels defined below) as Level 3. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivatives contracts based on the creditworthiness of its counterparties. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below.
         
Security Type   Percentage of Net Assets of the Fund  
Equity Securities
  92.3%
Futures Contracts
    0.2%
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.

 


 

Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include: fair value adjustments provided by an independent pricing service applied to equity securities (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) due to market events that have occurred since the local market close but prior to the close of the NYSE.
Level 3 — Valuations based primarily on inputs that are unobservable and significant. The Fund utilized a number of fair value techniques on Level 3 investments including the following: With respect to certain securities for which no current market or quoted prices were available, the Fund valued those securities at the most recent available market or quoted price. Certain of the Fund’s securities in Thailand were valued at the local price as adjusted by applying a premium or discount when the holdings exceed foreign ownership limitations.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
                                 
    Quoted Prices in                    
    Active Markets for     Significant Other     Significant        
    Identical Assets     Observable Inputs     Unobservable Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Common Stocks
                               
Australia
  $     $ 14,278,381     $     $ 14,278,381  
Austria
          2,123,669             2,123,669  
Belgium
          1,981,740             1,981,740  
Brazil
    254,696                   254,696  
Canada
    14,526,626                   14,526,626  
Chile
    164,551                   164,551  
China
          171,223             171,223  
Czech Republic
          100,204             100,204  
France
          16,403,075             16,403,075  
Germany
          22,657,906             22,657,906  
Greece
          2,032,566             2,032,566  
Hong Kong
          6,834,472             6,834,472  
India
          1,397,650             1,397,650  
Indonesia
          313,585             313,585  
Ireland
    135,029       7,861,053             7,996,082  
Israel
          1,313,231             1,313,231  
Italy
          15,625,749             15,625,749  
Japan
          112,191,238             112,191,238  
Malaysia
          404,172             404,172  
Netherlands
          6,054,141             6,054,141  
New Zealand
          39,969             39,969  
Norway
          2,244,844             2,244,844  
Philippines
          183,130             183,130  
Poland
          148,019             148,019  
Singapore
          7,094,151             7,094,151  
South Africa
          485,792             485,792  
South Korea
          9,686,940             9,686,940  
Spain
          7,556,791             7,556,791  
Sweden
          7,937,496       9,639       7,947,135  
Switzerland
          4,896,793             4,896,793  
Taiwan
          2,383,263             2,383,263  
Thailand
                42,624       42,624  
Turkey
          465,399             465,399  
United Kingdom
    773,530       69,586,397             70,359,927  
 
                       
TOTAL COMMON STOCKS
    15,854,432       324,453,039       52,263       340,359,734  
 
                       
Preferred Stocks
                               
Brazil
    253,262                   253,262  
Germany
          8,705,907             8,705,907  
Russia
          1,822,221             1,822,221  
 
                       
TOTAL PREFERRED STOCKS
    253,262       10,528,128             10,781,390  
 
                       
Rights/Warrants
                               
Australia
          5,399             5,399  

 


 

                                 
Malaysia
          1,861             1,861  
 
                       
TOTAL RIGHTS/WARRANTS
          7,260             7,260  
 
                       
Mutual Funds
                               
United States
    4,453,040                   4,453,040  
 
                       
TOTAL MUTUAL FUNDS
    4,453,040                   4,453,040  
 
                       
Short-Term Investments
    2,602,485                   2,602,485  
 
                       
Total Investments
    23,163,219       334,988,427       52,263       358,203,909  
 
                       
Derivatives *
                               
Forward Currency Contracts
                               
Foreign Currency risk
          431,886             431,886  
Futures Contracts
                               
Equity risk
    791       1,164,036             1,164,827  
 
                       
Total Derivatives
    791       1,595,922             1,596,713  
 
                       
Total
  $ 23,164,010     $ 336,584,349     $ 52,263     $ 359,800,622  
 
                       
LIABILITY VALUATION INPUTS
                                 
    Quoted Prices in                    
    Active Markets for                    
    Identical     Significant Other     Significant        
    Liabilities     Observable Inputs     Unobservable Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Derivatives *
                               
Forward Currency Contracts
                               
Foreign Currency risk
  $     $ (275,589 )   $     $ (275,589 )
Futures Contracts
                               
Equity risk
          (439,696 )           (439,696 )
 
                       
Total Derivatives
          (715,285 )           (715,285 )
 
                       
Total
  $     $ (715,285 )   $     $ (715,285 )
 
                       
The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
 
*   Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net value of the Fund’s direct investments in securities using Level 3 inputs was less than 0.1% of total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant unobservable inputs (Level 3) were used in determining value:

 


 

                                                                                 
                                                                            Net Change in  
                                                                            Unrealized  
                                                                            Appreciation  
                                                                            (Depreciation)  
                                                                            from  
                                            Change in                             Investments Still  
    Balances as of                     Accrued             Unrealized                     Balances as of     Held as of  
    February 28,                     Discounts/     Total Realized     Appreciation     Transfers into     Transfers out     November 30,     November 30,  
    2011     Purchases     Sales     Premiums     Gain/(Loss)     (Depreciation)     level 3 *     of level 3 *     2011     2011  
Common Stocks
                                                                               
Egypt
  $ 201,417     $     $ (109,955 )   $     $ (34,642 )   $ 118,561     $     $ (175,381) **   $     $  
South Korea
    85,393                               (1,472 )           (83,921) **            
Sweden
    10,297                               (658 )                 9,639       (658 )
Thailand
    627,570       286,165       (197,649 )           (199 )   $ (43,470 )           (629,793) **   $ 42,624       (36,988 )
 
                                                           
Total
  $ 924,677     $ 286,165     $ (307,604 )   $     $ (34,841 )   $ 72,961     $     $ (889,095 )   $ 52,263     $ (37,646 )
 
                                                           
 
*   The Fund accounts for investments and derivatives transferred into Level 3 at the value at the beginning of the period and transferred out of Level 3 at the value at the end of the period.
 
**   Financial assets transferred between Level 2 and Level 3 were due to a change in observable and/or unobservable inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If the Fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of the value of those investments. The Fund also may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Because the Fund normally does not take temporary defensive positions, declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Liquidity Risk — Shares of small- and mid-cap companies often have lower trading volumes and a limited number or no market makers. Thus, a large position may limit or prevent the Fund from selling those shares or unwinding derivative positions on them at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and

 


 

custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Leveraging Risk — The Fund’s use of derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies or in industries with high positive correlations to one another creates additional risk.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Among other trading agreements, the Fund is party to International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Agreements”) or other similar types of agreements with selected counterparties that generally govern over-the-counter derivative transactions entered into by the Fund. The ISDA Agreements typically include representations and warranties as well as contractual terms related to collateral, events of default, termination events, and other provisions. Termination events may include the decline in the net assets of the Fund below a certain level over a specified period of time and entitle a counterparty to elect to terminate early with respect to some or all the transactions under the ISDA Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse effect on the Fund’s operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. For example, the Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives, to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives. The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.

 


 

The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For example, if the Fund holds a large proportion of stocks of companies in a particular sector and the Manager believes that stocks of companies in another sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index). In adjusting its investment exposure, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net long exposures in excess of its net assets. The Fund’s foreign currency exposure may differ significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may

 


 

result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most forward currency contracts are not collateralized. During the period ended November 30, 2011, the Fund used forward currency contracts to manage against anticipated currency exchange rate changes and adjust exposure to foreign currencies. Forward currency contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded (unless otherwise adjusted due to the time at which foreign markets close). The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. During the period ended November 30, 2011, the Fund used futures contracts to adjust exposure to certain securities markets and maintain the diversity and liquidity of the portfolio. Futures contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC

 


 

 options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.

 


 

The Fund prices its swap agreements daily using models that may incorporate quotations from market makers (unless otherwise adjusted due to the time at which foreign markets close) and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. During the period ended November 30, 2011, the Fund used total return swap agreements to achieve returns comparable to holding and lending a direct equity position. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. During the period ended November 30, 2011, the Fund held rights and/or warrants received as a result of corporate actions. Rights and/or warrants held by the Fund at the end of the period are listed in the Fund’s Schedule of Investments.
The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Assets:
                                               
Investments, at value (rights and/or warrants)
  $     $     $     $ 7,260     $     $ 7,260  
Unrealized appreciation on forward currency contracts
          431,886                         431,886  
Unrealized appreciation on futures contracts*
                      1,164,827             1,164,827  
 
                                   
Total
  $     $ 431,886     $     $ 1,172,087     $     $ 1,603,973  
 
                                   
 
                                               
Liabilities:
                                               
Unrealized depreciation on forward currency contracts
  $     $ (275,589 )   $     $     $     $ (275,589 )
Unrealized depreciation on futures contracts*
                      (439,696 )           (439,696 )
 
                                   
Total
  $     $ (275,589 )   $     $ (439,696 )   $     $ (715,285 )
 
                                   
 
*   The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of futures contracts as reported in the Schedule of Investments.
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts, futures contracts and rights and/or warrants), notional amounts (swap agreements) outstanding at each month-end, was as follows for the period ended November 30, 2011:
                                 
    Forward                    
    Currency     Futures     Rights and /or     Swap  
    Contracts     Contracts     Warrants     Agreements  
Average amount outstanding
  $ 91,095,397     $ 45,194,288     $ 58,828     $ 71,339  

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Quality Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares     Description   Value ($)  
 
       
COMMON STOCKS — 96.4%
       
       
 
       
       
Capital Goods — 0.1%
       
  281,900    
3M Co.
    22,845,176  
  9,600    
United Technologies Corp.
    735,360  
       
 
     
       
Total Capital Goods
    23,580,536  
       
 
     
       
 
       
       
Consumer Durables & Apparel — 1.3%
       
  2,341,300    
Nike, Inc.-Class B
    225,186,234  
       
 
     
       
 
       
       
Consumer Services — 0.5%
       
  985,900    
McDonald’s Corp.
    94,173,168  
       
 
     
       
 
       
       
Energy — 8.6%
       
  11,061,149    
BP Plc
    80,108,778  
  5,567,370    
Chevron Corp.
    572,436,983  
  5,225,300    
Exxon Mobil Corp.
    420,323,132  
  6,371,784    
Royal Dutch Shell Group-Class A
    222,850,534  
  4,963,543    
Total SA
    256,081,687  
       
 
     
       
Total Energy
    1,551,801,114  
       
 
     
       
 
       
       
Food & Staples Retailing — 4.3%
       
  2,109,000    
Sysco Corp.
    60,190,860  
  3,620,500    
Walgreen Co.
    122,083,260  
  10,124,500    
Wal—Mart Stores, Inc.
    596,333,050  
       
 
     
       
Total Food & Staples Retailing
    778,607,170  
       
 
     
       
 
       
       
Food, Beverage & Tobacco — 18.3%
       
  178,500    
Altria Group, Inc.
    5,121,165  
  1,873,031    
Anheuser-Busch InBev NV
    112,001,132  
  5,286,577    
British American Tobacco Plc
    245,334,450  
  11,176,400    
Coca-Cola Co. (The)
    751,389,372  
  1,067,600    
Hansen Natural Corp.*
    98,432,720  
  1,046,400    
Lorillard, Inc.
    116,799,168  
  3,849,732    
Nestle SA
    216,057,490  
  6,939,200    
PepsiCo, Inc.
    444,108,800  
  12,209,300    
Philip Morris International, Inc.
    930,837,032  
  14,400    
Reynolds American, Inc.
    602,784  
  11,022,061    
Unilever NV
    375,409,341  
       
 
     
       
Total Food, Beverage & Tobacco
    3,296,093,454  
       
 
     
       
 
       
       
Health Care Equipment & Services — 5.1%
       
  44,600    
Baxter International, Inc.
    2,304,036  
  36,600    
Cerner Corp.*
    2,231,868  
  4,802,780    
Express Scripts, Inc.*
    219,246,907  
  301,500    
Henry Schein, Inc.*
    19,398,510  
  11,300    
Intuitive Surgical, Inc.*
    4,906,573  
  69,200    
Laboratory Corp. of America Holdings*
    5,931,824  
  600,500    
Lincare Holdings, Inc.
    14,231,850  
  5,568,730    
Medtronic, Inc.
    202,868,834  
  360,300    
Quest Diagnostics, Inc.
    21,135,198  
  6,486,494    
UnitedHealth Group, Inc.
    316,346,312  
  34,600    
WellPoint, Inc.
    2,441,030  
  2,151,275    
Zimmer Holdings, Inc.*
    108,746,951  
       
 
     
       
Total Health Care Equipment & Services
    919,789,893  
       
 
     

 


 

                 
       
Household & Personal Products — 4.1%
       
  714,700    
Church & Dwight Co., Inc.
    31,625,475  
  3,047,300    
Colgate—Palmolive Co.
    278,827,950  
  6,557,300    
Procter & Gamble Co. (The)
    423,404,861  
       
 
     
       
Total Household & Personal Products
    733,858,286  
       
 
     
       
 
       
       
Pharmaceuticals, Biotechnology & Life Sciences —19.6%
       
  7,471,005    
Abbott Laboratories
    407,543,323  
  3,062,160    
Amgen, Inc.
    177,329,686  
  2,448,798    
AstraZeneca Plc
    112,786,087  
  53,000    
Bristol—Myers Squibb Co.
    1,734,160  
  1,219,800    
Eli Lilly & Co.
    46,169,431  
  456,700    
Gilead Sciences, Inc.*
    18,199,495  
  8,847,180    
GlaxoSmithKline Plc
    196,071,467  
  15,367,500    
Johnson & Johnson
    994,584,600  
  7,298,900    
Merck & Co., Inc.
    260,935,675  
  4,083,830    
Novartis AG (Registered)
    220,543,989  
  34,030,548    
Pfizer, Inc.
    682,993,098  
  1,229,399    
Roche Holding AG
    195,565,630  
  2,392,367    
Sanofi-Aventis
    167,336,318  
  921,200    
Takeda Pharmaceutical Co Ltd
    37,837,331  
       
 
     
       
Total Pharmaceuticals, Biotechnology & Life Sciences
    3,519,630,290  
       
 
     
       
 
       
       
Retailing — 2.3%
       
  7,707,800    
Lowe’s Cos., Inc.
    185,064,278  
  4,343,600    
Target Corp.
    228,907,720  
       
 
     
       
Total Retailing
    413,971,998  
       
 
     
       
 
       
       
Software & Services — 19.8%
       
  1,286,660    
Google, Inc.-Class A*
    771,211,137  
  2,194,270    
International Business Machines Corp.
    412,522,760  
  473,980    
MasterCard, Inc.-Class A
    177,529,209  
  39,124,500    
Microsoft Corp.
    1,000,804,710  
  25,699,500    
Oracle Corp.
    805,679,325  
  2,578,107    
SAP AG
    154,375,252  
  2,130,800    
Visa, Inc.-Class A
    206,623,676  
  84,838    
Yahoo! Japan Corp.
    26,882,393  
       
 
     
       
Total Software & Services
    3,555,628,462  
       
 
     
       
 
       
       
Technology Hardware & Equipment — 11.5%
       
  1,562,990    
Apple, Inc.*
    597,374,778  
  51,704,800    
Cisco Systems, Inc.
    963,777,472  
  9,631,200    
Hewlett-Packard Co.
    269,192,040  
  4,350,100    
Qualcomm, Inc.
    238,385,480  
       
 
     
       
Total Technology Hardware & Equipment
    2,068,729,770  
       
 
     
       
 
       
       
Telecommunication Services — 0.9%
       
  96,242    
NTT Docomo Inc
    170,112,010  
       
 
     
       
 
       
       
TOTAL COMMON STOCKS (COST $15,128,584,447)
    17,351,162,385  
       
 
     
       
 
       
       
MUTUAL FUNDS — 0.3%
       
       
 
       
       
Affiliated Issuers — 0.3%
       
  2,596,128    
GMO U.S. Treasury Fund
    64,929,160  
       
 
     
       
 
       
       
TOTAL MUTUAL FUNDS (COST $64,918,441)
    64,929,160  
       
 
     

 


 

                 
Shares     Description   Value ($)  
 
       
SHORT-TERM INVESTMENTS — 2.7%
       
       
 
       
       
Money Market Funds — 1.0%
       
  177,352,250    
State Street Institutional Treasury Money Market Fund-Institutional Class, 0.00% (a)
    177,352,250  
       
 
     
       
 
       
       
U.S. Government — 1.7%
       
  300,000,000    
U.S. Treasury Bill, 0.06%, due 05/31/12 (b)
    299,916,600  
       
 
     
       
 
       
       
TOTAL SHORT-TERM INVESTMENTS (COST $477,246,083)
    477,268,850  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 99.4%
(Cost $15,670,748,971)
    17,893,360,395  
       
 
       
       
Other Assets and Liabilities (net) — 0.6%
    102,154,413  
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 17,995,514,808  
       
 
     
 
Notes to Schedule of Investments:
*   Non-income producing security.
 
(a)   Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.
 
(b)   Rate shown represents yield-to-maturity.

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                         
    Gross     Gross     Net Unrealized  
    Unrealized     Unrealized     Appreciation  
    Aggregate Cost       Appreciation     (Depreciation)     (Depreciation)  
$            16,010,037,366
  $ 1,953,519,707     $ (70,196,678 )   $ 1,883,323,029  
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjuction with the Fund’s Schedule of Investments.
A summary of the Fund’s transcations in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO U.S. Treasury Fund
  $ 52,104,000     $ 41,416,000     $ 28,613,000     $ 22,438     $ 2,934     $ 64,929,160  
 
                                   

 


 

         
Country Summary*   % of Investments
 
United States
    83.9 %
United Kingdom
    4.9  
Switzerland
    3.6  
France
    2.4  
Netherlands
    2.2  
Japan
    1.4  
Germany
    0.9  
Belgium
    0.7  
 
       
 
    100.0 %
 
       
 
*   The table above shows country exposure in the Fund. The table excludes short term investments. The table excludes exposure through forward currency contracts and includes exposure through other derivative financial instruments, if any. The table takes into account the market value of securities and options and the notional amounts of swap agreements and other derivative financial instruments, if any.
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below.
         
Security Type   Percentage of Net Assets of the Fund
Equity Securities
  15.5%  
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the

 


 

valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include: fair value adjustments provided by an independent pricing service applied to securities (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) due to market events that have occurred since the local market close but prior to the close of the NYSE.
Level 3 — Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Common Stocks
                               
Belgium
  $     $ 112,001,132     $     $ 112,001,132  
France
          423,418,005             423,418,005  
Germany
          154,375,252             154,375,252  
Japan
          234,831,734             234,831,734  
Netherlands
          375,409,341             375,409,341  
Switzerland
          632,167,109             632,167,109  
United Kingdom
          857,151,316             857,151,316  
United States
    14,561,808,496                   14,561,808,496  
 
                       
TOTAL COMMON STOCKS
    14,561,808,496       2,789,353,889             17,351,162,385  
 
                       
Mutual Funds
    64,929,160                   64,929,160  
Short-Term Investments
    477,268,850                   477,268,850  
 
                       
Total
  $ 15,104,006,506     $ 2,789,353,889     $     $ 17,893,360,395  
 
                       

 


 

The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If the Fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of the value of those investments. The Fund also may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Focused Investment Risk — Focusing investments in a limited number of countries, sectors or companies or in industries with high positive correlations to one another creates additional risk. The Fund invests its assets in the securities of a limited number of issuers, and a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund invested in the securities of a larger number of issuers.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to

 


 

be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Leveraging Risk — The Fund’s use of derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. For example, the Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives, to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives. The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For example, if the Fund holds a large proportion of stocks of companies in a particular sector and the Manager believes that stocks of companies in another sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index). In adjusting its investment exposure, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net long exposures in excess of its net assets. The Fund’s foreign currency exposure may differ significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund

 


 

may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most forward currency contracts are not collateralized. The Fund had no forward currency contracts outstanding at the end of the period.

 


 

Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded (unless otherwise adjusted due to the time at which foreign markets close). The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. During the period ended November 30, 2011, the Fund used futures contracts to maintain the diversity and liquidity of the portfolio and adjust exposure to certain securities markets. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.

 


 

Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers (unless otherwise adjusted due to the time at which foreign markets close) and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.

 


 

The volume of derivative activity, based on absolute values (futures contracts) outstanding at each month-end, was as follows for the period ended November 30, 2011:
         
    Futures
    Contracts
Average amount outstanding
  $ 28,589,137  

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Real Estate Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares     Description   Value ($)  
 
       
REAL ESTATE INVESTMENTS — 98.7%
       
       
 
       
       
REAL ESTATE INVESTMENT TRUSTS — 98.7%
       
       
 
       
       
Diversified — 6.3%
       
  2,500    
CapLease, Inc.
    10,375  
  3,200    
Colonial Properties Trust
    63,488  
  3,500    
Liberty Property Trust
    104,335  
  700    
PS Business Parks, Inc.
    36,890  
  9,446    
Vornado Realty Trust
    703,255  
  900    
Washington Real Estate Investment Trust
    24,489  
  1,300    
Winthrop Realty Trust
    12,142  
       
 
     
       
Total Diversified
    954,974  
       
 
     
       
 
       
       
Industrial — 4.1%
       
  9,200    
DCT Industrial Trust, Inc.
    44,252  
  2,400    
DuPont Fabros Technology, Inc.
    54,072  
  1,500    
EastGroup Properties, Inc.
    63,855  
  2,000    
First Industrial Realty Trust, Inc. *
    19,000  
  15,760    
ProLogis, Inc.
    438,443  
       
 
     
       
Total Industrial
    619,622  
       
 
     
       
 
       
       
Office — 15.1%
       
  3,170    
Alexandria Real Estate Equities, Inc.
    207,825  
  7,200    
BioMed Realty Trust, Inc.
    128,232  
  8,400    
Boston Properties, Inc.
    801,192  
  4,289    
Brandywine Realty Trust
    37,357  
  4,225    
CommonWealth REIT
    70,727  
  1,000    
Corporate Office Properties Trust
    20,850  
  3,300    
Digital Realty Trust, Inc.
    209,550  
  4,800    
Douglas Emmett, Inc.
    86,304  
  8,000    
Duke Realty Corp.
    92,800  
  2,900    
Franklin Street Properties Corp.
    31,639  
  1,200    
Government Properties Income Trust
    26,100  
  2,600    
Highwoods Properties, Inc.
    74,984  
  2,600    
Kilroy Realty Corp.
    93,834  
  4,608    
Lexington Realty Trust
    34,929  
  2,200    
Mack-Cali Realty Corp.
    56,056  
  3,200    
Piedmont Office Realty Trust, Inc.-Class A
    53,248  
  4,023    
SL Green Realty Corp.
    264,874  
       
 
     
       
Total Office
    2,290,501  
       
 
     
       
 
       
       
Residential — 18.5%
       
  1,800    
American Campus Communities, Inc.
    70,812  
  5,886    
Apartment Investment & Management Co.-Class A
    128,197  
  5,283    
AvalonBay Communities, Inc.
    659,583  
  4,000    
BRE Properties, Inc.
    194,640  
  2,700    
Camden Property Trust
    155,871  
  3,100    
Education Realty Trust, Inc.
    28,892  
  1,000    
Equity Lifestyle Properties, Inc.
    61,830  
  15,000    
Equity Residential
    827,850  
  1,170    
Essex Property Trust, Inc.
    155,435  
  1,800    
Home Properties, Inc.
    98,946  
  1,600    
Mid-America Apartment Communities, Inc.
    91,712  
  2,500    
Post Properties, Inc.
    99,975  
  1,000    
Sun Communities, Inc.
    35,740  

 


 

                 
  7,881    
UDR, Inc.
    185,203  
       
 
     
       
Total Residential
    2,794,686  
       
 
     
       
 
       
       
Retail — 26.9%
       
  1,984    
Acadia Realty Trust
    38,847  
  70    
Alexander’s, Inc.
    27,763  
  7,731    
CBL & Associates Properties, Inc.
    110,476  
  11,197    
DDR Corp.
    130,893  
  2,200    
Equity One, Inc.
    36,762  
  2,300    
Federal Realty Investment Trust
    203,389  
  5,200    
General Growth Properties, Inc.
    73,216  
  1,300    
Getty Realty Corp.
    20,800  
  18,258    
Kimco Realty Corp.
    287,928  
  7,396    
Macerich Co. (The)
    370,539  
  3,400    
National Retail Properties, Inc.
    89,964  
  3,300    
Ramco-Gershenson Properties Trust
    28,017  
  3,700    
Realty Income Corp.
    125,282  
  3,800    
Regency Centers Corp.
    141,208  
  300    
Saul Centers, Inc.
    10,473  
  16,153    
Simon Property Group, Inc.
    2,008,464  
  1,400    
Tanger Factory Outlet Centers, Inc.
    39,690  
  3,000    
Taubman Centers, Inc.
    186,990  
  1,000    
Urstadt Biddle Properties, Inc.
    16,870  
  5,900    
Weingarten Realty Investors
    122,071  
       
 
     
       
Total Retail
    4,069,642  
       
 
     
       
 
       
       
Specialized — 27.8%
       
  6,611    
DiamondRock Hospitality Co.
    58,045  
  2,600    
Entertainment Properties Trust
    116,220  
  4,300    
Extra Space Storage, Inc.
    103,630  
  18,500    
HCP, Inc.
    715,025  
  8,000    
Health Care, Inc.
    401,360  
  1,200    
Healthcare Realty Trust, Inc.
    21,144  
  6,100    
Hospitality Properties Trust
    134,383  
  22,137    
Host Hotels & Resorts, Inc.
    313,238  
  3,200    
LaSalle Hotel Properties
    74,912  
  1,200    
LTC Properties, Inc.
    34,500  
  6,300    
Medical Properties Trust, Inc.
    60,228  
  1,400    
National Health Investors, Inc.
    59,234  
  4,100    
Omega Healthcare Investors, Inc.
    73,513  
  8,484    
Public Storage
    1,119,040  
  8,200    
Senior Housing Properties Trust
    179,662  
  1,400    
Sovran Self Storage, Inc.
    58,296  
  4,500    
Sunstone Hotel Investors, Inc. *
    34,290  
  800    
Universal Health Realty Income Trust
    29,528  
  11,904    
Ventas, Inc.
    628,055  
       
 
     
       
Total Specialized
    4,214,303  
       
 
     
       
 
       
       
TOTAL REAL ESTATE INVESTMENT TRUSTS (COST $11,498,233)
    14,943,728  
       
 
     
       
 
       
       
TOTAL REAL ESTATE INVESTMENTS (COST $11,498,233)
    14,943,728  
       
 
     
       
 
       
       
 
       
       
MUTUAL FUNDS — 1.2%
       
       
 
       
       
Affiliated Issuers — 1.2%
       
  7,638    
GMO U.S. Treasury Fund
    191,041  
       
 
     

 


 

                 
       
 
       
       
TOTAL MUTUAL FUNDS (COST $191,041)
    191,041  
       
 
     
 
       
SHORT-TERM INVESTMENTS — 0.4%
       
       
 
       
       
Money Market Funds — 0.4%
       
  57,466    
State Street Institutional Treasury Money Market Fund-Institutional Class, 0.00%(a)
    57,466  
       
 
     
       
 
       
       
TOTAL SHORT-TERM INVESTMENTS (COST $57,466)
    57,466  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 100.3%
(Cost $11,746,740)
    15,192,235  
       
 
       
       
Other Assets and Liabilities (net) — (0.3%)
    (46,652 )
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 15,145,583  
       
 
     
 
Notes to Schedule of Investments:
REIT — Real Estate Investment Trust
*  Non-income producing security.
(a) Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                         
    Gross     Gross     Net Unrealized  
    Unrealized     Unrealized     Appreciation  
    Aggregate Cost       Appreciation     (Depreciation)     (Depreciation)  
$            12,740,566
  $ 2,731,021     $ (279,352 )   $ 2,451,669  
Investments in affiliated issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO U.S. Treasury Fund
  $ 201,043     $ 361,000     $ 371,062     $ 56     $ 2     $ 191,041  
 
                                   

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs.
Level 3 — Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Common Stocks
  $ 14,943,728     $     $     $ 14,943,728  
Mutual Funds
    191,041                   191,041  
Short-Term Investments
    57,466                   57,466  
 
                       
Total Investments
    15,192,235                   15,192,235  
 
                       
Total
  $ 15,192,235     $     $     $ 15,192,235  
 
                       
All of the Fund’s common stocks held at period end are classified as Level 1. Please refer to the Schedule of Investments for a more detailed categorization of common stocks.
The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Real Estate Risk — Real estate-related investments may decline in value as a result of factors affecting the real estate industry, such as the supply of real property in particular markets, changes in zoning laws, delays in completion of construction, changes in real estate values, changes in property taxes, levels of occupancy, adequacy of rent to cover operating expenses, and local and regional market conditions. The value of real estate-related investments also may be affected by changes in interest rates and social and economic trends. REITs are subject to the risk of fluctuations in income from underlying real estate assets, their inability to manage effectively the cash flows generated by those assets, prepayments and defaults by borrowers, and failing to qualify for the special tax treatment granted to REITs under the Internal Revenue Code of 1986 and/or to maintain exempt status under the 1940 Act.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If the Fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of value of those investments. The Fund also may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Because the Fund normally does not take temporary defensive positions, declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Models that have demonstrated an ability to explain prior market data often fail to accurately predict future market events. Further, the data used in models may be inaccurate and/or it may not include the

 


 

most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Focused Investment Risk — Focusing investments in sectors and industries with high positive correlations to one another creates additional risk. The Fund’s concentration in real estate-related investments make the Fund’s net asset value more susceptible to economic, market, political and other developments affecting the real estate industry.
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk and counterparty risk.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Leveraging Risk — The Fund’s use of derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
Market Risk — Fixed Income Securities — Typically, the market value of the Fund’s fixed income securities will decline during periods of rising interest rates and widening of credit spreads.
Market Risk — Asset-Backed Securities — Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. For example, the Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives, to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives.
The Fund also may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero).

 


 

In addition, the Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors and markets without actually having to sell existing investments or make new direct investments. For example, if the Fund holds a large proportion of stocks of companies in a particular sector and the Manager believes that stocks of companies in another sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index).
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net long exposure in excess of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives

 


 

transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded. The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.

 


 

Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.
For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Short-Duration Collateral Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Par Value ($)     Description   Value ($)  
 
       
DEBT OBLIGATIONS — 95.2%
       
       
 
       
       
Asset-Backed Securities — 92.8%
       
       
 
       
       
Airlines — 1.0%
       
  15,899,466    
Aircraft Finance Trust, Series 99-1A, Class A1, 144A, 1 mo. LIBOR + .48%, 0.73%, due 05/15/24
    7,631,744  
  5,543,053    
Continental Airlines, Inc., Series 99-1A, 6.55%, due 02/02/19
    5,743,712  
       
 
     
       
Total Airlines
    13,375,456  
       
 
     
       
 
       
       
Auto Financing — 5.0%
       
  3,408,323    
Capital Auto Receivable Asset Trust, Series 08-1, Class A4B, 1 mo. LIBOR + 1.35%, 1.60%, due 07/15/14
    3,418,991  
  18,763,784    
Carmax Auto Owner Trust, Series 08-2, Class A4B, 1 mo. LIBOR + 1.65%, 1.90%, due 08/15/13
    18,878,055  
  9,863,179    
Daimler Chrysler Auto Trust, Series 08-B, Class A4A, 5.32%, due 11/10/14
    9,917,427  
  7,695,934    
Daimler Chrysler Auto Trust, Series 08-B, Class A4B, 1 mo. LIBOR + 1.85%, 2.10%, due 11/10/14
    7,715,173  
  15,866,255    
Ford Credit Auto Owner Trust, Series 08-B, Class A4B, 1 mo. LIBOR + 2.00%, 2.25%, due 03/15/13
    15,936,860  
  571,193    
Franklin Auto Trust, Series 08-A, Class A4B, 1 mo. LIBOR + 1.95%, 2.20%, due 05/20/16
    571,759  
  7,761,609    
Wachovia Auto Owner Trust, Series 08-A, Class A4B, 1 mo. LIBOR + 1.15%, 1.40%, due 03/20/14
    7,787,921  
       
 
     
       
Total Auto Financing
    64,226,186  
       
 
     
       
 
       
       
Business Loans — 4.9%
       
  4,213,868    
ACAS Business Loan Trust, Series 07-1A, Class A, 144A, 3 mo. LIBOR + .14%, 0.60%, due 08/16/19
    4,108,522  
  2,391,864    
Bayview Commercial Asset Trust, Series 04-1, Class A, 144A, 1 mo. LIBOR + .36%, 0.62%, due 04/25/34
    1,817,816  
  1,941,375    
Bayview Commercial Asset Trust, Series 04-3, Class A1, 144A, 1 mo. LIBOR + .37%, 0.63%, due 01/25/35
    1,456,031  
  8,142,267    
Bayview Commercial Asset Trust, Series 05-4A, Class A2, 144A, 1 mo. LIBOR + .39%, 0.65%, due 01/25/36
    5,129,628  
  7,759,078    
Bayview Commercial Asset Trust, Series 07-3, Class A1, 144A, 1 mo. LIBOR + .24%, 0.50%, due 07/25/37
    4,888,219  
  29,790,702    
Bayview Commercial Asset Trust, Series 07-6A, Class A2, 144A, 1 mo. LIBOR + 1.30%, 1.56%, due 12/25/37
    20,853,492  
  2,507,397    
GE Business Loan Trust, Series 04-1, Class A, 144A, 1 mo. LIBOR + .29%, 0.54%, due 05/15/32
    2,219,046  
  4,958,169    
GE Business Loan Trust, Series 05-2A, Class A, 144A, 1 mo. LIBOR + .24%, 0.49%, due 11/15/33
    4,065,699  
  13,210,392    
Lehman Brothers Small Balance Commercial, Series 07-3A, Class 1A2, 144A, 1 mo. LIBOR + .85%, 1.11%, due 10/25/37
    10,563,293  
  6,275,837    
Lehman Brothers Small Balance Commercial, Series 05-1A, Class A, 144A, 1 mo. LIBOR + .25%, 0.51%, due 02/25/30
    4,829,633  
  3,695,292    
Lehman Brothers Small Balance Commercial, Series 05-2A, Class 1A, 144A, 1 mo. LIBOR + .25%, 0.51%, due 09/25/30
    2,915,216  
       
 
     
       
Total Business Loans
    62,846,595  
       
 
     
       
 
       
       
CMBS — 10.2%
       
  9,329,969    
Citigroup/Deutsche Bank Commercial Mortgage, Series 05-CD1, Class A2FL, 1 mo. LIBOR + .12%, 0.37%, due 07/15/44
    9,213,344  
  32,300,000    
Commercial Mortgage Pass-Through Certificates, Series 06-FL12, Class AJ, 144A, 1 mo. LIBOR + ..13%, 0.38%, due 12/15/20
    29,231,500  
  8,393,598    
GE Capital Commercial Mortgage Corp., Series 05-C4, Class A2, 5.31%, due 11/10/45
    8,393,598  
  12,996,913    
GE Capital Commercial Mortgage Corp., Series 06-C1, Class A2, 5.33%, due 03/10/44
    12,996,913  
  14,865,787    
GS Mortgage Securities Corp., Series 06-GG6, Class A2, 5.51%, due 04/10/38
    15,009,799  
  5,429,083    
GS Mortgage Securities Corp., Series 07-EOP, Class A1, 144A, 1 mo. LIBOR + .39%, 1.14%, due 03/06/20
    5,374,792  
  6,300,000    
GS Mortgage Securities Corp., Series 07-EOP, Class A2, 144A, 1 mo. LIBOR + .57%, 1.32%, due 03/06/20
    6,237,000  
  3,781,834    
J.P. Morgan Chase Commercial Mortgage Securities Corp., Series 06-LDP7, Class A2, 5.86%, due 04/15/45
    3,784,103  

 


 

                 
  18,540,572    
Merrill Lynch Mortgage Trust, Series 06-C1, Class A2, 5.62%, due 05/12/39
    18,903,967  
  7,084,521    
Morgan Stanley Capital I, Series 06-IQ11, Class A3, 5.69%, due 10/15/42
    7,222,598  
  15,599,822    
Wachovia Bank Commercial Mortgage Trust, Series 06-WL7A, Class A1, 144A, 1 mo. LIBOR + .09%, 0.34%, due 09/15/21
    14,819,831  
       
 
     
       
Total CMBS
    131,187,445  
       
 
     
       
 
       
       
CMBS Collateralized Debt Obligations — 2.9%
       
  4,398,348    
American Capital Strategies Ltd. Commercial Real Estate CDO Trust, Series 07-1A, Class A, 144A, 3 mo. LIBOR + .80%, 1.30%, due 11/23/52
    43,983  
  5,456,063    
Crest Exeter Street Solar, Series 04-1A, Class A1, 144A, 3 mo. LIBOR + .35%, 0.71%, due 06/28/19
    5,019,578  
  9,828,889    
G-Force LLC, Series 05-RR2, Class A2, 144A, 5.16%, due 12/25/39
    9,239,156  
  4,626,495    
Guggenheim Structured Real Estate Funding, Series 05-2A, Class A, 144A, 1 mo. LIBOR + .32%, 0.58%, due 08/26/30
    4,267,942  
  25,952,503    
Marathon Real Estate CDO, Series 06-1A, Class A1, 144A, 1 mo. LIBOR + .33%, 0.59%, due 05/25/46
    18,945,327  
       
 
     
       
Total CMBS Collateralized Debt Obligations
    37,515,986  
       
 
     
       
 
       
       
Corporate Collateralized Debt Obligations — 2.4%
       
  34,200,000    
Morgan Stanley ACES SPC, Series 06-13A, Class A, 144A, 3 mo. LIBOR + .29%, 0.64%, due 06/20/13
    30,126,780  
       
 
     
 
       
Credit Cards — 9.4%
       
  7,700,000    
Capital One Multi-Asset Execution Trust, Series 07-A4, Class A4, 1 mo. LIBOR + .03%, 0.28%, due 03/16/15
    7,689,451  
  39,000,000    
Charming Shoppes Master Trust, Series 07-1A, Class A1, 144A, 1 mo. LIBOR + 1.25%, 1.50%, due 09/15/17
    39,064,350  
  46,600,000    
Chase Issuance Trust, Series 05-A6, Class A6, 1 mo. LIBOR + .07%, 0.32%, due 07/15/14
    46,578,156  
  16,400,000    
Discover Card Master Trust I, Series 05-4, Class A2, 1 mo. LIBOR + .09%, 0.34%, due 06/16/15
    16,392,313  
  10,600,000    
World Financial Network Credit Card Master Trust, Series 06-A, Class A, 144A, 1 mo. LIBOR + ..13%, 0.38%, due 02/15/17
    10,517,214  
       
 
     
       
Total Credit Cards
    120,241,484  
       
 
     
       
 
       
       
Insured Auto Financing — 5.4%
       
  5,962,022    
AmeriCredit Automobile Receivables Trust, Series 07-AX, Class A4, XL, 1 mo. LIBOR + .04%, 0.29%, due 10/06/13
    5,947,117  
  5,854,354    
AmeriCredit Automobile Receivables Trust, Series 07-BF, Class A4, FSA, 1 mo. LIBOR + .05%, 0.30%, due 12/06/13
    5,854,236  
  6,083,450    
AmeriCredit Automobile Receivables Trust, Series 07-DF, Class A4B, FSA, 1 mo. LIBOR + .80%, 1.05%, due 06/06/14
    6,080,311  
  13,116,927    
AmeriCredit Prime Automobile Receivable Trust, Series 07-2M, Class A4B, MBIA, 1 mo. LIBOR + ..50%, 0.75%, due 03/08/16
    13,067,083  
  37,989,036    
Triad Auto Receivables Owner Trust, Series 07-B, Class A4B, FSA, 1 mo. LIBOR + 1.20%, 1.45%, due 07/14/14
    38,174,043  
       
 
     
       
Total Insured Auto Financing
    69,122,790  
       
 
     
       
 
       
       
Insured Business Loans — 0.1%
       
  2,105,328    
CNL Commercial Mortgage Loan Trust, Series 03-2A, Class A1, 144A, AMBAC, 1 mo. LIBOR + .44%, 0.70%, due 10/25/30
    1,526,363  
       
 
     
       
 
       
       
Insured High Yield Collateralized Debt Obligations ♣— 0.9%
       
  13,578,846    
Augusta Funding Ltd., Series 10A, Class F1, 144A, CapMAC, 3mo. LIBOR +.25%, 0.62%, due 06/30/17(a)
    11,935,260  
  223,575    
GSC Partners CDO Fund Ltd., Series 03-4A, Class A3, 144A, AMBAC, 3 mo. LIBOR + .46%, 0.87%, due 12/16/15
    220,221  
       
 
     
       
Total Insured High Yield Collateralized Debt Obligations
    12,155,481  
       
 
     

 


 

                 
       
Insured Other — 5.6%
       
  45,300,000    
Dominos Pizza Master Issuer LLC, Series 07-1, Class A2, 144A, MBIA, 5.26%, due 04/25/37
    45,474,405  
  9,429,020    
Henderson Receivables LLC, Series 06-3A, Class A1, 144A, MBIA, 1 mo. LIBOR + .20%, 0.45%, due 09/15/41
    8,354,628  
  8,892,105    
Henderson Receivables LLC, Series 06-4A, Class A1, 144A, MBIA, 1 mo. LIBOR + .20%, 0.45%, due 12/15/41
    7,910,847  
  9,277,851    
TIB Card Receivables Fund, Series 2005-B,144A, FGIC, 3 mo. LIBOR + .25%, 0.63%, due 01/05/14
    7,422,281  
  2,988,000    
Toll Road Investment Part II, Series 1999B, 144A, MBIA, Zero Coupon, due 02/15/30
    404,366  
  26,300,000    
Toll Road Investment Part II, Series C, 144A, MBIA, Zero Coupon, due 02/15/37
    1,646,117  
       
 
     
       
Total Insured Other
    71,212,644  
       
 
     
       
 
       
       
Insured Residential Asset-Backed Securities (United States) ♦— 0.9%
       
  2,134,976    
Ameriquest Mortgage Securities, Inc., Series 04-R6, Class A1, XL, 1 mo. LIBOR + .21%, 0.68%, due 07/25/34
    1,686,631  
  2,424,167    
Citigroup Mortgage Loan Trust, Inc., Series 03-HE3, Class A, AMBAC, 1 mo. LIBOR + .38%, 0.64%, due 12/25/33
    1,951,454  
  667,926    
Quest Trust, Series 04-X1, Class A, 144A, AMBAC, 1 mo. LIBOR + .33%, 0.59%, due 03/25/34
    500,945  
  10,432,111    
Residential Asset Mortgage Products, Inc., Series 05-RS9, Class AI3, FGIC, 1 mo. LIBOR + ..22%, 0.48%, due 11/25/35
    7,302,477  
       
 
     
       
Total Insured Residential Asset-Backed Securities (United States)
    11,441,507  
       
 
     
       
 
       
       
Insured Residential Mortgage-Backed Securities (United States) — 1.0%
       
  420,312    
Chevy Chase Mortgage Funding Corp., Series 03-4A, Class A1, 144A, AMBAC, 1 mo. LIBOR + .34%, 0.60%, due 10/25/34
    268,580  
  953,326    
Chevy Chase Mortgage Funding Corp., Series 04-1A, Class A2, 144A, AMBAC, 1 mo. LIBOR + .33%, 0.59%, due 01/25/35
    595,829  
  9,073,373    
Countrywide Home Equity Loan Trust, Series 07-E, Class A, MBIA, 1 mo. LIBOR + .15%, 0.40%, due 06/15/37
    5,353,290  
  4,763,061    
GMAC Mortgage Corp. Loan Trust, Series 04-HE3, Class A3, FSA, 1 mo. LIBOR + .23%, 0.49%, due 10/25/34
    3,341,763  
  242,574    
GreenPoint Home Equity Loan Trust, Series 04-1, Class A, AMBAC, 1 mo. LIBOR + .23%, 0.72%, due 07/25/29
    163,301  
  276,900    
GreenPoint Home Equity Loan Trust, Series 04-4, Class A, AMBAC, 1 mo. LIBOR + .28%, 0.81%, due 08/15/30
    171,041  
  563,319    
Lehman ABS Corp., Series 04-2, Class A, AMBAC, 1 mo. LIBOR + .22%, 0.70%, due 06/25/34
    371,790  
  132,446    
Residential Funding Mortgage Securities II, Series 03-HS1, Class AII, FGIC, 1 mo. LIBOR + ..29%, 0.55%, due 12/25/32
    38,409  
  3,313,882    
SBI Heloc Trust, Series 05-HE1, Class 1A, 144A, FSA, 1 mo. LIBOR + .19%, 0.45%, due 11/25/35
    3,002,046  
       
 
     
       
Total Insured Residential Mortgage-Backed Securities (United States)
    13,306,049  
       
 
     
       
 
       
       
Insured Time Share — 0.9%
       
  1,884,750    
Sierra Receivables Funding Co., Series 06-1A, Class A2, 144A, MBIA, 1 mo. LIBOR + .15%, 0.40%, due 05/20/18
    1,865,326  
  2,184,958    
Sierra Receivables Funding Co., Series 07-1A, Class A2, 144A, FGIC, 1 mo. LIBOR + .15%, 0.40%, due 03/20/19
    2,104,388  
       
 
     
  7,370,478    
Sierra Receivables Funding Co., Series 07-2A, Class A2, 144A, MBIA, 1 mo. LIBOR + 1.00%, 1.25%, due 09/20/19
    7,155,193  
       
 
     
       
Total Insured Time Share
    11,124,907  
       
 
     
       
 
       
       
Insured Transportation — 0.2%
       
  3,117,500    
GE Seaco Finance SRL, Series 04-1A, Class A, 144A, AMBAC, 1 mo. LIBOR + .30%, 0.55%, due 04/17/19
    3,031,769  
       
 
     
       
 
       
       
Rate Reduction Bonds — 0.7%
       
  8,775,803    
PG&E Energy Recovery Funding LLC, Series 05-1, Class A4, 4.37%, due 06/25/14
    8,852,591  
       
 
     

 


 

                 
       
Residential Asset-Backed Securities (United States) ♦ — 20.7%
       
  977,554    
Accredited Mortgage Loan Trust, Series 04-4, Class A1B, 1 mo. LIBOR + .39%, 0.65%, due 01/25/35
    766,158  
  2,479,463    
ACE Securities Corp., Series 06-ASL1, Class A, 1 mo. LIBOR + .14%, 0.40%, due 02/25/36
    514,489  
  5,363,172    
ACE Securities Corp., Series 06-ASP2, Class A2C, 1 mo. LIBOR + .18%, 0.44%, due 03/25/36
    4,438,024  
  2,387,816    
ACE Securities Corp., Series 06-ASP4, Class A2B, 1 mo. LIBOR + .10%, 0.36%, due 08/25/36
    2,205,745  
  20,300,000    
ACE Securities Corp., Series 06-ASP5, Class A2C, 1 mo. LIBOR + .18%, 0.44%, due 10/25/36
    5,684,000  
  5,819,433    
ACE Securities Corp., Series 06-CW1, Class A2B, 1 mo. LIBOR + .10%, 0.36%, due 07/25/36
    5,441,170  
  5,392,887    
ACE Securities Corp., Series 06-HE2, Class A2C, 1 mo. LIBOR + .16%, 0.42%, due 05/25/36
    2,642,514  
  1,865,498    
ACE Securities Corp., Series 06-HE3, Class A2B, 1 mo. LIBOR + .09%, 0.35%, due 06/25/36
    1,697,603  
  10,807,121    
ACE Securities Corp., Series 06-OP1, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 04/25/36
    6,322,166  
  3,505,575    
ACE Securities Corp., Series 06-SL1, Class A, 1 mo. LIBOR + .16%, 0.58%, due 09/25/35
    613,476  
  7,462,226    
ACE Securities Corp., Series 06-SL3, Class A1, 1 mo. LIBOR + .10%, 0.36%, due 06/25/36
    1,212,612  
  8,674,087    
ACE Securities Corp., Series 06-SL3, Class A2, 1 mo. LIBOR + .17%, 0.43%, due 06/25/36
    1,062,576  
  5,332,165    
ACE Securities Corp., Series 07-HE1, Class A2A, 1 mo. LIBOR + .09%, 0.35%, due 01/25/37
    1,572,988  
  3,159,888    
ACE Securities Corp., Series 07-WM1, Class A2A, 1 mo. LIBOR + .07%, 0.33%, due 11/25/36
    1,058,563  
  11,922,600    
Alliance Bancorp Trust, Series 07-S1, Class A1, 144A, 1 mo. LIBOR + .20%, 0.46%, due 05/25/37
    596,130  
  3,448,275    
Argent Securities, Inc., Series 04-W8, Class A5, 1 mo. LIBOR + .52%, 1.30%, due 05/25/34
    2,981,141  
  50,049,962    
Argent Securities, Inc., Series 06-M1, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 07/25/36
    12,997,350  
  7,692,188    
Argent Securities, Inc., Series 06-M2, Class A2B, 1 mo. LIBOR + .11%, 0.37%, due 09/25/36
    2,249,965  
  10,277,333    
Argent Securities, Inc., Series 06-W2, Class A2B, 1 mo. LIBOR + .19%, 0.45%, due 03/25/36
    2,980,427  
  288,926    
Argent Securities, Inc., Series 06-W4, Class A2B, 1 mo. LIBOR + .11%, 0.37%, due 05/25/36
    80,177  
  8,241,821    
Argent Securities, Inc., Series 06-W5, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 06/25/36
    2,168,629  
  9,546,891    
Asset Backed Funding Certificates, Series 06-OPT2, Class A3C, 1 mo. LIBOR + .15%, 0.41%, due 10/25/36
    5,537,197  
  17,228,615    
Asset Backed Funding Certificates, Series 07-NC1, Class A1, 144A, 1 mo. LIBOR + .22%, 0.48%, due 05/25/37
    13,567,534  
  5,238,129    
Bayview Financial Acquisition Trust, Series 04-B, Class A1, 144A, 1 mo. LIBOR + .50%, 1.26%, due 05/28/39
    1,702,392  
  5,461,028    
Bayview Financial Acquisition Trust, Series 04-B, Class A2, 144A, 1 mo. LIBOR + .65%, 1.56%, due 05/28/39
    1,542,740  
  9,592,824    
Bayview Financial Acquisition Trust, Series 05-A, Class A1, 144A, 1 mo. LIBOR + .50%, 1.26%, due 02/28/40
    5,765,287  
  3,394,916    
Bear Stearns Asset Backed Securities, Inc., Series 07-AQ1, Class A1, 1 mo. LIBOR + .11%, 0.37%, due 11/25/36
    2,060,375  
  8,500,000    
Bear Stearns Asset Backed Securities, Inc., Series 07-AQ1, Class A2, 1 mo. LIBOR + .20%, 0.46%, due 11/25/36
    1,134,750  
  2,271,390    
Bear Stearns Mortgage Funding Trust, Series 07-SL2, Class 1A, 1 mo. LIBOR + .16%, 0.58%, due 02/25/37
    359,107  
  991,099    
Carrington Mortgage Loan Trust, Series 07-FRE1, Class A1, 1 mo. LIBOR + .12%, 0.38%, due 02/25/37
    965,330  
  38,100,000    
Carrington Mortgage Loan Trust, Series 07-FRE1, Class A2, 1 mo. LIBOR + .20%, 0.46%, due 02/25/37
    23,481,030  
  8,802,480    
Centex Home Equity, Series 06-A, Class AV3, 1 mo. LIBOR + .16%, 0.42%, due 06/25/36
    6,689,885  
  158,405    
Chase Funding Mortgage Loan Trust, Series 03-3, Class 2A2, 1 mo. LIBOR + .27%, 0.80%, due 04/25/33
    133,060  
  83,407    
Citigroup Mortgage Loan Trust, Inc., Series 04-OPT1, Class A1B, 1 mo. LIBOR + .41%, 0.67%, due 10/25/34
    77,569  
  12,100,000    
Citigroup Mortgage Loan Trust, Inc., Series 06-HE3, Class A2C, 1 mo. LIBOR + .16%, 0.42%, due 12/25/36
    3,630,000  
  36,200,000    
Countrywide Asset-Backed Certificates, Series 06-BC3, Class 2A2, 1 mo. LIBOR + .14%, 0.40%, due 02/25/37
    26,335,500  
  821,482    
Countrywide Asset-Backed Certificates, Series 06-BC5, Class 2A1, 1 mo. LIBOR + .08%, 0.34%, due 03/25/37
    810,803  
  417,854    
Equity One ABS, Inc., Series 04-1, Class AV2, 1 mo. LIBOR + .30%, 0.56%, due 04/25/34
    300,202  
  11,400,028    
First Franklin Mortgage Loan Asset Backed Certificates, Series 06-FF5, Class 2A3, 1 mo. LIBOR + .16%, 0.42%, due 04/25/36
    6,768,767  
  3,647,944    
Fremont Home Loan Trust, Series 06-A, Class 1A2, 1 mo. LIBOR + .20%, 0.45%, due 05/25/36
    1,954,500  
  1,271,286    
Fremont Home Loan Trust, Series 06-B, Class 2A2, 1 mo. LIBOR + .10%, 0.36%, due 08/25/36
    423,497  

 


 

                 
  18,944,685    
Fremont Home Loan Trust, Series 06-B, Class 2A3, 1 mo. LIBOR + .16%, 0.42%, due 08/25/36
    5,304,512  
  12,877,893    
GE-WMC Mortgage Securities, Series 06-1, Class A2B, 1 mo. LIBOR + .15%, 0.41%, due 08/25/36
    3,219,473  
  2,681,085    
Household Home Equity Loan Trust, Series 05-2, Class A2, 1 mo. LIBOR + .31%, 0.56%, due 01/20/35
    2,303,219  
  2,325,868    
Household Home Equity Loan Trust, Series 05-3, Class A2, 1 mo. LIBOR + .29%, 0.54%, due 01/20/35
    2,046,037  
  7,947,775    
Household Home Equity Loan Trust, Series 06-1, Class A1, 1 mo. LIBOR + .16%, 0.41%, due 01/20/36
    6,994,042  
  26,684,086    
J.P. Morgan Mortgage Acquisition Corp., Series 06-WMC4, Class A3, 1 mo. LIBOR + .12%, 0.38%, due 12/25/36
    8,429,503  
  1,768,028    
Master Asset-Backed Securities Trust, Series 05-FRE1, Class A4, 1 mo. LIBOR + .25%, 0.51%, due 10/25/35
    1,661,947  
  1,989,571    
Master Asset-Backed Securities Trust, Series 06-AM3, Class A2, 1 mo. LIBOR + .13%, 0.39%, due 10/25/36
    1,929,884  
  16,263,328    
Master Asset-Backed Securities Trust, Series 06-FRE2, Class A4, 1 mo. LIBOR + .15%, 0.41%, due 03/25/36
    5,692,165  
  11,300,000    
Master Asset-Backed Securities Trust, Series 06-HE2, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 06/25/36
    3,390,000  
  21,026,429    
Master Asset-Backed Securities Trust, Series 06-HE3, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 08/25/36
    5,572,004  
  14,241,776    
Master Asset-Backed Securities Trust, Series 06-NC3, Class A4, 1 mo. LIBOR + .16%, 0.42%, due 10/25/36
    4,272,533  
  5,705,604    
Master Second Lien Trust, Series 06-1, Class A, 1 mo. LIBOR + .16%, 0.58%, due 03/25/36
    684,672  
  5,173,825    
Merrill Lynch Mortgage Investors, Series 07-HE2, Class A2A, 1 mo. LIBOR + .12%, 0.38%, due 02/25/37
    2,354,090  
  2,066,168    
Morgan Stanley Capital, Inc., Series 04-SD1, Class A, 1 mo. LIBOR + .40%, 0.66%, due 08/25/34
    1,482,476  
  32,500,000    
Morgan Stanley Capital, Inc., Series 07-HE4, Class A2C, 1 mo. LIBOR + .23%, 0.49%, due 02/25/37
    6,825,000  
  13,738,633    
Morgan Stanley Home Equity Loans, Series 06-3, Class A3, 1 mo. LIBOR + .16%, 0.42%, due 04/25/36
    5,770,226  
  3,443,715    
Morgan Stanley Home Equity Loans, Series 07-2, Class A1, 1 mo. LIBOR + .10%, 0.36%, due 04/25/37
    2,815,237  
  9,202,676    
Morgan Stanley IXIS Real Estate Capital Trust, Series 06-2, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 11/25/36
    2,254,656  
  5,734,841    
People’s Choice Home Loan Securities Trust, Series 05-4, Class 1A2, 1 mo. LIBOR + .26%, 0.52%, due 12/25/35
    3,302,121  
  5,460,722    
RAAC Series Trust, Series 06-SP1, Class A2, 1 mo. LIBOR + .19%, 0.45%, due 09/25/45
    4,526,938  
  1,272,455    
Residential Asset Mortgage Products, Inc., Series 05-RS8, Class A2, 1 mo. LIBOR + .29%, 0.55%, due 10/25/33
    1,165,951  
  3,424,257    
Residential Asset Securities Corp., Series 05-KS12, Class A2, 1 mo. LIBOR + .25%, 0.51%, due 01/25/36
    3,081,831  
  362,821    
Residential Asset Securities Corp., Series 07-KS3, Class AI1, 1 mo. LIBOR + .11%, 0.37%, due 04/25/37
    360,209  
  236,691    
Saxon Asset Securities Trust, Series 04-1, Class A, 1 mo. LIBOR + .27%, 0.80%, due 03/25/35
    147,488  
  434,413    
Securitized Asset Backed Receivables LLC, Series 06-NC1, Class A2, 1 mo. LIBOR + .16%, 0.42%, due 03/25/36
    399,660  
  270,613    
Security National Mortgage Loan Trust, Series 06-2A, Class A1, 144A, 1 mo. LIBOR + .29%, 0.55%, due 10/25/36
    268,583  
  1,044,869    
SG Mortgage Securities Trust, Series 05-OPT1, Class A2, 1 mo. LIBOR + .26%, 0.52%, due 10/25/35
    967,862  
  857,434    
Soundview Home Equity Loan Trust, Series 07-NS1, Class A1, 1 mo. LIBOR + .12%, 0.38%, due 01/25/37
    820,189  
  17,100,000    
Specialty Underwriting & Residential Finance, Series 06-BC3, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 06/25/37
    7,182,000  
  5,733,332    
Structured Asset Investment Loan Trust, Series 06-1, Class A3, 1 mo. LIBOR + .20%, 0.46%, due 01/25/36
    4,127,999  
  2,789,578    
Structured Asset Securities Corp., Series 05-S6, Class A2, 1 mo. LIBOR + .29%, 0.84%, due 11/25/35
    2,154,949  

 


 

                 
  13,800,276    
Yale Mortgage Loan Trust, Series 07-1, Class A, 144A, 1 mo. LIBOR + .40%, 0.66%, due 06/25/37
    1,104,022  
       
 
     
       
Total Residential Asset-Backed Securities (United States)
    265,136,906  
       
 
     
       
 
       
       
Residential Mortgage-Backed Securities (Australian) — 5.4%
       
  2,316,860    
Crusade Global Trust, Series 04-2, Class A1, 3 mo. LIBOR + .13%, 0.61%, due 11/19/37
    2,271,127  
  5,243,278    
Crusade Global Trust, Series 06-1, Class A1, 144A, 3 mo. LIBOR + .06%, 0.47%, due 07/20/38
    5,107,273  
  8,452,393    
Crusade Global Trust, Series 07-1, Class A1, 3 mo. LIBOR + .06%, 0.47%, due 04/19/38
    8,122,031  
  1,391,240    
Interstar Millennium Trust, Series 03-3G, Class A2, 3 mo. LIBOR + .25%, 0.86%, due 09/27/35
    1,276,936  
  13,959,309    
Interstar Millennium Trust, Series 04-2G, Class A, 3 mo. LIBOR + .20%, 0.74%, due 03/14/36
    12,837,818  
  898,718    
Interstar Millennium Trust, Series 05-1G, Class A, 3 mo. LIBOR + .12%, 0.74%, due 12/08/36
    799,858  
  1,512,234    
Interstar Millennium Trust, Series 06-2GA, Class A2, 144A, 3 mo. LIBOR + .08%, 0.81%, due 05/27/38
    1,382,968  
  1,157,504    
Medallion Trust, Series 05-1G, Class A1, 3 mo. LIBOR + .08%, 0.52%, due 05/10/36
    1,116,046  
  5,762,049    
Medallion Trust, Series 06-1G, Class A1, 3 mo. LIBOR + .05%, 0.39%, due 06/14/37
    5,606,376  
  2,352,319    
Medallion Trust, Series 07-1G, Class A1, 3 mo. LIBOR + .04%, 0.55%, due 02/27/39
    2,279,968  
  6,468,100    
National RMBS Trust, Series 06-3, Class A1, 144A, 3 mo. LIBOR + .07%, 0.48%, due 10/20/37
    6,267,235  
  8,106,032    
Puma Finance Ltd., Series G5, Class A1, 144A, 3 mo. LIBOR + .07%, 0.55%, due 02/21/38
    7,417,830  
  8,485,871    
Superannuation Members Home Loans Global Fund, Series 07-1, Class A1, 3 mo. LIBOR + .06%, 0.40%, due 06/12/40
    7,995,244  
  799,630    
Superannuation Members Home Loans Global Fund, Series 7, Class A1, 3 mo. LIBOR + .14%, 0.62%, due 03/09/36
    775,465  
  689,296    
Superannuation Members Home Loans Global Fund, Series 8, Class A1, 3 mo. LIBOR + .07%, 0.53%, due 01/12/37
    675,331  
  6,065,879    
Westpac Securitization Trust, Series 07-1G, Class A2A, 3 mo. LIBOR + .05%, 0.53%, due 05/21/38
    5,884,691  
       
 
     
       
Total Residential Mortgage-Backed Securities (Australian)
    69,816,197  
       
 
     
       
 
       
       
Residential Mortgage-Backed Securities (European) — 7.0%
       
  9,173,762    
Aire Valley Mortgages, Series 06-1A, Class 1A, 144A, 3 mo. LIBOR + .11%, 0.46%, due 09/20/66
    7,522,485  
  21,720,327    
Brunel Residential Mortgages, Series 07-1A, Class A4C, 144A, 3 mo. LIBOR + .10%, 0.50%, due 01/13/39
    19,243,776  
  3,458,494    
Granite Master Issuer Plc, Series 06-2, Class A4, 1 mo. LIBOR + .08%, 0.33%, due 12/20/54
    3,313,237  
  1,920,720    
Granite Mortgages Plc, Series 04-3, Class 2A1, 3 mo. LIBOR + .14%, 0.63%, due 09/20/44
    1,845,812  
  8,875,151    
Kildare Securities Ltd., Series 07-1A, Class A2, 144A, 3 mo. LIBOR + .06%, 0.40%, due 12/10/43
    7,898,884  
  3,162,698    
Leek Finance Plc, Series 17A, Class A2B, 144A, 3 mo. LIBOR + .28%, 0.63%, due 12/21/37
    2,830,615  
  6,131,587    
Paragon Mortgages Plc, Series 7A, Class A1A, 144A, 3 mo. LIBOR + .42%, 0.88%, due 05/15/34
    4,926,117  
  10,488,068    
Paragon Mortgages Plc, Series 12A, Class A2C, 144A, 3 mo. LIBOR + .22%, 0.68%, due 11/15/38
    7,767,988  
  6,097,557    
Paragon Mortgages Plc, Series 14A, Class A2C, 144A, 3 mo. LIBOR + .10%, 0.45%, due 09/15/39
    4,556,704  
  26,600,000    
Permanent Master Issuer Plc, Series 06-1, Class 5A, 3 mo. LIBOR + .11%, 0.51%, due 07/15/33
    26,341,980  
  3,200,000    
Permanent Master Issuer Plc, Series 07-1, Class 4A, 3 mo. LIBOR + .08%, 0.48%, due 10/15/33
    3,183,680  
       
 
     
       
Total Residential Mortgage-Backed Securities (European)
    89,431,278  
       
 
     
       
 
       
       
Residential Mortgage-Backed Securities (United States) — 0.2%
       
  498,215    
Chevy Chase Mortgage Funding Corp., Series 04-3A, Class A2, 144A, 1 mo. LIBOR + .30%, 0.56%, due 08/25/35
    311,385  
  2,428,688    
Mellon Residential Funding Corp., Series 04-TBC1, Class A, 144A, 1 mo. LIBOR + .25%, 0.51%, due 02/26/34
    1,967,237  
       
 
     
       
Total Residential Mortgage-Backed Securities (United States)
    2,278,622  
       
 
     
       
 
       
       
Student Loans — 7.9%
       
  20,300,000    
College Loan Corp. Trust, Series 07-2, Class A1, 3 mo. LIBOR + .25%, 0.67%, due 01/25/24
    19,792,500  
  421,906    
Goal Capital Funding Trust, Series 07-1, Class A1, 3 mo. LIBOR + .02%, 0.38%, due 06/25/21
    421,105  
  1,050,563    
National Collegiate Student Loan Trust, Series 06-1, Class A2, 1 mo. LIBOR + .14%, 0.40%, due 08/25/23
    1,019,046  
  9,600,000    
Nelnet Student Loan Trust, Series 05-2, Class A4, 3 mo. LIBOR + .08%, 0.44%, due 12/23/19
    9,475,584  
  9,914,408    
SLM Student Loan Trust, Series 05-1, Class A2, 3 mo. LIBOR + .08%, 0.50%, due 04/27/20
    9,761,469  
  24,600,000    
SLM Student Loan Trust, Series 05-3, Class A4, 3 mo. LIBOR + .07%, 0.49%, due 04/27/20
    24,307,752  
  3,224,037    
SLM Student Loan Trust, Series 07-A, Class A1, 3 mo. LIBOR + .03%, 0.38%, due 09/15/22
    3,215,977  
  16,916,058    
SLM Student Loan Trust, Series 07-2, Class A2, 3 mo. LIBOR, 0.42%, due 07/25/17
    16,704,607  
  5,500,000    
SLM Student Loan Trust, Series 07-6, Class A2, 3 mo. LIBOR + .25%, 0.67%, due 01/25/19
    5,476,900  

 


 

                 
  10,800,000    
SLM Student Loan Trust, Series 08-6, Class A3, 3 mo. LIBOR + .75%, 1.17%, due 01/25/19
    10,673,437  
       
 
     
       
Total Student Loans
    100,848,377  
       
 
     
       
 
       
       
Time Share — 0.1%
       
  1,787,417    
Sierra Receivables Funding Co., Series 08-1A, Class A2, 144A, 1 mo. LIBOR + 4.00%, 4.25%, due 02/20/20
    1,836,850  
       
 
     
       
Total Asset-Backed Securities
    1,190,642,263  
       
 
     
       
 
       
       
U.S. Government Agency — 2.4%
       
  11,250,000    
Agency for International Development Floater (Support of Morocco), 6 mo. LIBOR + .15%, 0.88%, due 10/29/26(a)
    10,541,726  
  13,331,250    
Agency for International Development Floater (Support of Morocco), 6 mo. LIBOR -0.02%, 0.72%, due 02/01/25(a)
    12,456,469  
  316,708    
Agency for International Development Floater (Support of Peru), Series A, 6 mo. U.S. Treasury Bill + .35%, 0.42%, due 05/01/14(a)
    310,612  
  8,460,000    
Agency for International Development Floater (Support of Tunisia), 6 mo. LIBOR, 0.73%, due 07/01/23(a)
    7,977,925  
       
 
     
       
Total U.S. Government Agency
    31,286,732  
       
 
     
 
       
TOTAL DEBT OBLIGATIONS (COST $1,661,242,751)
    1,221,928,995  
       
 
     
                 
Shares     Description   Value ($)  
 
       
SHORT-TERM INVESTMENTS — 4.7%
       
 
       
Money Market Funds — 4.7%
       
  21,940,350    
State Street Institutional Liquid Reserves Fund-Institutional Class, 0.17%(b)
    21,940,350  
  38,219,754    
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00%(c)
    38,219,754  
       
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $60,160,104)
    60,160,104  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 99.9%
(Cost $1,721,402,855)
    1,282,089,099  
       
 
       
       
Other Assets and Liabilities (net) — 0.1%
    1,402,763  
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 1,283,491,862  
       
 
     

 


 

A summary of outstanding financial instruments at November 30, 2011 is as follows:
Swap Agreements
Credit Default Swaps
                                 
                            Maximum Potential    
                    Implied       Amount of Future   Net Unrealized
Notional   Expiration       Receive   Annual   Credit   Reference   Payments by the Fund   Appreciation/
Amount   Date   Counterparty   (Pay)^   Premium   Spread(1)   Entity   Under the Contract(2)   (Depreciation)
31,000,000  USD
  3/20/2013     Morgan Stanley Capital Services Inc.     Receive   0.25%   2.05%   MS Synthetic 2006-1   31,000,000   USD $(734,788)
 
                             
 
                          Premiums to (Pay) Receive     $
 
                             
 
^   Receive — Fund receives premium and sells credit protection. If a credit event occurs, as defined under the terms of that particular swap agreement, the Fund will either (i) pay to the buyer of protection an amount equal to the notional amount of the swap and take delivery of the referenced obligation or underlying securities comprising the referenced index or (ii) pay a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation or underlying securities comprising the referenced index.

(Pay) — Fund pays premium and buys credit protection. If a credit event occurs, as defined under the terms of that particular swap agreement, the Fund will either (i) receive from the seller of protection an amount equal to the notional amount of the swap and deliver the referenced obligation or underlying securities comprising the referenced index or (ii) receive a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation or underlying securities comprising the referenced index.
 
(1)   Implied credit spreads, represented in absolute terms, utilized in determining the market value of credit default swap agreements on the reference security, as of November 30, 2011, serve as an indicator of the current status of the payment/performance risk and reflect the likelihood or risk of default for the reference entity. The implied credit spread of a particular referenced entity reflects the cost of buying/selling protection. Wider (i.e.higher) credit spreads represent a deterioration of the referenced entity’s credit soundness and a greater likelihood or risk of default or other credit event occurring as defined under the terms of the agreement.
 
(2)   The maximum potential amount the Fund could be required to pay as a seller of credit protection if a credit event occurs as defined under the terms of that particular swap agreement.
 
    As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
 
    Notes to Schedule of Investments:
 
    144A — Securities exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional investors.
 
    AMBAC — Insured as to the payment of principal and interest by AMBAC Assurance Corporation.
 
    CapMAC — Insured as to the payment of principal and interest by Capital Markets Assurance Corporation.
 
    CDO — Collateralized Debt Obligation
 
    CMBS — Commercial Mortgage Backed Security
 
    FGIC — Insured as to the payment of principal and interest by Financial Guaranty Insurance Corporation.
 
    FSA — Insured as to the payment of principal and interest by Financial Security Assurance.
 
    LIBOR — London Interbank Offered Rate
 
    MBIA — Insured as to the payment of principal and interest by MBIA Insurance Corp.
 
    RMBS — Residential Mortgage Backed Security
 
    XL — Insured as to the payment of principal and interest by XL Capital Assurance.
 
    The rates shown on variable rate notes are the current interest rates at November 30, 2011, which are subject to change based on the terms of the security.
 
  These securities were categorized as “high yield” as a result of being rated below investment grade at issuance.
 
  These securities are primarily backed by subprime mortgages.

 


 

(a)   Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust.
 
(b)   Rate disclosed, the 7 day net yield, is as of November 30, 2011.
 
(c)   Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.
Currency Abbreviations:
USD — United States Dollar

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                         
    Gross     Gross     Net Unrealized  
    Unrealized     Unrealized     Appreciation  
Aggregate Cost   Appreciation     (Depreciation)     (Depreciation)  
$    1,720,854,510
  $ 5,023,739     $ (443,789,150 )   $ (438,765,411 )

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 3.4% of net assets. The Fund classifies such securities (levels defined below) as Level 3. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivatives contracts based on the creditworthiness of its counterparties. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Typically the Fund values debt instruments based on the most recent quoted price supplied by a single pricing source chosen by the Manager. Although the Manager normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and may change a pricing source at any time. The Manager monitors erratic or unusual movements (including unusual inactivity) in the prices supplied for a security and has discretion to override a price supplied by a source (e.g., by taking a price supplied by another) when it believes that the price supplied is not reliable. Although alternative prices may be available for securities held by the Fund, those alternative sources are not typically part of the valuation process and do not necessarily provide greater certainty about the prices used by the Fund. As of November 30, 2011, the total value of securities held for which no alternative pricing source was available represented 11.0% of the net assets of the Fund.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit risk, yield curves and similar data.
Level 3 — Valuations based primarily on inputs that are unobservable and significant. The Fund utilized a number of fair value techniques on Level 3 investments, including the following: The Fund valued certain debt securities using quoted prices. The Fund valued certain other debt securities by using an estimated specified spread above the LIBOR Rate. The Fund also used third party valuation services to value credit default swaps using unobservable inputs.

 


 

The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Debt Obligations
                               
Asset-Backed Securities
  $     $ 300,646,872     $ 889,995,391     $ 1,190,642,263  
U.S. Government Agency
                31,286,732       31,286,732  
 
                       
TOTAL DEBT OBLIGATIONS
          300,646,872       921,282,123       1,221,928,995  
 
                       
Short-Term Investments
    60,160,104                   60,160,104  
 
                       
Total Investments
    60,160,104       300,646,872       921,282,123       1,282,089,099  
 
                       
Total
  $ 60,160,104     $ 300,646,872     $ 921,282,123     $ 1,282,089,099  
 
                       
LIABILITY VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Liabilities     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Derivatives*
                               
Swap Agreements
                               
Credit Risk
  $     $     $ (734,788 )   $ (734,788 )
 
                       
Total
  $     $     $ (734,788 )   $ (734,788 )
 
                       

 


 

The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
 
*   Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The aggregate net values of the Fund’s direct investments in securities and derivative financial instruments using Level 3 inputs were 71.8% and (0.1)% of total net assets, respectively.
The following is a reconciliation of investments and derivatives, if any, in which significant unobservable inputs (Level 3) were used in determining value:

 


 

                                                                               
                                                                          Net Change in
                                                                          Unrealized
                                                                          Appreciation
                                                                          (Depreciation)
                                                                    from
                                          Change in                           Investments Still
    Balances as of                 Accrued           Unrealized     Transfer     Transfer   Balances as of       Held as of
    February 28,                 Discounts/   Total Realized   Appreciation     into level     out of level   November 30,       November 30,
    2011     Purchases   Sales   Premiums   Gain/(Loss)   (Depreciation)     3 *     3 *   2011       2011
Debt Obligations
                                                                             
Asset-Backed Securities
  $ 1,361,784,127     $   $ (417,096,505 )   $ 179,010     $ (16,629,554 )   $ (38,241,687 )   $   $   $ 889,995,391         $ (54,525,187 )
U.S. Government Agency
    32,607,449           (1,707,407 )     17,788       (205 )     369,107               31,286,732           369,107  
Swap Agreements
    (254,652 )         (58,986 )           58,986       (480,136 )             (734,788 )         (480,136 )
 
                                                   
Total
  $ 1,394,136,924     $   $ (418,862,898 )   $ 196,798     $ (16,570,773 )   $ (38,352,716 )   $   $   $ 920,547,335         $ (54,636,216 )
 
                                                     
 
*   The Fund accounts for investments and derivatives transferred into Level 3 at the value at the beginning of the period and transferred out of Level 3 at the value at the end of the period.

 


 

Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase the security at an agreed upon price and date. The Fund, through its custodian, takes possession of securities it acquired under the repurchase agreement. The value of the securities acquired is required by contract to be marked to market daily and additional collateral is required to be transferred so that the market value is at least equal to the amount owed to the Fund by the seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings and/or the value of the securities subject to the repurchase agreement is insufficient, the Fund’s recovery of cash from the seller may be delayed and the Fund may incur a loss equal to the difference between the cash it paid and the value of the securities. The Fund had no repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same assets at an agreed upon price and date. The Fund can use the proceeds received from entering into a reverse repurchase agreement to make additional investments, which generally causes the Fund’s portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the securities it sold and as a result would realize a loss equal to the difference between the value of those securities and the payment it received for them. The size of this loss will depend upon the difference between what the buyer paid for the securities the Fund sold to it and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of $100). In the event of a buyer’s bankruptcy or insolvency, the Fund’s use of proceeds from the sale of its securities may be restricted while the other party or its trustee or receiver determines whether to honor the Fund’s right to repurchase the securities. The Fund had no reverse repurchase agreements outstanding at the end of the period.
Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income securities whose principal value is adjusted periodically according to the rate of inflation. Two structures are common. The U.S. Treasury and some other issuers use a structure that reflects inflation in the principal value of the bond. Most other issuers pay out any inflation related accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real interest rates. Real interest rates, in turn, are tied to the relationship between nominal interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e. nominal interest rate minus inflation) might decline, leading to an increase in value of inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than inflation, real interest rates might rise, leading to a decrease in value of inflation indexed bonds. There can be no assurance, however, that the value of inflation indexed bonds will be directly correlated to changes in nominal interest rates, and short term increases in inflation may lead to a decline in their value. Coupon payments received by the Fund from inflation indexed bonds are included in the Fund’s gross income for the period in which they accrue. In addition, any increase or decrease in the principal amount of an inflation indexed bond will increase or decrease taxable ordinary income to the Fund, even though principal is not paid until maturity. The Fund had no inflation-indexed bonds outstanding at the end of the period.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.

 


 

     Market Risk — Fixed Income Securities — Typically, the market value of the Fund’s fixed income securities will decline during periods of widening of credit spreads.
 
     Market Risk — Asset-Backed Securities — Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
 
     Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
 
     Focused Investment Risk — Focusing investments in countries, regions, sectors or companies with high positive correlations to one another, such as the Fund’s investments in asset-backed securities secured by different types of consumer debt (e.g., credit-card receivables, automobile loans and home equity loans), creates additional risk.
 
     Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating. The Fund’s investments in below investment grade securities have speculative characteristics, and changes in economic conditions or other circumstances are more likely to impair the capacity of issuers to make principal and interest payments than is the case with issuers of investment grade securities.
 
     Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
 
     Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk and counterparty risk.
 
     Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations. The risk of counterparty default is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions.
 
     Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments.
 
     Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
 
     Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.

 


 

The Fund invests in asset-backed securities, which may be backed by many types of assets, including pools of residential and commercial mortgages, automobile loans, educational loans, home equity loans, or credit card receivables, which expose the Fund to additional types of market risk. They also may be backed by pools of corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds and loans (commonly referred to as “collateralized debt obligations” or “collateralized loan obligations”) and by the fees earned by service providers. Payment of interest on asset backed securities and repayment of principal largely depend on the cash flows generated by the assets backing the securities. The market risk of a particular asset-backed security depends on many factors, including the deal structure (e.g., determination as to the amount of underlying assets or other support needed to produce the cash flows necessary to service interest and make principal payments), the quality of the underlying assets and, if any, the level of credit support and the credit quality of the credit-support provider. Asset-backed securities involve risk of loss of principal if obligors of the underlying obligations default and the value of the defaulted obligations exceeds whatever credit support the securities may have. The obligations of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and other laws affecting the rights and remedies of creditors. Many asset-backed securities in which the Fund has invested are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal and/or interest will be paid because the insurer could default on its obligations. In recent years, a significant number of asset-backed security insurers have defaulted on their obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about the creditworthiness of those securities (and underlying assets) caused credit spreads (the difference between yields on the asset-backed securities and U.S. Government securities) to widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions to make markets in many fixed income securities. These events reduced liquidity and contributed to substantial declines in the value of asset-backed and other fixed income securities. There can be no assurance these conditions will not occur again. Also, government actions and proposals affecting the terms of underlying home and consumer loans, changes in demand for products (e.g., automobiles) financed by those loans, and the inability of borrowers to refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying assets and is, therefore, subject to risks associated with the negligence or defalcation of its servicer. In some circumstances, the mishandling of related documentation also may affect the rights of security holders in and to the underlying assets. The insolvency of entities that generate receivables or that utilize the assets may result in a decline in the value of the underlying assets, as well as costs and delays. The obligations underlying asset-backed securities, in particular securities backed by pools of residential and commercial mortgages, also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as high a yield as is provided by the asset-backed security. The risk of investing in asset-backed securities has increased because performance of the various sectors in which the assets underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime mortgages, and credit card receivables) has become more highly correlated since the deterioration in worldwide economic and liquidity conditions.
Among other trading agreements, the Fund is party to International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Agreements”) or other similar types of agreements with selected counterparties that generally govern over-the-counter derivative transactions entered into by the Fund. The ISDA Agreements typically include representations and warranties as well as contractual terms related to collateral, events of default, termination events, and other provisions. Termination events may include the decline in the net assets of the Fund below a certain level over a specified period of time and entitle a counterparty to elect to terminate early with respect to some or all the transactions under the ISDA Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse effect on the Fund’s operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. In particular, the Fund may use swaps or other derivatives on an index, a single security or a basket of securities to gain investment exposures (e.g., by selling protection under a credit default swap). The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.

 


 

The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). For example, the Fund may use credit default swaps to take a short position with respect to the likelihood of default by an issuer. The Fund also may use currency derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For instance, the Manager may alter the interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is designed to maintain the Fund’s exposure to the credit of an issuer through the debt instrument but adjust the Fund’s interest rate exposure through the swap. With these swaps, the Fund and its counterparties exchange interest rate exposure, such as fixed versus variable rates and shorter duration versus longer duration exposure. In adjusting its investment exposures, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund is not limited in the extent to which it uses derivatives or in the absolute face value of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate exposure of its assets, and its net long exposure may exceed 100% of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.

 


 

When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk that it will be required to pay the full notional value of the swap contract in the event of a default.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself.
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. During the period ended November 30, 2011, the Fund used forward currency contracts to adjust exposure to foreign currencies and otherwise adjust currency exchange rate risk. The Fund had no forward currency contracts outstanding at the end of the period.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded. The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying

 


 

the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.

 


 

The Fund prices its swap agreements daily using models that may incorporate quotations from market makers and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. During the period ended November 30, 2011, the Fund used swap agreements to achieve exposure to a reference entity’s credit. Swap agreements outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.

 


 

The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Liabilities:
                                               
Unrealized depreciation on swap agreements
  $     $     $ (734,788 )   $     $     $ (734,788 )
 
                                   
Total
  $     $     $ (734,788 )   $     $     $ (734,788 )
 
                                   
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts) or notional amounts (swap agreements) outstanding at each month-end, was as follows for the period ended November 30, 2011:
                 
    Forward        
    Currency     Swap  
    Contracts     Agreements  
Average amount outstanding
  $ 24,074,973     $ 31,000,000  

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Short-Duration Collateral Share Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares     Description   Value ($)  
 
       
MUTUAL FUNDS — 100.0%
       
       
 
       
       
Affiliated Issuers — 100.0%
       
  4,907,620    
GMO Short-Duration Collateral Fund
    32,439,373  
       
 
     
       
TOTAL MUTUAL FUNDS (COST $31,097,413)
    32,439,373  
       
 
     
       
 
       
       
SHORT-TERM INVESTMENTS — 0.2%
       
       
 
       
       
Money Market Funds — 0.2%
       
  50,222    
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00%(a)
    50,222  
       
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $50,222)
    50,222  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 100.2%
(Cost $31,147,635)
    32,489,595  
       
 
       
       
Other Assets and Liabilities (net) — (0.2%)
    (55,595 )
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 32,434,000  
       
 
     
 
Notes to Schedule of Investments:
(a)   Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                               
    Gross     Gross     Net Unrealized  
    Unrealized     Unrealized     Appreciation  
Aggregate Cost   Appreciation     (Depreciation)     (Depreciation)  
$                    32,688,228
  $     $ (198,633 )   $ (198,633 )

 


 

Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                         
    Value,                             Return     Distributions        
    beginning of             Sales     Dividend     of     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income*     Capital*     Gains*     of period  
GMO Short-Duration Collateral Fund
  $ 34,983,226     $ 13,818,255     $ 1,435,000     $ 308,565     $ 13,590,787     $     $ 32,439,373  
 
                                         
 
*   The table above includes estimated sources of all distributions paid by GMO Short-Duration Collateral Fund (“SDCF”) during the period March 1, 2011 through November 30, 2011. The actual tax characterization of distributions paid by SDCF will be determined at the end of the fiscal year ending February 29, 2012.

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
GMO Short-Duration Collateral Share Fund (the “Fund”) invests substantially all of its assets in GMO Short-Duration Collateral Fund (“SDCF”) (an arrangement often referred to as a “master-feeder” structure) and, to a limited extent, in cash and cash equivalents.
Shares of SDCF are generally valued at their net asset value. Investments held by SDCF are valued as follows. Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. In addition, although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held indirectly that were fair valued using methods determined in good faith by or at the direction of the Trustees of GMO trust represented 3.4% of net assets. SDCF classifies such securities (levels defined below) as Level 3.
Typically SDCF values debt instruments based on the most recent quoted price supplied by a single pricing source chosen by the Manager. Although the Manager normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and may change a pricing source at any time. The Manager monitors erratic or unusual movements (including unusual inactivity) in the prices supplied for a security and has discretion to override a price supplied by a source (e.g., by taking a price supplied by another) when it believes that the price supplied is not reliable. Although alternative prices may be available for other securities held by SDCF, those alternative sources are not typically part of the valuation process and do not necessarily provide greater certainty about the prices used by SDCF. As of November 30, 2011, the total value of securities held indirectly for which no alternative pricing source was available represented 11.0% of the net assets of the Fund.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 —   Valuations based on quoted prices for identical securities in active markets.
Level 2 —   Valuations determined using other significant direct or indirect observable inputs.
Level 3 —   Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Mutual Funds
  $ 32,439,373     $     $     $ 32,439,373  
Short-Term Investments
    50,222                   50,222  
Total Investments
    32,489,595                   32,489,595  
 
                       
Total
  $ 32,489,595     $     $     $ 32,489,595  
 
                       

 


 

SDCF is classified as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of SDCF, please refer to SDCF’s portfolio valuation note. The aggregate net value of the Fund’s indirect investments (through SDCF) in securities and derivative financial instruments using Level 3 inputs were 71.8% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. Because the Fund invests substantially all of its assets in SDCF, the most significant risks of investing in the Fund are the risks to which the Fund is exposed through SDCF, which include those outlined in the following brief summary of selected risks. The selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time. The Fund and SDCF are non-diversified investment companies under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund or SDCF may affect the Fund’s performance more than if the Fund or SDCF were diversified.
 Market Risk Fixed Income Securities — Typically, the market value of SDCF’s fixed income securities will decline during periods of widening of credit spreads.
 Market Risk Asset-Backed Securities — Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
 Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent SDCF from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
 Focused Investment Risk — Focusing investments in countries, regions, sectors or companies with high positive correlations to one another, such as the Fund’s investments in asset-backed securities secured by different types of consumer debt (e.g., credit-card receivables, automobile loans and home equity loans), creates additional risk.
 Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating. The Fund’s investments in below investment grade securities have speculative characteristics, and changes in economic conditions or other circumstances are more likely to impair the capacity of issuers to make principal and interest payments than is the case with issuers of investment grade securities.
 Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in underlying funds, including the risk that the underlying funds in which it invests will not perform as expected.
 Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
 Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk and counterparty risk.

 


 

 Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations. The risk of counterparty default is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions.
 Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments.
 Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
 Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
The Fund invests indirectly in asset-backed securities, which may be backed by many types of assets, including pools of residential and commercial mortgages, automobile loans, educational loans, home equity loans, or credit card receivables, which expose the Fund to additional types of market risk. They also may be backed by pools of corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds and loans (commonly referred to as “collateralized debt obligations” or “collateralized loan obligations”) and by the fees earned by service providers. Payment of interest on asset backed securities and repayment of principal largely depend on the cash flows generated by the assets backing the securities. The market risk of a particular asset-backed security depends on many factors, including the deal structure (e.g., determination as to the amount of underlying assets or other support needed to produce the cash flows necessary to service interest and make principal payments), the quality of the underlying assets and, if any, the level of credit support and the credit quality of the credit-support provider. Asset-backed securities involve risk of loss of principal if obligors of the underlying obligations default and the value of the defaulted obligations exceeds whatever credit support the securities may have. The obligations of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and other laws affecting the rights and remedies of creditors. Many asset-backed securities in which the Fund has invested are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal and/or interest will be paid because the insurer could default on its obligations. In recent years, a significant number of asset-backed security insurers have defaulted on their obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about the creditworthiness of those securities (and underlying assets) caused credit spreads (the difference between yields on the asset-backed securities and U.S. Government securities) to widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions to make markets in many fixed income securities. These events reduced liquidity and contributed to substantial declines in the value of asset-backed and other fixed income securities. There can be no assurance these conditions will not occur again. Also, government actions and proposals affecting the terms of underlying home and consumer loans, changes in demand for products (e.g., automobiles) financed by those loans, and the inability of borrowers to refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying assets and is, therefore, subject to risks associated with the negligence or defalcation of its servicer. In some circumstances, the mishandling of

 


 

related documentation also may affect the rights of security holders in and to the underlying assets. The insolvency of entities that generate receivables or that utilize the assets may result in a decline in the value of the underlying assets, as well as costs and delays. The obligations underlying asset-backed securities, in particular securities backed by pools of residential and commercial mortgages, also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as high a yield as is provided by the asset-backed security. The risk of investing in asset-backed securities has increased because performance of the various sectors in which the assets underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime mortgages, and credit card receivables) has become more highly correlated since the deterioration in worldwide economic and liquidity conditions.
Derivative financial instruments
At November 30, 2011, the Fund held no derivative financial instruments directly. For a listing of derivative financial instruments held by SDCF, if any, please refer to SDCF’s’ Schedule of Investments.
For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Short-Duration Investment Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Par Value ($) /            
Shares     Description   Value ($)  
 
       
DEBT OBLIGATIONS — 6.6%
       
       
 
       
       
U.S. Government Agency — 6.6%
       
       
Agency for International Development Floater (Support of Botswana), 6 mo. U.S. Treasury Bill +
       
  23,333    
.40%, 0.47%, due 10/01/12(a)
    22,898  
       
Agency for International Development Floater (Support of C.A.B.E.I.), 6 mo. U.S. Treasury Bill +
       
  152,100    
.40%, 0.47%, due 10/01/12(a)
    150,332  
       
Agency for International Development Floater (Support of Peru), Series B, 6 mo. U.S. Treasury Bill
       
  14,976    
+.35%, 0.42%, due 05/01/14(a)
    14,688  
  175,197    
Small Business Administration Pool #502320, Prime - 2.19%, 1.06%, due 08/25/18
    176,461  
       
 
     
       
Total U.S. Government Agency
    364,379  
       
 
     
       
TOTAL DEBT OBLIGATIONS (COST $365,562)
    364,379  
       
 
     
       
 
       
       
MUTUAL FUNDS — 93.5%
       
       
 
       
       
Affiliated Issuers — 93.5%
       
  231,576    
GMO Short-Duration Collateral Fund
    1,530,718  
  9,192    
GMO Special Purpose Holding Fund(b)
    3,585  
  145,356    
GMO U.S. Treasury Fund
    3,635,355  
       
 
     
       
TOTAL MUTUAL FUNDS (COST $5,703,846)
    5,169,658  
       
 
     
       
 
       
       
SHORT-TERM INVESTMENTS — 0.5%
       
       
 
       
       
Money Market Funds — 0.5%
       
  28,961    
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00%(c)
    28,961  
       
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $28,961)
    28,961  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 100.6%
(Cost $6,098,369)
    5,562,998  
       
 
       
       
Other Assets and Liabilities (net) — (0.6%)
    (35,238 )
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 5,527,760  
       
 
     

 


 

Notes to Schedule of Investments:
C.A.B.E.I. — Central American Bank for Economic Integration
The rates shown on variable rate notes are the current interest rates at November 30, 2011, which are subject to change based on the terms of the security.
(a)   Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust.
 
(b)   Underlying investment represents interests in defaulted claims. See “Other Matters” for additional information.
 
(c)   Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                         
    Gross     Gross     Net Unrealized  
    Unrealized     Unrealized     Appreciation  
Aggregate Cost   Appreciation     (Depreciation)     (Depreciation)  
$6,713,866
  $ 5,570     $ (1,156,438 )   $ (1,150,868 )
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                         
    Value,                             Distributions              
    beginning of             Sales     Dividend     of Realized     Return of     Value, end  
Affiliate   period     Purchases     Proceeds     Income*     Gains*     Capital*     of period  
GMO Short-Duration Collateral Fund
  $ 2,403,760     $     $     $ 18,209     $     $ 801,998     $ 1,530,718  
GMO Special Purpose Holding Fund
    4,596                                     3,585  
GMO U.S. Treasury Fund
    2,863,916       1,195,179       425,000       1,210       169           $ 3,635,355  
 
                                         
Totals
  $ 5,272,272     $ 1,195,179     $ 425,000     $ 19,419     $ 169     $ 801,998     $ 5,169,658  
 
                                         
 
*   The table above includes estimated sources of all distributions paid by the underlying funds during the period March 1, 2011 through November 30, 2011 for tax purposes. The actual tax characterization of distributions paid by the underlying funds will be determined at the end of the fiscal year ending February 29, 2012.

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly and indirectly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 4.3% of net assets. The Fund and the underlying funds classify such securities (levels defined below) as Level 3.
Typically the Fund and the underlying funds value debt instruments based on the most recent quoted price supplied by a single pricing source chosen by the Manager. Although the Manager normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and may change a pricing source at any time. The Manager monitors erratic or unusual movements (including unusual inactivity) in the prices supplied for a security and has discretion to override a price supplied by a source (e.g., by taking a price supplied by another) when it believes that the price supplied is not reliable. Although alternative prices may be available for securities held by the Fund and the underlying funds, those alternative sources are not typically part of the valuation process and do not necessarily provide greater certainty about the prices used by the Fund and the underlying funds. As of November 30, 2011, the total value of securities held directly and indirectly for which no alternative pricing source was available represented 6.2% of the net assets of the Fund.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit risk, yield curves and similar data.
Level 3 — Valuations based primarily on inputs that are unobservable and significant. The Fund utilized a number of fair value techniques on Level 3 investments, including the following: The Fund valued certain debt securities using quoted prices. The Fund valued certain other debt securities by using an estimated specified spread above the LIBOR rate.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Debt Obligations U.S. Government Agency
  $     $     $ 364,379     $ 364,379  
 
                       
TOTAL DEBT OBLIGATIONS
                364,379       364,379  
 
                       
Mutual Funds
    5,166,073       3,585             5,169,658  
Short-Term Investments
    28,961                   28,961  
 
                       
Total Investments
    5,195,034       3,585       364,379       5,562,998  
 
                       
Total
  $ 5,195,034     $ 3,585     $ 364,379     $ 5,562,998  
 
                       

 


 

The underlying funds held at period end are classified above as either Level 1 or Level 2. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net values of the Fund’s investments (both direct and indirect) in securities and derivative financial instruments using Level 3 inputs were 26.5% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant unobservable inputs (Level 3) were used in determining value:

 


 

                                                                                   
                                                                              Net Change in  
                                                                              Unrealized  
                                                                              Appreciation  
                                            Change in                               (Depreciation) from  
    Balances as                     Accrued     Total     Unrealized     Transfers     Transfers     Balances as of       Investments Still  
    of February                     Discounts/     Realized     Appreciation     into level     out of level     November 30,       Held as of  
    28, 2011     Purchases     Sales     Premiums     Gain/(Loss)     (Depreciation)     3*     3*     2011       November 30, 2011  
Debt Obligations
                                                                                 
U.S. Government Agency
  $ 731,636     $     $ (369,405 )   $ 37     $ 26     $ 2,085     $     $     $ 364,379       $ 1,222  
 
                                                             
Total
  $ 731,636     $     $ (369,405 )   $ 37     $ 26     $ 2,085     $     $     $ 364,379       $ 1,222  
 
                                                             
 
*   The Fund accounts for investments transferred into Level 3 at the value at the beginning of the period and transferred out of Level 3 at the value at the end of the period.

 


 

Other matters
GMO Special Purpose Holding Fund (“SPHF”), an investment of the Fund, has litigation pending against various entities related to the 2002 fraud and related default of securities previously held by SPHF. The outcome of the lawsuits against the remaining defendants is not known and any potential recoveries are not reflected in the net asset value of SPHF. For the period ended November 30, 2011, the Fund received no distributions from SPHF in connection with the defaulted securities or the related litigation.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund and SDCF are non-diversified investment companies under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund or SDCF may affect the Fund’s performance more than if the Fund or SDCF were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Fixed Income Securities — Typically, the market value of the Fund’s fixed income securities will decline during periods of widening of credit spreads.
Market Risk — Asset-Backed Securities — Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies with high positive correlations to one another, such as the Fund’s investments in asset-backed securities secured by different types of consumer debt (e.g., credit-card receivables, automobile loans and home equity loans), creates additional risk.
Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating. The Fund’s investments in below investment grade securities have speculative characteristics, and changes in economic conditions or other circumstances are more likely to impair the capacity of issuers to make principal and interest payments than is the case with issuers of investment grade securities.
Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in underlying funds, including the risk that the underlying funds in which it invests will not perform as expected.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations. The risk of counterparty default is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions.

 


 

Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
The Fund invests (including through investment in underlying funds) in asset-backed securities, which may be backed by many types of assets, including pools of residential and commercial mortgages, automobile loans, educational loans, home equity loans, or credit card receivables, which expose the Fund to additional types of market risk. They also may be backed by pools of corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds and loans (commonly referred to as “collateralized debt obligations” or “collateralized loan obligations”) and by the fees earned by service providers. Payment of interest on asset backed securities and repayment of principal largely depend on the cash flows generated by the assets backing the securities. The market risk of a particular asset-backed security depends on many factors, including the deal structure (e.g., determination as to the amount of underlying assets or other support needed to produce the cash flows necessary to service interest and make principal payments), the quality of the underlying assets and, if any, the level of credit support and the credit quality of the credit-support provider. Asset-backed securities involve risk of loss of principal if obligors of the underlying obligations default and the value of the defaulted obligations exceeds whatever credit support the securities may have. The obligations of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and other laws affecting the rights and remedies of creditors. Many asset-backed securities in which the Fund has invested are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal and/or interest will be paid because the insurer could default on its obligations. In recent years, a significant number of asset-backed security insurers have defaulted on their obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about the creditworthiness of those securities (and underlying assets) caused credit spreads (the difference between yields on the asset-backed securities and U.S. Government securities) to widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions to make markets in many fixed income securities. These events reduced liquidity and contributed to substantial declines in the value of asset-backed and other fixed income securities. There can be no assurance these conditions will not occur again. Also, government actions and proposals affecting the terms of underlying home and consumer loans, changes in demand for products (e.g., automobiles) financed by those loans, and the inability of borrowers to refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying assets and is, therefore, subject to risks associated with the negligence or defalcation of its servicer. In some circumstances, the mishandling of related documentation also may affect the rights of security holders in and to the underlying assets. The insolvency of entities that generate receivables or that utilize the assets may result in a decline in the value of the underlying assets, as well as costs and delays. The obligations underlying asset-backed securities, in particular securities backed by pools of residential and commercial mortgages, also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as high a yield as is provided by the asset-backed security. The risk of investing in asset-backed securities has increased because performance of the various sectors in which the assets underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime mortgages, and credit card receivables) has become more highly correlated since the deterioration in worldwide economic and liquidity conditions.

 


 

Derivative financial instruments
At November 30, 2011, the Fund held no derivative financial instruments directly. For a listing of derivative financial instruments held by the underlying funds, if any, please refer to the underlying funds’ Schedule of Investments.
For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Special Purpose Holding Fund
(A Series of GMO Trust)
Consolidated Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares     Description   Value ($)  
 
       
DEBT OBLIGATIONS — 0.0% (a)
       
       
 
       
       
Asset-Backed Securities — 0.0%
       
       
 
       
       
Health Care Receivables — 0.0%
       
       
Interest related to the Bankruptcy Estate of NPF VI Inc. Series 02-1 Class A (b) (c)
     
       
Interest related to the Bankruptcy Estate of NPF XII Inc. Series 00-3 Class A (b) (c)
     
       
Interest related to the Bankruptcy Estate of NPF XII Inc. Series 02-1 Class A (b) (c)
     
       
 
     
       
 
       
       
Total Asset-Backed Securities
     
       
 
     
       
 
       
       
TOTAL DEBT OBLIGATIONS (COST $0)
     
       
 
     
       
 
       
       
SHORT-TERM INVESTMENTS — 9.8%
       
       
 
       
       
Money Market Funds — 9.8%
       
  10,696    
State Street Institutional Liquid Reserves Fund-Institutional Class, 0.17% (d)
    10,696  
  10,697    
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00% (e)
    10,697  
       
 
     
       
 
       
       
TOTAL SHORT-TERM INVESTMENTS (COST $21,393)
    21,393  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 9.8%
(Cost $21,393)
    21,393  
       
 
       
       
Other Assets and Liabilities (net) — 90.2%
    196,898 *
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 218,291  
       
 
     
 
*   For details on the composition of the balance see the basis of presentation and principles of consolidation footnote.
 
Notes to Consolidated Schedule of Investments:
 
(a)   Owned by GMO SPV I, LLC. GMO SPV I, LLC is a 74.9% subsidiary of GMO Special Purpose Holding Fund.
 
(b)   Security in default.
 
(c)   Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust.
 
(d)   Rate disclosed, the 7 day net yield, as of November 30, 2011.
 
(e)   Rate disclosed, the 7 day net yield, as of November 30, 2011. Note: Yield rounds to 0.00%.
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                                 
                        Net Unrealized  
Aggregate     Gross Unrealized     Gross Unrealized     Appreciation  
Cost     Appreciation     (Depreciation)     (Depreciation)  
$ 21,393     $     $     $    
 

 


 

Basis of presentation and principles of consolidation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
The accompanying consolidated schedule of investments consists primarily of the Fund and its majority owned investment in units of GMO SPV I, LLC (“SPV”) a special purpose vehicle that holds an interest in liquidating trusts, relating to certain defaulted asset-backed securities (the “NPF securities”) issued by NPF VI, Inc. and NPF XII, Inc.
The Fund has litigation pending against various entities related to the default of the NPF securities. The outcome of the lawsuit is not known and any potential recoveries are not reflected in the net asset value of the Fund.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 0.0% of net assets. The Fund classifies such securities (levels defined below) as Level 3.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs.
Level 3 — Valuations based primarily on inputs that are unobservable and significant. The Fund utilized a number of fair value techniques on Level 3 investments, including the following: Consistent with U.S. GAAP, the Fund valued potential litigation recoveries with respect to the bankruptcy proceedings at zero. The Fund valued interests related to bankruptcy proceedings at zero.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Debt Obligations
  $     $     $ 0 *   $  
Short-Term Investments
    21,393                   21,393  
 
                       
Total Investments
  $ 21,393     $     $ 0 *   $ 21,393  
 
                       
 
*   Represents the interest in securities that are defaulted and were determined to have a fair value of zero at November 30, 2011 or February 28,2011.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Litigation-Related Risk — The ultimate amount of the Fund’s recovery (through its investment in SPV) of losses on the defaulted NPF Securities and the total costs the Fund may incur with respect to its funding of litigation related to the NPF Securities is unknown at this time. Therefore, the Fund is subject to the risk that SPV may ultimately be unable to recover certain losses related to the NPF Securities.
Liquidity Risk — Low trading volume, lack of a market maker, a large size position or legal restrictions may limit or prevent the Fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind. Liquidity risk is particularly pronounced for the Fund due to the nature and size of its investment in the NPF Securities (through the SPV). The Fund may be exposed (through the SPV) to the NPF Securities for an indefinite period of time and may experience a substantial loss in the event the SPV sells the NPF Securities.
Market Risk — Fixed Income Securities — Typically, the value of fixed income securities will decline during periods of rising interest rates and widening of credit spreads.
Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Derivative financial instruments
At November 30, 2011, the Fund held no derivative contracts.
Subsequent events
On January 17, 2012, the Fund received $106,035 in connection with a distribution from the NPF VI and NPF XII bankruptcy estates.

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Special Situations Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Par Value ($) /              
Shares     Description     Value ($)  
 
       
DEBT OBLIGATIONS — 0.6%
       
       
 
       
       
Asset-Backed Securities — 0.6%
       
       
 
       
       
Residential Asset-Backed Securities (United States) ¨ — 0.6%
       
  182,975    
Countrywide Asset-Backed Certificates, Series 07-S2, Class A1, MBIA, 1 mo. LIBOR + .14%, 0.40%, due 05/25/37
    177,486  
  1,453,036    
Countrywide Asset-Backed Certificates, Series 07-S1, Class A1A, MBIA, 1 mo. LIBOR + .11%, 0.37%, due 11/25/36
    1,380,384  
  3,026,940    
Countrywide Asset-Backed Certificates, Series 06-S9, Class A2, MBIA, Variable Rate, 5.51%, due 08/25/36
    2,930,381  
       
 
     
       
Total Residential Asset-Backed Securities (United States)
    4,488,251  
       
 
     
       
Total Asset-Backed Securities
    4,488,251  
       
 
     
       
TOTAL DEBT OBLIGATIONS (COST $4,496,503)
    4,488,251  
       
 
     
       
 
       
       
MUTUAL FUNDS — 92.9%
       
       
 
       
       
Affiliated Issuers — 92.9%
       
  26,628,197    
GMO U.S. Treasury Fund
    665,971,194  
       
 
     
       
TOTAL MUTUAL FUNDS (COST $665,801,023)
    665,971,194  
       
 
     
       
 
       
       
SHORT-TERM INVESTMENTS — 7.6%
       
       
 
       
       
Money Market Funds — 7.6%
       
  54,843,809    
State Street Institutional Treasury Money Market Fund-Institutional Class, 0.00%(a)
    54,843,809  
       
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $54,843,809)
    54,843,809  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 101.1%
(Cost $725,141,335)
    725,303,254  
       
 
       
       
Other Assets and Liabilities (net) — (1.1%)
    (8,057,859 )
       
 
     
 
       
TOTAL NET ASSETS — 100.0%
  $ 717,245,395  
       
 
     


 

A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
                                         
                                    Net Unrealized  
Settlement                                 Appreciation  
Date     Counterparty   Deliver/Receive     Units of Currency     Value     (Depreciation)  
Buys †  
 
                               
  12/02/11    
Bank of America N.A.
  BRL     52,761,600     $ 29,176,653     $ 41,085  
  12/02/11    
Barclays Bank PLC
  BRL     272,624,400       150,758,647       635,079  
  12/02/11    
Brown Brothers Harriman & Co.
  BRL     139,050,000       76,893,300       108,276  
  12/02/11    
Royal Bank of Scotland PLC
  BRL     27,504,000       15,209,445       21,417  
  1/13/12    
Bank of America N.A.
  KRW     179,865,270,000       156,968,760       4,372,451  
  12/16/11    
Bank of America N.A.
  SGD     46,187,204       36,037,668       (346,539 )
  12/16/11    
Brown Brothers Harriman & Co.
  SGD     57,416,745       44,799,542       (371,369 )
  12/16/11    
Deutsche Bank AG
  SGD     104,131,800       81,249,067       (558,959 )
       
 
                             
       
 
                             
       
 
                  $ 591,093,082     $ 3,901,441  
       
 
                           
Sales #  
 
                               
  12/16/11    
Bank of America N.A.
  AUD     151,262,267     $ 155,304,835     $ (1,834,441 )
  12/16/11    
Bank of New York Mellon
  AUD     3,375,022       3,465,221       (59,926 )
  12/16/11    
Barclays Bank PLC
  AUD     3,375,000       3,465,199       (62,304 )
  12/16/11    
JPMorgan Chase Bank N.A.
  AUD     75,631,133       77,652,417       (1,478,252 )
  12/02/11    
Bank of America N.A.
  BRL     52,761,600       29,176,653       (376,653 )
  12/02/11    
Barclays Bank PLC
  BRL     272,624,400       150,758,647       (850,028 )
  3/02/12    
Barclays Bank PLC
  BRL     272,624,400       148,008,578       (596,228 )
  12/02/11    
Brown Brothers Harriman & Co.
  BRL     139,050,000       76,893,300       (4,893,301 )
  12/02/11    
Royal Bank of Scotland PLC
  BRL     27,504,000       15,209,445       (809,445 )
  12/16/11    
Bank of America N.A.
  CHF     12,782,051       13,996,492       193,962  
  12/16/11    
Bank of New York Mellon
  CHF     12,873,543       14,096,676       164,951  


 

                                                 
  12/16/11    
Brown Brothers Harriman & Co.
           CHF     4,750,520       5,201,874       62,444  
  12/16/11    
Royal Bank of Scotland PLC
          CHF     48,188,202       52,766,631       638,150  
  12/23/11    
Bank of America N.A.
          CLP     15,061,440,000       29,138,191       (338,191 )
  12/23/11    
Brown Brothers Harriman & Co.
          CLP     20,120,160,000       38,924,902       (524,902 )
  12/23/11    
Royal Bank of Scotland PLC
          CLP     14,798,400,000       28,629,308       170,692  
  12/22/11    
Bank of America N.A.
          PHP     2,109,792,000       48,285,554       295,727  
  12/22/11    
Bank of America N.A.
          RUB     1,881,240,000       61,077,505       (3,477,505 )
  12/22/11    
Brown Brothers Harriman & Co.
          RUB     927,648,000       30,117,595       (1,317,595 )
  12/22/11    
Royal Bank of Scotland PLC
          RUB     313,728,000       10,185,688       (585,688 )
  12/23/11    
Barclays Bank PLC
          ZAR     237,271,680       29,146,975       (346,975 )
  12/23/11    
Brown Brothers Harriman & Co.
          ZAR     475,672,320       58,432,634       (832,634 )
  12/23/11    
Royal Bank of Scotland PLC
          ZAR     76,443,360       9,390,470       209,529  
       
 
                                   
       
 
                          $ 1,089,324,790     $ (16,648,613 )
       
 
                                   
 
  Fund buys foreign currency; sells USD.
 
#   Fund sells foreign currency; buys USD.
Swap Agreements

Forward Starting Dividend Swaps
                                 
                            Net
Notional   Starting   Expiration               Unrealized
Amount   Date   Date   Counterparty   Fund Pays   Fund Receives   Appreciation/(Depreciation)
686,006
  EUR   12/19/2014   12/18/2015   Barclays Bank PLC   25,000 EUR for every 1 dividend
EURO STOXX 50 Index point
decrease in the actual dividends
from the Fixed Strike
  25,000 EUR for every 1 dividend
EURO STOXX 50 Index point
increase in the actual
dividends from the Fixed Strike
  $ 25,860  


 

                                 
2,020,000
  EUR   12/18/2015   12/16/2016   Barclays Bank PLC   25,000 EUR for every 1 dividend
25,000 EUR for every 1 dividend
EURO STOXX 50 Index point
decrease in the actual dividends
from the Fixed Strike
  25,000 EUR for every 1 dividend
EURO STOXX 50 Index point
increase in the actual
dividends from the Fixed Strike
    (15,147 )
5,436,000
  EUR   12/16/2016   12/15/2017   BNP Paribas   60,000 EUR for every 1 dividend
EURO STOXX 50 Index point
decrease in the actual dividends
from the Fixed Strike
  60,000 EUR for every 1
dividend EURO STOXX 50 Index point
increase in the actual
dividends from the Fixed Strike
    (767,456 )
2,072,500
  EUR   12/15/2017   12/21/2018   Barclays Bank PLC   25,000 EUR for every 1 dividend
EURO STOXX 50 Index point
decrease in the actual dividends
from the Fixed Strike
  25,000 EUR for every 1 dividend
EURO STOXX 50 Index point
increase in the actual
dividends from the Fixed Strike
    (102,042 )
2,065,000
  EUR   12/15/2017   12/21/2018   Barclays Bank PLC   25,000 EUR for every 1 dividend
EURO STOXX 50 Index point
decrease in the actual dividends
from the Fixed Strike
  25,000 EUR for every 1
dividend EURO STOXX 50 Index point
increase in the actual
dividends from the Fixed Strike
    (93,538 )
2,062,500
  EUR   12/15/2017   12/21/2018   BNP Paribas   25,000 EUR for every 1 dividend
EURO STOXX 50 Index point
decrease in the actual dividends
from the Fixed Strike
  25,000 EUR for every 1
dividend EURO STOXX 50 Index point
increase in the actual
dividends from the Fixed Strike
    (90,704 )


 

                                 
1,007,000
  EUR   12/15/2017   12/21/2018   BNP Paribas   10,000 EUR for every 1 dividend
EURO STOXX 50 Index point
decrease in the actual dividends
from the Fixed Strike
  10,000 EUR for every 1
dividend EURO STOXX 50 Index point
increase in the actual
dividends from the Fixed Strike
    (242,633 )
2,729,225
  EUR   12/21/2018   12/20/2019   BNP Paribas   30,000 EUR for every 1 dividend
EURO STOXX 50 Index point
decrease in the actual dividends
from the Fixed Strike
  30,000 EUR for every 1
dividend EURO STOXX 50 Index point
increase in the actual
dividends from the Fixed Strike
    (672,821 )
 
                             
 
                          $ (1,958,481 )
 
                             
 
                      Premiums to (Pay) Receive   $  
 
                             
Interest Rate Swaps
                                     
                                Net Unrealized
Notional   Expiration       Receive               Appreciation/
Amount   Date   Counterparty   (Pay)#   Fixed Rate     Variable Rate   (Depreciation)
3,100,000
  CHF   9/1/2021   Barclays Bank PLC   (Pay)     1.63 %   6 Month CHF BBA LIBOR   $  (83,191 )
3,200,000
  CHF   9/5/2021   Credit Suisse International   (Pay)     1.71 %   6 Month CHF BBA LIBOR     (113,850 )
840,000,000
  JPY   10/22/2020   Citibank N.A.   (Pay)     0.97 %   6 Month JPY BBA LIBOR     (15,805 )
840,000,000
  JPY   10/26/2020   Citibank N.A.   (Pay)     0.97 %   6 Month JPY BBA LIBOR     (14,950 )
840,000,000
  JPY   10/26/2020   Citibank N.A.   (Pay)     0.97 %   6 Month JPY BBA LIBOR     (17,003 )
840,000,000
  JPY   10/27/2020   Citibank N.A.   (Pay)     0.99 %   6 Month JPY BBA LIBOR     (28,417 )
2,130,000,000
  JPY   11/1/2020   Morgan Stanley Capital Services Inc.   (Pay)     1.04 %   6 Month JPY BBA LIBOR     (188,195 )
 
                                   
 
                              $(461,411 )
 
                                   
 
                          Premiums to (Pay) Receive   $          —  
 
                                   
 
#   Receive — Fund receives fixed rate and pays variable rate.
(Pay) — Fund pays fixed rate and receives variable rate.


 

Total Return Swaps
                                                 
Notional           Expiration                             Net Unrealized  
Amount           Date     Counterparty     Fund Pays     Fund Receives     Appreciation/ (Depreciation)  
29,105,044
  USD     5/16/2012     Goldman Sachs International   Return on Asia Equity Basket Swap   1 Month Federal Funds Effective Rate -.68%   $ (438,306 )
11,804,910
  USD     5/16/2012     Goldman Sachs International   Return on Europe Equity Basket Swap   1 Month Federal Funds Effective Rate -.33%     62,166  
2,860,440
  USD     5/16/2012     Goldman Sachs International   Return on U.S. Equity Basket Swap   1 Month Federal Funds Effective Rate -.80%     23,585  
178,419
  USD     11/1/2012     Morgan Stanley Capital Services   Return on Evergrande Real Estate Group Common Stock   1 Month Federal Funds Effective Rate - .16%     1,818  
545,392
  USD     11/1/2012     Morgan Stanley Capital Services   Return on Industrial and Commercial Bank of China Ltd. - Class H   1 Month Federal Funds Effective Rate - .40%     26,821  
4,400,000
  EUR     12/18/2015     Deutsche Bank AG   Depreciation of EURO STOXX 50 December 2015 Dividend Future   Appreciation of EURO STOXX 50 December 2015 Dividend Future     (409,828 )
8,880,000
  EUR     12/16/2016     Morgan Stanley Capital Services   Depreciation of EURO STOXX 50 December 2016 Dividend Future   Appreciation of EURO STOXX 50 December 2016 Dividend Future     (1,142,145 )
2,585,250
  EUR     12/15/2017     Deutsche Bank AG   Depreciation of EURO STOXX 50 December 2017 Dividend Future   Appreciation of EURO STOXX 50 December 2017 Dividend Future     (582,292 )
9,125,000
  EUR     12/15/2017     Morgan Stanley Capital Services   Depreciation of EURO STOXX 50 December 2017 Dividend Future   Appreciation of EURO STOXX 50 December 2017 Dividend Future     (1,551,973 )
547,500
  EUR     12/21/2018     Deutsche Bank AG   Depreciation of EURO STOXX 50 December 2018 Dividend Future   Appreciation of EURO STOXX 50 December 2018 Dividend Future     (202,899 )
789,000
  EUR     12/21/2018     Morgan Stanley Capital Services   Depreciation of EURO STOXX 50 December 2018 Dividend Future   Appreciation of EURO STOXX 50 December 2018 Dividend Future     (261,014 )
275,860
  EUR     12/21/2018     Morgan Stanley Capital Services   Depreciation of EURO STOXX 50 December 2018 Dividend Future   Appreciation of EURO STOXX 50 December 2018 Dividend Future     (93,629 )


 

                                                 
904,250
  EUR     12/21/2018     Morgan Stanley Capital Services   Depreciation of EURO STOXX 50 December 2018 Dividend Future   Appreciation of EURO STOXX 50 December 2018 Dividend Future     (277,353 )
2,663,701
  EUR     12/21/2018     Morgan Stanley Capital Services   Depreciation of EURO STOXX 50 December 2018 Dividend Future   Appreciation of EURO STOXX 50 December 2018 Dividend Future     (702,219 )
552,500
  EUR     12/20/2019     Deutsche Bank AG   Depreciation of EURO STOXX 50 December 2019 Dividend Future   Appreciation of EURO STOXX 50 December 2019 Dividend Future     (214,992 )
3,037,500
  EUR     12/20/2019     Deutsche Bank AG   Depreciation of EURO STOXX 50 December 2019 Dividend Future   Appreciation of EURO STOXX 50 December 2019 Dividend Future     (917,075 )
2,937,000
  EUR     12/20/2019     Deutsche Bank AG   Depreciation of EURO STOXX 50 December 2019 Dividend Future   Appreciation of EURO STOXX 50 December 2019 Dividend Future     (782,033 )
5,587,500
  EUR     12/20/2019     Deutsche Bank AG   Depreciation of EURO STOXX 50 December 2019 Dividend Future   Appreciation of EURO STOXX 50 December 2019 Dividend Future     (1,179,096 )
881,250
  EUR     12/20/2019     Morgan Stanley Capital Services   Depreciation of EURO STOXX 50 December 2019 Dividend Future   Appreciation of EURO STOXX 50 December 2019 Dividend Future     (393,032 )
 
                                           
 
                                          $ (9,033,496 )
 
                                           
 
                                  Premiums to (Pay) Receive   $  
 
                                           
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
 
Notes to Schedule of Investments:
 
BBA —   British Banks Association
 
LIBOR —   London Interbank Offered Rate
 
MBIA —   Insured as to the payment of principal and interest by MBIA Insurance Corp.
 
    The rates shown on variable rate notes are the current interest rates at November 30, 2011, which are subject to change based on the terms of the security.
 
¨   These securities are primarily backed by subprime mortgages.
 
(a)   Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.
Currency Abbreviations:
AUD — Australian Dollar
BRL — Brazilian Real


 

CHF — Swiss Franc

CLP — Chilean Peso

EUR — Euro

JPY — Japanese Yen

KRW — South Korean Won

PHP — Philippine Peso

RUB — Russian Ruble

SGD — Singapore Dollar

USD — United States Dollar

ZAR — South African Rand


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                         
    Gross     Gross     Net Unrealized  
    Unrealized     Unrealized     Appreciation  
Aggregate Cost   Appreciation     (Depreciation)     (Depreciation)  
$725,141,335
  $ 173,360     $ (11,441 )   $ 161,919  
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO U.S. Treasury Fund
  $ 659,449,307     $ 40,271,662     $ 34,000,000     $ 241,632     $ 30,030     $ 665,971,194  
 
                                   


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivative contracts based on the creditworthiness of its counterparties. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below.
           
Security Type   Percentage of Net Assets of the Fund
Swap Agreements
  (0.1)%
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit risk, yield curves and similar data. Inputs may also include: fair value adjustments provided by an independent pricing service applied to foreign equity securities (including the value of equity securities


 

that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) due to market events that have occurred since the local market close but prior to the close of the NYSE.
Level 3 — Valuations based primarily on inputs that are unobservable and significant. The Fund used the following fair value technique on Level 3 investments: The Fund valued certain debt securities using quoted prices.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Debt Obligations
                               
Asset-Backed Securities
  $     $     $ 4,488,251     $ 4,488,251  
 
                       
TOTAL DEBT OBLIGATIONS
                4,488,251       4,488,251  
 
                       
Mutual Funds
    665,971,194                   665,971,194  
Short-Term Investments
    54,843,809                   54,843,809  
 
                       
Total Investments
    720,815,003             4,488,251       725,303,254  
 
                       
Derivatives*
                               
Forward Currency Contracts
                               
Foreign Currency risk
          6,913,763             6,913,763  
Swap Agreements
                               
Equity risk
          140,250             140,250  
 
                       
Total
  $ 720,815,003     $ 7,054,013     $ 4,488,251     $ 732,357,267  
 
                       
LIABILITY VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Liabilities     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Derivatives*
                               
Forward Currency Contracts
                               
Foreign Currency risk
  $     $ (19,660,935 )   $     $ (19,660,935 )
Swap Agreements
                               
Interest risk
          (461,411 )           (461,411 )
Equity risk
          (11,132,227 )           (11,132,227 )
 
                       
Total
  $     $ (31,254,573 )   $     $ (31,254,573 )
 
                       


 

The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
 
*  Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net value of the Fund’s direct investments in securities using Level 3 inputs was 0.6% of total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.


 

The following is a reconciliation of investments and derivatives, if any, in which significant unobservable inputs (Level 3) were used in determining value:
                                                                                 
                                                                            Net Change in  
                                                                            Unrealized  
                                                                            Appreciation  
                                                                            (Depreciation)  
                                                                            from  
                                            Change in                             Investments Still  
    Balances as of                     Accrued     Total     Unrealized     Transfers     Transfers     Balances as of     Held as of  
    February 28,                     Discounts/     Realized     Appreciation     into level     out of level     November 30,     November 30,  
    2011     Purchases     Sales     Premiums     Gain/(Loss)     (Depreciation)     3 *     3 *     2011     2011  
Debt Obligations
                                                                               
Asset-Backed Securities
  $     $ 6,011,997     $ (1,577,127 )   $ 2,154     $ 59,478     $ (8,251 )   $     $     $ 4,488,251     $ (8,251 )
 
                                                           
Total
  $     $ 6,011,997     $ (1,577,127 )   $ 2,154     $ 59,478     $ (8,251 )   $     $     $ 4,488,251     $ (8,251 )
 
                                                           
 
*   The Fund accounts for investments transferred into Level 3 at the value at the beginning of the period and transferred out of
 
Level 3   at the value at the end of the period.


 

Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase the security at an agreed upon price and date. The Fund, through its custodian, takes possession of securities it acquired under the repurchase agreement. The value of the securities acquired is required by contract to be marked to market daily and additional collateral is required to be transferred so that the market value is at least equal to the amount owed to the Fund by the seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings and/or the value of the securities subject to the repurchase agreement is insufficient, the Fund’s recovery of cash from the seller may be delayed and the Fund may incur a loss equal to the difference between the cash it paid and the value of the securities. The Fund had no repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same assets at an agreed upon price and date. The Fund can use the proceeds received from entering into a reverse repurchase agreement to make additional investments, which generally causes the Fund’s portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the securities it sold and as a result would realize a loss equal to the difference between the value of those securities and the payment it received for them. The size of this loss will depend upon the difference between what the buyer paid for the securities the Fund sold to it and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of $100). In the event of a buyer’s bankruptcy or insolvency, the Fund’s use of proceeds from the sale of its securities may be restricted while the other party or its trustee or receiver determines whether to honor the Fund’s right to repurchase the securities. The Fund had no reverse repurchase agreements outstanding at the end of the period.
Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income securities whose principal value is adjusted periodically according to the rate of inflation. Two structures are common. The U.S. Treasury and some other issuers use a structure that reflects inflation in the principal value of the bond. Most other issuers pay out any inflation related accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real interest rates. Real interest rates, in turn, are tied to the relationship between nominal interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e. nominal interest rate minus inflation) might decline, leading to an increase in value of inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than inflation, real interest rates might rise, leading to a decrease in value of inflation indexed bonds. There can be no assurance, however, that the value of inflation indexed bonds will be directly correlated to changes in nominal interest rates, and short term increases in inflation may lead to a decline in their value. Coupon payments received by the Fund from inflation indexed bonds are included in the Fund’s gross income for the period in which they accrue. In addition, any increase or decrease in the principal amount of an inflation indexed bond will increase or decrease taxable ordinary income to the Fund, even though principal is not paid until maturity. The Fund had no inflation-indexed bonds outstanding at the end of the period.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.


 

Customized Investment Program Risk — Because the Fund is intended to complement the Manager’s asset allocation strategies, the risks associated with the Fund’s investments often will be far greater (and investment returns may be far more volatile) than if the Fund served as a stand-alone investment vehicle.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies.
Leveraging Risk — The Fund’s use of reverse repurchase agreements and other derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Liquidity Risk — Low trading volume, lack of a market maker, a large size position or legal restrictions may limit or prevent the Fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations. The risk of counterparty default is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions.
Focused Investment Risk — Focusing investments in particular countries, regions, sectors or companies, or in industries with high positive correlations to one another creates additional risk.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Market Risk — Fixed Income Securities — Typically, the value of fixed income securities will decline during periods of rising interest rates and widening of credit spreads.
Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating.


 

Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If the Fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of the value of those investments. The Fund also may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Because the Fund normally does not take temporary defensive positions, declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds, or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in the underlying funds, including the risk that the underlying funds in which it invests will not perform as expected or that the Fund will invest in underlying funds with higher fees or expenses.
Market Risk — Asset-Backed Securities — Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
Among other trading agreements, the Fund is party to International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Agreements”) or other similar types of agreements with selected counterparties that generally govern over-the-counter derivative transactions entered into by the Fund. The ISDA Agreements typically include representations and warranties as well as contractual terms related to collateral, events of default, termination events, and other provisions. Termination events may include the decline in the net assets of the Fund below a certain level over a specified period of time and entitle a counterparty to elect to terminate early with respect to some or all the transactions under the ISDA Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse effect on the Fund’s operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. For example, the Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives, to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives. The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For example, if the Fund holds a large proportion of stocks of companies in a particular sector and the Manager believes that stocks of companies in another sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index). In adjusting its investment exposure, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.


 

The Fund does not employ leverage as a principal investment strategy, but the Fund may have net long exposures in excess of its net assets. The Fund’s foreign currency exposure may differ significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other Risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency


 

exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most forward currency contracts are not collateralized. During the period ended November 30, 2011, the Fund used forward currency contracts to adjust exposure to foreign currencies and manage against anticipated currency exchange rate changes. Forward currency contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded (unless otherwise adjusted due to the time at which foreign markets close). The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. During the period ended November 30, 2011, the Fund used futures contracts to maintain the diversity and liquidity of the portfolio and to adjust exposure to equity markets. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. During the period ended November 30, 2011, the Fund used written options to adjust exposure of the portfolio to various equity markets. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
For the period ended November 30, 2011, investment activity in options contracts written by the Fund was as follows:


 

                                                 
    Puts     Calls  
    Principal     Number             Principal     Number        
    Amount of     of             Amount of     of        
    Contracts     Contracts     Premiums     Contracts     Contracts     Premiums  
Outstanding, beginning of period
  $           $     $           $  
Options written
          (351,384 )     (2,822,342 )                  
Options exercised
                                   
Options expired
                                   
Options bought back
          351,384       2,822,342                    
 
                                   
Outstanding, end of period
  $           $     $           $  
 
                                   
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund generally values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment


 

when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
Forward starting dividend swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive the changes in a dividend index point. The Fund gains exposure by either paying or receiving an amount in respect of an increase or decrease in the change of the relevant dividend index point based on a notional amount. For example, if the Fund took a long position on a dividend index swap, the Fund would receive payments if the relevant index point increased in value and would be obligated to pay if that index point decreased in value.
Future swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive the changes in an index. The Fund gains exposure by either paying or receiving an amount in respect of an increase or decrease in the change of the index based on a notional amount. For example, if the Fund took a long position on a future swap, the Fund would receive payments if the relevant index increased in value and would be obligated to pay if that index decreased in value.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers (unless otherwise adjusted due to the time at which foreign markets close) and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that the collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. During the period ended November 30, 2011, the Fund used swap agreements to adjust interest rate exposure, its exposure to certain securities markets, and its exposure to certain companies and industries, as well as to hedge some or all of the broad market exposure of the assets in which the Fund invests and manage the duration of the portfolio. Swap agreements outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.


 

The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Assets:
                                               
Unrealized appreciation on forward currency ontracts
  $     $ 6,913,763     $     $     $     $ 6,913,763  
Unrealized appreciation on swap agreements
                      140,250             140,250  
 
                                   
Total
  $     $ 6,913,763     $     $ 140,250     $     $ 7,054,013  
 
                                   
 
                                               
Liabilities:
                                               
Unrealized depreciation on forward currency contracts
  $     $ (19,660,935 )   $     $     $     $ (19,660,935 )
Unrealized depreciation on swap agreements
    (461,411 )                 (11,132,227 )           (11,593,638 )
 
                                   
Total
  $ (461,411 )   $ (19,660,935 )   $     $ (11,132,227 )   $     $ (31,254,573 )
 
                                   
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts and futures contracts), or notional amounts (swap agreements), outstanding at each month-end, was as follows for the period ended November 30, 2011:
                                 
    Forward                    
    Currency     Futures     Swap        
    Contracts     Contracts     Agreements     Options  
Average amount outstanding
  $ 1,158,205,988     $ 92,476,097     $ 223,997,423     $ 19,464 *
 
*   During the period ended November 30, 2011, the Fund did not hold written options at any month-end, therefore, the average amount outstanding was calculated using daily outstanding absolute values.


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.


 

GMO Strategic Fixed Income Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                         
Par Value ($)/            
Shares/            
Principal Amount     Description   Value ($)  
 
               
DEBT OBLIGATIONS — 12.3%
       
               
 
       
               
United States — 12.3%
       
               
 
       
               
U.S. Government — 12.3%
       
          79,661,775    
U.S. Treasury Inflation Indexed Note, 2.00% , due 04/15/12(a)(b)
    79,929,359  
          50,000,000    
U.S. Treasury Note, 0.38% , due 09/30/12
    50,101,550  
          33,000,000    
U.S. Treasury Note, 1.38% , due 01/15/13 (b)
    33,442,134  
          150,000,000    
U.S. Treasury Note, 1.75% , due 01/31/14
    154,687,500  
                       
               
Total United States
    318,160,543  
                       
               
 
       
               
TOTAL DEBT OBLIGATIONS (COST $316,822,869)
    318,160,543  
                       
               
 
       
               
MUTUAL FUNDS — 81.6%
       
               
 
       
               
United States — 81.6%
       
               
 
       
               
Affiliated Issuers
       
          9,402,704    
GMO Emerging Country Debt Fund, Class IV
    89,043,603  
          105,394,919    
GMO Short-Duration Collateral Fund
    696,660,416  
          30,779,190    
GMO U.S. Treasury Fund
    769,787,532  
          23,817,449    
GMO World Opportunity Overlay Fund
    562,091,794  
                       
               
Total United States
    2,117,583,345  
                       
               
 
       
               
TOTAL MUTUAL FUNDS (COST $2,228,126,239)
    2,117,583,345  
                       
               
 
       
               
OPTIONS PURCHASED — 0.9%
       
               
 
       
               
Options on Interest Rate Swaps — 0.9%
       
               
 
       
NZD     250,000,000    
Swaption Call, Expires 06/01/12, Strike 4.00, Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of 250,000,000 NZD in which it will pay a 3 month NZD Bank Bill and will receive 4.00%, maturing on June 6, 2013, (OTC) (CP — Morgan Stanley Capital Services Inc.)
    2,270,711  
               
 
       
NZD     500,000,000    
Swaption Call, Expires 05/11/12, Strike 3.63, Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of 500,000,000 NZD in which it will pay a 3 month NZD Bank Bill and will receive 3.63%, maturing on May 15, 2013, (OTC) (CP — Morgan Stanley Capital Services Inc.)
    3,295,186  
               
 
       
NZD     500,000,000    
Swaption Call, Expires 03/27/12, Strike 3.80, Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of 500,000,000 NZD in which it will pay a 3 month NZD Bank Bill and will receive 3.80%, maturing on March 28, 2013, (OTC) (CP — Morgan Stanley Capital Services Inc.)
    3,940,949  
               
 
       
NZD     500,000,000    
Swaption Call, Expires 03/26/12, Strike 3.80, Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of 500,000,000 NZD in which it will pay a 3 month NZD Bank Bill and will receive 3.80%, maturing on March 28, 2013, (OTC) (CP — Morgan Stanley Capital Services Inc.)
    3,942,121  

 


 

                         
NZD     500,000,000    
Swaption Call, Expires 02/15/12, Strike 4.22, Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of 500,000,000 NZD in which it will pay a 3 month NZD Bank Bill and will receive 4.22%, maturing on February 16, 2013, (OTC) (CP — Morgan Stanley Capital Services Inc.)
    5,599,474  
               
 
       
USD     400,000,000    
Swaption Call, Expires 05/20/13, Strike 0.77, Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of 400,000,000 USD in which it will pay a 3 month USD LIBOR and will receive 0.77%, maturing on May 22, 2014, (OTC) (CP — Merrill Lynch Capital Services Inc.)
    1,028,800  
               
 
       
USD     400,000,000    
Swaption Call, Expires 05/21/12, Strike 0.77, Upon potential excercise of the option, the Fund will enter into a swap with a notional amount of 400,000,000 USD in which it will pay a 3 month USD LIBOR and will receive 0.77%, maturing on May 23, 2013, (OTC) (CP — Merrill Lynch Capital Services Inc.)
    938,000  
               
 
       
USD     500,000,000    
Swaption Call, Expires 01/22/13, Strike 0.85, Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of 500,000,000 USD in which it will pay a 3 month USD LIBOR and will receive 0.85%, maturing on January 24, 2014, (OTC) (CP — Citibank N.A.)
    1,586,500  
               
 
       
USD     500,000,000    
Swaption Call, Expires 01/23/12, Strike 0.85, Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of 500,000,000 USD in which it will pay a 3 month USD LIBOR and will receive 0.85%, maturing on January 25, 2013, (OTC) (CP — Citibank N.A.)
    1,221,000  
               
 
     
               
 
       
               
Total Options on Interest Rate Swaps
    23,822,741  
               
 
     
               
 
       
               
TOTAL OPTIONS PURCHASED (COST $7,920,291)
    23,822,741  
               
 
     
               
 
       
               
SHORT-TERM INVESTMENTS — 1.1%
       
               
 
       
               
Money Market Funds — 0.0%
       
          1,036,332    
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00%(c)
    1,036,332  
               
 
       
               
U.S. Government — 1.1%
       
          27,300,000    
U.S. Treasury Bill, 0.09%, due 10/18/12(b)(d)
    27,275,594  
               
 
     
               
TOTAL SHORT-TERM INVESTMENTS (COST $28,309,960)
    28,311,926  
               
 
     
               
 
       
               
TOTAL INVESTMENTS — 95.9%
       
               
(Cost $2,581,179,359)
    2,487,878,555  
               
Other Assets and Liabilities (net) — 4.1%
    105,723,263  
               
 
     
               
 
       
               
TOTAL NET ASSETS — 100.0%
  $ 2,593,601,818  
               
 
     

 


 

A summary of outstanding financial instruments at November 30, 2011 is as follows:
Futures Contracts
                             
                        Net Unrealized
Number of       Expiration           Appreciation
Contracts   Type   Date   Value   (Depreciation)
 
Buys  
 
                   
  251    
Australian Government Bond 10 Yr.
  December 2011   $ 30,082,539   $ 853,169
  8,650    
Euro Dollar 90 Day
  March 2012     2,149,525,000     1,307,625
       
 
      $ 2,179,607,539   $ 2,160,794
       
 
                   
Sales  
 
                   
  565    
Australian Government Bond 3 Yr.
  December 2011   $ 62,742,637   $ (544,160)
  8,650    
Euro Dollar 90 Day
  March 2013     2,147,795,000     (2,726,962)
       
 
           
       
 
      $ 2,210,537,637   $ (3,271,122)
       
 
           
Written Options
A summary of open written option contracts for the Fund at November 30, 2011 is as follows:
Options on Interest Rate Swaps
                                               
                    Description of Underlying Swap              
Description   Notional
Amount
      Expiration
Date
  Counterparty   Receive
(Pay)
#
    Fixed
Rate
    Variable
Rate
    Premiums     Market Value  
 
Call- OTC 2 Year
Interest Rate Swap
  500,000,000   USD   01/23/12   Citibank N.A.   (Pay)     0.85 %   3 Month USD
LIBOR
  $ (200,000 )   (1,940,500 )
Call- OTC 2 Year
Interest Rate Swap
  400,000,000   USD   05/21/12   Merrill Lynch
Capital Services Inc.
  (Pay)     0.77 %   3 Month USD
LIBOR
    (310,000 )   (1,331,600 )
Call- OTC 1 Year
Interest Rate Swap
  250,000,000   NZD   06/01/12   Morgan Stanley
Capital Services Inc.
  (Pay)     3.25 %   3 Month NZD
Bank Bill
    (193,871 )   (1,057,466 )
Call- OTC 1 Year
Interest Rate Swap
  500,000,000   NZD   02/15/12   Morgan Stanley
Capital Services Inc.
  (Pay)     3.33 %   3 Month NZD
Bank Bill
    (281,812 )   (2,315,220 )
Call- OTC 1 Year
Interest Rate Swap
  500,000,000   NZD   05/11/12   Morgan Stanley
Capital Services Inc.
  (Pay)     3.13 %   3 Month NZD
Bank Bill
    (354,780 )   (1,765,892 )
Call- OTC 1 Year
Interest Rate Swap
  500,000,000   NZD   03/27/12   Morgan Stanley
Capital Services Inc.
  (Pay)     2.80 %   3 Month NZD
Bank Bill
    (263,568 )   (892,511 )
Call- OTC 1 Year
Interest Rate Swap
  500,000,000   NZD   03/26/12   Morgan Stanley
Capital Services Inc.
  (Pay)     2.80 %   3 Month NZD
Bank Bill
    (262,360 )   (890,169 )
       
 
                                 
 
                                  $ (1,866,391 ) $ (10,193,358 )
       
 
                                 

 


 

Swap Agreements
Interest Rate Swaps
                                         
                                    Net Unrealized
Notional   Expiration       Receive                   Appreciation/
Amount   Date   Counterparty   (Pay)#   Fixed Rate   Variable Rate   (Depreciation)
100,000,000
  AUD   8/25/2020   Barclays Bank PLC   Receive     5.27 %   6 Month AUD Bank Bill Rate   $ 4,186,177  
200,000,000
  AUD   8/26/2020   Morgan Stanley
Capital Services Inc.
  Receive     5.26 %   6 Month AUD Bank Bill Rate     8,192,129  
200,000,000
  AUD   8/30/2020   Morgan Stanley
Capital Services Inc.
  Receive     5.25 %   6 Month AUD Bank Bill Rate     7,984,899  
300,000,000
  AUD   9/20/2020   Morgan Stanley
Capital Services Inc.
  Receive     5.58 %   6 Month AUD Bank Bill Rate     19,408,732  
200,000,000
  AUD   9/22/2020   Morgan Stanley
Capital Services Inc.
  Receive     5.65 %   6 Month AUD Bank Bill Rate     13,930,294  
200,000,000
  AUD   4/5/2021   Morgan Stanley
Capital Services Inc.
  Receive     6.06 %   6 Month AUD Bank Bill Rate     20,692,066  
100,000,000
  NZD   7/14/2015   Barclays Bank PLC   Receive     4.87 %   3 Month NZD Bank Bill Rate     4,329,204  
100,000,000
  NZD   7/15/2015   Barclays Bank PLC   Receive     4.86 %   3 Month NZD Bank Bill Rate     4,303,455  
100,000,000
  NZD   7/15/2015   Citibank N.A.   Receive     4.85 %   3 Month NZD Bank Bill Rate     4,283,603  
125,000,000
  NZD   7/16/2015   Merrill Lynch
Capital Services Inc.
  Receive     4.86 %   3 Month NZD Bank Bill Rate     5,400,313  
1,215,000,000
  USD   2/8/2014   Morgan Stanley
Capital Services Inc.
  (Pay)     0.71 %   3 Month USD Libor     (332,626 )
505,000,000
  USD   2/8/2017   Morgan Stanley
Capital Services Inc.
  Receive     1.79 %   3 Month USD Libor     9,764,440  
 
                                       
 
                                102,142,686  
 
                                       
 
                          Premiums to (Pay) Receive   $  
 
                                       
 
#   Receive — Fund receives fixed rate and pays variable rate. (Pay) — Fund pays fixed rate and receives variable rate.
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
Notes to Schedule of Investments:
CP — Counterparty
LIBOR — London Interbank Offered Rate
OTC — Over-the-Counter
USD LIBOR — London Interbank Offered Rate denominated in United States Dollars.
(a)   Indexed security in which price and/or coupon is linked to the prices of a specific instrument or financial statistic.
 
(b)   All or a portion of this security has been pledged to cover margin requirements on futures contracts, collateral on swap contracts, forward currency contracts, and/or written options, if any.

 


 

(c)   Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.
 
(d)   Rate shown represents yield-to-maturity.
Currency Abbreviations:
AUD — Australian Dollar
NZD — New Zealand Dollar
USD — United States Dollar

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                         
    Gross     Gross     Net Unrealized  
    Unrealized     Unrealized     Appreciation  
Aggregate Cost   Appreciation     (Depreciation)     (Depreciation)  
$2,602,393,499
  $ 18,107,411     $ (132,622,355 )   $ (114,514,944 )

 


 

Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                         
    Value,                             Distributions              
    beginning of             Sales     Dividend     of Realized     Return of     Value, end  
Affiliate   period     Purchases     Proceeds     Income*     Gains*     Capital*     of period  
GMO Emerging Country Debt Fund, Class IV
  $ 74,177,360     $ 11,900,000     $     $ 1,026,777           $     $ 89,043,603  
GMO Short-Duration Collateral Fund
    1,093,999,261                   8,287,092             365,005,327       696,660,416  
GMO U.S. Treasury Fund
    639,615,835       642,115,000       512,250,000       289,788       39,047             769,787,532  
GMO World Opportunity Overlay Fund
    539,186,004       1,000,000                               562,091,794  
 
                                         
Totals
  $ 2,346,978,460     $ 655,015,000     $ 512,250,000     $ 9,603,657     $ 39,047     $ 365,005,327     $ 2,117,583,345  
 
                                         
 
  The table above includes estimated sources of all distributions paid by the underlying funds during the period March 1, 2011 through November 30, 2011 for tax purposes. The actual tax characterization of distributions paid by the underlying funds will be determined through fiscal year ending February 29, 2012.

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly and indirectly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 1.4% of net assets. The Fund and the underlying funds classify such securities (levels defined below) as Level 3. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivative contracts based on the creditworthiness of its counterparties. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Typically the Fund and the underlying funds value debt instruments based on the most recent quoted price supplied by a single pricing source chosen by the Manager. Although the Manager normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and may change a pricing source at any time. The Manager monitors erratic or unusual movements (including unusual inactivity) in the prices supplied for a security and has discretion to override a price supplied by a source (e.g., by taking a price supplied by another) when it believes that the price supplied is not reliable. Although alternative prices may be available for securities held by the Fund and the underlying funds, those alternative sources are not typically part of the valuation process and do not necessarily provide greater certainty about the prices used by the Fund and the underlying funds. As of November 30, 2011, the total value of securities held directly and indirectly for which no alternative pricing source was available represented 4.5% of the net assets of the Fund.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit risk, yield curves and similar data.
Level 3 — Valuations based primarily on inputs that are unobservable and significant.

 


 

The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Debt Obligations
                               
U.S. Government
  $ 238,231,184     $ 79,929,359     $     $ 318,160,543  
 
                       
TOTAL DEBT OBLIGATIONS
    238,231,184       79,929,359             318,160,543  
 
                       
Mutual Funds
    2,117,583,345                   2,117,583,345  
Options Purchased
          23,822,741             23,822,741  
Short-Term Investments
    28,311,926                   28,311,926  
 
                       
Total Investments
    2,384,126,455       103,752,100             2,487,878,555  
 
                       
Derivatives*
                               
Futures Contracts
                               
Interest rate risk
    2,160,794                   2,160,794  
Swap Agreements
                             
Interest rate risk
          102,475,312             102,475,312  
 
                       
Total
  $ 2,386,287,249     $ 206,227,412     $     $ 2,592,514,661  
 
                       
LIABILITY VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Liabilities     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Derivatives*
                               
Written Options
                               
Interest rate risk
  $     $ (10,193,358 )   $     $ (10,193,358 )
Futures Contracts
                               
Interest rate risk
    (3,271,122 )                 (3,271,122 )
Swap Agreements
                               
Interest rate risk
          (332,626 )           (332,626 )
 
                       
Total
  $ (3,271,122 )   $ (10,525,984 )   $     $ (13,797,106 )
 
                       
The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
 
*   Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net values of the Fund’s indirect investments in securities and derivative financial instruments using Level 3 inputs were 26.2% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011 whose fair value was categorized using Level 3 inputs.

 


 

Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase the security at an agreed upon price and date. The Fund, through its custodian, takes possession of securities it acquired under the repurchase agreement. The value of the securities acquired is required by contract to be marked to market daily and additional collateral is required to be transferred so that the market value is at least equal to the amount owed to the Fund by the seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings and/or the value of the securities subject to the repurchase agreement is insufficient, the Fund’s recovery of cash from the seller may be delayed and the Fund may incur a loss equal to the difference between the cash it paid and the value of the securities. The Fund had no repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same assets at an agreed upon price and date. The Fund can use the proceeds received from entering into a reverse repurchase agreement to make additional investments, which generally causes the Fund’s portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the securities it sold and as a result would realize a loss equal to the difference between the value of those securities and the payment it received for them. The size of this loss will depend upon the difference between what the buyer paid for the securities the Fund sold to it and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of $100). In the event of a buyer’s bankruptcy or insolvency, the Fund’s use of proceeds from the sale of its securities may be restricted while the other party or its trustee or receiver determines whether to honor the Fund’s right to repurchase the securities. The Fund had no reverse repurchase agreements outstanding at the end of the period.
Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income securities whose principal value is adjusted periodically according to the rate of inflation. Two structures are common. The U.S. Treasury and some other issuers use a structure that reflects inflation in the principal value of the bond. Most other issuers pay out any inflation related accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real interest rates. Real interest rates, in turn, are tied to the relationship between nominal interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e. nominal interest rate minus inflation) might decline, leading to an increase in value of inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than inflation, real interest rates might rise, leading to a decrease in value of inflation indexed bonds. There can be no assurance, however, that the value of inflation indexed bonds will be directly correlated to changes in nominal interest rates, and short term increases in inflation may lead to a decline in their value. Coupon payments received by the Fund from inflation indexed bonds are included in the Fund’s gross income for the period in which they accrue. In addition, any increase or decrease in the principal amount of an inflation indexed bond will increase or decrease taxable ordinary income to the Fund, even though principal is not paid until maturity. Inflation-indexed bonds outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.

 


 

Market Risk — Fixed Income Securities — Typically, the market value of the Fund’s fixed income securities will decline during periods of rising interest rates and widening of credit spreads.
Market Risk — Asset-Backed Securities — Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating. The Fund’s investments in below investment grade securities have speculative characteristics, and changes in economic conditions or other circumstances are more likely to impair the capacity of issuers to make principal and interest payments than is the case with issuers of investment grade securities.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations. The risk of counterparty default is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies.
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Leveraging Risk — The Fund’s use of reverse repurchase agreements and other derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies with high positive correlations to one another creates additional risk.

 


 

Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in underlying funds, including the risk that the underlying funds in which it invests will not perform as expected.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
The Fund invests (including through investment in underlying funds) in asset-backed securities, which may be backed by many types of assets, including pools of residential and commercial mortgages, automobile loans, educational loans, home equity loans, or credit card receivables, which expose the Fund to additional types of market risk. They also may be backed by pools of corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds and loans (commonly referred to as “collateralized debt obligations” or “collateralized loan obligations”) and by the fees earned by service providers. Payment of interest on asset backed securities and repayment of principal largely depend on the cash flows generated by the assets backing the securities. The market risk of a particular asset-backed security depends on many factors, including the deal structure (e.g., determination as to the amount of underlying assets or other support needed to produce the cash flows necessary to service interest and make principal payments), the quality of the underlying assets and, if any, the level of credit support and the credit quality of the credit-support provider. Asset-backed securities involve risk of loss of principal if obligors of the underlying obligations default and the value of the defaulted obligations exceeds whatever credit support the securities may have. The obligations of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and other laws affecting the rights and remedies of creditors. Many asset-backed securities in which the Fund has invested are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal and/or interest will be paid because the insurer could default on its obligations. In recent years, a significant number of asset-backed security insurers have defaulted on their obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about the creditworthiness of those securities (and underlying assets) caused credit spreads (the difference between yields on the asset-backed securities and U.S. Government securities) to widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions to make markets in many fixed income securities. These events reduced liquidity and contributed to substantial declines in the value of asset-backed and other fixed income securities. There can be no assurance these conditions will not occur again. Also, government actions and proposals affecting the terms of underlying home and consumer loans, changes in demand for products (e.g., automobiles) financed by those loans, and the inability of borrowers to refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying assets and is, therefore, subject to risks associated with the negligence or defalcation of its servicer. In some circumstances, the mishandling of related documentation also may affect the rights of security holders in and to the underlying assets. The insolvency of entities that generate receivables or that utilize the assets may result in a decline in the value of the underlying assets, as well as costs and delays. The obligations underlying asset-backed securities, in particular securities backed by pools of residential and commercial mortgages, also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as high a yield as is provided by the asset-backed security. The risk of investing in asset-backed securities has increased because performance of the various sectors in which the assets underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime mortgages, and credit card receivables) has become more highly correlated since the deterioration in worldwide economic and liquidity conditions.
Among other trading agreements, the Fund is party to International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Agreements”) or other similar types of agreements with selected counterparties that generally govern over-the-counter derivative transactions entered into by the Fund. The ISDA Agreements typically include representations and warranties as well as contractual terms related to collateral, events of default, termination events, and other provisions. Termination events may include the decline in the net assets of the Fund below a certain level over a specified period of time and entitle a counterparty to elect to terminate early with respect to some or all the transactions under the ISDA Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse effect on the Fund’s operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to

 


 

securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. In particular, the Fund may use swaps or other derivatives on an index, a single security or a basket of securities to gain investment exposures (e.g., by selling protection under a credit default swap). The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). For example, the Fund may use credit default swaps to take a short position with respect to the likelihood of default by an issuer. The Fund also may use currency derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For instance, the Manager may alter the interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is designed to maintain the Fund’s exposure to the credit of an issuer through the debt instrument but adjust the Fund’s interest rate exposure through the swap. With these swaps, the Fund and its counterparties exchange interest rate exposure, such as fixed versus variable rates and shorter duration versus longer duration exposure. In adjusting its investment exposures, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund is not limited in the extent to which it uses derivatives or in the absolute face value of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate exposure of its assets, and its net long exposure may exceed 100% of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the

 


 

Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk that it will be required to pay the full notional value of the swap contract in the event of a default.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. During the period ended November 30, 2011, the Fund used forward currency contracts to adjust exposure to foreign currencies and otherwise adjust currency exchange rate risk. The Fund had no forward currency contracts outstanding at the end of the period.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded. The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. During the period ended November 30, 2011, the Fund used futures contracts to adjust interest-rate exposure and maintain the diversity and liquidity of the portfolio. Futures contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss

 


 

associated with purchasing put and call options is limited to the premium paid. During the period ended November 30, 2011, the Fund used purchased option contracts to adjust interest rate exposure. Option contracts purchased by the Fund and outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. During the period ended November 30, 2011, the Fund used written option contracts to adjust interest rate exposure. Written options outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
For the period ended November 30, 2011, investment activity in options contracts written by the Fund was as follows:
                                                 
    Puts     Calls  
    Principal     Number             Principal     Number of        
    Amount of     of Futures     Premium     Amount of     Futures        
    Contracts     Contracts     s     Contracts     Contracts     Premiums  
Outstanding, beginning of period
              $       (1,000,000,000 )     (3,000 )   $ (700,812 )
Options written
                      (2,150,000,000 )           (1,384,579 )
Options bought back
                            3,000       219,000  
Options expired
                                   
Options sold
                                   
 
                                   
Outstanding, end of period
              $       (3,150,000,000 )         $ (1,866,391 )
 
                                   
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).

 


 

Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. During the period ended November 30, 2011, the Fund used swap agreements to adjust interest rate exposure and adjust its exposure to certain markets. Swap agreements outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.

 


 

The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Assets:
                                               
Investments, at value (purchased options)
  $ 23,822,741     $     $     $     $     $ 23,822,741  
Unrealized appreciation on futures contracts*
    2,160,794                               2,160,794  
Unrealized appreciation on swap agreements
    102,475,312                               102,475,312  
 
                                   
Total
  $ 128,458,847     $     $     $     $     $ 128,458,847  
 
                                   
 
                                               
Liabilities:
                                               
Unrealized depreciation on futures contracts*
    (3,271,122 )                             (3,271,122 )
Written options outstanding
  $ (10,193,358 )   $     $     $     $     $ (10,193,358 )
Unrealized depreciation on swap agreements
    (332,626 )                             (332,626 )
 
                                   
Total
  $ (13,797,106 )   $     $     $     $     $ (13,797,106 )
 
                                   
 
*   The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of futures contracts as reported in the Schedule of Investments.
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts and futures contracts), notional amounts (swap agreements), or principal amounts (options) outstanding at each month-end, was as follows for the period ended November 30, 2011:
                                 
    Forward                    
    Currency     Futures     Swap        
    Contracts     Contracts     Agreements     Options  
Average amount outstanding
  $ 281,995     $ 7,527,954,071     $ 5,180,197,268     $ 6,138,666,376  

 


 

Subsequent events
Effective December 9, 2011, the Fund instituted a premium on cash purchases equal to 0.20% of the amount invested and a fee on cash redemptions equal to 0.20% of the amount redeemed.
For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Strategic Opportunities Allocation Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                         
Shares     Description             Value ($)  
 
       
MUTUAL FUNDS — 99.3%
               
       
 
               
       
Affiliated Issuers — 99.3%
               
  811,285    
GMO Alpha Only Fund, Class IV
            20,192,889  
  6,170,977    
GMO Domestic Bond Fund, Class VI
            18,266,093  
  1,270,045    
GMO Emerging Country Debt Fund, Class IV
            12,027,328  
  6,264,385    
GMO Emerging Markets Fund, Class VI
            73,230,658  
  5,644,923    
GMO Flexible Equities Fund, Class VI
            96,753,984  
  10,231,698    
GMO International Growth Equity Fund, Class IV
            218,958,336  
  20,477,771    
GMO International Intrinsic Value Fund, Class IV
            399,316,531  
  32,391,339    
GMO Quality Fund, Class VI
            707,426,851  
  3,669,745    
GMO Special Situations Fund, Class VI
            97,028,061  
  11,909,015    
GMO Strategic Fixed Income Fund, Class VI
            202,691,433  
  2,516,982    
GMO U.S. Core Equity Fund, Class VI
            30,556,164  
  384,516    
GMO World Opportunity Overlay Fund
            9,074,584  
       
 
             
       
TOTAL MUTUAL FUNDS (COST $1,738,808,506)
            1,885,522,912  
       
 
             
                 
Par Value ($)     Description   Value ($)  
 
       
DEBT OBLIGATIONS — 0.7%
       
       
 
       
       
Asset-Backed Securities — 0.7%
       
       
 
       
       
Auto Financing — 0.0%
       
  400,979    
Capital Auto Receivable Asset Trust, Series 08-1, Class A4B, 1 mo. LIBOR + 1.35%, 1.60%, due 07/15/14
    402,234  
  221,148    
Daimler Chrysler Auto Trust, Series 08-B, Class A4B, 1 mo. LIBOR + 1.85%, 2.10%, due 11/10/14
    221,701  
       
 
     
       
Total Auto Financing
    623,935  
       
 
     
       
 
       
       
Business Loans — 0.1%
       
  796,526    
Bayview Commercial Asset Trust, Series 05-4A, Class A2, 144A, 1 mo. LIBOR + .39%, 0.65%, due 01/25/36
    501,811  
  290,713    
GE Business Loan Trust, Series 04-1, Class A, 144A, 1 mo. LIBOR + .29%, 0.54%, due 05/15/32
    257,281  
  541,552    
Lehman Brothers Small Balance Commercial, Series 05-2A, Class 1A, 144A, 1 mo. LIBOR + .25%, 0.51%, due 09/25/30
    427,230  
       
 
     
       
Total Business Loans
    1,186,322  
       
 
     
       
 
       
       
CMBS — 0.1%
       
  600,000    
Commercial Mortgage Pass-Through Certificates, Series 06-FL12, Class AJ, 144A, 1 mo. LIBOR + .13%, 0.38%, due 12/15/20
    543,000  
  162,667    
GE Capital Commercial Mortgage Corp., Series 05-C4, Class A2, 5.31%, due 11/10/45
    162,667  
  600,000    
GS Mortgage Securities Corp., Series 07-EOP, Class A2, 144A, 1 mo. LIBOR + .57%, 1.32%, due 03/06/20
    594,000  
  52,893    
J.P. Morgan Chase Commercial Mortgage Securities Corp., Series 06-LDP7, Class A2, 5.86%, due 04/15/45
    52,924  
  274,675    
Merrill Lynch Mortgage Trust, Series 06-C1, Class A2, 5.62%, due 05/12/39
    280,059  
  238,165    
Wachovia Bank Commercial Mortgage Trust, Series 06-WL7A, Class A1, 144A, 1 mo. LIBOR + .09%, 0.34%, due 09/15/21
    226,257  
       
 
     
       
Total CMBS
    1,858,907  
       
 
     
       
 
       
       
Corporate Collateralized Debt Obligations — 0.1%
       
  1,100,000    
Morgan Stanley ACES SPC, Series 06-13A, Class A, 144A, 3 mo. LIBOR + .29%, 0.64%, due 06/20/13
    968,990  
       
 
     
       
 
       
       
Credit Cards — 0.0%
       
  700,000    
Charming Shoppes Master Trust, Series 07-1A, Class A1, 144A, 1 mo. LIBOR + 1.25%, 1.50%, due 09/15/17
    701,155  
       
 
     

 


 

                 
       
Insured Auto Financing — 0.1%
       
  457,402    
AmeriCredit Automobile Receivables Trust, Series 07-DF, Class A4B, FSA, 1 mo. LIBOR + .80%, 1.05%, due 06/06/14
    457,166  
  518,369    
Triad Auto Receivables Owner Trust, Series 07-B, Class A4B, FSA, 1 mo. LIBOR + 1.20%, 1.45%, due 07/14/14
    520,894  
       
 
     
       
Total Insured Auto Financing
    978,060  
       
 
     
       
 
       
       
Insured Other — 0.1%
       
  900,000    
Dominos Pizza Master Issuer LLC, Series 07-1, Class A2, 144A, MBIA, 5.26%, due 04/25/37
    903,465  
       
 
     
       
 
       
       
Insured Residential Asset-Backed Securities (United States) ¨ — 0.0%
       
  107,825    
Residential Asset Mortgage Products, Inc., Series 05-RS9, Class AI3, FGIC, 1 mo. LIBOR + .22%, 0.48%, due 11/25/35
    75,478  
       
 
     
       
 
       
       
Insured Residential Mortgage-Backed Securities (United States) — 0.0%
       
  407,792    
Countrywide Home Equity Loan Trust, Series 07-E, Class A, MBIA, 1 mo. LIBOR + .15%, 0.40%, due 06/15/37
    240,597  
       
 
     
       
 
       
       
Insured Time Share — 0.0%
       
  183,688    
Sierra Receivables Funding Co., Series 07-2A, Class A2, 144A, MBIA, 1 mo. LIBOR + 1.00%, 1.25%, due 09/20/19
    178,323  
       
 
     
       
 
       
       
Residential Asset-Backed Securities (United States) ¨ — 0.2%
       
  418,142    
ACE Securities Corp., Series 06-SL3, Class A1, 1 mo. LIBOR + .10%, 0.36%, due 06/25/36
    67,948  
  289,140    
ACE Securities Corp., Series 07-WM1, Class A2A, 1 mo. LIBOR + .07%, 0.33%, due 11/25/36
    96,862  
  188,230    
Argent Securities, Inc., Series 06-W2, Class A2B, 1 mo. LIBOR + .19%, 0.45%, due 03/25/36
    54,587  
  153,844    
Argent Securities, Inc., Series 06-M2, Class A2B, 1 mo. LIBOR + .11%, 0.37%, due 09/25/36
    44,999  
  169,573    
Asset Backed Funding Certificates, Series 07-NC1, Class A1, 144A, 1 mo. LIBOR + .22%, 0.48%, due 05/25/37
    133,539  
  594,398    
Bayview Financial Acquisition Trust, Series 04-B, Class A2, 144A, 1 mo. LIBOR + .65%, 1.56%, due 05/28/39
    167,917  
  1,200,000    
Carrington Mortgage Loan Trust, Series 07-FRE1, Class A2, 1 mo. LIBOR + .20%, 0.46%, due 02/25/37
    739,560  
  17,933    
Chase Funding Mortgage Loan Trust, Series 03-3, Class 2A2, 1 mo. LIBOR + .27%, 0.80%, due 04/25/33
    15,064  
  1,600,000    
Countrywide Asset-Backed Certificates, Series 06-BC3, Class 2A2, 1 mo. LIBOR + .14%, 0.40%, due 02/25/37
    1,164,000  
  998,384    
J.P. Morgan Mortgage Acquisition Corp., Series 06-WMC4, Class A3, 1 mo. LIBOR + .12%, 0.38%, due 12/25/36
    315,390  
  311,111    
Master Asset-Backed Securities Trust, Series 06-FRE2, Class A4, 1 mo. LIBOR + .15%, 0.41%, due 03/25/36
    108,889  
  268,547    
Morgan Stanley Home Equity Loans, Series 07-2, Class A1, 1 mo. LIBOR + .10%, 0.36%, due 04/25/37
    219,537  
  286,599    
Residential Asset Securities Corp., Series 05-KS12, Class A2, 1 mo. LIBOR + .25%, 0.51%, due 01/25/36
    257,939  
       
 
     
       
Total Residential Asset-Backed Securities (United States)
    3,386,231  
       
 
     
       
 
       
       
Residential Mortgage-Backed Securities (Australian) — 0.0%
       
  117,224    
Interstar Millennium Trust, Series 05-1G, Class A, 3 mo. LIBOR + .12%, 0.74%, due 12/08/36
    104,329  
  93,463    
Superannuation Members Home Loans Global Fund, Series 7, Class A1, 3 mo. LIBOR + .14%, 0.62%, due 03/09/36
    90,639  
  282,134    
Westpac Securitization Trust, Series 07-1G, Class A2A, 3 mo. LIBOR + .05%, 0.53%, due 05/21/38
    273,706  
       
 
     
       
Total Residential Mortgage-Backed Securities (Australian)
    468,674  
       
 
     
       
 
       
       
Residential Mortgage-Backed Securities (European) — 0.0%
       
  423,123    
Brunel Residential Mortgages, Series 07-1A, Class A4C, 144A, 3 mo. LIBOR + .10%, 0.50%, due 01/13/39
    374,879  

 


 

                         
  465,690    
Paragon Mortgages Plc, Series 7A, Class A1A, 144A, 3 mo. LIBOR + .42%, 0.88%, due 05/15/34
            374,135  
       
 
           
       
Total Residential Mortgage-Backed Securities (European)
            749,014  
       
 
           
       
 
               
       
Student Loans — 0.0%
               
  12,287    
National Collegiate Student Loan Trust, Series 06-1, Class A2, 1 mo. LIBOR + .14%, 0.40%, due 08/25/23
            11,918  
  600,000    
Nelnet Student Loan Trust, Series 05-2, Class A4, 3 mo. LIBOR + .08%, 0.44%, due 12/23/19
            592,224  
       
 
           
       
Total Student Loans
            604,142  
       
 
           
       
Total Asset-Backed Securities
            12,923,293  
       
 
           
       
 
               
       
Corporate Debt — 0.0%
               
  147,000    
Health Care Property Investors, Inc., Series G, MTN, 5.63%, due 02/28/13
            151,624  
       
 
           
       
 
               
       
U.S. Government Agency — 0.0%
               
  150,000    
Agency for International Development Floater (Support of Morocco), 6 mo. U.S. Treasury Bill + .45%, 0.52%, due 11/15/14(a)
            146,779  
  33,334    
Agency for International Development Floater (Support of Zimbabwe), 3 mo. U.S. Treasury Bill x 115%, 0.04%, due 01/01/12(a)
            33,283  
       
 
           
       
Total U.S. Government Agency
            180,062  
       
 
           
       
TOTAL DEBT OBLIGATIONS (COST $12,821,165)
            13,254,979  
       
 
           
                 
    Shares     Description   Value ($)  
 
       
SHORT-TERM INVESTMENTS — 0.0%
       
       
 
       
       
Money Market Funds — 0.0%
       
  25,325    
State Street Institutional U.S. Government Money Market Fund-Institutional Class, 0.00%(b)
    25,325  
       
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $25,325)
    25,325  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 100.0%
(Cost $1,751,654,996)
    1,898,803,216  
       
Other Assets and Liabilities (net) — (0.0%)
    (108,184 )
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 1,898,695,032  
       
 
     

 


 

Notes to Schedule of Investments:
144A — Securities exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional investors.
CMBS — Commercial Mortgage Backed Security
FGIC — Insured as to the payment of principal and interest by Financial Guaranty Insurance Corporation.
FSA — Insured as to the payment of principal and interest by Financial Security Assurance.
LIBOR — London Interbank Offered Rate
MBIA — Insured as to the payment of principal and interest by MBIA Insurance Corp.
MTN — Medium Term Note
The rates shown on variable rate notes are the current interest rates at November 30, 2011, which are subject to change based on the terms of the security.
 
¨   These securities are primarily backed by subprime mortgages.
 
(a)   Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust.
 
(b)   Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
             
    Gross   Gross   Net Unrealized
    Unrealized   Unrealized   Appreciation
Aggregate Cost   Appreciation   (Depreciation)   (Depreciation)
$1,814,980,854
  $93,045,255   $(9,222,893)   $83,822,362
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                         
    Value,                             Distributions              
    beginning of             Sales     Dividend     of Realized     Return of     Value, end  
Affiliate   period     Purchases     Proceeds     Income*     Gains*     Capital*     of period  
GMO Alpha Only Fund, Class IV
  $ 76,562,509     $ 53,416,408     $ 115,917,730     $     $           $ 20,192,889  
GMO Asset Allocation Bond Fund, Class VI
    19,060,719       10,366,213       28,721,459       198,912       1,022,195              
GMO Domestic Bond Fund, Class VI
    28,263,076                   279,846             9,142,587       18,266,093  
GMO Emerging Country Debt Fund, Class IV
    10,590,652       1,014,705             148,048                   12,027,328  
GMO Emerging Markets Fund, Class VI
    71,011,675       20,260,404       2,625,458       28,999       5,307,398             73,230,658  
GMO Flexible Equities Fund, Class VI
    30,813,653       75,288,184       1,974,158                         96,753,984  
GMO International Growth Equity Fund, Class IV
    320,270,734       49,018,681       118,571,985       1,984,233                   218,958,336  
GMO International Intrinsic Value Fund, Class IV
    320,384,848       181,714,563       57,524,391       5,524,987                   399,316,531  
GMO Quality Fund, Class VI
    579,206,834       157,901,542       59,760,260       9,613,238                   707,426,851  
GMO Special Situations Fund, Class VI
    90,321,776       12,775,380       1,946,268                         97,028,061  
GMO Strategic Fixed Income Fund, Class VI
    123,130,167       66,087,293       3,779,693                         202,691,433  
GMO U.S. Core Equity Fund, Class VI
    52,712,842       4,035,646       25,208,759       816,162                   30,556,164  
GMO World Opportunity Overlay Fund
    8,720,829                                     9,074,584  
Totals
  $ 1,731,050,314     $ 631,879,019     $ 416,030,161     $ 18,594,425     $ 6,329,593     $ 9,142,587     $ 1,885,522,912  
 
                                         
 
*   The table above includes estimated sources of all distributions paid by the underlying funds during the period March 1, 2011 through November 30, 2011 for tax purposes. The actual tax characterization of distributions paid by the underlying funds will be determined at the end of the fiscal year ending February 29, 2012.

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Shares of the underlying funds and other investment funds are generally valued at their net asset value. Investments held by the underlying funds are valued as follows: Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly and indirectly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 0.4% of net assets. The Fund and the underlying funds classify such securities (levels defined below) as Level 3.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund, either directly or through investments in the underlying funds, that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below and as described in the disclosures of the underlying funds.
     
Security Type   Percentage of Net Assets of the Fund
Equity Securities
  43.0%
Futures Contracts
  0.1%
Swap Agreements
  0.1%
Typically the Fund and the underlying funds value debt instruments based on the most recent quoted price supplied by a single pricing source chosen by the Manager. Although the Manager normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and may change a pricing source at any time. The Manager monitors erratic or unusual movements (including unusual inactivity) in the prices supplied for a security and has discretion to override a price supplied by a source (e.g., by taking a price supplied by another) when it believes that the price supplied is not reliable. Although alternative prices may be available for securities held by the Fund and the underlying funds, those alternative sources are not typically part of the valuation process and do not necessarily provide greater certainty about the prices used by the Fund and the underlying funds. As of November 30, 2011, the total value of securities held directly and indirectly for which no alternative pricing source was available represented 0.8% of the net assets of the Fund.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the

 


 

valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit risk, yield curves and similar data.
Level 3 — Valuations based primarily on inputs that are unobservable and significant. The Fund utilized a number of fair value techniques on Level 3 investments, including the following: The Fund valued certain debt securities using quoted prices. The Fund valued certain other debt securities by using an estimated specified spread above the LIBOR rate.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Mutual Funds
  $ 1,885,522,912     $     $     $ 1,885,522,912  
Debt Obligations
                               
Asset-Backed Securities
          1,984,566       10,938,727       12,923,293  
Corporate Debt
          151,624             151,624  
U.S. Government Agency
                180,062       180,062  
 
                       
TOTAL DEBT OBLIGATIONS
          2,136,190       11,118,789       13,254,979  
 
                       
Short-Term Investments
    25,325                   25,325  
 
                       
Total Investments
    1,885,548,237       2,136,190       11,118,789       1,898,803,216  
 
                       
Total
  $ 1,885,548,237     $ 2,136,190     $ 11,118,789     $ 1,898,803,216  
 
                       

 


 

The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net values of the Fund’s investments (both direct and indirect) in securities and derivative financial instruments using Level 3 inputs were 4.6% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant unobservable inputs (Level 3) were used in determining value:

 


 

                                                                                 
                                                                            Net Change in  
                                                                            Unrealized  
                                                                            Appreciation  
                                                                            (Depreciation)  
                                            Change in                             from  
    Balances as                     Accrued     Total     Unrealized                       Investments Still  
    of February 28,                     Discounts/     Realized     Appreciation     Transfers     Transfers out     Balances as of     Held as of November 30,  
    2011     Purchases     Sales     Premiums     Gain/(Loss)     (Depreciation)     into level 3 *     of level 3 *     November 30, 2011     2011  
Debt Obligations
                                                                               
Asset-Backed Securities
  $ 16,149,456     $     $ (4,573,771 )   $ 300,204     $ 722,195     $ (1,659,357 )   $     $     $ 10,938,727     $ (1,320,007 )
U.S. Government Agency
    262,453             (83,104 )     684       1,657       (1,628 )                 180,062       (1,628 )
 
                                                           
Total
  $ 16,411,909     $     $ (4,656,875 )   $ 300,888     $ 723,852     $ (1,660,985 )   $     $     $ 11,118,789     $ (1,321,635 )
 
                                                           
 
*   The Fund accounts for investments and derivatives transferred into Level 3 at the value at the beginning of the period and transferred out of Level 3 at the value at the end of the period.

 


 

Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. References to investments include those held directly by the Fund and indirectly through the Fund’s investments in the underlying funds. Some of the underlying funds are non-diversified investment companies under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by those Funds may affect their performance more than if they were diversified. Selected risks of investing in the Fund are summarized below, including those risks to which the Fund is exposed as a result of its investments in the underlying funds. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
 Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If an underlying fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of the value of those investments. An underlying fund also may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
 
 Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
 
 Market Risk — Fixed Income Securities — Typically, the market value of fixed income securities will decline during periods of rising interest rates and widening of credit spreads.
 
 Market Risk — Asset-Backed Securities — Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
 
 Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund or an underlying fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
 
 Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.

 


 

 Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in the underlying funds, including the risk that the underlying funds in which it invests do not perform as expected. Because the Fund bears the fees and expenses of the underlying funds in which it invests, new investments in underlying funds with higher fees or expenses than those of the underlying funds in which the Fund is currently invested will increase the Fund’s total expenses. The fees and expenses associated with an investment in the Fund are less predictable and may be higher than fees and expenses associated with an investment in funds that charge a fixed management fee.
 
 Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
 
 Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
 
 Commodities Risk — To the extent an underlying fund has exposure to global commodity markets, the value of its shares is affected by factors particular to the commodity markets and may fluctuate more than the value of shares of a fund with a broader range of investments.
 
 Currency Risk — Fluctuations in exchange rates can adversely affect the market value of foreign currency holdings and investments denominated in foreign currencies, or that the U.S. dollar will decline in value relative to the foreign currency being hedged.
 
 Leveraging Risk — The use of reverse repurchase agreements and other derivatives and securities lending may cause the Fund’s portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
 
 Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating. Below investment grade securities have speculative characteristics, and changes in economic conditions or other circumstances are more likely to impair the capacity of issuers to make principal and interest payments than is the case with issuers of investment grade securities.
 
 Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
 
 Real Estate Risk — To the extent an underlying fund concentrates its assets in real estate-related investments, the value of its portfolio is subject to factors affecting the real estate industry and may fluctuate more than the value of a portfolio that consists of securities of companies in a broader range of industries.
 
 Short Sales Risk — The Fund runs the risk that an underlying fund’s loss on a short sale of securities that the underlying fund does not own is unlimited.
 
 Focused Investment Risk — Focusing investments in countries, regions, sectors or companies or in industries with high positive correlations to one another creates additional risk.
 
 Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.

 


 

 Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
The Fund invests (including through investment in underlying funds) in asset-backed securities, which may be backed by many types of assets, including pools of residential and commercial mortgages, automobile loans, educational loans, home equity loans, or credit card receivables, which expose the Fund to additional types of market risk. They also may be backed by pools of corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds and loans (commonly referred to as “collateralized debt obligations” or “collateralized loan obligations”) and by the fees earned by service providers. Payment of interest on asset backed securities and repayment of principal largely depend on the cash flows generated by the assets backing the securities. The market risk of a particular asset-backed security depends on many factors, including the deal structure (e.g., determination as to the amount of underlying assets or other support needed to produce the cash flows necessary to service interest and make principal payments), the quality of the underlying assets and, if any, the level of credit support and the credit quality of the credit-support provider. Asset-backed securities involve risk of loss of principal if obligors of the underlying obligations default and the value of the defaulted obligations exceeds whatever credit support the securities may have. The obligations of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and other laws affecting the rights and remedies of creditors. Many asset-backed securities in which the Fund has invested are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal and/or interest will be paid because the insurer could default on its obligations. In recent years, a significant number of asset-backed security insurers have defaulted on their obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about the creditworthiness of those securities (and underlying assets) caused credit spreads (the difference between yields on the asset-backed securities and U.S. Government securities) to widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions to make markets in many fixed income securities. These events reduced liquidity and contributed to substantial declines in the value of asset-backed and other fixed income securities. There can be no assurance these conditions will not occur again. Also, government actions and proposals affecting the terms of underlying home and consumer loans, changes in demand for products (e.g., automobiles) financed by those loans, and the inability of borrowers to refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying assets and is, therefore, subject to risks associated with the negligence or defalcation of its servicer. In some circumstances, the mishandling of related documentation also may affect the rights of security holders in and to the underlying assets. The insolvency of entities that generate receivables or that utilize the assets may result in a decline in the value of the underlying assets, as well as costs and delays. The obligations underlying asset-backed securities, in particular securities backed by pools of residential and commercial mortgages, also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as high a yield as is provided by the asset-backed security. The risk of investing in asset-backed securities has increased because performance of the various sectors in which the assets underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime mortgages, and credit card receivables) has become more highly correlated since the deterioration in worldwide economic and liquidity conditions.
Derivative financial instruments
At November 30, 2011, the Fund held no derivative financial instruments directly. For a listing of derivative financial instruments held by the underlying funds, if any, please refer to the underlying funds’ Schedule of Investments.
For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Taiwan Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares     Description   Value ($)  
 
       
COMMON STOCKS — 95.6%
       
       
 
       
       
Taiwan — 95.6%
       
  384,220    
Asia Cement Corp
    424,785  
  597,323    
Asustek Computer Inc
    4,173,566  
  444,448    
Catcher Technology Co Ltd
    2,171,801  
  186,755    
China Life Insurance Co Ltd.
    165,345  
  182,650    
China Petrochemical Development Corp
    161,905  
  444,938    
China Steel Corp
    433,484  
  653,065    
Chinatrust Financial Holding Co Ltd
    371,067  
  3,129,612    
Chunghwa Telecom Co Ltd
    10,374,302  
  13,400    
Chunghwa Telecom Co Ltd ADR
    447,962  
  4,291,486    
Compal Electronics Inc
    3,914,562  
  7,952    
Compeq Manufacturing Co Ltd *
    2,402  
  13,000    
Dynapack International Technology Corp
    45,327  
  936,000    
E Ink Holdings Inc
    1,735,519  
  1,601,767    
Far Eastone Telecommunications Co Ltd
    3,051,549  
  5,647    
First Financial Holding Co Ltd
    3,301  
  53,000    
Formosa Chemicals & Fibre Co
    139,376  
  10,605    
Formosa Petrochemical Corp
    33,446  
  419,000    
Fubon Financial Holding Co Ltd
    436,734  
  18,655    
Genesis Photonics Inc *
    25,441  
  61,531    
Gintech Energy Corp
    58,454  
  11,000    
Global Unichip Corp
    35,918  
  904,000    
Grand Pacific Petrochemical Corp
    378,286  
  262,000    
Highwealth Construction Corp
    394,657  
  890,936    
Hon Hai Precision Industry Co Ltd
    2,422,881  
  52,228    
HTC Corp
    859,851  
  2,000    
Largan Precision Co Ltd
    32,979  
  1,757,852    
Lite-On Technology Corp
    1,926,407  
  2,741,000    
Macronix International Co Ltd
    1,135,885  
  256,000    
MediaTek Inc
    2,443,068  
  653,180    
Mega Financial Holding Co Ltd
    436,877  
  189,180    
Nan Ya Plastics Corp
    352,320  
  305,000    
Neo Solar Power Corp
    184,672  
  175,995    
Novatek Microelectronics Corp Ltd
    443,272  
  598,425    
Powertech Technology Inc
    1,363,983  
  2,021,856    
Quanta Computer Inc
    4,069,459  
  103,080    
Radiant Opto-Electronics Corp
    313,233  
  250,000    
Senao International Co Ltd
    821,351  
  2,618,844    
Taishin Financial Holding Co Ltd
    976,418  
  366,000    
Taiwan Cement Corp
    407,152  
  9,350    
Taiwan Glass Industrial Corp
    9,432  
  796,158    
Taiwan Mobile Co Ltd
    2,562,034  
  2,628,190    
Taiwan Semiconductor Manufacturing Co Ltd
    6,588,899  
  106,710    
TPK Holding Co Ltd *
    1,461,676  
  29,400    
TSRC Corp
    70,837  
  4,906,000    
United Microelectronics Corp
    2,176,929  
  58,500    
United Microelectronics Corp Sponsored ADR
    133,965  
  1,947,060    
Wistron Corp
    2,451,609  
  2,968,195    
Ya Hsin Industrial Co Ltd * (a) (b)
    0  
  1,208,152    
Yungtay Engineering Co Ltd
    1,833,198  
       
 
     
       
Total Taiwan
    64,457,576  
       
 
     
       
TOTAL COMMON STOCKS (COST $71,684,342)
    64,457,576  
       
 
     

 


 

                 
       
INVESTMENT FUNDS — 2.9%
       
       
 
       
       
United States — 2.9%
       
  160,895    
iShares MSCI Taiwan Index Fund (c)
    1,987,053  
       
 
     
       
TOTAL INVESTMENT FUNDS (COST $1,971,085)
    1,987,053  
       
 
     
       
 
       
       
MUTUAL FUNDS — 1.3%
       
       
 
       
       
United States — 1.3%
       
       
 
       
       
Affiliated Issuers — 1.3%
       
  35,986    
GMO U.S. Treasury Fund
    900,001  
       
 
     
       
TOTAL MUTUAL FUNDS (COST $900,001)
    900,001  
       
 
     
                 
Par Value     Description   Value ($)  
 
       
SHORT-TERM INVESTMENTS — 0.4%
       
       
 
       
       
Time Deposits — 0.4%
       
USD 130,000  
Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11
    130,000  
USD 117,274  
Citibank (New York) Time Deposit, 0.03%, due 12/01/11
    117,274  
       
 
     
       
Total Time Deposits
    247,274  
       
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $247,274)
    247,274  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 100.2%
(Cost $74,802,702)
    67,591,904  
       
 
       
       
Other Assets and Liabilities (net) — (0.2%)
    (135,769 )
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 67,456,135  
       
 
     
 
Notes to Schedule of Investments:
 
ADR — American Depositary Receipt
 
MSCI — Morgan Stanley Capital International
 
*
  Non-income producing security.
 
(a)
  Bankrupt issuer.
 
(b)
  Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust.
 
(c)
  Represents an investment to equitize cash. The iShares® MSCI Taiwan Index Fund is a separate investment portfolio of iShares, Inc., and a registered investment company. The iShares® MSCI Taiwan Index Fund prospectus states that the fund invests in the Taiwanese market and seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI Taiwan Index. iShares® is a registered trademark of BlackRock. Neither BlackRock nor the iShares® Funds make any representations regarding the advisability of investing in the iShares® MSCI Taiwan Index Fund.
Currency Abbreviations
USD — United States Dollar

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                         
    Gross     Gross     Net Unrealized  
    Unrealized     Unrealized     Appreciation  
Aggregate Cost   Appreciation     (Depreciation)     (Depreciation)  
$76,374,226
  $ 3,985,467     $ (12,767,789 )   $ (8,782,322 )
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO U.S. Treasury Fund
  $     $ 11,050,118     $ 10,150,517     $ 135     $ 38     $ 900,001  
 
                                   

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented less than 0.1% of net assets. The Fund classifies such securities (levels defined below) as Level 3. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below.
         
Security Type   Percentage of Net Assets of the Fund  
Equity Securities
    94.7%  
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include: fair value adjustments provided by an independent pricing service applied to equity securities (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) due to market events that have occurred since the local market close but prior to the close of the NYSE.

 


 

Level 3 — Valuations based primarily on inputs that are unobservable and significant. The Fund used the following fair value technique on Level 3 investments: The Fund deemed certain bankrupt securities to be worthless.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices in                    
    Active Markets for     Significant Other     Significant        
    Identical Assets     Observable Inputs     Unobservable Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Common Stocks
                               
Taiwan
  $ 581,927     $ 63,875,649     $ 0 *   $ 64,457,576  
                         
TOTAL COMMON STOCKS
    581,927       63,875,649       0       64,457,576  
                         
Investment Funds
                               
United States
    1,987,053                   1,987,053  
                         
TOTAL INVESTMENT FUNDS
    1,987,053                   1,987,053  
                         
Mutual Funds
                               
United States
    900,001                   900,001  
                         
TOTAL MUTUAL FUNDS
    900,001                   900,001  
                         
Short-Term Investments
    247,274                   247,274  
                         
Total Investments
    3,716,255       63,875,649       0 *     67,591,904  
                         
Total
  $ 3,716,255     $ 63,875,649     $ 0 *   $ 67,591,904  
                         
 
*   Represents the interest in securities that were determined to have a fair value of zero as of November 30, 2011.

 


 

The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net value of the Fund’s direct investments in securities using Level 3 inputs was less than 0.1% of total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.

 


 

Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. Because the Fund normally does not take temporary defensive positions, declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries. Certain characteristics of Taiwan’s economy and geographic location also subject the Fund to risks. For example, Taiwan is a small island state with few raw material resources and limited land area and thus it relies heavily on imports for its commodity needs. Any fluctuations or shortages in the commodity markets could have a negative impact on the Taiwanese economy. Also, rising labor costs and increasing environmental consciousness have led some labor-intensive industries to relocate to countries with cheaper work forces, and continued labor outsourcing may adversely affect the Taiwanese economy. Taiwan’s economy also is intricately linked with economies of other Asian countries, which, like emerging market economies, often experience over-extensions of credit, frequent and pronounced currency fluctuations, devaluations and restrictions, rising unemployment and fluctuations in inflation. Currency devaluations in any one country can have a significant effect on the entire region. Political and social unrest in Asian countries could cause further economic and market uncertainty in Taiwan. In particular, the Taiwanese economy is dependent on the economies of Japan and China, and also the United States, and a reduction in purchases by any of them of Taiwanese products and services or negative changes in their economies would likely have an adverse impact on the Taiwanese economy. Taiwan’s geographic proximity to the People’s Republic of China and Taiwan’s history of political contention with China have resulted in ongoing tensions with China, including the continual risk of war with China. These tensions may materially affect the Taiwanese economy and securities markets. All of these risks could reduce the value of an investment in Taiwan Fund.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies.
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies with high positive correlations to one another, such as the Fund’s investments tied economically to Taiwan, creates additional risk.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.

 


 

Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Leveraging Risk — The Fund’s use of reverse repurchase agreements and other derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in underlying funds, including the risk that the underlying funds in which it invests will not perform as expected.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. For example, the Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives, to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives. The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For example, if the Fund holds a large proportion of stocks of companies in a particular sector and the Manager believes that stocks of companies in another sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index). In adjusting its investment exposure, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.

 


 

The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net long exposures in excess of its net assets. The Fund’s foreign currency exposure may differ significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.

 


 

Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most forward currency contracts are not collateralized. The Fund had no forward currency contracts outstanding at the end of the period.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded (unless otherwise adjusted due to the time at which foreign markets close). The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.

 


 

Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers (unless otherwise adjusted due to the time at which foreign markets close) and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of

 


 

purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov.

 


 

GMO Tax-Managed International Equities Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares     Description   Value ($)  
 
       
COMMON STOCKS — 95.2%
       
       
 
       
       
Australia — 3.7%
       
  219,598    
BlueScope Steel Ltd
    89,555  
  174,362    
Charter Hall Office (REIT)
    626,283  
  21,896    
Commonwealth Bank of Australia
    1,096,424  
  484,938    
Dexus Property Group (REIT)
    438,694  
  657,566    
Goodman Group (REIT)
    414,254  
  343,612    
GPT Group (REIT)
    1,127,644  
  42,482    
Iluka Resources Ltd
    685,529  
  302,836    
Mirvac Group (REIT)
    404,740  
  36,627    
National Australia Bank Ltd
    917,124  
  199,935    
QBE Insurance Group Ltd
    2,863,789  
  229,609    
Stockland (REIT)
    823,048  
  102,872    
TABCORP Holdings Ltd
    305,291  
  1,263,133    
Telstra Corp Ltd
    4,150,245  
  44,779    
Wesfarmers Ltd
    1,437,778  
  100,610    
Westpac Banking Corp
    2,198,027  
       
 
     
       
Total Australia
    17,578,425  
       
 
     
       
 
       
       
Austria — 0.8%
       
  8,027    
Andritz AG
    708,760  
  33,320    
Immofinanz AG *
    103,097  
  88,088    
Immofinanz AG (Entitlement Shares) *
     
  55,553    
OMV AG
    1,844,824  
  15,218    
Raiffeisen International Bank Holding
    361,762  
  29,277    
Voestalpine AG
    851,388  
       
 
     
       
Total Austria
    3,869,831  
       
 
     
       
 
       
       
Belgium — 0.5%
       
  149,206    
Ageas
    263,134  
  34,388    
Belgacom SA
    1,092,054  
  13,857    
Colruyt SA
    524,779  
  3,768    
Delhaize Group
    222,220  
  6,642    
Mobistar SA
    363,201  
       
 
     
       
Total Belgium
    2,465,388  
       
 
     
       
 
       
       
Canada — 2.6%
       
  9,300    
Alimentation Couche Tard Inc
    267,160  
  6,900    
Bank of Montreal
    403,602  
  30,600    
BCE Inc
    1,200,059  
  60,400    
Canadian Natural Resources Ltd
    2,268,664  
  4,700    
Canadian Tire Corp Ltd
    297,681  
  16,800    
Canadian National Railway Co
    1,299,099  
  73,300    
EnCana Corp
    1,476,852  
  18,000    
First Quantum Minerals Ltd
    363,547  
  26,000    
Husky Energy Inc
    647,483  
  28,300    
Manulife Financial Corp
    304,934  
  10,100    
Metro Inc Class A
    510,471  
  53,100    
Research In Motion Ltd *
    956,888  
  15,700    
Shoppers Drug Mart Corp
    653,429  
  72,100    
Sun Life Financial Inc
    1,304,933  
  12,900    
Valeant Pharmaceuticals International Inc *
    596,970  
       
 
     
       
Total Canada
    12,551,772  
       
 
     
       
 
       
       
Denmark — 0.3%
       
  14,358    
Novo-Nordisk A/S Class B
    1,629,924  
       
 
     

 


 

                 
       
Finland — 0.6%
       
  10,903    
Nokian Renkaat Oyj
    361,154  
  317,695    
Nokia Oyj
    1,836,148  
  17,504    
Sampo Oyj Class A
    457,260  
       
 
     
       
Total Finland
    2,654,562  
       
 
     
       
 
       
       
France — 11.6%
       
  6,500    
Arkema
    473,487  
  27,810    
BNP Paribas
    1,107,062  
  9,634    
Compagnie de Saint-Gobain
    408,510  
  3,861    
Compagnie Generale des Etablissements Michelin-Class B
    246,132  
  12,581    
Dassault Systemes SA
    1,030,119  
  12,316    
Essilor International SA
    880,420  
  1,613    
Esso SAF
    142,700  
  35,103    
European Aeronautic Defense and Space Co NV
    1,053,154  
  7,455    
Eutelsat Communications
    289,690  
  65,546    
France Telecom SA
    1,131,360  
  16,002    
GDF Suez VVPR Strip *
    22  
  3,105    
L’Oreal SA
    336,069  
  20,102    
Lagardere SCA
    489,558  
  9,419    
LVMH Moet Hennessy Louis Vuitton SA
    1,483,043  
  2,071    
Nexans SA
    121,693  
  4,045    
NYSE Euronext
    119,037  
  63,982    
PagesJaunes Groupe
    222,339  
  28,474    
Peugeot SA
    533,127  
  2,966    
PPR
    444,469  
  36,488    
Renault SA
    1,367,221  
  22,853    
Safran SA
    678,108  
  277,599    
Sanofi
    19,416,940  
  12,280    
SES SA Class A FDR
    302,642  
  7,719    
Technip SA
    735,446  
  362,046    
Total SA
    18,678,883  
  5,934    
Unibail-Rodamco SE (REIT)
    1,106,170  
  8,473    
Valeo SA
    375,184  
  12,315    
Vinci SA
    550,553  
  91,428    
Vivendi SA
    2,108,883  
       
 
     
       
Total France
    55,832,021  
       
 
     
       
 
       
       
Germany — 7.1%
       
  16,460    
Adidas AG
    1,160,773  
  16,187    
Aurubis AG
    923,683  
  57,657    
BASF AG
    4,212,041  
  21,934    
Bayerische Motoren Werke AG
    1,662,752  
  9,725    
Beiersdorf AG
    557,121  
  5,042    
Bilfinger & Berger SE
    460,615  
  3,285    
Continental AG *
    233,232  
  11,291    
Deutsche Bank AG (Registered)
    441,174  
  28,692    
Deutsche Post AG (Registered)
    433,691  
  408,729    
E.ON AG
    10,117,550  
  4,905    
Fraport AG
    279,347  
  9,357    
Fresenius SE & Co KGaA
    901,154  
  11,954    
Fresenius Medical Care AG & Co
    819,513  
  24,890    
GEA Group AG
    736,751  
  116,991    
Infineon Technologies AG
    972,558  
  6,289    
Kabel Deutschland Holding AG *
    349,594  
  16,442    
Lanxess AG
    922,350  
  12,445    
Leoni AG
    463,111  
  6,978    
Linde AG
    1,075,386  
  5,421    
Merck KGaA
    539,606  

 


 

                 
  44,549    
RWE AG
    1,846,747  
  13,513    
Salzgitter AG
    701,563  
  22,815    
SAP AG
    1,366,148  
  3,511    
SGL Carbon SE *
    211,582  
  7,692    
Siemens AG (Registered)
    778,424  
  20,733    
Software AG
    893,727  
  29,341    
Suedzucker AG
    934,727  
  1,625    
Volkswagen AG
    247,497  
       
 
     
       
Total Germany
    34,242,417  
       
 
     
       
 
       
       
Greece — 0.2%
       
  80,194    
OPAP SA
    719,535  
  31,481    
Public Power Corp SA
    179,846  
       
 
     
       
Total Greece
    899,381  
       
 
     
       
 
       
       
Hong Kong — 1.2%
       
  186,000    
AIA Group Ltd
    585,857  
  231,900    
CLP Holdings Ltd
    2,065,189  
  10    
Esprit Holdings Ltd
    14  
  265,800    
Hong Kong & China Gas
    615,495  
  583,000    
Pacific Basin Shipping Ltd
    260,997  
  196,500    
Power Assets Holdings Ltd
    1,472,320  
  41,500    
Swire Pacific Ltd
    506,613  
  163,500    
Yue Yuen Industrial Holdings
    471,171  
       
 
     
       
Total Hong Kong
    5,977,656  
       
 
     
       
 
       
       
Ireland — 1.0%
       
  57,269    
C&C Group Plc
    234,624  
  110,360    
CRH Plc
    2,106,846  
  17,890    
DCC Plc
    433,131  
  17,996    
Elan Corp Plc *
    196,004  
  31,679    
Kerry Group Plc Class A
    1,183,110  
  10,329    
Paddy Power Plc
    560,814  
  28,048    
Smurfit Kappa Group Plc *
    169,869  
       
 
     
       
Total Ireland
    4,884,398  
       
 
     
       
 
       
       
Italy — 5.8%
       
  47,666    
Benetton Group SPA
    234,132  
  71,755    
Campari
    513,120  
  1,680,455    
Enel SPA
    7,160,252  
  478,076    
ENI SPA
    10,124,829  
  12,403    
Exor SPA
    263,845  
  155,594    
Finmeccanica SPA
    675,038  
  74,327    
Mediaset SPA
    219,720  
  54,141    
Mediobanca SPA
    349,841  
  93,823    
Pirelli & C SPA
    887,611  
  34,942    
Recordati SPA
    268,451  
  33,277    
Saipem SPA
    1,488,959  
  217,524    
Snam Rete Gas SPA
    1,009,843  
  1,471,783    
Telecom Italia SPA
    1,666,242  
  1,553,914    
Telecom Italia SPA-Di RISP
    1,518,346  
  266,586    
Terna SPA
    956,592  
  3,659    
Tod’s SPA
    340,787  
       
 
     
       
Total Italy
    27,677,608  
       
 
     
       
 
       
       
Japan — 24.2%
       
  189    
Advance Residence Investment Corp (REIT)
    352,628  
  150,100    
Aeon Co Ltd
    2,051,049  

 


 

                 
  16,700    
Aisin Seiki Co Ltd
    504,618  
  76,800    
Alps Electric Co Ltd
    537,684  
  18,600    
Asahi Breweries Ltd
    412,849  
  60,500    
Astellas Pharma Inc
    2,332,058  
  72,300    
Bridgestone Corp
    1,675,339  
  14,700    
Canon Inc
    659,475  
  12,800    
Capcom
    328,332  
  27    
Central Japan Railway Co
    216,339  
  205,000    
Cosmo Oil Co Ltd
    566,916  
  127    
CyberAgent Inc
    421,582  
  62,300    
Daiei Inc *
    226,423  
  184,000    
Daikyo Inc *
    355,564  
  27,000    
Dainippon Screen Manufacturing Co Ltd
    206,050  
  39,400    
Daito Trust Construction Co Ltd
    3,514,050  
  31,900    
Dena Co Ltd
    990,331  
  20,700    
Don Quijote Co Ltd
    713,446  
  41,300    
Edion Corp
    323,444  
  46,900    
Eisai Co Ltd
    1,810,646  
  22,600    
Electric Power Development Co Ltd
    570,284  
  7,100    
Fanuc Ltd
    1,166,519  
  7,600    
Fast Retailing Co Ltd
    1,233,302  
  178,000    
Fuji Electric Co Ltd
    526,510  
  85,000    
Fuji Heavy Industries Ltd
    491,282  
  23,500    
Fuji Oil Co Ltd
    336,385  
  30,900    
Gree Inc
    1,037,406  
  66,000    
Hanwa Co Ltd
    286,118  
  371,000    
Hitachi Ltd
    2,058,646  
  17,600    
Honda Motor Co Ltd
    558,525  
  23,600    
Hosiden Corp
    166,174  
  191    
INPEX Corp
    1,289,418  
  252,000    
Itochu Corp
    2,560,922  
  368    
Japan Retail Fund Investment Corp (REIT)
    562,789  
  91    
Japan Tobacco Inc
    436,688  
  65,000    
JFE Holdings Inc
    1,196,456  
  30,000    
JGC Corp
    756,094  
  14,000    
JS Group Corp
    265,514  
  544,000    
JX Holdings Inc
    3,459,634  
  32,460    
K’s Holdings Corp
    1,279,468  
  486,000    
Kajima Corp
    1,463,527  
  62,000    
Kamigumi Co Ltd
    508,079  
  88,900    
Kao Corp
    2,352,696  
  229,000    
Kawasaki Kisen Kaisha Ltd
    398,169  
  733    
KDDI Corp
    4,856,710  
  42,000    
Kinugawa Rubber Industrial Co Ltd
    377,934  
  319,000    
Kobe Steel Ltd
    509,389  
  38,000    
Komatsu Ltd
    972,489  
  21,400    
Konami Corp
    643,658  
  13,000    
Kyudenko Corp
    78,459  
  18,800    
Lawson Inc
    1,113,387  
  131,400    
Leopalace21 Corp *
    303,310  
  9,900    
Makita Corp
    346,329  
  231,000    
Marubeni Corp
    1,427,055  
  267,000    
Mazda Motor Corp *
    486,937  
  53,700    
Medipal Holdings Corp
    527,787  
  180,000    
Mitsubishi Heavy Industries Ltd
    755,804  
  295,000    
Mitsubishi Chemical Holdings Corp
    1,713,784  
  34,900    
Mitsubishi Corp
    721,503  
  54,000    
Mitsubishi Electric Corp
    511,188  
  17,510    
Mitsubishi UFJ Lease & Finance Co Ltd
    670,355  
  27,400    
Mitsui & Co Ltd
    432,314  

 


 

                 
  329,000    
Mitsui Mining & Smelting Co Ltd
    852,492  
  198,000    
Mitsui OSK Lines Ltd
    629,414  
  976,000    
Mizuho Financial Group Inc
    1,284,835  
  16,100    
Nagase & Co
    175,701  
  22,700    
Namco Bandai Holdings Inc
    327,285  
  178    
Net One Systems Co Ltd
    459,184  
  13,900    
Nikon Corp
    325,461  
  4,300    
Nintendo Co Ltd
    654,621  
  19,000    
Nippon Corp
    165,385  
  23,000    
Nippon Paper Group Inc
    493,011  
  543,000    
Nippon Steel Corp
    1,318,158  
  97,800    
Nippon Telegraph & Telephone Corp
    4,823,347  
  191,000    
Nippon Yusen Kabushiki Kaisha
    425,480  
  138,800    
Nissan Motor Co Ltd
    1,274,644  
  24,000    
Nisshinbo Holdings Inc
    203,152  
  9,550    
Nitori Holdings Co Ltd
    892,686  
  14,300    
Nitto Denko Corp
    594,406  
  1,302    
NTT Docomo Inc
    2,301,345  
  186,000    
Obayashi Corp
    781,874  
  62,000    
OJI Paper Co Ltd
    309,055  
  12,000    
Ono Pharmaceutical Co Ltd
    625,189  
  15,390    
ORIX Corp
    1,298,530  
  133,000    
Osaka Gas Co Ltd
    507,401  
  31,000    
Pacific Metals Co Ltd
    158,473  
  111,500    
Penta Ocean Construction Co Ltd
    351,923  
  11,100    
Point Inc
    461,516  
  19,850    
Promise Co Ltd *
    207,044  
  694,600    
Resona Holdings Inc
    3,111,073  
  80,100    
Round One Corp
    478,624  
  14,200    
Ryohin Keikaku Co Ltd
    646,086  
  7,600    
Ryosan Co
    171,282  
  22,700    
Sankyo Co Ltd
    1,134,681  
  11,600    
Sanrio Co Ltd
    603,402  
  7,700    
Secom Co Ltd
    347,278  
  30,500    
Sega Sammy Holdings Inc
    623,729  
  24,500    
Seven & I Holdings Co Ltd
    684,052  
  4,600    
Shimamura Co Ltd
    437,221  
  3,700    
SMC Corp
    614,551  
  223,600    
Sojitz Corp
    350,869  
  8,600    
Start Today Co Ltd
    166,654  
  255,700    
Sumitomo Corp
    3,413,097  
  21,000    
Sumitomo Metal Mining Co Ltd
    283,360  
  592,000    
Taiheiyo Cement Co Ltd
    1,150,029  
  443,000    
Taisei Corp
    1,148,137  
  1,000    
Taisho Pharmaceutical Holdings Co Ltd *
    66,916  
  156,400    
Takeda Pharmaceutical Co Ltd
    6,423,970  
  165,000    
Tokyo Tatemono Co Ltd
    483,151  
  69,000    
TonenGeneral Sekiyu KK
    786,928  
  232,000    
Toray Industries Inc
    1,739,284  
  150,000    
Tosoh Corp
    438,967  
  26,900    
Toyota Motor Corp
    885,831  
  68,600    
Toyota Tsusho Corp
    1,154,301  
  4,300    
Unicharm Corp
    203,966  
  108,500    
UNY Co Ltd
    996,436  
  7,450    
USS Co Ltd
    647,786  
  10,158    
West Japan Railway Co
    419,323  
  2,471    
Yahoo Japan Corp
    782,980  
  45,380    
Yamada Denki Co Ltd
    3,282,476  
  28,200    
Yamaha Motor Co Ltd *
    393,524  
  35,200    
Yamato Holdings Co Ltd
    565,256  

 


 

                 
  46,000    
Zeon Corp
    391,139  
       
 
     
       
Total Japan
    116,535,791  
       
 
     
       
 
       
       
Malta — 0.0%
       
  1,718,063    
BGP Holdings Plc *
     
       
 
     
       
 
       
       
Netherlands — 1.3%
       
  216,631    
Aegon NV *
    945,684  
  10,641    
CSM NV
    139,861  
  4,124    
Heineken Holding NV
    165,484  
  274,147    
ING Groep NV *
    2,138,121  
  56,813    
Koninklijke BAM Groep NV
    196,814  
  6,905    
Koninklijke DSM NV
    336,258  
  69,055    
Unilever NV
    2,352,003  
       
 
     
       
Total Netherlands
    6,274,225  
       
 
     
       
 
       
       
New Zealand — 0.5%
       
  180,039    
Chorus Ltd *
    462,519  
  113,103    
Fletcher Building Ltd
    535,272  
  900,197    
Telecom Corp of New Zealand
    1,426,925  
       
 
     
       
Total New Zealand
    2,424,716  
       
 
     
       
 
       
       
Norway — 0.2%
       
  23,130    
Acergy SA *
    457,144  
  17,754    
Statoil ASA
    459,115  
       
 
     
       
Total Norway
    916,259  
       
 
     
       
 
       
       
Portugal — 0.2%
       
  155,807    
EDP — Energias de Portugal SA
    499,372  
  29,353    
Jeronimo Martins SGPS SA
    535,541  
       
 
     
       
Total Portugal
    1,034,913  
       
 
     
       
 
       
       
Singapore — 1.9%
       
  208,000    
CapitaCommercial Trust (REIT)
    176,835  
  346,000    
Ezra Holdings Ltd
    244,712  
  3,889,000    
Golden Agri-Resources Ltd
    2,196,674  
  198,000    
Ho Bee Investment Ltd
    188,526  
  370,200    
Jaya Holdings Ltd *
    140,023  
  169,400    
Keppel Corp Ltd
    1,258,364  
  164,000    
SembCorp Marine Ltd
    493,167  
  169,000    
Singapore Exchange Ltd
    830,271  
  250,000    
Singapore Press Holdings Ltd
    771,772  
  998,670    
Singapore Telecommunications
    2,434,234  
  32,002    
Suntec Real Estate Investment Trust (REIT)
    28,719  
  341,067    
Swiber Holdings Ltd *
    142,783  
  38,000    
Venture Corp Ltd
    196,592  
       
 
     
       
Total Singapore
    9,102,672  
       
 
     
       
 
       
       
Spain — 4.9%
       
  72,653    
Banco Bilbao Vizcaya Argentaria SA
    612,009  
  339,086    
Banco Popular Espanol SA
    1,447,980  
  309,163    
Banco Santander SA
    2,320,648  
  66,603    
Cintra Concesiones de Infraestructuras de Transporte SA
    825,928  
  19,186    
Fomento de Construcciones y Contratas SA
    496,571  
  152,744    
Gas Natural SDG SA
    2,659,089  
  36,407    
Grifols SA *
    588,664  
  230,862    
Iberdrola SA
    1,538,437  
  22,039    
Inditex SA
    1,874,045  

 


 

                 
  172,906    
Mapfre SA
    578,794  
  13,989    
Red Electrica de Espana
    614,949  
  104,342    
Repsol YPF SA
    3,150,185  
  367,029    
Telefonica SA
    6,892,199  
       
 
     
       
Total Spain
    23,599,498  
       
 
     
       
 
       
       
Sweden — 0.6%
       
  12,050    
Atlas Copco AB
    229,984  
  11,946    
Atlas Copco AB Class A
    256,325  
  11,862    
Hennes & Mauritz AB Class B
    376,856  
  51,797    
Investor AB B Shares
    966,092  
  62,088    
Swedbank AB Class A
    830,609  
  7,209    
Swedish Match AB
    236,463  
       
 
     
       
Total Sweden
    2,896,329  
       
 
     
       
 
       
       
Switzerland — 3.4%
       
  65,097    
Nestle SA (Registered)
    3,653,425  
  159,119    
Novartis AG (Registered)
    8,593,102  
  13,741    
Roche Holding AG (Non Voting)
    2,185,840  
  2,503    
Swatch Group AG
    976,246  
  890    
Swisscom AG (Registered)
    336,104  
  1,855    
Syngenta AG (Registered) *
    545,877  
       
 
     
       
Total Switzerland
    16,290,594  
       
 
     
       
 
       
       
United Kingdom — 22.6%
       
  47,044    
3i Group Plc
    140,933  
  38,511    
Aggreko Plc
    1,148,039  
  79,832    
Amlin Plc
    421,606  
  203,387    
ARM Holdings Plc
    1,911,183  
  14,809    
Associated British Foods Plc
    258,473  
  315,130    
AstraZeneca Plc
    14,514,181  
  149,674    
Aviva Plc
    734,652  
  611,764    
BAE Systems Plc
    2,641,166  
  97,895    
Balfour Beatty Plc
    387,557  
  1,144,856    
Barclays Plc
    3,298,015  
  142,347    
BG Group Plc
    3,053,176  
  22,363    
BHP Billiton Plc
    687,714  
  754,372    
BP Plc
    5,463,434  
  109,205    
British American Tobacco Plc
    5,067,883  
  1,200,752    
BT Group Plc
    3,593,154  
  108,950    
Burberry Group Plc
    2,182,657  
  39,353    
Capita Group Plc
    390,269  
  197,295    
Cobham Plc
    548,877  
  26,105    
Cookson Group Plc
    204,563  
  13,123    
Croda International Plc
    376,752  
  33,472    
Diageo Plc
    716,904  
  147,071    
Drax Group Plc
    1,295,295  
  20,106    
Experian Plc
    267,377  
  125,029    
FirstGroup Plc
    642,711  
  12,561    
Fresnillo Plc
    339,680  
  609,967    
GlaxoSmithKline Plc
    13,518,106  
  210,476    
Home Retail Group Plc
    297,519  
  41,712    
IMI Plc
    525,203  
  37,280    
Imperial Tobacco Group Plc
    1,341,223  
  92,859    
Inchcape Plc
    476,945  
  23,191    
Intertek Group Plc
    702,888  
  40,702    
Land Securities Group Plc (REIT)
    440,158  
  879,758    
Legal & General Group Plc
    1,469,606  
  1,406,216    
Lloyds Banking Group Plc *
    550,296  

 


 

                 
  103,105    
Man Group Plc
    231,090  
  49,343    
Next Plc
    2,085,591  
  65,833    
Pearson Plc
    1,195,909  
  13,060    
Petrofac Ltd
    298,593  
  62,929    
Prudential Plc
    619,387  
  213,300    
Punch Taverns Plc *
    40,359  
  6,983    
Randgold Resources Ltd
    742,913  
  16,795    
Reckitt Benckiser Group Plc
    852,056  
  46,335    
Rio Tinto Plc
    2,439,336  
  142,690    
Royal Dutch Shell Group Class A (Amsterdam)
    4,983,944  
  40,199    
Royal Dutch Shell Plc A Shares (London)
    1,405,943  
  222,874    
Royal Dutch Shell Plc B Shares (London)
    8,031,168  
  17,375    
SABMiller Plc
    613,469  
  156,433    
Sage Group Plc (The)
    714,930  
  63,700    
Scottish & Southern Energy Plc
    1,319,020  
  47,431    
Shire Plc
    1,595,009  
  47,433    
Smith & Nephew Plc
    433,370  
  213,300    
Spirit Pub Co Plc *
    133,022  
  22,723    
Standard Chartered Plc
    494,698  
  29,297    
Travis Perkins Plc
    384,628  
  106,249    
TUI Travel Plc
    288,366  
  2,768,253    
Vodafone Group Plc
    7,493,962  
  44,654    
Weir Group Plc (The)
    1,451,452  
  253,927    
William Hill Plc
    808,644  
  20,250    
Wolseley Plc
    607,127  
       
 
     
       
Total United Kingdom
    108,872,181  
       
 
     
       
TOTAL COMMON STOCKS (COST $429,021,652)
    458,210,561  
       
 
     
       
 
       
       
PREFERRED STOCKS — 1.1%
       
       
 
       
       
Germany — 1.1%
       
  6,211    
Hugo Boss AG 2.95%
    565,426  
  41,675    
Porsche Automobil Holding SE 1.12%
    2,553,790  
  24,058    
ProSiebenSat.1 Media AG 7.61%
    475,928  
  9,574    
Volkswagen AG 1.74%
    1,654,352  
       
 
     
       
Total Germany
    5,249,496  
       
 
     
       
TOTAL PREFERRED STOCKS (COST $4,334,397)
    5,249,496  
       
 
     
       
 
       
       
RIGHTS/WARRANTS — 0.0%
       
       
 
       
       
Australia — 0.0%
       
  175,678    
BlueScope Steel Ltd, Expires 12/14/11*
    1,987  
       
 
     
       
TOTAL RIGHTS/WARRANTS (COST $135,535)
    1,987  
       
 
     
       
 
       
       
MUTUAL FUNDS — 2.7%
       
       
 
       
       
United States — 2.7%
       
       
 
       
       
Affiliated Issuers
       
  520,833    
GMO U.S. Treasury Fund
    13,026,025  
       
 
     
       
TOTAL MUTUAL FUNDS (COST $13,026,025)
    13,026,025  
       
 
     

 


 

                         
Par Value     Description   Value ($)  
 
               
SHORT-TERM INVESTMENTS — 0.5%
       
               
 
       
               
Time Deposits — 0.5%
       
USD     1,691,160    
Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11
    1,691,160  
AUD     10,034    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 3.78%, due 12/01/11
    10,319  
CAD     10,228    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.25%, due 12/01/11
    10,028  
CHF     9,563    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.01%, due 12/01/11
    10,468  
DKK     55,076    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.14%, due 12/01/11
    9,952  
HKD     77,869    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.01%, due 12/01/11
    10,023  
NOK     57,310    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.95%, due 12/01/11
    9,922  
NZD     12,702    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 1.75%, due 12/01/11
    9,918  
SEK     67,859    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 1.06%, due 12/01/11
    10,028  
SGD     16,884    
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.01%, due 12/01/11
    13,174  
JPY     15,252,400    
Citibank (New York) Time Deposit, 0.01%, due 12/01/11
    196,653  
EUR     274,343    
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11
    368,635  
GBP     77,286    
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11
    121,254  
               
 
     
               
Total Time Deposits
    2,471,534  
               
 
     
               
TOTAL SHORT-TERM INVESTMENTS (COST $2,471,534)
    2,471,534  
               
 
     
               
 
       
               
TOTAL INVESTMENTS — 99.5%
(Cost $448,989,143)
    478,959,603  
               
Other Assets and Liabilities (net) — 0.5%
    2,619,887  
               
 
     
               
 
       
               
TOTAL NET ASSETS — 100.0%
  $ 481,579,490  
               
 
     

 


 

A summary of outstanding financial instruments at November 30, 2011 is as follows:
Futures Contracts
                                 
                            Net Unrealized  
Number of           Expiration             Appreciation  
Contracts   Type     Date     Value     (Depreciation)  
Buys
                               
96
  MSCI EAFE E-Mini   December 2011   $ 6,961,440     $ 390,035  
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
 
Notes to Schedule of Investments:
FDR — Fiduciary Depositary Receipt
REIT — Real Estate Investment Trust
*   Non-income producing security.
Currency Abbreviations:     
AUD — Australian Dollar
CAD — Canadian Dollar
CHF — Swiss Franc
DKK — Danish Krone
EUR — Euro
GBP — British Pound
HKD — Hong Kong Dollar
JPY — Japanese Yen
NOK — Norwegian Krone
NZD — New Zealand Dollar
SEK — Swedish Krona
SGD — Singapore Dollar
USD — United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                             
        Gross     Gross     Net Unrealized  
        Unrealized     Unrealized     Appreciation  
Aggregate Cost     Appreciation     (Depreciation)     (Depreciation)  
$ 454,244,273     $ 56,048,688     $ (31,333,358 )   $ 24,715,330  

 


 

Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO U.S. Treasury Fund
  $ 263,025     $ 26,467,000     $ 13,703,964     $ 167     $     $ 13,026,025  
 
                                   

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below.
     
Security Type   Percentage of Net Assets of the Fund
Equity Securities
   93.2%
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include: fair value adjustments provided by an independent pricing service applied to equity securities (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) due to market events that have occurred since the local market close but prior to the close of the NYSE.
Level 3 — Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices in             Significant        
    Active Markets for     Significant Other     Unobservable        
    Identical Assets     Observable Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Common Stocks
                               
Australia
  $     $ 17,578,425     $     $ 17,578,425  
Austria
          3,869,831             3,869,831  
Belgium
          2,465,388             2,465,388  
Canada
    12,551,772                   12,551,772  
Denmark
          1,629,924             1,629,924  
Finland
          2,654,562             2,654,562  
France
    22       55,831,999             55,832,021  
Germany
          34,242,417             34,242,417  
Greece
          899,381             899,381  
Hong Kong
          5,977,656             5,977,656  
Ireland
          4,884,398             4,884,398  
Italy
          27,677,608             27,677,608  
Japan
    66,916       116,468,875             116,535,791  
Malta
          0 *           0  
Netherlands
          6,274,225             6,274,225  
New Zealand
    1,889,444       535,272             2,424,716  
Norway
          916,259             916,259  
Portugal
          1,034,913             1,034,913  
Singapore
          9,102,672             9,102,672  
Spain
          23,599,498             23,599,498  
Sweden
          2,896,329             2,896,329  
Switzerland
          16,290,594             16,290,594  
United Kingdom
    133,022       108,739,159             108,872,181  
 
                       
TOTAL COMMON STOCKS
    14,641,176       443,569,385             458,210,561  
 
                       
Preferred Stocks
                               
Germany
          5,249,496             5,249,496  
 
                       
TOTAL PREFERRED STOCKS
          5,249,496             5,249,496  
 
                       
RIGHTS/WARRANTS
                               
Australia
          1,987             1,987  
 
                       
Total RIGHTS/WARRANTS
          1,987             1,987  
 
                       
Mutual Funds
                               
United States
    13,026,025                   13,026,025  
 
                       
TOTAL MUTUAL FUNDS
    13,026,025                   13,026,025  
 
                       
Short-Term Investments
    2,471,534                   2,471,534  
 
                       
Total Investments
    30,138,735       448,820,868             478,959,603  
 
                       
Derivatives**
                               
Futures Contracts
                               
Equity risk
    390,035                   390,035  
 
                       
Total Derivatives
    390,035                   390,035  
 
                       
Total
  $ 30,528,770     $ 448,820,868     $     $ 479,349,638  
 
                       
 
*   Represents the interest in securities that were determined to have a fair value of zero at November 30, 2011.

 


 

The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
** Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. There can be no assurance that the Fund’s tax management strategies will be effective, and you may incur tax liabilities that exceed your economic return. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If the Fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of the value of those investments. The Fund also may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Because the Fund normally does not take temporary defensive positions, declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to

 


 

the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Liquidity Risk — Shares of small- and mid-cap companies often have lower trading volumes and a limited number or no market makers. Thus, a large position may limit or prevent the Fund from selling those shares or unwinding derivative positions on them at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
Leveraging Risk — The Fund’s use of derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies or in industries with high positive correlations to one another creates additional risk.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. For example, the Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives, to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives. The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.

 


 

The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For example, if the Fund holds a large proportion of stocks of companies in a particular sector and the Manager believes that stocks of companies in another sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index). In adjusting its investment exposure, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net long exposures in excess of its net assets. The Fund’s foreign currency exposure may differ significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).

 


 

The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most forward currency contracts are not collateralized. The Fund had no forward currency contracts outstanding at the end of the period.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded (unless otherwise adjusted due to the time at which foreign markets close). The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. During the period ended November 30, 2011, the Fund used futures contracts to adjust exposure to certain securities markets and maintain the diversity and liquidity of the portfolio. Futures contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an

 


 

addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers (unless otherwise adjusted due to the time at which foreign markets close) and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is

 


 

insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. During the period ended November 30, 2011, the Fund used swap agreements to achieve returns comparable to holding and lending a direct equity position. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. During the period ended November 30, 2011, the Fund held rights and/or warrants received as a result of corporate actions. Rights and/or warrants held by the Fund at the end of the period are listed in the Fund’s Schedule of Investments.

 


 

The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Assets:
                                               
Investments, at value (rights and/or warrants)
  $     $     $     $ 1,987     $     $ 1,987  
Unrealized appreciation on futures contracts*
                      390,035             390,035  
 
                                   
Total
  $     $     $     $ 392,022     $     $ 392,022  
 
                                   
 
*     The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of futures contracts as
        reported in the Schedule of Investments.
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (futures contracts and rights and/or warrants) or notional amounts (swap agreements) outstanding at each month-end, was as follows for the period ended November 30, 2011:
                         
    Futures     Rights and/or     Swap  
    Contracts     Warrants     Agreements  
Average amount outstanding
  $ 3,243,091     $ 56,831     $ 27,174*  
* During the period ended November 30, 2011, the Fund did not hold swap agreements at any month-end, therefore, the average amount outstanding was calculated using daily outstanding notional amounts.

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO Tobacco-Free Core Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares     Description   Value ($)  
 
       
COMMON STOCKS — 98.6%
       
       
 
       
       
Automobiles & Components — 0.2%
       
  2,500    
General Motors Co.*
    53,224  
       
 
     
       
 
       
       
Banks — 0.1%
       
  100    
CapitalSource, Inc.
    645  
  600    
CIT Group, Inc.*
    20,316  
       
 
     
       
Total Banks
    20,961  
       
 
     
       
 
       
       
Capital Goods — 3.3%
       
  2,600    
3M Co.
    210,704  
  200    
Alliant Techsystems, Inc.
    11,768  
  1,400    
Danaher Corp.
    67,732  
  1,300    
Fastenal Co.
    54,145  
  1,400    
General Dynamics Corp.
    92,484  
  401    
GeoEye, Inc.*
    7,615  
  100    
Harsco Corp.
    2,064  
  350    
ITT Corp.
    7,060  
  320    
Joy Global, Inc.
    29,210  
  600    
L-3 Communications Holdings, Inc.
    39,780  
  500    
Northrop Grumman Corp.
    28,535  
  600    
Oshkosh Corp.*
    12,312  
  230    
Precision Castparts Corp.
    37,892  
  1,600    
United Technologies Corp.
    122,560  
  200    
WW Grainger, Inc.
    37,380  
  100    
Xylem, Inc
    2,390  
       
 
     
       
Total Capital Goods
    763,631  
       
 
     
       
 
       
       
Commercial & Professional Services — 0.4%
       
  300    
Copart, Inc.*
    13,479  
  1,000    
Pitney Bowes, Inc.
    18,630  
  750    
Rollins, Inc.
    16,650  
  1,400    
RR Donnelley & Sons Co.
    21,028  
  400    
Stericycle, Inc.*
    32,408  
       
 
     
       
Total Commercial & Professional Services
    102,195  
       
 
     
       
 
       
       
Consumer Durables & Apparel — 1.6%
       
  1,400    
Coach, Inc.
    87,626  
  300    
Fossil, Inc.*
    26,877  
  3,728    
KB Home
    27,401  
  1,800    
Nike, Inc.-Class B
    173,124  
  480    
VF Corp.
    66,571  
       
 
     
       
Total Consumer Durables & Apparel
    381,599  
       
 
     
       
 
       
       
Consumer Services — 2.5%
       
  1,500    
Apollo Group, Inc.-Class A*
    72,720  
  300    
DeVry, Inc.
    10,353  
  2,100    
H&R Block, Inc.
    33,033  
  100    
ITT Educational Services, Inc.*
    5,496  
  4,500    
McDonald’s Corp.
    429,840  
  400    
Weight Watchers International, Inc.
    23,508  
       
 
     
       
Total Consumer Services
    574,950  
       
 
     
       
 
       
       
Diversified Financials — 0.4%
       
  8,507    
Bank of America Corp.
    46,278  
  600    
Capital One Financial Corp.
    26,796  

 


 

                 
  2,200    
SLM Corp.
    28,336  
       
 
     
       
Total Diversified Financials
    101,410  
       
 
     
 
       
Energy — 8.1%
       
  600    
Anadarko Petroleum Corp.
    48,762  
  440    
Apache Corp.
    43,754  
  600    
Baker Hughes, Inc.
    32,766  
  300    
Berry Petroleum Co.-Class A
    13,164  
  3,860    
Chevron Corp.
    396,885  
  4,751    
ConocoPhillips
    338,841  
  7,500    
Exxon Mobil Corp.
    603,300  
  1,600    
Halliburton Co.
    58,880  
  300    
Key Energy Services, Inc.*
    4,530  
  2,300    
Marathon Oil Corp.
    64,308  
  700    
National Oilwell Varco, Inc.
    50,190  
  526    
Occidental Petroleum Corp.
    52,022  
  300    
Range Resources Corp.
    21,513  
  970    
Schlumberger Ltd.
    73,070  
  1,800    
Valero Energy Corp.
    40,086  
  900    
Williams Cos., Inc.
    29,052  
       
 
     
       
Total Energy
    1,871,123  
       
 
     
       
 
       
       
Food & Staples Retailing — 7.0%
       
  800    
Costco Wholesale Corp.
    68,240  
  3,100    
CVS Caremark Corp.
    120,404  
  2,700    
Kroger Co. (The)
    62,586  
  1,200    
Safeway, Inc.
    24,000  
  1,065    
Supervalu, Inc.
    7,828  
  2,500    
Sysco Corp.
    71,350  
  5,800    
Walgreen Co.
    195,576  
  17,930    
Wal—Mart Stores, Inc.
    1,056,077  
       
 
     
       
Total Food & Staples Retailing
    1,606,061  
       
 
     
       
 
       
       
Food, Beverage & Tobacco — 6.6%
       
  600    
Brown-Forman Corp.-Class B
    47,886  
  1,100    
Campbell Soup Co.
    35,860  
  8,400    
Coca-Cola Co. (The)
    564,732  
  1,200    
Dean Foods Co.*
    12,192  
  600    
Flowers Foods, Inc.
    11,862  
  2,400    
General Mills, Inc.
    95,880  
  700    
Hansen Natural Corp.*
    64,540  
  1,200    
Hershey Co. (The)
    69,216  
  900    
HJ Heinz Co.
    47,385  
  1,200    
Hormel Foods Corp.
    36,132  
  300    
J.M. Smucker Co. (The)
    22,794  
  1,400    
Kellogg Co.
    68,824  
  500    
McCormick & Co., Inc. (Non Voting)
    24,350  
  6,625    
PepsiCo, Inc.
    424,000  
       
 
     
       
Total Food, Beverage & Tobacco
    1,525,653  
       
 
     
       
 
       
       
Health Care Equipment & Services — 8.8%
       
  1,700    
Aetna, Inc.
    71,094  
  1,885    
Alere, Inc.*
    44,090  
  200    
AMERIGROUP Corp.*
    11,434  
  1,200    
AmerisourceBergen Corp.
    44,580  
  2,500    
Baxter International, Inc.
    129,150  
  900    
Becton, Dickinson and Co.
    66,402  
  700    
Brookdale Senior Living, Inc.*
    10,885  
  390    
C.R. Bard, Inc.
    34,004  

 


 

                 
  1,000    
Cardinal Health, Inc.
    42,460  
  800    
CareFusion Corp.*
    19,824  
  600    
Cerner Corp.*
    36,588  
  600    
Cigna Corp.
    26,538  
  900    
Coventry Health Care, Inc.*
    28,746  
  1,100    
Covidien Plc
    50,105  
  500    
DENTSPLY International, Inc.
    18,055  
  400    
Edwards Lifesciences Corp.*
    26,412  
  2,200    
Express Scripts, Inc.*
    100,430  
  200    
Gen-Probe, Inc.*
    12,598  
  300    
Henry Schein, Inc.*
    19,302  
  900    
Humana, Inc.
    79,812  
  300    
Idexx Laboratories, Inc.*
    22,557  
  130    
Intuitive Surgical, Inc.*
    56,447  
  400    
Laboratory Corp. of America Holdings*
    34,288  
  1,406    
Lincare Holdings, Inc.
    33,322  
  700    
McKesson Corp.
    56,917  
  200    
Mednax, Inc.*
    13,480  
  6,000    
Medtronic, Inc.
    218,580  
  500    
Patterson Cos., Inc.
    15,085  
  300    
Quality Systems, Inc.
    10,605  
  600    
Quest Diagnostics, Inc.
    35,196  
  600    
ResMed, Inc.*
    15,630  
  1,200    
Stryker Corp.
    58,596  
  1,200    
St Jude Medical, Inc.
    46,128  
  584    
Triple-S Management Corp.-Class B*
    11,377  
  6,676    
UnitedHealth Group, Inc.
    325,589  
  300    
Varian Medical Systems, Inc.*
    18,669  
  1,800    
WellPoint, Inc.
    126,990  
  1,300    
Zimmer Holdings, Inc.*
    65,715  
       
 
     
       
Total Health Care Equipment & Services
    2,037,680  
       
 
     
       
 
       
       
Household & Personal Products — 5.1%
       
  1,100    
Avon Products, Inc.
    18,700  
  700    
Church & Dwight Co., Inc.
    30,975  
  500    
Clorox Co.
    32,480  
  2,100    
Colgate—Palmolive Co.
    192,150  
  910    
Estee Lauder Cos. (The), Inc.-Class A
    107,362  
  1,000    
Herbalife Ltd.
    55,300  
  1,400    
Kimberly—Clark Corp.
    100,058  
  10,048    
Procter & Gamble Co. (The)
    648,799  
       
 
     
       
Total Household & Personal Products
    1,185,824  
       
 
     
       
 
       
       
Insurance — 1.2%
       
  500    
American International Group, Inc.*
    11,655  
  700    
Aon Corp.
    32,179  
  900    
Assurant, Inc.
    35,316  
  100    
Endurance Specialty Holdings Ltd.
    3,617  
  1,500    
Hartford Financial Services Group, Inc. (The)
    26,640  
  400    
Protective Life Corp.
    8,876  
  800    
Prudential Financial, Inc.
    40,512  
  1,800    
Travelers Cos. (The), Inc.
    101,250  
  300    
Validus Holdings Ltd.
    9,027  
       
 
     
       
Total Insurance
    269,072  
       
 
     
       
 
       
       
Materials — 0.4%
       
  700    
Ecolab, Inc.
    39,914  
  900    
LyondellBasell Industries NV-Class A
    29,403  

 


 

                 
  300    
Sigma—Aldrich Corp.
    19,443  
       
 
     
       
Total Materials
    88,760  
       
 
     
 
       
Media — 0.8%
       
  1,800    
CBS Corp.-Class B (Non Voting)
    46,872  
  700    
Charter Communications, Inc.-Class A*
    37,009  
  1,400    
DISH Network Corp.-Class A
    34,398  
  1,000    
Gannett Co., Inc.
    10,860  
  1,100    
McGraw-Hill Cos. (The), Inc.
    46,970  
       
 
     
       
Total Media
    176,109  
       
 
     
       
 
       
       
Pharmaceuticals, Biotechnology & Life Sciences — 17.9%
       
  9,000    
Abbott Laboratories
    490,950  
  1,100    
Allergan, Inc.
    92,092  
  4,200    
Amgen, Inc.
    243,222  
  1,120    
Biogen Idec, Inc.*
    128,744  
  6,600    
Bristol—Myers Squibb Co.
    215,952  
  8,600    
Eli Lilly & Co.
    325,510  
  900    
Endo Pharmaceuticals Holdings, Inc.*
    30,807  
  1,900    
Forest Laboratories, Inc.*
    56,924  
  3,300    
Gilead Sciences, Inc.*
    131,505  
  9,120    
Johnson & Johnson
    590,246  
  18,776    
Merck & Co., Inc.
    671,242  
  110    
Mettler-Toledo International, Inc.*
    17,578  
  51,286    
Pfizer, Inc.
    1,029,310  
  400    
Pharmaceutical Product Development, Inc.
    13,284  
  200    
Techne Corp.
    13,498  
  3,100    
Warner Chilcott Plc.-Class A*
    48,732  
  300    
Waters Corp.*
    24,000  
  200    
Watson Pharmaceuticals, Inc.*
    12,924  
       
 
     
       
Total Pharmaceuticals, Biotechnology & Life Sciences
    4,136,520  
       
 
     
       
 
       
       
Retailing — 3.0%
       
  500    
Advance Auto Parts, Inc.
    34,610  
  400    
Aeropostale, Inc.*
    6,204  
  700    
AutoNation, Inc.*
    25,277  
  90    
AutoZone, Inc.*
    29,554  
  1,900    
Best Buy Co., Inc.
    51,471  
  700    
Dollar Tree, Inc.*
    57,043  
  600    
Family Dollar Stores, Inc.
    35,652  
  1,000    
GameStop Corp.-Class A*
    23,120  
  600    
Genuine Parts Co.
    35,100  
  600    
J.C. Penney Co., Inc.
    19,224  
  1,600    
Liberty Media Corp.-Interactive-Class A*
    26,016  
  2,600    
Lowe’s Cos., Inc.
    62,426  
  70    
Priceline.com, Inc.*
    34,013  
  700    
Ross Stores, Inc.
    62,363  
  1,200    
Target Corp.
    63,240  
  2,000    
TJX Cos. (The), Inc.
    123,400  
       
 
     
       
Total Retailing
    688,713  
       
 
     
       
 
       
       
Semiconductors & Semiconductor Equipment — 0.4%
       
  100    
ON Semiconductor Corp.*
    753  
  2,700    
Texas Instruments, Inc.
    81,270  
       
 
     
       
Total Semiconductors & Semiconductor Equipment
    82,023  
       
 
     
       
 
       
       
Software & Services — 21.7%
       
  4,000    
Accenture Plc.-Class A
    231,720  

 


 

                 
  1,200    
Adobe Systems, Inc.*
    32,904  
  1,100    
Amdocs Ltd.*
    31,064  
  400    
Ansys, Inc.*
    24,788  
  100    
AOL, Inc.*
    1,434  
  1,500    
Automatic Data Processing, Inc.
    76,635  
  800    
BMC Software, Inc.*
    28,528  
  500    
Citrix Systems, Inc.*
    35,695  
  1,200    
Cognizant Technology Solutions Corp.-Class A*
    80,820  
  500    
Computer Sciences Corp.
    12,215  
  5,000    
eBay, Inc.*
    147,950  
  300    
Factset Research Systems, Inc.
    27,969  
  500    
Global Payments, Inc.
    22,115  
  1,470    
Google, Inc.-Class A*
    881,103  
  600    
Informatica Corp.*
    26,973  
  4,924    
International Business Machines Corp.
    925,712  
  1,200    
Intuit, Inc.
    63,888  
  400    
Jack Henry & Associates, Inc.
    13,284  
  380    
MasterCard, Inc.-Class A
    142,329  
  300    
Micros Systems, Inc.*
    14,151  
  45,336    
Microsoft Corp.
    1,159,695  
  27,300    
Oracle Corp.
    855,855  
  1,300    
Paychex, Inc.
    37,843  
  100    
Quest Software, Inc.*
    1,807  
  2,700    
Symantec Corp.*
    44,145  
  200    
Syntel, Inc.
    9,568  
  900    
Total System Services, Inc.
    18,036  
  600    
Visa, Inc.-Class A
    58,182  
       
 
     
       
Total Software & Services
    5,006,408  
       
 
     
       
 
       
       
Technology Hardware & Equipment — 6.7%
       
  1,190    
Apple, Inc.*
    454,818  
  600    
Arrow Electronics, Inc.*
    21,936  
  6,750    
Cisco Systems, Inc.
    125,820  
  6,380    
Dell, Inc.*
    100,549  
  400    
Harris Corp.
    14,240  
  10,000    
Hewlett-Packard Co.
    279,500  
  1,200    
Ingram Micro, Inc.-Class A*
    21,612  
  7,032    
Qualcomm, Inc.
    385,353  
  2,700    
Seagate Technology Plc
    46,170  
  1,000    
Vishay Intertechnology, Inc.*
    9,890  
  2,730    
Western Digital Corp.*
    79,361  
       
 
     
       
Total Technology Hardware & Equipment
    1,539,249  
       
 
     
       
 
       
       
Telecommunication Services — 2.1%
       
  6,600    
AT&T, Inc.
    191,268  
  600    
Level 3 Communications, Inc.*
    12,366  
  7,500    
Sprint Nextel Corp.*
    20,250  
  6,884    
Verizon Communications, Inc.
    259,733  
       
 
     
       
Total Telecommunication Services
    483,617  
       
 
     
       
 
       
       
Transportation — 0.3%
       
  600    
CH Robinson Worldwide, Inc.
    41,106  
  400    
Expeditors International of Washington, Inc.
    17,404  
       
 
     
       
Total Transportation
    58,510  
       
 
     
       
 
       
       
TOTAL COMMON STOCKS (COST $20,312,047)
    22,753,292  
       
 
     

 


 

                 
       
INVESTMENT FUNDS — 1.0%
       
       
 
       
  1,911    
SPDR S&P 500 ETF Trust (a)
    239,085  
       
 
     
       
 
       
       
TOTAL INVESTMENT FUNDS (COST $232,265)
    239,085  
       
 
     
       
 
       
       
MUTUAL FUNDS — 0.2%
       
       
 
       
       
Affiliated Issuers — 0.2%
       
  1,800    
GMO U.S. Treasury Fund
    45,018  
       
 
     
       
 
       
       
TOTAL MUTUAL FUNDS (COST $45,018)
    45,018  
       
 
     
 
       
SHORT-TERM INVESTMENTS — 0.0%
       
       
 
       
       
Money Market Funds — 0.0%
       
  9,002    
State Street Institutional Treasury Money Market Fund-Institutional Class, 0.00% (b)
    9,002  
       
 
     
       
 
       
       
TOTAL SHORT-TERM INVESTMENTS (COST $9,002)
    9,002  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 99.8%
(Cost $20,598,332)
    23,046,397  
       
 
       
       
Other Assets and Liabilities (net) — 0.2%
    35,236  
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 23,081,633  
       
 
     

 


 

A summary of outstanding financial instruments at November 30, 2011 is as follows:
Swap Agreements
Total Return Swaps
                                           
Notional   Expiration                             Net Unrealized  
Amount   Date     Counterparty     Fund Receives     Fund (Pays)/Receives     Appreciation/(Depreciation)  
43,704
   USD     1/19/2012     Deutsche Bank AG   18% of notional amount   Return on Sears Holding Corp.   $ (2,570 )
 
                                       
 
                            Premiums to (Pay) Receive   $  
 
                                       
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
 
Notes to Schedule of Investments:
 
ETF — Exchange-Traded Fund
 
SPDR — Standard and Poor’s Depositary Receipt
 
*   Non-income producing security.
 
(a)   Represents an investment to equitize cash. The SPDR S&P 500 ETF Trust is a unit investment trust that issues securities called “Trust Units” or “Units” that represent an undivided ownership interest in a portfolio of all of the common stocks of the Standard & Poor’s 500 Composite Stock Price Index®. The SPDR S&P 500 ETF Trust prospectus states that the Trust intends to provide investment results that, before expenses, generally correspond to the price and yield performance of the S&P 500 Index.
 
(b)   Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.
Currency Abbreviations:
USD — United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                         
    Gross     Gross     Net Unrealized  
    Unrealized     Unrealized     Appreciation  
    Aggregate Cost       Appreciation     (Depreciation)     (Depreciation)  
$            21,392,854
  $ 2,087,701     $ (434,158 )   $ 1,653,543  

 


 

Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO U.S. Treasury Fund
  $ 436,973     $ 679,000     $ 1,071,036     $ 66     $ 4     $ 45,018  
 
                                   

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivative contracts based on the creditworthiness of its counterparties. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs.
Level 3 — Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Common Stocks
  $ 22,753,292     $     $     $ 22,753,292  
Investment Funds
    239,085                   239,085  
Mutual Funds
    45,018                   45,018  
Short-Term Investments
    9,002                   9,002  
 
                       
Total Investments
  $ 23,046,397     $     $     $ 23,046,397  
 
                       
LIABILITY VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Liabilities     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Derivatives*
                               
Swap Agreements
                               
Equity Risk
  $     $ (2,570 )   $     $ (2,570 )
 
                       
Total
  $     $ (2,570 )   $     $ (2,570 )
 
                       
The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
 
* Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
All of the Fund’s common stocks held at period end are classified as Level 1. Please refer to the Schedule of Investments for a more detailed categorization of common stocks.
The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If the Fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of the value of those investments. The Fund also may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Because the Fund normally does not take temporary defensive positions, declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.

 


 

 Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
 Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk and counterparty risk.
 Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
 Leveraging Risk — The Fund’s use of derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
 Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
 Focused Investment Risk — Focusing investments in sectors or companies or in industries with high positive correlations to one another creates additional risk.
 Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
 Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Among other trading agreements, the Fund is party to International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Agreements”) or other similar types of agreements with selected counterparties that generally govern over-the-counter derivative transactions entered into by the Fund. The ISDA Agreements typically include representations and warranties as well as contractual terms related to collateral, events of default, termination events, and other provisions. Termination events may include the decline in the net assets of the Fund below a certain level over a specified period of time and entitle a counterparty to elect to terminate early with respect to some or all the transactions under the ISDA Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse effect on the Fund’s operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. For example, the Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives, to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives.
The Fund also may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero).

 


 

In addition, the Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors and markets without actually having to sell existing investments or make new direct investments. For example, if the Fund holds a large proportion of stocks of companies in a particular sector and the Manager believes that stocks of companies in another sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index).
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net long exposure in excess of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.

 


 

Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded. The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.

 


 

Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. During the period ended November 30, 2011, the Fund used total return swap agreements to achieve returns comparable to holding and lending a direct equity position. Swap agreements outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.

 


 

The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Liabilities:
                                               
Unrealized depreciation on swap agreements
  $     $     $     $ ( 2,570 )   $     $ ( 2,570 )
 
                                   
Total
  $     $     $     $ ( 2,570 )   $     $ ( 2,570 )
 
                                   
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The derivative financial instruments outstanding as of period end (as disclosed in the Schedule of Investments) serve as indicators of the volume of derivative activity for the Fund during the period.

 


 

Subsequent events
In 2011, the Board of Trustees of GMO Trust approved the liquidation of the Fund. The Fund was liquidated on December 28, 2011.
For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO U.S. Core Equity Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares     Description   Value ($)  
 
       
COMMON STOCKS — 97.9%
       
       
 
       
       
Automobiles & Components — 0.2%
       
  137,900    
General Motors Co.*
    2,935,891  
       
 
     
       
 
       
       
Banks — 0.1%
       
  32,600    
CIT Group, Inc.*
    1,103,836  
       
 
     
       
 
       
       
Capital Goods — 3.0%
       
  143,500    
3M Co.
    11,629,240  
  4,500    
Alliant Techsystems, Inc.
    264,780  
  75,700    
Danaher Corp.
    3,662,366  
  67,700    
Fastenal Co.
    2,819,705  
  78,200    
General Dynamics Corp.
    5,165,892  
  21,188    
GeoEye, Inc.*
    402,360  
  5,400    
Harsco Corp.
    111,456  
  18,650    
ITT Corp.
    376,170  
  11,620    
Joy Global, Inc.
    1,060,674  
  30,000    
L-3 Communications Holdings, Inc.
    1,989,000  
  25,500    
Northrop Grumman Corp.
    1,455,285  
  16,500    
Oshkosh Corp.*
    338,580  
  11,860    
Precision Castparts Corp.
    1,953,935  
  83,700    
United Technologies Corp.
    6,411,420  
  11,190    
WW Grainger, Inc.
    2,091,411  
       
 
     
       
Total Capital Goods
    39,732,274  
       
 
     
       
 
       
       
Commercial & Professional Services — 0.3%
       
  14,400    
Copart, Inc.*
    646,992  
  40,500    
Pitney Bowes, Inc.
    754,515  
  30,300    
Rollins, Inc.
    672,660  
  50,500    
RR Donnelley & Sons Co.
    758,510  
  17,800    
Stericycle, Inc.*
    1,442,156  
       
 
     
       
Total Commercial & Professional Services
    4,274,833  
       
 
     
       
 
       
       
Consumer Durables & Apparel — 1.6%
       
  70,900    
Coach, Inc.
    4,437,631  
  16,710    
Fossil, Inc.*
    1,497,049  
  202,024    
KB Home
    1,484,876  
  100,700    
Nike, Inc.-Class B
    9,685,326  
  24,360    
VF Corp.
    3,378,489  
       
 
     
       
Total Consumer Durables & Apparel
    20,483,371  
       
 
     
       
 
       
       
Consumer Services — 2.4%
       
  79,000    
Apollo Group, Inc.-Class A*
    3,829,920  
  14,600    
DeVry, Inc.
    503,846  
  97,500    
H&R Block, Inc.
    1,533,675  
  2,000    
ITT Educational Services, Inc.*
    109,920  
  252,500    
McDonald’s Corp.
    24,118,800  
  14,600    
Weight Watchers International, Inc.
    858,042  
       
 
     
       
Total Consumer Services
    30,954,203  
       
 
     
       
 
       
       
Diversified Financials — 0.4%
       
  421,032    
Bank of America Corp.
    2,290,414  
  37,500    
Capital One Financial Corp.
    1,674,750  
  119,800    
SLM Corp.
    1,543,024  
       
 
     
       
Total Diversified Financials
    5,508,188  
       
 
     

 


 

                 
       
Energy — 7.8%
       
  30,900    
Anadarko Petroleum Corp.
    2,511,243  
  24,110    
Apache Corp.
    2,397,498  
  34,300    
Baker Hughes, Inc.
    1,873,123  
  3,600    
Berry Petroleum Co.-Class A
    157,968  
  221,790    
Chevron Corp.
    22,804,448  
  264,468    
ConocoPhillips
    18,861,858  
  423,300    
Exxon Mobil Corp.
    34,050,252  
  85,700    
Halliburton Co.
    3,153,760  
  9,700    
Key Energy Services, Inc.*
    146,470  
  2,100    
Lufkin Industries, Inc.
    147,168  
  120,500    
Marathon Oil Corp.
    3,369,180  
  35,400    
National Oilwell Varco, Inc.
    2,538,180  
  22,298    
Occidental Petroleum Corp.
    2,205,272  
  16,900    
Range Resources Corp.
    1,211,899  
  51,400    
Schlumberger Ltd.
    3,871,962  
  94,400    
Valero Energy Corp.
    2,102,288  
  47,800    
Williams Cos., Inc.
    1,542,984  
       
 
     
       
Total Energy
    102,945,553  
       
 
     
       
 
       
       
Food & Staples Retailing — 6.7%
       
  43,700    
Costco Wholesale Corp.
    3,727,610  
  170,300    
CVS Caremark Corp.
    6,614,452  
  149,900    
Kroger Co. (The)
    3,474,682  
  54,000    
Safeway, Inc.
    1,080,000  
  16,225    
Supervalu, Inc.
    119,254  
  126,100    
Sysco Corp.
    3,598,894  
  324,900    
Walgreen Co.
    10,955,628  
  995,145    
Wal—Mart Stores, Inc.
    58,614,040  
       
 
     
       
Total Food & Staples Retailing
    88,184,560  
       
 
     
       
 
       
       
Food, Beverage & Tobacco — 9.6%
       
  30,600    
Brown-Forman Corp.-Class B
    2,442,186  
  56,300    
Campbell Soup Co.
    1,835,380  
  471,000    
Coca-Cola Co. (The)
    31,665,330  
  12,900    
Dean Foods Co.*
    131,064  
  37,050    
Flowers Foods, Inc.
    732,478  
  132,500    
General Mills, Inc.
    5,293,375  
  34,100    
Hansen Natural Corp.*
    3,144,020  
  59,800    
Hershey Co. (The)
    3,449,264  
  43,800    
HJ Heinz Co.
    2,306,070  
  57,800    
Hormel Foods Corp.
    1,740,358  
  17,600    
J.M. Smucker Co. (The)
    1,337,248  
  66,600    
Kellogg Co.
    3,274,056  
  41,050    
Lorillard, Inc.
    4,582,001  
  27,400    
McCormick & Co., Inc. (Non Voting)
    1,334,380  
  372,375    
PepsiCo, Inc.
    23,832,000  
  444,837    
Philip Morris International, Inc.
    33,914,373  
  123,700    
Reynolds American, Inc.
    5,178,082  
       
 
     
       
Total Food, Beverage & Tobacco
    126,191,665  
       
 
     
       
 
       
       
Health Care Equipment & Services — 8.1%
       
  93,700    
Aetna, Inc.
    3,918,534  
  89,950    
Alere, Inc.*
    2,103,931  
  7,600    
AMERIGROUP Corp.*
    434,492  
  65,700    
AmerisourceBergen Corp.
    2,440,755  
  130,400    
Baxter International, Inc.
    6,736,464  
  46,400    
Becton, Dickinson and Co.
    3,423,392  

 


 

                 
  7,500    
Brookdale Senior Living, Inc.*
    116,625  
  59,800    
Cardinal Health, Inc.
    2,539,108  
  27,500    
CareFusion Corp.*
    681,450  
  35,880    
Cerner Corp.*
    2,187,962  
  26,500    
Cigna Corp.
    1,172,095  
  42,900    
Coventry Health Care, Inc.*
    1,370,226  
  56,200    
Covidien Plc
    2,559,910  
  18,570    
CR Bard, Inc.
    1,619,118  
  23,400    
DENTSPLY International, Inc.
    844,974  
  16,860    
Edwards Lifesciences Corp.*
    1,113,266  
  109,850    
Express Scripts, Inc.*
    5,014,653  
  8,200    
Gen-Probe, Inc.*
    516,518  
  14,900    
Henry Schein, Inc.*
    958,666  
  44,400    
Humana, Inc.
    3,937,392  
  14,700    
Idexx Laboratories, Inc.*
    1,105,293  
  7,310    
Intuitive Surgical, Inc.*
    3,174,075  
  19,800    
Laboratory Corp. of America Holdings*
    1,697,256  
  65,163    
Lincare Holdings, Inc.
    1,544,363  
  35,800    
McKesson Corp.
    2,910,898  
  7,700    
Mednax, Inc.*
    518,980  
  335,600    
Medtronic, Inc.
    12,225,908  
  18,500    
Patterson Cos., Inc.
    558,145  
  9,800    
Quality Systems, Inc.
    346,430  
  31,300    
Quest Diagnostics, Inc.
    1,836,058  
  23,800    
ResMed, Inc.*
    619,990  
  64,300    
Stryker Corp.
    3,139,769  
  61,200    
St Jude Medical, Inc.
    2,352,528  
  31,642    
Triple-S Management Corp.-Class B*
    616,386  
  377,674    
UnitedHealth Group, Inc.
    18,419,161  
  19,200    
Varian Medical Systems, Inc.*
    1,194,816  
  95,700    
WellPoint, Inc.
    6,751,635  
  68,525    
Zimmer Holdings, Inc.*
    3,463,939  
       
 
     
       
Total Health Care Equipment & Services
    106,165,161  
       
 
     
       
 
       
       
Household & Personal Products — 5.0%
       
  58,900    
Avon Products, Inc.
    1,001,300  
  36,600    
Church & Dwight Co., Inc.
    1,619,550  
  27,873    
Clorox Co.
    1,810,630  
  115,600    
Colgate—Palmolive Co.
    10,577,400  
  49,360    
Estee Lauder Cos., Inc. (The), -Class A
    5,823,493  
  49,600    
Herbalife Ltd.
    2,742,880  
  73,900    
Kimberly—Clark Corp.
    5,281,633  
  568,500    
Procter & Gamble Co. (The)
    36,708,045  
       
 
     
       
Total Household & Personal Products
    65,564,931  
       
 
     
       
 
       
       
Insurance — 1.0%
       
  45,800    
American International Group, Inc.*
    1,067,598  
  33,000    
Aon Corp.
    1,517,010  
  45,400    
Assurant, Inc.
    1,781,496  
  3,400    
Endurance Specialty Holdings Ltd.
    122,978  
  56,700    
Hartford Financial Services Group, Inc. (The)
    1,006,992  
  7,000    
Protective Life Corp.
    155,330  
  37,200    
Prudential Financial, Inc.
    1,883,808  
  97,100    
Travelers Cos., Inc. (The)
    5,461,875  
  20,000    
Validus Holdings Ltd.
    601,800  
       
 
     
       
Total Insurance
    13,598,887  
       
 
     
       
 
       

 


 

                 
       
Materials — 0.4%
       
  40,100    
Ecolab, Inc.
    2,286,502  
  48,200    
LyondellBasell Industries NV-Class A
    1,574,694  
  9,827    
Schweitzer-Mauduit International, Inc.
    699,879  
  15,100    
Sigma—Aldrich Corp.
    978,631  
       
 
     
       
Total Materials
    5,539,706  
       
 
     
       
 
       
       
Media — 0.7%
       
  100,700    
CBS Corp.-Class B (Non Voting)
    2,622,228  
  32,200    
Charter Communications, Inc.-Class A*
    1,702,414  
  59,400    
DISH Network Corp.-Class A
    1,459,458  
  60,900    
Gannett Co., Inc.
    661,374  
  53,100    
McGraw-Hill Cos., Inc. (The)
    2,267,370  
       
 
     
       
Total Media
    8,712,844  
       
 
     
       
 
       
       
Pharmaceuticals, Biotechnology & Life Sciences — 17.6%
       
  505,600    
Abbott Laboratories
    27,580,480  
  59,000    
Allergan, Inc.
    4,939,480  
  235,300    
Amgen, Inc.
    13,626,223  
  60,620    
Biogen Idec, Inc.*
    6,968,269  
  371,300    
Bristol—Myers Squibb Co.
    12,148,936  
  481,600    
Eli Lilly & Co.
    18,228,560  
  38,500    
Endo Pharmaceuticals Holdings, Inc.*
    1,317,855  
  108,100    
Forest Laboratories, Inc.*
    3,238,676  
  177,400    
Gilead Sciences, Inc.*
    7,069,390  
  516,300    
Johnson & Johnson
    33,414,936  
  1,042,362    
Merck & Co., Inc.
    37,264,441  
  6,670    
Mettler-Toledo International, Inc.*
    1,065,866  
  2,898,336    
Pfizer, Inc.
    58,169,604  
  17,700    
Pharmaceutical Product Development, Inc.
    587,817  
  7,300    
Techne Corp.
    492,677  
  161,200    
Warner Chilcott Plc.-Class A*
    2,534,064  
  15,100    
Waters Corp.*
    1,208,000  
  11,700    
Watson Pharmaceuticals, Inc.*
    756,054  
       
 
     
       
Total Pharmaceuticals, Biotechnology & Life Sciences
    230,611,328  
       
 
     
       
 
       
       
Retailing — 2.7%
       
  28,400    
Advance Auto Parts, Inc.
    1,965,848  
  9,100    
Aeropostale, Inc.*
    141,141  
  38,100    
AutoNation, Inc.*
    1,375,791  
  4,484    
AutoZone, Inc.*
    1,472,456  
  92,600    
Best Buy Co., Inc.
    2,508,534  
  36,100    
Dollar Tree, Inc.*
    2,941,789  
  25,500    
Family Dollar Stores, Inc.
    1,515,210  
  41,200    
GameStop Corp.-Class A*
    952,544  
  31,700    
Genuine Parts Co.
    1,854,450  
  27,600    
J.C. Penney Co., Inc.
    884,304  
  90,600    
Liberty Media Corp.-Interactive-Class A*
    1,473,156  
  140,000    
Lowe’s Cos., Inc.
    3,361,400  
  3,610    
Priceline.com, Inc.*
    1,754,063  
  36,400    
Ross Stores, Inc.
    3,242,876  
  66,100    
Target Corp.
    3,483,470  
  106,800    
TJX Cos., Inc. (The)
    6,589,560  
       
 
     
       
Total Retailing
    35,516,592  
       
 
     
       
 
       
       
Semiconductors & Semiconductor Equipment — 0.3%
       
  146,200    
Texas Instruments, Inc.
    4,400,620  
       
 
     
       
 
       
       
Software & Services — 21.2%
       
  227,700    
Accenture Plc.-Class A
    13,190,661  
  54,800    
Adobe Systems, Inc.*
    1,502,616  

 


 

                 
  59,100    
Amdocs Ltd.*
    1,668,984  
  15,000    
Ansys, Inc.*
    929,550  
  8,900    
AOL, Inc.*
    127,626  
  83,200    
Automatic Data Processing, Inc.
    4,250,688  
  39,100    
BMC Software, Inc.*
    1,394,306  
  28,900    
Citrix Systems, Inc.*
    2,063,171  
  66,400    
Cognizant Technology Solutions Corp.-Class A*
    4,472,040  
  27,600    
Computer Sciences Corp.
    674,268  
  272,500    
eBay, Inc.*
    8,063,275  
  11,200    
Factset Research Systems, Inc.
    1,044,176  
  17,200    
Global Payments, Inc.
    760,756  
  83,240    
Google, Inc.-Class A*
    49,893,224  
  30,600    
Informatica Corp.*
    1,375,623  
  277,953    
International Business Machines Corp.
    52,255,164  
  68,400    
Intuit, Inc.
    3,641,616  
  20,900    
Jack Henry & Associates, Inc.
    694,089  
  20,140    
MasterCard, Inc.-Class A
    7,543,437  
  16,700    
Micros Systems, Inc.*
    787,739  
  2,559,957    
Microsoft Corp.
    65,483,700  
  1,537,630    
Oracle Corp.
    48,204,700  
  75,500    
Paychex, Inc.
    2,197,805  
  7,100    
Quest Software, Inc.*
    128,297  
  148,400    
Symantec Corp.*
    2,426,340  
  2,600    
Syntel, Inc.
    124,384  
  36,200    
Total System Services, Inc.
    725,448  
  29,900    
Visa, Inc.-Class A
    2,899,403  
       
 
     
       
Total Software & Services
    278,523,086  
       
 
     
       
 
       
       
Technology Hardware & Equipment — 6.4%
       
  67,000    
Apple, Inc.*
    25,607,400  
  28,900    
Arrow Electronics, Inc.*
    1,056,584  
  371,834    
Cisco Systems, Inc.
    6,930,986  
  344,506    
Dell, Inc.*
    5,429,414  
  20,100    
Harris Corp.
    715,560  
  559,900    
Hewlett-Packard Co.
    15,649,205  
  64,400    
Ingram Micro, Inc.-Class A*
    1,159,844  
  396,300    
Qualcomm, Inc.
    21,717,240  
  137,200    
Seagate Technology Plc
    2,346,120  
  11,600    
Vishay Intertechnology, Inc.*
    114,724  
  130,455    
Western Digital Corp.*
    3,792,327  
       
 
     
       
Total Technology Hardware & Equipment
    84,519,404  
       
 
     
       
 
       
       
Telecommunication Services — 2.1%
       
  356,000    
AT&T, Inc.
    10,316,880  
  31,300    
Level 3 Communications, Inc.*
    645,093  
  470,600    
Sprint Nextel Corp.*
    1,270,620  
  386,122    
Verizon Communications, Inc.
    14,568,383  
       
 
     
       
Total Telecommunication Services
    26,800,976  
       
 
     
       
 
       
       
Transportation — 0.3%
       
  36,500    
CH Robinson Worldwide, Inc.
    2,500,615  
  22,900    
Expeditors International of Washington, Inc.
    996,379  
       
 
     
       
Total Transportation
    3,496,994  
       
 
     
       
 
       
       
TOTAL COMMON STOCKS (COST $1,143,549,411)
    1,285,764,903  
       
 
     

 


 

                 
       
INVESTMENT FUNDS — 0.9%
       
       
 
       
  92,066    
SPDR S&P 500 ETF Trust (a)
    11,518,377  
       
 
     
       
 
       
       
TOTAL INVESTMENT FUNDS (COST $11,312,476)
    11,518,377  
       
 
     
       
 
       
       
MUTUAL FUNDS — 0.7%
       
       
 
       
       
Affiliated Issuers — 0.7%
       
  392,685    
GMO U.S. Treasury Fund
    9,821,035  
       
 
     
       
 
       
       
TOTAL MUTUAL FUNDS
(COST $9,821,035)
    9,821,035  
       
 
     
       
 
       
       
SHORT-TERM INVESTMENTS — 0.1%
       
       
 
       
       
Money Market Funds — 0.1%
       
  720,025    
State Street Institutional Treasury Money Market Fund-Institutional Class, 0.00% (b)
    720,025  
       
 
     
       
 
       
       
TOTAL SHORT-TERM INVESTMENTS (COST $720,025)
    720,025  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 99.6%
(Cost $1,165,402,947)
    1,307,824,340  
 
       
Other Assets and Liabilities (net) — 0.4%
    5,524,844  
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 1,313,349,184  
       
 
     

 


 

A summary of outstanding financial instruments at November 30, 2011 is as follows:
Swap Agreements
Total Return Swaps
                                                 
Notional     Expiration                             Net Unrealized  
Amount     Date     Counterparty   Fund Receives   Fund (Pays)/Receives   Appreciation/(Depreciation)  
2,696,769
  USD       1/19/2012     Deutsche Bank AG   18% of notional amount   Return on Sears Holding Corp.   $ (158,580 )
 
                                             
 
                                  Premiums to (Pay) Receive   $  
 
                                             
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
 
Notes to Schedule of Investments:
ETF — Exchange-Traded Fund
 
SPDR — Standard and Poor’s Depositary Receipt
 
*   Non-income producing security.
 
(a)   Represents an investment to equitize cash. The SPDR S&P 500 ETF Trust is a unit investment trust that issues securities called “Trust Units” or “Units” that represent an undivided ownership interest in a portfolio of all of the common stocks of the Standard & Poor’s 500 Composite Stock Price Index®. The SPDR S&P 500 ETF Trust prospectus states that the Trust intends to provide investment results that, before expenses, generally correspond to the price and yield performance of the S&P 500 Index.
 
(b)   Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.
Currency Abbreviations:
USD — United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                           
      Gross     Gross     Net Unrealized  
      Unrealized     Unrealized     Appreciation  
Aggregate Cost   Appreciation     (Depreciation)     (Depreciation)  
$ 1,223,190,421         $ 105,549,017           $ (20,915,098 )     $ 84,633,919  

 


 

Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO U.S. Treasury Fund
  $ 23,221,000     $ 176,577,000     $ 189,976,965     $ 6,453     $     $ 9,821,035  
 
                                   

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivatives contracts based on the creditworthiness of its counterparties. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs.
Level 3 — Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Common Stocks
  $ 1,285,764,903     $     $     $ 1,285,764,903  
Investment Funds
    11,518,377                   11,518,377  
Mutual Funds
    9,821,035                   9,821,035  
Short-Term Investments
    720,025                   720,025  
 
                       
Total Investments
    1,307,824,340                   1,307,824,340  
 
                       
Total
  $ 1,307,824,340     $     $     $ 1,307,824,340  
 
                       
LIABILITY VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Liabilities     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Derivatives*
                               
Swap Agreements
                               
Equity Risk
  $     $ (158,580 )   $     $ (158,580 )
 
                       
Total
  $     $ (158,580 )   $     $ (158,580 )
 
                       

 


 

The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
 
*   Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
All of the Fund’s common stocks held at period end are classified as Level 1. Please refer to the Schedule of Investments for a more detailed categorization of common stocks.
The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If the Fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of the value of those investments. The Fund also may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Because the Fund normally does not take temporary defensive positions, declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk and counterparty risk.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Leveraging Risk — The Fund’s use of derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
Focused Investment Risk — Focusing investments in sectors or companies or in industries with high positive correlations to one another creates additional risk.

 


 

Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Among other trading agreements, the Fund is party to International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Agreements”) or other similar types of agreements with selected counterparties that generally govern over-the-counter derivative transactions entered into by the Fund. The ISDA Agreements typically include representations and warranties as well as contractual terms related to collateral, events of default, termination events, and other provisions. Termination events may include the decline in the net assets of the Fund below a certain level over a specified period of time and entitle a counterparty to elect to terminate early with respect to some or all the transactions under the ISDA Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse effect on the Fund’s operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. For example, the Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives, to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives.
The Fund also may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero).
In addition, the Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors and markets without actually having to sell existing investments or make new direct investments. For example, if the Fund holds a large proportion of stocks of companies in a particular sector and the Manager believes that stocks of companies in another sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index).
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net long exposure in excess of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.

 


 

Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded. The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. During the period ended November 30, 2011, the Fund used futures contracts to maintain the diversity and liquidity of the portfolio. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When

 


 

the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.

 


 

The Fund prices its swap agreements daily using models that may incorporate quotations from market makers and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. During the period ended November 30, 2011, the Fund used total return swap agreements to achieve returns comparable to holding and lending a direct equity position. Swap agreements outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.

 


 

The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Value of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Liabilities:
                                               
Unrealized depreciation on swap agreements
  $     $     $     $ (158,580 )   $     $ (158,580 )
 
                                   
Total
  $     $     $     $ (158,580 )   $     $ (158,580 )
 
                                   
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (future contracts), or notional amounts (swap agreements) outstanding at each month-end, was as follows for the period ended November 30, 2011:
             
    Futures   Swap
    Contracts   Agreements
Average amount outstanding
  $705,275*   $ 3,675,852  
 
*   During the period ended November 30, 2011, the Fund did not hold futures contracts at any month-end, therefore, the average amount outstanding was calculated using daily outstanding absolute values.

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO U.S. Equity Allocation Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares / Par Value ($)     Description   Value ($)  
 
       
MUTUAL FUNDS — 100.0%
       
       
 
       
       
Affiliated Issuers — 100.0%
       
  1,408,287    
GMO Quality Fund, Class VI
    30,756,983  
  2,375,932    
GMO U.S. Core Equity Fund, Class VI
    28,843,820  
  57,498    
GMO U.S. Small/Mid Cap Growth Fund, Class III
    698,030  
  77,922    
GMO U.S. Small/Mid Cap Value Fund, Class III
    614,802  
       
 
     
       
TOTAL MUTUAL FUNDS (COST $47,166,236)
    60,913,635  
       
 
     
       
 
       
       
SHORT-TERM INVESTMENTS — 0.1%
       
       
 
       
       
Time Deposit — 0.1%
       
  31,952    
State Street Eurodollar Time Deposit, 0.01%, due 12/1/11
    31,952  
       
 
     
       
TOTAL SHORT-TERM INVESTMENTS (COST $31,952)
    31,952  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 100.1%
(Cost $47,198,188)
    60,945,587  
       
 
       
       
Other Assets and Liabilities (net) — (0.1%)
    (36,812 )
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 60,908,775  
       
 
     

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
             
    Gross   Gross   Net Unrealized
    Unrealized   Unrealized   Appreciation
Aggregate Cost   Appreciation   (Depreciation)   (Depreciation)
$48,737,206
  $12,208,381   $—   $12,208,381
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO Quality Fund, Class VI
  $ 46,703,245     $ 5,794,571     $ 23,651,910     $ 595,605     $     $ 30,756,983  
GMO U.S. Core Equity Fund, Class VI
    46,968,900       1,582,595       20,408,750       582,595             28,843,820  
GMO U.S. Small/Mid Cap Growth Fund, Class III
    1,194,609       254,434       499,425       977       253,457       698,030  
GMO U.S. Small/Mid Cap Value Fund, Class III
    1,055,906       6,032       429,587       6,032             614,802  
 
                                   
Totals
  $ 95,922,660     $ 7,637,632     $ 44,989,672     $ 1,185,209     $ 253,457     $ 60,913,635  
 
                                   

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Shares of the underlying funds and other investment funds are generally valued at their net asset value. Investments held by the underlying funds are valued as follows: Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund, either directly or through investments in the underlying funds, that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below and as described in the disclosures of the underlying funds.
        .
     
Security Type   Percentage of Net Assets of the Fund
Equity Securities
  7.8%
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs.
Level 3 — Valuations based primarily on inputs that are unobservable and significant.

 


 

The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
                         
    Quoted Prices                    
    in Active     Significant     Significant        
    Markets for Identical     Other Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Mutual Funds
  $ 60,913,635     $     $     $ 60,913,635  
Short-Term Investments
    31,952                   31,952  
 
                       
Total Investments
    60,945,587                   60,945,587  
 
                       
Total
  $ 60,945,587     $     $     $ 60,945,587  
 
                       

 


 

The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. References to investments include those held directly by the Fund and indirectly through the Fund’s investments in the underlying funds. The Fund and some of the underlying funds are non-diversified investment companies under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund or an underlying fund may affect the Fund’s or the underlying fund’s performance more than if the Fund or the underlying fund were diversified. Selected risks of investing in the Fund are summarized below, including those risks to which the Fund is exposed as a result of its investments in the underlying funds. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If an underlying fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of the value of those investments. An underlying fund also may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Because the Fund and the underlying funds normally do not take temporary defensive positions, declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in the underlying funds, including the risk that the underlying funds in which it invests do not perform as expected. Because the Fund bears the fees and expenses of the underlying funds in which it invests, new investments in underlying funds with higher fees or expenses than those of the underlying funds in which the Fund is currently invested will increase the Fund’s total expenses. The fees and expenses associated with an investment in the Fund are less predictable and may be higher than fees and expenses associated with an investment in funds that charge a fixed management fee.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of foreign currency holdings and investments denominated in foreign currencies.
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund or an underlying fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.

 


 

Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Real Estate Risk — To the extent an underlying fund concentrates its assets in real estate-related investments, the value of its portfolio is subject to factors affecting the real estate industry and may fluctuate more than the value of a portfolio that consists of securities of companies in a broader range of industries.
Short Sales Risk — The Fund runs the risk that an underlying fund’s loss on a short sale of securities that the underlying fund does not own is unlimited.
Leveraging Risk — The use of derivatives and securities lending may cause the Fund’s portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies or in industries with high positive correlations to one another creates additional risk.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Derivative financial instruments
At November 30, 2011, the Fund held no derivative financial instruments directly. For a listing of derivative financial instruments held by the underlying funds, if any, please refer to the underlying funds’ Schedule of Investments.
For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO U.S. Growth Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares     Description   Value ($)  
 
       
COMMON STOCKS — 97.7%
       
       
 
       
       
Automobiles & Components — 0.3%
       
  100    
Johnson Controls, Inc.
    3,148  
  100    
Tesla Motors, Inc.*
    3,274  
       
 
     
       
Total Automobiles & Components
    6,422  
       
 
     
       
 
       
       
Capital Goods — 4.3%
       
  486    
3M Co.
    39,385  
  200    
Emerson Electric Co.
    10,450  
  62    
Goodrich Corp.
    7,565  
  136    
TransDigm Group, Inc.*
    13,113  
  450    
United Technologies Corp.
    34,470  
  100    
WABCO Holdings, Inc.*
    4,701  
       
 
     
       
Total Capital Goods
    109,684  
       
 
     
       
 
       
       
Commercial & Professional Services — 0.1%
       
  100    
Nielsen Holdings NV*
    2,905  
       
 
     
       
 
       
       
Consumer Durables & Apparel — 1.5%
       
  236    
Nike, Inc.-Class B
    22,698  
  100    
Ralph Lauren Corp.
    14,186  
       
 
     
       
Total Consumer Durables & Apparel
    36,884  
       
 
     
       
 
       
       
Consumer Services — 3.5%
       
  260    
Apollo Group, Inc.-Class A*
    12,605  
  300    
H&R Block, Inc.
    4,719  
  100    
Marriott International, Inc.-Class A
    3,062  
  10    
Marriott Vacations Worldwide Corp.*
    160  
  566    
McDonald’s Corp.
    54,064  
  100    
Royal Caribbean Cruises Ltd.
    2,771  
  100    
Starwood Hotels & Resorts Worldwide, Inc.
    4,768  
  119    
Yum! Brands, Inc.
    6,669  
       
 
     
       
Total Consumer Services
    88,818  
       
 
     
       
 
       
       
Diversified Financials — 0.2%
       
  5    
BlackRock, Inc.
    860  
  299    
TD Ameritrade Holding Corp.
    4,871  
       
 
     
       
Total Diversified Financials
    5,731  
       
 
     
       
 
       
       
Energy — 6.1%
       
  200    
Chevron Corp.
    20,564  
  1,244    
Exxon Mobil Corp.
    100,067  
  205    
Range Resources Corp.
    14,701  
  200    
Schlumberger Ltd.
    15,066  
  100    
Whiting Petroleum Corp.*
    4,651  
       
 
     
       
Total Energy
    155,049  
       
 
     
       
 
       
       
Food & Staples Retailing — 5.8%
       
  219    
Costco Wholesale Corp.
    18,682  
  462    
Kroger Co. (The)
    10,709  
  748    
Sysco Corp.
    21,348  
  678    
Walgreen Co.
    22,862  
  1,137    
Wal—Mart Stores, Inc.
    66,969  
  100    
Whole Foods Market, Inc.
    6,810  
       
 
     
       
Total Food & Staples Retailing
    147,380  
       
 
     

 


 

                 
       
Food, Beverage & Tobacco — 16.0%
       
  579    
Altria Group, Inc.
    16,611  
  157    
Brown-Forman Corp.-Class B
    12,530  
  330    
Campbell Soup Co.
    10,758  
  100    
Coca-Cola Enterprises, Inc.
    2,612  
  1,165    
Coca-Cola Co. (The)
    78,323  
  200    
ConAgra Foods, Inc.
    5,052  
  549    
Flowers Foods, Inc.
    10,854  
  576    
General Mills, Inc.
    23,011  
  219    
Hansen Natural Corp.*
    20,192  
  304    
Hershey Co. (The)
    17,535  
  272    
HJ Heinz Co.
    14,321  
  500    
Hormel Foods Corp.
    15,055  
  345    
Kellogg Co.
    16,960  
  361    
McCormick & Co., Inc. (Non Voting)
    17,581  
  19    
Mead Johnson Nutrition Co.
    1,432  
  898    
PepsiCo, Inc.
    57,472  
  913    
Philip Morris International, Inc.
    69,607  
  400    
Reynolds American, Inc.
    16,744  
       
 
     
       
Total Food, Beverage & Tobacco
    406,650  
       
 
     
       
 
       
       
Health Care Equipment & Services — 3.0%
       
  38    
Baxter International, Inc.
    1,963  
  100    
Cardinal Health, Inc.
    4,246  
  89    
DaVita, Inc.*
    6,780  
  254    
Express Scripts, Inc.*
    11,595  
  200    
HCA Holdings, Inc.*
    4,876  
  336    
Health Management Associates, Inc.-Class A*
    2,762  
  55    
Lincare Holdings, Inc.
    1,304  
  100    
Medco Health Solutions, Inc.*
    5,667  
  100    
Mednax, Inc.*
    6,740  
  563    
Medtronic, Inc.
    20,510  
  100    
St Jude Medical, Inc.
    3,844  
  100    
Thoratec Corp.*
    3,042  
  100    
Universal Health Services, Inc.-Class B
    4,022  
       
 
     
       
Total Health Care Equipment & Services
    77,351  
       
 
     
       
 
       
       
Household & Personal Products — 7.3%
       
  540    
Avon Products, Inc.
    9,180  
  424    
Church & Dwight Co., Inc.
    18,762  
  214    
Clorox Co.
    13,901  
  344    
Colgate—Palmolive Co.
    31,476  
  383    
Estee Lauder Cos., Inc. (The), -Class A
    45,186  
  232    
Herbalife Ltd.
    12,830  
  319    
Kimberly—Clark Corp.
    22,799  
  475    
Procter & Gamble Co. (The)
    30,671  
       
 
     
       
Total Household & Personal Products
    184,805  
       
 
     
       
 
       
       
Insurance — 0.1%
       
  100    
Marsh & McLennan Cos., Inc.
    3,019  
       
 
     
       
 
       
       
Materials — 1.4%
       
  100    
International Flavors & Fragrances, Inc.
    5,426  
  200    
Monsanto Co.
    14,690  
  100    
Mosaic Co. (The)
    5,276  
  116    
Sherwin-Williams Co. (The)
    10,072  
       
 
     
       
Total Materials
    35,464  
       
 
     

 


 

                 
       
Media — 4.1%
       
  700    
Cablevision Systems Corp.-Class A
    10,500  
  100    
Comcast Corp.-Class A
    2,267  
  239    
DirectTV — Class A*
    11,286  
  200    
Discovery Communications, Inc.*
    8,396  
  600    
Liberty Global, Inc.-Class A*
    23,634  
  500    
Sirius XM Radio, Inc.*
    900  
  400    
Time Warner Cable, Inc.
    24,192  
  500    
Viacom, Inc.-Class B
    22,380  
       
 
     
       
Total Media
    103,555  
       
 
     
       
 
       
       
Pharmaceuticals, Biotechnology & Life Sciences — 5.5%
       
  1,008    
Abbott Laboratories
    54,986  
  100    
Charles River Laboratories International, Inc.*
    2,835  
  443    
Eli Lilly & Co.
    16,768  
  195    
Gilead Sciences, Inc.*
    7,771  
  99    
Illumina, Inc.*
    2,754  
  851    
Johnson & Johnson
    55,077  
       
 
     
       
Total Pharmaceuticals, Biotechnology & Life Sciences
    140,191  
       
 
     
       
 
       
       
Retailing — 4.9%
       
  189    
Amazon.com, Inc.*
    36,343  
  100    
Bed Bath & Beyond, Inc.*
    6,051  
  420    
Dollar General Corp.*
    17,039  
  217    
Dollar Tree, Inc.*
    17,683  
  89    
Family Dollar Stores, Inc.
    5,288  
  131    
Home Depot, Inc.
    5,138  
  116    
Netflix, Inc.*
    7,486  
  100    
O’Reilly Automotive, Inc.*
    7,724  
  26    
Priceline.com, Inc.*
    12,633  
  300    
Urban Outfitters, Inc.*
    8,094  
       
 
     
       
Total Retailing
    123,479  
       
 
     
       
 
       
       
Semiconductors & Semiconductor Equipment — 1.0%
       
  100    
Broadcom Corp.-Class A*
    3,034  
  100    
First Solar, Inc.*
    4,786  
  72    
Marvell Technology Group Ltd*
    1,017  
  100    
Skyworks Solutions, Inc.*
    1,631  
  347    
Texas Instruments, Inc.
    10,445  
  100    
Xilinx, Inc.
    3,271  
       
 
     
       
Total Semiconductors & Semiconductor Equipment
    24,184  
       
 
     
       
 
       
       
Software & Services — 18.3%
       
  300    
Accenture Plc.-Class A
    17,379  
  19    
Autodesk, Inc.*
    647  
  220    
Citrix Systems, Inc.*
    15,706  
  200    
Cognizant Technology Solutions Corp.-Class A*
    13,470  
  426    
eBay, Inc.*
    12,605  
  20    
Equinix, Inc.*
    2,000  
  200    
Genpact Ltd.*
    3,114  
  136    
Google, Inc.-Class A*
    81,517  
  519    
International Business Machines Corp.
    97,572  
  41    
MasterCard, Inc.-Class A
    15,357  
  3,811    
Microsoft Corp.
    97,485  
  2,685    
Oracle Corp.
    84,175  
  100    
Teradata Corp.*
    5,423  

 


 

                 
  205    
Visa, Inc.-Class A
    19,879  
       
 
     
       
Total Software & Services
    466,329  
       
 
     
       
 
       
       
Technology Hardware & Equipment — 12.0%
       
  485    
Apple, Inc.*
    185,367  
  61    
Cisco Systems, Inc.
    1,137  
  1,116    
EMC Corp.*
    25,679  
  60    
Hewlett-Packard Co.
    1,677  
  31    
Itron, Inc.*
    1,098  
  300    
NetApp, Inc.*
    11,049  
  1,450    
Qualcomm, Inc.
    79,460  
       
 
     
       
Total Technology Hardware & Equipment
    305,467  
       
 
     
       
 
       
       
Telecommunication Services — 1.3%
       
  126    
American Tower Corp.-Class A*
    7,434  
  283    
Crown Castle International Corp.*
    11,977  
  20    
Level 3 Communications, Inc.*
    412  
  100    
NII Holdings, Inc.*
    2,301  
  300    
Verizon Communications, Inc.
    11,319  
       
 
     
       
Total Telecommunication Services
    33,443  
       
 
     
       
 
       
       
Transportation — 1.0%
       
  400    
Delta Air Lines, Inc.*
    3,248  
  300    
United Continental Holdings, Inc.*
    5,391  
  241    
United Parcel Service, Inc.-Class B
    17,292  
       
 
     
       
Total Transportation
    25,931  
       
 
     
       
 
       
       
TOTAL COMMON STOCKS (COST $2,157,482)
    2,482,741  
       
 
     
       
 
       
       
MUTUAL FUNDS — 3.2%
       
       
 
       
       
Affiliated Issuers — 3.2%
       
  3,279    
GMO U.S. Treasury Fund
    82,023  
       
 
     
       
 
       
       
TOTAL MUTUAL FUNDS (COST $82,023)
    82,023  
       
 
     
 
Shares  
Description
  Value ($)
 
       
SHORT-TERM INVESTMENTS — 0.8%
       
       
 
       
       
Money Market Funds — 0.8%
       
  20,221    
State Street Institutional Treasury Money Market Fund-Institutional Class, 0.00% (a)
    20,221  
       
 
     
       
 
       
       
TOTAL SHORT-TERM INVESTMENTS (COST $20,221)
    20,221  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 101.7%
(Cost $2,259,726)
    2,584,985  
       
 
       
       
Other Assets and Liabilities (net) — (1.7%)
    (43,321 )
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 2,541,664  
       
 
     
 
Notes to Schedule of Investments:
*   Non-income producing security.
 
(a)   Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                           
      Gross     Gross     Net Unrealized  
      Unrealized     Unrealized     Appreciation  
Aggregate Cost   Appreciation     (Depreciation)     (Depreciation)  
$ 2,284,024       $ 371,965         $ (71,004 )       $ 300,961  
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO U.S. Treasury Fund
  $ 100,999     $ 114,000     $ 133,000     $ 32     $ 4     $ 82,023  
                                     

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs.
Level 3 — Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active                    
    Markets for     Significant Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Common Stocks
  $ 2,482,741     $     $     $ 2,482,741  
Mutual Funds
    82,023                   82,023  
Short-Term Investments
    20,221                   20,221  
 
                       
Total Investments
    2,584,985                   2,584,985  
 
                       
Total
  $ 2,584,985     $     $     $ 2,584,985  
 
                       

 


 

All of the Fund’s common stocks held at period end are classified as Level 1. Please refer to the Schedule of Investments for a more detailed categorization of common stocks.
The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. The Fund may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Because the Fund normally does not take temporary defensive positions, declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk and counterparty risk.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Leveraging Risk — The Fund’s use of derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
Focused Investment Risk — Focusing investments in sectors or companies or in industries with high positive correlations to one another creates additional risk.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.

 


 

Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. For example, the Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives, to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives.
The Fund also may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero).
In addition, the Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors and markets without actually having to sell existing investments or make new direct investments. For example, if the Fund holds a large proportion of stocks of companies in a particular sector and the Manager believes that stocks of companies in another sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index).
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net long exposure in excess of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.

 


 

The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded. The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. During the period ended November 30, 2011, the Fund used futures contracts to maintain the diversity and liquidity of the portfolio. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.

 


 

When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves

 


 

counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.

 


 

The volume of derivative activity, based on absolute values (futures contracts), outstanding at each month-end, was as follows for the period ended November 30, 2011:
         
    Futures  
    Contracts  
Average amount outstanding
  $ 15,020  

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO U.S. Intrinsic Value Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares     Description   Value ($)  
 
       
COMMON STOCKS — 97.4%
       
       
 
       
       
Automobiles & Components — 0.1%
       
  100    
Autoliv, Inc.
    5,328  
       
 
     
       
 
       
       
Banks — 0.2%
       
  200    
Prosperity Bancshares, Inc.
    7,998  
  100    
SVB Financial Group*
    4,704  
       
 
     
       
Total Banks
    12,702  
       
 
     
       
 
       
       
Capital Goods — 3.5%
       
  300    
3M Co.
    24,312  
  200    
AGCO Corp.*
    9,149  
  180    
Eaton Corp.
    8,084  
  100    
Exelis, Inc.
    894  
  200    
Fluor Corp.
    10,964  
  200    
General Cable Corp.*
    5,300  
  1,500    
General Electric Co.
    23,865  
  1,300    
General Dynamics Corp.
    85,878  
  50    
ITT Corp.
    1,009  
  200    
KBR, Inc.
    5,780  
  300    
L-3 Communications Holdings, Inc.
    19,890  
  170    
Lockheed Martin Corp.
    13,285  
  400    
Northrop Grumman Corp.
    22,828  
  100    
Parker Hannifin Corp.
    8,278  
  40    
Precision Castparts Corp.
    6,590  
  500    
Raytheon Co.
    22,785  
  100    
Roper Industries, Inc.
    8,519  
  100    
Timken Co. (The)
    4,201  
  100    
United Technologies Corp.
    7,660  
  200    
WESCO International, Inc.*
    10,192  
  100    
Xylem, Inc
    2,390  
       
 
     
       
Total Capital Goods
    301,853  
       
 
     
       
 
       
       
Commercial & Professional Services — 0.2%
       
  200    
Pitney Bowes, Inc.
    3,726  
  800    
RR Donnelley & Sons Co.
    12,016  
       
 
     
       
Total Commercial & Professional Services
    15,742  
       
 
     
       
 
       
       
Consumer Durables & Apparel — 0.4%
       
  100    
Coach, Inc.
    6,259  
  70    
Fossil, Inc.*
    6,271  
  200    
Garmin Ltd
    7,318  
  100    
Nike, Inc.-Class B
    9,618  
  60    
VF Corp.
    8,322  
       
 
     
       
Total Consumer Durables & Apparel
    37,788  
       
 
     
       
 
       
       
Consumer Services — 0.6%
       
  400    
H&R Block, Inc.
    6,292  
  500    
McDonald’s Corp.
    47,760  
       
 
     
       
Total Consumer Services
    54,052  
       
 
     
       
 
       
       
Diversified Financials — 2.6%
       
  3,000    
Bank of America Corp.
    16,320  
  120    
BlackRock, Inc.
    20,645  
  400    
Capital One Financial Corp.
    17,864  
  1,800    
Citigroup, Inc.
    49,464  

 


 

                 
  1,300    
Discover Financial Services
    30,966  
  170    
Goldman Sachs Group (The), Inc.
    16,296  
  300    
Invesco Ltd.
    6,075  
  400    
Leucadia National Corp.
    9,368  
  200    
Moody’s Corp.
    6,942  
  500    
Morgan Stanley
    7,395  
  700    
NASDAQ OMX Group, Inc. (The)*
    18,375  
  800    
SLM Corp.
    10,304  
  200    
Stifel Financial Corp.*
    6,340  
  400    
TD Ameritrade Holding Corp.
    6,516  
       
 
     
       
Total Diversified Financials
    222,870  
       
 
     
       
 
       
       
Energy — 17.1%
       
  500    
Anadarko Petroleum Corp.
    40,635  
  100    
Atwood Oceanics, Inc.*
    4,100  
  700    
Baker Hughes, Inc.
    38,227  
  600    
Chesapeake Energy Corp.
    15,204  
  3,720    
Chevron Corp.
    382,491  
  4,629    
ConocoPhillips
    330,140  
  100    
Devon Energy Corp.
    6,546  
  100    
Diamond Offshore Drilling, Inc.
    6,015  
  400    
El Paso Corp.
    10,004  
  100    
EQT Corp.
    6,201  
  3,600    
Exxon Mobil Corp.
    289,584  
  100    
Helmerich & Payne, Inc.
    5,696  
  280    
Hess Corp.
    16,862  
  2,000    
Marathon Oil Corp.
    55,920  
  200    
Murphy Oil Corp.
    11,184  
  200    
Nabors Industries Ltd.*
    3,588  
  1,200    
National Oilwell Varco, Inc.
    86,040  
  200    
Oceaneering International, Inc.
    9,512  
  100    
Oil States International, Inc.*
    7,525  
  400    
Patterson-UTI Energy, Inc.
    8,408  
  200    
Peabody Energy Corp.
    7,846  
  200    
Plains Exploration & Production Co.*
    7,116  
  200    
Rowan Cos, Inc.*
    6,782  
  80    
Schlumberger Ltd.
    6,026  
  100    
SM Energy Co.
    7,949  
  500    
Sunoco, Inc.
    19,405  
  100    
Tidewater, Inc.
    5,040  
  1,500    
Valero Energy Corp.
    33,405  
  300    
Weatherford International Ltd.*
    4,548  
  800    
Williams Cos., Inc.
    25,824  
  200    
World Fuel Services Corp.
    8,574  
       
 
     
       
Total Energy
    1,466,397  
       
 
     
       
 
       
       
Food & Staples Retailing — 5.1%
       
  1,500    
CVS Caremark Corp.
    58,260  
  1,500    
Kroger Co. (The)
    34,770  
  500    
Safeway, Inc.
    10,000  
  3,000    
Walgreen Co.
    101,160  
  3,900    
Wal—Mart Stores, Inc.
    229,710  
       
 
     
       
Total Food & Staples Retailing
    433,900  
       
 
     
       
 
       
       
Food, Beverage & Tobacco — 5.4%
       
  1,300    
Altria Group, Inc.
    37,297  
  200    
Archer-Daniels-Midland Co.
    6,024  
  100    
Bunge Ltd.
    6,250  
  2,600    
Coca-Cola Co. (The)
    174,798  

 


 

                 
  600    
Dean Foods Co.*
    6,096  
  200    
General Mills, Inc.
    7,990  
  200    
Hansen Natural Corp.*
    18,440  
  207    
Kraft Foods, Inc.-Class A
    7,483  
  140    
Lorillard, Inc.
    15,627  
  1,097    
PepsiCo, Inc.
    70,208  
  1,400    
Philip Morris International, Inc.
    106,736  
  224    
Tyson Foods, Inc.-Class A
    4,511  
       
 
     
       
Total Food, Beverage & Tobacco
    461,460  
       
 
     
       
 
       
       
Health Care Equipment & Services — 11.7%
       
  1,500    
Aetna, Inc.
    62,730  
  100    
AMERIGROUP Corp.*
    5,717  
  600    
AmerisourceBergen Corp.
    22,290  
  100    
Baxter International, Inc.
    5,166  
  2,000    
Boston Scientific Corp.*
    11,800  
  1,400    
Cardinal Health, Inc.
    59,444  
  600    
Cigna Corp.
    26,538  
  100    
Cooper Cos, Inc. (The)
    6,126  
  600    
Coventry Health Care, Inc.*
    19,164  
  100    
Covidien Plc
    4,555  
  280    
Express Scripts, Inc.*
    12,782  
  400    
Health Net, Inc.*
    12,456  
  1,000    
Humana, Inc.
    88,680  
  800    
McKesson Corp.
    65,048  
  2,200    
Medtronic, Inc.
    80,146  
  100    
Omnicare, Inc.
    3,261  
  200    
Quest Diagnostics, Inc.
    11,732  
  200    
Stryker Corp.
    9,766  
  6,467    
UnitedHealth Group, Inc.
    315,396  
  1,900    
WellPoint, Inc.
    134,045  
  800    
Zimmer Holdings, Inc.*
    40,440  
       
 
     
       
Total Health Care Equipment & Services
    997,282  
       
 
     
       
 
       
       
Household & Personal Products — 1.4%
       
  300    
Colgate—Palmolive Co.
    27,450  
  100    
Energizer Holdings, Inc.*
    7,228  
  100    
Herbalife Ltd.
    5,530  
  1,200    
Procter & Gamble Co. (The)
    77,484  
       
 
     
       
Total Household & Personal Products
    117,692  
       
 
     
       
 
       
       
Insurance — 7.8%
       
  800    
ACE Ltd.
    55,624  
  1,000    
AFLAC Inc.
    43,440  
  100    
Allied World Assurance Co Holdings Ltd.
    5,949  
  1,400    
Allstate Corp. (The)
    37,506  
  400    
American Financial Group, Inc.
    14,400  
  1,500    
American International Group, Inc.*
    34,965  
  600    
Arch Capital Group Ltd.*
    22,662  
  200    
Aspen Insurance Holdings Ltd.
    5,304  
  400    
Assurant, Inc.
    15,696  
  400    
Axis Capital Holdings Ltd.
    12,772  
  762    
Berkshire Hathaway Inc.-Class B*
    60,015  
  300    
Brown & Brown, Inc.
    6,258  
  700    
Chubb Corp.
    47,208  
  900    
CNO Financial Group, Inc.*
    5,688  
  200    
Endurance Specialty Holdings Ltd.
    7,234  
  100    
Everest Re Group Ltd.
    8,773  
  800    
Hartford Financial Services Group, Inc. (The)
    14,208  

 


 

                 
  400    
HCC Insurance Holdings, Inc.
    10,752  
  500    
Lincoln National Corp.
    10,090  
  100    
PartnerRe Ltd.
    6,572  
  400    
Principal Financial Group, Inc.
    9,652  
  1,000    
Progressive Corp. (The)
    18,860  
  300    
Protective Life Corp.
    6,657  
  100    
Prudential Financial, Inc.
    5,064  
  200    
Reinsurance Group of America, Inc.
    10,300  
  200    
RenaissanceRe Holdings Ltd.
    14,688  
  200    
StanCorp Financial Group, Inc.
    7,052  
  450    
Torchmark Corp.
    19,166  
  100    
Transatlantic Holdings, Inc.
    5,464  
  1,900    
Travelers Cos. (The), Inc.
    106,875  
  600    
Unum Group
    13,506  
  300    
W.R. Berkley Corp.
    10,233  
  900    
XL Group Plc
    18,558  
       
 
     
       
Total Insurance
    671,191  
       
 
     
       
 
       
       
Materials — 0.6%
       
  1,200    
Alcoa, Inc.
    12,024  
  300    
Dow Chemical Co. (The)
    8,313  
  600    
Du Pont (E.I.) de Nemours & Co.
    28,632  
  200    
MeadWestvaco Corp.
    5,970  
       
 
     
       
Total Materials
    54,939  
       
 
     
       
 
       
       
Media — 0.4%
       
  1,000    
CBS Corp.-Class B (Non Voting)
    26,040  
  400    
News Corp.-Class A
    6,976  
  100    
Viacom, Inc.-Class B
    4,476  
       
 
     
       
Total Media
    37,492  
       
 
     
       
 
       
       
Pharmaceuticals, Biotechnology & Life Sciences — 15.1%
       
  2,000    
Abbott Laboratories
    109,100  
  2,300    
Amgen, Inc.
    133,193  
  1,100    
Biogen Idec, Inc.*
    126,445  
  400    
Bristol—Myers Squibb Co.
    13,088  
  4,900    
Eli Lilly & Co.
    185,465  
  500    
Endo Pharmaceuticals Holdings, Inc.*
    17,115  
  1,500    
Forest Laboratories, Inc.*
    44,940  
  900    
Gilead Sciences, Inc.*
    35,865  
  2,500    
Johnson & Johnson
    161,800  
  1,600    
Merck & Co., Inc.
    57,200  
  100    
Mylan, Inc.*
    1,953  
  19,976    
Pfizer, Inc.
    400,918  
  100    
Thermo Fisher Scientific, Inc.*
    4,725  
       
 
     
       
Total Pharmaceuticals, Biotechnology & Life Sciences
    1,291,807  
       
 
     
       
 
       
       
Real Estate — 0.3%
       
  800    
Annaly Capital Management, Inc. REIT
    12,856  
  300    
ProLogis, Inc. REIT
    8,346  
       
 
     
       
Total Real Estate
    21,202  
       
 
     
       
 
       
       
Retailing — 1.5%
       
  100    
Abercrombie & Fitch Co.-Class A
    4,791  
  100    
Advance Auto Parts, Inc.
    6,922  
  450    
Aeropostale, Inc.*
    6,980  
  200    
AutoNation, Inc.*
    7,222  
  30    
AutoZone, Inc.*
    9,851  

 


 

                 
  200    
Best Buy Co., Inc.
    5,418  
  200    
Dollar Tree, Inc.*
    16,298  
  100    
Family Dollar Stores, Inc.
    5,942  
  400    
Foot Locker, Inc.
    9,436  
  300    
GameStop Corp.-Class A*
    6,936  
  100    
Genuine Parts Co.
    5,850  
  100    
Guess?, Inc.
    2,812  
  200    
J.C. Penney Co., Inc.
    6,408  
  500    
Lowe’s Cos., Inc.
    12,005  
  100    
O’Reilly Automotive, Inc.*
    7,724  
  200    
Rent-A-Center, Inc.
    7,190  
  100    
Target Corp.
    5,270  
       
 
     
       
Total Retailing
    127,055  
       
 
     
       
 
       
       
Semiconductors & Semiconductor Equipment — 0.5%
       
  600    
Applied Materials, Inc.
    6,468  
  200    
KLA-Tencor Corp.
    9,220  
  900    
LSI Corp.*
    5,058  
  600    
Texas Instruments, Inc.
    18,060  
       
 
     
       
Total Semiconductors & Semiconductor Equipment
    38,806  
       
 
     
       
 
       
       
Software & Services — 10.6%
       
  200    
Cognizant Technology Solutions Corp.-Class A*
    13,470  
  2,700    
eBay, Inc.*
    79,893  
  100    
Fiserv, Inc.*
    5,766  
  350    
Google, Inc.-Class A*
    209,786  
  330    
International Business Machines Corp.
    62,040  
  9,100    
Microsoft Corp.
    232,778  
  8,400    
Oracle Corp.
    263,340  
  1,700    
Symantec Corp.*
    27,795  
  100    
Visa, Inc.-Class A
    9,697  
       
 
     
       
Total Software & Services
    904,565  
       
 
     
       
 
       
       
Technology Hardware & Equipment — 7.0%
       
  620    
Apple, Inc.*
    236,964  
  200    
Arrow Electronics, Inc.*
    7,312  
  3,200    
Cisco Systems, Inc.
    59,648  
  700    
Dell, Inc.*
    11,032  
  4,100    
Hewlett-Packard Co.
    114,595  
  700    
Ingram Micro, Inc.-Class A*
    12,607  
  200    
Juniper Networks, Inc.*
    4,542  
  400    
Lexmark International, Inc.
    13,384  
  200    
Motorola Solutions, Inc.
    9,334  
  1,700    
Qualcomm, Inc.
    93,160  
  200    
Tech Data Corp.*
    9,846  
  1,000    
Western Digital Corp.*
    29,070  
       
 
     
       
Total Technology Hardware & Equipment
    601,494  
       
 
     
       
 
       
       
Telecommunication Services — 4.4%
       
  7,658    
AT&T, Inc.
    221,929  
  200    
Centurylink, Inc.
    7,504  
  200    
MetroPCS Communications, Inc.*
    1,676  
  3,952    
Verizon Communications, Inc.
    149,109  
       
 
     
       
Total Telecommunication Services
    380,218  
       
 
     
       
 
       
       
Transportation — 0.6%
       
  300    
CSX Corp.
    6,513  
  100    
Norfolk Southern Corp.
    7,554  

 


 

                 
  350    
Union Pacific Corp.
    36,193  
       
 
     
       
Total Transportation
    50,260  
       
 
     
       
 
       
       
Utilities — 0.3%
       
  300    
Aqua America, Inc.
    6,570  
  500    
Exelon Corp.
    22,155  
       
 
     
       
Total Utilities
    28,725  
       
 
     
       
 
       
       
TOTAL COMMON STOCKS (COST $7,431,353)
    8,334,820  
       
 
     
       
 
       
       
MUTUAL FUNDS — 2.5%
       
       
 
       
       
Affiliated Issuers — 2.5%
       
  8,479    
GMO U.S. Treasury Fund
    212,069  
       
 
     
       
 
       
       
TOTAL MUTUAL FUNDS (COST $212,001)
    212,069  
       
 
     
       
 
       
       
RIGHTS/WARRANTS — 0.0%
       
       
 
       
       
Insurance — 0.0%
       
  160    
American International Group, Inc., Warrants, Strike 45.00 *
    979  
       
 
       
       
Pharmaceuticals, Biotechnology & Life Sciences — 0.0%
       
  400    
Sanofi Aventis, Rights, Expires 12/31/20 *
    520  
       
 
     
       
 
       
       
TOTAL RIGHTS/WARRANTS (COST $3,659)
    1,499  
       
 
     
       
 
       
       
SHORT-TERM INVESTMENTS — 0.4%
       
       
 
       
       
Money Market Funds — 0.4%
       
  38,962    
State Street Institutional Treasury Money Market Fund-Institutional Class, 0.00% (a)
    38,962  
       
 
     
       
 
       
       
TOTAL SHORT-TERM INVESTMENTS (COST $38,962)
    38,962  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 100.3%
(Cost $7,685,975)
    8,587,350  
       
 
       
       
Other Assets and Liabilities (net) — (0.3%)
    (29,746 )
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 8,557,604  
       
 
     
 
Notes to Schedule of Investments:
REIT — Real Estate Investment Trust
 
*   Non-income producing security.
 
(a)   Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                         
      Gross   Gross     Net Unrealized  
      Unrealized   Unrealized     Appreciation  
Aggregate Cost   Appreciation   (Depreciation)     (Depreciation)  
$ 7,955,773   $ 961,886   $ (330,309 )   $ 631,577  
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO U.S. Treasury Fund
  $ 205,992     $ 119,000     $ 113,000     $ 69     $ 8     $ 212,069  
 
                                   

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs.
Level 3 — Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Common Stocks
  $ 8,334,820     $     $     $ 8,334,820  
Mutual Funds
    212,069                   212,069  
Rights/Warrants
          1,499             1,499  
Short-Term Investments
    38,962                   38,962  
 
                       
Total Investments
    8,585,851       1,499             8,587,350  
 
                       
Total
  $ 8,585,851     $ 1,499     $     $ 8,587,350  
 
                       

 


 

All of the Fund’s common stocks held at period end are classified as Level 1. Please refer to the Schedule of Investments for a more detailed categorization of common stocks.
The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If the Fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of value of those investments. The Fund also may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Because the Fund normally does not take temporary defensive positions, declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk and counterparty risk.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Leveraging Risk — The Fund’s use of derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
Focused Investment Risk — Focusing investments in sectors or companies or in industries with high positive correlations to one another creates additional risk.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.

 


 

Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. For example, the Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives, to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives.
The Fund also may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero).
In addition, the Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors and markets without actually having to sell existing investments or make new direct investments. For example, if the Fund holds a large proportion of stocks of companies in a particular sector and the Manager believes that stocks of companies in another sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index).
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net long exposure in excess of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the

 


 

Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded. The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.

 


 

Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is

 


 

insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. During the period ended November 30, 2011, the Fund used total return swap agreements to achieve returns comparable to holding and lending a direct equity position. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. During the period ended November 30, 2011, the Fund held rights and/or warrants received as a result of corporate actions. Rights and/or warrants held by the Fund at the end of the period are listed in the Fund’s Schedule of Investments.

 


 

The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Assets:
                                               
Investments, at value (rights and/or warrants)
  $     $     $     $ 1,499     $     $ 1,499  
 
                                   
Total
  $     $     $     $ 1,499     $     $ 1,499  
 
                                   
The volume of derivative activity, based on absolute values (rights and/or warrants) or notional amounts (swap agreements) outstanding at each month-end, was as follows for the period ended November 30, 2011:
                 
    Swap         Rights and/or  
    Agreements     Warrants  
Average amount outstanding
  $ 3,420     $ 1,919  

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO U.S. Small/Mid Cap Growth Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares     Description   Value ($)  
 
       
COMMON STOCKS — 99.5%
       
       
 
       
       
Automobiles & Components — 1.2%
       
  500    
Dorman Products, Inc.*
    19,340  
  300    
Exide Technologies*
    828  
  2,500    
Goodyear Tire & Rubber Co. (The)*
    34,975  
       
 
     
       
Total Automobiles & Components
    55,143  
       
 
     
       
 
       
       
Banks — 0.1%
       
  100    
Signature Bank/New York NY*
    5,843  
       
 
     
       
 
       
       
Capital Goods — 9.4%
       
  200    
Applied Industrial Technologies, Inc.
    6,906  
  100    
Armstrong World Industries, Inc.
    3,969  
  440    
Astronics Corp.*
    15,691  
  300    
Blount International, Inc.*
    4,593  
  200    
CAI International, Inc.*
    3,068  
  800    
Chicago Bridge & Iron Co NV (NY Shares)
    33,080  
  600    
Colfax Corp.*
    17,586  
  400    
DXP Enterprises, Inc.*
    12,100  
  800    
Gardner Denver, Inc.
    68,576  
  100    
General Cable Corp.*
    2,650  
  700    
Graco, Inc.
    30,093  
  100    
KBR, Inc.
    2,890  
  100    
Kennametal, Inc.
    3,811  
  400    
Lincoln Electric Holdings, Inc.
    15,792  
  800    
Manitowoc Co. (The), Inc.
    8,856  
  300    
Middleby Corp.*
    27,384  
  100    
MSC Industrial Direct Co., Inc.-Class A
    6,953  
  100    
Nordson Corp.
    4,706  
  1,200    
Polypore International, Inc.*
    58,860  
  200    
Primoris Services Corp.
    2,844  
  100    
Raven Industries, Inc.
    6,024  
  900    
Sauer-Danfoss, Inc.*
    33,831  
  100    
Thomas & Betts Corp.*
    5,201  
  200    
Titan International, Inc.
    4,308  
  100    
Titan Machinery, Inc.*
    2,170  
  1,000    
Trimas Corp.*
    20,410  
  300    
WABCO Holdings, Inc.*
    14,103  
  200    
Wabtec Corp.
    13,650  
       
 
     
       
Total Capital Goods
    430,105  
       
 
     
       
 
       
       
Commercial & Professional Services — 3.2%
       
  200    
Acacia Research — Acacia Technologies*
    6,964  
  300    
Brink’s Co. (The)
    7,386  
  100    
CBIZ, Inc.*
    602  
  400    
Clean Harbors, Inc.*
    23,988  
  100    
CompX International, Inc.
    1,552  
  1,200    
Copart, Inc.*
    53,916  
  500    
Deluxe Corp.
    11,430  
  100    
Huron Consulting Group, Inc.*
    3,472  
  300    
Insperity, Inc.
    7,437  
  100    
KAR Auction Services, Inc.*
    1,314  
  400    
Knoll, Inc.
    6,064  
  300    
Rollins, Inc.
    6,660  
  100    
Steelcase, Inc.-Class A
    784  

 


 

                 
  500    
Waste Connections, Inc.
    16,385  
       
 
     
       
Total Commercial & Professional Services
    147,954  
       
 
     
       
 
       
       
Consumer Durables & Apparel — 7.4%
       
  200    
CROCS, Inc.*
    3,102  
  1,500    
Fossil, Inc.*
    134,385  
  300    
Oxford Industries, Inc.
    11,379  
  800    
Polaris Industries, Inc.
    48,080  
  300    
Steven Madden Ltd.*
    10,698  
  1,500    
Tempur-Pedic International, Inc.*
    81,915  
  200    
True Religion Apparel, Inc.*
    7,040  
  700    
Tupperware Brands Corp.
    40,782  
       
 
     
       
Total Consumer Durables & Apparel
    337,381  
       
 
     
       
 
       
       
Consumer Services — 3.1%
       
  100    
AFC Enterprises, Inc.*
    1,570  
  100    
Ameristar Casinos, Inc.
    1,750  
  100    
BJ’s Restaurants, Inc.*
    4,808  
  400    
Brinker International, Inc.
    9,632  
  100    
DineEquity, Inc.*
    4,708  
  700    
Domino’s Pizza, Inc.*
    23,058  
  600    
Krispy Kreme Doughnuts, Inc.*
    4,512  
  200    
Papa John’s International, Inc.*
    7,580  
  1,400    
Weight Watchers International, Inc.
    82,278  
       
 
     
       
Total Consumer Services
    139,896  
       
 
     
       
 
       
       
Diversified Financials — 3.7%
       
  200    
Advance America Cash Advance Centers, Inc.
    1,704  
  1,100    
BGC Partners, Inc.-Class A
    6,952  
  200    
Cash America International, Inc.
    9,942  
  200    
Credit Acceptance Corp.*
    16,402  
  1,000    
DFC Global Corp.*
    18,150  
  600    
EZCORP, Inc.-Class A*
    17,454  
  400    
Financial Engines, Inc.*
    8,788  
  900    
First Cash Financial Services, Inc.*
    32,670  
  104    
Kohlberg Capital Corp.
    656  
  200    
Virtus Investment Partners, Inc.*
    15,178  
  700    
Waddell and Reed Financial, Inc.
    19,026  
  300    
World Acceptance Corp.*
    20,586  
       
 
     
       
Total Diversified Financials
    167,508  
       
 
     
       
 
       
       
Energy — 11.5%
       
  200    
Apco Oil and Gas International, Inc.
    15,890  
  100    
Atwood Oceanics, Inc.*
    4,100  
  400    
Basic Energy Services, Inc.*
    7,536  
  900    
Cabot Oil & Gas Corp.
    79,731  
  500    
Callon Petroleum Co.*
    2,685  
  100    
CARBO Ceramics, Inc.
    14,232  
  400    
Clayton Williams Energy, Inc.*
    29,584  
  1,100    
CVR Energy, Inc.*
    20,020  
  1,700    
Golar LNG Ltd.
    74,120  
  300    
Gulfport Energy Corp.*
    9,525  
  4,300    
HollyFrontier Corp.
    99,975  
  1,000    
ION Geophysical Corp.*
    5,810  
  300    
Lufkin Industries, Inc.
    21,024  
  100    
Oil States International, Inc.*
    7,525  
  950    
RPC, Inc.
    18,544  
  2,100    
SandRidge Energy, Inc.*
    15,435  
  300    
SM Energy Co.
    23,847  

 


 

                 
  1,400    
Stone Energy Corp.*
    39,606  
  200    
Superior Energy Services, Inc.*
    5,942  
  700    
W&T Offshore, Inc.
    14,014  
  900    
Western Refining, Inc.*
    10,701  
  100    
World Fuel Services Corp.
    4,287  
       
 
     
       
Total Energy
    524,133  
       
 
     
       
 
       
       
Food & Staples Retailing — 0.9%
       
  600    
PriceSmart, Inc.
    40,710  
       
 
     
       
 
       
       
Food, Beverage & Tobacco — 4.4%
       
  200    
B&G Foods, Inc.
    4,438  
  100    
Boston Beer Co., Inc.-Class A*
    9,991  
  1,800    
Darling International, Inc.*
    25,866  
  1,200    
Flowers Foods, Inc.
    23,724  
  1,500    
Hansen Natural Corp.*
    138,300  
       
 
     
       
Total Food, Beverage & Tobacco
    202,319  
       
 
     
       
 
       
       
Health Care Equipment & Services — 9.6%
       
  500    
Accretive Health, Inc.*
    11,540  
  100    
Air Methods Corp.*
    8,072  
  900    
AMERIGROUP Corp.*
    51,453  
  100    
athenahealth, Inc.*
    5,940  
  100    
Centene Corp.*
    3,871  
  200    
Chemed Corp.
    10,732  
  500    
Cooper Cos, Inc. (The)
    30,630  
  400    
CorVel Corp.*
    19,084  
  300    
Ensign Group, Inc. (The)
    7,113  
  900    
Gen-Probe, Inc.*
    56,691  
  100    
Haemonetics Corp.*
    5,923  
  1,500    
Health Management Associates, Inc.-Class A*
    12,330  
  300    
Healthspring, Inc.*
    16,386  
  200    
Hill-Rom Holdings, Inc.
    6,320  
  300    
HMS Holdings Corp.*
    9,099  
  200    
IPC The Hospitalist Co., Inc.*
    9,220  
  500    
MAKO Surgical Corp.*
    14,400  
  200    
Medidata Solutions, Inc.*
    4,036  
  300    
Mednax, Inc.*
    20,220  
  200    
National Research Corp.
    6,726  
  400    
Neogen Corp.*
    14,092  
  100    
Orthofix International NV*
    3,427  
  100    
Providence Service Corp. (The)*
    1,171  
  900    
PSS World Medical, Inc.*
    21,942  
  600    
Quality Systems, Inc.
    21,210  
  200    
Sirona Dental Systems, Inc.*
    8,888  
  1,400    
Sunrise Senior Living, Inc.*
    7,042  
  100    
SXC Health Solutions Corp*
    5,882  
  100    
Team Health Holdings, Inc.*
    2,196  
  600    
WellCare Health Plans, Inc.*
    35,070  
  100    
West Pharmaceutical Services, Inc.
    3,853  
  100    
Zoll Medical Corp.*
    4,603  
       
 
     
       
Total Health Care Equipment & Services
    439,162  
       
 
     
       
 
       
       
Household & Personal Products — 2.6%
       
  2,100    
Herbalife Ltd.
    116,130  
  64    
USANA Health Sciences, Inc.*
    2,185  
       
 
     
       
Total Household & Personal Products
    118,315  
       
 
     

 


 

                 
       
Insurance — 1.5%
       
  100    
AmTrust Financial Services, Inc.
    2,651  
  913    
Erie Indemnity Co.-Class A
    67,370  
       
 
     
       
Total Insurance
    70,021  
       
 
     
       
 
       
       
Materials — 6.5%
       
  400    
Albemarle Corp.
    21,812  
  100    
Balchem Corp.-Class B
    4,150  
  200    
Carpenter Technology Corp.
    10,828  
  1,200    
Crown Holdings, Inc.*
    38,772  
  400    
Flotek Industries, Inc.*
    3,644  
  1,200    
Globe Specialty Metals, Inc.
    17,916  
  300    
Hawkins, Inc.
    11,853  
  300    
International Flavors & Fragrances, Inc.
    16,278  
  300    
Koppers Holdings, Inc.
    9,909  
  400    
Kraton Performance Polymers, Inc.*
    8,408  
  500    
LSB Industries, Inc.*
    15,635  
  200    
NewMarket Corp.
    39,578  
  300    
Noranda Aluminum Holding Corp.
    2,466  
  900    
Omnova Solutions, Inc.*
    3,915  
  600    
PolyOne Corp.
    6,456  
  900    
Rockwood Holdings, Inc.*
    40,104  
  100    
Schnitzer Steel Industries, Inc.-Class A
    4,639  
  200    
Silgan Holdings, Inc.
    7,788  
  300    
Temple-Inland, Inc.
    9,549  
  3,200    
US Gold Corp.*
    13,280  
  200    
W.R. Grace & Co.*
    8,334  
  100    
Worthington Industries, Inc.
    1,759  
       
 
     
       
Total Materials
    297,073  
       
 
     
       
 
       
       
Media — 0.1%
       
  100    
Arbitron, Inc.
    3,761  
       
 
     
       
 
       
       
Pharmaceuticals, Biotechnology & Life Sciences — 6.9%
       
  2,800    
Akorn, Inc.*
    30,128  
  1,600    
ARIAD Pharmaceuticals, Inc.*
    19,344  
  700    
Bruker Corp.*
    8,764  
  300    
Cepheid, Inc.*
    10,290  
  900    
Charles River Laboratories International, Inc.*
    25,515  
  100    
Covance, Inc.*
    4,591  
  300    
Cubist Pharmaceuticals, Inc.*
    11,571  
  1,000    
Depomed, Inc.*
    4,870  
  300    
Exelixis, Inc.*
    1,383  
  300    
Impax Laboratories, Inc.*
    6,042  
  1,400    
Jazz Pharmaceuticals, Inc.*
    55,468  
  100    
Medicines Co.*
    1,891  
  800    
Medicis Pharmaceutical Corp.-Class A
    26,120  
  60    
Mettler-Toledo International, Inc.*
    9,588  
  600    
PDL BioPharma, Inc.
    3,840  
  300    
Pharmaceutical Product Development, Inc.
    9,963  
  300    
Pharmasset, Inc.*
    39,297  
  600    
Questcor Pharmaceuticals, Inc.*
    26,970  
  100    
Regeneron Pharmaceuticals, Inc.*
    5,942  
  200    
Spectrum Pharmaceuticals, Inc.*
    2,770  
  200    
Techne Corp.
    13,498  
       
 
     
       
Total Pharmaceuticals, Biotechnology & Life Sciences
    317,845  
       
 
     

 


 

                 
       
Real Estate — 0.1%
       
  100    
Anworth Mortgage Asset Corp. REIT
    633  
  100    
Getty Realty Corp. REIT
    1,600  
  100    
Rayonier, Inc. REIT
    4,064  
       
 
     
       
Total Real Estate
    6,297  
       
 
     
       
 
       
       
Retailing — 7.1%
       
  100    
Aaron’s, Inc.
    2,628  
  500    
Abercrombie & Fitch Co.-Class A
    23,955  
  200    
ANN, Inc.*
    4,692  
  100    
Cato Corp. (The)-Class A
    2,559  
  1,300    
Chico’s FAS, Inc.
    13,520  
  100    
Destination Maternity Corp.
    1,465  
  200    
Express, Inc.
    4,538  
  100    
Finish Line (The), Inc.-Class A
    2,108  
  200    
Hibbett Sports, Inc.*
    9,102  
  150    
Jos. A. Bank Clothiers, Inc.*
    7,392  
  2,200    
Sally Beauty Holdings, Inc.*
    44,220  
  400    
Select Comfort Corp.*
    7,412  
  1,600    
Tractor Supply Co.
    115,568  
  1,200    
Ulta Salon Cosmetics & Fragrance, Inc.*
    83,556  
       
 
     
       
Total Retailing
    322,715  
       
 
     
       
 
       
       
Semiconductors & Semiconductor Equipment — 1.1%
       
  500    
AXT, Inc.*
    2,105  
  300    
Cypress Semiconductor Corp.*
    5,721  
  300    
Entegris, Inc.*
    2,529  
  800    
GT Advanced Technologies, Inc.*
    6,176  
  400    
IXYS Corp.*
    4,616  
  500    
LSI Corp.*
    2,810  
  200    
Micrel, Inc.
    2,080  
  100    
NVE Corp.*
    5,858  
  900    
ON Semiconductor Corp.*
    6,777  
  2,100    
Silicon Image, Inc.*
    10,311  
       
 
     
       
Total Semiconductors & Semiconductor Equipment
    48,983  
       
 
     
       
 
       
       
Software & Services — 12.0%
       
  300    
ACI Worldwide, Inc.*
    9,024  
  1,300    
Alliance Data Systems Corp.*
    133,133  
  200    
Ancestry.com, Inc.*
    4,742  
  100    
Ariba, Inc.*
    3,035  
  100    
Broadridge Financial Solutions, Inc.
    2,257  
  100    
Compuware Corp.*
    826  
  300    
DST Systems, Inc.
    14,259  
  100    
Echo Global Logistics, Inc.*
    1,572  
  100    
Factset Research Systems, Inc.
    9,323  
  1,900    
Fortinet, Inc.*
    45,581  
  400    
Genpact Ltd.*
    6,228  
  900    
Global Payments, Inc.
    39,807  
  200    
Heartland Payment Systems, Inc.
    4,510  
  900    
Informatica Corp.*
    40,460  
  300    
Liquidity Services, Inc.*
    10,218  
  300    
LivePerson, Inc.*
    3,774  
  500    
LoopNet, Inc.*
    9,025  
  1,100    
Magma Design Automation, Inc.*
    6,292  
  500    
MAXIMUS, Inc.
    20,800  
  300    
Micros Systems, Inc.*
    14,151  
  900    
NIC, Inc.
    11,700  

 


 

                 
  400    
Opnet Technologies, Inc.
    14,268  
  700    
Rackspace Hosting, Inc.*
    30,366  
  100    
S1 Corp.*
    974  
  100    
Solera Holdings, Inc.
    4,732  
  500    
Syntel, Inc.
    23,920  
  300    
TeleNav, Inc.*
    2,466  
  600    
TeleTech Holdings, Inc.*
    10,566  
  2,100    
TIBCO Software, Inc.*
    57,540  
  100    
Tyler Technologies, Inc.*
    3,205  
  200    
Valueclick, Inc.*
    3,092  
  200    
Virtusa Corp.*
    3,148  
  100    
VistaPrint NV*
    3,271  
       
 
     
       
Total Software & Services
    548,265  
       
 
     
       
 
       
       
Technology Hardware & Equipment — 4.4%
       
  400    
Anixter International, Inc.*
    24,564  
  300    
Arrow Electronics, Inc.*
    10,968  
  100    
Cognex Corp.
    3,567  
  300    
DDi Corp.
    2,703  
  100    
Faro Technologies, Inc.*
    4,845  
  200    
FEI Co.*
    8,072  
  500    
Finisar Corp.*
    9,220  
  200    
InterDigital, Inc.
    8,792  
  600    
IPG Photonics Corp.*
    22,998  
  200    
National Instruments Corp.
    5,260  
  1,900    
NCR Corp.*
    33,231  
  100    
Newport Corp.*
    1,303  
  100    
Oplink Communications, Inc.*
    1,651  
  2,000    
Polycom, Inc.*
    33,800  
  100    
Rofin-Sinar Technologies, Inc.*
    2,406  
  64    
Vishay Precision Group, Inc.*
    912  
  700    
Zebra Technologies Corp.*
    26,502  
       
 
     
       
Total Technology Hardware & Equipment
    200,794  
       
 
     
       
 
       
       
Telecommunication Services — 0.6%
       
  600    
Cogent Communications Group, Inc.*
    10,206  
  1,800    
MetroPCS Communications, Inc.*
    15,084  
  100    
Neutral Tandem, Inc.*
    1,081  
       
 
     
       
Total Telecommunication Services
    26,371  
       
 
     
       
 
       
       
Transportation — 2.1%
       
  700    
Avis Budget Group, Inc.*
    8,260  
  400    
Copa Holdings SA
    25,824  
  500    
Landstar System, Inc.
    23,135  
  800    
Old Dominion Freight Line, Inc.*
    31,048  
  100    
Park-Ohio Holdings Corp.*
    1,940  
  300    
UTi Worldwide, Inc.
    4,668  
       
 
     
       
Total Transportation
    94,875  
       
 
     
       
 
       
       
TOTAL COMMON STOCKS (COST $4,284,479)
    4,545,469  
       
 
     
       
 
       
       
MUTUAL FUNDS — 1.4%
       
       
 
       
       
Affiliated Issuers — 1.4%
       
  2,561    
GMO U.S. Treasury Fund
    64,034  
       
 
     
       
 
       
       
TOTAL MUTUAL FUNDS (COST $64,034)
    64,034  
       
 
     

 


 

                 
Shares     Description   Value ($)  
 
       
SHORT-TERM INVESTMENTS — 0.2%
       
       
 
       
       
Money Market Funds — 0.2%
       
  7,259    
State Street Institutional Treasury Money Market Fund-Institutional Class, 0.00% (a)
    7,259  
       
 
     
       
 
       
       
TOTAL SHORT-TERM INVESTMENTS (COST $7,259)
    7,259  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 101.1%
(Cost $4,355,772)
    4,616,762  
       
 
       
       
Other Assets and Liabilities (net) — (1.1%)
    (48,625 )
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 4,568,137  
       
 
     

 


 

 
Notes to Schedule of Investments:
 
REIT —   Real Estate Investment Trust
 
* Non-income producing security.
 
(a)   Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                           
      Gross     Gross     Net Unrealized  
      Unrealized     Unrealized     Appreciation  
Aggregate Cost   Appreciation     (Depreciation)     (Depreciation)  
$ 4,359,204   $ 586,747     $ (329,189 )   $ 257,558  
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO U.S. Treasury Fund
  $ 101,000     $ 399,000     $ 435,962     $ 24     $     $ 64,034  
 
                                   

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs.
Level 3 — Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Common Stocks
  $ 4,545,469     $     $     $ 4,545,469  
Mutual Funds
    64,034                   64,034  
Short-Term Investments
    7,259                   7,259  
 
                       
Total Investments
    4,616,762                   4,616,762  
 
                       
Total
  $ 4,616,762     $     $     $ 4,616,762  
 
                       

 


 

All of the Fund’s common stocks held at period end are classified as Level 1. Please refer to the Schedule of Investments for a more detailed categorization of common stocks.
The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. The Fund may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Because the Fund normally does not take temporary defensive positions, declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Liquidity Risk — Shares of small- and mid-cap companies often have lower trading volumes and a limited number or no market makers. Thus, a large position may limit or prevent the Fund from selling those shares or unwinding derivative positions on them at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk and counterparty risk.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Leveraging Risk — The Fund’s use of derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Focused Investment Risk — Focusing investments in sectors or companies or in industries with high positive correlations to one another creates additional risk.

 


 

Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. For example, the Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives, to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives.
The Fund also may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero).
In addition, the Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors and markets without actually having to sell existing investments or make new direct investments. For example, if the Fund holds a large proportion of stocks of companies in a particular sector and the Manager believes that stocks of companies in another sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index).
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net long exposure in excess of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.

 


 

The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded. The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.

 


 

When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves

 


 

counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.
Subsequent events
The Board of Trustees of GMO Trust has approved the liquidation of the Fund. It is expected that the Fund will be liquidated on or about January 31, 2012.
For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO U.S. Small/Mid Cap Value Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares     Description   Value ($)  
 
       
COMMON STOCKS — 97.3%
       
       
 
       
       
Automobiles & Components — 0.2%
       
  400    
Standard Motor Products, Inc.
    7,812  
       
 
     
       
 
       
       
Banks — 0.4%
       
  200    
Federal Agricultural Mortgage Corp.-Class C
    3,398  
  500    
MainSource Financial Group, Inc.
    4,140  
  300    
Prosperity Bancshares, Inc.
    11,997  
       
 
     
       
Total Banks
    19,535  
       
 
     
       
 
       
       
Capital Goods — 4.4%
       
  900    
Aircastle Ltd.
    10,458  
  200    
Alliant Techsystems, Inc.
    11,768  
  400    
Applied Industrial Technologies, Inc.
    13,812  
  600    
Carlisle Cos., Inc.
    26,760  
  500    
Crane Co.
    23,995  
  400    
Curtiss-Wright Corp.
    13,180  
  200    
DXP Enterprises, Inc.*
    6,050  
  500    
Hubbell, Inc.-Class B
    32,710  
  100    
Preformed Line Products Co.
    5,317  
  400    
Primoris Services Corp.
    5,688  
  15    
Seaboard Corp.
    30,146  
  100    
Standex International Corp.
    3,193  
  500    
Teledyne Technologies, Inc.*
    28,340  
       
 
     
       
Total Capital Goods
    211,417  
       
 
     
       
 
       
       
Commercial & Professional Services — 5.4%
       
  200    
Brink’s Co. (The)
    4,924  
  1,500    
Cintas Corp.
    45,600  
  700    
Deluxe Corp.
    16,002  
  700    
Equifax, Inc.
    26,005  
  400    
FTI Consulting, Inc.*
    17,156  
  300    
G&K Services Inc.-Class A
    8,970  
  200    
Huron Consulting Group, Inc.*
    6,944  
  400    
Iron Mountain, Inc.
    12,148  
  300    
Multi-Color Corp.
    7,866  
  1,800    
RR Donnelley & Sons Co.
    27,036  
  600    
Sykes Enterprises, Inc.*
    9,774  
  900    
Towers Watson & Co.-Class A
    58,644  
  100    
UniFirst Corp.
    5,783  
  400    
United Stationers, Inc.
    13,416  
       
 
     
       
Total Commercial & Professional Services
    260,268  
       
 
     
       
 
       
       
Consumer Durables & Apparel — 4.8%
       
  200    
American Greetings Corp.-Class A
    3,398  
  100    
Blyth, Inc.
    6,582  
  700    
Carter’s, Inc.*
    27,839  
  170    
Deckers Outdoor Corp.*
    18,521  
  100    
Fossil, Inc.*
    8,959  
  200    
Helen of Troy Ltd.*
    5,974  
  700    
Iconix Brand Group, Inc.*
    12,082  
  400    
Jakks Pacific, Inc.
    7,636  
  600    
Jarden Corp.
    18,684  
  200    
Oxford Industries, Inc.
    7,586  
  100    
Polaris Industries, Inc.
    6,010  
  400    
PVH Corp.
    27,156  
  150    
Steven Madden Ltd.*
    5,349  

 


 

                 
  200    
True Religion Apparel, Inc.*
    7,040  
  800    
Tupperware Brands Corp.
    46,608  
  600    
Wolverine World Wide, Inc.
    22,104  
       
 
     
       
Total Consumer Durables & Apparel
    231,528  
       
 
     
       
 
       
       
Consumer Services — 5.0%
       
  300    
Apollo Group, Inc.-Class A*
    14,544  
  200    
Bob Evans Farms, Inc.
    6,696  
  600    
Bridgepoint Education, Inc.*
    13,200  
  800    
Brinker International, Inc.
    19,264  
  600    
Career Education Corp.*
    4,236  
  600    
DeVry, Inc.
    20,706  
  600    
Domino’s Pizza, Inc.*
    19,764  
  1,300    
Education Management Corp.*
    28,964  
  3,200    
H&R Block, Inc.
    50,336  
  300    
ITT Educational Services, Inc.*
    16,488  
  200    
Matthews International Corp.-Class A
    6,634  
  300    
Papa John’s International, Inc.*
    11,370  
  100    
Red Robin Gourmet Burgers, Inc.*
    2,658  
  400    
Six Flags Entertainment Corp.
    15,200  
  100    
Steiner Leisure Ltd.*
    4,700  
  100    
Weight Watchers International, Inc.
    5,877  
       
 
     
       
Total Consumer Services
    240,637  
       
 
     
       
 
       
       
Diversified Financials — 2.4%
       
  800    
Advance America Cash Advance Centers, Inc.
    6,816  
  400    
Cash America International, Inc.
    19,884  
  100    
Credit Acceptance Corp.*
    8,201  
  200    
Encore Capital Group, Inc.*
    4,360  
  700    
EZCORP, Inc.-Class A*
    20,363  
  300    
First Cash Financial Services, Inc.*
    10,890  
  1,100    
NASDAQ OMX Group, Inc. (The)*
    28,875  
  400    
Primus Guaranty Ltd.*
    2,336  
  200    
World Acceptance Corp.*
    13,724  
       
 
     
       
Total Diversified Financials
    115,449  
       
 
     
       
 
       
       
Energy — 3.2%
       
  700    
Energen Corp.
    35,504  
  1,600    
HollyFrontier Corp.
    37,200  
  200    
SEACOR Holdings, Inc.
    17,354  
  1,000    
Tesoro Corp.*
    23,890  
  600    
Western Refining, Inc.*
    7,134  
  800    
World Fuel Services Corp.
    34,296  
       
 
     
       
Total Energy
    155,378  
       
 
     
       
 
       
       
Food & Staples Retailing — 1.1%
       
  600    
Ruddick Corp.
    23,910  
  400    
Spartan Stores, Inc.
    7,212  
  1,500    
Supervalu, Inc.
    11,025  
  100    
Susser Holdings Corp.*
    2,298  
  200    
Weis Markets, Inc.
    7,984  
       
 
     
       
Total Food & Staples Retailing
    52,429  
       
 
     
       
 
       
       
Food, Beverage & Tobacco — 6.5%
       
  300    
Cal-Maine Foods, Inc.
    10,158  
  100    
Coca-Cola Bottling Co.
    5,600  
  1,300    
Constellation Brands, Inc.-Class A*
    25,311  
  500    
Corn Products International, Inc.
    25,995  

 


 

                 
  2,300    
Dean Foods Co.*
    23,368  
  900    
Dole Food Co., Inc.*
    7,605  
  1,200    
Flowers Foods, Inc.
    23,724  
  700    
Fresh Del Monte Produce, Inc.
    17,563  
  200    
Hain Celestial Group (The), Inc.*
    7,468  
  400    
Hansen Natural Corp.*
    36,880  
  100    
J&J Snack Foods Corp.
    5,188  
  200    
Lancaster Colony Corp.
    14,080  
  400    
National Beverage Corp.
    6,688  
  800    
Ralcorp Holdings, Inc.*
    65,056  
  1,200    
Smithfield Foods, Inc.*
    29,388  
  200    
Universal Corp.
    9,476  
       
 
     
       
Total Food, Beverage & Tobacco
    313,548  
       
 
     
       
 
       
       
Health Care Equipment & Services — 13.8%
       
  700    
AMERIGROUP Corp.*
    40,019  
  200    
AmSurg Corp.*
    5,216  
  200    
Cantel Medical Corp.
    5,262  
  600    
Centene Corp.*
    23,226  
  200    
Chemed Corp.
    10,732  
  400    
Conmed Corp.*
    10,516  
  600    
Cooper Cos, Inc. (The)
    36,756  
  1,900    
Coventry Health Care, Inc.*
    60,686  
  1,400    
DENTSPLY International, Inc.
    50,554  
  300    
Greatbatch, Inc.*
    6,636  
  100    
Haemonetics Corp.*
    5,923  
  1,100    
Health Net, Inc.*
    34,254  
  1,000    
Healthspring, Inc.*
    54,620  
  200    
ICU Medical, Inc.*
    8,802  
  300    
Integra LifeSciences Holdings Corp.*
    9,639  
  300    
Invacare Corp.
    6,162  
  500    
LifePoint Hospitals, Inc.*
    19,615  
  300    
Magellan Health Services, Inc.*
    15,198  
  400    
Mednax, Inc.*
    26,960  
  1,241    
Metropolitan Health Networks, Inc.*
    8,985  
  450    
Molina Healthcare, Inc.*
    9,832  
  1,600    
Omnicare, Inc.
    52,176  
  200    
Orthofix International (Non Voting)*
    6,854  
  600    
Owens & Minor, Inc.
    18,480  
  800    
Patterson Cos., Inc.
    24,136  
  400    
PharMerica Corp.*
    6,260  
  700    
PSS World Medical, Inc.*
    17,066  
  500    
Teleflex, Inc.
    30,440  
  1,000    
Universal American Corp.
    13,130  
  300    
US Physical Therapy, Inc.
    5,901  
  500    
WellCare Health Plans, Inc.*
    29,225  
  200    
West Pharmaceutical Services, Inc.
    7,706  
       
 
     
       
Total Health Care Equipment & Services
    660,967  
       
 
     
       
 
       
       
Household & Personal Products — 4.6%
       
  1,500    
Church & Dwight Co., Inc.
    66,375  
  400    
Elizabeth Arden, Inc.*
    15,120  
  700    
Energizer Holdings, Inc.*
    50,596  
  1,100    
Herbalife Ltd.
    60,830  
  200    
Nu Skin Enterprises, Inc.-Class A
    9,548  
  500    
Revlon, Inc.-Class A*
    7,715  
  400    
Spectrum Brands Holdings, Inc.*
    11,208  
       
 
     
       
Total Household & Personal Products
    221,392  
       
 
     

 


 

                 
       
Insurance — 7.4%
       
  200    
Allied World Assurance Co Holdings Ltd.
    11,898  
  1,000    
American Financial Group, Inc.
    36,000  
  700    
AmTrust Financial Services, Inc.
    18,557  
  800    
Arch Capital Group Ltd.*
    30,216  
  3,000    
CNO Financial Group, Inc.*
    18,960  
  120    
Enstar Group Ltd.*
    12,133  
  400    
FBL Financial Group, Inc.-Class A
    13,592  
  900    
HCC Insurance Holdings, Inc.
    24,192  
  400    
Kemper Corp.
    11,020  
  400    
ProAssurance Corp.
    31,844  
  800    
Reinsurance Group of America, Inc.
    41,200  
  200    
RLI Corp.
    14,174  
  1,000    
Torchmark Corp.
    42,590  
  700    
Validus Holdings Ltd.
    21,063  
  800    
W.R. Berkley Corp.
    27,288  
       
 
     
       
Total Insurance
    354,727  
       
 
     
       
 
       
       
Materials — 3.6%
       
  1,100    
Ball Corp.
    38,621  
  500    
Eastman Chemical Co.
    19,810  
  200    
Innospec, Inc.*
    5,812  
  600    
International Flavors & Fragrances, Inc.
    32,556  
  1,300    
RPM International, Inc.
    30,680  
  400    
Sensient Technologies Corp.
    15,108  
  600    
Silgan Holdings, Inc.
    23,364  
  200    
TPC Group, Inc.*
    4,800  
       
 
     
       
Total Materials
    170,751  
       
 
     
       
 
       
       
Media — 1.9%
       
  700    
Charter Communications, Inc.-Class A*
    37,009  
  600    
John Wiley and Sons, Inc.-Class A
    28,860  
  1,000    
Sinclair Broadcast Group, Inc.
    10,340  
  45    
Washington Post Co. (The)-Class B
    16,151  
       
 
     
       
Total Media
    92,360  
       
 
     
       
 
       
       
Pharmaceuticals, Biotechnology & Life Sciences — 4.2%
       
  300    
Bio-Rad Laboratories, Inc.*
    28,290  
  600    
Charles River Laboratories International, Inc.*
    17,010  
  400    
Covance, Inc.*
    18,364  
  600    
Cubist Pharmaceuticals, Inc.*
    23,142  
  1,500    
Endo Pharmaceuticals Holdings, Inc.*
    51,345  
  200    
Hi-Tech Pharmacal Co., Inc.*
    8,304  
  500    
Medicis Pharmaceutical Corp.-Class A
    16,325  
  500    
PerkinElmer, Inc.
    9,460  
  900    
Viropharma, Inc.*
    21,609  
  100    
Watson Pharmaceuticals, Inc.*
    6,462  
       
 
     
       
Total Pharmaceuticals, Biotechnology & Life Sciences
    200,311  
       
 
     
       
 
       
       
Real Estate — 1.8%
       
  1,700    
American Capital Agency Corp. REIT
    48,773  
  1,200    
Anworth Mortgage Asset Corp. REIT
    7,596  
  900    
Capstead Mortgage Corp. REIT
    11,232  
  500    
Hatteras Financial Corp. REIT
    13,400  
  700    
Newcastle Investment Corp. REIT
    3,115  
       
 
     
       
Total Real Estate
    84,116  
       
 
     

 


 

                 
       
Retailing — 12.4%
       
  700    
Aaron’s, Inc.
    18,396  
  900    
Abercrombie & Fitch Co.-Class A
    43,119  
  400    
Asbury Automotive Group, Inc.*
    7,888  
  800    
Ascena Retail Group, Inc.*
    22,016  
  900    
AutoNation, Inc.*
    32,499  
  400    
Big Lots, Inc.*
    16,044  
  600    
Buckle (The), Inc.
    23,976  
  200    
Cato Corp. (The)-Class A
    5,118  
  1,700    
Chico’s FAS, Inc.
    17,680  
  100    
Core-Mark Holding Co., Inc.
    3,856  
  700    
Dillard’s, Inc.-Class A
    32,900  
  130    
DSW, Inc.-Class A
    5,850  
  300    
Express, Inc.
    6,807  
  100    
Family Dollar Stores, Inc.
    5,942  
  300    
Finish Line (The), Inc.-Class A
    6,324  
  1,200    
Foot Locker, Inc.
    28,308  
  1,800    
GameStop Corp.-Class A*
    41,616  
  300    
Genesco, Inc.*
    17,715  
  300    
Group 1 Automotive, Inc.
    14,733  
  100    
Hibbett Sports, Inc.*
    4,551  
  300    
Jos. A. Bank Clothiers, Inc.*
    14,784  
  400    
Lithia Motors, Inc.-Class A
    8,884  
  1,000    
LKQ Corp.*
    30,530  
  500    
Men’s Wearhouse (The), Inc.
    13,915  
  1,100    
Penske Auto Group, Inc.
    22,319  
  1,200    
PetSmart, Inc.
    57,900  
  800    
Rent-A-Center, Inc.
    28,760  
  300    
Select Comfort Corp.*
    5,559  
  100    
Shoe Carnival, Inc.*
    2,378  
  500    
Sonic Automotive, Inc.
    7,385  
  300    
Stage Stores, Inc.
    3,762  
  400    
Systemax, Inc.*
    5,880  
  100    
Tiffany & Co.
    6,704  
  200    
Tractor Supply Co.
    14,446  
  500    
Williams-Sonoma, Inc.
    18,885  
       
 
     
       
Total Retailing
    597,429  
       
 
     
       
 
       
       
Semiconductors & Semiconductor Equipment — 0.3%
       
  1,100    
GT Advanced Technologies, Inc.*
    8,492  
  700    
Kulicke & Soffa Industries, Inc.*
    6,370  
       
 
     
       
Total Semiconductors & Semiconductor Equipment
    14,862  
       
 
     
       
 
       
       
Software & Services — 8.3%
       
  500    
Alliance Data Systems Corp.*
    51,205  
  800    
Amdocs Ltd.*
    22,592  
  400    
CACI International, Inc.-Class A*
    22,552  
  1,100    
CIBER, Inc.*
    4,554  
  400    
DST Systems, Inc.
    19,012  
  100    
ePlus, Inc.*
    2,777  
  400    
Fair Isaac Corp.
    14,548  
  800    
Global Payments, Inc.
    35,384  
  300    
Heartland Payment Systems, Inc.
    6,765  
  800    
IAC/InterActiveCorp
    33,504  
  500    
j2 Global Communications, Inc.
    13,555  
  500    
Jack Henry & Associates, Inc.
    16,605  
  400    
Mantech International Corp.-Class A
    13,520  
  200    
MAXIMUS, Inc.
    8,320  
  50    
MicroStrategy, Inc.-Class A*
    6,156  

 


 

                 
  600    
NeuStar, Inc.-Class A*
    20,244  
  800    
Synopsys, Inc.*
    22,376  
  300    
TeleNav, Inc.*
    2,466  
  700    
TeleTech Holdings, Inc.*
    12,327  
  2,600    
Total System Services, Inc.
    52,104  
  1,200    
United Online, Inc.
    6,336  
  400    
Valueclick, Inc.*
    6,184  
  300    
Websense, Inc.*
    5,433  
       
 
     
       
Total Software & Services
    398,519  
       
 
     
       
 
       
       
Technology Hardware & Equipment — 4.0%
       
  1,400    
Arrow Electronics, Inc.*
    51,184  
  400    
Brightpoint, Inc.*
    3,996  
  300    
Comtech Telecommunications Corp.
    9,087  
  200    
Harris Corp.
    7,120  
  1,400    
Ingram Micro, Inc.-Class A*
    25,214  
  400    
Insight Enterprises, Inc.*
    5,856  
  1,200    
NCR Corp.*
    20,988  
  400    
PC Connection, Inc.
    4,052  
  200    
Scansource, Inc.*
    7,022  
  400    
SYNNEX Corp.*
    11,740  
  600    
Tech Data Corp.*
    29,538  
  400    
Zebra Technologies Corp.*
    15,144  
       
 
     
       
Total Technology Hardware & Equipment
    190,941  
       
 
     
       
 
       
       
Telecommunication Services — 0.3%
       
  1,800    
Cincinnati Bell, Inc.*
    5,292  
  200    
IDT Corp.-Class B
    2,600  
  700    
Premiere Global Services, Inc.*
    5,789  
       
 
     
       
Total Telecommunication Services
    13,681  
       
 
     
       
 
       
       
Utilities — 1.3%
       
  700    
Atmos Energy Corp.
    23,947  
  500    
PNM Resources, Inc.
    9,555  
  400    
Portland General Electric Co.
    10,020  
  600    
UGI Corp.
    17,976  
       
 
     
       
Total Utilities
    61,498  
       
 
     
       
 
       
       
TOTAL COMMON STOCKS (COST $4,364,629)
    4,669,555  
       
 
     
       
 
       
       
MUTUAL FUNDS — 3.3%
       
       
 
       
       
Affiliated Issuers — 3.3%
       
  6,399    
GMO U.S. Treasury Fund
    160,048  
       
 
     
       
 
       
       
TOTAL MUTUAL FUNDS (COST $160,048)
    160,048  
       
 
     
       
 
       
       
RIGHTS/WARRANTS — 0.2%
       
       
 
       
       
Insurance — 0.2%
       
  1,295    
American International Group, Inc., Warrants, Strike 45.00 *
    7,926  
       
 
     
       
 
       
       
TOTAL RIGHTS/WARRANTS (COST $22,015)
    7,926  
       
 
     

 


 

                 
Shares     Description   Value ($)  
 
       
SHORT-TERM INVESTMENTS — 0.6%
       
       
 
       
       
Money Market Funds — 0.6%
       
  27,309    
State Street Institutional Treasury Money Market Fund-Institutional Class, 0.00% (a)
    27,309  
       
 
     
       
 
       
       
TOTAL SHORT-TERM INVESTMENTS (COST $27,309)
    27,309  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 101.4%
(Cost $4,574,001)
    4,864,838  
       
 
       
       
Other Assets and Liabilities (net) — (1.4%)
    (66,885 )
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 4,797,953  
       
 
     
 
Notes to Schedule of Investments:
REIT —  Real Estate Investment Trust
* Non-income producing security.
(a)  Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                           
      Gross     Gross     Net Unrealized  
      Unrealized     Unrealized     Appreciation  
Aggregate Cost   Appreciation     (Depreciation)     (Depreciation)  
$ 4,590,427   $ 512,956     $ (238,545 )   $ 274,411  

 


 

Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A Summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO U.S. Treasury Fund
  $ 185,000     $ 694,000     $ 718,952     $ 44     $     $ 160,048  
 
                                   


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs.
Level 3 — Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Common Stocks
  $ 4,669,555     $     $     $ 4,669,555  
Mutual Funds
    160,048                   160,048  
Rights/Warrants
          7,926             7,926  
Short-Term Investments
    27,309                   27,309  
 
                       
Total Investments
    4,856,912       7,926             4,864,838  
 
                       
Total
  $ 4,856,912     $ 7,926     $     $ 4,864,838  
 
                       

 


 

All of the Fund’s common stocks held at period end are classified as Level 1. Please refer to the Schedule of Investments for a more detailed categorization of common stocks.
The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If the Fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of value of those investments. The Fund also may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Because the Fund normally does not take temporary defensive positions, declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Liquidity Risk — Shares of small- and mid-cap companies often have lower trading volumes and a limited number or no market makers. Thus, a large position may limit or prevent the Fund from selling those shares or unwinding derivative positions on them at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk and counterparty risk.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Leveraging Risk — The Fund’s use of derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Focused Investment Risk — Focusing investments in sectors or companies or in industries with high positive correlations to one another creates additional risk.

 


 

Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. For example, the Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives, to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives.
The Fund also may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero).
In addition, the Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors and markets without actually having to sell existing investments or make new direct investments. For example, if the Fund holds a large proportion of stocks of companies in a particular sector and the Manager believes that stocks of companies in another sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index).
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net long exposure in excess of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.

 


 

The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates, or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded. The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. During the period ended November 30, 2011, the Fund used futures contracts to maintain the diversity and liquidity of the portfolio. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. The Fund had no written option contracts outstanding at the end of the period.

 


 

When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.

 


 

Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. During the period ended November 30, 2011, the Fund held rights and/or warrants received as a result of a corporate action. Rights and/or warrants held by the Fund at the end of the period are listed in the Fund’s Schedule of Investments.

 


 

The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Assets:
                                               
Investments, at value (rights and/or warrants)
  $     $     $     $ 7,926     $     $ 7,926  
 
                                   
Total
  $     $     $     $ 7,926     $     $ 7,926  
 
                                   
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (futures contracts and rights and/or warrants) outstanding at each month-end, was as follows for the period ended November 30, 2011:
                 
    Futures       Rights and/or
    Contracts   Warrants
Average amount outstanding
  $ 20,021     $ 11,596  


 

Subsequent events
Effective January 16, 2012, GMO U.S. Small/Mid Cap Value Fund was renamed “GMO U.S. Small/Mid Cap Fund.” As of that date, the Manager will seek to achieve the Fund’s investment objective by investing in equities or groups of equities that the Manager believes will provide higher returns than the Russell 2500 Index.
Effective January 16, 2012, the Fund’s benchmark is the Russell 2500 Index. The Russell 2500 Index is an independently maintained and widely published index that measures the performance of the small to mid-cap segment of the U.S. equity universe. The Russell 2500 is a subset of the Russell 3000 Index. It includes approximately 2500 of the smallest securities based on a combination of their market cap and current index membership. Russell Investment Group is the source and owner of the trademarks, service marks and copyrights related to the Russell Indexes. Russell® is a trademark of Russell Investment Group.
For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO U.S. Treasury Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares/Par            
Value ($)     Description   Value ($)  
       
SHORT-TERM INVESTMENTS — 110.9%
       
       
 
       
       
U.S. Government — 110.7%
       
  246,695,000    
U.S. Treasury Bill, 0.00%, due 12/01/11 (b)
    246,695,000  
  53,075,000    
U.S. Treasury Bill, 0.00%, due 12/08/11 (b)
    53,075,000  
  158,800,000    
U.S. Treasury Bill, 0.01%, due 12/15/11 (b)
    158,799,354  
  346,850,000    
U.S. Treasury Bill, 0.01%, due 12/22/11 (b)
    346,847,930  
  769,080,000    
U.S. Treasury Bill, 0.02%, due 12/29/11 (b)
    769,070,496  
  85,000,000    
U.S. Treasury Bill, 0.01%, due 02/09/12 (b)
    84,998,045  
  125,000,000    
U.S. Treasury Bill, 0.01%, due 02/16/12 (b)
    124,996,750  
  134,400,000    
U.S. Treasury Bill, 0.02%, due 02/23/12 (b)
    134,396,237  
  150,000,000    
U.S. Treasury Bill, 0.02%, due 03/01/12 (b)
    149,993,100  
  69,000,000    
U.S. Treasury Bill, 0.03%, due 04/12/12 (b)
    68,992,341  
  66,000,000    
U.S. Treasury Note, 0.88%, due 01/31/12
    66,092,796  
  50,000,000    
U.S. Treasury Note, 1.38%, due 02/15/12
    50,138,650  
  84,000,000    
U.S. Treasury Note, 0.88%, due 02/29/12
    84,173,880  
  100,000,000    
U.S. Treasury Note, 1.00%, due 03/31/12
    100,316,400  
  38,000,000    
U.S. Treasury Note, 1.38%, due 04/15/12
    38,185,554  
  25,000,000    
U.S. Treasury Note, 1.00%, due 04/30/12
    25,097,650  
       
 
     
       
Total U.S. Government
    2,501,869,183  
       
 
     
       
 
       
       
Money Market Funds — 0.2%
       
  4,632,968    
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00%(a)
    4,632,968  
       
 
     
       
 
       
       
TOTAL SHORT-TERM INVESTMENTS (COST $2,506,509,306)
    2,506,502,151  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 110.9%
(Cost $2,506,509,306)
    2,506,502,151  
       
 
       
       
Other Assets and Liabilities (net) — (10.9%)
    (245,890,599 )
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 2,260,611,552  
       
 
     
 
Notes to Schedule of Investments:
 
(a)   Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.
 
(b)   Rate shown represents yield-to-maturity.

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                                 
        Gross     Gross     Net Unrealized  
        Unrealized     Unrealized     Appreciation  
Aggregate Cost     Appreciation     (Depreciation)     (Depreciation)  
$ 2,506,509,306     $ 6,739     $ (13,894 )   $ (7,155 )  
 

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost, which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. U.S. Treasury Bills having sixty days or less to final maturity were valued using amortized cost.
Level 3 — Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Short-Term Investments
  $ 932,014,371     $ 1,574,487,780     $     $ 2,506,502,151  
 
                       
Total Investments
    932,014,371       1,574,487,780             2,506,502,151  
 
                       
Total
  $ 932,014,371     $ 1,574,487,780     $     $ 2,506,502,151  
 
                       

 


 

At November 30, 2011, the Fund’s investments in U.S. Treasury Bills having sixty days or less to final maturity were valued using amortized cost, in accordance with rules under the Investment Company Act of 1940. Amortized cost approximates the current fair value of a security, as the value is not obtained from a quoted price in an active market. Securities valued at amortized cost are considered to be valued using Level 2.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase the security at an agreed upon price and date. The Fund, through its custodian, takes possession of securities it acquired under the repurchase agreement. The value of the securities acquired is required by contract to be marked to market daily and additional collateral is required to be transferred so that the market value is at least equal to the amount owed to the Fund by the seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings and/or the value of the securities subject to the repurchase agreement is insufficient, the Fund’s recovery of cash from the seller may be delayed and the Fund may incur a loss equal to the difference between the cash it paid and the value of the securities. The Fund had no repurchase agreements outstanding at the end of the period.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Fixed Income Securities — Typically, the market value of the Fund’s U.S. Treasury and other fixed income securities will decline during periods of rising interest rates, and yields on the Fund’s securities may equal or approach zero under some market conditions.
 
Credit Risk — Securities issued by the U.S. Treasury or U.S. government agencies generally present minimal credit risk. However, a security backed by the full faith and credit of the U.S. government is guaranteed only as to the timely payment of interest and principal when held to maturity. The market prices for such securities are not guaranteed and will fluctuate.
 
Focused Investment Risk — Focusing investments in a particular type of security (e.g., Direct U.S. Treasury Obligations) creates additional risk.
 
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
 
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
 
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Derivative financial instruments
At November 30, 2011, the Fund held no derivative financial instruments.
For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO World Opportunities Equity Allocation Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Shares / Par Value ($)     Description   Value ($)  
       
MUTUAL FUNDS — 100.0%
       
       
 
       
       
Affiliated Issuers — 100.0%
       
  2,615,976    
GMO Emerging Markets Fund, Class VI
    30,580,758  
  2,568,052    
GMO Flexible Equities Fund, Class VI
    44,016,406  
  8,201,643    
GMO International Growth Equity Fund, Class IV
    175,515,155  
  15,535,839    
GMO International Intrinsic Value Fund, Class IV
    302,948,868  
  22,576,199    
GMO Quality Fund, Class VI
    493,064,184  
  8,164,162    
GMO U.S. Core Equity Fund, Class VI
    99,112,927  
       
 
     
       
TOTAL MUTUAL FUNDS (COST $1,077,652,693)
    1,145,238,298  
       
 
     
 
       
SHORT-TERM INVESTMENTS — 0.0%
       
       
 
       
       
Time Deposits — 0.0%
       
  24,047    
State Street Eurodollar Time Deposit, 0.01%, due 12/01/11
    24,047  
       
 
     
       
 
       
       
TOTAL SHORT-TERM INVESTMENTS (COST $24,047)
    24,047  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 100.0%
(Cost $1,077,676,740)
    1,145,262,345  
       
 
       
       
Other Assets and Liabilities (net) — (0.0%)
    (70,921 )
       
 
       
       
 
     
       
TOTAL NET ASSETS — 100.0%
  $ 1,145,191,424  
       
 
     

 


 

As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                         
    Gross   Gross   Net Unrealized
    Unrealized   Unrealized   Appreciation
Aggregate Cost   Appreciation   (Depreciation)   (Depreciation)
$1,193,510,682
  $     $ (48,248,337 )   $ (48,248,337 )
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (“underlying funds”). The Schedule of Investments of the underlying funds should be read in conjunction with the Fund’s Schedule of Investments.
A summary of the Fund’s transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
                                                 
    Value,                             Distributions        
    beginning of             Sales     Dividend     of Realized     Value, end  
Affiliate   period     Purchases     Proceeds     Income     Gains     of period  
GMO Emerging Markets Fund,
Class VI
  $ 36,098,808     $ 3,411,279     $ 1,716,225     $ 12,287     $ 2,750,906     $ 30,580,758  
GMO Flexible Equities Fund, Class VI
    13,135,642       36,831,894       1,990,803                   44,016,406  
GMO International Growth Equity Fund, Class IV
    308,748,264       6,362,079       109,464,934       1,947,735             175,515,155  
GMO International Intrinsic Value Fund, Class IV
    308,871,163       79,474,947       39,665,571       5,358,282             302,948,868  
GMO Quality Fund, Class VI
    438,782,086       65,243,784       31,461,291       7,183,905             493,064,184  
GMO U.S. Core Equity Fund,
Class VI
    109,432,403       3,816,168       14,821,574       1,627,346             99,112,927  
 
                                   
Totals
  $ 1,215,068,366     $ 195,140,151     $ 199,120,398     $ 16,129,555     $ 2,750,906     $ 1,145,238,298  
 
                                   

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Shares of the underlying funds and other investment funds are generally valued at their net asset value. Investments held by the underlying funds are valued as follows: Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly and indirectly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 0.1% of net assets. The underlying funds classify such securities (levels defined below) as Level 3.
Additionally, the fair value of equity securities listed on foreign exchanges and securities markets that are closed prior to the close of the NYSE due to time zone differences (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees. The table below shows the percentage of the net assets of the Fund, either directly or through investments in the underlying funds, that were valued using fair value prices obtained from an independent pricing service as of November 30, 2011. These securities listed on foreign exchanges (including the value of equity securities that underlie futures (to the extent the market for such futures closes prior to the close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table below and as described in the disclosures of the underlying funds.
     
Security Type   Percentage of Net Assets of the Fund
Equity Securities
  49.9%
Futures Contracts
  0.2%
Swap Agreements
  (0.0)%^
 
^   Rounds to 0.0%.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:

 


 

Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs.
Level 3 — Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:

 


 

ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
 
                       
Mutual Funds
  $ 1,145,238,298     $     $     $ 1,145,238,298  
Short-Term Investments
    24,047                   24,047  
 
                       
Total Investments
    1,145,262,345                   1,145,262,345  
 
                       
Total
  $ 1,145,262,345     $     $     $ 1,145,262,345  
 
                       

 


 

The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the underlying funds’ portfolio valuation notes. The aggregate net values of the Fund’s indirect investments in securities and derivative financial instruments using Level 3 inputs were 0.1% and 0.0% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30, 2011 or February 28, 2011 whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. References to investments include those held directly by the Fund and indirectly through the Fund’s investments in the underlying funds. Some of the underlying funds are non-diversified investment companies under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by those funds may affect their performance more than if they were diversified. Selected risks of investing in the Fund are summarized below, including those risks to which the Fund is exposed as a result of its investments in the underlying funds. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.
Market Risk — Equity Securities — The market value of equity investments may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. If an underlying fund purchases equity investments at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not increase to that value for a variety of reasons, one of which may be the Manager’s overestimation of the value of those investments. An underlying fund also may purchase equity investments that typically trade at higher multiples of current earnings than other securities, and the market values of these investments often are more sensitive to changes in future earnings expectations than those other securities. Because the Fund and the underlying funds normally do not take temporary defensive positions, declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries.
Liquidity Risk — Low trading volume, lack of a market maker, large size of position or legal restrictions may limit or prevent the Fund or an underlying fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
Fund of Funds Risk — The Fund is indirectly exposed to all of the risks of an investment in the underlying funds, including the risk that the underlying funds in which it invests do not perform as expected. Because the Fund bears the fees and expenses of the underlying funds in which it invests, new investments in underlying funds with higher fees or expenses than those of the underlying funds in which the Fund is currently invested will increase the Fund’s total expenses. The fees and expenses associated with an investment in the Fund are less predictable and may be higher than fees and expenses associated with an investment in funds that charge a fixed management fee.

 


 

Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
Smaller Company Risk — Smaller companies may have limited product lines, markets or financial resources, may lack the competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and midcap companies often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
Commodities Risk — To the extent an underlying fund has exposure to global commodity markets, the value of its shares is affected by factors particular to the commodity markets and may fluctuate more than the value of shares of a fund with a broader range of investments.
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of foreign currency holdings and investments denominated in foreign currencies, or that the U.S. dollar will decline in value relative to the foreign currency being hedged.
Leveraging Risk — The use of reverse repurchase agreements and other derivatives and securities lending may cause the Fund’s portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations.
Real Estate Risk — To the extent an underlying fund concentrates its assets in real estate-related investments, the value of its portfolio is subject to factors affecting the real estate industry and may fluctuate more than the value of a portfolio that consists of securities of companies in a broader range of industries.
Short Sales Risk — The Fund runs the risk that an underlying fund’s loss on a short sale of securities that the underlying fund does not own is unlimited.
Market Risk — Fixed Income Securities — Typically, the market value of fixed income securities will decline during periods of rising interest rates and widening of credit spreads.
Market Risk — Asset-Backed Securities — Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating.
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies or in industries with high positive correlations to one another creates additional risk.
Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.

 


 

Derivative financial instruments
At November 30, 2011, the Fund held no derivative financial instruments directly. For a listing of derivative financial instruments held by the underlying funds, if any, please refer to the underlying funds’ Schedule of Investments.
For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

GMO World Opportunity Overlay Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
                 
Par Value ($)     Description   Value ($)  
 
       
DEBT OBLIGATIONS — 96.9%
       
       
 
       
       
Asset-Backed Securities — 25.5%
       
       
Auto Financing — 1.4%
       
  6,892,818    
Carmax Auto Owner Trust, Series 08-2, Class A4B, 1 mo. LIBOR + 1.65%, 1.90%, due 08/15/13
    6,934,796  
  2,072,152    
Daimler Chrysler Auto Trust, Series 08-B, Class A4A, 5.32%, due 11/10/14
    2,083,549  
  2,201,416    
Merrill Auto Trust Securitization, Series 08-1, Class A4B, 1 mo. LIBOR + 2.20%, 2.45%, due 04/15/15
    2,210,001  
  575,858    
Merrill Auto Trust Securitization, Series 07-1, Class A4, 1 mo. LIBOR + .06%, 0.31%, due 12/15/13
    575,685  
       
 
     
       
Total Auto Financing
    11,804,031  
       
 
     
       
 
       
       
Business Loans — 1.4%
       
  1,213,359    
Bayview Commercial Asset Trust, Series 04-3, Class A1, 144A, 1 mo. LIBOR + .37%, 0.63%, due 01/25/35
    910,019  
  1,770,058    
Bayview Commercial Asset Trust, Series 05-4A, Class A2, 144A, 1 mo. LIBOR + .39%, 0.65%, due 01/25/36
    1,115,137  
  8,593,472    
Bayview Commercial Asset Trust, Series 07-6A, Class A2, 144A, 1 mo. LIBOR + 1.30%, 1.56%, due 12/25/37
    6,015,430  
  1,254,477    
GE Business Loan Trust, Series 05-2A, Class A, 144A, 1 mo. LIBOR + .24%, 0.49%, due 11/15/33
    1,028,671  
  1,511,906    
Lehman Brothers Small Balance Commercial, Series 05-1A, Class A, 144A, 1 mo. LIBOR + .25%, 0.51%, due 02/25/30
    1,163,503  
  1,019,391    
Lehman Brothers Small Balance Commercial, Series 05-2A, Class 1A, 144A, 1 mo. LIBOR + .25%, 0.51%, due 09/25/30
    804,197  
  1,312,822    
Lehman Brothers Small Balance Commercial, Series 07-3A, Class 1A2, 144A, 1 mo. LIBOR + .85%, 1.11%, due 10/25/37
    1,049,759  
       
 
     
       
Total Business Loans
    12,086,716  
       
 
     
       
 
       
       
CMBS — 3.5%
       
  2,540,096    
Citigroup/Deutsche Bank Commercial Mortgage, Series 05-CD1, Class A2FL, 1 mo. LIBOR + .12%, 0.37%, due 07/15/44
    2,508,345  
  11,500,000    
Commercial Mortgage Pass-Through Certificates, Series 06-FL12, Class AJ, 144A, 1 mo. LIBOR + .13%, 0.38%, due 12/15/20
    10,407,500  
  1,691,733    
GE Capital Commercial Mortgage Corp., Series 05-C4, Class A2, 5.31%, due 11/10/45
    1,691,733  
  2,760,406    
GE Capital Commercial Mortgage Corp., Series 06-C1, Class A2, 5.33%, due 03/10/44
    2,760,406  
  3,279,218    
GS Mortgage Securities Corp., Series 06-GG6, Class A2, 5.51%, due 04/10/38
    3,310,985  
  3,708,115    
Merrill Lynch Mortgage Trust, Series 06-C1, Class A2, 5.62%, due 05/12/39
    3,780,794  
  1,738,928    
Morgan Stanley Capital I, Series 06-IQ11, Class A3, 5.69%, due 10/15/42
    1,772,820  
  4,128,197    
Wachovia Bank Commercial Mortgage Trust, Series 06-WL7A, Class A1, 144A, 1 mo. LIBOR + .09%, 0.34%, due 09/15/21
    3,921,787  
       
 
     
       
Total CMBS
    30,154,370  
       
 
     
       
 
       
       
CMBS Collateralized Debt Obligations — 0.7%
       
  6,777,455    
American Capital Strategies Ltd. Commercial Real Estate CDO Trust, Series 07-1A, Class A, 144A, 3 mo. LIBOR + .80%, 1.30%, due 11/23/52
    67,774  
  1,149,499    
Guggenheim Structured Real Estate Funding, Series 05-2A, Class A, 144A, 1 mo. LIBOR + .32%, 0.58%, due 08/26/30
    1,060,413  
  6,176,887    
Marathon Real Estate CDO, Series 06-1A, Class A1, 144A, 1 mo. LIBOR + .33%, 0.59%, due 05/25/46
    4,509,128  
       
 
     
       
Total CMBS Collateralized Debt Obligations
    5,637,315  
       
 
     
       
 
       
       
Corporate Collateralized Debt Obligations — 0.5%
       
  4,800,000    
Morgan Stanley ACES SPC, Series 06-13A, Class A, 144A, 3 mo. LIBOR + .29%, 0.64%, due 06/20/13
    4,228,320  
       
 
     

 


 

                 
       
Credit Cards — 1.5%
       
  7,700,000    
Charming Shoppes Master Trust, Series 07-1A, Class A1, 144A, 1 mo. LIBOR + 1.25%, 1.50%, due 09/15/17
    7,712,705  
  3,900,000    
Discover Card Master Trust I, Series 05-4, Class A2, 1 mo. LIBOR + .09%, 0.34%, due 06/16/15
    3,898,172  
  900,000    
World Financial Network Credit Card Master Trust, Series 06-A, Class A, 144A, 1 mo. LIBOR + .13%, 0.38%, due 02/15/17
    892,971  
       
 
     
       
Total Credit Cards
    12,503,848  
       
 
     
       
 
       
       
Insured Auto Financing — 1.6%
       
  755,016    
AmeriCredit Automobile Receivables Trust, Series 07-AX, Class A4, XL, 1 mo. LIBOR + .04%, 0.29%, due 10/06/13
    753,128  
  1,234,986    
AmeriCredit Automobile Receivables Trust, Series 07-DF, Class A4B, FSA, 1 mo. LIBOR + .80%, 1.05%, due 06/06/14
    1,234,349  
  3,098,487    
AmeriCredit Prime Automobile Receivable Trust, Series 07-2M, Class A4B, MBIA, 1 mo. LIBOR + .50%, 0.75%, due 03/08/16
    3,086,713  
  8,145,797    
Triad Auto Receivables Owner Trust, Series 07-B, Class A4B, FSA, 1 mo. LIBOR + 1.20%, 1.45%, due 07/14/14
    8,185,467  
       
 
     
       
Total Insured Auto Financing
    13,259,657  
       
 
     
       
 
       
       
Insured Other — 0.7%
       
  2,691,272    
Henderson Receivables LLC, Series 06-3A, Class A1, 144A, MBIA, 1 mo. LIBOR + .20%, 0.45%, due 09/15/41
    2,384,614  
  2,074,825    
Henderson Receivables LLC, Series 06-4A, Class A1, 144A, MBIA, 1 mo. LIBOR + .20%, 0.45%, due 12/15/41
    1,845,865  
  1,727,859    
TIB Card Receivables Fund, Series 2005-B,144A, FGIC, 3 mo. LIBOR + .25%, 0.63%, due 01/05/14
    1,382,287  
  9,200,000    
Toll Road Investment Part II, Series C, 144A, MBIA, Zero Coupon, due 02/15/37
    575,828  
       
 
     
       
Total Insured Other
    6,188,594  
       
 
     
       
 
       
       
Insured Residential Asset-Backed Securities (United States) ♦— 0.7%
       
  7,122,517    
Ameriquest Mortgage Securities, Inc., Series 04-R6, Class A1, XL, 1 mo. LIBOR + .21%, 0.68%, due 07/25/34
    5,626,788  
       
 
     
       
 
       
       
Insured Residential Mortgage-Backed Securities (United States) — 0.1%
       
  803,365    
SBI Heloc Trust, Series 05-HE1, Class 1A, 144A, FSA, 1 mo. LIBOR + .19%, 0.45%, due 11/25/35
    727,769  
       
 
     
       
 
       
       
Insured Time Share — 0.3%
       
  261,468    
Sierra Receivables Funding Co., Series 06-1A, Class A2, 144A, MBIA, 1 mo. LIBOR + .15%, 0.40%, due 05/20/18
    258,774  
  2,273,138    
Sierra Receivables Funding Co., Series 07-2A, Class A2, 144A, MBIA, 1 mo. LIBOR + 1.00%, 1.25%, due 09/20/19
    2,206,742  
       
 
     
       
Total Insured Time Share
    2,465,516  
       
 
     
       
 
       
       
Insured Transportation — 0.4%
       
  3,578,198    
CLI Funding LLC, Series 06-1A, Class A, 144A, AMBAC, 1 mo. LIBOR + .18%, 0.43%, due 08/18/21
    3,291,942  
       
 
     
       
 
       
       
Residential Asset-Backed Securities (United States) ♦ — 8.4%
       
  9,400,000    
ACE Securities Corp., Series 06-ASP5, Class A2C, 1 mo. LIBOR + .18%, 0.44%, due 10/25/36
    2,632,000  
  1,407,928    
ACE Securities Corp., Series 06-CW1, Class A2B, 1 mo. LIBOR + .10%, 0.36%, due 07/25/36
    1,316,412  
  10,877,178    
ACE Securities Corp., Series 06-HE2, Class A2C, 1 mo. LIBOR + .16%, 0.42%, due 05/25/36
    5,329,817  
  403,351    
ACE Securities Corp., Series 06-HE3, Class A2B, 1 mo. LIBOR + .09%, 0.35%, due 06/25/36
    367,050  
  733,192    
ACE Securities Corp., Series 06-SL1, Class A, 1 mo. LIBOR + .16%, 0.58%, due 09/25/35
    128,309  
  1,817,309    
ACE Securities Corp., Series 06-SL3, Class A1, 1 mo. LIBOR + .10%, 0.36%, due 06/25/36
    295,313  
  1,975,874    
ACE Securities Corp., Series 06-SL3, Class A2, 1 mo. LIBOR + .17%, 0.43%, due 06/25/36
    242,045  
  1,090,999    
ACE Securities Corp., Series 06-SL4, Class A1, 1 mo. LIBOR + .12%, 0.38%, due 09/25/36
    223,655  
  4,243,165    
ACE Securities Corp., Series 07-ASL1, Class A2, 1 mo. LIBOR + .17%, 0.43%, due 12/25/36
    403,101  
  1,154,495    
ACE Securities Corp., Series 07-WM1, Class A2A, 1 mo. LIBOR + .07%, 0.33%, due 11/25/36
    386,756  

 


 

                 
  9,692,520    
Argent Securities, Inc., Series 06-M1, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 07/25/36
    2,517,026  
  5,538,375    
Argent Securities, Inc., Series 06-M2, Class A2B, 1 mo. LIBOR + .11%, 0.37%, due 09/25/36
    1,619,975  
  1,807,004    
Argent Securities, Inc., Series 06-W2, Class A2B, 1 mo. LIBOR + .19%, 0.45%, due 03/25/36
    524,031  
  1,974,603    
Argent Securities, Inc., Series 06-W5, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 06/25/36
    519,567  
  2,552,139    
Asset Backed Funding Certificates, Series 06-OPT2, Class A3C, 1 mo. LIBOR + .15%, 0.41%, due 10/25/36
    1,480,241  
  4,273,239    
Asset Backed Funding Certificates, Series 07-NC1, Class A1, 144A, 1 mo. LIBOR + .22%, 0.48%, due 05/25/37
    3,365,176  
  3,522,365    
Bayview Financial Acquisition Trust, Series 05-A, Class A1, 144A, 1 mo. LIBOR + .50%, 1.26%, due 02/28/40
    2,116,942  
  2,413,254    
Bear Stearns Asset Backed Securities, Inc., Series 07-AQ1, Class A1, 1 mo. LIBOR + .11%, 0.37%, due 11/25/36
    1,464,604  
  5,400,000    
Bear Stearns Asset Backed Securities, Inc., Series 07-AQ1, Class A2, 1 mo. LIBOR + .20%, 0.46%, due 11/25/36
    720,900  
  798,536    
Bear Stearns Mortgage Funding Trust, Series 07-SL2, Class 1A, 1 mo. LIBOR + .16%, 0.58%, due 02/25/37
    126,248  
  1,788,004    
Centex Home Equity, Series 06-A, Class AV3, 1 mo. LIBOR + .16%, 0.42%, due 06/25/36
    1,358,883  
  2,600,000    
Citigroup Mortgage Loan Trust, Inc., Series 06-HE3, Class A2C, 1 mo. LIBOR + .16%, 0.42%, due 12/25/36
    780,000  
  6,600,000    
Citigroup Mortgage Loan Trust, Inc., Series 06-WFH4, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 11/25/36
    4,554,000  
  8,112,000    
Countrywide Asset-Backed Certificates, Series 06-BC3, Class 2A2, 1 mo. LIBOR + .14%, 0.40%, due 02/25/37
    5,901,480  
  220,454    
Countrywide Asset-Backed Certificates, Series 06-BC5, Class 2A1, 1 mo. LIBOR + .08%, 0.34%, due 03/25/37
    217,588  
  4,183,519    
Fremont Home Loan Trust, Series 06-B, Class 2A3, 1 mo. LIBOR + .16%, 0.42%, due 08/25/36
    1,171,385  
  965,191    
Household Home Equity Loan Trust, Series 05-2, Class A2, 1 mo. LIBOR + .31%, 0.56%, due 01/20/35
    829,160  
  367,242    
Household Home Equity Loan Trust, Series 05-3, Class A2, 1 mo. LIBOR + .29%, 0.54%, due 01/20/35
    323,058  
  6,171,830    
J.P. Morgan Mortgage Acquisition Corp., Series 06-WMC4, Class A3, 1 mo. LIBOR + .12%, 0.38%, due 12/25/36
    1,949,681  
  228,804    
Master Asset-Backed Securities Trust, Series 05-FRE1, Class A4, 1 mo. LIBOR + .25%, 0.51%, due 10/25/35
    215,076  
  3,422,221    
Master Asset-Backed Securities Trust, Series 06-FRE2, Class A4, 1 mo. LIBOR + .15%, 0.41%, due 03/25/36
    1,197,777  
  2,700,000    
Master Asset-Backed Securities Trust, Series 06-HE2, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 06/25/36
    810,000  
  5,561,305    
Master Asset-Backed Securities Trust, Series 06-HE3, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 08/25/36
    1,473,746  
  3,065,938    
Master Asset-Backed Securities Trust, Series 06-NC3, Class A4, 1 mo. LIBOR + .16%, 0.42%, due 10/25/36
    919,781  
  1,193,335    
Master Second Lien Trust, Series 06-1, Class A, 1 mo. LIBOR + .16%, 0.58%, due 03/25/36
    143,200  
  2,349,442    
Merrill Lynch Mortgage Trust, Series 06-SD1, Class A, 1 mo. LIBOR + .28%, 0.54%, due 01/25/47
    1,450,780  
  2,228,016    
Morgan Stanley IXIS Real Estate Capital Trust, Series 06-2, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 11/25/36
    545,864  
  8,800,000    
Nationstar Home Equity Loan Trust, Series 06-B, Class AV3, 1 mo. LIBOR + .17%, 0.43%, due 09/25/36
    6,846,125  
  9,100,000    
Nomura Home Equity Loan, Inc., Series 06-HE3, Class 2A3, 1 mo. LIBOR + .15%, 0.41%, due 07/25/36
    3,576,016  
  1,505,396    
People’s Choice Home Loan Securities Trust, Series 05-4, Class 1A2, 1 mo. LIBOR + .26%, 0.52%, due 12/25/35
    866,807  
  3,074,515    
Saxon Asset Securities Trust, Series 06-3, Class A2, 1 mo. LIBOR + .11%, 0.37%, due 10/25/46
    2,813,182  
  9,100,000    
Securitized Asset-Backed Receivables LLC Trust, Series 06-HE1, Class A2C, 1 mo. LIBOR + .16%, 0.42%, due 07/25/36
    2,912,000  
  191,773    
Security National Mortgage Loan Trust, Series 06-2A, Class A1, 144A, 1 mo. LIBOR + .29%, 0.55%, due 10/25/36
    190,335  
  272,834    
SG Mortgage Securities Trust, Series 05-OPT1, Class A2, 1 mo. LIBOR + .26%, 0.52%, due 10/25/35
    252,726  

 


 

                 
  1,132,283    
Soundview Home Equity Loan Trust, Series 07-NS1, Class A1, 1 mo. LIBOR + .12%, 0.38%, due 01/25/37
    1,083,099  
  3,600,000    
Specialty Underwriting & Residential Finance, Series 06-BC3, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 06/25/37
    1,512,000  
  1,394,594    
Structured Asset Investment Loan Trust, Series 06-1, Class A3, 1 mo. LIBOR + .20%, 0.46%, due 01/25/36
    1,004,108  
  450,248    
Structured Asset Securities Corp., Series 05-S6, Class A2, 1 mo. LIBOR + .29%, 0.84%, due 11/25/35
    347,816  
       
 
     
       
Total Residential Asset-Backed Securities (United States)
    71,024,841  
       
 
     
       
 
       
       
Residential Mortgage-Backed Securities (Australian) — 1.1%
       
  1,558,144    
Crusade Global Trust, Series 06-1, Class A1, 144A, 3 mo. LIBOR + .06%, 0.47%, due 07/20/38
    1,517,727  
  3,916,128    
Interstar Millennium Trust, Series 04-2G, Class A, 3 mo. LIBOR + .20%, 0.74%, due 03/14/36
    3,601,506  
  1,660,673    
Interstar Millennium Trust, Series 05-1G, Class A, 3 mo. LIBOR + .12%, 0.74%, due 12/08/36
    1,477,999  
  964,587    
Medallion Trust, Series 05-1G, Class A1, 3 mo. LIBOR + .08%, 0.52%, due 05/10/36
    930,038  
  2,308,680    
Puma Finance Ltd., Series G5, Class A1, 144A, 3 mo. LIBOR + .07%, 0.55%, due 02/21/38
    2,112,673  
       
 
     
       
Total Residential Mortgage-Backed Securities (Australian)
    9,639,943  
       
 
     
       
 
       
       
Residential Mortgage-Backed Securities (European) — 2.8%
       
  6,414,736    
Aire Valley Mortgages, Series 06-1A, Class 1A, 144A, 3 mo. LIBOR + .11%, 0.46%, due 09/20/66
    5,260,084  
  4,019,671    
Brunel Residential Mortgages, Series 07-1A, Class A4C, 144A, 3 mo. LIBOR + .10%, 0.50%, due 01/13/39
    3,561,348  
  2,439,169    
Granite Master Issuer Plc, Series 06-3, Class A3, 1 mo. LIBOR + .04%, 0.29%, due 12/20/54
    2,329,406  
  4,002,519    
Kildare Securities Ltd., Series 07-1A, Class A2, 144A, 3 mo. LIBOR + .06%, 0.40%, due 12/10/43
    3,562,242  
  2,760,018    
Paragon Mortgages Plc, Series 12A, Class A2C, 144A, 3 mo. LIBOR + .22%, 0.68%, due 11/15/38
    2,044,207  
  2,510,759    
Paragon Mortgages Plc, Series 14A, Class A2C, 144A, 3 mo. LIBOR + .10%, 0.45%, due 09/15/39
    1,876,290  
  2,700,000    
Permanent Master Issuer Plc, Series 06-1, Class 5A, 3 mo. LIBOR + .11%, 0.51%, due 07/15/33
    2,673,810  
  2,250,000    
Permanent Master Issuer Plc, Series 07-1, Class 4A, 3 mo. LIBOR + .08%, 0.48%, due 10/15/33
    2,238,525  
       
 
     
       
Total Residential Mortgage-Backed Securities (European)
    23,545,912  
       
 
     
       
 
       
       
Student Loans — 0.4%
       
  3,100,000    
College Loan Corp. Trust, Series 07-2, Class A1, 3 mo. LIBOR + .25%, 0.67%, due 01/25/24
    3,022,500  
  67,580    
National Collegiate Student Loan Trust, Series 06-1, Class A2, 1 mo. LIBOR + .14%, 0.40%, due 08/25/23
    65,553  
       
 
     
       
Total Student Loans
    3,088,053  
       
 
     
       
Total Asset-Backed Securities
    215,273,615  
       
 
     
       
 
       
       
Foreign Government Obligations — 5.7%
       
  GBP 25,000,000    
U.K. Treasury Bond, 4.25%, due 12/07/46(a)
    48,569,241  
       
 
     
       
 
       
       
U.S. Government — 65.6%
       
  270,291,005    
U.S. Treasury Inflation Indexed Note, 2.00%, due 04/15/12(b)(c)
    271,198,912  
  150,000,000    
U.S. Treasury Note, 1.38%, due 01/15/13
    152,009,700  
  65,000,000    
U.S. Treasury Strip Coupon, due 05/15/22
    50,760,450  
  105,000,000    
U.S. Treasury Strip Coupon, due 08/15/22
    81,101,370  
       
 
     
       
Total U.S. Government
    555,070,432  
       
 
     
       
 
       
       
U.S. Government Agency — 0.1%
       
  800,000    
U.S. Department of Transportation, 144A, 6.00%, due 12/07/21
    877,624  
       
 
     
       
TOTAL DEBT OBLIGATIONS (COST $898,341,982)
    819,790,912  
       
 
     

 


 

                 
Principal Amount     Description   Value ($)  
 
       
OPTIONS PURCHASED — 1.8%
       
       
 
       
       
Currency Options — 0.1%
       
EUR 3,000,000    
EUR Call/CHF Put Expires 06/16/15, Strike 1.56 (OTC) (CP — JPMorgan Chase Bank, N.A.)
    829,540  
       
 
     
       
Total Currency Options
    829,540  
       
 
     
       
 
       
       
Options on Interest Rate Swaps — 1.7%
       
USD  64,000,000    
Swaption Straddle Expires 04/10/18, Strike TBD Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of 64,000,000 USD in which it will pay 3 month USD LIBOR and will receive a rate to be determined, maturing on April 12, 2023, (OTC) (CP — Morgan Stanley Capital Services, Inc.) (d)
    4,924,672  
USD 64,000,000    
Swaption Straddle Expires 04/23/18, Strike TBD Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of 64,000,000 USD in which it will pay 3 month USD LIBOR and will receive a rate to be determined, maturing on April 25, 2023, (OTC) (CP — Morgan Stanley Capital Services, Inc.) (d)
    4,910,208  
USD 64,000,000    
Swaption Straddle Expires 05/01/18, Strike TBD Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of 64,000,000 USD in which it will pay 3 month USD LIBOR and will receive a rate to be determined, maturing on May 3, 2023, (OTC) (CP — Morgan Stanley Capital Services, Inc.) (d)
    4,896,704  
       
 
     
       
Total Options on Interest Rate Swaps
    14,731,584  
       
 
     
       
TOTAL OPTIONS PURCHASED (COST $10,543,550)
    15,561,124  
       
 
     
                 
Shares     Description   Value ($)  
 
       
SHORT-TERM INVESTMENTS — 9.5%
       
       
 
       
       
Money Market Funds — 9.5%
       
  41,799,410    
State Street Institutional Liquid Reserve Fund-Institutional Class, 0.17%(e)
    41,799,410  
  38,219,754    
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00% (f)
    38,219,754  
       
 
     
       
 
       
       
TOTAL SHORT-TERM INVESTMENTS (COST $80,019,164)
    80,019,164  
       
 
     
       
 
       
       
TOTAL INVESTMENTS — 108.2%
(Cost $988,904,696)
    915,371,200  
       
 
       
       
Other Assets and Liabilities (net) — (8.2%)
    (69,168,444 )
       
 
     
       
 
       
       
TOTAL NET ASSETS — 100.0%
  $ 846,202,756  
       
 
     

 


 

A summary of outstanding financial instruments at November 30, 2011 is as follows:
Reverse Repurchase Agreements
                 
Face Value     Description   Market Value  
 
GBP   30,810,000    
Barclays Bank PLC, 0.53% dated 11/18/11, to be repurchased on demand at face value plus accrued interest with a stated maturity date of 12/19/11.
  $ (48,347,034 )
       
 
     
       
 
       
Average balance outstanding   $ (42,189,986 )
Average interest rate     0.56 %
Maximum balance outstanding   $ (48,647,471 )
Average balance outstanding was calculated based on daily face value balances outstanding during the period that the Fund has entered into reverse repurchase agreements.
Futures Contracts
                         
                    Net Unrealized  
Number of       Expiration           Appreciation  
Contracts   Type   Date   Contract Value     (Depreciation)  
Buys
                       
6,480
  Euro Dollar 90 Day   March 2012   $ 1,610,280,000     $ 979,610  
       
 
           
Sales
                       
6,480
  Euro Dollar 90 Day   March 2013   $ 1,608,984,000     $ (2,053,550 )
       
 
           

 


 

GMO World Opportunity Overlay Fund
(A Series of GMO Trust)
Schedule of Investments — (Continued)
November 30, 2011 (Unaudited)
Written Options
A summary of open written option contracts for the Fund at November 30, 2011 is as follows:
                                             
Principal                          
Amount     Expiration Date     Description     Premiums     Market Value  
Call     3,000,000     6/14/2013   EUR Call/CHF Put, Strike 1.56%   $ (1,097,998 )   $ (242,168 )
 
                                       
Swap Agreements
Credit Default Swaps
                                                                     
                                                Maximum Potential     Net  
                                    Implied         Amount of Future     Unrealized  
Notional     Expiration       Receive   Annual     Credit     Reference   Payments by the Fund     Appreciation/  
Amount   Date   Counterparty   (Pay)^   Premium     Spread (1)     Entity   Under the Contract (2)   (Depreciation)  
 
  96,449,886   USD   12/20/2012   Morgan Stanley Capital Services Inc.   Receive     0.71 %     0.010 %   Reference security within CDX IG index     96,449,886     USD   $ 856,176  
 
  250,769,703   USD   12/20/2012   Morgan Stanley Capital Services Inc.   Receive     0.71 %     0.010 %   Reference security within CDX IG Index     250,769,703     USD     2,226,059  
 
  100,000,000   USD   12/20/2012   Morgan Stanley Capital Services Inc.   (Pay)     1.20 %     0.052 %   Reference security within CDX IG Index     N/A               (1,462,375 )
 
  50,000,000   USD   12/20/2012   Morgan Stanley Capital Services Inc.   (Pay)     1.93 %     0.330 %   Reference security within CDX IG index     N/A               (1,044,071 )
 
  7,000,000   USD   3/20/2013   Morgan Stanley Capital Services Inc.   Receive     0.25 %     2.053 %   MS Synthetic 2006-1     7,000,000     USD     (165,920 )
 
                                                                 
 
                                                              $ 409,869  
 
                                                                 
                                                Premiums to (Pay) Receive   $  
 
                                                                 
 
^   Receive — Fund receives premium and sells credit protection.
 
    (Pay) — Fund pays premium and buys credit protection.
 
(1)   Implied credit spreads, represented in absolute terms, utilized in determining the market value of credit default swap agreements on the reference security, as of November 30, 2011, serve as an indicator of the current status of the payment/performance risk and reflect the likelihood or risk of default for the reference entity. The implied credit spread of a particular referenced entity reflects the cost of buying/selling protection. Wider (i.e.higher) credit spreads represent a deterioration of the referenced entity’s credit soundness and a greater likelihood or risk of default or other credit event occurring as defined under the terms of the agreement.
 
(2)   The maximum potential amount the Fund could be required to pay as a seller of credit protection if a credit event occurs as defined under the terms of that particular swap agreement.

 


 

Interest Rate Swaps
                                             
                                        Net Unrealized  
Notional     Expiration       Receive               Appreciation/  
Amount   Date   Counterparty   (Pay)#   Fixed Rate     Variable Rate   (Depreciation)  
 
  1,000,000,000   CHF   8/5/2012   Credit Suisse International   Pay     0.10 %   3 Month CHF LIBOR   $ (731,706 )
 
  1,500,000,000   CHF   8/5/2012   Merrill Lynch Capital Services   Pay     0.10 %   3 Month CHF LIBOR     (1,070,636 )
 
  225,000,000   CHF   8/5/2012   Deutsche Bank AG   Pay     0.10 %   3 Month CHF LIBOR     (157,462 )
 
  250,000,000   CHF   8/5/2012   Morgan Stanley Capital Services Inc.   Pay     0.10 %   3 Month CHF LIBOR     (189,657 )
 
  12,100,000,000   JPY   12/21/2013   Bank of America   Receive     0.50 %   6 Month JPY LIBOR     322,409  
 
  157,000,000   SEK   12/21/2013   Bank of America   Pay     3.25 %   3 Month SEK STIBOR     (667,752 )
 
  153,000,000   CHF   12/21/2013   Barclays Bank PLC   Pay     1.00 %   6 Month CHF LIBOR     (3,033,750 )
 
  307,000,000   SEK   12/21/2013   Barclays Bank PLC   Pay     3.25 %   3 Month SEK STIBOR     (1,317,116 )
 
  35,000,000   GBP   12/21/2013   Barclays Bank PLC   Receive     2.00 %   6 Month GBP LIBOR     607,345  
 
  134,000,000   CAD   12/21/2013   Citibank N.A.   Pay     2.00 %   3 Month CAD BA’S     (2,269,134 )
 
  2,200,000,000   JPY   12/21/2013   Citibank N.A.   Pay     0.50 %   6 Month JPY LIBOR     (58,620 )
 
  943,000,000   SEK   12/21/2013   Citibank N.A.   Receive     3.25 %   3 Month SEK STIBOR     4,045,736  
 
  141,000,000   CHF   12/21/2013   Credit Suisse International   Receive     1.00 %   6 Month CHF LIBOR     2,795,809  
 
  281,000,000   CAD   12/21/2013   Deutsche Bank AG   Pay     2.00 %   3 Month CAD BA’S     (4,758,407 )
 
  93,000,000   CHF   12/21/2013   Deutsche Bank AG   Pay     1.00 %   6 Month CHF LIBOR     (1,844,044 )
 
  76,000,000   GBP   12/21/2013   Deutsche Bank AG   Receive     2.00 %   6 Month GBP LIBOR     1,318,806  
 
  1,923,000,000   SEK   12/21/2013   Deutsche Bank AG   Pay     3.25 %   3 Month SEK STIBOR     (8,250,212 )
 
  184,000,000   CAD   12/21/2013   Goldman Sachs International   Pay     2.00 %   3 Month CAD BA’S     (3,115,825 )
 
  172,000,000   GBP   12/21/2013   Goldman Sachs International   Receive     2.00 %   6 Month GBP LIBOR     2,984,667  
 
  25,300,000,000   JPY   12/21/2013   Goldman Sachs International   Receive     0.50 %   6 Month JPY LIBOR     674,127  
 
  152,000,000   CAD   12/21/2013   JPMorgan Chase Bank, N.A.   Pay     2.00 %   3 Month CAD BA’S     (2,573,943 )
 
  109,000,000   CAD   12/21/2013   Merrill Lynch Capital Service   Receive     2.00 %   3 Month CAD BA’S     1,845,788  
 
  9,000,000   CHF   12/21/2013   Merrill Lynch Capital Services   Receive     1.00 %   6 Month CHF LIBOR     178,456  
 
  19,500,000   GBP   12/21/2013   Merrill Lynch Capital Services   Pay     2.00 %   6 Month GBP LIBOR     (338,378 )
 
  27,100,000,000   JPY   12/21/2013   Merrill Lynch Capital Services   Receive     0.50 %   6 Month JPY LIBOR     722,089  
 
  907,000,000   USD   2/10/2014   Deutsche Bank AG   Pay     0.68 %   3 Month USD LIBOR     306,660  

 


 

                                             
 
  79,000,000   AUD   6/20/2014   Citibank N.A.   Pay     3.75 %   3 Month AUD BBSW     126,006  
 
  107,000,000   EUR   6/20/2014   Deutsche Bank AG   Receive     1.50 %   6 Month EURIBOR     161,806  
 
  313,000,000   USD   6/20/2014   Deutsche Bank AG   Pay     1.00 %   3 Month USD LIBOR     (1,449,777 )
 
  378,000,000   USD   2/10/2017   Deutsche Bank AG   Receive     1.72 %   3 Month USD LIBOR     5,979,275  
 
  2,500,000,000   JPY   12/21/2021   Bank of America   Pay     1.50 %   6 Month JPY LIBOR     (1,268,452 )
 
  13,000,000   SEK   12/21/2021   Bank of America   Receive     3.75 %   3 Month SEK STIBOR     231,483  
 
  7,000,000   SEK   12/21/2021   Barclays Bank PLC   Receive     3.75 %   3 Month SEK STIBOR     124,645  
 
  6,000,000   GBP   12/21/2021   Barclays Bank PLC   Pay     3.75 %   6 Month GBP LIBOR     (1,027,630 )
 
  29,000,000   CAD   12/21/2021   Citibank N.A.   Receive     3.50 %   3 Month CAD BA’S     2,876,146  
 
  32,000,000   CHF   12/21/2021   Barclays Bank PLC   Receive     2.25 %   6 Month CHF LIBOR     2,837,505  
 
  31,000,000   CHF   12/21/2021   Credit Suisse International   Pay     2.25 %   6 Month CHF LIBOR     (2,748,833 )
 
  700,000,000   JPY   12/21/2021   Citibank N.A.   Receive     1.50 %   6 Month JPY LIBOR     355,167  
 
  220,000,000   SEK   12/21/2021   Citibank N.A.   Pay     3.75 %   3 Month SEK STIBOR     (3,917,409 )
 
  63,000,000   CAD   12/21/2021   Deutsche Bank AG   Receive     3.50 %   3 Month CAD BA'S     6,248,180  
 
  18,000,000   CHF   12/21/2021   Deutsche Bank AG   Receive     2.25 %   6 Month CHF LIBOR     1,596,096  
 
  17,000,000   GBP   12/21/2021   Deutsche Bank AG   Pay     3.75 %   6 Month GBP LIBOR     (2,911,617 )
 
  418,000,000   SEK   12/21/2021   Deutsche Bank AG   Receive     3.75 %   3 Month SEK STIBOR     7,443,077  
 
  34,000,000   CAD   12/21/2021   Goldman Sachs International   Receive     3.50 %   3 Month CAD BA'S     3,372,033  
 
  38,000,000   GBP   12/21/2021   Goldman Sachs International   Pay     3.75 %   6 Month GBP LIBOR     (6,508,321 )
 
  5,200,000,000   JPY   12/21/2021   Goldman Sachs International   Pay     1.50 %   6 Month JPY LIBOR     (2,638,381 )
 
  33,500,000   CAD   12/21/2021   JPMorgan Chase Bank, N.A.   Receive     3.50 %   3 Month CAD BA’S     3,322,445  
 
  24,000,000   CAD   12/21/2021   Merrill Lynch Capital Service   Pay     3.50 %   6 Month CAD BA’S     (2,380,259 )
 
  2,000,000   CHF   12/21/2021   Merrill Lynch Capital Services   Pay     2.25 %   6 Month CHF LIBOR     (177,344 )
 
  11,000,000   GBP   12/21/2021   Merrill Lynch Capital Services   Receive     3.75 %   6 Month GBP LIBOR     1,883,988  
 
  5,600,000,000   JPY   12/21/2021   Merrill Lynch Capital Services   Pay     1.50 %   6 Month JPY LIBOR     (2,841,333 )
 
  65,000,000   USD   5/15/2022   JPMorgan Chase Bank N.A.   Pay     0.00 %   3 Month USD LIBOR     (14,786,717 )
 
  19,000,000   AUD   6/20/2022   Citibank N.A.   Receive     4.75 %   6 Month AUD BBSW     (174,038 )
 
  24,000,000   EUR   6/20/2022   Deutsche Bank AG   Pay     3.00 %   6 Month EURIBOR     (391,281 )
 
  68,000,000   USD   6/20/2022   Deutsche Bank AG   Receive     2.25 %   3 Month USD LIBOR     (725,607 )
 
  105,000,000   USD   8/15/2022   JPMorgan Chase Bank N.A.   Pay     0.00 %   3 Month USD LIBOR     (23,768,362 )

 


 

                                             
 
  25,000,000   GBP   12/7/2046   Merrill Lynch Capital Services   Pay     4.36 %   6 month GBP LIBOR     (11,369,019 )
 
                                         
 
                                      $ (57,101,278 )
 
                                         
 
                                  Premiums to (Pay) Receive   $ 26,197,588  
 
                                         
 
#   Receive — Fund receives fixed rate and pays variable rate.
(Pay) — Fund pays fixed rate and receives variable rate.
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
Notes to Schedule of Investments:
144A — Securities exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional investors.
AMBAC — Insured as to the payment of principal and interest by AMBAC Assurance Corporation.
BBSW — Bank Bill Swap Reference Rate
CAD BA — Canadian Brokers Acceptance Rate
CDO — Collateralized Debt Obligation
CHF LIBOR — London Interbank Offered Rate denominated in Swiss Franc.
CMBS — Commercial Mortgage Backed Security
CP — Counterparty
EURIBOR — Euro Interbank Offered Rate
FGIC — Insured as to the payment of principal and interest by Financial Guaranty Insurance Corporation.
FSA — Insured as to the payment of principal and interest by Financial Security Assurance.
GBP LIBOR — London Interbank Offered Rate denominated in British Pounds.
JPY LIBOR — London Interbank Offered Rate denominated in Japanese Yen
LIBOR — London Interbank Offered Rate
MBIA — Insured as to the payment of principal and interest by MBIA Insurance Corp.
OTC — Over-the-Counter
SEK STIBOR — Stockholm Interbank Offered Rate denominated in Swedish Krona.
USD LIBOR — London Interbank Offered Rate denominated in United States Dollars.
XL — Insured as to the payment of principal and interest by XL Capital Assurance.
The rates shown on variable rate notes are the current interest rates at November 30, 2011, which are subject to change based on the terms of the security.
 
  These securities are primarily backed by subprime mortgages.
 
(a)   All or a portion of this security has been pledged to cover collateral requirements on reverse repurchase agreements.
 
(b)   Indexed security in which price and/or coupon is linked to the prices of a specific instrument or financial statistic.
 
(c)   All or a portion of this security has been pledged to cover margin requirements on futures contracts, collateral on swap contracts, forward currency contracts, and/or written options, if any.
 
(d)   Security valued at fair value using methods determined by or at the direction of the Trustees of GMO Trust.
 
(e)   Rate disclosed, the 7 day net yield, is as of November 30, 2011.
 
(f)   Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.
Currency Abbreviations:
AUD — Australian Dollar

CAD — Canadian Dollar

CHF — Swiss Franc

EUR — Euro

GBP — British Pound

JPY — Japanese Yen

SEK — Swedish Krona

 


 

USD — United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
                             
    Gross   Gross   Net Unrealized    
    Unrealized   Unrealized   Appreciation    
Aggregate Cost   Appreciation   (Depreciation)   (Depreciation)    
$ 988,904,696     $ 42,849,889       $ (116,383,385 )     $ (73,533,496 )    

 


 

Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Schedule of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price as of the close of regular trading on the New York Stock Exchange (“NYSE”) or, (iii) if there is no such reported sale or official closing price (or in the event the Manager deems the over-the-counter (“OTC”) market to be a better indicator of market value), at the most recent quoted price. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuer’s creditworthiness has become impaired), which approximates market value. Shares of open-end investment companies are generally valued at their net asset value. Derivatives and other securities for which quotations are not readily available or whose values the Manager has determined to be unreliable are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the securities might reasonably expect to receive upon their current sale, because of the uncertainty inherent in fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. As of November 30, 2011, the total value of securities held directly that were fair valued using methods determined in good faith by or at the direction of the Trustees of the Trust represented 1.7% of net assets. For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivative contracts based on the creditworthiness of its counterparties. See “Derivative financial instruments” below for a further discussion on valuation of derivatives.
Typically the Fund values debt instruments based on the most recent quoted price supplied by a single pricing source chosen by the Manager. Although the Manager normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and may change a pricing source at any time. The Manager monitors erratic or unusual movements (including unusual inactivity) in the prices supplied for a security and has discretion to override a price supplied by a source (e.g., by taking a price supplied by another) when it believes that the price supplied is not reliable. Although alternative prices may be available for securities held by the Fund, those alternative sources are not typically part of the valuation process and do not necessarily provide greater certainty about the prices used by the Fund. As of November 30, 2011, the total value of securities held for which no alternative pricing source was available represented 3.5% of the net assets of the Fund.
“Quotation” or “quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If the pricing convention for a security does not involve a bid or an ask, “quotation” or “quoted price” may be a market quotation provided by a market participant or other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Fund’s investments. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting guidance that requires new disclosures and clarifies existing disclosure requirements about fair value measurements. Specifically, the amendment requires purchases, sales, issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 — Valuations based on quoted prices for identical securities in active markets.
Level 2 — Valuations determined using other significant direct or indirect observable inputs. These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit risk, yield curves and similar data. The Fund also used third party valuation services (which use industry models and inputs from pricing vendors) to value certain credit default swaps.
Level 3 — Valuations based primarily on inputs that are unobservable and significant. The Fund utilized a number of fair value techniques on Level 3 investments, including the following: The Fund valued certain debt securities and OTC derivatives using quoted prices. The Fund also used third party valuation services to value certain credit default swaps using unobservable inputs.

 


 

The following is a summary of the respective levels assigned to the Fund’s investments and derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Assets     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Debt Obligations
                               
Asset-Backed Securities
  $     $ 16,983,645     $ 198,289,970     $ 215,273,615  
Foreign Government Obligations
          48,569,241             48,569,241  
U.S. Government
    152,009,700       403,060,732             555,070,432  
U.S. Government Agency
          877,624             877,624  
 
                       
TOTAL DEBT OBLIGATIONS
    152,009,700       469,491,242       198,289,970       819,790,912  
 
                       
Options Purchased
          829,540       14,731,584       15,561,124  
Short-Term Investments
    80,019,164                   80,019,164  
 
                       
Total Investments
    232,028,864       470,320,782       213,021,554       915,371,200  
 
                       
Derivatives *
                               
Swap Agreements
                               
Credit Risk
          3,082,235             3,082,235  
Interest Rate Risk
          52,359,744             52,359,744  
Futures Contracts
                               
Interest Rate Risk
    979,610                   979,610  
 
                       
Total
  $ 233,008,474     $ 525,762,761     $ 213,021,554     $ 971,792,789  
 
                       
LIABILITY VALUATION INPUTS
                                 
    Quoted Prices                    
    in Active     Significant              
    Markets for     Other     Significant        
    Identical     Observable     Unobservable        
    Liabilities     Inputs     Inputs        
Description   (Level 1)     (Level 2)     (Level 3)     Total  
Derivatives*
                               
Written Options
                               
Foreign Currency Risk
  $     $ (242,168 )   $     $ (242,168 )
Swap Agreements
                               
Credit Risk
          (2,506,446 )     (165,920 )     (2,672,366 )
Interest Rate Risk
          (109,461,022 )           (109,461,022 )
Futures Contracts
                               
Interest Rate Risk
    (2,053,550 )                 (2,053,550 )
 
                       
Total
  $ (2,053,550 )   $ (112,209,636 )   $ (165,920 )   $ (114,429,106 )
 
                       
The risks referenced above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.
 
*   Because the tables above are based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives, the uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Fund’s net asset value than the uncertainties surrounding inputs for a non-derivative security with the same market value.
The aggregate net values of the Fund’s direct investments in securities and derivative financial instruments using Level 3 inputs were 25.2% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and Level 2.

 


 

The following is a reconciliation of investments and derivatives, if any, in which significant unobservable inputs (Level 3) were used in determining value:

 


 

                                                                                 
                                                                            Net Change in  
                                                                            Unrealized  
                                                                            Appreciation  
                                                                            (Depreciation)  
                                            Change in                             from  
    Balances as                     Accrued     Total     Unrealized     Transfers     Transfers     Balances as     Investments  
    of February                     Discounts/     Realized     Appreciation     into     out of     of November 30,     Still Held as of  
    28, 2011     Purchases     Sales     Premiums     Gain/(Loss)     (Depreciation)     level 3 *     level 3 *     2011     November 30, 2011  
Debt Obligations
                                                                               
Asset-Backed Securities
  $ 293,962,357     $     $ (80,059,746 )   $ 16,448     $ (178,828 )   $ (15,450,261 )   $     $     $ 198,289,970     $ (15,405,855 )
Purchased Options
    12,123,200                               2,608,384                   14,731,584       2,608,384  
Swaps
    (57,502 )           (13,319 )           13,319       (108,418 )                 (165,920 )     (108,418 )
 
                                                           
Total
  $ 306,028,055     $     $ (80,073,065 )   $ 16,448     $ (165,509 )   $ (12,950,295 )   $     $     $ 212,855,634     $ (12,905,889 )
 
                                                           
 
*   The Fund accounts for investments and derivatives transferred into Level 3 at the value at the beginning of the period and transferred out of Level 3 at the value at the end of the period.

 


 

Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE on the business day the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase the security at an agreed upon price and date. The Fund, through its custodian, takes possession of securities it acquired under the repurchase agreement. The value of the securities acquired is required by contract to be marked to market daily and additional collateral is required to be transferred so that the market value is at least equal to the amount owed to the Fund by the seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings and/or the value of the securities subject to the repurchase agreement is insufficient, the Fund’s recovery of cash from the seller may be delayed and the Fund may incur a loss equal to the difference between the cash it paid and the value of the securities. The Fund had no repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same assets at an agreed upon price and date. The Fund can use the proceeds received from entering into a reverse repurchase agreement to make additional investments, which generally causes the Fund’s portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the securities it sold and as a result would realize a loss equal to the difference between the value of those securities and the payment it received for them. The size of this loss will depend upon the difference between what the buyer paid for the securities the Fund sold to it and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of $100). In the event of a buyer’s bankruptcy or insolvency, the Fund’s use of proceeds from the sale of its securities may be restricted while the other party or its trustee or receiver determines whether to honor the Fund’s right to repurchase the securities. As of November 30, 2011, the Fund had received $48,647,471 from reverse repurchase agreements relating to securities with a market value, plus accrued interest, of $48,551,832. Reverse repurchase agreements outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income securities whose principal value is adjusted periodically according to the rate of inflation. Two structures are common. The U.S. Treasury and some other issuers use a structure that reflects inflation in the principal value of the bond. Most other issuers pay out any inflation related accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real interest rates. Real interest rates, in turn, are tied to the relationship between nominal interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e. nominal interest rate minus inflation) might decline, leading to an increase in value of inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than inflation, real interest rates might rise, leading to a decrease in value of inflation indexed bonds. There can be no assurance, however, that the value of inflation indexed bonds will be directly correlated to changes in nominal interest rates, and short term increases in inflation may lead to a decline in their value. Coupon payments received by the Fund from inflation indexed bonds are included in the Fund’s gross income for the period in which they accrue. In addition, any increase or decrease in the principal amount of an inflation indexed bond will increase or decrease taxable ordinary income to the Fund, even though principal is not paid until maturity. Inflation-indexed bonds outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
Investment and other risks
The value of the Fund’s shares changes with the value of the Fund’s investments. Many factors can affect this value, and you may lose money by investing in the Fund. The Fund is a non-diversified investment company under the Investment Company Act of 1940 (the “1940 Act”) and therefore a decline in the market value of a particular security held by the Fund may affect the Fund’s performance more than if the Fund were diversified. Selected risks of investing in the Fund are summarized below. The risks of investing in the Fund depend on the types of investments in its portfolio and the investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to additional risks because of the types of investments it makes and market conditions, which may change over time.

 


 

Market Risk — Fixed Income Securities — Typically, the value of fixed income securities will decline during periods of rising interest rates and widening of credit spreads.
 
Market Risk — Asset-Backed Securities — Asset-backed securities are subject to severe credit downgrades, illiquidity, defaults and declines in market value.
 
Credit Risk — The Fund runs the risk that the issuer or guarantor of a fixed income security or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor its obligations. The market value of a fixed income security normally will decline as a result of the issuer’s failure to meet its payment obligations or the market’s expectation of a default, which may result from the downgrading of the issuer’s credit rating. The Fund’s investments in below investment grade securities have speculative characteristics, and changes in economic conditions or other circumstances are more likely to impair the capacity of issuers to make principal and interest payments than is the case with issuers of investment grade securities.
 
Liquidity Risk — Low trading volume, lack of a market maker, a large size position or legal restrictions may limit or prevent the Fund from selling particular securities or unwinding derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more likely it is to honor a redemption request in-kind.
 
Derivatives Risk — The use of derivatives involves the risk that their value may not move as expected relative to the value of the relevant underlying assets, rates or indices. Derivatives also present other Fund risks, including market risk, liquidity risk, currency risk and counterparty risk.
 
Leveraging Risk — The Fund’s use of reverse repurchase agreements and other derivatives and securities lending may cause its portfolio to be leveraged. Leverage increases the Fund’s portfolio losses when the value of its investments decline.
 
Counterparty Risk — The Fund runs the risk that the counterparty to an OTC derivatives contract or a borrower of the Fund’s securities will be unable or unwilling to make timely settlement payments or otherwise honor its obligations. The risk of counterparty default is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions.
 
Focused Investment Risk — Focusing investments in countries, regions, sectors or companies with high positive correlations to one another, such as the Fund’s investments in asset-backed securities secured by different types of consumer debt (e.g., credit-card receivables, automobile loans and home equity loans), creates additional risk.
 
Foreign Investment Risk — The market prices of many foreign securities fluctuate more than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other income payable on foreign securities, on transactions in those securities and on the repatriation of proceeds generated from those securities. Also, many foreign markets require a license for the Fund to invest directly in those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments.
 
Management and Operational Risk — The Fund relies on GMO’s ability to achieve its investment objective by effectively implementing its investment approach. The Fund runs the risk that GMO’s proprietary investment techniques will fail to produce the desired results. The Fund’s portfolio managers may use quantitative analyses and/or models and any imperfections or limitations in such analyses and/or models could affect the ability of the portfolio managers to implement strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate and/or it may not include the most recent information about a company or a security. The Fund is also subject to the risk that deficiencies in the Manager’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.

 


 

Market Disruption and Geopolitical Risk — Geopolitical and other events may disrupt securities markets and adversely affect global economies and markets. Those events as well as other changes in foreign and domestic economic and political conditions could adversely affect the value of the Fund’s investments.
 
Large Shareholder Risk — To the extent that shares of the Fund are held by large shareholders (e.g., institutional investors, asset allocation funds, or other GMO Funds), the Fund is subject to the risk that these shareholders will disrupt the Fund’s operations by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
 
Currency Risk — Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies.
The Fund invests in asset-backed securities, which may be backed by many types of assets, including pools of residential and commercial mortgages, automobile loans, educational loans, home equity loans, or credit card receivables, which expose the Fund to additional types of market risk. They also may be backed by pools of corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds and loans (commonly referred to as “collateralized debt obligations” or “collateralized loan obligations”) and by the fees earned by service providers. Payment of interest on asset backed securities and repayment of principal largely depend on the cash flows generated by the assets backing the securities. The market risk of a particular asset-backed security depends on many factors, including the deal structure (e.g., determination as to the amount of underlying assets or other support needed to produce the cash flows necessary to service interest and make principal payments), the quality of the underlying assets and, if any, the level of credit support and the credit quality of the credit-support provider. Asset-backed securities involve risk of loss of principal if obligors of the underlying obligations default and the value of the defaulted obligations exceeds whatever credit support the securities may have. The obligations of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and other laws affecting the rights and remedies of creditors. Many asset-backed securities in which the Fund has invested are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal and/or interest will be paid because the insurer could default on its obligations. In recent years, a significant number of asset-backed security insurers have defaulted on their obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about the creditworthiness of those securities (and underlying assets) caused credit spreads (the difference between yields on the asset-backed securities and U.S. Government securities) to widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions to make markets in many fixed income securities. These events reduced liquidity and contributed to substantial declines in the value of asset-backed and other fixed income securities. There can be no assurance these conditions will not occur again. Also, government actions and proposals affecting the terms of underlying home and consumer loans, changes in demand for products (e.g., automobiles) financed by those loans, and the inability of borrowers to refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying assets and is, therefore, subject to risks associated with the negligence or defalcation of its servicer. In some circumstances, the mishandling of related documentation also may affect the rights of security holders in and to the underlying assets. The insolvency of entities that generate receivables or that utilize the assets may result in a decline in the value of the underlying assets, as well as costs and delays. The obligations underlying asset-backed securities, in particular securities backed by pools of residential and commercial mortgages, also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as high a yield as is provided by the asset-backed security. The risk of investing in asset-backed securities has increased because performance of the various sectors in which the assets underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime mortgages, and credit card receivables) has become more highly correlated since the deterioration in worldwide economic and liquidity conditions.
Among other trading agreements, the Fund is party to International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Agreements”) or other similar types of agreements with selected counterparties that generally govern over-the-counter derivative transactions entered into by the Fund. The ISDA Agreements typically include representations and warranties as well as contractual terms related to collateral, events of default, termination events, and other provisions. Termination events may include the decline in the net assets of the Fund below a certain level over a specified period of time and entitle a counterparty to elect to terminate early with respect to some or all the transactions under the ISDA Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse effect on the Fund’s operations.

 


 

Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the investment exposures of the Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and related indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other assets. In particular, the Fund may use swaps or other derivatives on an index, a single security or a basket of securities to gain investment exposures (e.g., by selling protection under a credit default swap). The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result in a reduction below zero). For example, the Fund may use credit default swaps to take a short position with respect to the likelihood of default by an issuer. The Fund also may use currency derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For instance, the Manager may alter the interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is designed to maintain the Fund’s exposure to the credit of an issuer through the debt instrument but adjust the Fund’s interest rate exposure through the swap. With these swaps, the Fund and its counterparties exchange interest rate exposure, such as fixed versus variable rates and shorter duration versus longer duration exposure. In adjusting its investment exposures, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities lending.
The Fund is not limited in the extent to which it uses derivatives or in the absolute face value of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate exposure of its assets, and its net long exposure may exceed 100% of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with the other party to the contract. If the counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its claims against the counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral (e.g., foreign currency forwards), that require collateral but that do not provide for the Fund’s security interest in it to be perfected, that require a significant upfront deposit by the Fund unrelated to the derivative’s intrinsic value, or that do not require the collateral to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are required by contract to be collateralized, there is usually a lag between the day the collateral is called for and the day the Fund receives it. When a counterparty’s obligations are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may invest in derivatives with a limited number of counterparties, and events affecting the creditworthiness of any of those counterparties may have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market disruptions, the Fund may have a greater need for cash to provide collateral for large swings in its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in “Investment and other risks” above. Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used by the Fund or their pricing agents may not produce valuations that are consistent with the values realized when OTC derivatives are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with

 


 

more standardized terms. As a result, incorrect valuations may result in increased cash payments to counterparties, undercollateralization and/or errors in the calculation of the Fund’s net asset value.
The Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the economic costs of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise reduce the Fund’s risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative to the value of the assets, rates or indices they are designed to track. The use of derivatives also may increase or accelerate the taxes payable by shareholders.
When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk that it will be required to pay the full notional value of the swap contract in the event of a default.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In addition, the Fund is not limited in the extent to which it may use derivatives or in the absolute face value of its derivative positions, and, as a result, it may be leveraged in relation to its assets (see “Leveraging Risk” above).
The U.S. government recently enacted legislation that provides for new regulation of the derivatives markets, including clearing, margin, reporting and registration requirements. Because the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations could, among other things, restrict the Fund’s ability to engage in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to the Fund) and/or increase the costs of such derivatives transactions (for example, by increasing margin or capital requirements), and the Fund may be unable to execute its investment strategy as a result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market value of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked to market daily using rates supplied by a quotation service and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose the Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. The Fund had no forward currency contracts outstanding at the end of the period.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, the Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded. The value of each of the Fund’s futures contracts is marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a closing transaction due to an illiquid market. During the period ended November 30, 2011, the Fund used futures contracts to adjust interest-rate exposure and maintain the diversity and liquidity of the portfolio. Futures contracts outstanding at the end of the period are listed in the Fund’s Schedule of Investments.

 


 

Options
The Fund may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. By purchasing options the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. The Fund pays a premium for a purchased option. That premium is disclosed in the Schedule of Investments and is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. During the period ended November 30, 2011, the Fund used purchased option contracts to adjust exposure to currencies and otherwise adjust currency exchange rate risk, as well as to enhance the diversity and liquidity of the portfolio and to adjust interest rate exposure. Option contracts purchased by the Fund and outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
The Fund may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies it owns or in which it may invest. Writing options alters the Fund’s exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating the Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When the Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that the Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. During the period ended November 30, 2011, the Fund used written option contracts to adjust exposure to currencies and otherwise adjust currency exchange rate risk, as well as to enhance the diversity and liquidity of the portfolio and to adjust interest rate exposure. Written options outstanding at the end of the period are listed in the Fund’s Schedule of Investments.
When an option contract is closed, the Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed.
For the period ended November 30, 2011, investment activity in options contracts written by the Fund was as follows:
                                                 
    Puts     Calls  
    Principal     Number             Principal     Number of        
    Amount of     of Futures             Amount of     Futures        
    Contracts     Contracts     Premiums     Contracts     Contracts     Premiums  
Outstanding, beginning of period
  $           $       (503,000,000 )         $ (1,797,998 )
Options written
                                   
Options bought back
                                   
Options expired
                      500,000,000             700,000  
 
                                   
Outstanding, end of period
  $           $       (3,000,000 )         $ (1,097,998 )
 
                                   
Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Fund generally values OTC options using inputs provided by primary pricing sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation, swaps on securities and securities indices, interest rate swaps, total return swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps and other types of

 


 

available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A liquidation payment received or made at the termination of the swap agreements is recorded as realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or future contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap agreements on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market makers and records the change in value, if any, as unrealized gain or loss. Gains or losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them may differ significantly from the values that would be realized upon termination, and the differences could be material. Entering into swap agreements involves counterparty credit, legal, and documentation risk that is generally not reflected in the models used to price the swap agreement. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. During the period ended November 30, 2011, the Fund used swap agreements to hedge against default risk, to adjust interest rate exposure, and to achieve exposure to a reference entity’s credit. Swap agreements outstanding at the end of the period are listed in the Fund’s Schedule of Investments.

 


 

Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.

 


 

The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
                                                 
    Interest rate     Foreign currency     Credit     Equity     Other        
    contracts     contracts     contracts     contracts     contracts     Total  
Assets:
                                               
Investments, at value (purchased options, rights and/or warrants)
  $ 14,731,584     $ 829,540     $     $     $     $ 15,561,124  
Unrealized appreciation on futures contracts*
    979,610                               979,610  
Unrealized appreciation on swap agreements
    52,359,744             3,082,235                   55,441,979  
 
                                   
Total
  $ 68,070,938     $ 829,540     $ 3,082,235     $     $     $ 71,982,713  
 
                                   
 
                                               
Liabilities:
                                               
Written options outstanding
  $     $ (242,168 )   $     $     $     $ (242,168 )
Unrealized depreciation on futures contracts*
    (2,053,550 )                             (2,053,550 )
Unrealized depreciation on swap agreements
    (109,461,022 )           (2,672,366 )                 (112,133,388 )
 
                                   
Total
  $ (111,514,572 )   $ (242,168 )   $ (2,672,366 )   $     $     $ (114,429,106 )
 
                                   
 
*   The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of futures contracts as reported in the Schedule of Investments.
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (futures contracts), notional amounts (swap agreements), or principal amounts (options) outstanding at each month-end, was as follows for the period ended November 30, 2011:
                         
    Futures   Swap    
    Contracts   Agreements   Options
Average amount outstanding
  $ 5,195,714,653     $ 9,134,167,501     $ 300,485,432  

 


 

For additional information regarding the Fund’s Schedule of Investments, please see the Fund’s most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission’s website, www.sec.gov, or visit GMO’s website at www.gmo.com.

 


 

Item 2. Controls and Procedures.
  (a)   The registrant’s Principal Executive Officer and Principal Financial Officer have concluded as of a date within 90 days of the filing of this report, based on their evaluation of the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) that the design and operation of such procedures are effective to provide reasonable assurance that information required to be disclosed by the registrant on Form N-Q is recorded, processed, summarized, and reported within the time periods specified in the Commission’s rules and forms.
 
  (b)   There were no changes in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) that occurred during the registrant’s last fiscal quarter that has materially affected, or are reasonably likely to materially affect, the registrant’s internal control over financial reporting.
Item 3. Exhibits.
    Certifications by the Principal Executive Officer and Principal Financial Officer of the registrant as required by Rule 30a-2(a) under the Investment Company Act of 1940 are attached hereto as EX- 99.CERT.

 


 

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
       
(Registrant)   GMO Trust
 
   
By (Signature and Title):
  /s/ J.B. Kittredge
 
  J.B. Kittredge, Chief Executive Officer
 
   
Date: January 26, 2012
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
       
By (Signature and Title):
  /s/ J.B. Kittredge
 
  J.B. Kittredge, Principal Executive Officer
 
   
Date:  January 26, 2012
 
   
By (Signature and Title):
  /s/ Sheppard N. Burnett
 
  Sheppard N. Burnett, Principal Financial Officer
 
   
Date:  January 26, 2012

 

EX-99.CERT 2 b89666a1exv99wcert.htm CERTIFICATIONS exv99wcert
EX-99.CERT
CERTIFICATION PURSUANT TO RULE 30(a)-2(a) UNDER THE 1940 ACT AND SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002:
I, J.B. Kittredge, Principal Executive Officer of the registrant, certify that:
1. I have reviewed this report on Form N-Q of GMO Trust;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
             
Date:
  January 26, 2012        
 
      /s/ J.B. Kittredge
 
J.B. Kittredge, Principal Executive Officer
   

 


 

EX-99.CERT
CERTIFICATION PURSUANT TO RULE 30(a)-2(a) UNDER THE 1940 ACT AND SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002:
I, Sheppard N. Burnett, Principal Financial Officer of the registrant, certify that:
1. I have reviewed this report on Form N-Q of GMO Trust;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
             
Date:
  January 26, 2012        
 
      /s/ Sheppard N. Burnett
 
Sheppard N. Burnett, Principal Financial Officer